PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ransom, JH				Ransom, JH			Esophageal retention of loratadine plus pseudoephedrine extended-release tablets (Claritin-D 24 Hour)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Topeka Allergy & Asthma Clin, Topeka, KS USA		Ransom, JH (corresponding author), Topeka Allergy & Asthma Ctr, Fleming Pl Off Pk,1123 SW Gage Blvd, Topeka, KS 66604 USA.							BASSO L, 1997, 199729853 SCH LAB; *SCH PLOUGH INC, 1997, CLAR D 24 HOUR PACK	2	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	1				287	288		10.1016/S0091-6749(98)70397-5	http://dx.doi.org/10.1016/S0091-6749(98)70397-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YZ342	9500767	Bronze			2022-12-18	WOS:000072244800023
J	Weiss, KB				Weiss, KB			Cost implications of upper respiratory allergic diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, ILLINOIS				ASTHMA		Rush Med Coll, Rush Primary Care Inst, Ctr Hlth Sci Res, Ctr Hlth Serv Res, Chicago, IL 60612 USA	Rush University	Weiss, KB (corresponding author), Rush Med Coll, Rush Primary Care Inst, Ctr Hlth Sci Res, Ctr Hlth Serv Res, 1653 W Congress Pkwy, Chicago, IL 60612 USA.							HEADRICK L, 1994, JOINT COMM J QUAL IM, V20, P562, DOI 10.1016/S1070-3241(16)30102-X; MEMENAMIN P, 1995, CHRONIC AIRWAYS DIS, P26; Stempel DA, 1996, ARCH FAM MED, V5, P36, DOI 10.1001/archfami.5.1.36	3	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S383	S385		10.1016/S0091-6749(98)70226-X	http://dx.doi.org/10.1016/S0091-6749(98)70226-X			3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZA245	9500734				2022-12-18	WOS:000072343900010
J	Corren, J; Diaz-Sanchez, D; Reimann, J; Saxon, A; Adelman, D				Corren, J; Diaz-Sanchez, D; Reimann, J; Saxon, A; Adelman, D			Effects of anti-IgE antibody therapy on nasal reactivity to allergen and IgE synthesis in-vivo.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			436	S105	S105						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800436
J	Frederick, JM; Gill, LS; Warner, JO; Colwell, BM; Warner, JA				Frederick, JM; Gill, LS; Warner, JO; Colwell, BM; Warner, JA			Allergen avoidance in the homes of atopic asthmatic parents during pregnancy.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Southampton, Southampton SO9 5NH, Hants, England	University of Southampton			Warner, John/AAF-9587-2020						0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			111	S26	S26						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800112
J	Golding, J; Fox, DES; Lack, G				Golding, J; Fox, DES; Lack, G			Prevalence and natural history of peanut allergy in children in the UK	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			429	S103	S103						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800429
J	Gras, J; Llenas, J; Palacios, JM; Roberts, D				Gras, J; Llenas, J; Palacios, JM; Roberts, D			Ebastine, in contrast to terfenadine, does not increase the QTc interval in guinea pigs pre-treated with kefoconazole.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Almirall Prodesfarma, Res Dept, Barcelona, Spain	Almirall			Llenas, Jesus/AAQ-3569-2020						0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			1054	S254	S254						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924801050
J	Lipworth, BJ; Wilson, AM				Lipworth, BJ; Wilson, AM			24 hour adrenocortical profiles in asthmatics receiving inhaled and intra-nasal corticosteroids.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Dundee, Dept Clin Pharmacol & Resp Med, Dundee DD1 4HN, Scotland	University of Dundee									0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			34	S8	S8						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800035
J	Lundahl, J; Sehmi, R; Hayes, L; Upham, J; Howie, K; Denburg, JA				Lundahl, J; Sehmi, R; Hayes, L; Upham, J; Howie, K; Denburg, JA			Induction of eosinophilic differentiation involves selective up-regulation of beta-7 integrin.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									McMaster Univ, Hamilton, ON, Canada	McMaster University			Upham, John/F-4420-2010	Upham, John/0000-0002-0017-3433					0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			912	S219	S219						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800909
J	McLaughlin, T; Vaughan, JW; Perzanowski, M; Platts-Mills, TAE				McLaughlin, T; Vaughan, JW; Perzanowski, M; Platts-Mills, TAE			Effect of fabric pore size in blocking cat and dust mite allergen.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Asthma & Allerg Dis Ctr, Charlottesville, VA USA										0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			690	S167	S167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800690
J	Rabjohn, P; West, CM; Helm, E; Helm, R; Stanley, JS; Huang, SK; Sampson, H; Burks, AW; Bannon, GA				Rabjohn, P; West, CM; Helm, E; Helm, R; Stanley, JS; Huang, SK; Sampson, H; Burks, AW; Bannon, GA			Glycinin, a third major peanut allergen identified by soy-adsorbed serum IgE from peanut sensitive individuals.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Arkansas, Sch Med, Little Rock, AR 72204 USA; Johns Hopkins Univ, Baltimore, MD USA; Mt Sinai Hosp, New York, NY 10029 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Johns Hopkins University; Icahn School of Medicine at Mount Sinai									0	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			996	S240	S240						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800992
J	Rance, F; Kanny, G; Dutau, G; Moneret-Vautrin, DA				Rance, F; Kanny, G; Dutau, G; Moneret-Vautrin, DA			Peanut hypersensitivity: a study of 132 paediatric cases.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Serv Med D, Nancy, France; Serv Med Infantile F, Toulouse, France				Kanny, Gisèle/AHA-8910-2022						0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			367	S88	S88						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800367
J	Sicherer, SH; Burks, AW; Sampson, HA				Sicherer, SH; Burks, AW; Sampson, HA			Features of acute allergic reactions to peanut (PN and tree nuts (TN) in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Arkansas, Sch Med, Little Rock, AR USA; Mt Sinai Hosp, New York, NY 10029 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Icahn School of Medicine at Mount Sinai									0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			432	S104	S104						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800432
J	Simon, RA; Bosso, JV; Daffern, PD; Ward, B				Simon, RA; Bosso, JV; Daffern, PD; Ward, B			Prevalence of sensitivity to food/drug additives in patients with chronic idiopathic urticaria (CIUA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Scripps Clin, La Jolla, CA USA	Scripps Research Institute			Bosso, John/L-7326-2019						0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			640	S154	S155						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800640
J	Soussi-Gounni, A; Lamkhioued, B; Christodoulopoulos, P; Nutku, E; Hamid, Q				Soussi-Gounni, A; Lamkhioued, B; Christodoulopoulos, P; Nutku, E; Hamid, Q			Human neutrophils express the high affinity receptor for IgE (Fc epsilon RI).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									McGill Univ, Meakins Christie Labs, Montreal, PQ H3A 2T5, Canada; Harvard Univ, Sch Med, Boston, MA USA	McGill University; Harvard University; Harvard Medical School			LAMKHIOUED, Bouchaib/AAL-4201-2021						0	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			714	S173	S173						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800714
J	Stellato, C; Plitt, JR; Bickel, CA; White, J; Schleimer, RP				Stellato, C; Plitt, JR; Bickel, CA; White, J; Schleimer, RP			Differential regulation of epithelial-derived C-C chemokines by cytokines and budesonide.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; SmithKline Beecham, King Of Prussia, PA USA	Johns Hopkins University; Johns Hopkins Medicine; GlaxoSmithKline			Stellato, Cristiana/P-3001-2015	Stellato, Cristiana/0000-0002-1294-8355					0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			954	S230	S230						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800951
J	Swanson, MC; Caldas, EF; Soriano, JB; Maranon, F; Morell, F; Reed, CE				Swanson, MC; Caldas, EF; Soriano, JB; Maranon, F; Morell, F; Reed, CE			Immunoassay validation for quantification of low molecular mass asthmagenic glycoproteins associated with airborne soybean dust.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Hosp Vall Hebron, Barcelona, Spain; IMIM, Barcelona, Spain; LETI SA, Madrid, Spain; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Hospital Universitari Vall d'Hebron; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Mayo Clinic									0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			546	S131	S131						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800546
J	Weinstein, A; Sheslow, D; Wasserman, P; de Lancey, E; Miller, M; Wilmington, DE				Weinstein, A; Sheslow, D; Wasserman, P; de Lancey, E; Miller, M; Wilmington, DE			Outpatient (OUT) vs inpatient (IN) rehabilitation (Rehab) for severe asthmatic children (SAC): Morbidity and economic outcomes.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			730	S178	S178						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800730
J	Yamamoto, H; Sedgwick, JB; Busse, WW				Yamamoto, H; Sedgwick, JB; Busse, WW			Differential regulation of eosinophil (EOS) adhesion and transmigration by human pulmonary microvascular endothelial cells (HPMEC).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison									0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			225	S52	S52						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800226
J	Yasuda, Y; Nishijima, I; Watanabe, S; Arai, K				Yasuda, Y; Nishijima, I; Watanabe, S; Arai, K			Thymocyte proliferation and differentiation in human granulocyte-macrophage colony-stimulating factor receptor transgenic mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology	JUL 06, 1996	TOKYO, JAPAN	Novartis Pharma KK, Tokyo, Japan		GM-CSF receptor; transgenic mice; receptor expression; thymocyte proliferation; thymocyte differentiation; fetal thymic organ culture	GM-CSF RECEPTOR; THYMUS ORGAN-CULTURE; T-CELL DEVELOPMENT; INTERLEUKIN-3 RECEPTOR; ADULT MICE; ALPHA-BETA; EXPRESSION; RECONSTITUTION; CLONING; SUBUNIT	Thymocytes display varying responses to cytokines depending on their stage of differentiation. Whether these responses are due to stage-specific cytokine receptor expression or to downstream signaling mechanisms is unknown. We examined the relationship between receptor expression and thymocyte proliferation or differentiation by using thymocytes from transgenic mice that constitutively expressed the human granulocyte-macrophage colony stimulating factor (hGM-CSF) receptor. Transgenic CD4(-)CD8(-), CD4(+)CD8(-), and CD4(-)CD8(+) thymocyte populations expressing the hGM-CSF receptor proliferated when cultured with hGM-CSF, whereas CD4(+)CD8(+) cells failed to proliferate despite expressing this receptor. We next examined the effect of hGM-CSF receptor signaling on thymocyte differentiation in fetal thymic organ culture supporting a full program of T cell development in vitro. Addition of hGM-CSF to the transgenic fetal thymic organ culture resulted in failure of CD4(-)CD8(-) cells to differentiate into CD4(+)CD8(+) cells. To investigate this maturational inhibition more closely, we repopulated mild-type fetal lobes with sorted pro-T, pre-T or post pre-T precursor cells from hGM-CSF receptor transgenic mice. In these cultures hGM-CSP blocked both pro-T and pre-T cell differentiation, whereas the more mature post pre-T cells differentiated normally. These results suggest that hGM-CSF receptor signaling during thymocyte differentiation causes stage-specific inhibition of precursor cell maturation. In addition, repopulation studies of transgenic fetal lobes with sorted wild-type thymocyte precursors indicated that hGM-CSP inhibited proliferation and differentiation of the wild-type precursors, suggesting a secondary effect via transgenic stromal cells.	Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, Tokyo 108, Japan	University of Tokyo	Arai, K (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.							FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KINGSTON R, 1985, NATURE, V317, P811, DOI 10.1038/317811a0; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; KITAMURA T, 1992, BLOOD, V80, P84; LESLEY J, 1990, CELL IMMUNOL, V128, P63, DOI 10.1016/0008-8749(90)90007-E; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; METCALF D, 1986, BLOOD, V68, P46; METCALF D, 1987, EXP HEMATOL, V15, P1; MIYAJIMA A, 1993, BLOOD, V82, P1960; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NISHIJIMA I, 1995, MOL BIOL CELL, V6, P497, DOI 10.1091/mbc.6.5.497; Nishijima I, 1997, BLOOD, V90, P1031, DOI 10.1182/blood.V90.3.1031.1031_1031_1038; PALACIOS R, 1992, DEVELOPMENT, V115, P1133; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PENIT C, 1995, J IMMUNOL, V154, P5103; PLUM J, 1990, J IMMUNOL, V145, P1066; PLUM J, 1993, J IMMUNOL, V150, P2706; PLUM J, 1995, J IMMUNOL, V154, P5789; RENARD V, 1995, P NATL ACAD SCI USA, V92, P7545, DOI 10.1073/pnas.92.16.7545; SUDA T, 1991, J IMMUNOL, V146, P3068; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; WATANABE S, 1993, MOL CELL BIOL, V13, P1440, DOI 10.1128/MCB.13.3.1440; Yasuda Y, 1997, BLOOD, V89, P1349, DOI 10.1182/blood.V89.4.1349; ZLOTNIK A, 1995, CURR OPIN IMMUNOL, V7, P206, DOI 10.1016/0952-7915(95)80005-0	32	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1997	100	6	2	S			S87	S96		10.1016/S0091-6749(97)70012-5	http://dx.doi.org/10.1016/S0091-6749(97)70012-5			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	YR026	9440552				2022-12-18	WOS:000071449600012
J	Takami, A; Asakura, H; Yamazaki, H; Mizuhashi, K; Matsuda, T; Mizushima, N				Takami, A; Asakura, H; Yamazaki, H; Mizuhashi, K; Matsuda, T; Mizushima, N			Pneumonitis and eosinophilia induced by ethambutol	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									KANAZAWA WAKAMATSU NATL SANITARIUM,DEPT MED,KANAZAWA,ISHIKAWA,JAPAN		Takami, A (corresponding author), KANAZAWA UNIV,SCH MED,DEPT MED 3,13-1 TAKARAMACHI,KANAZAWA,ISHIKAWA 920,JAPAN.		Takami, Akiyoshi/O-5677-2019	Takami, Akiyoshi/0000-0002-1822-9976				DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; GIRLING DJ, 1982, DRUGS, V23, P56, DOI 10.2165/00003495-198223010-00003; LEES A W, 1971, Tubercle, V52, P182, DOI 10.1016/0041-3879(71)90041-9; SNAVELY SR, 1984, ANN INTERN MED, V101, P92, DOI 10.7326/0003-4819-101-1-92; WONG CF, 1994, CHEST, V106, P1638, DOI 10.1378/chest.106.5.1638	5	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1997	100	5					712	713		10.1016/S0091-6749(97)70178-7	http://dx.doi.org/10.1016/S0091-6749(97)70178-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YG202	9389304				2022-12-18	WOS:A1997YG20200021
J	Armentia, A; Vega, JM				Armentia, A; Vega, JM			Allergy syndrome after ingestion of salami	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Armentia, A (corresponding author), HOSP RIO HORTEGA,SECC ALERGIA,CARDENAL TORQUEMADA SN,VALLADOLID 47010,SPAIN.		Armentia, Alicia/GLS-3358-2022					Armentia A, 1996, ALLERGY, V51, P137, DOI 10.1111/j.1398-9995.1996.tb04575.x; Armentia A, 1994, Allergol Immunopathol (Madr), V22, P152; ARMENTIA A, 1992, ANN ALLERGY, V68, P398; Liccardi G, 1996, J ALLERGY CLIN IMMUN, V98, P850, DOI 10.1016/S0091-6749(96)70139-2	4	4	4	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1997	100	1					142	143						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XP428	9257802				2022-12-18	WOS:A1997XP42800024
J	Graft, DF				Graft, DF			Discontinuing venom immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Graft, DF (corresponding author), PK NICOLLET CLIN,DEPT ALLERGY,3800 PK NICOLLET BLVD,MINNEAPOLIS,MN 55416, USA.							GOLDEN, 1996, J ALLERGY CLIN IMMUN, V97, P579	1	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1997	99	2					271	271						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH831	9042064				2022-12-18	WOS:A1997WH83100030
J	Alenius, H; Mikkola, J; Turjanmaa, K; Reunala, T; Palosuo, T				Alenius, H; Mikkola, J; Turjanmaa, K; Reunala, T; Palosuo, T			Chitin-binding proteins in natural rubber latex (NRL) and in several plants contain cross-reacting IgE-binding epitopes.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV HELSINKI,NATL PUBL HLTH INST,INST OCCUPAT HLTH,DEPT DERMATOL,FIN-00014 HELSINKI,FINLAND; UNIV TAMPERE,DEPT DERMATOL,FIN-33101 TAMPERE,FINLAND	Finland National Institute for Health & Welfare; University of Helsinki; Tampere University				Alenius, Harri/0000-0003-0106-8923					0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			2036	2036						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14202030
J	Berkowitz, RB; Nolop, KB; MesarinaWicki, BE				Berkowitz, RB; Nolop, KB; MesarinaWicki, BE			Onset of action of mometasone furoate (Nasonex(TM)) nasal spray in seasonal allergic rhinitis.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1790	1790						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201784
J	Burger, RA; Torres, AR; Warren, RP; Huges, BG				Burger, RA; Torres, AR; Warren, RP; Huges, BG			Echinacea purpurea induced cytokine production in human peripheral blood adherent mononuclear cells (PBAC).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									PLANT BIOACT RES INST,OREM,UT										0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1153	1153						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201150
J	Cheng, CC; Baroody, FM; Reed, KD; Cook, C; Rogenes, P; Sengupta, E; Togias, AG; Naclerio, RM				Cheng, CC; Baroody, FM; Reed, KD; Cook, C; Rogenes, P; Sengupta, E; Togias, AG; Naclerio, RM			Effects of one year treatment with fluticasone propionate aqueous nasal spray (FPANS) and terfenadine (TER) on the nasal mucosa .1. A safety study using electron and light microscopy.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV CHICAGO,CHICAGO,IL 60637; JOHNS HOPKINS UNIV,BALTIMORE,MD; GLAXO WELLCOME INC,RES TRIANGLE PK,NC 27709	University of Chicago; Johns Hopkins University; GlaxoSmithKline									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			2013	2013						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14202007
J	Goodwin, B; Bowers, B; Hampel, F; Cook, C; Westlund, R; Fox, F				Goodwin, B; Bowers, B; Hampel, F; Cook, C; Westlund, R; Fox, F			Superior improvement in disease-specific quality of life for SAR patients receiving intranasal fluticasone vs loratadine tablets.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									CENT TEXAS HLTH RES,NEW BRAUNFELS,TX; GLAXO WELLCOME INC,RES TRIANGLE PK,NC 27709	GlaxoSmithKline									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1100	1100						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201097
J	Juliusson, S; Jakobinudottir, S; Runarsdottir, V; Blondal, T; Gislason, D; Bjornsdottir, US				Juliusson, S; Jakobinudottir, S; Runarsdottir, V; Blondal, T; Gislason, D; Bjornsdottir, US			Environmental control (EC) can effectively reduce cat allergen (Fel d I) in house dust samples without removal of the cat.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV HOSP,REYKJAVIK,ICELAND	Landspitali National University Hospital									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1583	1583						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201579
J	Kemp, JP; Dockhorn, RJ; Shapiro, GG; Nguyen, HH; Guerreiro, DA; Reiss, TF; Friedman, BS; Knorr, BA				Kemp, JP; Dockhorn, RJ; Shapiro, GG; Nguyen, HH; Guerreiro, DA; Reiss, TF; Friedman, BS; Knorr, BA			Montelukast, a leukotriene receptor antagonist, inhibits exercise-induced bronchoconstriction in 6- to- 14- year old children.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									AAMGRC,SAN DIEGO,CA; IMTC INC,PRAIRIE VILLAGE,KS; ASTHMA INC,SEATTLE,WA; MERCK & CO INC,RAHWAY,NJ 07065	Merck & Company									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1314	1314						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201309
J	Naas, FM; Simons, FER; Simons, KJ				Naas, FM; Simons, FER; Simons, KJ			The effect of the coadministration of the H-2-receptor antagonist (H(2)RA) ranitidine (R) on the pharmacokinetics (PK) and pharmacodynamics (PD) of the N-1-receptor antagonist (H(1)RA) hydroxyzine (H).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV MANITOBA,WINNIPEG,MB,CANADA	University of Manitoba									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1940	1940						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201934
J	Shin, D; Sampson, HA; Huang, SK; Compadre, C; Burks, AW; Bannon, GA				Shin, D; Sampson, HA; Huang, SK; Compadre, C; Burks, AW; Bannon, GA			Characterization of a major peanut allergen: Mutational analysis of the Ara h 1 IgE binding epitopes.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV ARKANSAS,SCH MED,LITTLE ROCK,AR 72204; JOHNS HOPKINS UNIV,BALTIMORE,MD	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Johns Hopkins University									0	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			570	570						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14200568
J	Toru, H; Ra, C; Nonoyama, S; Suzuki, K; Yata, J; Nakahata, T				Toru, H; Ra, C; Nonoyama, S; Suzuki, K; Yata, J; Nakahata, T			Induction of high affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV TOKYO,INST MED SCI,TOKYO,JAPAN; JUNTENDO UNIV,SCH MED,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,TOKYO 113,JAPAN	University of Tokyo; Juntendo University; Tokyo Medical & Dental University (TMDU)									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			420	420						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14200418
J	Yanagihara, Y; Basaki, Y; Ikizawa, K; Kajiwara, K; Koshio, T; Akiyama, K				Yanagihara, Y; Basaki, Y; Ikizawa, K; Kajiwara, K; Koshio, T; Akiyama, K			Involvement of nuclear factor-kappa B activation in IgE synthesis in human B cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL-4; CD40; nuclear factor-kappa B; n-acetyl-L-cysteine; germline C epsilon transcription; mature C epsilon transcription	INTERLEUKIN-4-INDUCED TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; SELECTIVE INHIBITOR; MYELOID CELLS; IL-4 RECEPTOR; KINASE; CD40; PHOSPHORYLATION; EPSILON	Nuclear factor-kappa B (NF-kappa B) is a transcription factor that binds to the consensus DNA sequence in the cis-acting elements of various genes. Although NF-kappa B activates the expression of many genes involved in immune and inflammatory responses, little is known about the role of NF-kappa B activation in the induction of IgE synthesis in human B cells. therefore we first examined the participation of NF-kappa B in germline C epsilon transcription in a human Burkitt lymphoma B cell line, DND39. Stimulation of DND39 cells with IL-4 or anti-CD40 monoclonal antibody (mAb) activated phosphatidylinositol 3-kinase and subsequently induced nuclear expression of NF-kappa B, which was identified by electrophoretic mobility shift assays. n-Acetyl-L-cysteine (NAC), a potent antioxidant, blocked NF-kappa B activation caused by IL-4 and by anti-CD40 mAb. Although inhibition of IL-4-driven germline C epsilon transcription by NAC was not sufficient, the agent remarkably diminished anti-CD40 mAb-mediated up-regulation of germline C epsilon transcription. Second, we studied the effect of NAC on IgE synthesis in human normal B cells costimulated with IL-4 and anti-CD40 mAb. NAC was effective in inhibiting mature C epsilon transcription and IgE synthesis in the T cell-independent culture system. However, NAC did not significantly affect the spontaneous production of IgE by atopic B cells. These results indicate that NF-kappa B activity is commonly inducible in DND39 cells by IL-4 and anti-CD40 mAb and suggest that NF-kappa B sensitive to NAC may play a role in regulating IgE synthesis in B cells.			Yanagihara, Y (corresponding author), NATL SAGAMIHARA HOSP,CLIN RES CTR ALLERGY,18-1 SAKURADAI,SAGAMIHARA,KANAGAWA 228,JAPAN.							BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; CROCE CM, 1984, LAB INVEST, V51, P258; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; FRANCIS DA, 1995, INT IMMUNOL, V7, P151, DOI 10.1093/intimm/7.2.151; FUJITA K, 1995, INT IMMUNOL, V7, P1529, DOI 10.1093/intimm/7.9.1529; GAUCHAT JF, 1992, INT IMMUNOL, V4, P397, DOI 10.1093/intimm/4.3.397; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HU MH, 1994, J BIOL CHEM, V269, P30069; Ikizawa K, 1996, CELL IMMUNOL, V170, P134, DOI 10.1006/cimm.1996.0143; IKIZAWA K, 1994, J ALLERGY CLIN IMMUN, V94, P620, DOI 10.1016/0091-6749(94)90138-4; IZUHARA K, 1993, J BIOL CHEM, V268, P13097; JEANNIN P, 1995, J EXP MED, V182, P1785, DOI 10.1084/jem.182.6.1785; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KOHLER I, 1993, EUR J IMMUNOL, V23, P3066, DOI 10.1002/eji.1830231204; LALMANACHGIRARD AC, 1993, J EXP MED, V177, P1215, DOI 10.1084/jem.177.4.1215; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NAKANISHI S, 1990, MOL PHARMACOL, V37, P482; OKADA T, 1994, J BIOL CHEM, V269, P3568; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEN R, 1986, CELL, V46, P706; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Snapper CM, 1996, J IMMUNOL, V156, P183; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; SUZUKI YJ, 1994, J IMMUNOL, V153, P5008; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; Yanagihara Y, 1995, J ALLERGY CLIN IMMUN, V96, P1145, DOI 10.1016/S0091-6749(95)70199-0; YANO H, 1993, J BIOL CHEM, V268, P25846	38	4	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	2	S			S224	S229		10.1016/S0091-6749(96)70070-2	http://dx.doi.org/10.1016/S0091-6749(96)70070-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WC447	8977531				2022-12-18	WOS:A1996WC44700008
J	Creticos, PS				Creticos, PS			Effects of nedocromil sodium on inflammation and symptoms in therapeutic studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LONG-TERM TREATMENT; BRONCHIAL-ASTHMA; BECLOMETHASONE DIPROPIONATE; DOUBLE-BLIND; FLOW-RATE; MANAGEMENT; PLACEBO; HYPERRESPONSIVENESS; MULTICENTER; TRIAL	This review cites clinical evidence demonstrating that nedocromil sodium can reverse the clinical features of airway inflammation in asthma, as shown by decreased bronchial responsiveness, decreased diurnal variation in peak expiratory flow, improved baseline lung function, and a dea ease in the frequency and severity of chronic symptoms. Clinical trials have also shown that nedocromil sodium has a statistically significant and clinically relevant effect on daytime and nighttime asthma symptoms within 3 days of starting treatment. On an analysis of relevant trials the effect on asthmatic cough was significant within 24 hours. This rapid effect on symptoms, together with a reversal of the underlying airways inflammation is a beneficial combination in the management of asthma.			Creticos, PS (corresponding author), FRANCIS SCOTT KEY MED CTR,JOHNS HOPKINS ASTHMA & ALLERGY CTR,DIV CLIN IMMUNOL & ALLERGY,BALTIMORE,MD 21224, USA.							AALBERS R, 1991, J ALLERGY CLIN IMMUN, V87, P993, DOI 10.1016/0091-6749(91)90422-K; BEL EH, 1990, AM REV RESPIR DIS, V141, P21, DOI 10.1164/ajrccm/141.1.21; BERGMANN KC, 1989, CURR MED RES OPIN, V11, P533, DOI 10.1185/03007998909110465; CALLAGHAN B, 1992, CHEST, V101, P787, DOI 10.1378/chest.101.3.787; CARRAO WM, 1979, NEW ENGL J MED, V300, P633; CHERNIACK R M, 1990, Chest, V97, P1299; CRETICOS P, 1995, J ALLERGY CLIN IMMUN, V95, P829, DOI 10.1016/S0091-6749(95)70126-5; CRIMI E, 1991, ALLERGY CLIN IMMUN S, V1, P328; DEJONG JW, 1994, AM J RESP CRIT CARE, V149, P91, DOI 10.1164/ajrccm.149.1.8111606; EDWARDS AM, 1993, EUR RESPIR J, V6, P35; FAIRFAX AJ, 1988, J INT MED RES, V16, P216, DOI 10.1177/030006058801600309; *GLOB IN ASTHM, 1995, 953659 NHLBI; GREIF J, 1989, CHEST, V96, P583, DOI 10.1378/chest.96.3.583; HARPER GD, 1990, RESP MED, V84, P463, DOI 10.1016/S0954-6111(08)80110-2; HETZEL MR, 1980, THORAX, V35, P732, DOI 10.1136/thx.35.10.732; Hosny H., 1994, European Respiratory Journal, V7, p384S; JONES PW, 1994, EUR RESPIR J, V7, P55, DOI 10.1183/09031936.94.07010055; OREFICE U, 1992, RESPIRATION, V59, P97; REBUCK AS, 1990, J ALLERGY CLIN IMMUN, V85, P612, DOI 10.1016/0091-6749(90)90101-9; RYAN G, 1982, THORAX, V37, P423, DOI 10.1136/thx.37.6.423; SCHWARTZ HJ, 1993, J ALLERGY CLIN IMMUN, V92, P204, DOI 10.1016/0091-6749(93)90110-2; SPELMAN R, 1991, BRIT J GEN PRACT, V41, P406; Stevens M. T., 1996, European Respiratory Journal Supplement, V9, p351S; SVENDSEN UG, 1991, EUR RESPIR J, V4, P992; WASSERMAN SI, 1995, J ALLERGY CLIN IMMUN, V95, P541, DOI 10.1016/S0091-6749(95)70316-0; WELLS A, 1992, RESP MED, V86, P311, DOI 10.1016/S0954-6111(06)80030-2; WILLIAMS AJ, 1986, EUR J RESPIR DIS, V69, P340	27	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S143	S149		10.1016/S0091-6749(96)80142-4	http://dx.doi.org/10.1016/S0091-6749(96)80142-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939190				2022-12-18	WOS:A1996VW14000031
J	Djukanovic, R; Davies, RJ; RodriguezRoisin, R; Laitinen, A; Fabbri, LM; Virchow, JC; Aalbers, R; Holgate, ST; Chang, KF; Wenzel, SE; Pauwels, R; Seale, JP; Calhoun, WJ; Norris, AA; Alton, EWFW				Djukanovic, R; Davies, RJ; RodriguezRoisin, R; Laitinen, A; Fabbri, LM; Virchow, JC; Aalbers, R; Holgate, ST; Chang, KF; Wenzel, SE; Pauwels, R; Seale, JP; Calhoun, WJ; Norris, AA; Alton, EWFW			Effect of regular nedocromil sodium or albuterol on bronchial inflammation in chronic asthma - Discussion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material													Fabbri, Leonardo M/I-4055-2012	Fabbri, Leonardo M/0000-0001-8894-1689					0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S64	S66						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140					2022-12-18	WOS:A1996VW14000012
J	Lebo, DB; Ditto, AM; Boxer, MB; Grammer, LC; Bonagura, VR; Roberts, M				Lebo, DB; Ditto, AM; Boxer, MB; Grammer, LC; Bonagura, VR; Roberts, M			Anaphylaxis to ackee fruit	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									LONG ISL JEWISH MED CTR,DIV ALLERGY IMMUNOL,NEW HYDE PK,NY 11042; NORTHWESTERN UNIV,SCH MED,DIV ALLERGY IMMUNOL,CHICAGO,IL	Northwell Health; Northwestern University				Bonagura, Vincent/0000-0002-0681-2099; Grammer, Leslie/0000-0001-6860-2014				ENGVALL E, 1972, J IMMUNOL, V109, P129; MELVILLE GN, 1988, W INDIAN MED J, V37, P97; Morton JF, 1990, ACTA HORTIC, V275, P401; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x	4	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	1				997	998		10.1016/S0091-6749(96)80019-4	http://dx.doi.org/10.1016/S0091-6749(96)80019-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VU764	8939166				2022-12-18	WOS:A1996VU76400019
J	Myers, AC; Riccio, MM; Undem, BJ				Myers, AC; Riccio, MM; Undem, BJ			Effect of nedocromil sodium on neurogenic mechanisms in vitro	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						afferent; airways; axon-reflex; efferent; nodose ganglia; parasympathetic ganglia; sensory nerve; vagus nerve	NODOSE GANGLION NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES	We have developed a guinea pig model that allows monitoring of single afferent nerve fiber activity after stimulation of tracheal nerve endings with various stimuli. Action potentials from nodose or jugular neurons are recorded extracellularly. Previous experiments have shown that the excitability of the nerve endings to, for example, mechanical stimuli can be increased by antigen challenge of presensitized guinea pigs. Nedocromil sodium 10(-4) mol/L significantly reduced by more than 50% the generation of action potentials in C fibers in response to stimulation by capsaicin. The precise mechanism is not known, although the membrane depolarization induced by capsaicin was reduced in the presence of nedocromil sodium. This agent did not have a generalized inhibitory effect on afferent excitability because it had no effect on sensitivity to electrical or mechanical stimuli. Nedocromil sodium did not affect the generation of action potentials in A delta and C fibers in the presence of hypertonic saline solution.			Myers, AC (corresponding author), JOHNS HOPKINS ASTHMA & ALLERGY CTR,5501 HOPKINS BAYVIEW CIRCLE,BALTIMORE,MD 21224, USA.							FOX AJ, 1993, J PHYSIOL-LONDON, V469, P21, DOI 10.1113/jphysiol.1993.sp019802; Jackson D M, 1989, Pulm Pharmacol, V2, P179, DOI 10.1016/0952-0600(89)90018-5; KUMMER W, 1992, REGUL PEPTIDES, V37, P135, DOI 10.1016/0167-0115(92)90662-E; LUNDBERG JM, 1984, CELL TISSUE RES, V235, P251; MYERS AC, 1993, J PHYSIOL-LONDON, V470, P665, DOI 10.1113/jphysiol.1993.sp019881; MYERS AC, 1995, AM J PHYSIOL-LUNG C, V268, pL879, DOI 10.1152/ajplung.1995.268.6.L879; MYERS AC, 1990, AM J PHYSIOL, V259, pL403, DOI 10.1152/ajplung.1990.259.6.L403; MYERS AC, 1991, J APPL PHYSIOL, V71, P970, DOI 10.1152/jappl.1991.71.3.970; MYERS AC, IN PRESS J AUTON NER; Riccio MM, 1996, J PHYSIOL-LONDON, V491, P499, DOI 10.1113/jphysiol.1996.sp021234; UNDEM BJ, 1993, J AUTONOM NERV SYST, V44, P35, DOI 10.1016/0165-1838(93)90376-6; UNDEM BJ, 1993, J AUTONOM NERV SYST, V44, P17, DOI 10.1016/0165-1838(93)90375-5	12	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S107	S111		10.1016/S0091-6749(96)80137-0	http://dx.doi.org/10.1016/S0091-6749(96)80137-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939185	hybrid			2022-12-18	WOS:A1996VW14000024
J	Pauwels, R				Pauwels, R			The current place of nedocromil sodium in the treatment of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; nedocromil sodium; treatment guidelines	BECLOMETHASONE DIPROPIONATE	Current guidelines for the treatment of asthma are based on the fact that asthma is an inflammatory disease and that all forms of persistent asthma, whether mild, moderate, or severe, require treatment with a controller medication to reverse or prevent the underlying inflammation. A patient can be considered to have mild persistent asthma if symptoms occur one or more times a week (but less than daily), if exacerbations are affecting activity or sleep, if nighttime symptoms occur more than twice a month, or if peak expiratory flow or FEV(1) is equal to or greater than 80% of the predicted value or has a variability of 20% to 30%. Just one of these clinical features is needed to define the condition. A patient with this condition should be treated with a controller medication that is taken daily; the physician may choose between a low dose of inhaled corticosteroid, nedocromil sodium or cromolyn sodium, or slow-release theophylline. The choice will vary depending on the physician and the type of patient being treated. Data on clinical efficacy and safety support the current position of nedocromil sodium as a primary treatment for mild persistent asthma.			Pauwels, R (corresponding author), STATE UNIV GHENT HOSP,DEPT RESP DIS,DE PINTELAAN 185,B-9000 GHENT,BELGIUM.							ARMENIO L, 1993, ARCH DIS CHILD, V68, P193, DOI 10.1136/adc.68.2.193; AUTY RM, 1989, ALLERGY ASTHMA NEW A; BEL EH, 1990, AM REV RESPIR DIS, V141, P21, DOI 10.1164/ajrccm/141.1.21; BUSSE W W, 1989, Drugs, V37, P1; CHERNIACK R M, 1990, Chest, V97, P1299; DOULL IJM, 1995, AM J RESP CRIT CARE, V151, P1715, DOI 10.1164/ajrccm.151.6.7767512; EDWARDS AM, 1993, EUR RESPIR J, V6, P35; *NAT HEART LUNG BL, 1995, 953659 NIH NAT HEART; *NAT HEART LUNG BL, 1992, 923091 NIH NAT HEART; THOMSON NC, 1989, RESP MED, V83, P269, DOI 10.1016/S0954-6111(89)80195-7	10	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S151	S155		10.1016/S0091-6749(96)80143-6	http://dx.doi.org/10.1016/S0091-6749(96)80143-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939191				2022-12-18	WOS:A1996VW14000033
J	Codina, R; FernandezCaldas, E; Trudeau, WL; Rodrigo, MJ; Morell, F; Lockey, RF				Codina, R; FernandezCaldas, E; Trudeau, WL; Rodrigo, MJ; Morell, F; Lockey, RF			Mite allergens did not cause asthma epidemics in Barcelona, Spain	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SOYBEAN-DUST		UNIV VALL HEBRON, GEN HOSP, SERV BIOQUIM, U INMUNOL, BARCELONA 08035, SPAIN; UNIV S FLORIDA, COLL MED, DEPT INTERNAL MED, DIV CLIN IMMUNOL & ALLERGY, TAMPA, FL 33620 USA; JAMES A HALEY VET HOSP, TAMPA, FL 33612 USA; HOSP GEN UNIV VALL HEBRON, SERV PNEUMOL, BARCELONA, SPAIN	Hospital Universitari Vall d'Hebron; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Hospital Universitari Vall d'Hebron				Morell Brotad, Ferran/0000-0002-7206-4543				ANTO JM, 1989, NEW ENGL J MED, V320, P1097, DOI 10.1056/NEJM198904273201701; BLAINEY AD, 1989, J ALLERGY CLIN IMMUN, V84, P296, DOI 10.1016/0091-6749(89)90411-9; CHAPMAN MD, 1987, J ALLERGY CLIN IMMUN, V80, P184, DOI 10.1016/0091-6749(87)90128-X; LLERENA LP, 1991, J ALLERGY CLIN IMMUN, V88, P943, DOI 10.1016/0091-6749(91)90252-J; RODRIGO MJ, 1990, J ALLERGY CLIN IMMUN, V85, P778, DOI 10.1016/0091-6749(90)90198-D; SILTON RP, 1991, J ALLERGY CLIN IMMUN, V88, P595, DOI 10.1016/0091-6749(91)90153-F; SUNYER J, 1989, LANCET, V1, P179; SWANSON MC, 1991, J ALLERGY CLIN IMMUN, V87, P783, DOI 10.1016/0091-6749(91)90123-6	8	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1996	98	1					236	238		10.1016/S0091-6749(96)70249-X	http://dx.doi.org/10.1016/S0091-6749(96)70249-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VA692	8765841				2022-12-18	WOS:A1996VA69200030
J	Adkinson, NF; Rich, RR; Lichtenstein, LM				Adkinson, NF; Rich, RR; Lichtenstein, LM			Justifying a mechanism-based specialty	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Discussion									BAYLOR COLL MED,DEPT FAMILY MED,HOUSTON,TX 77030; JOHNS HOPKINS MED CTR,ASTHMA ALLERGY CTR,BALTIMORE,MD	Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Adkinson, NF (corresponding author), JOHNS HOPKINS ALLERGY CTR,BALTIMORE,MD, USA.								0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1996	97	3					868	871		10.1016/S0091-6749(96)70004-0	http://dx.doi.org/10.1016/S0091-6749(96)70004-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UA975	8613648				2022-12-18	WOS:A1996UA97500024
J	Arrighi, HM; Cook, CK; Redding, GJ				Arrighi, HM; Cook, CK; Redding, GJ			The prevalence and impact of allergic rhinitis among teenagers.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				990	990						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600990
J	Chen, Z; Posch, A; RaulfHeimsoth, M; Baur, X				Chen, Z; Posch, A; RaulfHeimsoth, M; Baur, X			Isolation and identification of hevein as a major IgE-binding polypeptide in latex from Hevea brasiliensis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				982	982						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600982
J	DiPiro, JT; Howdieshell, TR; Hamilton, RG; Adkinson, F; Mansberger, AR				DiPiro, JT; Howdieshell, TR; Hamilton, RG; Adkinson, F; Mansberger, AR			Increased plasma IgE levels in patients with sepsis after traumatic injury	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXPRESSION		UNIV GEORGIA,COLL PHARM,ATHENS,GA 30602; JOHNS HOPKINS UNIV,SCH MED,CTR ASTHMA & ALLERGY,BALTIMORE,MD	University System of Georgia; University of Georgia; Johns Hopkins University	DiPiro, JT (corresponding author), MED COLL GEORGIA,DEPT SURG,FI-1087,AUGUSTA,GA 30912, USA.			DiPiro, Joseph/0000-0002-5442-0129; Howdieshell, Thomas/0000-0002-4480-4479				DIPIRO JT, 1992, ANN SURG, V215, P460, DOI 10.1097/00000658-199205000-00008; FAIST E, 1986, ARCH SURG-CHICAGO, V121, P1000; FENTON MJ, 1992, J IMMUNOL, V149, P1283; LIVINGSTON DH, 1988, ARCH SURG-CHICAGO, V123, P1309; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0	5	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	1				135	136		10.1016/S0091-6749(96)70294-4	http://dx.doi.org/10.1016/S0091-6749(96)70294-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TR947	8568128	hybrid			2022-12-18	WOS:A1996TR94700019
J	Faller, M; deBlay, F; Lett, E; Verot, A; Bessot, JC; Pauli, G; Wachsmann				Faller, M; deBlay, F; Lett, E; Verot, A; Bessot, JC; Pauli, G; Wachsmann			Measurement of Ficus benjamina antigen using polyclonal antibody sandwich ELISA.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				132	132						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600132
J	Green, R; Custovic, A; Smith, A; Chapman, MD; Woodcock, A				Green, R; Custovic, A; Smith, A; Chapman, MD; Woodcock, A			Avoidance of dog allergen can f1 with the dog in situ: Washing the dog and use of a HEPA air filter.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									WYTHENSHAWE HOSP,NW LUNG CTR,MANCHESTER M23 9LT,LANCS,ENGLAND	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital			Custovic, Adnan/A-2435-2012	Custovic, Adnan/0000-0001-5218-7071					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				479	479						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600479
J	Hobbs, K; Mascali, J; Klemm, D; Borish, L				Hobbs, K; Mascali, J; Klemm, D; Borish, L			Contribution of interleukin (IL)-10 promoter polymorphism to allergic inflammation.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				714	714						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600714
J	Kerstjens, HAM; Kauffman, HF; Postma, DS				Kerstjens, HAM; Kauffman, HF; Postma, DS			Corticosteroids and IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE		UNIV HOSP,DEPT ALLERGOL,GRONINGEN,NETHERLANDS	University of Groningen	Kerstjens, HAM (corresponding author), UNIV HOSP,DEPT PULMONOL,GRONINGEN,NETHERLANDS.		Kerstjens, Huib/N-4754-2017	Kerstjens, Huib/0000-0001-7705-7927				BRAND PLP, 1993, J ALLERGY CLIN IMMUN, V91, P560, DOI 10.1016/0091-6749(93)90262-E; KERSTJENS HAM, 1992, NEW ENGL J MED, V327, P1413, DOI 10.1056/NEJM199211123272003; ZIEG, 1994, J ALLERGY CLIN IMMUN, V95, P222	3	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	1				138	138						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TR947	8568130				2022-12-18	WOS:A1996TR94700021
J	Knowles, SR; Weber, E; Shear, NH				Knowles, SR; Weber, E; Shear, NH			Allergic reactions during general anesthesia (GA).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				645	645						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600645
J	Reid, M; Gurka, G				Reid, M; Gurka, G			Deaths associated with skin testing and immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				195	195						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600195
J	Stephens, L; Proud, D; Togias, A				Stephens, L; Proud, D; Togias, A			Nasal cold, dry air (CDA) challenge results in stronger nasal and pulmonary responses in asthmatics compared to patients with rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				531	531						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600531
J	Tinkelman, D; Falliers, C; Bronsky, E; Kaiser, H; Mason, J				Tinkelman, D; Falliers, C; Bronsky, E; Kaiser, H; Mason, J			Efficacy and safety of fexofenadine HCl in fall seasonal allergic rhinitis.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				1009	1009						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53601009
J	Umland, SP; Nahrebne, DK; Razac, S; Billah, MM; Egan, RW				Umland, SP; Nahrebne, DK; Razac, S; Billah, MM; Egan, RW			Effects of mometasone furoate and other glucocorticoids on cytokine production from cultured peripheral blood CD4(+) T cells.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				423	423						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600423
J	Zaoming, W; Codina, R; FernandezCaldas, E; Lockey, F; Bukanz, SC				Zaoming, W; Codina, R; FernandezCaldas, E; Lockey, F; Bukanz, SC			Partial characterization of the silk allergens in mulberry silk extract.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV S FLORIDA,TAMPA,FL 33620; VA HOSP,TAMPA,FL; BEIJING UNION MED COLL,BEIJING,PEOPLES R CHINA	State University System of Florida; University of South Florida; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College									0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				109	109						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600109
J	Mayumi, M; Sumimoto, S; Ohshima, Y; Katamura, K; Heike, T; Hata, D; Kanazashi, S; Furusho, K				Mayumi, M; Sumimoto, S; Ohshima, Y; Katamura, K; Heike, T; Hata, D; Kanazashi, S; Furusho, K			Role of LFA-1/ICAM-1-dependent cell adhesion in CD40-mediated inhibition of anti-IgM antibody-induced B-cell death	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	New Trends in Immunopharmacology 1994 Conference	JUL   23, 1994	TOKYO, JAPAN	Sandoz Pharm Ltd		B-cell apoptosis; surface IgM; CD40; leukocyte function-associated antigen-1; intercellular adhesion molecule-1	MEDIATED GROWTH-INHIBITION; X-LINKED IMMUNODEFICIENCY; REACTIVE LYMPHOCYTES-B; CROSS-LINKING; SURFACE IGM; LEUKOCYTE ADHESION; IMMUNOGLOBULIN-M; CLONAL DELETION; TRANSGENIC MICE; LYMPHOMA MODELS	Cross-linking of surface IgM by anti-IgM antibody caused activation-induced cell death of a surface IgM(+), IgD(+) human B lymphoma cell line, B104. The dying B104 cells did not show the morphology of apoptosis but did show that of necrosis. However, anti-IgM antibody caused apoptosis of another surface IgM(+), IgD(+) human B lymphoma cell line, DND-39. The influx of extracellular Ca2+ was necessary for the cell deaths of B104 and DND-39 caused by anti-IgM antibody. Their cell deaths were inhibited by cyclosporine. The anti-IgM antibody-induced cell death of DND-39, but not that of B104, was prevented by costimulation with anti-CD40 antibody. In human peripheral blood B-cells, anti-IgM antibody inhibited cell cycle transition induced by Staphylococcus aureus Cowan I at the G2/M interphase without inhibition of DNA synthesis. In this system, too anti-CD40 antibody canceled the inhibitory signal transduced through surface IgM and increased the number of M phase cells. Blocking antibodies against the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 system decreased the rescue effect of anti-CD40 antibody in both DND-39 cells and peripheral B-cells, which shows that leukocyte function-associated antigen-1/intercellular adhesion molecule-1-dependent cell adhesion plays an important role in the CD40-mediated inhibition of surface IgM-mediated negative signals.			Mayumi, M (corresponding author), KYOTO UNIV HOSP,DEPT PEDIAT,SAKYO KU,SHOGOIN KAWAHARACHO 54,KYOTO 60601,JAPAN.			Ohshima, Yusei/0000-0002-4488-0308				ADAMS E, 1990, P NATL ACAD SCI USA, V87, P5687, DOI 10.1073/pnas.87.15.5687; ALESMARTINEZ JE, 1992, EUR J IMMUNOL, V22, P845, DOI 10.1002/eji.1830220332; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BARRETT TB, 1991, J IMMUNOL, V146, P1722; BECKWITH M, 1991, J IMMUNOL, V147, P2411; BISHOP GA, 1993, J IMMUNOL, V150, P2565; BOYD AW, 1981, J IMMUNOL, V126, P2466; BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991; BROMBACHER F, 1991, J EXP MED, V174, P1335, DOI 10.1084/jem.174.6.1335; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; CLARK EA, 1990, J IMMUNOL, V145, P1400; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HEATH AW, 1993, CELL IMMUNOL, V152, P468, DOI 10.1006/cimm.1993.1305; HIGAKI Y, 1994, IMMUNOL CELL BIOL, V72, P205, DOI 10.1038/icb.1994.31; ICHIKI T, 1993, J IMMUNOL, V150, P5408; ISHIGAMI T, 1992, J IMMUNOL, V148, P360; JAKWAY JP, 1986, J IMMUNOL, V137, P2225; KANSAS GS, 1991, J IMMUNOL, V147, P4094; KIM KM, 1991, J IMMUNOL, V146, P819; KIM KM, 1992, J IMMUNOL, V148, P29; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LEDERMAN S, 1994, J IMMUNOL, V152, P2163; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MAYUMI M, 1994, J ALLERGY CLIN IMMUN, V94, P612, DOI 10.1016/0091-6749(94)90137-6; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; PARRY SL, 1994, J IMMUNOL, V152, P2821; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; SCOTT DW, 1987, J IMMUNOL, V139, P3924; SCOTT DW, 1985, CELL IMMUNOL, V93, P124, DOI 10.1016/0008-8749(85)90393-4; SUMIMOTO SI, 1994, J IMMUNOL, V153, P2488; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; UCKUN FM, 1991, J BIOL CHEM, V266, P17478; UDHAYAKUMAR V, 1991, EUR J IMMUNOL, V21, P2605, DOI 10.1002/eji.1830211043; VALENTINE MA, 1992, EUR J IMMUNOL, V22, P3141, DOI 10.1002/eji.1830221217; VALMU L, 1991, EUR J IMMUNOL, V21, P2857, DOI 10.1002/eji.1830211130; YAMAOKA K, 1993, IMMUNOL LETT, V36, P203, DOI 10.1016/0165-2478(93)90053-5	46	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	2	S			1136	1144		10.1016/S0091-6749(95)70198-2	http://dx.doi.org/10.1016/S0091-6749(95)70198-2			9	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ509	8543770				2022-12-18	WOS:A1995TQ50900009
J	REISMAN, RE				REISMAN, RE			INSECT STING CHALLENGES - DO NO HARM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANAPHYLAXIS; SEVERITY				REISMAN, RE (corresponding author), BUFFALO MED GRP PC,295 ESSJAY RD,WILLIAMSVILLE,NY 14221, USA.							BLAAUW PK, 1985, J ALLERGY CLIN IMMUN, V75, P566; FRANKEN HH, 1994, J ALLERGY CLIN IMMUN, V93, P431, DOI 10.1016/0091-6749(94)90351-4; PARKER JL, 1982, J ALLERGY CLIN IMMUN, V69, P200, DOI 10.1016/0091-6749(82)90100-2; REISMAN RE, 1992, J ALLERGY CLIN IMMUN, V90, P335, DOI 10.1016/S0091-6749(05)80012-0; REISMAN RE, 1993, J ALLERGY CLIN IMMUN, V91, P1100, DOI 10.1016/0091-6749(93)90227-7; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936; VANDERLINDEN PWG, 1992, J ALLERGY CLIN IMMUN, V90, P110, DOI 10.1016/S0091-6749(06)80017-5	7	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1995	96	5	1				702	702		10.1016/S0091-6749(95)70274-1	http://dx.doi.org/10.1016/S0091-6749(95)70274-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TG528	7499692				2022-12-18	WOS:A1995TG52800021
J	KAWANE, H				KAWANE, H			BRONCHIAL-ASTHMA CAUSED BY ONION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PLATELET-AGGREGATION				KAWANE, H (corresponding author), Kawasaki Med Sch, DEPT MED, KURASHIKI, OKAYAMA 70101, JAPAN.							BAYER T, 1988, LANCET, V2, P906; KAWAKISHI S, 1988, LANCET, V2, P330; MAKHEJA AN, 1979, LANCET, V1, P781	3	4	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1995	96	4					568	568		10.1016/S0091-6749(95)70307-1	http://dx.doi.org/10.1016/S0091-6749(95)70307-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TA095	7560675				2022-12-18	WOS:A1995TA09500024
J	RAJAKULASINGAM, K; MAKKER, HK; HOWARTH, PH; HOLGATE, ST				RAJAKULASINGAM, K; MAKKER, HK; HOWARTH, PH; HOLGATE, ST			CROSS REFRACTORINESS BETWEEN BRADYKININ AND HYPERTONIC SALINE CHALLENGES IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						TACHYPHYLAXIS; BRADYKININ; HYPERTONIC SALINE; CROSS REFRACTORINESS	INDUCED BRONCHOCONSTRICTION; BRONCHIAL-ASTHMA; AIRWAY RESPONSIVENESS; INHALED BRADYKININ; RAT TRACHEA; INHALATION; HISTAMINE; INHIBITION; EXERCISE; RESPONSES	Background: Repeated inhalation of bradykinin and hypertonic saline leads to I refractoriness of the bronchoconstrictor response in asthma. It is not known whether cross-refractoriness exists between these stimuli. Objective: We postulated that repeated bradykinin and hypertonic saline bronchial challenges might reduce the ail-way response to subsequent hypertonic saline and bradykinin challenges, respectively. Methods: Eleven atopic asthmatic subjects underwent two concentration-response studies, separated by I hour, with either inhaled histamine or bradykinin. After recovery a hypertonic saline challenge was performed. During the next phase, nine subjects underwent two concentration-response studies, separated by I hour, with hypertonic saline. After recovery, a bradykinin challenge was performed. Results: On the histamine study day, the mean provocative volume of agonist required to produce 20% drop in forced expiratory volume in 1 second (PD20) hypertonic saline was 220.7 L (+/-42.7 L) and this was not significantly different from that measured at baseline. On the bradykinin study day the geometric mean provocative concentration of agonist required to produce a 20% drop in forced expiratory volume in 1 second (PC20) was 0.39 mg/ml (0.01 to 11.73 mg/ml) for the first test and significantly higher at 1.38 mg/ml (0.01 to >16.0 mg/ml) for the second test (p = 0.006). The hypertonic saline PD20 increased significantly fi om a baseline of 159.2 L (+/-27.3 L) to 377.6 (+/-64.7 L) (p = 0.003). On the hypertonic saline study day, the mean PD, was 152.8 L for the first rest, and 337.7 L for the second rest (p = 0,01). PC20 bradykinin increased significantly from a baseline of 0.57 to 2.56 mg/ml (p = 0.02). A significant correlation was found between loss of response to bradykinin and to hypertonic saline (r(s), 0.63 and 0.76). Conclusion: Refractoriness produced by repeated exposure of the airways to bradykinin and hypertonic saline results in loss of responsiveness to hypertonic saline and bradykinin respectively, suggesting a shaved mechanism for refractoriness produced by these stimuli.	UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,IMMUNOPHARMACOL GRP,SOUTHAMPTON,HANTS,ENGLAND	University of Southampton				Howarth, Peter/0000-0003-0619-7927				BELCHER NG, 1987, AM REV RESPIR DIS, V135, P822, DOI 10.1164/arrd.1987.135.4.822; BELCHER NG, 1989, EUR RESPIR J, V2, P44; BELCHER NG, 1988, AM REV RESPIR DIS, V137, P1026, DOI 10.1164/ajrccm/137.5.1026; BROKAW JJ, 1990, AM REV RESPIR DIS, V141, P1434, DOI 10.1164/ajrccm/141.6.1434; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; DIXON CMS, 1989, BRIT J CLIN PHARMACO, V27, P831, DOI 10.1111/j.1365-2125.1989.tb03446.x; FINNERTY JP, 1989, AM REV RESPIR DIS, V140, P593, DOI 10.1164/ajrccm/140.3.593; FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; HAWKSWORTH RJ, 1992, EUR RESPIR J, V5, P963; ICHINOSE M, 1992, LANCET, V340, P1248, DOI 10.1016/0140-6736(92)92948-F; MAKKER HK, 1993, J ALLERGY CLIN IMMUN, V92, P82, DOI 10.1016/0091-6749(93)90041-D; NEWMAN SP, 1986, CLIN PHYS PHYSIOL M, V7, P139, DOI 10.1088/0143-0815/7/2/004; OHICKEY SP, 1989, EUR RESPIR J, V2, P923; OHICKEY SP, 1989, J ALLERGY CLIN IMMUN, V83, P472, DOI 10.1016/0091-6749(89)90136-X; POLOSA R, 1990, EUR RESPIR J, V3, P914; POLOSA R, 1990, ALLERGY, V45, P174, DOI 10.1111/j.1398-9995.1990.tb00480.x; POLOSA R, 1992, EUR RESPIR J, V5, P700; POLOSA R, 1990, AM REV RESPIR DIS, V142, P1367, DOI 10.1164/ajrccm/142.6_Pt_1.1367; RAJAKULASINGAM K, 1993, J ALLERGY CLIN IMMUN, V92, P140, DOI 10.1016/0091-6749(93)90049-L; SARIA A, 1988, AM REV RESPIR DIS, V137, P1330, DOI 10.1164/ajrccm/137.6.1330; SMITH CM, 1989, J ALLERGY CLIN IMMUN, V84, P781, DOI 10.1016/0091-6749(89)90309-6; TURCOTTE H, 1988, J ALLERGY CLIN IMMUN, V81, P182, DOI 10.1016/0091-6749(88)90293-X; UEDA N, 1984, J PHARMACOL EXP THER, V230, P469; UMENO E, 1990, J CLIN INVEST, V85, P1905, DOI 10.1172/JCI114652	24	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1995	96	4					502	509		10.1016/S0091-6749(95)70294-6	http://dx.doi.org/10.1016/S0091-6749(95)70294-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TA095	7560662	Bronze			2022-12-18	WOS:A1995TA09500011
J	DHALIWAL, AK; FINK, JN				DHALIWAL, AK; FINK, JN			VAGINAL ITCHING AS A MANIFESTATION OF SEASONAL ALLERGIC DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							VAGINITIS		MED COLL WISCONSIN,DEPT MED,DIV ALLERGY IMMUNOL,MILWAUKEE,WI 53226; MED COLL WISCONSIN,DEPT PEDIAT,MILWAUKEE,WI 53226	Medical College of Wisconsin; Medical College of Wisconsin								DWORETZKY M, 1989, AM J OBSTET GYNECOL, V161, P1752, DOI 10.1016/0002-9378(89)90978-2; GALLAND L, 1989, AM J OBSTET GYNECOL, V161, P1753, DOI 10.1016/0002-9378(89)90979-4; LEVINE BB, 1973, NEW ENGL J MED, V288, P894, DOI 10.1056/NEJM197304262881707; ORIEL JD, 1977, P ROY SOC MED, V70, P7, DOI 10.1177/00359157770700S403; WITKIN SS, 1988, AM J OBSTET GYNECOL, V159, P32, DOI 10.1016/0002-9378(88)90489-9	5	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1995	95	3					780	782		10.1016/S0091-6749(95)70189-3	http://dx.doi.org/10.1016/S0091-6749(95)70189-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QM017	7897167				2022-12-18	WOS:A1995QM01700024
J	ALVARADO, C; REED, C; GLEICH, T; FIELD, E; POBINER, B; WISNIEWSKI, M				ALVARADO, C; REED, C; GLEICH, T; FIELD, E; POBINER, B; WISNIEWSKI, M			FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY REDUCES NASAL EOSINOPHILS AND CYTOKINE ACTIVITY OF PATIENTS WITH ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				193	193						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400212
J	BACHERT, C; HAUSER, U; WAGENMANN, M; BRANDT, A; DATER, I; PREM, B				BACHERT, C; HAUSER, U; WAGENMANN, M; BRANDT, A; DATER, I; PREM, B			INTERLEUKIN-5 PROTEIN IS DETECTED IN NASAL POLYPS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Wagenman, Martin/B-2524-2012; Bachert, Claus/J-8825-2012	Wagenman, Martin/0000-0002-9734-0241; 					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				389	389						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400994
J	BENHABIB, GO; MASPERO, JF; KOHAN, MJ; GARDES, A; PAULIN, P				BENHABIB, GO; MASPERO, JF; KOHAN, MJ; GARDES, A; PAULIN, P			LATEX ALLERGY IS NOT COMMON IN MENINGOMYELOCELE CHILDREN IN ARGENTINA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HOSP NINOS DR RICARDO GUTIERREZ,BUENOS AIRES,DF,ARGENTINA	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires									0	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				152	152						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400046
J	CHEN, Z; CZUPPON, AB; BAUR, X				CHEN, Z; CZUPPON, AB; BAUR, X			ANALYSIS OF CONTINUOUS ALLERGENIC B-CELL EPITOPES ON LATEX ALLERGEN HEV-B-1 BY ELISA USING BIOTINYLATED PEPTIDES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				154	154						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400054
J	CHEW, FT; GOH, DYT; LEE, BW; HUI, JM; ONG, S; TAN, HTW; TAN, TK; LIM, SH; GAN, YY				CHEW, FT; GOH, DYT; LEE, BW; HUI, JM; ONG, S; TAN, HTW; TAN, TK; LIM, SH; GAN, YY			ASTHMA EXACERBATION AND AIR-POLLUTION IN SINGAPORE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NATL UNIV SINGAPORE,DEPT PAEDIAT,SINGAPORE,SINGAPORE	National University of Singapore			Tan, Hugh Tiang Wah/H-9802-2012; Chew, Fook Tim/E-7259-2010; Goh, Daniel/D-8573-2015	Chew, Fook Tim/0000-0003-1337-5146; 					0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				261	261						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400481
J	COHAN, VL; SHOWELL, HJ; PETTIPHER, ER; FISHER, DA; PAZOLES, CJ; WATSON, JW; TURNER, CR; CHENG, JB				COHAN, VL; SHOWELL, HJ; PETTIPHER, ER; FISHER, DA; PAZOLES, CJ; WATSON, JW; TURNER, CR; CHENG, JB			IN-VITRO PHARMACOLOGY OF THE NOVEL TYPE-IV PHOSPHODIESTERASE (PDE(IV)) INHIBITOR, CP-80,633	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									PFIZER INC,CENT RES,GROTON,CT	Pfizer									0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				350	350						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400838
J	CRETICOS, PS; SPECTOR, SL; BUSSE, WW; ISRAEL, E; NICODEMUS, CF; JONES, NH; OLSON, T; GEFTER, ML; LICHTENSTEIN, LM; NORMAN, PS				CRETICOS, PS; SPECTOR, SL; BUSSE, WW; ISRAEL, E; NICODEMUS, CF; JONES, NH; OLSON, T; GEFTER, ML; LICHTENSTEIN, LM; NORMAN, PS			EVALUATION OF T-CELL EPITOPE DEFINED PEPTIDES FROM CAT ALLERGEN BY BRONCHIAL CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				390	390						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400996
J	DURHAM, SR; SCHOTMAN, E; JACOBSON, M; WALKER, S; HAMID, Q				DURHAM, SR; SCHOTMAN, E; JACOBSON, M; WALKER, S; HAMID, Q			GRASS-POLLEN IMMUNOTHERAPY (IT) - INHIBITION OF ALLERGEN-INDUCED LATE SKIN-RESPONSES (LPR) IS ASSOCIATED WITH AN INCREASE IN IL-12 MESSENGER RNA+ CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		DURHAM SR, 1993, J CLIN INVEST, V92, P644; VARNEY VA, 1991, BRIT MED J, V302, P265, DOI 10.1136/bmj.302.6771.265	2	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				304	304						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400654
J	GOLDEN, DBK; HAMILTON, RG; BIRENBERG, A; KRESHTOOL, B; HAGLAUER, C; ADKINSON, NE				GOLDEN, DBK; HAMILTON, RG; BIRENBERG, A; KRESHTOOL, B; HAGLAUER, C; ADKINSON, NE			LATEX SENSITIZATION IN SURGICAL PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				157	157						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400067
J	GREISNER, WA; SETTIPANE, GA				GREISNER, WA; SETTIPANE, GA			HEREDITARY FACTOR FOR NASAL POLYPS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				205	205						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400259
J	HAGAMAN, DD; BRIDGES, TA; SERAFIN, WE				HAGAMAN, DD; BRIDGES, TA; SERAFIN, WE			GLUCOCORTICOIDS INHIBIT CYTOKINE PRODUCTION BY HUMAN AND MURINE MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				298	298						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400628
J	HOLMAN, JM; MANNING, S; GRUCHALLA, R				HOLMAN, JM; MANNING, S; GRUCHALLA, R			IMMUNOLOGICAL CHARACTERIZATION OF ALLERGIC BIPOLARIS (FUNGAL) SINUSITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				201	201						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400241
J	KEITH, PK; CONWAY, M; EVANS, S; EDNEY, P; JENNINGS, B; ANDERSSON, B; DOLOVICH, J				KEITH, PK; CONWAY, M; EVANS, S; EDNEY, P; JENNINGS, B; ANDERSSON, B; DOLOVICH, J			A DOUBLE-BLIND COMPARISON OF INTRANASAL BUDESONIDE DRY POWDER VS PLACEBO IN NASAL POLYPOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									MCMASTER UNIV,HAMILTON,ON,CANADA	McMaster University									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				204	204						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400256
J	KEMP, JP; GLASS, M; MINKWITZ, MC				KEMP, JP; GLASS, M; MINKWITZ, MC			ONSET OF ACTION OF THE LEUKOTRIENE-RECEPTOR ANTAGONIST, ZAFIRLUKAST (ACCOLATE(TM)), IN PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				351	351						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400842
J	KOREN, LGH; JANSSEN, E; WILLEMSE, A				KOREN, LGH; JANSSEN, E; WILLEMSE, A			CAT ALLERGEN AVOIDANCE - A WEEKLY CAT TREATMENT TO KEEP THE CAT AT HOME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				322	322						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400725
J	MACY, EM				MACY, EM			CURRENT SULFAMETHOXAZOLE SKIN-TEST REAGENTS FAIL TO PREDICT RECURRENT ADVERSE REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1991, J ALLERGY CLIN IMMUN, V88, P748	1	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				171	171						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400124
J	NAGATA, H; WOROBEC, A; OH, C; SUZUKI, Y; METCALFE, DD				NAGATA, H; WOROBEC, A; OH, C; SUZUKI, Y; METCALFE, DD			IDENTIFICATION OF A POINT MUTATION OF THE PROTOONCOGENE C-KIT IN PATIENTS WITH MASTOCYTOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				176	176						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400142
J	PFUTZNER, W; THOMAS, P; PRZYBILLA, B				PFUTZNER, W; THOMAS, P; PRZYBILLA, B			INFLUENCE OF SUSPENDED DIESEL EXHAUST PARTICLES (DEP) ON NUMBER AND ACTIVITY OF IGE-SECRETING-CELLS IN-VITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				335	335						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400775
J	SPICAK, V; KLANOVA, M; HULHOVEN, R; DESAGER, JP; DELONGUEVILLE, M; HARVENGT, C				SPICAK, V; KLANOVA, M; HULHOVEN, R; DESAGER, JP; DELONGUEVILLE, M; HARVENGT, C			PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				197	197						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400227
J	VANDERLINDEN, PWG; HACK, CE; STRUYVENBERG, A; VANDERZWAN, JK				VANDERLINDEN, PWG; HACK, CE; STRUYVENBERG, A; VANDERZWAN, JK			INTENTIONAL DIAGNOSTIC STING CHALLENGES - AN IMPORTANT MEDICAL ISSUE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INSECT; VENOM				VANDERLINDEN, PWG (corresponding author), LICHTENBERG HOSP,DEPT INTERNAL MED,UTRECHTSEWEG 160,3818 ES AMERSFOORT,NETHERLANDS.		Levi, Marcel/AAZ-8559-2020					HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; KAMPELMACHER MJ, 1987, CLIN ALLERGY, V17, P317, DOI 10.1111/j.1365-2222.1987.tb02021.x; LOCKEY RF, 1988, J ALLERGY CLIN IMMUN, V82, P370, DOI 10.1016/0091-6749(88)90008-5; WALDHAUSEN E, 1987, ANAESTHESIST, V36, P150	4	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	1				563	564		10.1016/0091-6749(94)90219-4	http://dx.doi.org/10.1016/0091-6749(94)90219-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG907	7993450	Bronze			2022-12-18	WOS:A1994PG90700021
J	GALATAS, ID				GALATAS, ID			RE-STING REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											GALATAS, ID (corresponding author), ARMY GEN HOSP ATHENS,DEPT ALLERGOL,233 MESSOGION AVE,GR-15451 ATHENS,GREECE.								0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2					272	272		10.1016/0091-6749(94)90055-8	http://dx.doi.org/10.1016/0091-6749(94)90055-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC926	8064085	Bronze			2022-12-18	WOS:A1994PC92600024
J	LOCKEY, JE; ROSS, CS				LOCKEY, JE; ROSS, CS			RADON AND MAN-MADE VITREOUS FIBERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Symposium on Building-Related and Home-Related Complaints and Illnesses: Sick Building Syndrome	DEC 03-05, 1992	LAKE BUENA VISTA, FL			RADON; MAN-MADE VITREOUS FIBER; GLASS FIBER; INDOOR AIR; LUNG CANCER	UNITED-STATES HOMES; MINERAL FIBERS; LUNG-CANCER; EXPOSURE; DUST; RN	Epidemiologic studies of miners have established a causal association between radon exposure and development of lung cancer. During the past decade the focus of attention has turned to the potential risk from exposure to radon in indoor air. Governmental involvement thus far has primarily been aimed at gathering further data and issuing voluntary guidelines for radon control in the indoor environment. The federal government's most recent risk assessment for exposure to indoor radon published in 1992 concluded that exposure to indoor radon results in 13,600 radon-induced lung cancer deaths in the United States each year. As public awareness of such environmental issues continues to grow, physicians will be faced with the need to respond to inquiries regarding potential health effects. Man-made vitreous fibers are silicate glass that have a noncrystalline structure. They have been in production for more than 100 years and are used in numerous applications in residential and commercial settings. The health risk from man-made vitreous fibers that are used in residential and commercial settings are limited to skin and occasional respiratory tract irritation under circumstances of improper installation or maintenance. When glass fiber contaminates an indoor environment, proper repair measures and thorough cleaning of the indoor environment will lead to resolution of any resultant irritant symptoms.			LOCKEY, JE (corresponding author), UNIV CINCINNATI,COLL MED,DEPT ENVIRONM HLTH,DIV OCCUPAT & ENVIRONM MED,CINCINNATI,OH 45267, USA.							BALZERJL, 1971, AM IND HYG ASSOC J, V32, P512; BJORNBERG A, 1985, AM J IND MED, V8, P395, DOI 10.1002/ajim.4700080420; CHOLAK J, 1971, ARCH ENVIRON HEALTH, V22, P220, DOI 10.1080/00039896.1971.10665835; COHEN BL, 1991, HEALTH PHYS, V60, P243, DOI 10.1097/00004032-199102000-00013; COHEN BL, 1991, HEALTH PHYS, V60, P631, DOI 10.1097/00004032-199105000-00001; DODGSON J, TM8718 I OCC MED REP; EASTES W, 1991, NOMENCLATURE MAN MAD; ESMEN NA, 1980, ENVIRON RES, V22, P450, DOI 10.1016/0013-9351(80)90157-7; FARKAS J, 1983, CONTACT DERMATITIS, V9, P79, DOI 10.1111/j.1600-0536.1983.tb04636.x; GUILMETTE RA, 1991, ANNU REV PHARMACOL, V31, P569; HARLEY NH, 1992, ENV TOXICANTS HUMAN, P520; HELSEL EB, 1968, ARCH ENVIRON HEALTH, V17, P705; JAFFREY TSAM, 1990, ATMOS ENVIRON A-GEN, V24, P133, DOI 10.1016/0960-1686(90)90448-V; KENNEDY CJ, 1991, HEALTH EDUC QUART, V18, P319, DOI 10.1177/109019819101800305; KONZEN JL, 1982, OCCUPATIONAL IND DER; LIPPMANN M, 1990, TOXICOL IND HEALTH, V6, P225, DOI 10.1177/074823379000600203; LOCKEY JE, 1992, CLIN CHEST MED, V13, P329; MILBY TH, 1969, JOM-J OCCUP MED, V11, P409, DOI 10.1097/00043764-196908000-00002; MOREY PR, 1992, 1992 AM SOC HEAT REF, P94; MOSSMAN KL, 1991, HEALTH PHYS, V60, P169, DOI 10.1097/00004032-199102000-00004; NERO AV, 1988, RADON ITS DECAY PROD, P1; NEUBERGER JS, 1992, HEALTH PHYS, V63, P503, DOI 10.1097/00004032-199211000-00001; NEUBERGER JS, 1991, CANCER DETECT PREV, V15, P435; Nevissi A. E., 1987, INDOOR RADON END ITS, P42; NEWHALL HH, 1976, ENVIRON RES, V12, P201; POSSICK PA, 1970, AM IND HYG ASSOC J, V31, P12, DOI 10.1080/0002889708506201; PUNDSACK FI, 1976, NIOSH76151 PUBL, P11; PUSKIN JS, 1992, RISK ANAL, V12, P277, DOI 10.1111/j.1539-6924.1992.tb00675.x; ROBKIN MA, 1987, INDOOR RADON ITS HAZ, P51; SAMET JM, 1991, HEALTH PHYS, V60, P223, DOI 10.1097/00004032-199102000-00010; SAMET JM, 1992, ENV OCCUPATIONAL MED, P1085; SCHNEIDER T, 1986, Environment International, V12, P61, DOI 10.1016/0160-4120(86)90014-0; SCHNEIDER T, 1990, SCAND J WORK ENV HEA, V16, P434, DOI 10.5271/sjweh.1763; STOKHOLM J, 1982, SCAND J WORK ENV HEA, V8, P185, DOI 10.5271/sjweh.2481; VERBECK SJA, 1981, CONTACT DERMATITIS, V7, P354, DOI 10.1111/j.1600-0536.1981.tb04115.x; WHITE SB, 1992, HEALTH PHYS, V62, P41, DOI 10.1097/00004032-199201000-00005; 1992, DHHS PHS402K92003 PU; 1989, 103 NAT COUNC RAD PR; 1988, IARC MONOGRAPHS EVAU; 1991, ARCH INTERN MED, V151, P674; AH115492 N AM INS MA; [No title captured]; 1992, DHHS PHS402K92001 PU; 1992, J OCCUP MED, V34, P1028; 1992, EPA400R92011; 1991, INDOOR AIR POLLUTION	46	4	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				310	317		10.1053/ai.1994.v94.a56010	http://dx.doi.org/10.1053/ai.1994.v94.a56010			8	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG770	8077584				2022-12-18	WOS:A1994PG77000006
J	SALVAGGIO, JE				SALVAGGIO, JE			USE AND MISUSE OF BIOMARKER TESTS IN ENVIRONMENTAL-CONDITIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Symposium on Building-Related and Home-Related Complaints and Illnesses: Sick Building Syndrome	DEC 03-05, 1992	LAKE BUENA VISTA, FL				ANTI-NUCLEAR ANTIBODIES; AUTOIMMUNE-DISEASE; AUTOANTIBODIES; INTERLEUKIN-2; ACTIVATION; INDUCTION; CADMIUM; SYSTEM; SERUM; MICE				SALVAGGIO, JE (corresponding author), TULANE UNIV,MED CTR,1430 TULANE AVE,NEW ORLEANS,LA 70112, USA.							Bigazzi P. E., 1985, IMMUNOTOXICOLOGY IMM, P277; BOZELKA BE, 1985, ENVIRON CARCINOG REV, V3, P1; CAMPEN DH, 1988, ARTHRITIS RHEUM, V31, P1358, DOI 10.1002/art.1780311103; COTNER T, 1983, J EXP MED, V157, P461, DOI 10.1084/jem.157.2.461; DESHAZO RD, 1987, JAMA-J AM MED ASSOC, V258, P3011, DOI 10.1001/jama.258.20.3011; DINARELLO CA, 1987, NEW ENGL J MED, V317, P940, DOI 10.1056/NEJM198710083171506; GIORGI JV, 1986, MANUAL CLIN LABORATO, P236; HARMON CE, 1985, MED CLIN N AM, V69, P547, DOI 10.1016/S0025-7125(16)31032-X; HIRSCH F, 1982, EUR J IMMUNOL, V12, P620, DOI 10.1002/eji.1830120716; JONES S, 1989, IMMUNOCHEMICA, V3; JOSIMOVIC-ALASEVIC O, 1988, Clinical and Experimental Immunology, V72, P249; OHSAWA M, 1988, CLIN EXP IMMUNOL, V73, P98; PELLETIER L, 1988, J IMMUNOL, V140, P750; ROBINSON CJG, 1983, FED PROC, V42, P1213; SALVAGGIO JE, 1991, ANN ALLERGY, V66, P493; SALVAGGIO JE, 1992, IN PRESS CONTROVERSI; SETHI KK, 1986, IMMUNOL LETT, V13, P179, DOI 10.1016/0165-2478(86)90052-0; TAN EM, 1982, ADV IMMUNOL, V33, P167, DOI 10.1016/S0065-2776(08)60836-6; VANDERWOUDE FJ, 1985, LANCET, V1, P425; WARRINGTON RJ, 1988, J RHEUMATOL, V15, P616; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B; 1990, REPORT NIAID TASK FO, P49; 1992, BIOL MARKERS IMMUNOT	23	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				380	384						5	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG770	8077594				2022-12-18	WOS:A1994PG77000016
J	SEGGEV, JS				SEGGEV, JS			FATAL PULMONARY NOCARDIOSIS IN A PATIENT WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SEGGEV, JS (corresponding author), UNIV NEVADA,SCH MED,DEPT INTERNAL MED,ALLERGY & CLIN IMMUNOL SECT,2040 W CHARLESTON BLVD,LAS VEGAS,NV 89102, USA.							FEIGIN R D, 1974, Pediatrics, V53, P63; HERROD HG, 1990, J PEDIATR-US, V116, P377, DOI 10.1016/S0022-3476(05)82824-0; KIRKPATRICK CH, 1992, CANDIDIASIS, P167; KIRKPATRICK CH, 1981, IMMUNODERMATOLOGY, P495; Lerner P. I., 1990, Principles and practice of infectious diseases., P1926; 1986, AMA DRUG EVALUATION, P1559	6	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2					259	262		10.1016/0091-6749(94)90049-3	http://dx.doi.org/10.1016/0091-6749(94)90049-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC926	8064079				2022-12-18	WOS:A1994PC92600018
J	YEN, A; MATHIEUCOSTELLO, O; GIGLI, I; BARRETT, KE				YEN, A; MATHIEUCOSTELLO, O; GIGLI, I; BARRETT, KE			INHIBITION OF MAST-CELL MEDIATOR SECRETION INDUCED BY PROTOPORPHYRIN PLUS LONG-WAVE ULTRAVIOLET-LIGHT - A MORPHOMETRIC AND ULTRASTRUCTURAL ANALYSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MAST CELLS; PROTOPORPHYRIN; LONG-WAVE ULTRAVIOLET LIGHT; PLASMA MEMBRANE; MORPHOLOGY; MORPHOMETRY	RAT PERITONEAL; HISTAMINE-RELEASE; UV-LIGHT; MODULATION; PSORALEN; SINGLE; EVENTS	It has been shown that treatment of rat peritoneal mast cells with protoporphyrin plus long-wave ultraviolet light (UVA) irradiation can suppress mediator secretion. In this study we conducted a morphometric and ultrastructural analysis of rat peritoneal mast cells to investigate possible alterations produced by this treatment before or after stimulation with calcium ionophore. Protoporphyrin plus UVA, at doses causing inhibition of mediator release, had no effect or, either cell size or viability but increased cellular sphericity. There was a 43% reduction of the cell surface area, and qualitative inspection of the cells revealed that this change was associated with a reduction in microfolds on the cell surface. After 1 minute of incubation with calcium ionophore A23187 (1 mu mol/L), both cells that were pretreated with protoporphyrin plus UVA and control cells showed dramatic changes in granule structure. Although treated cells had an unchanged tendency to have granules that closely approached the plasma membrane, there was an inhibition of granule extrusion in response to ionophore stimulation. These observations may be relevant to the inhibitory effect of protoporphyrin plus UVA on the generation and release of mast cell mediators.	UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,SAN DIEGO,CA 92103	University of California System; University of California San Diego			Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019	Barrett, Kim Elaine/0000-0002-6704-998X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI024992] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL17331] Funding Source: Medline; NIAID NIH HHS [AI24992, AI20474] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BURWEN SJ, 1977, J CELL BIOL, V74, P690, DOI 10.1083/jcb.74.3.690; Cochran W.G., 2007, SAMPLING TECHNIQUES; FJELLNER B, 1982, ACTA DERM-VENEREOL, V62, P137; HAMMEL I, 1989, EXP CELL RES, V184, P518, DOI 10.1016/0014-4827(89)90349-2; HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221; HORNICEK FJ, 1989, J INVEST DERMATOL, V93, P96, DOI 10.1111/1523-1747.ep12277365; KALIMO K, 1983, ARCH DERMATOL RES, V275, P374, DOI 10.1007/BF00417336; KINSOLVING CR, 1975, J PHARMACOL EXP THER, V192, P654; LAGUNOFF D, 1978, J INVEST DERMATOL, V71, P81, DOI 10.1111/1523-1747.ep12544430; MALININ GI, 1986, PHOTOBIOCH PHOTOBIOP, V13, P145; MIO M, 1989, PHARMACOLOGY, V38, P191, DOI 10.1159/000138537; MORAN NC, 1975, FED PROC, V34, P718; NISHIGAKI T, 1988, VIRCHOWS ARCH B, V55, P311; NOSAL R, 1990, AGENTS ACTIONS, V30, P74, DOI 10.1007/BF01969002; ROHLICH P, 1971, J CELL BIOL, V51, P465, DOI 10.1083/jcb.51.2.465; SULLIVAN TJ, 1975, J IMMUNOL, V114, P1473; WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1, P101; YEN A, 1991, J ALLERGY CLIN IMMUN, V88, P395, DOI 10.1016/0091-6749(91)90103-U; YEN A, 1990, J IMMUNOL, V144, P4327; YEN A, 1991, T ASSOC AM PHYSICIAN, V104, P194; YEN A, 1992, J INVEST DERMATOL, V98, P488, DOI 10.1111/1523-1747.ep12499864	21	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1994	93	5					909	918		10.1016/0091-6749(94)90385-9	http://dx.doi.org/10.1016/0091-6749(94)90385-9			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NL919	8182233				2022-12-18	WOS:A1994NL91900016
J	ALEXANDER, M; SMALL, P; THOMSON, D; DROUIN, M; YANG, WH; MAZZA, JA; MOOTE, DW				ALEXANDER, M; SMALL, P; THOMSON, D; DROUIN, M; YANG, WH; MAZZA, JA; MOOTE, DW			EFFICACY AND TOLERABILITY OF CETIRIZINE, LORATADINE AND PLACEBO IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS (SAR) - A CANADIAN MULTICENTER STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				163	163						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700002
J	ARRUDA, LK; FERNANDEZCALDAS, E; NASPITZ, CK; MONTEALEGRE, F; CHAPMAN, MD				ARRUDA, LK; FERNANDEZCALDAS, E; NASPITZ, CK; MONTEALEGRE, F; CHAPMAN, MD			MOLECULAR-CLONING OF BLOMIA-TROPICALIS ALLERGEN BLO-T-5 AND ITS SEQUENCE HOMOLOGY TO D-PTERONYSSINUS-DER P5	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Arruda, L. Karla/D-5845-2013	Arruda, L. Karla/0000-0002-7505-210X					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				205	205						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700255
J	BERTOLIS, P; STRUNK, RC; ARFKEN, CL; GOODMAN, G; KNUTSON, A; BLOOMBERG, GR				BERTOLIS, P; STRUNK, RC; ARFKEN, CL; GOODMAN, G; KNUTSON, A; BLOOMBERG, GR			A 9-YEAR STUDY OF HOSPITALIZATIONS FOR ASTHMA IN CHILDREN IN ST-LOUIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				293	293						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700785
J	BJERKE, T; KOCHAN, J; NIELSEN, S; SCHIOTZ, PO; ROBBINS, K; TOBKES, N; POULSEN, LK; CHRISTENSEN, EI; JARDIEU, P				BJERKE, T; KOCHAN, J; NIELSEN, S; SCHIOTZ, PO; ROBBINS, K; TOBKES, N; POULSEN, LK; CHRISTENSEN, EI; JARDIEU, P			HUMAN IGE RECEPTOR ALPHA-SUBUNIT IS RELEASED FROM HUMAN BASOPHILS AND INHIBITS IGE SYNTHESIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Poulsen, Lars K/J-3065-2019	Poulsen, Lars K/0000-0002-1730-847X					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				218	218						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700332
J	BORISH, LC; MASCALI, JJ; KLINNERT, M; LEPPERT, M; ROSENWASSER, LJ				BORISH, LC; MASCALI, JJ; KLINNERT, M; LEPPERT, M; ROSENWASSER, LJ			POLYMORPHISMS IN THE CHROMOSOME-5 GENE-CLUSTER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				220	220						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700344
J	BRONZERT, CT; WISENAUER, JA; ADKINSON, NF; HAMILTON, RG				BRONZERT, CT; WISENAUER, JA; ADKINSON, NF; HAMILTON, RG			QUANTITATION OF LATEX ALLERGEN IN RUBBER GLOVES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				306	306						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700851
J	CHOWDHURY, BA; KALINER, MA; FRASER, CM				CHOWDHURY, BA; KALINER, MA; FRASER, CM			CLONING OF A GENE ENCODING THE HUMAN H1 HISTAMINE-RECEPTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NIAID,CLIN INVEST LAB,BETHESDA,MD 20892; INST GENOM RES,GAITHERSBURG,MD	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); J. Craig Venter Institute									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				215	215						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700313
J	DEANDRADE, AD; CHARPIN, D; BIRNBAUM, J; JALILCOLOME, J; LANTEAUME, A; VERVLOET, D				DEANDRADE, AD; CHARPIN, D; BIRNBAUM, J; JALILCOLOME, J; LANTEAUME, A; VERVLOET, D			EXPOSURE TO MITE, CAT AND COCKROACH ALLERGENS IN DAY-NURSERIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UFPE,CNPQ,RECIFE,BRAZIL	Universidade Federal de Pernambuco			Dornelas de Andrade, Armele/AAO-7337-2021	Dornelas de Andrade, Armele/0000-0001-9430-4395					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				255	255						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700556
J	ERMEL, RW; FRICK, OL; REINHART, GA				ERMEL, RW; FRICK, OL; REINHART, GA			DOES THE GASTROINTESTINAL-TRACT HAVE A LATE-PHASE INFLAMMATORY RESPONSE TO A FOOD ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				208	208						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700275
J	GREENBERGER, PA; MILLER, M				GREENBERGER, PA; MILLER, M			URINE HISTAMINE DURING EPISODES OF ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				302	302						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700838
J	HAMPEL, F; HOWLAND, W; MARTIN, B; RATNER, P; VANBAVEL, J; FIELD, E; KRAL, K; SCOTT, C				HAMPEL, F; HOWLAND, W; MARTIN, B; RATNER, P; VANBAVEL, J; FIELD, E; KRAL, K; SCOTT, C			THE EFFICACY OF FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY FOR TREATMENT OF RHINITIS IS DEPENDENT ON TOPICAL APPLICATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				165	165						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700016
J	JALILCOLOME, J; DORNELAS, A; BIRNBAUM, J; CASANOVA, D; MEGE, JL; CHARPIN, D; VERVLOET, D				JALILCOLOME, J; DORNELAS, A; BIRNBAUM, J; CASANOVA, D; MEGE, JL; CHARPIN, D; VERVLOET, D			SEX DIFFERENCE IN FEL D-I ALLERGEN PRODUCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													MEGE, JEAN-LOUIS/O-6063-2016						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				180	180						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700104
J	KITA, H; HORIE, S; GLEICH, GJ				KITA, H; HORIE, S; GLEICH, GJ			LAMININ AND FIBRONECTIN INHIBIT ADHESION AND DEGRANULATION OF EOSINOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				212	212						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700299
J	KLEIN, JS; SQUILLACE, DL; LOEGERING, DA; GLEICH, GJ				KLEIN, JS; SQUILLACE, DL; LOEGERING, DA; GLEICH, GJ			MOLECULAR-FORMS OF EOSINOPHIL GRANULE MAJOR BASIC-PROTEIN IN HUMAN BLOOD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				212	212						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700295
J	KNOTTNERUS, I; PELIKAN, Z				KNOTTNERUS, I; PELIKAN, Z			THE EFFECTS OF CROMOLYN (DSCG), NEDOCROMIL (NS) AND BUDESONIDE (BUD) ON THE EARLY (EAR) AND THE LATE (LAR) ASTHMATIC RESPONSE, INHALED BEFORE AND AFTER ALLERGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				198	198						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700210
J	KUNA, P; LAZAROVICH, M; KAPLAN, AP				KUNA, P; LAZAROVICH, M; KAPLAN, AP			STUDIES OF MCAF/MCP-1, RANTES, MIP-1 ALPHA, IL-8, HISTAMINE, ECP AND TRYPTASE IN ALLERGIC RHINITIS SUFFERERS AND ASYMPTOMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				216	216						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700320
J	LINDFORS, A; HEDLIN, G; RIETZ, H; NORDVALL, L; WICKMAN, M				LINDFORS, A; HEDLIN, G; RIETZ, H; NORDVALL, L; WICKMAN, M			INDOOR RISKFACTORS IN YOUNG-CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				290	290						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700763
J	LOH, RKS; JABARA, HH; GEHA, RS				LOH, RKS; JABARA, HH; GEHA, RS			CROMOLYN SODIUM (CS) AND NEDOCROMIL SODIUM (NS) INHIBIT S-MU -] S-SIGMA DELETIONAL SWITCH RECOMBINATION AND IGE SYNTHESIS IN HUMAN B-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,DIV IMMUNOL,BOSTON,MA 02115; PRINCESS MARGARET HOSP CHILDREN,DEPT IMMUNOL,SUBIACO,WA,AUSTRALIA	Harvard University; Boston Children's Hospital; Harvard Medical School									0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				219	219						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700338
J	MARONE, G; PATELLA, V; CASOLARO, V; MARCHESI, E; BIANCHI, B				MARONE, G; PATELLA, V; CASOLARO, V; MARCHESI, E; BIANCHI, B			INHIBITION OF MEDIATOR RELEASE FROM HUMAN MAST-CELLS BY LORATADINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV NAPLES,DIV CLIN IMMUNOL & ALLERGY,I-80138 NAPLES,ITALY; SCHERING PLOUGH CORP,MILAN,ITALY	University of Naples Federico II; Merck & Company			Casolaro, Vincenzo/E-9144-2010	Casolaro, Vincenzo/0000-0001-9810-0488					0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				258	258						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700570
J	MURPHY, G; LEVENTHAL, L; ZWEIMAN, B				MURPHY, G; LEVENTHAL, L; ZWEIMAN, B			ENDOTHELIAL CD62 AND E-SELECTIN EXPRESSION IN DEVELOPING LATE-PHASE IGE-MEDIATED SKIN REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				183	183						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700122
J	NEELY, JD; BREAZEALE, D; SCHOU, C; FREIDHOFF, LR; BEATY, T; MARSH, DG				NEELY, JD; BREAZEALE, D; SCHOU, C; FREIDHOFF, LR; BEATY, T; MARSH, DG			SIB-PAIR ANALYSIS OF TOTAL AND SPECIFIC IGE AND DNA POLYMORPHISMS ON CHROMOSOME-11Q13 IN THE AMISH	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				220	220						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700343
J	SIMONS, FER; MURRAY, HE; YI, Z; SIMONS, KJ				SIMONS, FER; MURRAY, HE; YI, Z; SIMONS, KJ			CETIRIZINE AND HYDROXYZINE CONCENTRATIONS IN HUMAN SKIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Murray, Heather/GQY-8016-2022						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				222	222						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700356
J	STVINCENT, JCM; WATSON, WTA				STVINCENT, JCM; WATSON, WTA			UNSUSPECTED SOURCE OF COWS MILK PROTEIN IN FOOD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				209	209						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700281
J	SWYSTUN, VA; BHAGAT, R; OBYRNE, PM; COCKCROFT, DW				SWYSTUN, VA; BHAGAT, R; OBYRNE, PM; COCKCROFT, DW			REGULAR INHALED SALBUTAMOL INCREASES ALLERGEN-INDUCED LATE ASTHMATIC RESPONSIVENESS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				260	260						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700586
J	TODT, JC; OWNBY, DR				TODT, JC; OWNBY, DR			AMINO-ACID-ANALYSIS OF ALLERGENIC PROTEINS FROM RAW NON-AMMONIATED LATEX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				283	283						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700720
J	CRIMI, E; VIOLANTE, B; PELLEGRINO, R; BRUSASCO, V				CRIMI, E; VIOLANTE, B; PELLEGRINO, R; BRUSASCO, V			EFFECT OF MULTIPLE DOSES OF NEDOCROMIL SODIUM GIVEN AFTER ALLERGEN INHALATION IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; DRUG THERAPY; BRONCHIAL PROVOCATION TEST; BRONCHOCONSTRICTION; BRONCHIAL HYPERREACTIVITY; LATE-PHASE RESPONSE	MAST-CELLS; MILD ASTHMA; RESPONSIVENESS; HISTAMINE; CROMOGLYCATE; RECRUITMENT; EOSINOPHILS; INHIBITION; ACTIVATION; INCREASES	Aim: - Twelve subjects with asthma took part in a placebo-controlled crossover study designed to investigate whether nedocromil sodium given after the occurrence of the early-phase asthmatic reaction to allergen has an effect on the late-phase response and the associated increase in airway responsiveness. Methods: The treatments were administered four times at 4-hour intervals at a dose of 4 mg, with the first dose given 1 hour after the last allergen challenge Changes in airway caliber were monitored for 15 hours after allergen exposure by measuring forced expiratory volume in 1 second hourly. Airway responsiveness to methacholine was determined 24 hours before and 24 hours after allergen challenge. Results: Nedocromil sodium faded to reduce significantly the maximum late fall in forced expiratory volume in 1 second as compared with placebo but delayed its occurrence by 1.5 hours (p = 0.05). Nonspecific airway responsiveness to methacholine was similarly increased after allergen challenge when patients received nedocromil sodium and placebo. No unusual events were reported during the study period by any patient. These results indicate that nedocromil sodium is not able to interrupt the ongoing cascade of inflammatory events leading to the late-phase reaction and the associated increase in airway responsiveness. Conclusion: In allergic asthma, nedocromil can be used only as a preventive treatment.	OSPED A CARLE,SERV FISIOPATOL RESPIRATORIA,CUNEO,ITALY		CRIMI, E (corresponding author), UNIV GENOA,CATTEDRA FISIOPATOL,DIPARTIMENTO SCI MOTORIE,VIALE BENEDETTO 15 10,I-16132 GENOA,ITALY.		Pellegrino, Riccardo/AAA-1667-2022					ABRAHAM WM, 1985, PROG RESPIR RES, V19, P48; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; Blackley CH., 1873, EXPT RES CAUSES NATU; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOOIJ-NOORD H, 1972, Clinical Allergy, V2, P43, DOI 10.1111/j.1365-2222.1972.tb01267.x; BOOIJNOORD H, 1971, J ALLERGY CLIN IMMUN, V48, P344, DOI 10.1016/0091-6749(71)90080-7; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; BRUSASCO V, 1990, J APPL PHYSIOL, V69, P2209, DOI 10.1152/jappl.1990.69.6.2209; CRIMI E, 1989, J ALLERGY CLIN IMMUN, V83, P985, DOI 10.1016/0091-6749(89)90116-4; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P600, DOI 10.1164/ajrccm/136.3.600; HERXHEIMER H, 1952, INT ARCH ALLER A IMM, V3, P323, DOI 10.1159/000227979; KAY AB, 1989, ALLERGY ASTHMA NEW T, P151; LEUNG KBP, 1988, THORAX, V43, P756, DOI 10.1136/thx.43.10.756; MATTOLI S, 1987, J ALLERGY CLIN IMMUN, V79, P747, DOI 10.1016/0091-6749(87)90206-5; MOQBEL R, 1988, ALLERGY, V43, P268, DOI 10.1111/j.1398-9995.1988.tb00899.x; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; ROSSI GA, 1991, AM REV RESPIR DIS, V144, P379, DOI 10.1164/ajrccm/144.2.379; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P232, DOI 10.1159/000234508; WELLS E, 1986, J IMMUNOL, V137, P3941; 1962, AM REV RESPIR DIS, V84, P762	23	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1993	92	6					777	783		10.1016/0091-6749(93)90053-I	http://dx.doi.org/10.1016/0091-6749(93)90053-I			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ML893	8258611				2022-12-18	WOS:A1993ML89300001
J	WANTKE, F; DEMMER, CC; GOTZ, M; JARISCH, R				WANTKE, F; DEMMER, CC; GOTZ, M; JARISCH, R			REDUCTION OF SIDE-EFFECTS OF SPECIFIC IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											WANTKE, F (corresponding author), DERMATOL & PEDIAT ALLERGY CLIN,VIENNA,AUSTRIA.							GOTZ M, 1993, J ALLERGY CLIN IMMUN, V91, P369; JARISCH R, 1989, PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, P387; STEWART GE, 1992, J ALLERGY CLIN IMMUN, V90, P567, DOI 10.1016/0091-6749(92)90129-P; WEKKELI M, 1989, WIEN KLIN WOCHENSCHR, V101, P639	4	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1993	92	3					497	498		10.1016/0091-6749(93)90132-Y	http://dx.doi.org/10.1016/0091-6749(93)90132-Y			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LX309	8103062				2022-12-18	WOS:A1993LX30900018
J	BARNES, PJ				BARNES, PJ			EFFECT OF NEDOCROMIL SODIUM ON PLATELET-ACTIVATING-FACTOR INDUCED AIRWAY RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HUMAN EOSINOPHILS; RESPONSIVENESS; STIMULATION; EPITHELIUM; MEDIATOR; INVITRO; CELLS	Platelet-activating factor (PAF) is one of the chemical mediators that may participate in the inflammatory process underlying asthma. It has been shown to produce a prolonged increase in airway responsiveness in several species, including humans. In humans the increase in bronchial reactivity peaks 3 days after inhalation and can last as long as several weeks. PAF may induce this response by recruiting eosinophils into the airways and activating them in the airway walls, with the subsequent release of basic proteins. This process causes eosinophils, which are rich sources of PAF, to release their contents and sets up a self-perpetuating cycle. Nedocromil sodium reduces the increased bronchial responsiveness of asthma and can prevent the development of increased responsiveness after inhaled PAF. The precise mechanism by which this result occurs is not known and requires further investigation.			BARNES, PJ (corresponding author), NATL HEART & LUNG INST,DEPT THORAC MED,LONDON,ENGLAND.			Barnes, Peter/0000-0002-5122-4018				BARNES PJ, 1988, J ALLERGY CLIN IMMUN, V81, P919, DOI 10.1016/0091-6749(88)90952-9; BARNES PJ, 1989, PLATELET ACTIVATING, P158; CHUNG KF, 1989, THORAX, V44, P108, DOI 10.1136/thx.44.2.108; CUSS FM, 1986, LANCET, V2, P189; DENJEAN A, 1988, American Review of Respiratory Disease, V137, P283; DENT G, 1989, PLATELET ACTIVATING, P58; DIMARIA GV, 1989, AM REV RESPIR DIS, V139, pA109; EVANS TW, 1987, J APPL PHYSIOL, V63, P479, DOI 10.1152/jappl.1987.63.2.479; GLEICH GJ, 1988, J ALLERGY CLIN IMMUN, V81, P776, DOI 10.1016/0091-6749(88)90931-1; HAYES JP, 1992, EUR RESPIR J, V5, P1173; HENOCQ E, 1988, J ALLERGY CLIN IMMUN, V81, P691, DOI 10.1016/0091-6749(88)91040-8; KIDNEY JC, 1993, AM REV RESPIR DIS, V147, P215, DOI 10.1164/ajrccm/147.1.215; KIMANI G, 1988, J IMMUNOL, V140, P3161; KROEGEL C, 1989, J IMMUNOL, V142, P3518; KROEGEL C, 1988, IMMUNOLOGY, V64, P559; LEE TC, 1984, J BIOL CHEM, V259, P5526; YUKAWA T, 1990, AM J RESP CELL MOL, V2, P341, DOI 10.1165/ajrcmb/2.4.341	17	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				187	189		10.1016/0091-6749(93)90104-N	http://dx.doi.org/10.1016/0091-6749(93)90104-N			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8393026				2022-12-18	WOS:A1993LQ35400010
J	BARNES, PJ				BARNES, PJ			EFFECT OF NEDOCROMIL SODIUM ON MICROVASCULAR LEAKAGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INFLAMMATORY MEDIATORS; PLASMA EXUDATION; GUINEA-PIG; ASTHMA; PERMEABILITY; INHIBITION; DRUGS	The recognition that asthma is a chronic inflammatory disease has focused attention on microvascular leakage, which is a component of the inflammatory process. Epithelial shedding, airway edema, increased airway resistance, and airway hyperresponsiveness can result from the plasma extravasation caused by leakage. The chain of inflammatory events set off by microvascular leakage may contribute to the development of the late-phase asthmatic response. Thus the search for drugs that ameliorate this leakage continues. Intravenous nedocromil sodium in a dose of 100 mug/kg is effective in blocking microvascular leakage induced by intravenous allergen in sensitized guinea pigs but has no effect on leakage induced by either intravenous histamine or platelet-activating factor, which suggests that it acts predominantly on mediator release. Studies in hamsters, however, have demonstrated that nedocromil sodium is effective in blocking leakage induced by histamine, which acts directly on endothelial cells. The ability of nedocromil sodium to reduce microvascular leakage may contribute to its effectiveness in preventing the late-phase response, but the mechanism by which this reduction occurs is not completely understood.			BARNES, PJ (corresponding author), NATL HEART & LUNG INST,DEPT THORAC MED,LONDON,ENGLAND.			Barnes, Peter/0000-0002-5122-4018				BARNES PJ, 1988, PHARMACOL REV, V40, P49; BARNES PJ, 1989, DRUGS, V37, P94, DOI 10.2165/00003495-198900371-00017; BOSCHETTO P, 1989, AM REV RESPIR DIS, V139, P416, DOI 10.1164/ajrccm/139.2.416; BOSCHETTO P, 1991, AM REV RESPIR DIS, V143, P605, DOI 10.1164/ajrccm/143.3.605; BROGAN TD, 1975, THORAX, V30, P72, DOI 10.1136/thx.30.1.72; CHRISTIANSEN SC, 1987, J CLIN INVEST, V79, P188, DOI 10.1172/JCI112782; CHUNG KF, 1990, EUR RESPIR J, V3, P329; DAHLEN SE, 1989, DRUGS, V37, P63, DOI 10.2165/00003495-198900371-00013; DULFANO MJ, 1982, THORAX, V37, P646, DOI 10.1136/thx.37.9.646; ERJEFALT I, 1986, ACTA PHYSIOL SCAND, V128, P653, DOI 10.1111/j.1748-1716.1986.tb08027.x; EVANS TW, 1989, CLIN SCI, V76, P479, DOI 10.1042/cs0760479; EVANS TW, 1988, AM REV RESPIR DIS, V138, P395, DOI 10.1164/ajrccm/138.2.395; EVANS TW, 1987, J APPL PHYSIOL, V63, P479, DOI 10.1152/jappl.1987.63.2.479; FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; HUI KP, 1989, THORAX, V44, pP895; HUI KP, 1991, AM REV RESPIR DIS, V103, P1119; JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242; LAM S, 1985, CHEST, V88, P856, DOI 10.1378/chest.88.6.856; PERSSON CGA, 1988, LUNG, V166, P1, DOI 10.1007/BF02714025; REGAL J F, 1989, Pulmonary Pharmacology, V2, P3, DOI 10.1016/S0952-0600(89)80003-1; TOKUYAMA K, 1991, EUR J PHARMACOL, V193, P35, DOI 10.1016/0014-2999(91)90197-X	21	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				197	199		10.1016/0091-6749(93)90107-Q	http://dx.doi.org/10.1016/0091-6749(93)90107-Q			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8393029				2022-12-18	WOS:A1993LQ35400013
J	CLARK, B				CLARK, B			GENERAL PHARMACOLOGY, PHARMACOKINETICS, AND TOXICOLOGY OF NEDOCROMIL SODIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							OBSTRUCTIVE AIRWAYS DISEASE	The pharmacokinetic properties of nedocromil sodium give this agent a high safety margin in the treatment of asthma. Only 5% to 10% of an inhaled dose is absorbed, primarily from the respiratory tract, but also from the secondary oral route. Nedocromil sodium has very rapid plasma clearance and is confined to the extravascular space. The drug is not metabolized in either humans or animals, which renders animal testing relevant to the safety of this compound in humans. Tests conducted in several models did not uncover any adverse effects, even at high infused or inhaled doses. Also, nedocromil did not appear to interact with a variety of other drugs that are likely to be used concomitantly. These data support the long-term use of nedocromil sodium at doses required for therapeutic efficacy.			CLARK, B (corresponding author), FISONS PLC,DIV PHARMACEUT,BAKEWELL RD,LOUGHBOROUGH LE11 0RH,LEICS,ENGLAND.							CLARK B, 1986, EUR J RESPIR DIS, V69, P248; EADY RP, 1987, ACTUAL CHIM THER, V14, P55; GONZALEZ JP, 1987, DRUGS, V34, P560, DOI 10.2165/00003495-198734050-00004; NEALE MG, 1987, BRIT J CLIN PHARMACO, V24, P493, DOI 10.1111/j.1365-2125.1987.tb03203.x; STRINATI R, 1987, MED BAMBINO, V10, P794	5	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				200	202		10.1016/0091-6749(93)90108-R	http://dx.doi.org/10.1016/0091-6749(93)90108-R			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8393030	Bronze			2022-12-18	WOS:A1993LQ35400014
J	ROTH, M; SOLER, M; LEFKOWITZ, H; CHEM, I; EMMONS, LR; ANSTINE, D; HORNUNG, M; PERRUCHOUD, AP				ROTH, M; SOLER, M; LEFKOWITZ, H; CHEM, I; EMMONS, LR; ANSTINE, D; HORNUNG, M; PERRUCHOUD, AP			INHIBITION OF RECEPTOR-MEDIATED PLATELET ACTIVATION BY NEDOCROMIL SODIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PLATELET ACTIVATION; PLATELET ACTIVATING FACTOR; THROMBIN; CA-2+-IONOPHORE; NEDOCROMIL SODIUM; RECEPTOR SPECIFICITY	PAF-ACETHER; MAST-CELLS; ASTHMA; CROMOGLYCATE; INVITRO; RESPONSIVENESS; NEUTROPHILS; RESPONSES; HISTAMINE; BN-52021	Background: Platelet activation by platelet activating factor (PAF) seems to be involved in the inflammatory process in asthma and may serve as a possible target for the antiinflammatory drug nedocromil sodium, which is known to inhibit cell activation by different stimuli. Methods: We investigated the effect and the mode of action of nedocromil sodium on platelet activation by PAF. In a set of healthy volunteers (n = 45) we investigated seven different parameters of platelet activation by PAF, thrombin, and Ca2+-ionophore. Results: Nedocromil sodium inhibited. (1) PAF-induced ''shape change'' reaction up to 78% (50% inhibitory concentration [IC50]: 3 x 10(-9) mol/L), thrombin-mediated ''shape change'' up to 80% (IC50: 2 x 10(-8) mol/L), but not the Ca2+-ionophore-dependent reaction, (2) platelet aggregation by PAF up to 85% (IC50: 2 x 10(-9) mol/L); (3) release of thromboxane B2 up to 82% (IC50: 5 x 10(-9) mol/L); (4) formation of inositol 1,4,5-triphosphate by PAF (IC50: 3 X 10(-7) mol/L), by thrombin (IC50: 1 X 10(-7) mol/L), but not by Ca2+ ionophore; (5) increase of intracellular free calcium (IC50: 4 x 10(-7) mol/L); (6) formation of diacylglycerol (IC50: 9 x 10(-9) mol/L), and (7) translocation of protein kinase C (IC50: 1 X 10(-7) mol/L). Conclusions: In the concentration range of the IC50 values found in these experiments, nedocromil sodium reduced PAF binding to platelets by only 10% to 20%, such that this interference cannot explain the observed effects of the compound. Inhibition of receptor-mediated platelet activation at an early stage in the signal transduction pathway, and without effect on Ca2+-ionophore-induced platelet activation, suggests an action of nedocromil sodium at the level of the cell membrane.	UNIV HOSP BASEL,DEPT RES,DIV PULM,CH-4031 BASEL,SWITZERLAND; UNIV HOSP BASEL,DEPT INTERNAL MED,DIV PULM,CH-4031 BASEL,SWITZERLAND	University of Basel; University of Basel			Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821				AALBERS R, 1991, J ALLERGY CLIN IMMUN, V87, P993, DOI 10.1016/0091-6749(91)90422-K; ABRAHAM WM, 1988, AM REV RESPIR DIS, V138, P1565, DOI 10.1164/ajrccm/138.6.1565; AVERILL FJ, 1992, AM REV RESPIR DIS, V145, P571, DOI 10.1164/ajrccm/145.3.571; BARNES PJ, 1985, BRIT J HOSP MED, V34, P339; BARNES PJ, 1987, TRENDS PHARMACOL SCI, V8, P285, DOI 10.1016/0165-6147(87)90115-5; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BLOCK LH, 1989, AM J RESP CELL MOL, V1, P277, DOI 10.1165/ajrcmb/1.4.277; BLOCK LH, 1990, RESPIRATION, V1, P372; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BRAQUET P, 1985, LANCET, V1, P1501; BRUIJNZEEL PLB, 1989, BRIT J PHARMACOL, V97, P1251, DOI 10.1111/j.1476-5381.1989.tb12586.x; BRUIJNZEEL PLB, 1989, DRUGS, V37, P9, DOI 10.2165/00003495-198900371-00004; BRUIJNZEEL PLB, 1987, 6TH C EUR SOC PNEUM, P22; BRUIJNZEEL PLB, 1987, 6TH C EUR SOC PNEUM, P23; CATT KJ, 1991, J BIOENERG BIOMEMBR, V23, P7; CUSS FM, 1986, LANCET, V2, P189; DAMON M, 1989, EUR RESPIR J, V2, P202; DURHAM SR, 1985, LANCET, V2, P36; ERNE P, 1987, J RECEPTOR RES, V4, P587; FEINBERG H, 1988, BLOOD, V72, P766; FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; GIBSON PG, 1989, THORAX, V44, P693, DOI 10.1136/thx.44.9.693; GREIF J, 1989, CHEST, V96, P583, DOI 10.1378/chest.96.3.583; HOLGATE ST, 1986, EUR J RESPIR DIS, V69, P149; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; KAY AB, 1989, J ASTHMA, V23, P335; KELLY C, 1988, THORAX, V43, P684, DOI 10.1136/thx.43.9.684; KLOPROGGE E, 1984, BIOCHEM J, V223, P901, DOI 10.1042/bj2230901; KNAUER KA, 1981, NEW ENGL J MED, V304, P1404, DOI 10.1056/NEJM198106043042307; LELLOUCHTUBIANA A, 1985, BRIT J EXP PATHOL, V66, P345; LEUNG KBP, 1988, THORAX, V43, P756, DOI 10.1136/thx.43.10.756; LUCAS AM, 1987, BIOCHEM PHARMACOL, V36, P562, DOI 10.1016/0006-2952(87)90368-6; MARQUETTE CH, 1990, BRIT J CLIN PHARMACO, V29, P525, DOI 10.1111/j.1365-2125.1990.tb03675.x; MOQBEL R, 1988, ALLERGY, V43, P268, DOI 10.1111/j.1398-9995.1988.tb00899.x; MOQBEL R, 1986, EUR J RESPIR DIS S69, V1457, P227; NELSESTUEN GL, 1991, J BIOENERG BIOMEMBR, V23, P43; OREFICE U, 1987, BILIOTHEEK, P49; RUGGIERI F, 1989, European Respiratory Journal, V2, p568S; SACHS L, 1969, STATISTISCHE AUSWERT; SMITH LJ, 1991, AM REV RESPIR DIS, pS100; SPRY CJF, 1986, EUR J RESPIR DIS, V69, P241; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P227, DOI 10.1159/000234507; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P232, DOI 10.1159/000234508; WARDLAW AJ, 1989, J ALLERGY CLIN IMMUN, V84, P19, DOI 10.1016/0091-6749(89)90173-5	44	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1993	91	6					1217	1225		10.1016/0091-6749(93)90325-A	http://dx.doi.org/10.1016/0091-6749(93)90325-A			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LG740	8389778				2022-12-18	WOS:A1993LG74000014
J	ZWEIMAN, B; LAVKER, RM; PRESTI, C; ATKINS, PC				ZWEIMAN, B; LAVKER, RM; PRESTI, C; ATKINS, PC			COMPARISONS OF INFLAMMATORY RESPONSES IN IGE-MEDIATED AND CODEINE-INDUCED SKIN REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							HISTAMINE; CHALLENGE; TRYPTASE; RELEASE		UNIV PENN,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA 19104	University of Pennsylvania	ZWEIMAN, B (corresponding author), UNIV PENN,SCH MED,DEPT MED,DIV ALLERGY & IMMUNOL,512 JOHNSON PAVIL,PHILADELPHIA,PA 19104, USA.				NIAID NIH HHS [AI 14332] Funding Source: Medline; NIAMS NIH HHS [P01 AR 39674] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039674] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P360, DOI 10.1016/S0091-6749(05)80099-5; CHURCH MK, 1991, SKIN PHARM S4, V1, P15; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; SHALIT M, 1987, J ALLERGY CLIN IMMUN, V80, P87, DOI 10.1016/S0091-6749(87)80196-3; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V83, P691, DOI 10.1016/0091-6749(89)90084-5; SHALIT M, 1990, J ALLERGY CLIN IMMUN, V86, P117, DOI 10.1016/S0091-6749(05)80131-9; SLOTT RI, 1975, J ALLERGY CLIN IMMUN, V88, P232; WALSH LJ, 1990, LAB INVEST, V63, P592; ZWEIMAN B, 1988, CLIN ALLERGY, V18, P847	10	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1993	91	4					963	965		10.1016/0091-6749(93)90356-K	http://dx.doi.org/10.1016/0091-6749(93)90356-K			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KY251	8473686				2022-12-18	WOS:A1993KY25100019
J	SAMPSON, HA				SAMPSON, HA			FOOD ANTIGEN-INDUCED LYMPHOCYTE-PROLIFERATION IN CHILDREN WITH ATOPIC-DERMATITIS AND FOOD HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							RESPONSES; ALLERGY				SAMPSON, HA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,CMSC 1103,600 N WOLFE ST,BALTIMORE,MD 21205, USA.							AGATA H, 1993, J ALLERGY CLIN IMMUN, V91, P668, DOI 10.1016/0091-6749(93)90273-I; BOCK SA, 1978, J ALLERGY CLIN IMMUN, V62, P327, DOI 10.1016/0091-6749(78)90132-X; BOCK SA, 1988, J ALLERGY CLIN IMMUN, V82, P986; BRUYNZEELKOOMEN C, 1986, ARCH DERMATOL RES, V278, P199, DOI 10.1007/BF00412924; BUCKLEY RH, 1977, J ALLERGY CLIN IMMUN, V59, P70, DOI 10.1016/0091-6749(77)90180-4; BURKS AW, 1988, J PEDIATR-US, V113, P447, DOI 10.1016/S0022-3476(88)80626-7; HILL DJ, 1986, J PEDIATR-US, V109, P270, DOI 10.1016/S0022-3476(86)80384-5; KONDO N, 1990, J ALLERGY CLIN IMMUN, V86, P253, DOI 10.1016/S0091-6749(05)80073-9; KONDO N, 1993, J ALLERGY CLIN IMMUN, V91, P658, DOI 10.1016/0091-6749(93)90272-H; MAGGI E, 1992, J IMMUNOL, V148, P2142; May C D, 1972, Clin Allergy, V2, P335, DOI 10.1111/j.1365-2222.1972.tb01298.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; ORINO E, 1992, J IMMUNOL, V149, P925; SAGER N, 1992, J ALLERGY CLIN IMMUN, V89, P801, DOI 10.1016/0091-6749(92)90434-4; SAMPSON HA, 1988, J ALLERGY CLIN IMMUN, V81, P635, DOI 10.1016/0091-6749(88)91033-0; SAMPSON HA, 1990, CLIN EXP ALLERGY, V20, P459, DOI 10.1111/j.1365-2222.1990.tb03137.x; TONG AKF, 1986, CLIN REV ALLERG, V4, P27; VANDERHEIJDEN FL, 1991, J INVEST DERMATOL, V97, P389, DOI 10.1111/1523-1747.ep12480966; VANSICKLE GJ, 1985, GASTROENTEROLOGY, V88, P1915, DOI 10.1016/0016-5085(85)90019-8	19	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1993	91	2					549	551		10.1016/0091-6749(93)90259-I	http://dx.doi.org/10.1016/0091-6749(93)90259-I			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KN548	8436769				2022-12-18	WOS:A1993KN54800001
J	WEBB, EL				WEBB, EL			NASAL CANDIDIASIS IN A PATIENT ON LONG-TERM TOPICAL INTRANASAL CORTICOSTEROID-THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							BECLOMETHASONE DIPROPIONATE AEROSOL; PERENNIAL RHINITIS				WEBB, EL (corresponding author), WILFORD HALL USAF MED CTR,SGHMA,2200 BERGQUIST DR,SUITE 1,LACKLAND AFB,TX 78236, USA.							HOLOPAINEN E, 1982, ACTA OTOLARYNGOLOG S, V386, P270; KIRKPATRICK CH, 1984, AM J MED, V77, P1; KNIGHT A, 1983, ANN ALLERGY, V50, P81; TARLO SM, 1977, J ALLERGY CLIN IMMUN, V59, P232, DOI 10.1016/0091-6749(77)90155-5; 1992, PHYSICIANS DESK REFE, P574	5	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1993	91	2					680	681		10.1016/0091-6749(93)90274-J	http://dx.doi.org/10.1016/0091-6749(93)90274-J			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KN548	8436781				2022-12-18	WOS:A1993KN54800016
J	BOULET, LP; TURCOTTE, H; LAVIOLETTE, M; BOUTET, M				BOULET, LP; TURCOTTE, H; LAVIOLETTE, M; BOUTET, M			AIRWAY INFLAMMATION IN NONASTHMATIC SUBJECTS WITH SEASONAL RHINITIS DURING NATURAL EXPOSURE TO POLLEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				350	350						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100835
J	BURKS, AW; HELM, RM; COCKRELL, G; STANLEY, JS; BANNON, GA				BURKS, AW; HELM, RM; COCKRELL, G; STANLEY, JS; BANNON, GA			CLONING OF THE ARA-H-II PEANUT ALLERGEN BY POLYMERASE CHAIN-REACTION (PCR) AMPLIFICATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				341	341						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100801
J	CABALLERO, F; GUNCZLER, P				CABALLERO, F; GUNCZLER, P			SEVERE ADRENAL SUPPRESSION IN A 12-YEAR-OLD INDUCED BY BECLOMETHASONA DIPROPIONATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				261	261						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100483
J	CHAND, N; SOFIA, RD				CHAND, N; SOFIA, RD			NOVEL T-CELL-MODULATORY, ANTIINFLAMMATORY AND ANTIASTHMATIC ACTIVITIES OF AZELASTINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									WALLACE LABS,CRANBURY,NJ 08512										0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				163	163						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100090
J	DURHAM, SR; VARNEY, VA; JACOBSON, MR; SUDDERICK, RM; KAY, AB				DURHAM, SR; VARNEY, VA; JACOBSON, MR; SUDDERICK, RM; KAY, AB			EFFECT OF GRASS-POLLEN IMMUNOTHERAPY ON ALLERGEN-INDUCED EARLY AND LATE NASAL RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				290	290						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100598
J	FOLGERT, JP; WEST, SM; HEFLE, SL; CHU, FS; BUSH, RK				FOLGERT, JP; WEST, SM; HEFLE, SL; CHU, FS; BUSH, RK			ISOLATION OF A PEANUT ALLERGEN USING PREPARATIVE ELECTROPHORESIS AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY (HPLC)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				341	341						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100802
J	FRICK, OL; DERER, M; BIGLER, B; DEWECK, AL				FRICK, OL; DERER, M; BIGLER, B; DEWECK, AL			IMMUNODOT ASSAY FOR IGE ANTIBODIES IN ATOPIC DOGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				316	316						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100703
J	FRIERI, M; KARNIK, A; KNAPIK, M				FRIERI, M; KARNIK, A; KNAPIK, M			CYTOKINE DETECTION IN NASAL LAVAGE FLUID IN PATIENTS WITH ALLERGIC RHINITIS AFTER NASAL PROVOCATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				182	182						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100165
J	HAMILTON, RG; CHAROUS, BL; YUNGINGER, JW				HAMILTON, RG; CHAROUS, BL; YUNGINGER, JW			EVALUATION OF CRUDE AND END-PRODUCT LATEX RUBBER AS ALLERGENS FOR IGE ANTI-LATEX ASSAYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				241	241						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100402
J	JAMES, JM; EGGLESTON, PA; SAMPSON, HA				JAMES, JM; EGGLESTON, PA; SAMPSON, HA			FOOD ALLERGY INCREASES AIRWAY REACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				344	344						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100811
J	LIM, M; BAROODY, FM; LEE, BJ; NACLERIO, RM; TAYLOR, RM				LIM, M; BAROODY, FM; LEE, BJ; NACLERIO, RM; TAYLOR, RM			NASAL MUCOSAL CELLULAR-CHANGES AFTER ALLERGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				181	181						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100161
J	MORENO, F; BLANCA, M; MAYORGA, C; TERRADOS, S; FERNANDEZ, J; VEGA, JM; GARCIA, J; PEREZ, E				MORENO, F; BLANCA, M; MAYORGA, C; TERRADOS, S; FERNANDEZ, J; VEGA, JM; GARCIA, J; PEREZ, E			STUDIES ON THE SPECIFICITIES OF IGE ANTIBODIES TO AMOXICILLIN AND BENZYL PENICILLIN USING DIFFERENT PARTS OF THESE MOLECULES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Perez-Inestrosa, Ezequiel/H-9801-2015; Mayorga, Lina/FBO-7730-2022; Mayorga, Cristobalina/D-7167-2018	Perez-Inestrosa, Ezequiel/0000-0001-7546-5273; Mayorga, Cristobalina/0000-0001-8852-8077					0	4	4	0	6	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				361	361						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100881
J	PELIKAN, Z				PELIKAN, Z			EFFECTS OF CETIRIZINE (CZ) ON THE IMMEDIATE (INR) AND LATE NASAL RESPONSE (LNR) AND ON THE EOSINOPHILS IN THE NASAL SECRETIONS (NS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				193	193						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100210
J	RHOADES, RB				RHOADES, RB			SKIN-TEST REACTIVITY TO IMPORTED FIRE ANT (IFA) WHOLE-BODY EXTRACT (WBE) - COMPARISON OF 3 COMMERCIAL SOURCES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				282	282						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100567
J	WARD, GW; HAYDEN, ML; ROSE, G; CALL, R; PLATTSMILLS, T				WARD, GW; HAYDEN, ML; ROSE, G; CALL, R; PLATTSMILLS, T			TRICHOPHYTON ASTHMA - RESPONSE TO ORAL ANTIFUNGAL THERAPY WITH FLUCONAZOLE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1991, J IMMUNOL, V147, P96; 1989, LANCET, V1, P859	2	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				226	226						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100342
J	DALES, RE; FYFE, M; SCHWEITZER, I				DALES, RE; FYFE, M; SCHWEITZER, I			DOES FORCED AIR HEATING EXACERBATE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; ENVIRONMENTAL POLLUTION	SEASONAL-VARIATION; INDOOR ENVIRONMENT; CHILDHOOD ASTHMA; GENERAL-PRACTICE; ADMISSION RATES; SPORE COUNTS; HOUSE DUST; TRENDS; MORTALITY; CHILDREN	Asthma morbidity increases in the Canadian autumn coincident with the beginning of home heating. To test the hypothesis that forced air heating exacerbates asthma, 51 subjects were randomly assigned to one of two groups: the intervention (off1-on2) group was instructed to keep their home forced air heating off from September 9 to 17 and then to set the thermostat to 22-degrees-C from 8 PM to 8 AM between September 18 and 25. The concurrent control (off1-off2) group was instructed to keep their forced air heating off during the entire study period. Forty-eight of the 51 subjects randomized recorded morning peak flows, asthma symptoms, and bronchodilator use during the study period. For the intervention group, results before compared with during home heating, respectively, were as follows: mean nocturnal awakenings 0.36 versus 0.36; any breathing difficulties on awakening 82 % versus 73%; mean morning peak flows 406 lpm versus 409 lpm, a difference of 3.3% +/- 6.7% (SEM), p = 0.6. There was a 95% probability that the true change in peak flows with forced air was less than 2%. For the control group, the comparable results were as follows: mean nocturnal awakening 0.40 versus 0.47; breathing difficulties on awakening 40% versus 4 7%; mean morning peak flows 400 lpm versus 399 lpm (p = 0.9). The commencement of forced air heating did not exacerbate asthma in this clinical population and is therefore unlikely to be an important problem for most people suffering from asthma.	UNIV OTTAWA,DEPT MED,OTTAWA K1N 6N5,ONTARIO,CANADA; UNIV OTTAWA,DEPT EPIDEMIOL & COMMUNITY HLTH,OTTAWA K1N 6N5,ONTARIO,CANADA	University of Ottawa; University of Ottawa								AYRES JG, 1986, THORAX, V41, P111, DOI 10.1136/thx.41.2.111; BATES DV, 1990, ENVIRON RES, V51, P51, DOI 10.1016/S0013-9351(05)80182-3; BURGE H, 1990, J ALLERGY CLIN IMMUN, V86, P687, DOI 10.1016/S0091-6749(05)80170-8; DEBLAY F, 1991, J ALLERGY CLIN IMMUN, V88, P919, DOI 10.1016/0091-6749(91)90249-N; DEKKER C, 1991, CHEST, V100, P922, DOI 10.1378/chest.100.4.922; GOLDSTEIN IF, 1980, INT J BIOMETEOROL, V24, P329, DOI 10.1007/BF02250575; HUNTER CA, 1988, INT BIODETERIOR, V24, P81, DOI 10.1016/0265-3036(88)90052-8; KHOT A, 1984, BRIT MED J, V289, P235, DOI 10.1136/bmj.289.6439.235; KNOT A, 1984, BRIT MED J, V289, P233; MAO Y, 1990, CAN J PUBLIC HEALTH, V81, P226; MURRAY AB, 1980, ANN ALLERGY, V45, P347; MURRAY AB, 1983, PEDIATRICS, V71, P418; PEDERSEN PA, 1984, ALLERGY, V39, P165, DOI 10.1111/j.1398-9995.1984.tb02620.x; PLATTSMILLS TA, 1987, J ALLERGY CLIN IMMUN, V809, P755; SALVAGGIO J, 1971, J ALLERGY CLIN IMMUN, V48, P96, DOI 10.1016/0091-6749(71)90091-1; SCHUTZ RW, 1987, RES Q EXERCISE SPORT, V58, P132, DOI 10.1080/02701367.1987.10605437; STRACHAN DP, 1990, THORAX, V45, P382, DOI 10.1136/thx.45.5.382; WEISS KB, 1990, JAMA-J AM MED ASSOC, V263, P2323	18	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1992	90	5					803	807		10.1016/0091-6749(92)90105-B	http://dx.doi.org/10.1016/0091-6749(92)90105-B			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JZ319	1430705				2022-12-18	WOS:A1992JZ31900011
J	MAGNUSSEN, H; RABE, KF				MAGNUSSEN, H; RABE, KF			THE PROTECTIVE EFFECT OF LOW-DOSE INHALED FENOTEROL AGAINST METHACHOLINE AND EXERCISE-INDUCED BRONCHOCONSTRICTION IN ASTHMA - A DOSE-RESPONSE STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; EXERCISE; LOW-DOSE FENOTEROL; AIRWAY HYPERRESPONSIVENESS	RESPIRATORY HEAT-EXCHANGE; COLD AIR; IPRATROPIUM BROMIDE; BRONCHIAL-ASTHMA; HISTAMINE; CHALLENGE; HYPERVENTILATION; TERBUTALINE; INHALATION; SALBUTAMOL	We compared in a randomized, double-blind study the protective effect of low doses of fenoterol on the airway response to exercise during cold air breathing and an inhalation challenge with methacholine. In six asymptomatic asthmatic persons (mean age, 20.3 years) exercise and methacholine challenges were performed under control conditions and 15 minutes after the inhalation from a metered-dose inhaler of either placebo or 30, 50, 100, and 200 mug fenoterol, resulting in 12 separate study sessions within a 3-week period. Airway response was determined by measuring specific airway resistance (sRaw). Exercise tests were standardized by maintaining a constant respiratory heat exchange, with an average (range) of 1.28 (1.15 to 1.45) kcal/min. Methacholine was inhaled at increasing doses until sRaw had doubled (PD100sRaw). Mean postexertional increase of sRaw (SD) after control conditions, placebo, and 30, 50, 100, and 200 mug fenoterol aerosol was 27.8 (6.9), 28.9 (10.0), 7.20 (2.7), 9.33 (3.8), 5.57 (2.3), and 5.28 (1.6) cm H2O . s. Fenoterol aerosol was equally effective at all doses administered, whereas methacholine-induced bronchoconstriction was attenuated in a dose-dependent manner. From these observations we suggest that low-dose fenoterol protects against bronchoconstriction induced by exercise, a naturally occurring stimulus reflecting airway hyperresponsiveness.	GROSSHANSDORF HOSP,CTR PNEUMOL & THORAC SURG,GROSSHANSDORF,GERMANY	Grosshansdorf Hospital			Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401				ANDERSON SD, 1979, J ALLERGY CLIN IMMUN, V5, P544; BELCHER NG, 1989, EUR RESPIR J, V2, P44; BRITTON J, 1988, THORAX, V43, P300, DOI 10.1136/thx.43.4.300; BUNDGAARD A, 1982, ANN ALLERGY, V48, P36; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CRANE J, 1989, LANCET, V1, P917; DEAL EC, 1979, J APPL PHYSIOL, V46, P467, DOI 10.1152/jappl.1979.46.3.467; EMIRGIL C, 1977, ANN ALLERGY, V39, P415; HANLEY SP, 1985, AM REV RESPIR DIS S4, V133, pA177; HEATON RW, 1984, CHEST, V86, P810, DOI 10.1378/chest.86.6.810; HIGGINS BG, 1991, EUR RESPIR J, V4, P415; JORRES R, 1990, ATEMWEG LUNGENKRANK, V7, P259; LARSSON S, ANN ALLERGY, V93, P362; MAGNUSSEN H, 1984, KLIN WOCHENSCHR, V62, P168, DOI 10.1007/BF01731639; MAGNUSSEN H, 1991, CLIN EXP ALLERGY, V21, P379, DOI 10.1111/j.1365-2222.1991.tb01674.x; MALO JL, 1989, AM REV RESPIR DIS, V140, P817, DOI 10.1164/ajrccm/140.3.817; NIJENS HJ, 1982, THORAX, V36, P517; OBYRNE PM, 1982, THORAX, V37, P913, DOI 10.1136/thx.37.12.913; OBYRNE PM, 1982, AM REV RESPIR DIS, V125, P281; PENNOCK BE, 1977, CHEST, V72, P731, DOI 10.1378/chest.72.6.731; SACHS L, 1978, ANGEWANDTE STATISTIK; SALOME CM, 1981, THORAX, V36, P580, DOI 10.1136/thx.36.8.580; SALOME CM, 1983, THORAX, V38, P854, DOI 10.1136/thx.38.11.854; SCHARF SM, 1985, CHEST, V88, P586, DOI 10.1378/chest.88.4.586; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; TATTERSFIELD AE, 1988, AM REV RESPIR DIS, pS64; WONG CS, 1990, LANCET, V336, P1389	27	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1992	90	5					846	851		10.1016/0091-6749(92)90111-E	http://dx.doi.org/10.1016/0091-6749(92)90111-E			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JZ319	1430709				2022-12-18	WOS:A1992JZ31900017
J	ROSSI, GL; YEN, A; BARRETT, KE				ROSSI, GL; YEN, A; BARRETT, KE			IGE AND ADENOSINE-5' TRIPHOSPHATE RECEPTORS ON IMMATURE MURINE MAST-CELLS ARE FUNCTIONALLY LINKED TO SIGNAL TRANSDUCTION MECHANISMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MAST CELLS; CALCIUM; SIGNAL TRANSDUCTION; IGE RECEPTORS; ATP	FC-EPSILON-RI; CALCIUM MOBILIZATION; ATP4 RECEPTOR; BONE-MARROW; T-CELLS; RELEASE; ACETYLCHOLINE	Calcium mobilization in response to IgE-receptor cross-linking by antigen was assessed in immature murine mast cells cultured from bone marrow to determine whether the early expression of IgE receptors on such cells may be of functional significance. IgE receptors were expressed by approximately 30% of cells after 1 week in culture and by an increased proportion at 2 and 3 weeks. The ability of a non-IgE-dependent stimulus, adenosine 5' triphosphate (ATP), to increase intracellular calcium in these cells was also tested. Calcium mobilization in large numbers of individual cells was monitored with use of a fluorimetric reagent and flow cytometry. Both antigen and ATP had significant effects on intracellular calcium in cells cultured for as little as 1 week with interleukin-3, when few cells exhibited morphologic or functional chracteristics of mast cells. Longer times in culture were associated with an increase in the proportion of cells responding to these stimuli with calcium mobilization, but not with a change in the magnitude of the response. We conclude that the early expression of IgE receptors during mast cell development may be functionally significant, since these receptors appear to be linked to cellular signal transduction mechanisms. The data additionally imply a possible role for ATP in mast cell development.	UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,DIV ALLERG & IMMUNOL DIS,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,SCH MED,DIV DERMATOL,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego			Barrett, Kim Elaine/AAE-7762-2019; Barrett, Kim/AAE-2794-2022	Barrett, Kim Elaine/0000-0002-6704-998X; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI024992] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 24992] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENDER JG, 1988, J CELL PHYSIOL, V135, P71, DOI 10.1002/jcp.1041350110; BIENENSTOCK J, 1991, AM REV RESPIR DIS, V143, pS55, DOI 10.1164/ajrccm/143.3_Pt_2.S55; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; COCKCROFT S, 1980, BIOCHEM J, V188, P789, DOI 10.1042/bj1880789; COWEN DS, 1989, J CLIN INVEST, V83, P1651, DOI 10.1172/JCI114064; GOMPERTS BD, 1990, J EXP PATHOL, V71, P423; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; INGERMAN CM, 1979, THROMB RES, V16, P335, DOI 10.1016/0049-3848(79)90081-1; MARQUARDT DL, 1986, AM REV RESPIR DIS, V133, P1105; MARQUARDT DL, 1986, BIOCHEM PHARMACOL, V36, P4297; MOREL N, 1981, J NEUROCHEM, V36, P1766, DOI 10.1111/j.1471-4159.1981.tb00429.x; NEGISHI M, 1991, BIOCHEM BIOPH RES CO, V176, P102, DOI 10.1016/0006-291X(91)90895-E; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; ROJAS E, 1985, FEBS LETT, V185, P323, DOI 10.1016/0014-5793(85)80931-5; ROSSI GL, 1990, AGENTS ACTIONS, V31, P257, DOI 10.1007/BF01997617; SCHWARTZ LB, 1979, J IMMUNOL, V123, P1445; SEDER RA, 1991, J IMMUNOL, V147, P903; TATHAM PER, 1988, EUR J PHARMACOL, V147, P13, DOI 10.1016/0014-2999(88)90628-0; THOMPSON HL, 1990, J CLIN INVEST, V85, P1227, DOI 10.1172/JCI114557; WASSERMAN SI, 1990, J ALLERGY CLIN IMMUN, V86, P590, DOI 10.1016/S0091-6749(05)80221-0	22	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1992	90	5					765	771		10.1016/0091-6749(92)90100-G	http://dx.doi.org/10.1016/0091-6749(92)90100-G			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JZ319	1430702	Bronze			2022-12-18	WOS:A1992JZ31900006
J	ANDO, N; FUKUDA, T; NAKAJIMA, H; MAKINO, S				ANDO, N; FUKUDA, T; NAKAJIMA, H; MAKINO, S			EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IS UP-REGULATED IN THE BRONCHIAL-MUCOSA OF SYMPTOMATIC ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				215	215						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000233
J	BAKER, C; ALTMAN, LC				BAKER, C; ALTMAN, LC			THE EFFECTS OF DEXAMETHASONE (D) AND CROMOLYN SODIUM (CS) ON INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) EXPRESSION ON HUMAN NASAL EPITHELIAL-CELLS (HNE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				212	212						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000221
J	BRENEMAN, D; BERGSTRESSER, P; BOGGS, P; BRONSKY, E; GROSSMAN, J; KALIVAS, J; KLEIN, G; ROTH, H; SOTOR, N; THARP, M; TREGER, C				BRENEMAN, D; BERGSTRESSER, P; BOGGS, P; BRONSKY, E; GROSSMAN, J; KALIVAS, J; KLEIN, G; ROTH, H; SOTOR, N; THARP, M; TREGER, C			A MULTISITE COMPARATIVE-STUDY OF THE EFFICACY AND SAFETY OF CETIRIZINE (C) VS ASTEMIZOLE (A) AND PLACEBO (P) IN THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				249	249						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000370
J	EHNERT, B; LAUSCHADENDORF, S; WEBER, A; WAHN, PBU				EHNERT, B; LAUSCHADENDORF, S; WEBER, A; WAHN, PBU			DOMESTIC CAT AND MITE ALLERGEN EXPOSURE AND HOUSING CONDITIONS OF ATOPIC AND NONATOPIC FAMILIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				312	312						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000623
J	ELLIS, MH; JACOBSON, RS; HOFFMAN, DR				ELLIS, MH; JACOBSON, RS; HOFFMAN, DR			ALLERGY TO SOLENOPSIS-AUREA, AN UNCOMMON NATIVE FIRE ANT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				293	293						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000546
J	FERNANDEZ, J				FERNANDEZ, J			ALLERGENIC ACTIVITY OF DATE PALM (PHOENIX-DACTILIFERA) POLLEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				148	148						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000013
J	HUNT, TC; HEUSSER, C; MUELLER, R; BULLOCK, G; OKAYAMA, Y; ASHMAN, LK; CHURCH, MK				HUNT, TC; HEUSSER, C; MUELLER, R; BULLOCK, G; OKAYAMA, Y; ASHMAN, LK; CHURCH, MK			HUMAN LUNG MAST-CELLS PRODUCE INTERLEUKIN-4	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													ASHMAN, LEONIE/G-7631-2013	ASHMAN, LEONIE/0000-0003-3559-3611					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				245	245						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000353
J	KELSO, JM; JONES, RT; YUNGINGER, JW				KELSO, JM; JONES, RT; YUNGINGER, JW			ANAPHYLAXIS TO MMR VACCINE AND GELATIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				351	351						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000776
J	MCCANN, M; GREINWALD, R; SONNENBORN, U; NELSON, R; GOOD, RA				MCCANN, M; GREINWALD, R; SONNENBORN, U; NELSON, R; GOOD, RA			LONG-LASTING REMISSIONS OF INFLAMMATORY BOWEL-DISEASE PRODUCED BY SUSTAINED RECOLONIZATION WITH NONPATHOGENIC ESCHERICHIA-COLI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				290	290						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000533
J	METZGER, WJ; ATKINSON, LB; HENRIKSEN, RA; FISHER, RH				METZGER, WJ; ATKINSON, LB; HENRIKSEN, RA; FISHER, RH			LOW-MOLECULAR-WEIGHT (LMW) HEPARIN BLOCKS LATE ASTHMATIC RESPONSE (LAR), BRONCHIAL HYPERRESPONSIVENESS (BHR), AND LUNG EOSINOPHILIA IN THE ALLERGIC RABBIT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				235	235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000316
J	MONROE, E; BERNSTEIN, D; BRONSKY, E; HANIFIN, J; PRENNER, B; SCHOENWETTER, W; SPECTOR, S; STAFFORD, C; STROH, J; WANDERER, A; MCNUTT, B; HUSTER, W				MONROE, E; BERNSTEIN, D; BRONSKY, E; HANIFIN, J; PRENNER, B; SCHOENWETTER, W; SPECTOR, S; STAFFORD, C; STROH, J; WANDERER, A; MCNUTT, B; HUSTER, W			A DOUBLE-BLIND, RANDOMIZED, PLACEBO (P) CONTROLLED, PARALLEL STUDY COMPARING THE SAFETY AND EFFICACY OF TERFENADINE (T) 60 MG BID TO HYDROXYZINE (H) 25 MG QID ADMINISTERED FOR 6 TO 12 WEEKS IN THE TREATMENT (TRT) OF CHRONIC IDIOPATHIC URTICARIA (CIU)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				248	248						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000368
J	MUSKEN, H; BERGMANN, KC				MUSKEN, H; BERGMANN, KC			STORAGE MITES - SENSITIZATION AND CLINICAL ALLERGY IN GERMANY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bergmann, Karl-Christian/AAA-4104-2019						0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				258	258						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000408
J	PASMANS, SGMA; AALBERS, M; KNOL, EF; AALBERSE, RC				PASMANS, SGMA; AALBERS, M; KNOL, EF; AALBERSE, RC			IS HUMAN PROFILIN AN IGE DEPENDENT HISTAMINE RELEASING-FACTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV AMSTERDAM,CLB,AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,EXPTL CLIN IMMUNOL LAB,AMSTERDAM,NETHERLANDS	University of Amsterdam; University of Amsterdam			Pasmans, Suzanne/AAI-6016-2021	Pasmans, Suzanne/0000-0003-1018-4475					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				276	276						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000479
J	TEJEDOR, MA; PEREZ, C; DELAHOZ, B; JAUREGUI, I; PURAS, A; ALVAREZCUESTA, E				TEJEDOR, MA; PEREZ, C; DELAHOZ, B; JAUREGUI, I; PURAS, A; ALVAREZCUESTA, E			IDIOPATHIC ANAPHYLAXIS - CLINIC DIFFERENCES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HOSP GEN ALBACETE,ALBACETE,SPAIN				Alonso, Miguel Angel Tejedor/AAM-8217-2021; de la Hoz, Belen/AAA-8067-2019; PRESA, IGNACIO JAUREGUI/U-6625-2019	de la Hoz, Belen/0000-0002-5127-8702; PRESA, IGNACIO JAUREGUI/0000-0001-9721-7246					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				349	349						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000770
J	BUSSE, W				BUSSE, W			EXERCISED-INDUCED ASTHMA - A ROLE FOR THE EOSINOPHIL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							CIRCULATING BASOPHILS; PULMONARY-FUNCTION; PLASMA HISTAMINE; MEDIATORS; HEAT				BUSSE, W (corresponding author), UNIV WISCONSIN,SCH MED,J5 220 CLIN SCI CTR,600 HIGHLAND AVE,MADISON,WI 53792, USA.							ANDERSON SD, 1989, ALLERGY PROC, V10, P215, DOI 10.2500/108854189778960054; ANDERSON SD, 1975, BRIT J DIS CHEST, V69, P1; ANDERSON SD, 1985, J ALLERGY CLIN IMMUN, V76, P763, DOI 10.1016/0091-6749(85)90745-6; BADER D, 1987, J PEDIATR-US, V110, P693, DOI 10.1016/S0022-3476(87)80004-5; BARNES PJ, 1981, CLIN SCI, V61, P159, DOI 10.1042/cs0610159; BROIDE DH, 1990, AM REV RESPIR DIS, V141, P563, DOI 10.1164/ajrccm/141.3.563; CHEN WY, 1977, RESPIRATION, V34, P305, DOI 10.1159/000193842; DEAL EC, 1979, J APPL PHYSIOL, V46, P467, DOI 10.1152/jappl.1979.46.3.467; DEAL EC, 1980, J CLIN INVEST, V65, P659, DOI 10.1172/JCI109711; EGGLESTON PA, 1984, AM REV RESPIR DIS, V130, P86; FINDLAY SR, 1981, J CLIN INVEST, V67, P604; FINNEY MJB, 1987, RESP PHYSIOL, V69, P277, DOI 10.1016/0034-5687(87)90082-X; GODFREY S, 1984, J ALLERGY CLIN IMMUN, V73, P630, DOI 10.1016/0091-6749(84)90295-1; HOWARTH PH, 1984, J ALLERGY CLIN IMMUN, V73, P391, DOI 10.1016/0091-6749(84)90414-7; LEE TH, 1982, J ALLERGY CLIN IMMUN, V70, P73, DOI 10.1016/0091-6749(82)90232-9; LEMANSKE RF, 1989, PERSPECTIVES EXERCIS, V2, P465; LOUGHLIN GM, 1979, J PEDIATR-US, V94, P365, DOI 10.1016/S0022-3476(79)80572-7; MCFADDEN ER, 1990, LANCET, V335, P880, DOI 10.1016/0140-6736(90)90478-N; MCFADDEN ER, 1986, J CLIN INVEST, V78, P18, DOI 10.1172/JCI112549; MCFADDEN ER, 1987, NEW ENGL J MED, V317, P502, DOI 10.1056/NEJM198708203170809; MCFADDEN ER, 1982, J CLIN INVEST, V69, P700, DOI 10.1172/JCI110498; MCFADDEN ER, 1987, CHEST, V91, P515; MORGAN DJR, 1983, THORAX, V38, P771, DOI 10.1136/thx.38.10.771; PIERSON WE, 1972, J ALLERGY CLIN IMMUN, V49, P129; SHOEFFEL RE, 1981, BRIT MED J, V283, P1285; VENGE P, 1991, J ALLERGY CLIN IMMUN, V88, P699, DOI 10.1016/0091-6749(91)90175-N; VENGE P, 1989, EUR RESPIR J S6, V2, P4305	27	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1991	88	5					696	698		10.1016/0091-6749(91)90174-M	http://dx.doi.org/10.1016/0091-6749(91)90174-M			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GQ452	1955629	Bronze			2022-12-18	WOS:A1991GQ45200002
J	SHEFFER, AL; FINK, JN				SHEFFER, AL; FINK, JN			ASTHMA 90 - IMMUNOPHARMACOLOGICAL UPDATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											SHEFFER, AL (corresponding author), HARVARD UNIV,SCH MED,BOSTON,MA 02115, USA.								0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1991	88	3	1				303	303		10.1016/0091-6749(91)90092-3	http://dx.doi.org/10.1016/0091-6749(91)90092-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GG126					2022-12-18	WOS:A1991GG12600003
J	MULLARKEY, MF				MULLARKEY, MF			METHOTREXATE AND ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							CORTICOSTEROID-DEPENDENT ASTHMA; JUVENILE RHEUMATOID-ARTHRITIS				MULLARKEY, MF (corresponding author), VIRGINIA MASON CLIN,1100 9TH AVE,POB 900,SEATTLE,WA 98111, USA.							ASMUNDSSON T, 1971, J ALLERGY, V47, P136, DOI 10.1016/S0091-6749(71)80292-0; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BLEYER WA, 1985, AM ASS CLIN CHEM, V6, P1; COHEN EP, 1965, ANN INTERN MED, V62, P103, DOI 10.7326/0003-4819-62-1-103; DIAZ CJ, 1951, ANN RHEUM DIS, V10, P144, DOI 10.1136/ard.10.2.144; DYER PD, 1991, J ALLERGY CLIN IMMUN, V88, P208, DOI 10.1016/0091-6749(91)90330-Q; FAIRRIS GM, 1989, BRIT MED J, V289, P801; FINUCANE KE, 1985, MED J AUSTRALIA, V142, P602, DOI 10.5694/j.1326-5377.1985.tb113530.x; GUBNER R, 1951, AM J MED SCI, V221, P176, DOI 10.1097/00000441-195102000-00009; HEALEY LA, 1986, B RHEUM DIS, V36, P1; KREMER JM, 1989, J RHEUMATOL, V16, P261; MULLARKEY MF, 1990, ANN INTERN MED, V112, P577, DOI 10.7326/0003-4819-112-8-577; MULLARKEY MF, 1988, NEW ENGL J MED, V318, P603, DOI 10.1056/NEJM198803103181004; ROSE CD, 1990, J PEDIATR-US, V117, P653, DOI 10.1016/S0022-3476(05)80709-7; SHINER RJ, 1990, LANCET, V336, P137, DOI 10.1016/0140-6736(90)91659-X; STEINBERG AD, 1973, J ALLERGY CLIN IMMUN, V52, P242, DOI 10.1016/0091-6749(73)90062-6; SUGIHARA H, 1965, DIAGNOSIS TREATMENT, V53, P750; TENNENBAUM JI, 1966, ANN ALLERGY, V24, P37; VOOG R, 1969, PRESSE MED, V77, P1995; WALDBOTT G L, 1952, Ann Allergy, V10, P428; WALLACE CA, 1989, ARTHRITIS RHEUM, V32, P677, DOI 10.1002/anr.1780320604; WILLKENS RF, 1983, AM J MED, V75, P19, DOI 10.1016/0002-9343(83)90324-8; WILSKE KR, 1990, CONT INT MED     JUL, P8	23	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1991	88	2					272	274		10.1016/0091-6749(91)90338-O	http://dx.doi.org/10.1016/0091-6749(91)90338-O			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB225	1880327	Bronze			2022-12-18	WOS:A1991GB22500017
J	VANTOORENENBERGEN, AW; HUIJSKESHEINS, MIE; DIEGES, PH; LEIJNSE, B				VANTOORENENBERGEN, AW; HUIJSKESHEINS, MIE; DIEGES, PH; LEIJNSE, B			OCCUPATIONAL ALLERGY TO PANCREATIC POWDER - CHARACTERIZATION OF IGE-BINDING ANTIGENS IN PANCREATIC EXTRACT BY IMMUNOBLOTTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NITROCELLULOSE IMMUNOPRINT TECHNIQUE; CYSTIC-FIBROSIS; HYPERSENSITIVITY; PARENTS; SERA	The IgE response to inhaled dust of pancreatic powder was studied with sera from two employees of a pharmacy. IgE from both sera was directed against both porcine and bovine trypsin preparations. The major IgE-binding structures had an isoelectric point in the pH 8 to 9 range. The molecular weight of the IgE-binding structures was different for both patients. In one patient, most IgE was directed against a 28 to 30 kd structure, whereas the second patient had IgE directed against components with a molecular weight of 35 and 45 kd, respectively.	ERASMUS UNIV,HOSP DIJKZIGT,DEPT ALLERGOL,3015 GD ROTTERDAM,NETHERLANDS; ERASMUS UNIV,HOSP DIJKZIGT,DEPT CHEM PATHOL,3015 GD ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	VANTOORENENBERGEN, AW (corresponding author), ERASMUS UNIV,HOSP DIJKZIGT,DEPT CLIN CHEM,ALLERGOL LAB,MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS.							BAUER X, 1983, CLIN ALLERGY, V12, P9; BAUER X, 1979, CLIN ALLERGY, V9, P443; BAUER X, 1984, DEUT MED WOCHENSCHR, V109, P257; BENGTSSON A, 1986, INT ARCH ALLER A IMM, V80, P383, DOI 10.1159/000234085; BENGTSSON A, 1985, INT ARCH ALLER A IMM, V78, P139, DOI 10.1159/000233876; BERGNER A, 1975, PEDIATRICS, V55, P814; GANIER M, 1979, CLIN ALLERGY, V9, P125, DOI 10.1111/j.1365-2222.1979.tb01531.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPKIN GW, 1987, LANCET, V1, P392; MOSS DW, 1987, FUNDAMENTALS CLIN CH, P401; Norman P, 1986, MANUAL CLIN LABORATO, P660; PARKES WR, 1982, OCCUPATIONAL LUNG DI, P415; PELTRE G, 1982, IMMUNOL LETT, V5, P127, DOI 10.1016/0165-2478(82)90096-7; PEPYS J, 1969, LANCET, V1, P1181; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; SCHEELE G, 1986, EXOCRINE PANCREAS, P185; Siraganian RP, 1986, MANUAL CLIN LABORATO, P675; TWAROG FJ, 1977, J ALLERGY CLIN IMMUN, V59, P35, DOI 10.1016/0091-6749(77)90174-9; VANTOORENENBERGEN AW, 1988, INT ARCH ALLER A IMM, V86, P117, DOI 10.1159/000234616; VANTOORENENBERGEN AW, 1987, J ALLERGY CLIN IMMUN, V79, P108, DOI 10.1016/S0091-6749(87)80024-6; WIESSMANN KJ, 1985, EUR J RESPIR DIS, V66, P13	21	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1991	87	3					650	654		10.1016/0091-6749(91)90383-Y	http://dx.doi.org/10.1016/0091-6749(91)90383-Y			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FB801	1706368				2022-12-18	WOS:A1991FB80100007
J	MAHAN, C; SPECTOR, SL; SIEGEL, SC; KATZ, RM; RACHELEFSKY, GS; ROHR, AS				MAHAN, C; SPECTOR, SL; SIEGEL, SC; KATZ, RM; RACHELEFSKY, GS; ROHR, AS			MULTITEST VERSUS MORROW BROWN NEEDLE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																		ADINOFF AD, 1989, J ALLERGY CLIN IMMUN, V84, P168, DOI 10.1016/0091-6749(89)90321-7; BASARAN, 1988, J ALLERGY CLIN IMMUN, V81, P171	2	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1990	86	2					275	276		10.1016/S0091-6749(05)80080-6	http://dx.doi.org/10.1016/S0091-6749(05)80080-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DV316	2384658				2022-12-18	WOS:A1990DV31600024
J	REED, MA; BUTCHER, BT				REED, MA; BUTCHER, BT			IMPORTED FIRE ANT (IFA) SENSITIVITY - IFA-SPECIFIC LEVELS OF SERUM IGG AND IGG4	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											REED, MA (corresponding author), TULANE UNIV,DEPT MED,CLIN IMMUNOL SECT,1700 PERDIDO ST,NEW ORLEANS,LA 70112, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021552] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 21552] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAHNA SL, 1988, J ALLERGY CLIN IMMUN, V82, P419, DOI 10.1016/0091-6749(88)90014-0; BUTCHER BT, 1988, INT ARCH ALLER A IMM, V85, P458, DOI 10.1159/000234551; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P33, DOI 10.1016/0091-6749(88)90217-5; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V82, P770, DOI 10.1016/0091-6749(88)90078-4; CHEUNG NKV, 1983, ANN ALLERGY, V50, P155; DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X; DJURUP R, 1985, J ALLERGY CLIN IMMUN, V76, P46, DOI 10.1016/0091-6749(85)90803-6; DJURUP R, 1985, ALLERGY, V40, P469, DOI 10.1111/j.1398-9995.1985.tb00253.x; GOLDEN DBK, 1982, J ALLERGY CLIN IMMUN, V69, P489, DOI 10.1016/0091-6749(82)90172-5; GOLDEN DBK, 1981, JAMA-J AM MED ASSOC, V246, P2460, DOI 10.1001/jama.246.21.2460; GRANT JA, 1981, J ALLERGY CLIN IMMUN, V68, P112, DOI 10.1016/0091-6749(81)90168-8; HALPERN GM, 1986, IMMUNOL ALLERGY PRAC, V8, P386; HOFFMAN DR, 1985, J ALLERGY CLIN IMMUN, V75, P606, DOI 10.1016/0091-6749(85)90037-5; HOLLANDER M, 1973, NONPARAMETRIC STATIS; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; MALLING HJ, 1985, ALLERGY, V40, P373, DOI 10.1111/j.1398-9995.1985.tb00250.x; MOSS RB, 1987, J ALLERGY CLIN IMMUN, V79, P387, DOI 10.1016/0091-6749(87)90160-6; NAKAGAWA T, 1985, INT ARCH ALLER A IMM, V77, P204, DOI 10.1159/000233787; OHASHI Y, 1987, ANN OTO RHINOL LARYN, V96, P434, DOI 10.1177/000348948709600417; RHOADES RB, 1988, J ALLERGY CLIN IMMUN, V81, P202, DOI 10.1016/0091-6749(88)90373-9; STABLEIN JJ, 1987, CLIN REV ALLERG, V5, P161; TRIPLETT RF, 1976, SOUTHERN MED J, V69, P258, DOI 10.1097/00007611-197603000-00002; URBANEK R, 1986, MONATSSCHR KINDERH, V134, P536; URBANEK R, 1986, CLIN ALLERGY, V16, P317, DOI 10.1111/j.1365-2222.1986.tb01963.x; 1985, STATISTIX INTERACTIV; 1985, ELISAMATE ENZYME IMM	26	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					737	742		10.1016/0091-6749(90)90192-7	http://dx.doi.org/10.1016/0091-6749(90)90192-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2324412				2022-12-18	WOS:A1990DA43700009
J	ZEIGER				ZEIGER			CORRECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		ZEIGERRS, 1989, J ALLERGYY CLIN IMMU, V84, P72	1	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1989	84	5	1				677	677						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA314					2022-12-18	WOS:A1989CA31400004
J	MANSFIELD, LE; TAN, M; MARTINEZ, G; RAEL, E; HARRIS, NS				MANSFIELD, LE; TAN, M; MARTINEZ, G; RAEL, E; HARRIS, NS			USE OF ENZYME-DEVELOPED IMMUNOBLOTS SCANNED BY DENSITOMETRY TO COMPARE LOT-TO-LOT VARIABILITY OF RUSSIAN-THISTLE EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV TEXAS,EL PASO INST MED RES & DEV,EL PASO,TX 79968; TEXAS TECH REG HLTH SCI CTR,EL PASO,TX	University of Texas System; University of Texas El Paso; Texas Tech University System; Texas Tech University Health Science Center								ANDERSON MC, 1984, RAST INHIBITION PROC; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BURKS AW, 1988, J ALLERGY CLIN IMMUN, V81, P1135, DOI 10.1016/0091-6749(88)90881-0; CRETICOS PS, 1986, CLIN REV ALLERG, V4, P355; DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9; FORD SA, 1987, J ALLERGY CLIN IMMUN, V79, P711, DOI 10.1016/0091-6749(87)90201-6; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; HAMPTON SF, 1949, J ALLERGY, V20, P19, DOI 10.1016/0021-8707(49)90080-5; LOWENSTEIN H, 1983, J IMMUNOL, V130, P727; Lowenstein H, 1978, Prog Allergy, V25, P1, DOI 10.1159/000314432; MARSH DG, 1975, ANTIGENS, V3, P271; Nelson H, 1980, J ALLERGY CLIN IMMUN, V67, P64; NORMAN PS, 1986, J ALLERGY CLIN IMMUN, V77, P405, DOI 10.1016/0091-6749(86)90173-9; NORMAN PS, 1982, J ALLERGY CLIN IMMUN, V69, P1, DOI 10.1016/0091-6749(82)90079-3; NORMAN PS, 1971, IMMUNOLOGICAL DISEAS, P840; NORMAN PS, 1971, J ALLERGY CLIN IMMUN, P840; TEE RD, 1987, J ALLERGY CLIN IMMUN, V79, P627, DOI 10.1016/S0091-6749(87)80159-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURKELTAUB PC, 1986, CLIN REV ALLERG, V4, P371; 1974, J ALLERGY CLIN IMMUN, V54, P305	20	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	1				529	537		10.1016/0091-6749(89)90367-9	http://dx.doi.org/10.1016/0091-6749(89)90367-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW760	2794296				2022-12-18	WOS:A1989AW76000015
J	BECKER, AB; CHUNG, KF; AIZAWA, H; FRICK, OL; GOLD, WM				BECKER, AB; CHUNG, KF; AIZAWA, H; FRICK, OL; GOLD, WM			INHIBITION OF THE CUTANEOUS RESPONSE TO ANTIGEN BY A THROMBOXANE-SYNTHETASE INHIBITOR (OKY-046) IN ALLERGIC DOGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,1327-M,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Chung, Kian Fan/I-8456-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015233] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-24136] Funding Source: Medline; NIAID NIH HHS [R01 AI15233] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AIZAWA H, 1985, J APPL PHYSIOL, V59, P1918, DOI 10.1152/jappl.1985.59.6.1918; BECKER AB, 1988, J ALLERGY CLIN IMMUN, V81, P441, DOI 10.1016/0091-6749(88)90914-1; BECKER AB, 1985, ANAT REC, V213, P477, DOI 10.1002/ar.1092130402; BECKER AB, 1986, J ALLERGY CLIN IMMUN, V78, P937, DOI 10.1016/0091-6749(86)90243-5; BOURNE HR, 1971, SCIENCE, V175, P743; CHUNG KF, 1986, J PHARMACOL EXP THER, V236, P580; CHUNG KF, 1986, AM REV RESPIR DIS, V134, P258; CHUNG KF, 1985, J APPL PHYSIOL, V58, P1347, DOI 10.1152/jappl.1985.58.4.1347; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; COLEMAN RA, 1981, BRIT J PHARMACOL, V73, P773, DOI 10.1111/j.1476-5381.1981.tb16814.x; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; DORSCH W, 1981, J ALLERGY CLIN IMMUN, V67, P117, DOI 10.1016/0091-6749(81)90006-3; DORSCH W, 1982, J ALLERGY CLIN IMMUN, V70, P236, DOI 10.1016/0091-6749(82)90059-8; ELIAS H, 1983, GUIDE PRACTICAL STER, P75; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289, DOI 10.1111/apm.1966.66.3.289; FRICK OL, 1983, AM J VET RES, V44, P440; FUKUMOTO S, 1983, PROSTA LEUKOTR MED, V11, P179, DOI 10.1016/0262-1746(83)90018-5; GOMORI G, 1953, J HISTOCHEM CYTOCHEM, V1, P469, DOI 10.1177/1.6.469; GORMAN RR, 1983, PROSTAGLANDINS, V26, P325, DOI 10.1016/0090-6980(83)90099-0; IIZUKA K, 1981, J MED CHEM, V24, P1139, DOI 10.1021/jm00142a005; LEDER L-D, 1979, American Journal of Dermatopathology, V1, P39; MCMANUS JFA, 1960, STAINING METHODS HIS, P65; NAITO J, 1983, EUR J PHARMACOL, V91, P41, DOI 10.1016/0014-2999(83)90359-X; OBYRNE PM, 1984, PROSTAGLANDINS, V28, P537, DOI 10.1016/0090-6980(84)90242-9; OBYRNE PM, 1985, J APPL PHYSIOL, V59, P1941, DOI 10.1152/jappl.1985.59.6.1941; OGAWA K, 1983, ADV PROSTAGLANDIN TH, P371; SMOLEN AJ, 1983, J NEUROCYTOL, V12, P739, DOI 10.1007/BF01258148; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; WALTERS EH, 1984, J APPL PHYSIOL, V57, P129, DOI 10.1152/jappl.1984.57.1.129	29	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1989	84	2					206	213		10.1016/0091-6749(89)90326-6	http://dx.doi.org/10.1016/0091-6749(89)90326-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL836	2760361				2022-12-18	WOS:A1989AL83600011
J	CREER, TL; MCLOUGHLIN, JA				CREER, TL; MCLOUGHLIN, JA			THE EFFECTS OF THEOPHYLLINE ON COGNITIVE AND BEHAVIORAL PERFORMANCE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV LOUISVILLE,SCH EDUC,LOUISVILLE,KY 40292	University of Louisville	CREER, TL (corresponding author), OHIO UNIV,DEPT PSYCHOL,ATHENS,OH 45701, USA.							ACHENBACH TM, 1983, CHILD BEHAVIOR CHECK; BAER RA, 1987, J APPL BEHAV ANAL, V20, P225, DOI 10.1901/jaba.1987.20-225; CREER TL, IN PRESS PEDIATRICS; CREER TL, IN PRESS PED ASTHMA; CURATOLO PW, 1983, ANN INTERN MED, V98, P641, DOI 10.7326/0003-4819-98-5-641; FURUKAWA CT, 1988, J ALLERGY CLIN IMMUN, V81, P83, DOI 10.1016/0091-6749(88)90224-2; FURUKAWA CT, 1989, J ALLERGY CLIN IMMUN, V83, P1140; FURUKAWA CT, 1989, J ALLERGY CLIN IMMUN, V83, P1142; LERNER JA, 1989, J ALLERGY CLIN IMMUN, V83, P1141; MORRIS RD, 1988, J CONSULT CLIN PSYCH, V56, P789; TAYLOR HG, 1988, J CONSULT CLIN PSYCH, V56, P795, DOI 10.1037/0022-006X.56.6.795; WALLACE G, 1988, LEARNING DISABILITIE; WEINBERGER M, 1987, J PEDIATR-US, V111, P471, DOI 10.1016/S0022-3476(87)80483-3; WEINBERGER M, 1989, J ALLERGY CLIN IMMUN, V83, P1139; 1987, LEARNING DISABILITIE; 1987, DIAGNOSTIC STANDARD	16	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1989	83	6					1027	1029		10.1016/0091-6749(89)90442-9	http://dx.doi.org/10.1016/0091-6749(89)90442-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	AC235	2732403	Bronze			2022-12-18	WOS:A1989AC23500003
J	KEAHEY, TM; INDRISANO, J; KALINER, MA				KEAHEY, TM; INDRISANO, J; KALINER, MA			DISSOCIATION OF CUTANEOUS VASCULAR-PERMEABILITY AND THE DEVELOPMENT OF CUTANEOUS LATE-PHASE ALLERGIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,ALLERG DIS SECT,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								ATKINS P, 1973, J ALLERGY CLIN IMMUN, V51, P263, DOI 10.1016/0091-6749(73)90128-0; BJORK J, 1982, INFLAMMATION, V6, P189, DOI 10.1007/BF00916243; CHANG RLS, 1975, BIOPHYS J, V15, P887, DOI 10.1016/S0006-3495(75)85863-2; DESHAZO RD, 1979, J IMMUNOL, V122, P692; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; DURHAM SR, 1984, NEW ENGL J MED, V311, P1398, DOI 10.1056/NEJM198411293112202; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; DVORACEK JE, 1984, J ALLERGY CLIN IMMUN, V73, P363, DOI 10.1016/0091-6749(84)90409-3; GALLIN JI, 1984, CLIN RES, V32, P320; LEMANSKE R, 1982, CRC CRIT REV IMMUNOL, V1, P547; LEMANSKE RF, 1983, INT J DERMATOL, V22, P401, DOI 10.1111/j.1365-4362.1983.tb02158.x; LEMANSKE RF, 1983, J IMMUNOL, V130, P1881; LEMANSKE RF, 1983, J IMMUNOL, V130, P2837; LETTBROWN MA, 1984, CELL IMMUNOL, V87, P445, DOI 10.1016/0008-8749(84)90013-3; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; ODONNELL MC, 1983, J EXP MED, V157, P1981, DOI 10.1084/jem.157.6.1981; OERTEL HL, 1981, J IMMUNOL, V127, P1398; PIENKOWSKI M, 1984, Journal of Allergy and Clinical Immunology, V73, P147; SCHULMAN ES, 1985, AM REV RESPIR DIS, V131, P230; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; TALBOT SF, 1984, J ALLERGY CLIN IMMUN, V74, P819, DOI 10.1016/0091-6749(84)90185-4; TANNENBAUM S, 1980, J IMMUNOL, V125, P325; WELLER PF, 1983, P NATL ACAD SCI-BIOL, V80, P7626, DOI 10.1073/pnas.80.24.7626; WHITE MV, 1987, J IMMUNOL, V139, P1624	27	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1989	83	3					669	676		10.1016/0091-6749(89)90081-X	http://dx.doi.org/10.1016/0091-6749(89)90081-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T8596	2926085	Bronze			2022-12-18	WOS:A1989T859600015
J	VANHOEYVELD, EM; LEJOLY, M; WALRAVENS, MJF; STEVENS, EAM				VANHOEYVELD, EM; LEJOLY, M; WALRAVENS, MJF; STEVENS, EAM			ANALYSIS OF THE STABILIZING EFFECT OF EPSILON-AMINOCAPROIC ACID BY ELECTROPHORETIC TECHNIQUES AND IMMUNOBLOTTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CATHOLIC UNIV LEUVEN,HOSP ST RAFAEL,DEPT MED,DIV CLIN IMMUNOL,CLIN IMMUNOL LAB,B-3000 LOUVAIN,BELGIUM	KU Leuven								ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; ANDERSON MC, 1983, RAST INHIBITION ISOE, P113; ARAKAWA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P169, DOI 10.1016/0003-9861(83)90201-1; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; AYUSO R, 1984, ANN ALLERGY, V53, P426; BAER H, 1980, J ALLERGY CLIN IMMUN, V66, P281, DOI 10.1016/0091-6749(80)90022-6; BOUSQUET J, 1985, CLIN ALLERGY, V15, P29, DOI 10.1111/j.1365-2222.1985.tb02251.x; DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9; FRANCIS DM, 1976, CONTRIB MINERAL PETR, V58, P51, DOI 10.1007/BF00384744; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; HAAS H, 1986, INT ARCH ALLER A IMM, V79, P434, DOI 10.1159/000234014; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARSH DG, 1981, J ALLERGY CLIN IMMUN, V67, P206, DOI 10.1016/0091-6749(81)90063-4; MARTINDALE L, 1982, EXTRA PHARMACOPOEIA, P733; NELSON HS, 1981, J ALLERGY CLIN IMMUN, V67, P64, DOI 10.1016/0091-6749(81)90047-6; PELTRE G, 1982, IMMUNOL LETT, V5, P127, DOI 10.1016/0165-2478(82)90096-7; PELTRE G, 1984, APPLICATION NITROCEL, P121; TOVEY ER, 1985, INT ARCH ALLER A IMM, V76, P82, DOI 10.1159/000233667; VANHOEYVELD EM, 1985, J ALLERGY CLIN IMMUN, V76, P543, DOI 10.1016/0091-6749(85)90773-0; VIK H, 1983, INT ARCH ALLER A IMM, V71, P47, DOI 10.1159/000233361	21	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1989	83	3					601	609		10.1016/0091-6749(89)90072-9	http://dx.doi.org/10.1016/0091-6749(89)90072-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T8596	2926082				2022-12-18	WOS:A1989T859600006
J	ALAM, R; WELTER, J; FORSYTHE, P; BOUSQUET, J; RANKIN, J; BOYARS, M; LETTBROWN, MA; GRANT, JA				ALAM, R; WELTER, J; FORSYTHE, P; BOUSQUET, J; RANKIN, J; BOYARS, M; LETTBROWN, MA; GRANT, JA			HISTAMINE-RELEASE INHIBITORY FACTORS (HRIF) AND HISTAMINE RELEASING FACTORS (HRF) IN BRONCHOALVEOLAR LAVAGE (BAL) FLUIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					236	236						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900278
J	ALFRAYH, A; HASNAIN, SM; HARFI, HA				ALFRAYH, A; HASNAIN, SM; HARFI, HA			RESPIRATORY ALLERGY AND AERO ALLERGENS IN SAUDI-ARABIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Hasnain, Syed M./AAF-9368-2020	Hasnain, Syed M./0000-0001-6930-3497					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					198	198						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900129
J	BUCKLEY, R; SCHIFF, R; SCHIFF, S; MARKERT, L; GERBER, P; PARADISE, C				BUCKLEY, R; SCHIFF, R; SCHIFF, S; MARKERT, L; GERBER, P; PARADISE, C			RECOMBINANT HUMAN INTERLEUKIN-2 (RHIL-2) THERAPY IN PRIMARY IMMUNODEFICIENCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					296	296						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900521
J	GODARD, P; CHANEZ, P; HORST, V; CLAUZEL, AM; MICHEL, FB; BOUSQUET, J				GODARD, P; CHANEZ, P; HORST, V; CLAUZEL, AM; MICHEL, FB; BOUSQUET, J			EVALUATION OF A SYMPTOM-MEDICATION SCORE FOR CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					175	175						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900038
J	JENEY, E; RAPHAEL, G; MEREDITH, S; BARANIUK, J; KALINER, M				JENEY, E; RAPHAEL, G; MEREDITH, S; BARANIUK, J; KALINER, M			NASAL SECRETIONS IN RECURRENT SINUSITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					214	214						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900191
J	JOOS, GF; KIPS, JC; PUTTEMANS, M; PAUWELS, RA; VANDERSTRAETEN, ME				JOOS, GF; KIPS, JC; PUTTEMANS, M; PAUWELS, RA; VANDERSTRAETEN, ME			THE EFFECT OF AEROSOLIZED SKF-104353-Z2 ON BRONCHOCONSTRICTION INDUCED BY INHALED LEUKOTRIENE-D4 IN ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					187	187						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900085
J	KAISER, H; WEISBERG, S; MORRIS, R; MANSMANN, H; MITCHELL, D; SETTIPANE, G; TINKELMAN, D; ALTMAN, R; LOVE, S; SAMUELS, L				KAISER, H; WEISBERG, S; MORRIS, R; MANSMANN, H; MITCHELL, D; SETTIPANE, G; TINKELMAN, D; ALTMAN, R; LOVE, S; SAMUELS, L			A COMPARISON OF CETRIZINE AND CHLORPHENIRAMINE VS PLACEBO IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					306	306						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900558
J	MASSEY, W; COHAN, V; BAGAVAN, B; KAGEYSOBOTKA, A; LICHTENSTEIN, LM				MASSEY, W; COHAN, V; BAGAVAN, B; KAGEYSOBOTKA, A; LICHTENSTEIN, LM			THE ISOLATION AND CHARACTERIZATION OF HUMAN UTERINE MAST-CELLS (UMC)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					233	233						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900268
J	MENON, V; MENON, P; HILLMAN, B; STANKUS, R; LEHRER, S				MENON, V; MENON, P; HILLMAN, B; STANKUS, R; LEHRER, S			AMERICAN (PERIPLANETA-AMERICANA) AND GERMAN (BLATELLA-GERMANICA) GERMANICA) COCKROACH SKIN-TEST REACTIVITY IN ATOPIC ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					265	265						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900395
J	VIRANT, F; BAKER, C; KOENIG, J; MARSHALL, S; WILLIAMS, P; MCMANUS, M; LUCHTEL, D; ALTMAN, L				VIRANT, F; BAKER, C; KOENIG, J; MARSHALL, S; WILLIAMS, P; MCMANUS, M; LUCHTEL, D; ALTMAN, L			OZONE MEDIATED INJURY OF HUMAN NASAL EPITHELIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					266	266						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900400
J	WARNER, JO; NIKOLAIZIK, W; MARCHANT, JL; LAW, CM; PREECE, MA				WARNER, JO; NIKOLAIZIK, W; MARCHANT, JL; LAW, CM; PREECE, MA			THE SYSTEM EFFECTS OF INHALED CORTICOSTEROIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Warner, John/AAF-9587-2020						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					220	220						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900217
J	HILL, M; HENDELES, L				HILL, M; HENDELES, L			EVALUATION OF AN OFFICE METHOD OF MEASURING THEOPHYLLINE SERUM CONCENTRATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV FLORIDA,J HILLIS MILLER HLTH CTR,COLL PHARM,DEPT PHARM PRACTICE,BOX J-486,GAINESVILLE,FL 32610; UNIV FLORIDA,DIV PEDIAT CLIN PHARMACOL TOXICOL,GAINESVILLE,FL 32611	State University System of Florida; University of Florida; State University System of Florida; University of Florida								BONHAM A, 1980, AM REV RESPIR DIS, V122, P829; GINCHANSKY E, 1977, J PEDIATR-US, V91, P655, DOI 10.1016/S0022-3476(77)80527-1; HENDELES L, 1977, DRUG INTEL CLIN PHAR, V11, P12, DOI 10.1177/106002807701100101; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; JOHNSON CE, 1984, AM J HOSP PHARM, V41, P2065, DOI 10.1093/ajhp/41.10.2065; KOUP JR, 1978, AM REV RESPIR DIS, V117, P1135; LOTNER GZ, 1985, ANN ALLERGY, V55, P454; NEIJENS HJ, 1985, J PEDIATR-US, V107, P811, DOI 10.1016/S0022-3476(85)80426-1; ORCUTT JJ, 1977, CLIN CHEM, V23, P599; SHAW KN, 1988, J PEDIATR-US, V112, P131, DOI 10.1016/S0022-3476(88)80138-0; SHEINER LB, 1981, J PHARMACOKINET BIOP, V9, P503, DOI 10.1007/BF01060893; VAUGHAN LM, 1986, LANCET, V1, P184; VAUGHAN LM, 1986, DRUG INTEL CLIN PHAR, V20, P118, DOI 10.1177/106002808602000204; WEINBERG.MM, 1974, J PEDIATR-US, V84, P421; WOLFE JD, 1978, NEW ENGL J MED, V298, P363, DOI 10.1056/NEJM197802162980703	15	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1988	82	1					30	34		10.1016/0091-6749(88)90047-4	http://dx.doi.org/10.1016/0091-6749(88)90047-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P4004	3392368				2022-12-18	WOS:A1988P400400006
J	RANDOLPH, C; LAPEY, A; SHANNON, DC				RANDOLPH, C; LAPEY, A; SHANNON, DC			BILATERAL ABDUCTOR PARESIS MASQUERADING AS ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MASSACHUSETTS GEN HOSP,CHILDRENS SERV,PEDIAT PULM UNIT,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital								BLUESTONE CD, 1972, ANN OTO RHINOL LARYN, V81, P778, DOI 10.1177/000348947208100604; CHRISTOPHER KL, 1983, NEW ENGL J MED, V308, P1566, DOI 10.1056/NEJM198306303082605; CORMIER Y, 1979, CHEST, V75, P423, DOI 10.1378/chest.75.4.423; DECAMPORA E, 1985, J LARYNGOL OTOL, V99, P379, DOI 10.1017/S0022215100096870; EJNELL H, 1984, LARYNGOSCOPE, V94, P954; ESKEW JR, 1983, OTOLARYNG HEAD NECK, V91, P294, DOI 10.1177/019459988309100317; FRIEDMAN S, 1966, LARYNGOSCOPE, V76, P1520, DOI 10.1002/lary.5540760903; GACEK RR, 1977, ANN OTO RHINOL LARYN, V86, P770, DOI 10.1177/000348947708600610; GRUNDFAST KM, 1982, ANN OTO RHINOL LARYN, V91, P564, DOI 10.1177/000348948209100604; HOLINGER LD, 1976, ANN OTO RHINOL LARYN, V85, P428, DOI 10.1177/000348947608500402; HOLINGER PC, 1978, J PEDIATR-US, V92, P368, DOI 10.1016/S0022-3476(78)80421-1; HOLINGER PC, 1979, ANN OTO RHINOL LARYN, V88, P205, DOI 10.1177/000348947908800210; HOLINGER PC, 1980, J NERV MENT DIS, V168, P46, DOI 10.1097/00005053-198001000-00009; KIRCHNER FR, 1979, LARYNGOSCOPE, V89, P1779; LAKIN RC, 1984, CHEST, V86, P499, DOI 10.1378/chest.86.3.499; LIM RY, 1985, ARCH OTOLARYNGOL, V111, P262; MORELLI G, 1982, ANN OTO RHINOL LARYN, V91, P323, DOI 10.1177/000348948209100319; OTTO RA, 1985, AM J SURG, V150, P447, DOI 10.1016/0002-9610(85)90151-5; OTTO RA, 1985, OTOLARYNG HEAD NECK, V93, P634, DOI 10.1177/019459988509300512; PLOTT D, 1964, NEW ENGL J MED, V271, P593, DOI 10.1056/NEJM196409172711203; REMSEN K, 1985, OTOLARYNG HEAD NECK, V93, P645, DOI 10.1177/019459988509300514; SCHMIDTNOWARA WW, 1984, ARCH NEUROL-CHICAGO, V41, P567, DOI 10.1001/archneur.1984.04050170117030; TENHOLDER MF, 1987, IMMUNOL ALLERGY PRAC, V9, P33; THORNELL WC, 1949, ARCH OTOLARYNGOL, V50, P634	24	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1988	81	6					1122	1125		10.1016/0091-6749(88)90879-2	http://dx.doi.org/10.1016/0091-6749(88)90879-2			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P0023	3379224	Bronze			2022-12-18	WOS:A1988P002300009
J	FURUKAWA, CT				FURUKAWA, CT			CONDUCTIVE HEARING-LOSS AND SPEECH DEVELOPMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BAX M, 1981, INFANTS RISK PEDIATR, V5, P106; BENNETT FC, 1980, PEDIATRICS, V66, P254; BIERMAN CW, 1978, PEDIATRICS, V61, P768; BLUESTONE CD, 1979, ANN OTO RHINOL LARYN, V88, P13, DOI 10.1177/00034894790880S503; BLUESTONE CD, 1983, PEDIATRICS, V71, P639; BOND GL, 1935, TEACHERS CONTRIBUTIO, V657; BROOKS DN, 1979, ANN OTO RHINOL LARYN, V88, P29, DOI 10.1177/00034894790880S504; BURT C, 1950, BACKWARD CHILD; COHEN D, 1972, CAN J OTOLARYNGOL, V1, P27; COOPER JC, 1977, LARYNGOSCOPE, V87, P92; DALZELL J, 1976, BRIT J AUDIOL, V10, P87; DOWNS MP, 1975, PUBLIC HEALTH REV, V4, P255; DOWNS MP, 1977, CHILDHOOD DEAFNESS C, P95; FRIEDMAN PA, 1983, J ALLERGY CLIN IMMUN, V71, P442; FRIELPATTI S, 1982, PEDIATR INFECT DIS J, V1, P104, DOI 10.1097/00006454-198203000-00008; HAMILTON P, 1974, BRIT J AUDIOL, V8, P27; HARBERT F, 1970, EYE EAR NOSE THROAT, V49, P409; HOLM VA, 1969, PEDIATRICS, V43, P833; Howie V M, 1980, J Dev Behav Pediatr, V1, P34; KAPLAN GJ, 1973, PEDIATRICS, V52, P577; Katz J, 1978, ASHA, V20, P879; KRAEMER MJ, 1983, JAMA-J AM MED ASSOC, V249, P1022, DOI 10.1001/jama.249.8.1022; LEWIS N, 1976, ARCH OTOLARYNGOL, V102, P387; LING D, 1972, OTITIS MEDIA, P249; MASTERS L, 1978, J LEARN DISABIL, V11, P103, DOI 10.1177/002221947801100207; MENYUK P, 1980, ANN OTO RHINOL LARYN, V89, P257, DOI 10.1177/00034894800890S360; MENYUK P, 1979, LANGUAGE ACQUISITION; MENYUK P, 1977, HEARING LOSS CHILDRE, P621; Menyuk P, 1977, LANGUAGE MATURATION; NEEDLEMAN H, 1977, HEARING LOSS CHILDRE, P642; PARADISE JL, 1976, ANN OTO RHINOL LARYN, V85, P285, DOI 10.1177/00034894760850S254; PARADISE JL, 1981, PEDIATRICS, V68, P869; RAPIN I, 1979, ANN OTO RHINOL LARYN, V88, P3, DOI 10.1177/00034894790880S502; ROBERTS JE, 1986, PEDIATRICS, V78, P423; SAK RJ, 1981, ANN OTO RHINOL LARYN, V90, P546, DOI 10.1177/000348948109000607; TEELE DW, 1983, JAMA-J AM MED ASSOC, V249, P1026, DOI 10.1001/jama.249.8.1026; TEELE DW, 1984, PEDIATRICS, V74, P282; VENTRY IM, 1980, J SPEECH HEAR DISORD, V45, P143, DOI 10.1044/jshd.4502.143; WIEDERHOLD ML, 1980, ANN OTO RHINOL LARYN, V89, P185, DOI 10.1177/00034894800890S343; ZINKUS PW, 1978, AM J DIS CHILD, V132, P1100, DOI 10.1001/archpedi.1978.02120360056010; ZINKUS PW, 1980, AM J DIS CHILD, V134, P94, DOI 10.1001/archpedi.1980.02130130076031; 1984, MIDDLE EAR DISEASE L; 1956, HEARING DEFECTS SCH	43	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			1015	1020		10.1016/0091-6749(88)90171-6	http://dx.doi.org/10.1016/0091-6749(88)90171-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	3286726				2022-12-18	WOS:A1988N703700016
J	PIERSON, WE				PIERSON, WE			OBJECTIVE MEASUREMENTS OF NASAL AIRWAY TESTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		ANGGARD E, 1969, ANNALS OTOLOGY RHINO, V78, P657; AOKI FY, 1976, BRIT J CLIN PHARMACO, V3, P869, DOI 10.1111/j.1365-2125.1976.tb00640.x; BLUESTONE CD, 1981, ANN OTO RHINOL LARYN, V90, P552, DOI 10.1177/000348948109000608; BORUM P, 1983, EUR J RESPIR DI S128, V67, P65; BROOKS CD, 1981, ANN ALLERGY, V47, P316; CHEVANCE LG, 1971, ACTA OTO-LARYNGOL, V72, P121, DOI 10.3109/00016487109122464; COCKCROFT DW, 1979, AM REV RESPIR DIS, V120, P697; COLE P, 1980, J OTOLARYNGOL, V9, P309; CONNELL JT, 1968, J ALLERGY, V41, P101; CONNELL JT, 1985, PHARMACOTHERAPY, V5, P201; CONNELL JT, 1982, ANN ALLERGY, V49, P179; CONNELL JT, 1987, AM J RHINOL, V1, P3; CRETICOS PS, 1984, NEW ENGL J MED, V310, P1626, DOI 10.1056/NEJM198406213102502; DAVIES HJ, 1978, CLIN ALLERGY, V8, P517, DOI 10.1111/j.1365-2222.1978.tb01505.x; DAVIS D., 1957, ANN OTOL RHINOL AND LARYNGOL, V66, P622; DRETTNER B, 1974, ACTA OTO-LARYNGOL, V78, P259, DOI 10.3109/00016487409126353; DRUCE H, 1983, J ALLERGY CLIN IMMUN, V71, P90, DOI 10.1016/0091-6749(83)90130-6; FIREMAN P, 1988, J ALLERGY CLIN IMMUN, V81, P953, DOI 10.1016/0091-6749(88)90159-5; FRIEDMAN PA, 1983, J ALLERGY CLIN IMMUN, V71, P442; GREENSTONE M, 1983, EUR J RESPIR DIS, V64, P449; JACKSON RT, 1970, CURR THER RES CLIN E, V12, P711; KAWABORI S, 1983, J SUBMICR CYTOL PATH, V15, P823; KAWABORI S, 1983, CLIN ALLERGY, V13, P181, DOI 10.1111/j.1365-2222.1983.tb02586.x; KNOWLES GK, 1981, CLIN ALLERGY, V11, P287, DOI 10.1111/j.1365-2222.1981.tb01596.x; KONNO A, 1981, ARCH OTO-RHINO-LARYN, V232, P253, DOI 10.1007/BF00457450; MATHEWS KP, 1981, INT ARCH ALLER A IMM, V66, P218, DOI 10.1159/000232821; MATHEWS KP, 1980, J ALLERGY CLIN IMMUN, V65, P191; MCCAFFREY TV, 1979, ANN OTO RHINOL LARYN, V88, P247, DOI 10.1177/000348947908800217; MCLEAN JA, 1977, J ALLERGY CLIN IMMUN, V59, P165, DOI 10.1016/0091-6749(77)90220-2; MCLEAN JA, 1978, J ALLERGY CLIN IMMUN, V61, P191, DOI 10.1016/0091-6749(78)90450-5; MCLEAN JA, 1979, ANN OTORHINOLARYNGOL, V88, P288; MCLEAN JA, 1985, IMMUNOL ALLERGY PRAC, V7, P31; MYGIND N, 1975, ACTA ALLERGOL, V30, P298, DOI 10.1111/j.1398-9995.1975.tb00206.x; Mygind N., 1979, NASAL ALLERGY; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NICKELSEN JA, 1981, J ALLERGY CLIN IMMUN, V68, P33, DOI 10.1016/0091-6749(81)90120-2; OCONNOR RD, 1984, ANN ALLERGY, V53, P468; PETERS SD, 1985, CHEST, V87, P1625; PIERSON WE, 1983, J ALLERGY CLIN IMMUN, V71, P156, DOI 10.1016/0091-6749(83)90393-7; PROCTOR DF, 1973, ARCH INTERN MED, V131, P132, DOI 10.1001/archinte.131.1.132; ROSENBERG GL, 1983, J ALLERGY CLIN IMMUN, V71, P303; SOLOMON WR, 1983, PROVOCATIVE CHALLENG; SPEIZER FE, 1964, J APPL PHYSIOL, V19, P176, DOI 10.1152/jappl.1964.19.1.176; STROMME O, 1952, ARCH OTOLARYNGOL S S, V104; TAKAGI Y, 1971, ANN OTORHINOLARYNGOL, V80, P736; TANIMOTO H, 1983, Rhinology (Utrecht), V21, P59; TAYLOR G, 1973, J ALLERGY CLIN IMMUN, V52, P193, DOI 10.1016/0091-6749(73)90057-2; WALKER SB, 1985, J ALLERGY CLIN IMMUN, V76, P158, DOI 10.1016/0091-6749(85)90694-3; WARREN DW, 1984, AM J ORTHOD DENTOFAC, V86, P306, DOI 10.1016/0002-9416(84)90141-6; WARREN DW, 1987, AM J ORTHOD DENTOFAC, V91, P111, DOI 10.1016/0889-5406(87)90467-7; WATANABE K, 1981, ANN OTO RHINOL LARYN, V90, P204, DOI 10.1177/000348948109000302; WELSH PW, 1981, J ALLERGY CLIN IMMUN, V67, P237, DOI 10.1016/0091-6749(81)90067-1; WIHL JA, 1977, ACTA OTO-LARYNGOL, V84, P281, DOI 10.3109/00016487709123968; YERGIN BM, 1978, J APPL PHYSIOL, V44, P964, DOI 10.1152/jappl.1978.44.6.964	54	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			949	952		10.1016/0091-6749(88)90158-3	http://dx.doi.org/10.1016/0091-6749(88)90158-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	3286734	Bronze			2022-12-18	WOS:A1988N703700003
J	NORDLEE, JA; NAIDU, SG; TAYLOR, SL				NORDLEE, JA; NAIDU, SG; TAYLOR, SL			FALSE POSITIVE AND FALSE NEGATIVE REACTIONS ENCOUNTERED IN THE USE OF SULFITE TEST STRIPS FOR THE DETECTION OF SULFITE-TREATED FOODS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN, FOOD RES INST, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT FOOD SCI, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT FOOD MICROBIOL & TOXICOL, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison								[Anonymous], 1986, FED REGISTER, V51, P25012; BAKER GJ, 1981, MED J AUSTRALIA, V2, P614, DOI 10.5694/j.1326-5377.1981.tb113018.x; BUSH RK, 1986, J ALLERGY CLIN IMMUN, V78, P191, DOI 10.1016/0091-6749(86)90012-6; BUSH RK, 1986, AM J MED, V81, P816, DOI 10.1016/0002-9343(86)90351-7; FOGG AG, 1966, ANAL CHIM ACTA, V36, P248, DOI 10.1016/0003-2670(66)80040-5; KUTTER D, 1969, CLIN CHIM ACTA, V24, P211, DOI 10.1016/0009-8981(69)90314-3; MARKLEY B, 1986, ANAL LETT, V19, P37; MARTIN LB, 1986, J FOOD PROTECT, V49, P126, DOI 10.4315/0362-028X-49.2.126; STEVENSON DD, 1981, J ALLERGY CLIN IMMUN, V68, P26, DOI 10.1016/0091-6749(81)90119-6; Taylor S L, 1986, Adv Food Res, V30, P1, DOI 10.1016/S0065-2628(08)60347-X; U.S. Food and Drug Administration, 1986, FED REG, V51, P25; WANDERER AA, 1987, ANN ALLERGY, V58, P41; WEDZICHA BL, 1984, CHEM SULPHUR DIOXIDE, P86; WEINGARTNER KE, 1977, J FOOD PROTECT, V40, P234, DOI 10.4315/0362-028X-40.4.234; WILLIAMS S, 1984, OFFICIAL METHODS ANA, P393; 1985, DIRECTIONS USE SULFI	16	4	4	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1988	81	3					526	530		10.1016/0091-6749(88)90191-1	http://dx.doi.org/10.1016/0091-6749(88)90191-1			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M6181					2022-12-18	WOS:A1988M618100007
J	TOVEY, ER; BALDO, BA				TOVEY, ER; BALDO, BA			AN ONLINE COMPUTER-DATA BANK OF MONOCLONAL-ANTIBODIES THAT RECOGNIZE ALLERGENS - INVITATION FOR ENTRIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									ROYAL N SHORE HOSP, KOLLING INST MED RES, ST LEONARDS, NSW 2065, AUSTRALIA; UNIV SYDNEY, DEPT MED, SYDNEY, NSW 2006, AUSTRALIA	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney			Tovey, Euan R/G-8604-2017	Tovey, Euan R/0000-0002-1802-7266				AALBERSE RC, 1983, REGULATORY CONTROLS, V78, P137; BALDO BA, 1980, MED J AUSTRALIA, V2, P651, DOI 10.5694/j.1326-5377.1980.tb131962.x; BALDO BA, 1983, ALLERGY, V38, P535, DOI 10.1111/j.1398-9995.1983.tb04137.x; BALDO BA, 1986, 12TH P INT C ALL CLI, P411; BOSE R, 1986, IMMUNOLOGY, V59, P309; CHAPMAN MD, 1987, J IMMUNOL, V139, P1479; CHAPMAN MD, 1987, J ALLERGY CLIN IMMUN, V80, P184, DOI 10.1016/0091-6749(87)90128-X; CHAPMAN MD, 1984, J IMMUNOL, V133, P2488; CHAPMAN MD, UNPUB IMMUNOCHEMICAL; CHAPMAN MD, IN PRESS ALLERGY; CORBI AL, 1985, MOL IMMUNOL, V22, P1081, DOI 10.1016/0161-5890(85)90111-7; DEWECK AL, 1986, 12 P INT C ALL IMM, P406; EKRAMODDOULLAH AKM, 1984, MOL IMMUNOL, V21, P375, DOI 10.1016/0161-5890(84)90034-8; EKRAMODDOULLAH AKM, 1986, MOL IMMUNOL, V23, P111, DOI 10.1016/0161-5890(86)90031-3; EKRAMODDOULLAH AKM, 1987, J IMMUNOL, V138, P1739; EKRAMODDOULLAH AKM, 1986, INT ARCH ALLER A IMM, V80, P100, DOI 10.1159/000234033; ESCH RE, 1987, J ALLERGY CLIN IMMUN, V79, P489, DOI 10.1016/0091-6749(87)90367-8; HAAS H, 1986, INT ARCH ALLER A IMM, V79, P434, DOI 10.1159/000234014; KAHN CR, 1986, MOL IMMUNOL, V23, P1281, DOI 10.1016/0161-5890(86)90013-1; KRILIS S, 1981, INT ARCH ALLER A IMM, V66, P252, DOI 10.1159/000232912; KRILIS S, 1983, J ALLERGY CLIN IMMUN, V71, P261, DOI 10.1016/0091-6749(83)90079-9; KRILIS S, 1981, RES MONOGRAPHS IMMUN, V3, P337; LEY V, 1986, MOL IMMUNOL, V23, P1311, DOI 10.1016/0161-5890(86)90016-7; MOURAD W, 1986, J IMMUNOL METHODS, V89, P53, DOI 10.1016/0022-1759(86)90031-1; OLSON JR, 1986, J IMMUNOL, V136, P2109; SINGH MB, 1985, INT ARCH ALLER A IMM, V78, P300, DOI 10.1159/000233901; TOVEY ER, IN PRESS J MED ENTOM; 1986, B WHO, V64, P767	28	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1988	81	3					598	604		10.1016/0091-6749(88)90202-3	http://dx.doi.org/10.1016/0091-6749(88)90202-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M6181					2022-12-18	WOS:A1988M618100018
J	ALLEN, M; ARLIAN, L; BERNSTEIN, L; FRIEDMAN, S; GRANT, A; LIEBERMAN, P; LOPEZ, M; METZGER, J; SCHATZ, M; SPECTOR, S; WASSERMAN, S				ALLEN, M; ARLIAN, L; BERNSTEIN, L; FRIEDMAN, S; GRANT, A; LIEBERMAN, P; LOPEZ, M; METZGER, J; SCHATZ, M; SPECTOR, S; WASSERMAN, S			PREVALENCE OF DUST MITES IN THE HOMES OF ASTHMATICS IN SEVERAL UNITED-STATES GEOGRAPHICAL REGIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					270	270		10.1016/0091-6749(88)90642-2	http://dx.doi.org/10.1016/0091-6749(88)90642-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400429
J	KURIHARA, K; WARDLAW, AJ; MOQBEL, R; KAY, AB				KURIHARA, K; WARDLAW, AJ; MOQBEL, R; KAY, AB			THE GINKGOLIDE (BN-52021) INHIBITS PAF-INDUCED CHEMOTAXIS AND SPECIFIC BINDING TO HUMAN EOSINOPHILS AND NEUTROPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					208	208		10.1016/0091-6749(88)90395-8	http://dx.doi.org/10.1016/0091-6749(88)90395-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400182
J	LEUNG, DYM; JABARA, H; ACKERMAN, SJ; VERCELLI, D; GEHA, RS				LEUNG, DYM; JABARA, H; ACKERMAN, SJ; VERCELLI, D; GEHA, RS			INDUCTION OF IGE SYNTHESIS AND EOSINOPHIL (EOS) DIFFERENTIATION BY SUPERNATANTS (SUPS) OF A HUMAN TYPE-2 (TH2) HELPER-T-CELL CLONE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					303	303		10.1016/0091-6749(88)90776-2	http://dx.doi.org/10.1016/0091-6749(88)90776-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400563
J	SCHLEIMER, RP; DAVIDSON, DA; DERSE, C; GILLIS, S; PLAUT, M; LICHTENSTEIN, LM				SCHLEIMER, RP; DAVIDSON, DA; DERSE, C; GILLIS, S; PLAUT, M; LICHTENSTEIN, LM			THE EFFECT OF CYTOKINES ON HUMAN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					301	301		10.1016/0091-6749(88)90765-8	http://dx.doi.org/10.1016/0091-6749(88)90765-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400552
J	SETTIPANE, RA; STEVENSON, DD				SETTIPANE, RA; STEVENSON, DD			CROSS SENSITIVITY WITH ACETAMINOPHEN IN ASA-SENSITIVE ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract														Settipane, Russell/0000-0002-6328-8780					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					180	180		10.1016/0091-6749(88)90284-9	http://dx.doi.org/10.1016/0091-6749(88)90284-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400071
J	SHAKER, G; GLOVSKY, MM; KEBO, D; GLOVSKY, S; DOWELL, A				SHAKER, G; GLOVSKY, MM; KEBO, D; GLOVSKY, S; DOWELL, A			REVERSAL OF EXERCISE INDUCED ASTHMA BY THE LTD4, LTE4 ANTAGONISTS (LY171883)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033; ELI LILLY & CO,INDIANAPOLIS,IN 46285	University of Southern California; Eli Lilly									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					315	315		10.1016/0091-6749(88)90823-8	http://dx.doi.org/10.1016/0091-6749(88)90823-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400610
J	PARKER, SR				PARKER, SR			THE FUTURE-ROLE OF ASTHMA SELF-MANAGEMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PARKER, SR (corresponding author), NIHLBI,DIV LUNG DIS,PREVENT EDUC & RES TRAINING BRANCH,ROOM 640C,5333 WESTBARD AVE,BETHESDA,MD 20892, USA.							CLARK NM, 1986, J ALLERGY CLIN IMMUN, V78, P108, DOI 10.1016/0091-6749(86)90122-3; CLARK NM, 1984, J SCHOOL HEALTH, V54, P143, DOI 10.1111/j.1746-1561.1984.tb08796.x; CREER TL, 1987, HDB PEDIATRIC PSYCHO; HINDIALEXANDER M, 1981, ANN ALLERGY, V46, P143; HINDIALEXANDER MC, 1984, J ALLERGY CLIN IMMUN, V74, P505, DOI 10.1016/0091-6749(84)90386-5; LEWIS CE, 1984, PEDIATRICS, V74, P478; MARION R, 1985, SOC BEHAVIORAL MED A; MCNABB WL, 1985, AM J PUBLIC HEALTH, V75, P1219, DOI 10.2105/AJPH.75.10.1219; Parcel G S, 1980, J Dev Behav Pediatr, V1, P128; PARCEL GS, 1980, TEACHING MY PARENTS; RAKOS RF, 1985, J PSYCHOSOM RES, V29, P101, DOI 10.1016/0022-3999(85)90014-5; TAPLIN PS, 1978, J ASTHMA RES, V16, P15, DOI 10.3109/02770907809106608; WILSONPESSANO SR, 1985, PREV MED, V14, P670, DOI 10.1016/0091-7435(85)90066-0; 1984, NIH842362 NAT HEART; 1982, SUPERSTUFF PEDIATRIC; 1985, NIH852364 NAT HEART; 1984, NIH842336 NAT HEART; 1984, NIH842365 NAT HEART	18	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			511	514		10.1016/0091-6749(87)90088-1	http://dx.doi.org/10.1016/0091-6749(87)90088-1			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3624708	Bronze			2022-12-18	WOS:A1987K103700035
J	SHIMODA, T; KRZANOWSKI, J; LOCKEY, R; MARTIN, DF; PEREZCRUET, M; POLSON, J; DUNCAN, R				SHIMODA, T; KRZANOWSKI, J; LOCKEY, R; MARTIN, DF; PEREZCRUET, M; POLSON, J; DUNCAN, R			LOWER AIRWAY SMOOTH-MUSCLE CONTRACTION INDUCED BY PTYCHODISCUS-BREVIS (RED TIDE) TOXIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV S FLORIDA,COLL MED,DEPT PHARMACOL & THERAPEUT,TAMPA,FL 33612; UNIV S FLORIDA,COLL NAT SCI,CTR CHEM & ENVIRONM MANAGEMENT SERV,TAMPA,FL 33612; JAMES A HALEY VET ADM MED CTR,DEPT INTERNAL MED,ALLERGY & IMMUNOL SECT,TAMPA,FL 33612	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	SHIMODA, T (corresponding author), UNIV S FLORIDA,COLL MED,DEPT INTERNAL MED,DIV ALLERGY & IMMUNOL,12901 N 30TH ST,TAMPA,FL 33612, USA.							ALAM M, 1982, J AM CHEM SOC, V104, P5232, DOI 10.1021/ja00383a043; Anderson W H, 1980, Adv Prostaglandin Thromboxane Res, V7, P995; ASAI S, 1982, J ALLERGY CLIN IMMUN, V69, P418, DOI 10.1016/0091-6749(82)90116-6; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; BADEN DG, 1982, TOXICON, V20, P929, DOI 10.1016/0041-0101(82)90081-2; BADEN DG, 1984, TOXICON, V22, P75, DOI 10.1016/0041-0101(84)90140-5; BADEN DG, 1984, SEAFOOD TOXINS, P359; CREESE BR, 1981, CLIN EXP PHARMACOL P, V8, P175, DOI 10.1111/j.1440-1681.1981.tb00149.x; FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339; FURUKAWA TARO, 1959, JAPANESE JOUR PHYSIOL, V9, P143; GALLAGHER JP, 1980, BRIT J PHARMACOL, V69, P367, DOI 10.1111/j.1476-5381.1980.tb07023.x; HEDQVIST P, 1974, ACTA PHYSIOL SCAND, V90, P153, DOI 10.1111/j.1748-1716.1974.tb05573.x; HEMMERT WH, 1975, 1ST P INT C TOX DIN, P489; HORTON EW, 1965, BRIT J PHARM CHEMOTH, V24, P470, DOI 10.1111/j.1476-5381.1965.tb01736.x; HUDGINS PM, 1968, J PHARMACOL EXP THER, V159, P91; INOUE T, 1984, J PHYSIOL-LONDON, V349, P553, DOI 10.1113/jphysiol.1984.sp015173; ITO Y, 1981, J PHYSIOL-LONDON, V319, P379, DOI 10.1113/jphysiol.1981.sp013915; ITO Y, 1979, J PHYSIOL-LONDON, V297, P521, DOI 10.1113/jphysiol.1979.sp013054; ITO Y, 1984, BRIT J PHARMACOL, V83, P677, DOI 10.1111/j.1476-5381.1984.tb16221.x; ITO Y, 1984, BRIT J PHARMACOL, V83, P667, DOI 10.1111/j.1476-5381.1984.tb16220.x; KATZ B, 1967, P R SOC LOND, V169, P8; MAIN IHM, 1964, BRIT J PHARM CHEMOTH, V22, P511, DOI 10.1111/j.1476-5381.1964.tb01705.x; MARTIN DF, 1976, J CHEM EDUC, V53, P614, DOI 10.1021/ed053p614; MEISHERI KD, 1981, J MEMBRANE BIOL, V59, P19, DOI 10.1007/BF01870817; MIDDLETON E, 1980, J PHARM SCI-US, V69, P243, DOI 10.1002/jps.2600690244; OREHEK J, 1975, J PHARMACOL EXP THER, V194, P554; PUGLISI L, 1973, ADV BIOSCI, V9, P219; RUSSI EW, 1984, CHEST, V86, P475, DOI 10.1378/chest.86.3.475; SAKAMOTO Y, 1985, J ALLERGY CLIN IMMUN, V76, P117, DOI 10.1016/0091-6749(85)90814-0; SHORE S, 1985, CHEST, V87, pS161, DOI 10.1378/chest.87.5_Supplement.161S; SNEDECOR GW, 1959, STATISTICAL METHODS; Steidinger K.A., 1983, Progress phycol. Res., V2, P147; STEPHENS NL, 1970, AIRWAY DYNAMICS PHYS, P199; SWEATMAN WJ, 1968, NATURE, V217, P69, DOI 10.1038/217069a0; VOGEL SM, 1982, FED PROC, V41, P8487; YAMAGUCHI T, 1976, AM J PHYSIOL, V230, P1737, DOI 10.1152/ajplegacy.1976.230.6.1737; YAMASHITA K, 1977, JPN J PHYSIOL, V27, P551	37	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1987	79	6					899	908		10.1016/0091-6749(87)90239-9	http://dx.doi.org/10.1016/0091-6749(87)90239-9			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H9044	3584745				2022-12-18	WOS:A1987H904400011
J	PINNAS, JL; BERNSTEIN, IL; BRONSKY, EE; BUSH, RK; CHERVINSKY, P; CONDEMI, JJ; DOCKHORN, RJ; NATHAN, RA; REPSHER, LH; BHATT, BD; NEIDL, MJ; MINGO, TS				PINNAS, JL; BERNSTEIN, IL; BRONSKY, EE; BUSH, RK; CHERVINSKY, P; CONDEMI, JJ; DOCKHORN, RJ; NATHAN, RA; REPSHER, LH; BHATT, BD; NEIDL, MJ; MINGO, TS			MULTICENTER STUDY OF BITOLTEROL AND ISOPROTERENOL NEBULIZER SOLUTIONS IN NONSTEROID-USING PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PINNAS, JL (corresponding author), UNIV ARIZONA,SCH MED,DEPT INTERNAL MED,TUCSON,AZ 85724, USA.							ANDERSSON RG, 1974, EXPERIENTIA, V30, P784, DOI 10.1007/BF01924186; BHATT BD, 1985, ANN ALLERGY, V55, P396; BRANSCOMB BV, 1978, CHEST, V73, P1002, DOI 10.1378/chest.73.6_Supplement.1002; COCKCROFT DW, 1981, CURR THER RES CLIN E, V30, P817; CONOLLY ME, 1971, BR J PHARM, V43, P380; EARIS JE, 1978, BRIT MED J, V1, P1554, DOI 10.1136/bmj.1.6126.1554-a; ELLULMICALLEF R, 1975, LANCET, V2, P1269; FRANCIS PWJ, 1980, PEDIATRICS, V66, P103; FRASER CM, 1980, BIOCHEM BIOPH RES CO, V94, P390, DOI 10.1016/S0006-291X(80)80233-6; HEIMER D, 1980, J ALLERGY CLIN IMMUN, V66, P75, DOI 10.1016/0091-6749(80)90141-4; HOLGATE ST, 1977, LANCET, V2, P375; HUI KKP, 1982, CLIN PHARMACOL THER, V32, P566, DOI 10.1038/clpt.1982.204; JENNE JW, 1977, J ALLERGY CLIN IMMUN, V59, P383, DOI 10.1016/0091-6749(77)90023-9; Joseph X, 1981, Fundam Appl Toxicol, V1, P443, DOI 10.1016/S0272-0590(81)80025-5; KASS I, 1980, CHEST, V78, P283, DOI 10.1378/chest.78.2.283; KEMP JP, 1984, J ALLERGY CLIN IMMUN, V73, P32, DOI 10.1016/0091-6749(84)90481-0; KEMP JP, 1986, J ALLERGY CLIN IMMUN, V77, P509, DOI 10.1016/0091-6749(86)90187-9; LARSSON S, 1977, Scandinavian Journal of Respiratory Diseases Supplementum, V101, P91; MANO K, 1979, LIFE SCI, V25, P1925, DOI 10.1016/0024-3205(79)90614-3; MINATOYA H, 1978, J PHARMACOL EXP THER, V206, P515; NICKLAS RA, 1982, NEW ENGL J MED, V307, P557; ORGEL HA, 1985, J ALLERGY CLIN IMMUN, V75, P55, DOI 10.1016/0091-6749(85)90012-0; PATERSON LC, 1976, BR MED J, V10, P76; PETTY LP, 1984, CHEST, V86, P405; PINNAS JL, IN PRESS CHEST; PLISS LB, 1981, ANN EMERG MED, V10, P353, DOI 10.1016/S0196-0644(81)80235-1; PLUMMER AL, 1978, CHEST, V73, P949, DOI 10.1378/chest.73.6.949; SAUNDERS KB, 1965, BRIT MED J, V1, P1037, DOI 10.1136/bmj.1.5441.1037; SHENFIELD GM, 1973, THORAX, V28, P124, DOI 10.1136/thx.28.2.124; SHIM C, 1980, ANN INTERN MED, V93, P428; SVEDMYR N, 1980, EUR J RESPIR DIS, V61, P83; SVEDMYR NLV, 1976, CHEST, V69, P479, DOI 10.1378/chest.69.4.479; TULLAR BF, 1976, J MED CHEM, V19, P834, DOI 10.1021/jm00228a020; WHITEHURST VE, 1983, J AM COLL TOXICOL, V2, P147, DOI 10.3109/10915818309140676; WOOLCOCK AJ, 1977, AM REV RESPIR DIS, V115, P191	35	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1987	79	5					768	775		10.1016/0091-6749(87)90209-0	http://dx.doi.org/10.1016/0091-6749(87)90209-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H4349	3571768				2022-12-18	WOS:A1987H434900012
J	HINOJOSA, M; MONEO, I; CUEVAS, M; DIAZMATEO, P; SUBIZA, J; LOSADA, E				HINOJOSA, M; MONEO, I; CUEVAS, M; DIAZMATEO, P; SUBIZA, J; LOSADA, E			OCCUPATIONAL ASTHMA CAUSED BY VOACANGA-AFRICANA SEED DUST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOSP RAMON & CAJAL,SERV INMUNOL,E-28034 MADRID,SPAIN	Hospital Universitario Ramon y Cajal	HINOJOSA, M (corresponding author), HOSP RAMON CAJAL,SERV ALERGIA,CARRETERA COLMENAR KM 9,E-28034 MADRID,SPAIN.							BUSH RK, 1977, CLIN ALLERGY, V7, P369, DOI 10.1111/j.1365-2222.1977.tb01465.x; BUSSE WW, 1975, ANN INTERN MED, V83, P361, DOI 10.7326/0003-4819-83-3-361; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; CUEVAS M, 1983, INT ARCH ALLER A IMM, V72, P184, DOI 10.1159/000234864; DAVIES R, 1983, ALLERGY PRINCIPLES P, V2, P1037; DOMINGUEZ J, 1984, ALLERGY, V39, P529, DOI 10.1111/j.1398-9995.1984.tb00874.x; FALLERONI AE, 1981, J ALLERGY CLIN IMMUN, V68, P156, DOI 10.1016/0091-6749(81)90173-1; HINOJOSA M, 1984, J ALLERGY CLIN IMMUN, V74, P782, DOI 10.1016/0091-6749(84)90179-9; HINOJOSA M, 1986, CLIN ALLERGY, V16, P145, DOI 10.1111/j.1365-2222.1986.tb00758.x; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; LOSADA E, 1986, J ALLERGY CLIN IMMUN, V77, P635, DOI 10.1016/0091-6749(86)90358-1; MONEO I, 1983, INT ARCH ALLER A IMM, V71, P285, DOI 10.1159/000233406; OUCHTERLONY O, 1953, ACTA PATHOL MIC SC, V32, P231	13	4	4	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1987	79	4					574	578		10.1016/S0091-6749(87)80151-3	http://dx.doi.org/10.1016/S0091-6749(87)80151-3			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G9720	3549840				2022-12-18	WOS:A1987G972000004
J	SHAPIRO, GG; FURUKAWA, CT; PIERSON, WE; CHAPKO, MK; SHARPE, M; BIERMAN, CW				SHAPIRO, GG; FURUKAWA, CT; PIERSON, WE; CHAPKO, MK; SHARPE, M; BIERMAN, CW			DOUBLE-BLIND, DOSE-RESPONSE STUDY OF METAPROTERENOL INHALANT SOLUTION IN CHILDREN WITH ACUTE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ASTHMA INC,SEATTLE,WA; UNIV WASHINGTON,CHILDRENS HOSP & MED CTR,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195	Seattle Children's Hospital; University of Washington; University of Washington Seattle								AVNER BP, 1981, J ALLERGY CLIN IMMUN, V68, P51, DOI 10.1016/0091-6749(81)90123-8; BECKER AB, 1983, J PEDIATR-US, V102, P465, DOI 10.1016/S0022-3476(83)80679-9; GOLDFARB F, 1984, J ALLERGY CLIN IMMUN, V73, P135; HEIMER D, 1980, J ALLERGY CLIN IMMUN, V66, P75, DOI 10.1016/0091-6749(80)90141-4; JENNE JW, 1982, J ALLERGY CLIN IMMUN, V70, P413, DOI 10.1016/0091-6749(82)90002-1; KOEPKE JW, 1983, J ALLERGY CLIN IMMUN, V72, P504, DOI 10.1016/0091-6749(83)90588-2; MCEVOY JDS, 1973, AM REV RESPIR DIS, V108, P490; MORRIS HG, 1980, J ALLERGY CLIN IMMUN, V65, P83, DOI 10.1016/0091-6749(80)90190-6; POPA VT, 1976, CHEST, V70, P2; REILLY PA, 1983, J PEDIATR-US, V103, P121, DOI 10.1016/S0022-3476(83)80797-5; SACHNER M, 1978, CHEST, V73, P802; STEPHAN WC, 1980, J ALLERGY CLIN IMMUN, V65, P105, DOI 10.1016/0091-6749(80)90193-1; STEVENSON DD, 1984, J ALLERGY CLIN IMMUN, V74, P469, DOI 10.1016/0091-6749(84)90380-4	13	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1987	79	2					378	386		10.1016/0091-6749(87)90159-X	http://dx.doi.org/10.1016/0091-6749(87)90159-X			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G1791	3546466				2022-12-18	WOS:A1987G179100014
J	ARM, JP; HORTON, CE; LEE, TH				ARM, JP; HORTON, CE; LEE, TH			ENHANCED LEUKOTRIENE B4 (LTB4) GENERATION BY CIRCULATING NEUTROPHILS (PMN) FOLLOWING EXERCISE-INDUCED ASTHMA (EIA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									GUYS HOSP,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust				Lee, Tak/0000-0002-7554-4059					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					129	129						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000039
J	BIERMAN, W; PIERSON, W; SHAPIRO, G; FURUKAWA, C; SHARPE, M				BIERMAN, W; PIERSON, W; SHAPIRO, G; FURUKAWA, C; SHARPE, M			KETOTIFEN REDUCES BRONCHIAL HYPERREACTIVITY IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					184	184						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000262
J	FUKUDA, T; NUMAO, T; MAKINO, S				FUKUDA, T; NUMAO, T; MAKINO, S			SPECIFIC BINDING OF PLATELET-ACTIVATING-FACTOR (PAF) BY HUMAN EOSINOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					172	172						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000214
J	GALANT, S; POSNER, L; LEE, N; HICKS, D; WILKINSON, B; ELLIS, M				GALANT, S; POSNER, L; LEE, N; HICKS, D; WILKINSON, B; ELLIS, M			IMMEDIATE HYPERSENSITIVITY TO SEMISYNTHETIC PENICILLINS IN CYSTIC-FIBROSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					199	199						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000321
J	HILBERT, JM; MATZKE, GR; RADWANSKI, E; MORITZEN, V; LUC, V; AFFRIME, M; SYMCHOWICZ, S; ZAMPAGLIONE, N				HILBERT, JM; MATZKE, GR; RADWANSKI, E; MORITZEN, V; LUC, V; AFFRIME, M; SYMCHOWICZ, S; ZAMPAGLIONE, N			LORATADINE PHARMACOKINETICS IN RENAL IMPAIRMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									SCHERING PLOUGH CORP,BLOOMFIELD,NJ 07003; HENNEPIN CTY MED CTR,MINNEAPOLIS,MN 55415	Merck & Company; Schering Plough Corporation; Hennepin County Medical Center									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					206	206						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000348
J	IRANI, AA; BUCKLEY, R; HAYNES, B; SCHECHTER, NM; SCHWARTZ, LB				IRANI, AA; BUCKLEY, R; HAYNES, B; SCHECHTER, NM; SCHWARTZ, LB			SELECTIVE DEPLETION OF T-MAST CELLS IN INTESTINAL-MUCOSA OF PATIENTS WITH DEFECTIVE LYMPHOCYTE-T FUNCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					179	179						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000241
J	KEMP, JP; MELTZER, EO; ORGEL, HA; WELCH, MJ; BAHNA, SL; CHERVINSKY, P; RACHELEFSKY, GS; SELTZER, JM; STOUWE, RAV; VALERO, RN				KEMP, JP; MELTZER, EO; ORGEL, HA; WELCH, MJ; BAHNA, SL; CHERVINSKY, P; RACHELEFSKY, GS; SELTZER, JM; STOUWE, RAV; VALERO, RN			A COMPARISON OF LORATADINE, CLEMASTINE AND PLACEBO IN PATIENTS WITH SEASONAL RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					190	190						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000286
J	LEE, TH; ARM, JP; SPUR, BW				LEE, TH; ARM, JP; SPUR, BW			LEUKOTRIENE E4 (LTE4) ENHANCES AIRWAYS HISTAMINE RESPONSIVENESS IN ASTHMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									GUYS HOSP,LONDON SE1 9RT,ENGLAND; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Guy's & St Thomas' NHS Foundation Trust; Harvard University; Harvard Medical School				Lee, Tak/0000-0002-7554-4059					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					256	256						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000550
J	LOPEZ, M; VOIGTLANDER, JR; SALVAGGIO, JE; LEHRER, SB				LOPEZ, M; VOIGTLANDER, JR; SALVAGGIO, JE; LEHRER, SB			BRONCHOPROVOCATION STUDIES OF BASIDIOSPORE (BS) SKIN-TEST AND RAST POSITIVE ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					207	207						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000352
J	MICHEL, FB; BOUSQUET, J; LEBEL, B; MOREL, A; GUERIN, B				MICHEL, FB; BOUSQUET, J; LEBEL, B; MOREL, A; GUERIN, B			CORRELATION BETWEEN SYMPTOMS AND RELEASE OF MEDIATORS IN SECRETIONS DURING NASAL CHALLENGE WITH POLLEN GRAINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					247	247						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000514
J	PATEL, KR; ALBAZZAZ, MK				PATEL, KR; ALBAZZAZ, MK			PROTECTIVE EFFECT OF CROMOLYN SODIUM AND NEDOCROMIL SODIUM IN EXERCISE-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									WESTERN INFIRM,DEPT RESP MED,GLASGOW G11 6NT,SCOTLAND										0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					187	187						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000272
J	RESHEF, A; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NORMAN, PS				RESHEF, A; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NORMAN, PS			THE PATTERN AND KINETICS OF MEDIATORS IN THE ACUTE AND LATE PHASE RESPONSE (LPR) IN HUMAN-SKIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Reshef, Avner/AAL-3638-2020						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					248	248						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000517
J	RESSLER, C; KNAPP, MM; TATAKE, JG; BALLOW, M; RAPACZ, P				RESSLER, C; KNAPP, MM; TATAKE, JG; BALLOW, M; RAPACZ, P			HUMAN-IGM ANTIBODY TO SULFAMETHOXAZOLE IN AN ADVERSE REACTION TO TRIMETHOPRIM-SULFAMETHOXAZOLE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					198	198						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000318
J	RYAN, JR; MCMAHON, FG; VARGAS, R; GOTZKOWSKY, S				RYAN, JR; MCMAHON, FG; VARGAS, R; GOTZKOWSKY, S			ANTIMUSCARINIC ACTIVITY OF TERFENADINE (T), CHLORPHENIRAMINE (C), ATROPINE (A) AND PLACEBO (P) IN NORMAL VOLUNTEERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									CLIN RES CTR,NEW ORLEANS,LA										0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					190	190						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000284
J	SMALL, P; BARRETT, D				SMALL, P; BARRETT, D			EFFECTS OF BOTH IMMUNOTHERAPY AND BECLOMETHASONE DIPROPIONATE NASAL SPRAY ON ALLERGEN INDUCED NASAL PROVOCATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					255	255						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000543
J	SWENSON, C; DICK, E; BUSSE, W				SWENSON, C; DICK, E; BUSSE, W			RHINOVIRUS UPPER RESPIRATORY-INFECTION ENHANCES AIRWAY HYPERREACTIVITY AND BASOPHIL HISTAMINE RELEASABILITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					194	194						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000301
J	TOOGOOD, JH; BASKERVILLE, J				TOOGOOD, JH; BASKERVILLE, J			PATIENT COMPLIANCE DURING INHALED STEROID (IS) THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					144	144						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000101
J	TURKELTAUB, PC; ANDERSON, MC; BAER, H				TURKELTAUB, PC; ANDERSON, MC; BAER, H			RELATIVE POTENCY (RP), COMPOSITIONAL DIFFERENCES (CD), AND ASSIGNMENT OF ALLERGY UNITS (AU) TO MITE EXTRACTS (DP AND DF) ASSAYED BY PARALLEL LINE SKIN-TEST (PLST)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													turkeltaub, paul/AAG-6160-2019; turkeltaub, paul/U-7729-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					235	235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000466
J	WACHS, M; PROUD, D; LICHTENSTEIN, LM; KAGEYSOBOTKA, A; NORMAN, PS; NACLERIO, RM				WACHS, M; PROUD, D; LICHTENSTEIN, LM; KAGEYSOBOTKA, A; NORMAN, PS; NACLERIO, RM			NASAL PRIMING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					253	253						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000536
J	WALSH, GM; MOQBEL, R; WARDLAW, AJ; KAY, AB				WALSH, GM; MOQBEL, R; WARDLAW, AJ; KAY, AB			ENHANCEMENT OF IGG AND IGE RECEPTORS ON GRANULOCYTES BY PAF-ACETHER AND OTHER INFLAMMATORY MEDIATORS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									CARDIOTHORAC INST,LONDON SW3 6HP,ENGLAND				Walsh, Garry/D-4869-2013	Walsh, Garry/0000-0002-7138-4078					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					172	172						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000211
J	SZEFLER, SJ				SZEFLER, SJ			ERRATIC ABSORPTION OF THEOPHYLLINE FROM SLOW-RELEASE PRODUCTS IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	SZEFLER, SJ (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,1400 JACKSON ST,DENVER,CO 80206, USA.				NHLBI NIH HHS [HL-30513] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DEDERICH RA, 1981, J ALLERGY CLIN IMMUN, V67, P465, DOI 10.1016/0091-6749(81)90100-7; HALTOM JR, 1985, J PEDIATR-US, V107, P805, DOI 10.1016/S0022-3476(85)80425-X; HENDELES L, 1985, CHEST, V87, P758, DOI 10.1378/chest.87.6.758; HENDELES L, 1984, CLIN PHARMACOKINET, V9, P95, DOI 10.2165/00003088-198409020-00001; KARIM A, 1985, CLIN PHARMACOL THER, V38, P77, DOI 10.1038/clpt.1985.138; KELLY HW, 1979, AM J HOSP PHARM, V36, P1698, DOI 10.1093/ajhp/36.12.1698; LAGAS M, 1983, EUR J CLIN PHARMACOL, V24, P761, DOI 10.1007/BF00607084; LEEDS NH, 1982, J CLIN PHARMACOL, V22, P196, DOI 10.1002/j.1552-4604.1982.tb02162.x; LEVINE RR, 1970, AM J DIG DIS, V15, P171, DOI 10.1007/BF02235648; MINAMI H, 1984, GASTROENTEROLOGY, V86, P1592; MOLLER H, 1983, SUSTAINED RELEASE TH, P57; NIMMO W S, 1976, Clinical Pharmacokinetics, V1, P189, DOI 10.2165/00003088-197601030-00002; PEDERSEN S, 1985, CLIN ALLERGY, V15, P253, DOI 10.1111/j.1365-2222.1985.tb02282.x; PEDERSEN S, 1984, PEDIATRICS, V74, P534; PEDERSEN S, 1981, BRIT J CLIN PHARMACO, V12, P904, DOI 10.1111/j.1365-2125.1981.tb01329.x; POLLACK GM, 1984, INT J PHARM, V21, P3, DOI 10.1016/0378-5173(84)90198-4; ROGERS RJ, 1985, J PEDIATR-US, V106, P496, DOI 10.1016/S0022-3476(85)80690-9; SCOTT PH, 1981, J PEDIATR-US, V99, P476, DOI 10.1016/S0022-3476(81)80354-X; SIMONS KJ, 1984, J PHARM SCI, V73, P939, DOI 10.1002/jps.2600730719; STPIERRE MV, 1985, CLIN PHARMACOL THER, V38, P89, DOI 10.1038/clpt.1985.140; TAYLOR DR, 1984, BRIT J CLIN PHARMACO, V18, P27, DOI 10.1111/j.1365-2125.1984.tb05017.x; TAYLOR DR, 1983, BRIT J CLIN PHARMACO, V16, P413, DOI 10.1111/j.1365-2125.1983.tb02186.x; WAGNER JG, 1983, J PHARM SCI, V72, P578, DOI 10.1002/jps.2600720531; WAGNER JG, 1963, J PHARM SCI, V52, P610, DOI 10.1002/jps.2600520629; WARREN JB, 1985, BRIT J CLIN PHARMACO, V19, P707, DOI 10.1111/j.1365-2125.1985.tb02701.x; ZUK RF, 1985, CLIN CHEM, V31, P1144	26	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				710	715		10.1016/0091-6749(86)90050-3	http://dx.doi.org/10.1016/0091-6749(86)90050-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684	3534052				2022-12-18	WOS:A1986E568400008
J	WELLIVER, RC				WELLIVER, RC			ALLERGY AND THE SYNDROME OF CHRONIC EPSTEIN-BARR VIRUS-INFECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									CHILDRENS HOSP,DIV INFECT DIS,BUFFALO,NY 14222; CHILDRENS HOSP,CLIN MICROBIOL LABS,BUFFALO,NY 14222	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	WELLIVER, RC (corresponding author), SUNY COLL BUFFALO,SCH MED,DEPT PEDIAT,BUFFALO,NY 14222, USA.							BAHNA SL, 1978, J ALLERGY CLIN IMMUN, V62, P167, DOI 10.1016/0091-6749(78)90102-1; FRICK OL, 1979, J ALLERGY CLIN IMMUN, V63, P228, DOI 10.1016/0091-6749(79)90106-4; IDA S, 1977, J EXP MED, V145, P892, DOI 10.1084/jem.145.4.892; JONES JF, 1985, ANN INTERN MED, V102, P1, DOI 10.7326/0003-4819-102-1; LAMY ME, 1982, ACTA CLIN BELG, V37, P281; MICHAELS AA, 1979, J ALLERGY CLIN IMMUN, V63, P169; PERELMUTTER L, 1979, J ALLERGY CLIN IMMUN, V64, P127, DOI 10.1016/0091-6749(79)90046-0; SALONEN EM, 1985, J MED VIROL, V16, P1, DOI 10.1002/jmv.1890160102; STRAUS SE, 1985, ANN INTERN MED, V102, P7, DOI 10.7326/0003-4819-102-1-7; SUMAYA CV, 1977, J INFECT DIS, V135, P374, DOI 10.1093/infdis/135.3.374; SUMAYA CV, 1975, J INFECT DIS, V131, P403, DOI 10.1093/infdis/131.4.403; TOBI M, 1982, LANCET, V1, P61; TOBI M, 1985, ANN INTERN MED, V103, P951, DOI 10.7326/0003-4819-103-6-951; WELLIVER RC, 1985, PEDIATR RES, V19, P716, DOI 10.1203/00006450-198507000-00016; WELLIVER RC, 1984, J IMMUNOL, V133, P1925; WELLIVER RC, 1980, NEW ENGL J MED, V303, P1198, DOI 10.1056/NEJM198011203032103; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501; WELLIVER RC, 1982, J PEDIATR-US, V101, P889, DOI 10.1016/S0022-3476(82)80005-X; WELLIVER RC, 1986, AM J DIS CHILD, V140, P34, DOI 10.1001/archpedi.1986.02140150036029	19	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1986	78	2					278	281		10.1016/S0091-6749(86)80076-8	http://dx.doi.org/10.1016/S0091-6749(86)80076-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D7261	3016065				2022-12-18	WOS:A1986D726100006
J	GORDIS, L				GORDIS, L			DESIGN OF CLINICAL-TRIALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											GORDIS, L (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,615 N WOLFE ST,BALTIMORE,MD 21205, USA.							EDERER F, 1975, AM J EPIDEMIOL, V102, P111, DOI 10.1093/oxfordjournals.aje.a112138; EDERER F, 1975, AM J OPHTHALMOL, V79, P7; FRIEDMAN LM, 1982, FUNDAMENTALS CLIN TR; Johnson F.N., 1977, CLIN TRIALS; JOYCE CRB, 1965, J CHRON DIS, V18, P367, DOI 10.1016/0021-9681(65)90040-8; LEVINE MI, 1946, AM REV TUBERC PULM, V53, P517; Meinert CL, 1986, CLIN TRIALS DESIGN C; Pocock SJ, 1983, CLIN TRIALS PRACTICA; WILSON EB, 1975, AM J OPHTHALMOL, V79, P11; [No title captured]; 1984, NIH842442 US DEP HLT	11	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	2	S			155	160		10.1016/0091-6749(86)90007-2	http://dx.doi.org/10.1016/0091-6749(86)90007-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2997	3088087				2022-12-18	WOS:A1986D299700007
J	SAKAMOTO, Y; KRZANOWSKI, JJ; LOCKEY, RF; DUNCAN, R; POLSON, JB; SZENTIVANYI, A				SAKAMOTO, Y; KRZANOWSKI, JJ; LOCKEY, RF; DUNCAN, R; POLSON, JB; SZENTIVANYI, A			THE MECHANISM OF ERGONOVINE-INDUCED AIRWAY SMOOTH-MUSCLE CONTRACTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV S FLORIDA, COLL MED, DEPT PHARMACOL & THERAPEUT, TAMPA, FL 33612 USA; JAMES A HALEY VET ADM MED CTR, ALLERGY & IMMUNOL SECT, TAMPA, FL 33612 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	SAKAMOTO, Y (corresponding author), UNIV S FLORIDA, COLL MED, DEPT INTERNAL MED, DIV ALLERGY & IMMUNOL, TAMPA, FL 33612 USA.							ANDERSON WH, 1979, N-S ARCH PHARMACOL, V308, P117, DOI 10.1007/BF00499053; APPERLEY E, 1980, BRIT J PHARMACOL, V68, P215, DOI 10.1111/j.1476-5381.1980.tb10410.x; ARMITAGE P, 1971, STATISTICAL METHODS, P355; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Berde B, 1980, Adv Biochem Psychopharmacol, V23, P3; BESSE JC, 1976, J PHARMACOL EXP THER, V197, P66; Bowman W., 1980, TXB PHARM, Vsecond; BRAZENOR RM, 1981, J PHARMACOL EXP THER, V218, P530; BROCKLEHURST WE, 1976, BRONCHIAL ASTHMA, P117; BROSS W, 1963, LANCET, V1, P85; BROWNING DJ, 1974, MED J AUSTRALIA, V1, P957, DOI 10.5694/j.1326-5377.1974.tb93459.x; BUXTON A, 1980, AM J CARDIOL, V46, P329, DOI 10.1016/0002-9149(80)90080-6; CASADY GN, 1960, JAMA-J AM MED ASSOC, V172, P1011, DOI 10.1001/jama.1960.03020100019004; CIPRIANO PR, 1979, CIRCULATION, V59, P82, DOI 10.1161/01.CIR.59.1.82; COHEN ML, 1981, J PHARMACOL EXP THER, V218, P421; COMROE JH, 1953, AM J PHYSIOL, V173, P379, DOI 10.1152/ajplegacy.1953.173.3.379; CONSTANTINE JW, 1964, J PHARMACOL EXP THER, V146, P400; CRAWFORD JS, 1980, ANAESTHESIA, V35, P397, DOI 10.1111/j.1365-2044.1980.tb05138.x; CREVEY BJ, 1981, CIRCULATION, V64, P853; Dart A M, 1980, Eur Heart J, V1, P91; DAVIES AE, 1980, BRIT J OBSTET GYNAEC, V87, P539, DOI 10.1111/j.1471-0528.1980.tb04593.x; ERSPAMER VITTORIO, 1966, HANDBUCH EXP PHARMAKOL, V19, P132; FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339; FRIEDMAN EA, 1957, AM J OBSTET GYNECOL, V73, P1306, DOI 10.1016/0002-9378(57)90274-0; FURCHGOT.RF, 1967, ANN NY ACAD SCI, V139, P553, DOI 10.1111/j.1749-6632.1967.tb41229.x; FURCHGOTT RF, 1967, ANN NY ACAD SCI, V144, P882, DOI 10.1111/j.1749-6632.1967.tb53817.x; GADDUM JH, 1954, BRIT J PHARM CHEMOTH, V9, P240, DOI 10.1111/j.1476-5381.1954.tb00848.x; HERXHEIMER H, 1953, J PHYSIOL-LONDON, V122, pP49; HERXHEIMER H, 1955, J PHYSIOL-LONDON, V128, P435, DOI 10.1113/jphysiol.1955.sp005317; HOFMANN A, 1978, PHARMACOLOGY, V16, P1, DOI 10.1159/000136803; HOLTZ J, 1982, BASIC RES CARDIOL, V77, P278, DOI 10.1007/BF01908043; KRSTIC MK, 1982, EUR J PHARMACOL, V85, P225, DOI 10.1016/0014-2999(82)90471-X; LOUIE S, 1985, CLIN ALLERGY, V15, P173, DOI 10.1111/j.1365-2222.1985.tb02271.x; MACDONNELL KF, 1976, BRONCHIAL ASTHMA MEC, P679; MULLERSCHWEINIT.E, 1978, HDB EXPT PHARM, V49, P87; MULLERSCHWEINITZER E, 1980, J CARDIOVASC PHARM, V2, P645; PEROUTKA SJ, 1979, MOL PHARMACOL, V16, P687; RINGROSE CA, 1962, CAN MED ASSOC J, V87, P121; RODBARD S, 1972, ANGIOLOGY, V23, P188, DOI 10.1177/000331977202300402; RUFFOLO RR, 1979, J PHARMACOL EXP THER, V209, P429; SAKANASHI M, 1980, EUR J PHARMACOL, V64, P157, DOI 10.1016/0014-2999(80)90038-2; SCHROEDER JS, 1977, AM J CARDIOL, V40, P487, DOI 10.1016/0002-9149(77)90060-1; SELLERS WFS, 1979, ANAESTHESIA, V34, P909, DOI 10.1111/j.1365-2044.1979.tb08556.x; STEPHENS NL, 1970, AIRWAY DYNAMICS PHYS, P199; THEROUX P, 1979, CIRCULATION, V60, P504, DOI 10.1161/01.CIR.60.3.504; VALENTINE BH, 1977, BRIT J ANAESTH, V49, P81, DOI 10.1093/bja/49.1.81; VANNUETEN JM, 1983, LANCET, V1, P297	47	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1986	77	2					354	364		10.1016/S0091-6749(86)80118-X	http://dx.doi.org/10.1016/S0091-6749(86)80118-X			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A0899	3944386				2022-12-18	WOS:A1986A089900016
J	BAHNA, SL; YEE, EH				BAHNA, SL; YEE, EH			COMPARISON OF RAST BY DIFFERENT MANUFACTURERS FOR IGE TO MOLDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			242	242						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800482
J	CASTELLS, M; IRANI, AA; SCHWARTZ, LB				CASTELLS, M; IRANI, AA; SCHWARTZ, LB			EVALUATION OF HUMAN PERIPHERAL-BLOOD LEUKOCYTES FOR MAST-CELL TRYPTASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			246	246						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800500
J	FERNANDEZCALDAS, E; SWANSON, MC; YUNGINGER, JW; REED, CE				FERNANDEZCALDAS, E; SWANSON, MC; YUNGINGER, JW; REED, CE			IMMUNOCHEMICAL DEMONSTRATION OF RED OAK AEROALLERGENS OUTSIDE THE OAK POLLINATION SEASON	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			197	197						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800304
J	FITZHARRIS, P; MOQBEL, R; THORNE, KJI; RICHARDSON, BA; BUTTERWORTH, AE; HARTNELL, A; CROMWELL, O; KAY, AB				FITZHARRIS, P; MOQBEL, R; THORNE, KJI; RICHARDSON, BA; BUTTERWORTH, AE; HARTNELL, A; CROMWELL, O; KAY, AB			MONOCYTE-DERIVED EOSINOPHIL ACTIVATING FACTOR (EAF) ENHANCES LTC4 PRODUCTION BY HUMAN EOSINOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND; BROMPTON HOSP,INST CARDIOTHORAC,LONDON SW3 6HP,ENGLAND	University of Cambridge; Royal Brompton Hospital									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			235	235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800455
J	FLEEKOP, P; ATKINS, P; VONALLMEN, C; ZIGMOND, S; ZWEIMAN, B				FLEEKOP, P; ATKINS, P; VONALLMEN, C; ZIGMOND, S; ZWEIMAN, B			CELLULAR INFLAMMATORY RESPONSES IN ALLERGIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			243	243						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800488
J	FREELAND, HS; PIPKORN, U; NACLERIO, RM; ADKINSON, NF; LICHTENSTEIN, LM; PETERS, SP				FREELAND, HS; PIPKORN, U; NACLERIO, RM; ADKINSON, NF; LICHTENSTEIN, LM; PETERS, SP			THE ROLE OF LEUKOTRIENE B4(LTB4) IN HUMAN ALLERGIC LATE PHASE REACTIONS - LACK OF LTB4 INHIBITION BY SYSTEMIC GLUCOCORTICOIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			244	244						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800489
J	GONZALEZ, C; DIAZ, P; GALLEGUILLOS, F; ANCIC, P; KAY, AB				GONZALEZ, C; DIAZ, P; GALLEGUILLOS, F; ANCIC, P; KAY, AB			T-HELPER (TH) AND SUPPRESSOR (TS) CELLS IN BRONCHOALVEOLAR LAVAGE DURING ANTIGEN-INDUCED LATE-PHASE ASTHMATIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									BROMPTON HOSP,INST CARDIOTHORAC,LONDON SW3 6HP,ENGLAND	Royal Brompton Hospital	GONZALEZ, C (corresponding author), CLIN ENFERMEDADES RESP,SANTIAGO,CHILE.								0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			244	244						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800490
J	HILMAN, BC; RAO, K				HILMAN, BC; RAO, K			DESENSITIZATION WITH ANTI-PSEUDOMONAL PENICILLINS AFTER ALLERGIC REACTIONS TO UREIDOPENICILLINS IN CYSTIC-FIBROSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			167	167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800181
J	LARCHEVEQUE, J; MALO, JL; CARTIER, A				LARCHEVEQUE, J; MALO, JL; CARTIER, A			TIME-COURSE OF THE CHANGES IN HISTAMINE BRONCHIAL RESPONSIVENESS AFTER AN ANTIGEN CHALLENGE WHICH DID NOT CAUSE SIGNIFICANT CHANGES IN AIRWAY CALIBER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			170	170						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800193
J	MAPP, CE; DIGIACOMO, GR; ZEDDA, L; BROSEGHINI, C; FABBRI, LM				MAPP, CE; DIGIACOMO, GR; ZEDDA, L; BROSEGHINI, C; FABBRI, LM			ISOCYANATE-INDUCED ASTHMA - REVIEW OF 165 CASES STUDIED IN 1983-5	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Fabbri, Leonardo M/I-4055-2012	Fabbri, Leonardo M/0000-0001-8894-1689					0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			173	173						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800205
J	METZGER, WJ; SJOERDSMA, KW; WASSERMAN, SI				METZGER, WJ; SJOERDSMA, KW; WASSERMAN, SI			NEUTROPHIL CHEMOTACTIC ACTIVITY (NCA) IN BRONCHIAL LAVAGE FLUID DURING EARLY AND LATE PHASE AIRWAY RESPONSES IN ALLERGIC RABBITS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			245	245						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800495
J	MICHEL, FB; SKASSABROCIEK, W; SEGALEN, C; DREBORG, S; BOUSQUET, J				MICHEL, FB; SKASSABROCIEK, W; SEGALEN, C; DREBORG, S; BOUSQUET, J			REPRODUCIBILITY OF 6 METHODS OF SKIN PRICK TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			222	222						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800402
J	MILAVETZ, G; VAUGHAN, L; WEINBERGER, M; HARRIS, J; MULLENIX, T				MILAVETZ, G; VAUGHAN, L; WEINBERGER, M; HARRIS, J; MULLENIX, T			BIOAVAILABILITY OF ORAL THEOPHYLLINE - SINGLE AND MULTIPLE DOSE STUDIES OF UNIPHYL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Weinberger, Miles/H-6743-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			146	146						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800100
J	PRZYBILLA, B; RING, J; WIELGOSCH, J				PRZYBILLA, B; RING, J; WIELGOSCH, J			INVITRO HISTAMINE-RELEASE (HR) AS ADDITIONAL METHOD FOR DIAGNOSIS OF INSECT VENOM ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			143	143						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800087
J	SKASSABROCIEK, W; MONTES, F; VERDIER, M; SCHWAB, D; LHERMINIER, M; BOUSQUET, J; MICHEL, FB				SKASSABROCIEK, W; MONTES, F; VERDIER, M; SCHWAB, D; LHERMINIER, M; BOUSQUET, J; MICHEL, FB			SCH 29851 IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			137	137						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800067
J	WILSON, MC; MURPHY, KR; HASLETT, C; LARSEN, GL				WILSON, MC; MURPHY, KR; HASLETT, C; LARSEN, GL			THE EFFECT OF POLYMORPHONUCLEAR LEUKOCYTE (PML) DEPLETION AND REPLETION ON THE LATE ASTHMATIC RESPONSE (LAR) AND AIRWAYS REACTIVITY (AR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			245	245						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800494
J	SAGONA, MA; BRUSZER, GV; LIN, L; PEARSON, FC; SERKES, K; MASCOLI, CC				SAGONA, MA; BRUSZER, GV; LIN, L; PEARSON, FC; SERKES, K; MASCOLI, CC			EVALUATION OF PAPAIN CHYMOPAPAIN CROSS ALLERGENICITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SAGONA, MA (corresponding author), TRAVENOL LABS INC,DEPT LIFE SCI,ROUND LAKE,IL 60073, USA.							BERNSTEIN DI, 1984, J ALLERGY CLIN IMMUN, V74, P258, DOI 10.1016/0091-6749(84)90255-0; BERNSTEIN IL, 1983, JAMA-J AM MED ASSOC, V250, P1167, DOI 10.1001/jama.250.9.1167; COGEN F, 1984, Journal of Allergy and Clinical Immunology, V73, P179; EDER J, 1973, IMMUNOCHEMISTRY, V10, P535, DOI 10.1016/0019-2791(73)90226-7; FLINDT MLH, 1978, LANCET, V1, P430; GRAYBILL FA, 1976, THEORY APPLICATION L, P291; HALL BB, 1983, J BONE JOINT SURG AM, V65, P1215, DOI 10.2106/00004623-198365090-00001; HAVERLY R W, 1984, Journal of Allergy and Clinical Immunology, V73, P179; MANSFIELD LE, 1983, J ALLERGY CLIN IMMUN, V71, P371, DOI 10.1016/0091-6749(83)90064-7; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; RAJAGOPALAN R, 1974, ANESTH ANALG, V53, P191; SAGONA MA, 1985, J ALLERGY CLIN IMMUN, V75, P659, DOI 10.1016/0091-6749(85)90090-9; TARLO SM, 1978, CLIN ALLERGY, V8, P207, DOI 10.1111/j.1365-2222.1978.tb03216.x; Watts C, 1977, Neurosurgery, V1, P2; WIDE L, 1967, LANCET, V2, P1105	15	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1985	76	6					776	781		10.1016/0091-6749(85)90747-X	http://dx.doi.org/10.1016/0091-6749(85)90747-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AWX93	4067127	Bronze			2022-12-18	WOS:A1985AWX9300003
J	ALLEN, D; DELOHERY, J				ALLEN, D; DELOHERY, J			METABISULFITE INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					145	145		10.1016/0091-6749(85)90299-4	http://dx.doi.org/10.1016/0091-6749(85)90299-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200164
J	BAER, H; ANDERSON, MC; BERNARD, K; QUINNAN, G				BAER, H; ANDERSON, MC; BERNARD, K; QUINNAN, G			BETA-PROPIOLACTONE TREATED HUMAN-SERUM ALBUMIN (BPL-HSA) AN ALLERGEN FOR HUMANS RECEIVING RABIES VACCINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					137	137		10.1016/0091-6749(85)90265-9	http://dx.doi.org/10.1016/0091-6749(85)90265-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200130
J	BAHNA, SL; GANDHI, MD				BAHNA, SL; GANDHI, MD			EVALUATION OF RAST IN FOOD SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					204	204		10.1016/0091-6749(85)90533-0	http://dx.doi.org/10.1016/0091-6749(85)90533-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200398
J	CHANG, B; SLY, RM; EBY, D; MIDDLETON, HB				CHANG, B; SLY, RM; EBY, D; MIDDLETON, HB			DELIVERY OF ALBUTEROL AEROSOL BY INHAL-AID TO YOUNG-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					159	159		10.1016/0091-6749(85)90355-0	http://dx.doi.org/10.1016/0091-6749(85)90355-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200220
J	COHEN, M; SPLANSKY, GL; GALLAGHER, J; BERNSTEIN, DI; BERNSTEIN, IL				COHEN, M; SPLANSKY, GL; GALLAGHER, J; BERNSTEIN, DI; BERNSTEIN, IL			EPIDEMIOLOGIC SURVEY AND VALIDATION OF ADVERSE FOOD REACTIONS (AFR) IN ADULT-POPULATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					206	206		10.1016/0091-6749(85)90540-8	http://dx.doi.org/10.1016/0091-6749(85)90540-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200405
J	CUNDELL, DR; DAVIES, RJ				CUNDELL, DR; DAVIES, RJ			NCA RELEASE FROM HUMAN-BLOOD LYMPHOCYTES - EFFECTS OF SALBUTAMOL AND SODIUM CROMOLYN (SC) ON THIS RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									ST BARTHOLOMEWS HOSP,LONDON EC1A 7BE,ENGLAND	University of London; Queen Mary University London									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					109	109		10.1016/0091-6749(85)90153-8	http://dx.doi.org/10.1016/0091-6749(85)90153-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200018
J	FLAHERTY, M; STORMONT, JM; CONDEMI, JJ				FLAHERTY, M; STORMONT, JM; CONDEMI, JJ			METABISULFITE(MBS)-ASSOCIATED HEPATOTOXICITY AND PROTECTION BY COBALAMINS (B-12)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					198	198		10.1016/0091-6749(85)90510-X	http://dx.doi.org/10.1016/0091-6749(85)90510-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200375
J	HENDELES, L; HILL, M; MOORE, P; HARMAN, E; PIEPER, J				HENDELES, L; HILL, M; MOORE, P; HARMAN, E; PIEPER, J			BLOCKING OF EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB) BY INHALED VERAPAMIL (V)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					173	173		10.1016/0091-6749(85)90410-5	http://dx.doi.org/10.1016/0091-6749(85)90410-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200275
J	HOFFMAN, M; KIECHEL, F; MEADOWS, CD; SPECTOR, S; WOLFE, J; WYATT, R				HOFFMAN, M; KIECHEL, F; MEADOWS, CD; SPECTOR, S; WOLFE, J; WYATT, R			WHOLE-BLOOD PLASMA RATIO DETERMINED BY A NEW THEOPHYLLINE TEST WITHOUT INSTRUMENTATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					128	128		10.1016/0091-6749(85)90228-3	http://dx.doi.org/10.1016/0091-6749(85)90228-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200093
J	JOAD, J; AHRENS, R; LINDGREN, S; WEINBERGER, M				JOAD, J; AHRENS, R; LINDGREN, S; WEINBERGER, M			PHYSIOLOGICAL AND PSYCHOLOGICAL VARIABLES DURING MAINTENANCE THERAPY WITH INHALED ALBUTEROL (A) AND THEOPHYLLINE (T) USED SEPARATELY AND IN COMBINATION (C)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					113	113		10.1016/0091-6749(85)90170-8	http://dx.doi.org/10.1016/0091-6749(85)90170-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200035
J	JOHANSSON, SGO; NORDVALL, S; LEDFORD, D; LOCKEY, R				JOHANSSON, SGO; NORDVALL, S; LEDFORD, D; LOCKEY, R			SPECIFIC IGE AND IGE RESPONSES TO IMMUNOTHERAPY (IT) WITH IMPORTED FIRE ANT WHOLE-BODY EXTRACT (IFA-WBE) IN IFA HYPERSENSITIVITY (H)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					208	208		10.1016/0091-6749(85)90551-2	http://dx.doi.org/10.1016/0091-6749(85)90551-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200416
J	KROUTIL, L; BUSH, R				KROUTIL, L; BUSH, R			DETECTION OF ALTERNARIA (ALT) ALLERGENS BY WESTERN BLOTTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					174	174		10.1016/0091-6749(85)90414-2	http://dx.doi.org/10.1016/0091-6749(85)90414-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200279
J	LEE, TH; SHORE, S; COREY, EJ; AUSTEN, KF; DRAZEN, JM				LEE, TH; SHORE, S; COREY, EJ; AUSTEN, KF; DRAZEN, JM			LEUKOTRIENE E4(LTE4)-INDUCED AIRWAY HYPERRESPONSIVENESS TO HISTAMINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract														Lee, Tak/0000-0002-7554-4059					0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					140	140		10.1016/0091-6749(85)90278-7	http://dx.doi.org/10.1016/0091-6749(85)90278-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200143
J	MCGRATH, KG; PICK, R; LEBOFFRIES, E; PATTERSON, R				MCGRATH, KG; PICK, R; LEBOFFRIES, E; PATTERSON, R			FACTITIOUS DESQUAMATIVE GINGIVITIS SIMULATING A POSSIBLE IMMUNOLOGICAL DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT PERIODONT,GEN MED SECT,CHICAGO,IL 60611	Northwestern University; Northwestern University					NIAID NIH HHS [AI 11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AYER W A, 1974, Journal of Oral Medicine, V29, P4; BLANTON PL, 1977, J PERIODONTOL, V48, P33, DOI 10.1902/jop.1977.48.1.33; REICH P, 1983, ANN INTERN MED, V99, P240, DOI 10.7326/0003-4819-99-2-240; SHAFER N, 1980, NEW YORK STATE J MED, V80, P594; STEWART DJ, 1972, DENT PRACT DENT REC, V22, P418	5	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					44	46		10.1016/0091-6749(85)90010-7	http://dx.doi.org/10.1016/0091-6749(85)90010-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ABF26	3968327				2022-12-18	WOS:A1985ABF2600006
J	ORGEL, HA; MELTZER, EO; WELCH, MJ; KEMP, JP				ORGEL, HA; MELTZER, EO; WELCH, MJ; KEMP, JP			INHALED ALBUTEROL POWDER FOR THE TREATMENT OF ASTHMA - A DOSE-RESPONSE STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									PEDIAT ALLERGY MED GRP,SAN DIEGO,CA									BIERMAN WC, 1983, CLIN REV ALLERGY, V1, P87; CHAMBERS S, 1980, ARCH DIS CHILD, V55, P73, DOI 10.1136/adc.55.1.73; CHOUKANG YFT, 1969, BR MED J, V2, P287; GRIMWOOD K, 1981, BRIT MED J, V282, P105, DOI 10.1136/bmj.282.6258.105; HETZEL MR, 1977, CLIN ALLERGY, V7, P563, DOI 10.1111/j.1365-2222.1977.tb01486.x; LENNEY W, 1978, ARCH DIS CHILD, V53, P958, DOI 10.1136/adc.53.12.958; MCLEAN AEM, 1977, BR J CLIN PHARM, V4, P669; PATTERSON IC, 1976, BRIT MED J, V1, P76; PRATT HF, 1982, CLIN ALLERGY, V12, P203, DOI 10.1111/j.1365-2222.1982.tb01640.x; THOMPSON PJ, 1983, BR MED J, V2, P1515; TOBIN MJ, 1982, AM REV RESPIR DIS, V126, P670; WALKER SR, 1972, J PHARM PHARMACOL, V24, P525, DOI 10.1111/j.2042-7158.1972.tb09051.x; WEBER RW, 1979, J ALLERGY CLIN IMMUN, V63, P116, DOI 10.1016/0091-6749(79)90201-X	13	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	4					468	471						4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AFY44	3884688				2022-12-18	WOS:A1985AFY4400006
J	OTSUKA, H; DENBURG, J; DOLOVICH, J; HITCH, D; LAPP, P; RAJAN, R; BIENENSTOCK, J; BEFUS, D				OTSUKA, H; DENBURG, J; DOLOVICH, J; HITCH, D; LAPP, P; RAJAN, R; BIENENSTOCK, J; BEFUS, D			HUMAN NASAL METACHROMATIC CELL (NMC) HETEROGENEITY - RELATION TO CLINICAL STATUS AND RESPONSE TO BECLOMETHASONE DIPROPIONATE (BDP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Befus, Dean/C-5561-2009	Befus, Dean/0000-0002-1611-2897					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					153	153		10.1016/0091-6749(85)90330-6	http://dx.doi.org/10.1016/0091-6749(85)90330-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200195
J	SIMON, RA				SIMON, RA			REACTIVITY TO INHALED BRONKOSOL-R IN SULFITE SENSITIVE ASTHMATICS (SSA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					145	145		10.1016/0091-6749(85)90297-0	http://dx.doi.org/10.1016/0091-6749(85)90297-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200162
J	TEE, RD; GORDON, DJ; TAYLOR, AJN				TEE, RD; GORDON, DJ; TAYLOR, AJN			ALLERGY TO LOCUSTS (SCHISTOCERCA-GREGARIA AND LOCUSTA-MIGRATORIA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					122	122		10.1016/0091-6749(85)90204-0	http://dx.doi.org/10.1016/0091-6749(85)90204-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200069
J	BERNSTEIN, IL				BERNSTEIN, IL			BRONCHOALVEOLAR LAVAGE IN ASTHMA - SOMETHING OLD, SOMETHING NEW	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV CINCINNATI,MED CTR,DEPT MED,DIV IMMUNOL,ALLERGY TRAINING PROGRAM,CINCINNATI,OH 45267	University System of Ohio; University of Cincinnati	BERNSTEIN, IL (corresponding author), UNIV CINCINNATI,MED CTR,DEPT MED,DIV IMMUNOL,ALLERGY RES LAB,CINCINNATI,OH 45267, USA.							AMBIAVAGAR M, 1967, ANAESTHESIA, V22, P375, DOI 10.1111/j.1365-2044.1967.tb02760.x; BROOM B, 1960, LANCET, V1, P899; CALVANICO NJ, 1980, J LAB CLIN MED, V96, P129; CRYSTAL RG, 1981, ANN INTERN MED, V94, P73, DOI 10.7326/0003-4819-94-1-73; CRYSTAL RG, 1976, ANN INTERN MED, V85, P769, DOI 10.7326/0003-4819-85-6-769; DIAZ P, 1984, J ALLERGY CLIN IMMUN, V74, P41, DOI 10.1016/0091-6749(84)90085-X; GODARD J, 1984, AM REV RESPIR DIS, V129, P86; GODARD P, 1981, NOUV PRESSE MED, V10, P3141; HELM WH, 1972, ANN ALLERGY, V30, P518; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; HUNNINGHAKE GW, 1981, NEW ENGL J MED, V305, P429, DOI 10.1056/NEJM198108203050804; HUNNINGHAKE GW, 1981, J CLIN INVEST, V68, P259, DOI 10.1172/JCI110242; HUNNINGHAKE GW, 1980, J CLIN INVEST, V66, P473, DOI 10.1172/JCI109878; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; KELLER R H, 1984, Journal of Allergy and Clinical Immunology, V73, P127; LAM S, 1984, AM REV RESPIR DIS, V129, P152; MERRILL WW, 1980, J CLIN INVEST, V65, P268, DOI 10.1172/JCI109668; RAMIREZ RJ, 1971, CHEST, V59, P146; RAMIREZR J, 1966, DIS CHEST, V50, P581; REYNOLDS HY, 1974, J LAB CLIN MED, V84, P559; REYNOLDS HY, 1977, J CLIN INVEST, V59, P165, DOI 10.1172/JCI108615; VOISIN C, 1981, LUNG, V159, P11; WEINBERGER SE, 1978, ANN INTERN MED, V89, P459, DOI 10.7326/0003-4819-89-4-459	23	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	1					22	25		10.1016/0091-6749(84)90082-4	http://dx.doi.org/10.1016/0091-6749(84)90082-4			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SZ648	6429228	Bronze			2022-12-18	WOS:A1984SZ64800003
J	FELDMAN, CH; SHER, TH; HUTCHINSON, VE; FELDMAN, BR; DAVIS, WJ				FELDMAN, CH; SHER, TH; HUTCHINSON, VE; FELDMAN, BR; DAVIS, WJ			FENOTEROL DOSE-RESPONSE STUDY IN CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BABIES HOSP,NEW YORK,NY 10032; ST MARYS HOSP CHILDREN,BAYSIDE,NY		FELDMAN, CH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PEDIAT,DIV ALLERGY,NEW YORK,NY 10032, USA.							ALVARADO RW, 1977, RESPIR CARE, V22, P409; ANDERSON G, 1979, BRIT J DIS CHEST, V73, P81, DOI 10.1016/0007-0971(79)90010-X; BACKLUND L, 1968, SCAND J RESPIR DIS, V49, P284; BANNER AS, 1979, ARCH INTERN MED, V139, P434, DOI 10.1001/archinte.139.4.434; BEARDSHAW J, 1974, CHEST, V65, P507, DOI 10.1378/chest.65.5.507; BENJAMIN C, 1972, MED P JOHANNESBURG, V18, P35; BEUMER HM, 1971, RESPIRATION, V28, P148, DOI 10.1159/000192811; BOOIJNOORD H, 1971, INT J CLIN PHARMAC S, V4, P69; Brittain R T, 1970, Adv Drug Res, V5, P197; BRITTAIN RT, 1976, PHARMACOL THER PT B, V2, P423, DOI 10.1016/0306-039X(76)90001-5; CHERVINSKY P, 1977, ANN ALLERGY, V39, P179; COLEMAN AJ, 1973, S AFR MED J, V47, P618; DACOSTA JL, 1973, MED J AUSTRALIA, V2, P588; DAMATO G, 1983, ALLERGY, V38, P19, DOI 10.1111/j.1398-9995.1983.tb00851.x; DULFANO MJ, 1973, CURR THER RES CLIN E, V15, P150; EMIRGIL C, 1977, ANN ALLERGY, V39, P415; FELDMAN C H, 1981, American Review of Respiratory Disease, V123, P160; GEUMEI AM, 1976, CHEST, V70, P460, DOI 10.1378/chest.70.4.460; GRAFFLONNEVIG V, 1976, ACTA ALLERGOL, V31, P463, DOI 10.1111/j.1398-9995.1976.tb01496.x; GRAFFLONNEVIG V, 1979, J ALLERGY CLIN IMMUN, V64, P534, DOI 10.1016/0091-6749(79)90064-2; HAMBLETON G, 1977, LANCET, V1, P381; HAMM J, 1970, KLIN WOCHENSCHR, V48, P515; Hendeles L, 1980, APPLIED PHARMACOKINE, P95; LEFFERT F, 1980, J PEDIATR-US, V97, P875, DOI 10.1016/S0022-3476(80)80414-8; LEIFER KN, 1975, ANN ALLERGY, V35, P69; LICHTENS.LM, 1968, SCIENCE, V161, P902, DOI 10.1126/science.161.3844.902; LIEBMAN J, 1968, HEART DISEASE INFANT, P199; MATTILA MJ, 1967, ARZNEI-FORSCHUNG, V17, P362; MCFADDEN ER, 1981, J ALLERGY CLIN IMMUN, V68, P91, DOI 10.1016/0091-6749(81)90164-0; MCLAUGHLIN ET, 1982, ANN ALLERGY, V49, P191; MILLER J, 1977, ANN ALLERGY, V39, P418; MILLER WC, 1980, ANN ALLERGY, V44, P15; MINETTE A, 1970, RESPIRATION, V27, P276, DOI 10.1159/000192688; MINETTE A, 1976, B EUR PHYSIOPATH RES, V12, P545; NOLTE D, 1970, RESPIRATION, V27, P396, DOI 10.1159/000192696; ODONNELL SR, 1970, EUR J PHARMACOL, V12, P35, DOI 10.1016/0014-2999(70)90026-9; PATERSON JW, 1979, AM REV RESPIR DIS, V120, P1149; PEARLMAN DS, 1980, ALLERGIC DISEASES IN, P581; PENNOCK BE, 1977, CHEST, V72, P731, DOI 10.1378/chest.72.6.731; REBUCK AS, 1972, MED J AUSTRALIA, V1, P225, DOI 10.5694/j.1326-5377.1972.tb46770.x; RUFFIN RE, 1979, CLIN PHARMACOL THER, V25, P821; SIEGEL SC, 1978, ALLERGY PRINCIPLES P, P708; SIMI WW, 1977, J ALLERGY CLIN IMMUN, V59, P178, DOI 10.1016/0091-6749(77)90222-6; STANESCU D, 1976, RESPIRATION, V33, P1; STEEN SN, 1977, CHEST, V72, P724, DOI 10.1378/chest.72.6.724; STEEN SN, 1977, CHEST, V72, P291, DOI 10.1378/chest.72.3.291; SVEDMYR K, 1981, EUR J RESPIR DI S116, V62, P1; WATANABE S, 1981, CHEST, V80, P292, DOI 10.1378/chest.80.3.292; WEINBERG EG, 1972, MED P, V18, P73; WEINBERGER M, 1978, J PEDIATR-US, V92, P1, DOI 10.1016/S0022-3476(78)80058-4; WOITOWITZ HJ, 1972, RESPIRATION, V29, P549, DOI 10.1159/000192925; WOLFSDORF J, 1972, MED P, V18, P70; WYATT R, 1978, J PEDIATR-US, V92, P125, DOI 10.1016/S0022-3476(78)80093-6; 1981, PEDIATRICS, V68, P874	54	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	3					356	362		10.1016/0091-6749(84)90408-1	http://dx.doi.org/10.1016/0091-6749(84)90408-1			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SK155	6699315	Bronze			2022-12-18	WOS:A1984SK15500009
J	FRASER, CM; VENTER, JC				FRASER, CM; VENTER, JC			AUTOANTIBODIES TO BETA-ADRENERGIC RECEPTORS AND ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											FRASER, CM (corresponding author), NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT MOLEC IMMUNOL,BUFFALO,NY 14263, USA.			Fraser, Claire/0000-0003-1462-2428				BLECHER M, 1984, J ALLERGY CLIN IMMUN, V74, P246, DOI 10.1016/0091-6749(84)90253-7; BOAT TF, 1975, CHEST, V67, P325; CABEZAS GA, 1971, J APPL PHYSIOL, V31, P651, DOI 10.1152/jappl.1971.31.5.651; CHARLTON RR, 1980, BIOCHEM BIOPH RES CO, V94, P1221, DOI 10.1016/0006-291X(80)90549-5; FARFEL Z, 1980, NEW ENGL J MED, V303, P237, DOI 10.1056/NEJM198007313030501; FRASER CM, 1981, NEW ENGL J MED, V305, P1165, DOI 10.1056/NEJM198111123052001; FRASER CM, 1980, BIOCHEM BIOPH RES CO, V94, P390, DOI 10.1016/S0006-291X(80)80233-6; FRASER CM, J ALLERGY CLIN IMMUN; FRASER CM, 1980, MEMBRANES RECEPTORS, P127; HARDEN TK, 1979, J CYCLIC NUCL PROT, V5, P99; HARRISON LC, 1982, RECEPTORS ANTIBODIES, P248; KALINER M, 1982, ANN INTERN MED, V96, P349, DOI 10.7326/0003-4819-96-3-349; PARKER CW, 1981, NEW ENGL J MED, V305, P1212, DOI 10.1056/NEJM198111123052009; VENTER JC, 1980, SCIENCE, V207, P1361, DOI 10.1126/science.6153472; VENTER JC, 1984, BETA ADRENOCEPTORS A, P147; VENTER JC, 1981, ADRENOCEPTORS CATECH, P213; WILLIAMS LT, 1977, J BIOL CHEM, V252, P2787	17	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					227	229		10.1016/0091-6749(84)90250-1	http://dx.doi.org/10.1016/0091-6749(84)90250-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TJ808	6088607				2022-12-18	WOS:A1984TJ80800002
J	FURUKAWA, CT				FURUKAWA, CT			OTHER PHARMACOLOGIC AGENTS THAT MAY AFFECT BRONCHIAL HYPERREACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											FURUKAWA, CT (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195, USA.							ASSEM ESK, 1973, INT ARCH ALLER A IMM, V45, P697, DOI 10.1159/000231069; BAIGELMAN W, 1977, CHEST, V71, P324, DOI 10.1378/chest.71.3.324; BARNES PJ, 1984, LANCET, V1, P112; BIANCO S, 1974, BMJ-BRIT MED J, V4, P18, DOI 10.1136/bmj.4.5935.18; BOOYNOORD H, 1957, INT ARCH ALLER A IMM, V10, P321, DOI 10.1159/000228391; BORUT TC, 1977, J ALLERGY CLIN IMMUN, V60, P127, DOI 10.1016/0091-6749(77)90038-0; BRETZ U, 1983, EUR J PHARMACOL, V86, P321, DOI 10.1016/0014-2999(83)90180-2; BURNS RBP, 1983, IMMUNOL ALLERGY PRAC, V5, P49; CASALI L, 1979, INT J CLIN PHARM TH, V7, P277; CASE RL, 1982, JAMA-J AM MED ASSOC, V247, P661, DOI 10.1001/jama.247.5.661; CERRINA J, 1981, AM REV RESPIR DIS, V123, P156; CHANYEUNG M, 1977, CHEST, V71, P320, DOI 10.1378/chest.71.3.320; CHEN WY, 1981, CHEST, V79, P651, DOI 10.1378/chest.79.6.651; CHO YW, 1976, CLIN PHARMACOL THER, V19, P104; CORRIS PA, 1983, AM REV RESPIR DIS, V128, P991; DEAL EC, 1978, J APPL PHYSIOL, V45, P238, DOI 10.1152/jappl.1978.45.2.238; DEBEULE R, 1977, ACTA ALLERGOL, V32, P278; FANTA CH, 1983, AM REV RESPIR DIS, V127, P673; FANTA CH, 1980, AM REV RESPIR DIS, V123, P180; FISH JE, 1977, AM REV RESPIR DIS, V115, P371; GOLD WM, 1972, J APPL PHYSIOL, V33, P719, DOI 10.1152/jappl.1972.33.6.719; GRAFFLONNEVIG V, 1980, ALLERGY, V35, P341, DOI 10.1111/j.1398-9995.1980.tb01776.x; GROSS GN, 1974, CHEST, V66, P397, DOI 10.1378/chest.66.4.397; GROSS NJ, 1975, AM REV RESPIR DIS, V112, P823; HALTZMAN MJM, 1980, AM REV RESPIR DIS, V122, P17; HAYDU SP, 1975, BRIT MED J, V3, P283, DOI 10.1136/bmj.3.5978.283-a; HENRIKSEN JM, 1983, AM REV RESPIR DIS, V128, P993; INOUE S, 1975, J PEDIATR PRACT, V38, P1387; KATCHER ML, 1980, J ALLERGY CLIN IMMUN, V66, P223, DOI 10.1016/0091-6749(80)90043-3; KESSLER GF, 1973, J APPL PHYSIOL, V35, P703, DOI 10.1152/jappl.1973.35.5.703; KONIG P, 1974, J ALLERGY CLIN IMMUN, V54, P14, DOI 10.1016/S0091-6749(74)80003-5; KRIESMAN H, 1978, AM REV RESPIR DIS, V117, P142; LILJA G, 1983, ALLERGY, V38, P31, DOI 10.1111/j.1398-9995.1983.tb00853.x; MARTIN U, 1977, ALLERGOL IMMUNOPATH, V5, P461; MOXHAM J, 1979, CLIN ALLERGY, V9, P61, DOI 10.1111/j.1365-2222.1979.tb01523.x; MUITTARI H, 1978, CLIN ALLERGY, V2, P81; NOLTE D, 1974, WIENER MEDIZINIS S21, V124, P22; PAKES GE, 1981, CURR THER, V22, P33; PATAKAS D, 1983, J ALLERGY CLIN IMMUN, V72, P269, DOI 10.1016/0091-6749(83)90031-3; PAUWELS R, 1976, ACTA ALLERGOL, V31, P239, DOI 10.1111/j.1398-9995.1976.tb01684.x; PAUWELS R, 1976, CLIN ALLERGY, V6, P463, DOI 10.1111/j.1365-2222.1976.tb01930.x; PEREMANS W, 1981, DERMATOLOGICA, V162, P42, DOI 10.1159/000250232; PETHERAM IS, 1981, THORAX, V36, P308, DOI 10.1136/thx.36.4.308; POPPIUS H, 1975, POSTGRAD MED J, V51, P105; ROSENTHAL RR, 1977, J APPL PHYSIOL, V42, P600, DOI 10.1152/jappl.1977.42.4.600; RUDD RM, 1983, BRIT J DIS CHEST, V77, P78, DOI 10.1016/S0007-0971(83)80061-8; SIMONSSON BG, 1964, ACTA ALLERGOL, V19, P304; SLY RM, 1967, J ALLERGY, V40, P93, DOI 10.1016/0021-8707(67)90102-5; STEMMANN EA, 1975, POSTGRAD MED J, V51, P105; STOKES TC, 1981, BRIT J DIS CHEST, V75, P1, DOI 10.1016/S0007-0971(81)80002-2; SUGITA M, 1976, JPN J CLIN EXP MED, V53, P3380; TINKELMAN DG, 1976, AM REV RESPIR DIS, V114, P87; TULLETT WM, 1983, BRIT MED J, V286, P1934, DOI 10.1136/bmj.286.6382.1934-a; VANDERBIJL WJF, 1980, LARYNGOSCOPE, V90, P145, DOI 10.1288/00005537-198001000-00015; WATT GD, 1980, J ALLERGY CLIN IMMUN, V66, P286, DOI 10.1016/0091-6749(80)90023-8; WEISS EB, 1980, AM REV RESPIR DIS, V123, P42; ZIELINSKI J, 1977, RESPIRATION, V34, P31, DOI 10.1159/000193773	57	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					693	698		10.1016/0091-6749(84)90308-7	http://dx.doi.org/10.1016/0091-6749(84)90308-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS046	6143771				2022-12-18	WOS:A1984SS04600015
J	GOLDSTEIN, RA; PATTERSON, R				GOLDSTEIN, RA; PATTERSON, R			SYMPOSIUM PROCEEDINGS ON DRUG ALLERGY - PREVENTION, DIAGNOSIS, TREATMENT, DECEMBER 1, 1983, WASHINGTON, DC - SUMMARY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									NORTHWESTERN UNIV,SCH MED,DEPT MED,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,CTR ASTHMA & ALLERGY DIS,CHICAGO,IL 60611	Northwestern University; Northwestern University	GOLDSTEIN, RA (corresponding author), NIAID,ALLERGY & CLIN IMMUNOL BRANCH,IMMUNOL ALLERG & IMMUNOL DIS PROGRAM,BETHESDA,MD 20205, USA.							DESWARTE RD, 1980, ALLERGIC DISEASES DI, P452; GRAMMER LC, 1983, J ALLERGY CLIN IMMUN, V71, P250, DOI 10.1016/0091-6749(83)90107-0; GREENBERGER PA, 1981, J ALLERGY CLIN IMMUN, V67, P185, DOI 10.1016/0091-6749(81)90059-2; LAWSON DH, 1976, AM J PUBLIC HEALTH, V66, P644, DOI 10.2105/AJPH.66.7.644; MILLER RR, 1973, AM J HOSP PHARM, V30, P584, DOI 10.1093/ajhp/30.7.584; SOGN DD, 1983, J ALLERGY CLIN IMMUN, V71, P147, DOI 10.1016/0091-6749(83)90358-5; SULLIVAN TJ, 1982, J ALLERGY CLIN IMMUN, V69, P275, DOI 10.1016/S0091-6749(82)80004-3	7	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	4					643	644		10.1016/0091-6749(84)90120-9	http://dx.doi.org/10.1016/0091-6749(84)90120-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ163		Bronze			2022-12-18	WOS:A1984TQ16300017
J	LEWIS, RA; AUSTEN, KF				LEWIS, RA; AUSTEN, KF			MOLECULAR DETERMINANTS FOR FUNCTIONAL-RESPONSES TO THE SULFIDOPEPTIDE LEUKOTRIENES - METABOLISM AND RECEPTOR SUBCLASSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT RHEUMATOL & IMMUNOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital					NIAID NIH HHS [AI-20081, AI-07722, AI-10356] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUSTEN KF, 1983, BRIT J PHARMACOL, V80, P47, DOI 10.1111/j.1476-5381.1983.tb11048.x; BURKE JA, 1982, J PHARMACOL EXP THER, V221, P235; DRAZEN JM, 1980, P NATL ACAD SCI-BIOL, V77, P4354, DOI 10.1073/pnas.77.7.4354; DRAZEN JM, 1981, P NATL ACAD SCI-BIOL, V78, P3195, DOI 10.1073/pnas.78.5.3195; GOETZL EJ, 1982, BIOCHEM BIOPH RES CO, V106, P270, DOI 10.1016/0006-291X(82)91105-6; HENDERSON WR, 1982, J IMMUNOL, V128, P2609; KRILIS S, 1983, J CLIN INVEST, V72, P1516, DOI 10.1172/JCI111109; KRILIS S, 1983, J CLIN INVEST, V71, P909, DOI 10.1172/JCI110845; KRILIS S, P NATL ACAD SCI US; LEE CW, 1982, P NATL ACAD SCI-BIOL, V79, P4166, DOI 10.1073/pnas.79.13.4166; LEE CW, 1983, J BIOL CHEM, V258, P5004; Lee TH, P NATL ACAD SCI US; LEWIS RA, 1983, ADV PROSTAG THROMB L, V11, P15; LEWIS RA, 1974, J EXP MED, V140, P1133, DOI 10.1084/jem.140.5.1133; LEWIS RA, 1981, P NATL ACAD SCI-BIOL, V78, P4579, DOI 10.1073/pnas.78.7.4579; LEWIS RA, 1980, BIOCHEM BIOPH RES CO, V96, P271, DOI 10.1016/0006-291X(80)91210-3; MACGLASHAN DW, 1982, J CLIN INVEST, V70, P747, DOI 10.1172/JCI110670; PONG SS, 1983, J BIOL CHEM, V258, P9616; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; RAZIN E, 1982, P NATL ACAD SCI-BIOL, V79, P4665, DOI 10.1073/pnas.79.15.4665; WELLER PF, 1983, P NATL ACAD SCI-BIOL, V80, P7626, DOI 10.1073/pnas.80.24.7626	21	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					369	372		10.1016/0091-6749(84)90132-5	http://dx.doi.org/10.1016/0091-6749(84)90132-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633	6088612	Bronze			2022-12-18	WOS:A1984TQ63300012
J	PETERSON, MW; BUSSE, WW				PETERSON, MW; BUSSE, WW			INFLUENZA-A VIRUS ENHANCES THE HUMAN POLYMORPHONUCLEAR LEUKOCYTE CHEMOLUMINESCENCE RESPONSE WITHOUT EFFECTING INHIBITION BY TRIFLUOPERAZINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN HOSP,MADISON,WI 53792; UNIV WISCONSIN,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NIAID NIH HHS [AI00343] Funding Source: Medline; PHS HHS [A115685, A110404] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLEN RC, 1976, BIOCHEM BIOPH RES CO, V69, P245, DOI 10.1016/S0006-291X(76)80299-9; ALLEN RC, 1972, BIOCHEM BIOPH RES CO, V47, P679, DOI 10.1016/0006-291X(72)90545-1; ALLEN RC, 1974, BIOCHEM BIOPH RES CO, V60, P909, DOI 10.1016/0006-291X(74)90401-X; ALOBAIDI T, 1981, BIOCHIM BIOPHYS ACTA, V675, P316, DOI 10.1016/0304-4165(81)90020-9; ATKINS PC, 1978, J ALLERGY CLIN IMMUN, V62, P149, DOI 10.1016/0091-6749(78)90099-4; BECKER EL, 1979, AM J PATHOL, V95, P81; BECKER EL, 1972, Z IMMUNITATSFORSCH, V143, pS466; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BUSSE W, 1982, Journal of Allergy and Clinical Immunology, V69, P152; BUSSE WW, 1981, AM REV RESPIR DIS, V123, P654; BUSSE WW, 1977, AM REV RESPIR DIS, V115, P783; BUSSE WW, 1983, J ALLERGY CLIN IMMUN, V71, P382, DOI 10.1016/0091-6749(83)90066-0; CHAFOULEAS JG, 1979, J BIOL CHEM, V254, P262; CHEUNG WY, 1981, CELL CALCIUM, V2, P263, DOI 10.1016/0143-4160(81)90020-8; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; DECHATELET LR, 1982, J IMMUNOL, V129, P1589; DECHATELET LR, 1978, J RETICULOENDOTH SOC, V24, P73; FABBRI LM, 1984, AM REV RESPIR DIS, V129, P288; FANTONE JC, 1982, AM J PATHOL, V107, P397; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4055; HENRICKS PAJ, 1982, J IMMUNOL, V129, P745; HENSON PM, 1972, AM J PATHOL, V68, P593; HORN MEC, 1979, ARCH DIS CHILD, V54, P587, DOI 10.1136/adc.54.8.587; HORN MEC, 1973, CHEST              S, V63, P44; IDA S, 1977, J EXP MED, V145, P892, DOI 10.1084/jem.145.4.892; IGNARRO LJ, 1974, J EXP MED, V139, P1395, DOI 10.1084/jem.139.6.1395; JOHNSON KJ, 1981, J CLIN INVEST, V67, P893; JONES HP, 1982, BIOCHIM BIOPHYS ACTA, V714, P152, DOI 10.1016/0304-4165(82)90137-4; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; LAPORTE DC, 1979, BIOCHEM BIOPH RES CO, V86, P1169, DOI 10.1016/0006-291X(79)90240-7; LAVER WG, 1969, FUNDAMENTAL TECHNIQU, P82; LEVIN RM, 1978, BIOCHIM BIOPHYS ACTA, V540, P197, DOI 10.1016/0304-4165(78)90132-0; LIN YM, 1982, MOL CELL BIOCHEM, V45, P101; MARONE G, 1983, IRCS MED SCI-BIOCHEM, V11, P97; MCINTOSH K, 1973, J PEDIATR-US, V82, P578, DOI 10.1016/S0022-3476(73)80582-7; MINOR TE, 1974, JAMA-J AM MED ASSOC, V227, P292, DOI 10.1001/jama.227.3.292; MINOR TE, 1976, AM REV RESPIR DIS, V113, P149; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; O'Flaherty J T, 1977, Inflammation, V2, P265, DOI 10.1007/BF00921006; PRENDERGAST E, 1981, J CLIN MICROBIOL, V13, P390, DOI 10.1128/JCM.13.2.390-392.1981; PROZIALECK WC, 1982, J PHARMACOL EXP THER, V222, P509; ROMEO D, 1975, NATURE, V253, P542, DOI 10.1038/253542a0; ROUFOGALIS BD, 1981, BIOCHEM BIOPH RES CO, V98, P607, DOI 10.1016/0006-291X(81)91157-8; SHOWELL HJ, 1977, J IMMUNOL, V119, P804; SIMCHOWITZ L, 1979, J LAB CLIN MED, V93, P583; WEENING RS, 1975, J LAB CLIN MED, V85, P245; WEISS SJ, 1982, LAB INVEST, V47, P5; WILKINSON PC, 1975, EXP CELL RES, V93, P420, DOI 10.1016/0014-4827(75)90468-1; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550	49	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	6					787	793		10.1016/0091-6749(84)90180-5	http://dx.doi.org/10.1016/0091-6749(84)90180-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW418	6501748				2022-12-18	WOS:A1984TW41800005
J	ANDERSON, MC; BAER, H; RICHMAN, P; KAHN, H; TURKELTAUB, PC				ANDERSON, MC; BAER, H; RICHMAN, P; KAHN, H; TURKELTAUB, PC			IMMUNOELECTROPHORETIC STUDIES OF ROACH ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													turkeltaub, paul/U-7729-2019; turkeltaub, paul/AAG-6160-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					105	105		10.1016/0091-6749(83)90191-4	http://dx.doi.org/10.1016/0091-6749(83)90191-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200068
J	BAHNA, SL				BAHNA, SL			CONCORDANCES IN ATOPIC TWINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					100	100		10.1016/0091-6749(83)90170-7	http://dx.doi.org/10.1016/0091-6749(83)90170-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200047
J	BONINI, S; RASI, G; TRILLO, ME; FRANCI, A				BONINI, S; RASI, G; TRILLO, ME; FRANCI, A			ATOPY IN TWINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV ROME,MED CLIN 1,I-00100 ROME,ITALY	Sapienza University Rome			Bonini, Sergio/T-6594-2019; Rasi, Guido/AAC-8172-2021	Bonini, Sergio/0000-0003-0079-3031; Rasi, Guido/0000-0002-2191-1386					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					100	100		10.1016/0091-6749(83)90169-0	http://dx.doi.org/10.1016/0091-6749(83)90169-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200046
J	DRUCE, H; PATOW, C; BONNER, R; CHOO, P; SUMMERS, R; KALINER, M				DRUCE, H; PATOW, C; BONNER, R; CHOO, P; SUMMERS, R; KALINER, M			NASAL BLOOD-FLOW RESPONSES TO NASAL PROVOCATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					90	90		10.1016/0091-6749(83)90130-6	http://dx.doi.org/10.1016/0091-6749(83)90130-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200007
J	DURHAM, SR; LEE, TH; MERRETT, TG; MERRETT, J; BROWN, MJ; CAUSON, R; KAY, AB				DURHAM, SR; LEE, TH; MERRETT, TG; MERRETT, J; BROWN, MJ; CAUSON, R; KAY, AB			IMMUNOLOGICAL STUDIES OF ANTIGEN-INDUCED LATE ASTHMATIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					146	146		10.1016/0091-6749(83)90355-X	http://dx.doi.org/10.1016/0091-6749(83)90355-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200232
J	GALLAGHER, JS; MOLLER, DR; ROSENMAN, KD; BERNSTEIN, DI; OLEARY, K; BERNSTEIN, IL				GALLAGHER, JS; MOLLER, DR; ROSENMAN, KD; BERNSTEIN, DI; OLEARY, K; BERNSTEIN, IL			INVITRO DEMONSTRATION OF SPECIFIC IGE IN A WORKER EXPOSED TO HIMIC ANHYDRIDE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					157	157		10.1016/0091-6749(83)90400-1	http://dx.doi.org/10.1016/0091-6749(83)90400-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200277
J	LEVISON, H; ISLES, A				LEVISON, H; ISLES, A			ASTHMA IN CHILDHOOD - RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LEVISON, H (corresponding author), HOSP SICK CHILDREN,TORONTO M5G 1X8,ONTARIO,CANADA.		Isles, Alan F/B-3268-2011					ABERG G, 1973, BRIT J PHARMACOL, V47, P181, DOI 10.1111/j.1476-5381.1973.tb08173.x; AUBIER M, 1981, NEW ENGL J MED, V305, P249, DOI 10.1056/NEJM198107303050503; BLUMENTHAL I, 1981, BR J CLIN PRACT S, V10, P67; CLARK TJH, J RESPIR DIS; ELLULMICALLEF R, 1980, THORAX, V35, P620, DOI 10.1136/thx.35.8.620; FAIRFAX AJ, 1980, THORAX, V35, P526, DOI 10.1136/thx.35.7.526; FANTA CH, 1983, AM J MED, V74, P845, DOI 10.1016/0002-9343(83)91076-8; FRANCIS PWJ, 1980, PEDIATRICS, V66, P103; GODFREY S, 1980, J ALLERGY CLIN IMMUN, V65, P97, DOI 10.1016/0091-6749(80)90192-X; GOMM SA, 1980, THORAX, V35, P552, DOI 10.1136/thx.35.7.552; GURWITZ D, 1983, ANN ALLERGY, V50, P166; GURWITZ D, 1983, J ASTHMA, V20, P31, DOI 10.3109/02770908309070909; GURWITZ D, 1980, DEV PHARMACOL THERAP, V1, P265, DOI 10.1159/000455545; HAMBLETON G, 1977, LANCET, V1, P381; HARVEY JE, THORAX; HENDELES L, 1978, AM J DIS CHILD, V132, P876; HENDELES L, 1980, DRUG INTELL CLIN PHA, V14, P523; KATTAN M, 1980, J PEDIATR-US, V96, P596, DOI 10.1016/S0022-3476(80)80872-9; LARSSON S, 1977, AM REV RESPIR DIS, V116, P861; LENNEY W, 1978, ARCH DIS CHILD, V53, P707, DOI 10.1136/adc.53.9.707; MCFADDEN ER, 1981, J ALLERGY CLIN IMMUN, V68, P91, DOI 10.1016/0091-6749(81)90164-0; MILNER AD, 1980, EUR J CLIN PHARMACOL, V18, P117, DOI 10.1007/BF00561488; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; NADEL JA, 1981, J ALLERGY CLIN IMMUN, V67, P417; NEWTH CJL, 1982, AUST NZ J MED, V12, P232, DOI 10.1111/j.1445-5994.1982.tb02467.x; NOLAN G, 1982, ANN ALLERGY, V49, P93; PHELAN PD, 1969, AUSTRALIAN PAEDIATRI, V5, P187; PIERSON WE, 1974, PEDIATRICS, V54, P282; RACHELEFSKY GS, 1980, ANN ALLERGY, V45, P207; RACHELEFSKY GS, 1981, ANN ALLERGY, V47, P143; RILEY DJ, 1983, CHEST, V83, P590, DOI 10.1378/chest.83.4.590; RIVLIN J, 1983, J PEDIATR-US, V102, P470, DOI 10.1016/S0022-3476(83)80680-5; RIVLIN J, J PEDIATR; RUTTER N, 1975, ARCH DIS CHILD, V50, P719, DOI 10.1136/adc.50.9.719; SCHULLER DE, 1982, CLIN PEDIATR, V21, P135, DOI 10.1177/000992288202100301; SMITH JA, 1980, CHEST, V78, P816, DOI 10.1378/chest.78.6.816; SVENDMYR K, 1981, EUR J RESPIR DI S116, V62, P8; TABACHNIK E, 1982, J PEDIATR-US, V100, P489, DOI 10.1016/S0022-3476(82)80467-8; TABACHNIK E, 1981, J ALLERGY CLIN IMMUN, V67, P339, DOI 10.1016/0091-6749(81)90077-4; TASHKIN DP, 1982, AM REV RESPIR DIS, V125, P185; TATTERSFIELD AE, J RESPIR DIS; TOBIN MJ, 1982, AM REV RESPIR DIS, V126, P670; WEBB J, 1981, THORAX, V36, P18, DOI 10.1136/thx.36.1.18; WHITSETT JA, 1981, J PEDIATR-US, V98, P1021; WOLFE JD, 1978, NEW ENGL J MED, V298, P363, DOI 10.1056/NEJM197802162980703; WYATT R, 1978, J PEDIATR-US, V92, P125, DOI 10.1016/S0022-3476(78)80093-6; ZIMENT I, 1978, RESPIRATORY PHARM TH, P147; 1980, FDA DRUG B, V10, P4	48	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					539	544		10.1016/0091-6749(83)90480-3	http://dx.doi.org/10.1016/0091-6749(83)90480-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RS163	6417213	Bronze			2022-12-18	WOS:A1983RS16300006
J	MULLALLY, DI; SOGN, DD; GOLDSTEIN, RA; COHEN, SG				MULLALLY, DI; SOGN, DD; GOLDSTEIN, RA; COHEN, SG			ACADEMIC MANPOWER NEEDS IN ALLERGY AND CLINICAL IMMUNOLOGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									NIAID,IMMUNOL ALLERG & IMMUNOL DIS PROGRAM,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								Balyeat RM, 1930, J ASSOC AM MED COLL, V5, P276; NORMAN PS, 1978, J ALLERGY CLIN IMMUN, V62, P61; SCHLEITER MK, 1981, ANN INTERN MED, V95, P762, DOI 10.7326/0003-4819-95-6-762; SWINEFORD O, 1946, J ASS AM MED COLL, V20, P265; 1980, REPORT GRADUATE MED	5	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	3					252	254		10.1016/0091-6749(83)90028-3	http://dx.doi.org/10.1016/0091-6749(83)90028-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RH938	6886259	Bronze			2022-12-18	WOS:A1983RH93800004
J	MULLEN, PD; MULLEN, LR				MULLEN, PD; MULLEN, LR			IMPLEMENTING ASTHMA SELF-MANAGEMENT EDUCATION IN MEDICAL-CARE SETTINGS - ISSUES AND STRATEGIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MULLEN, PD (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR HLTH PROMOT RES & DEV,HOUSTON,TX 77025, USA.							Aday LA, 1975, DEV INDICES ACCESS M; [Anonymous], 1978, ASSESSING EFFICACY S; BECKER MH, 1970, AM J PUBLIC HLTH, V48, P38; BEHRENS R, 1981, HLTH ED PUBLIC 80S; BINGHAM RD, 1976, INNOVATION BUREAUCRA; Coleman JS, 1966, MED INNOVATION DIFFU; CREER TL, 1980, DEV EVALUATION SELF; DALTROY LH, 1978, HOSPITALS, V52, P31; DEEDS S, 1979, MODEL PATIENT ED PRO; FELDMAN C, 1982, ASTHMA SELF MANAGEME; FREUDENBERG NA, 1981, INT Q COMMUN HLTH ED, V2, P215; GARRITY TF, 1980, PATIENT COMPLIANCE P; GIBSON RM, 1982, HLTH CARE FINANC SEP; GLICK PC, 1979, J SOC ISSUES, V35, P170, DOI 10.1111/j.1540-4560.1979.tb00820.x; GOLDSMITH J, 1981, CAN HOSPITALS SURVIV; GOODMAN LJ, 1977, PUBLIC HEALTH REP, V92, P430; Gordon Gerald, 1975, DIFFUSION MED TECHNO; GREENBERG B, 1981, MED CARE, V19, P967, DOI 10.1097/00005650-198110000-00001; GREER AL, 1977, MILBANK FUND Q, V55, P505, DOI 10.2307/3349663; HAGE J, 1967, AM J SOCIOL, V72, P503, DOI 10.1086/224380; Haynes RB., 1979, COMPLIANCE HLTH CARE; KALUZNY AD, 1973, J HEALTH SOC BEHAV, V14, P124, DOI 10.2307/2137062; Katz E., 1955, PERSONAL INFLUENCE P; KIMBERLY JR, 1978, J HEALTH SOC BEHAV, V19, P361, DOI 10.2307/2136583; KISSICK WL, 1970, NEW ENGL J MED, V282, P1343, DOI 10.1056/NEJM197006112822405; Lalonde M., 1974, NEW PERSPECTIVE HLTH; LAVE LB, 1974, CONSUMER INCENTIVES; LEE E, 1982, COMMUNICATION   0823; Levin L. S., 1979, SELF CARE LAY INITIA; LEWIS CE, 1979, DESCRIPTION ACTIONS; MCKINLAY JB, 1977, MILBANK FUND Q, V55, P405, DOI 10.2307/3349539; MENGEL H, 1960, AM SOCIOL REV, V25, P704; Merton Robert King, 1957, SOTSIALNAYA TEORIYA; MILLER LV, 1972, NEW ENGL J MED, V286, P1388, DOI 10.1056/NEJM197206292862605; MOHR LB, 1969, AM POLIT SCI REV, V63, P111, DOI 10.2307/1954288; MOSER RH, 1969, DISEASES MED PROGR S; MULLEN PD, 1982, GUIDELINES HLTH PROM; MUMFORD E, 1982, AM J PUBLIC HEALTH, V72, P141, DOI 10.2105/AJPH.72.2.141; NATHANSON CA, 1980, J HEALTH SOC BEHAV, V21, P315, DOI 10.2307/2136409; PARCEL GS, 1979, HLTH ED PROGRAM CHIL; PLESS IB, 1975, CHILD HLTH COMMUNITY; Rogers Everett, 1973, COMMUNICATION STRATE; Roos N P, 1974, J Health Soc Behav, V15, P78, DOI 10.2307/2137187; ROSENBERG SG, 1971, HSMHA HEALTH REP, V86, P793, DOI 10.2307/4594300; ROTER DL, 1977, HEALTH EDUC QUART, V5, P281, DOI 10.1177/109019817700500402; RUSSELL LB, 1976, INT J HEALTH SERV, V6, P557, DOI 10.2190/X99R-9HKN-T4H1-KRG2; STIREWALT CF, 1982, MED CARE, V20, P739, DOI 10.1097/00005650-198207000-00009; Strauss AL., 1975, CHRONIC ILLNESS QUAL; STROSS JK, 1981, MICHIGAN COMMUNITY H; WEISBORD MR, 1978, J APPL BEHAV SCI, V14, P263, DOI 10.1177/002188637801400301; WILSON SR, 1981, DEV EVALUATION SELF; WING K, 1976, LAW PUBLICS HLTH; Zapka J G, 1982, J Am Coll Health Assoc, V30, P197; 1976, GUIDE HLTH ED AMBULA; 1981, BETTER HLTH OUR CHIL, V3; 1982, 12 US DEP HLTH HUM S; 1978, MANPOWER POLICY PRIM; 1980, HIGHLIGHTS WAVE 1 NA; 1982, MED TECHNOLOGY PROPO; 1980, SUMMARY REPORT GRADU; 1981, ACCREDITATION MANUAL; 1978, HEALTH US; 1981, REIMBURSEMENT PHYSIC; 1980, HLTH ED SERVICES COM; 1982, 1981 82 SOURCE BOOK; 1977, FINANCING HOSPITAL P; 1981, SELF MANAGEMENT ED P, V2; 1981, DIABETES CONTROL PRO, V2, P3; 1979, MORTAL MORBID WEEKLY, V28, P577; 1979, SURGEON GENERALS REP; 1975, INCENTIVES DECISIONS; 1981, SELF MANAGEMENT ED P, V1; 1974, WHITE PAPER PATIENT; 1980, SPECIAL TABULATIONS; 1972, PATIENTS BILL RIGHTS	75	4	4	1	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					611	622		10.1016/0091-6749(83)90489-X	http://dx.doi.org/10.1016/0091-6749(83)90489-X			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	RS163	6358328				2022-12-18	WOS:A1983RS16300015
J	PIERSON, WE; MORGAN, M; SHPAIRO, GG; FURUKAWA, CT; BIERMAN, CW				PIERSON, WE; MORGAN, M; SHPAIRO, GG; FURUKAWA, CT; BIERMAN, CW			ASSESSMENT OF NASAL PATENCY USING THE ENERGY-COST OF NOSE-BREATHING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV WASHINGTON,SEATTLE,WA 98195	University of Washington; University of Washington Seattle									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					156	156		10.1016/0091-6749(83)90393-7	http://dx.doi.org/10.1016/0091-6749(83)90393-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200270
J	SWANSON, MC; AGARWAL, MK; YUNGINGER, JW; REED, CE				SWANSON, MC; AGARWAL, MK; YUNGINGER, JW; REED, CE			GUINEA-PIG DERIVED ALLERGENS - CHARACTERIZATION, CLINICO-IMMUNOLOGIC STUDIES AND ATMOSPHERIC IMMUNOCHEMICAL QUANTITATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901	Mayo Clinic									0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					95	95		10.1016/0091-6749(83)90150-1	http://dx.doi.org/10.1016/0091-6749(83)90150-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200027
J	TINKELMAN, DG; KEMP, J; WEBB, R; MINGO, T				TINKELMAN, DG; KEMP, J; WEBB, R; MINGO, T			COMPARISON OF AEROSOLS BITOLTEROL MESYLATE (B) AND ALBUTEROL (A)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					126	126		10.1016/0091-6749(83)90274-9	http://dx.doi.org/10.1016/0091-6749(83)90274-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200151
J	EVANS, R				EVANS, R			A UNITED-STATES REFERENCE FOR HUMAN IMMUNOGLOBULIN-E	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WALTER REED ARMY MED CTR,ALLERGY IMMUNOL SERV,WASHINGTON,DC 20012	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	EVANS, R (corresponding author), WALTER REED ARMY MED CTR,ALLERGY CLIN IMMUNOL SERV,AMER ACAD ALLERGY,COMM INVITRO TESTS,WASHINGTON,DC 20012, USA.							GAYLOR DW, 1970, BIOMETRICS, V26, P641, DOI 10.2307/2528712; 1978, J ALLERGY CLIN IMMUN, V61, P169; 1980, WHOBS791240 PUB	3	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	68	1					79	82		10.1016/0091-6749(81)90127-5	http://dx.doi.org/10.1016/0091-6749(81)90127-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LY101	7240602				2022-12-18	WOS:A1981LY10100013
J	HUNJAN, BS; SILVERMAN, IH; CURLOVIC, KM; OSUAMKPE, CO; MELVIN, JR; CRONHOLM, LS				HUNJAN, BS; SILVERMAN, IH; CURLOVIC, KM; OSUAMKPE, CO; MELVIN, JR; CRONHOLM, LS			A SIMPLIFIED INVITRO ASSAY OF DELAYED-HYPERSENSITIVITY IN DIAGNOSIS OF DERMATOMYCOSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTON CHILDRENS HOSP,LOUISVILLE,KY		HUNJAN, BS (corresponding author), UNIV LOUISVILLE,DEPT BIOL LIFE SCI,HISTOPLASMOSIS RES LAB,LOUISVILLE,KY 40201, USA.							BUDTZJOR.E, 1972, ACTA ALLERGOL, V27, P41, DOI 10.1111/j.1398-9995.1972.tb01641.x; CLAUSEN JE, 1969, ACTA MED SCAND, V186, P227; CLAUSEN JE, 1970, ACTA MED SCAND, V188, P59; GRAPPEL SF, 1974, BACTERIOL REV, V38, P222, DOI 10.1128/MMBR.38.2.222-250.1974; HUNJAN BS, 1979, J ALLERGY CLIN IMMUN, V63, P361, DOI 10.1016/0091-6749(79)90132-5; LEPPER A W D, 1969, Review of Medical and Veterinary Mycology, V6, P435; MACLEOD TM, 1976, BRIT J DERMATOL, V94, P63, DOI 10.1111/j.1365-2133.1976.tb04342.x; RAJKA G, 1970, ACTA DERM-VENEREOL, V50, P281; RAJKA G, 1968, ACTA DERM-VENEREOL, V48, P186; RAUCH HC, 1973, INT ARCH ALLER A IMM, V44, P862, DOI 10.1159/000230989; Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115; SOBORG M, 1967, ACTA MED SCAND, V182, P167; TIO D, 1976, BRIT J DERMATOL, V94, P65, DOI 10.1111/j.1365-2133.1976.tb04343.x; UEHARA M, 1974, ACTA DERM-VENEREOL, V54, P279	14	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	6					485	494		10.1016/0091-6749(81)90103-2	http://dx.doi.org/10.1016/0091-6749(81)90103-2			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LU068	7050213				2022-12-18	WOS:A1981LU06800011
J	NADEL, JA				NADEL, JA			REGULATION OF FLUID AND MUCOUS SECRETIONS IN AIRWAYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	NADEL, JA (corresponding author), UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143, USA.							BOAT TF, 1980, FED PROC, V39, P3067; NADEL JA, 1977, AM REV RESPIR DIS, V115, P117; NADEL JA, 1980, FED PROC, V39, P3075; NADEL JA, 1979, ANNU REV PHYSIOL, V41, P369, DOI 10.1146/annurev.ph.41.030179.002101; NADEL JA, 1978, RESPIRATORY TRACT MU, P133; WIDDICOMBE JH, 1980, FED PROC, V39, P3062	6	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	6					417	420						4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LU068	6286745				2022-12-18	WOS:A1981LU06800001
J	REISMAN, RE				REISMAN, RE			STANDARDS OF PRACTICE - OUR RESPONSIBILITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	68	1					1	4		10.1016/0091-6749(81)90115-9	http://dx.doi.org/10.1016/0091-6749(81)90115-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LY101	7240594				2022-12-18	WOS:A1981LY10100001
J	WANG, SR; ZWEIMAN, B				WANG, SR; ZWEIMAN, B			INHIBITORY EFFECTS OF CORTICOSTEROIDS AND HISTAMINE ON HUMAN-LYMPHOCYTES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PENN,SCH MED,DEPT MED,IMMUNOL SECT,PHILADELPHIA,PA 19104; VET ADM HOSP,PHILADELPHIA,PA 19104	University of Pennsylvania	WANG, SR (corresponding author), CHANG GUNG MEM HOSP,DEPT MED,ALLERGY & IMMUNOL SECT,TAIPEI 105,TAIWAN.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 14332, IT 32-AI-07031] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BALLET JJ, 1976, CELL IMMUNOL, V24, P250, DOI 10.1016/0008-8749(76)90210-0; BAXER JD, 1976, PHARM THER B, V2, P605; BAXER JD, 1972, AM J MED, V53, P573; BOBORNKITTI S, 1960, DIS CHEST, V38, P51; CLARK RB, 1971, P NATL ACAD SCI USA, V68, P2757, DOI 10.1073/pnas.68.11.2757; FAUCI AS, 1974, J CLIN INVEST, V53, P240, DOI 10.1172/JCI107544; FRANDSEN EK, 1976, LIFE SCI, V18, P529, DOI 10.1016/0024-3205(76)90331-3; GRANNER D, 1968, SCIENCE, V162, P1018, DOI 10.1126/science.162.3857.1018; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HENNEY CS, 1972, J IMMUNOL, V108, P1526; LICHTENSTEIN LM, 1975, INT ARCH ALLER A IMM, V49, P143, DOI 10.1159/000231390; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; MELMON KL, 1974, J CLIN INVEST, V53, P22, DOI 10.1172/JCI107542; NOWELL PC, 1961, CANCER RES, V21, P1518; PARKER CW, 1973, J CLIN INVEST, V52, P1342, DOI 10.1172/JCI107306; Perkins J P, 1973, Adv Cyclic Nucleotide Res, V3, P1; PLAUT M, 1973, J IMMUNOL, V111, P389; ROCKLIN RE, 1977, J IMMUNOL, V118, P1734; ROCKLIN RE, 1976, J CLIN INVEST, V57, P1051, DOI 10.1172/JCI108347; STEINER AL, 1972, J BIOL CHEM, V247, P1106; WANG SR, 1978, CELL IMMUNOL, V36, P28, DOI 10.1016/0008-8749(78)90247-2; WANG SR, 1980, IMMUNOPHARMACOLOGY, V2, P95, DOI 10.1016/0162-3109(80)90001-6; WEBEL ML, 1974, J LAB CLIN MED, V83, P383; WEBEL ML, 1977, CELL IMMUNOL, V32, P287, DOI 10.1016/0008-8749(77)90205-2; ZEILLER K, 1974, IMMUNOLOGY, V26, P995	25	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	1					39	44		10.1016/0091-6749(81)90043-9	http://dx.doi.org/10.1016/0091-6749(81)90043-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KZ173	6256422				2022-12-18	WOS:A1981KZ17300008
J	BARR, L; DONLON, M; CHOCK, E; CATRAVAS, GN; KALINER, M				BARR, L; DONLON, M; CHOCK, E; CATRAVAS, GN; KALINER, M			AMILORIDE-INDUCED HISTAMINE-RELEASE FROM RAT PERITONEAL MAST-CELLS (RPMCS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					171	171						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000027
J	BLEECKER, ER; FISH, J; ROSENTHAL, RR; MENKES, H; MASON, P; PERMUTT, S; NORMAN, PS				BLEECKER, ER; FISH, J; ROSENTHAL, RR; MENKES, H; MASON, P; PERMUTT, S; NORMAN, PS			ACUTE AND DELAYED-EFFECTS OF ANTIGEN ON AIRWAYS TONE AND REACTIVITY IN HAY-FEVER AND ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					209	209						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000147
J	COOK, DA; ORT, H; JALOWAYSKI, A; HAMBURGER, RN				COOK, DA; ORT, H; JALOWAYSKI, A; HAMBURGER, RN			OTOLOGIC RESPONSE TO INTRANASAL ANTIGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					215	215						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000168
J	HENDELES, L; SARRAZIN, E; WEINBERGER, M				HENDELES, L; SARRAZIN, E; WEINBERGER, M			DOSE-DEPENDENT KINETICS FOR THEOPHYLLINE - OBSERVATIONS AMONG AMBULATORY ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					177	177						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000047
J	HUSSAIN, R; MARSH, DG				HUSSAIN, R; MARSH, DG			CHARACTERIZATION AND ALLERGENIC ACTIVITY OF RAGWEED ALLERGENS RA6, RA7, AND RA8	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Hussain, Rabia/M-6649-2015; Hussain, Rabia/E-9982-2015	Hussain, Rabia/0000-0001-9995-8742; 					0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					230	230						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000217
J	KNIKER, WT; MURPHREE, JT; DEFILIPPI, I				KNIKER, WT; MURPHREE, JT; DEFILIPPI, I			IMMUNOTHERAPY REGIMENS COMPARED IN MOUNTAIN CEDAR ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					193	193						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000096
J	LEWIS, RA; ROBERTS, LJ; HOLGATE, ST; OATES, JA; AUSTEN, KF				LEWIS, RA; ROBERTS, LJ; HOLGATE, ST; OATES, JA; AUSTEN, KF			IMMUNOLOGICAL GENERATION OF MAST-CELL PROSTAGLANDINS AND THEIR EFFECTS ON MAST-CELL CYCLIC-NUCLEOTIDES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					235	235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000235
J	LOWENSTEIN, H; SOBOTKA, AK; LICHTENSTEIN, LM				LOWENSTEIN, H; SOBOTKA, AK; LICHTENSTEIN, LM			IDENTIFICATION OF AND IMMUNOCHEMICAL RELATIONSHIP BETWEEN INDIVIDUAL ALLERGENS OF VESPID VENOMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					201	201						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000122
J	MCLEAN, JA; BACON, JR; MATHEWS, KP; THRALL, JH; BANAS, JM; BAYNE, NK				MCLEAN, JA; BACON, JR; MATHEWS, KP; THRALL, JH; BANAS, JM; BAYNE, NK			DISTRIBUTION AND CLEARANCE OF SOLUTIONS APPLIED TO THE NASAL-MUCOSA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					188	188						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000081
J	NASSIF, E; WEINBERGER, M; THOMPSON, R; SHERMAN, B				NASSIF, E; WEINBERGER, M; THOMPSON, R; SHERMAN, B			EFFECTS OF CONTINUOUS CORTICOSTEROID-THERAPY ON CHILDREN WITH CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					219	220						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000182
J	SUTTON, PL; ROSE, JQ; GOLDSTEIN, S; KOUP, JR; MIDDLETON, E; JUSKO, WJ				SUTTON, PL; ROSE, JQ; GOLDSTEIN, S; KOUP, JR; MIDDLETON, E; JUSKO, WJ			THEOPHYLLINE PHARMACOKINETICS DURING PREGNANCY AND POST PARTUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Jusko, William J/G-4885-2015						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					177	177						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000046
J	SWANSON, M; REED, CE; FORD, AM				SWANSON, M; REED, CE; FORD, AM			APPLICATION OF A SOLID-PHASE RADIOIMMUNOASSAY FOR IGG ANTIBODY IN AN INDUSTRIAL OUTBREAK OF HYPERSENSITIVITY PNEUMONITIS DUE TO A CONTAMINATED CHILLED-WATER AIR-CONDITIONING SYSTEM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		HAMILTON, 1979, J IMMUNOL, V122, P1073	1	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					228	228						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000211
J	WEINBERGER, M				WEINBERGER, M			CROMOLYN SODIUM AND THEOPHYLLINE IN CHRONIC PERENNIAL ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											WEINBERGER, M (corresponding author), UNIV IOWA,HOSP & CLIN,DIV PEDIAT ALLERGY & PULM,IOWA CITY,IA 52240, USA.							GODFREY S, 1980, J ALLERGY CLIN IMMUN, V65, P97, DOI 10.1016/0091-6749(80)90192-X; GODFREY S, 1976, THORAX, V31, P137, DOI 10.1136/thx.31.2.137; HAMBLETON G, 1977, LANCET, V1, P381; HENDELES L, 1978, AM J DIS CHILD, V132, P876; NASSIF E, 1980, MAY ANN M AM THOR SO; POLLOCK J, 1977, PEDIATRICS, V60, P840; WEINBERGER M, 1978, NEW ENGL J MED, V299, P852, DOI 10.1056/NEJM197810192991603	7	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	5					428	428		10.1016/0091-6749(80)90124-4	http://dx.doi.org/10.1016/0091-6749(80)90124-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KQ965	6777417				2022-12-18	WOS:A1980KQ96500013
J	BOREL, Y; KING, TP; SINCLAIR, KJ; BLOCH, KJ				BOREL, Y; KING, TP; SINCLAIR, KJ; BLOCH, KJ			SUPPRESSION BY ANTIGEN E-IGG CONJUGATES OF THE IGE ANTIBODY-RESPONSE TO RAGWEED AGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					176	177						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400142
J	GREEN, AW; REISMAN, RE; ARBESMAN, CE				GREEN, AW; REISMAN, RE; ARBESMAN, CE			CLINICAL AND IMMUNOLOGICAL STUDIES OF PATIENTS WITH LARGE LOCAL REACTIONS FOLLOWING INSECT STINGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					135	135						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400002
J	GREENBERGER, P; PATTERSON, R				GREENBERGER, P; PATTERSON, R			PREDNISONE-DIPHENHYDRAMINE REGIMEN PRIOR TO USE OF RADIOGRAPHIC CONTRAST-MEDIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											GREENBERGER, P (corresponding author), NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60611, USA.		Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498				KELLY JF, 1978, J ALLERGY CLIN IMMUN, V62, P181, DOI 10.1016/0091-6749(78)90104-5; PATTERSON R, 1975, J ALLERGY CLIN IMMUN, V56, P328, DOI 10.1016/0091-6749(75)90108-6; SCHATZ M, 1975, J ALLERGY CLIN IMMUN, V55, P358, DOI 10.1016/0091-6749(75)90007-X; ZWEIMAN B, 1975, ANN INTERN MED, V83, P159, DOI 10.7326/0003-4819-83-2-159	4	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	4					295	295		10.1016/0091-6749(79)90116-7	http://dx.doi.org/10.1016/0091-6749(79)90116-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GR842	429707				2022-12-18	WOS:A1979GR84200012
J	KAPLAN, MJ				KAPLAN, MJ			SEIZURES IN ASTHMATIC-CHILDREN WITH NORMAL THEOPHYLLINE BLOOD-LEVELS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					157	157						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400076
J	KOHN, BA; TWAROG, FJ; GEHA, RS				KOHN, BA; TWAROG, FJ; GEHA, RS			DIFFERENTIAL EFFECTS OF PHARMACOLOGIC AGENTS ON EAC3 ROSETTE FORMATION BY LYMPHOCYTES FROM NORMAL AND ASTHMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS HOSP MED CTR,DIV ALLERGY,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DEPT MED,DIV IMMUNOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School								ALSTON WC, 1974, BRIT MED J, V1, P90, DOI 10.1136/bmj.1.5898.90; BOURNE HR, 1971, J PHARMACOL EXP THER, V178, P1; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CHESS L, 1974, J IMMUNOL, V113, P1113; CHESS L, 1977, ADV IMMUNOL, V25, P213; CHISARI FV, 1974, J EXP MED, V140, P1122, DOI 10.1084/jem.140.4.1122; CONOLLY ME, 1976, J CLIN INVEST, V58, P1307, DOI 10.1172/JCI108586; DALTON RW, 1964, IMMUNOLOGY, V7, P40; FU SM, 1974, J EXP MED, V139, P451, DOI 10.1084/jem.139.2.451; GALANT SP, 1975, J IMMUNOL, V114, P512; GILLESPIE E, 1974, J ALLERGY CLIN IMMUN, V53, P27, DOI 10.1016/0091-6749(74)90096-7; GRIECO MH, 1963, AM J MED, V44, P863; ITO M, 1977, NATURE, V266, P633, DOI 10.1038/266633a0; LANG P, 1978, J ALLERGY CLIN IMMUN, V61, P248, DOI 10.1016/0091-6749(78)90199-9; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P691, DOI 10.1172/JCI107230; LOCKEY SD, 1967, J ALLERGY, V40, P349, DOI 10.1016/0021-8707(67)90024-X; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; LOGSDON PJ, 1973, J ALLERGY CLIN IMMUN, V52, P148, DOI 10.1016/0091-6749(73)90031-6; MORRIS HG, 1978, J ALLERGY CLIN IMMUN, V61, P294, DOI 10.1016/0091-6749(78)90050-7; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; PARKER CW, 1973, J CLIN INVEST, V52, P1342, DOI 10.1172/JCI107306; PARKER CW, 1973, J CLIN INVEST, V52, P1336, DOI 10.1172/JCI107305; PATEL KR, 1974, CLIN ALLERGY, V4, P311, DOI 10.1111/j.1365-2222.1975.tb01868.x; SCHWARTZ HJ, 1973, J ALLERGY CLIN IMMUN, V51, P88, DOI 10.1016/S0091-6749(73)80024-7; SMITH JW, 1971, J CLIN INVEST, V50, P432, DOI 10.1172/JCI106510; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2	26	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	3					182	188		10.1016/0091-6749(79)90093-9	http://dx.doi.org/10.1016/0091-6749(79)90093-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HL221	469118	Bronze			2022-12-18	WOS:A1979HL22100005
J	LEWIS, RA; ROBERTS, LJ; LAWSON, JA; AUSTEN, KF; OATES, JA				LEWIS, RA; ROBERTS, LJ; LAWSON, JA; AUSTEN, KF; OATES, JA			GENERATION OF OXIDATIVE METABOLITES OF ARACHIDONIC-ACID FROM RAT SEROSAL MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					220	220						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400294
J	MELTZER, EO; KEMP, JP; ORGEL, HA; COOPER, WC				MELTZER, EO; KEMP, JP; ORGEL, HA; COOPER, WC			FLUNISOLIDE AEROSOL IN TREATMENT OF STEROID-INDEPENDENT BRONCHIAL-ASTHMA IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					162	162						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400093
J	NELSON, TL; KLEIN, GL; GALANT, SP				NELSON, TL; KLEIN, GL; GALANT, SP			SEVERE EOSINOPHILIC GASTROENTERITIS SUCCESSFULLY TREATED WITH AN ELEMENTAL DIET (VIVONEX)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					198	198						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400219
J	POSEY, WC; TINKELMAN, DG				POSEY, WC; TINKELMAN, DG			DOSE-RESPONSE CHARACTERISTICS OF NEBULIZED ISOPROTERENOL IN ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR,DEPT ALLERGY & CLIN IMMUNOL,DENVER,CO 80240; NATL JEWISH HOSP & RES CTR,DEPT PEDIAT,ALLERGY & CLIN IMMUNOL SECT,DENVER,CO 80206	National Jewish Health								AHLQUIST RP, 1948, AM J PHYSIOL, V153, P586, DOI 10.1152/ajplegacy.1948.153.3.586; AVIADO DM, 1975, J CLIN PHARMACOL, V15, P86, DOI 10.1002/j.1552-4604.1975.tb01436.x; AVNER SE, 1975, PEDIATR CLIN N AM, V22, P129; CHANG N, 1972, AM REV RESPIR DIS, V106, P867, DOI 10.1164/arrd.1972.106.6.867; CHOOKANG YF, 1969, BMJ-BRIT MED J, V2, P287, DOI 10.1136/bmj.2.5652.287; CLARK DG, 1972, ANN ALLERGY, V30, P536; COHEN AA, 1965, AM J MED SCI, V249, P97; EISENSTADT WS, 1969, ANN ALLERGY, V27, P283; ELSHABOURY H, 1964, BRIT MED J, V2, P1037; EMERGIL C, 1969, AM J MED, V47, P367; FEATHERBY EA, 1969, ARCH DIS CHILD, V44, P382, DOI 10.1136/adc.44.235.382; FEINMAN L, 1969, BRIT MED J, V1, P515; GAZIOGLU K, 1971, AM REV RESPIR DIS, V104, P188; GOLDBERG I, 1965, AM REV RESPIR DIS, V91, P13, DOI 10.1164/arrd.1965.91.1.13; HAMBLETON G, 1970, ARCH DIS CHILD, V45, P766, DOI 10.1136/adc.45.244.766; HOFFBRAND BI, 1966, BMJ-BRIT MED J, V1, P1014, DOI 10.1136/bmj.1.5494.1014; HOLMES TH, 1968, CLIN PHARMACOL THER, V9, P615; INMAN WHW, 1969, LANCET, V2, P279; KEIGHLEY JF, 1966, ANN INTERN MED, V65, P985, DOI 10.7326/0003-4819-65-5-985; KEIGHLEY JF, 1968, AM REV RESPIR DIS, V98, P879; KNUDSON RJ, 1967, J APPL PHYSIOL, V22, P402, DOI 10.1152/jappl.1967.22.3.402; LANDS A. M., 1967, LIFE SCI, V6, P2241, DOI 10.1016/0024-3205(67)90031-8; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; LEIFER KN, 1975, ANN ALLERGY, V35, P69; LEVINE ER, 1966, DIS CHEST, V49, P610, DOI 10.1378/chest.49.6.610; MILLER RD, 1955, DIS CHEST, V28, P309, DOI 10.1378/chest.28.3.309; MOORE RB, 1972, J ALLERGY CLIN IMMUN, V49, P137, DOI 10.1016/0091-6749(72)90107-8; MOTLEY HL, 1948, AM J MED, V5, P853, DOI 10.1016/0002-9343(48)90165-X; MURRAY AB, 1974, PEDIATRICS, V54, P746; MUSHIN GJ, 1967, THORAX, V22, P538, DOI 10.1136/thx.22.6.538; PALMER KNV, 1967, LANCET, V2, P1232; PATERSON JW, 1968, LANCET, V2, P426; PELZ HH, 1967, AM J MED SCI, V253, P321, DOI 10.1097/00000441-196703000-00009; PIERSON RN, 1969, AM REV RESPIR DIS, V100, P533; REISMAN RE, 1970, J ALLERGY, V46, P162, DOI 10.1016/0021-8707(70)90095-X; ROTH MJ, 1977, ANN ALLERGY, V38, P16; SCHONELL M, 1972, CAN MED ASSOC J, V106, P339; SEGAL M S, 1947, Ann Allergy, V5, P317; SEGAL M S, 1947, Bull New Engl Med Cent, V9, P62; SHELDON GP, 1972, ANN ALLERGY, V30, P24; SHENFIELD GM, 1973, AM REV RESPIR DIS, V108, P501; SILVERGLADE A, 1972, J AMER MED ASSOC, V222, P827, DOI 10.1001/jama.222.7.827; SMELZER TH, 1973, JAMA-J AM MED ASSOC, V223, P884; SOBOL BJ, 1974, ANN ALLERGY, V32, P137; TALA E, 1971, POSTGRAD MED J, V47, P61; TATTERSFIELD AE, 1969, NEW ENGL J MED, V281, P1323, DOI 10.1056/NEJM196912112812402; TAYLOR GJ, 1970, J AMER MED ASSOC, V214, P81, DOI 10.1001/jama.214.1.81; VANMETRE TE, 1969, J ALLERGY, V43, P101, DOI 10.1016/0021-8707(69)90130-0; WADDELL JA, 1967, BRIT MED J, V2, P402, DOI 10.1136/bmj.2.5549.402; WARRELL DA, 1970, BMJ-BRIT MED J, V1, P65, DOI 10.1136/bmj.1.5688.65; WINER BJ, 1962, STATISTICAL PRINCIPL, P85; 1962, AM REV RESPIR DIS, V85, P762	52	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	4					258	266		10.1016/0091-6749(79)90110-6	http://dx.doi.org/10.1016/0091-6749(79)90110-6			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GR842	372290				2022-12-18	WOS:A1979GR84200006
J	SHEFFER, AL; MCFADDEN, ER; GROSSMAN, J; AUSTEN, KF				SHEFFER, AL; MCFADDEN, ER; GROSSMAN, J; AUSTEN, KF			EXERCISE-INDUCED SYNCOPE WITH PRURITUS, URTICARIA, AND ANGIOEDEMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		MATHEWS K P, 1970, Algerie Medicale, V72, P241	1	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					174	175						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400135
J	SPAULDING, HS; MANSFIELD, LE; SELNER, J				SPAULDING, HS; MANSFIELD, LE; SELNER, J			FURTHER INVESTIGATIONS OF THE ASSOCIATION BETWEEN GASTROESOPHAGEAL REFLUX AND BRONCHOCONSTRICTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					218	218						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400286
J	WISE, PJ; ROSENTHAL, RR; KILLIAN, P; NORMAN, PS; EVANS, R				WISE, PJ; ROSENTHAL, RR; KILLIAN, P; NORMAN, PS; EVANS, R			CONTROLLED-STUDY OF PLACEBO TREATMENT OF HAY-FEVER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					216	216						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400280
J	ALLANSMITH, MR; BAIRD, RS				ALLANSMITH, MR; BAIRD, RS			MAST-CELLS, EOSINOPHILS, AND BASOPHILS IN VERNAL CONJUNCTIVITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					154	154		10.1016/0091-6749(78)90325-1	http://dx.doi.org/10.1016/0091-6749(78)90325-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300086
J	BERNSTEIN, IL; JOHNSON, CL; GALLAGHER, JS; ARCHER, D; JOHNSON, H				BERNSTEIN, IL; JOHNSON, CL; GALLAGHER, JS; ARCHER, D; JOHNSON, H			ARE TARTRAZINE REACTIONS MEDIATED BY IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					191	191		10.1016/0091-6749(78)90448-7	http://dx.doi.org/10.1016/0091-6749(78)90448-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300209
J	CHIOU, WL				CHIOU, WL			DISCREPANCY OF CONVERSION FACTOR BETWEEN THEOPHYLLINE AND AMINOPHYLLINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									UNIV ILLINOIS,MED CTR,COLL PHARM,DEPT PHARM,CHICAGO,IL 60612	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	CHIOU, WL (corresponding author), UNIV ILLINOIS,MED CTR,CLIN PHARMACOKINET LAB,CHICAGO,IL 60612, USA.							ARANDA JV, 1976, NEW ENGL J MED, V295, P413, DOI 10.1056/NEJM197608192950803; ELLIS EF, 1974, J ALLERGY CLIN IMMUN, V53, P116, DOI 10.1016/0091-6749(74)90073-6; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; LOUGHNAN PM, 1976, J PEDIATR-US, V88, P874, DOI 10.1016/S0022-3476(76)81136-5; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; RANGSITHIENCHAI P, 1977, J PEDIATR-US, V91, P325, DOI 10.1016/S0022-3476(77)80845-7; TONG TG, 1973, DRUG INTEL CLIN PHAR, V7, P156, DOI 10.1177/106002807300700402; WEINBERGER MW, 1976, JAMA-J AM MED ASSOC, V235, P2110, DOI 10.1001/jama.235.19.2110; 1976, PHYSICIANS DESK REFE; 1975, US PHARMACOPEIA, V19	10	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	6					408	409		10.1016/0091-6749(78)90123-9	http://dx.doi.org/10.1016/0091-6749(78)90123-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC593	659734				2022-12-18	WOS:A1978FC59300012
J	GILMORE, NJ; YANG, WH; DORVAL, G				GILMORE, NJ; YANG, WH; DORVAL, G			CIRCULATING IMMUNE-COMPLEXES DURING IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					168	168		10.1016/0091-6749(78)90371-8	http://dx.doi.org/10.1016/0091-6749(78)90371-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300132
J	GREEN, AW; STOKLOSA, J; MIDDLETON, E				GREEN, AW; STOKLOSA, J; MIDDLETON, E			INHALED ATROPINE SULFATE IN STATUS-ASTHMATICUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					149	149		10.1016/0091-6749(78)90309-3	http://dx.doi.org/10.1016/0091-6749(78)90309-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300070
J	HOFFMAN, DR				HOFFMAN, DR			BIOCHEMICAL AND ALLERGENIC STUDIES OF VESPID VENOMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					135	136		10.1016/0091-6749(78)90262-2	http://dx.doi.org/10.1016/0091-6749(78)90262-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300023
J	HUTCHCROFT, BJ; MOORE, E; ORANGE, RP				HUTCHCROFT, BJ; MOORE, E; ORANGE, RP			H-1 AND H-2 ANTIHISTAMINES IN ALLERGIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					192	192		10.1016/0091-6749(78)90451-7	http://dx.doi.org/10.1016/0091-6749(78)90451-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300212
J	KING, GW; FILE, J; LOBUGLIO, AF				KING, GW; FILE, J; LOBUGLIO, AF			NORMAL HUMAN MONOCYTES INHIBIT TUMOR-CELL GROWTH INVITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									OHIO STATE UNIV,COLL MED,DEPT MED,DIV HEMATOL & ONCOL,COLUMBUS,OH 43210	Ohio State University								ANDERSON SE, 1974, J EXP MED, V139, P1154, DOI 10.1084/jem.139.5.1154; HIBBS JB, 1976, J RETICULOENDOTH SOC, V20, P223; HIBBS JB, 1972, SCIENCE, V177, P998, DOI 10.1126/science.177.4053.998; HOLTERMANN OA, 1974, P SOC EXP BIOL MED, V147, P456; KELLER R, 1974, IMMUNOLOGY, V27, P285; KELLER R, 1974, INT J CANCER, V14, P675, DOI 10.1002/ijc.2910140515; KING GW, 1975, CELL IMMUNOL, V16, P389, DOI 10.1016/0008-8749(75)90127-6; KING GW, 1977, J LAB CLIN MED, V89, P316; KOLLER CA, 1973, J IMMUNOL, V111, P1610; KRAHENBUHL JL, 1976, CLIN RES, V24, pA158; KRAKENBUHL JL, 1976, IMMUNOLOGY, V31, P837; KRAKENBUHL JL, 1971, INFECT IMMUNITY, V4, P337; LOBUGLIO AF, 1967, SCIENCE, V158, P1582, DOI 10.1126/science.158.3808.1582; NATHAN CF, 1971, J EXP MED, V133, P1356, DOI 10.1084/jem.133.6.1356; PARKER JW, 1971, AM J CLIN PATHOL, V56, P174; PIESSENS WF, 1975, J IMMUNOL, V114, P293; RINEHART J, 1977, CLIN RES, V25, pA411; RINEHART JJ, 1974, J CLIN INVEST, V54, P1337, DOI 10.1172/JCI107880; ROCKLIN RE, 1974, J CLIN INVEST, V53, P559, DOI 10.1172/JCI107590; SAGONE AL, 1976, J CLIN INVEST, V57, P1352, DOI 10.1172/JCI108403; STEWART CC, 1967, BLOOD-J HEMATOL, V29, P628, DOI 10.1182/blood.V29.4.628.628; VANFURTH R, 1970, SEMIN HEMATOL, V7, P125; WORCESTER J, 1966, NEW ENGL J MED, V274, P27, DOI 10.1056/NEJM196601062740106	23	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	62	5					283	288		10.1016/0091-6749(78)90159-8	http://dx.doi.org/10.1016/0091-6749(78)90159-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FW432	701663				2022-12-18	WOS:A1978FW43200005
J	KORDASH, TR; GLEICH, GJ; KERN, EB; OFALLON, WM				KORDASH, TR; GLEICH, GJ; KERN, EB; OFALLON, WM			EVIDENCE FOR INCREASED RISK OF DEVELOPMENT OF ASTHMA IN PATIENTS WITH NASAL POLYPS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					138	138		10.1016/0091-6749(78)90271-3	http://dx.doi.org/10.1016/0091-6749(78)90271-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300032
J	KURUP, VP				KURUP, VP			IDENTIFICATION OF THERMOPHILIC ACTINOMYCETES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note											KURUP, VP (corresponding author), MED COLL WISCONSIN,MILWAUKEE,WI 53233, USA.								0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					232	233		10.1016/0091-6749(78)90193-8	http://dx.doi.org/10.1016/0091-6749(78)90193-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	632469				2022-12-18	WOS:A1978EV08000018
J	LOWELL, FC				LOWELL, FC			CHRONIC-BRONCHITIS AND ASTHMA - POOR TERMS FOR 2 COMMON DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	62	6					325	326		10.1016/0091-6749(78)90131-8	http://dx.doi.org/10.1016/0091-6749(78)90131-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GA292	712018				2022-12-18	WOS:A1978GA29200002
J	MARX, J				MARX, J			INVOLVEMENT OF COMPLEMENT-SYSTEM IN HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MARX, J (corresponding author), MARSHFIELD MED FDN,MARSHFIELD,WI 54449, USA.								0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					208	210		10.1016/0091-6749(78)90181-1	http://dx.doi.org/10.1016/0091-6749(78)90181-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	416060	Bronze			2022-12-18	WOS:A1978EV08000006
J	MICHAELSON, ED; SILVA, GT; FORREST, TR; MARKS, MB; SERAFINI, SM; SACKNER, MA				MICHAELSON, ED; SILVA, GT; FORREST, TR; MARKS, MB; SERAFINI, SM; SACKNER, MA			EFFECTS OF ORAL TERBUTALINE IN CHILDREN WITH BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MICHAELSON, ED (corresponding author), MT SINAI MED CTR,DEPT MED,DIV PULM DIS,MIAMI BEACH,FL 33140, USA.							BLUMBERG MZ, 1977, PEDIATRICS, V60, P14; COMROE JH, 1959, J APPL PHYSIOL, V14, P439, DOI 10.1152/jappl.1959.14.3.439; FAGERBERG E, 1972, SCAND J RESPIR DIS, V53, P3; FORMGREN H, 1970, SCAND J RESPIR DIS, V51, P195; FREEDMAN BJ, 1971, BRIT MED J, V1, P633, DOI 10.1136/bmj.1.5750.633; HANSING B, 1972, ACTA ALLERGOL, V27, P130, DOI 10.1111/j.1398-9995.1972.tb01409.x; KUSOFFSKY E, 1974, ACTA ALLERGOL, V29, P256, DOI 10.1111/j.1398-9995.1974.tb01653.x; LEEGARD J, 1963, ARCH DIS CHILD, V48, P229; LINDQUIST EF, 1953, DESIGN ANAL EXPT PSY, P90; PAIN MCF, 1963, AUSTRALAS ANN MED, V12, P216, DOI 10.1111/imj.1963.12.3.216; Polgar G, 1971, PULMONARY FUNCTION T; SACKNER MA, CHEST; SLY RM, 1977, J ALLERGY CLIN IMMUN, V59, P128, DOI 10.1016/0091-6749(77)90214-7; 1975, CHEST, V67, P583	14	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	6					365	369		10.1016/0091-6749(78)90115-X	http://dx.doi.org/10.1016/0091-6749(78)90115-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC593	659728				2022-12-18	WOS:A1978FC59300004
J	MOORE, V				MOORE, V			HUMORAL AND CELLULAR IMMUNOLOGICAL ASPECTS OF HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MOORE, V (corresponding author), MED COLL WISCONSIN,MILWAUKEE,WI 53233, USA.								0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					210	213		10.1016/0091-6749(78)90182-3	http://dx.doi.org/10.1016/0091-6749(78)90182-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	632463				2022-12-18	WOS:A1978EV08000007
J	ASKENASE, PW; DEBERNARDO, R; KASHGARIAN, M; DOUGLAS, J; TAUBEN, D				ASKENASE, PW; DEBERNARDO, R; KASHGARIAN, M; DOUGLAS, J; TAUBEN, D			ANAPHYLACTIC TYPE BASOPHIL DEGRANULATION AT DELAYED CUTANEOUS BASOPHIL REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					193	194						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000012
J	BRUCE, CA; BIAS, WB; NORMAN, PS; LICHTENSTEIN, LM; MARSH, DG				BRUCE, CA; BIAS, WB; NORMAN, PS; LICHTENSTEIN, LM; MARSH, DG			STUDIES OF HL-A ANTIGEN FREQUENCIES, IGE LEVELS, AND SPECIFIC ALLERGIC SENSITIVITIES IN PATIENTS HAVING RAGWEED HAY-FEVER, WITH AND WITHOUT ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					228	229						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000096
J	KERSHNAR, H; KATZ, R; TASHKIN, D; RACHELEFSKY, G; SIEGEL, S				KERSHNAR, H; KATZ, R; TASHKIN, D; RACHELEFSKY, G; SIEGEL, S			COMPARISON OF CROMOLYN SODIUM (CS), AEROSOLIZED ATROPINE (A), ISOPROTERENOL (I), AND A + I IN PREVENTION OF EXERCISE-INDUCED ASTHMA (EIA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					261	262						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000176
J	KOHLER, PF				KOHLER, PF			ASTHMA HYPOSENSITIZATION AND ARTERITIS - DIRECT RELATIONSHIP OR RED HERRING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					232	232						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000104
J	SOBOTKA, AK; LESSOF, MH; LICHTENSTEIN, LM				SOBOTKA, AK; LESSOF, MH; LICHTENSTEIN, LM			ABSOLUTE BLOCKING ANTIBODY LEVELS IN PASSIVELY AND ACTIVELY TREATED HONEYBEE-SENSITIVE PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					247	247						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000141
J	TURKELTAUB, PC; ADKINSON, NF; LICHTENSTEIN, LM; NORMAN, PS				TURKELTAUB, PC; ADKINSON, NF; LICHTENSTEIN, LM; NORMAN, PS			RUSH IMMUNOTHERAPY OF RAGWEED HAY-FEVER WITH CRUDE RAGWEED EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													turkeltaub, paul/AAG-6160-2019; turkeltaub, paul/U-7729-2019						0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					232	232						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000105
J	WASSERMAN, SI; BOSWELL, RN; DRAZEN, JM; GOETZL, EJ; AUSTEN, KF				WASSERMAN, SI; BOSWELL, RN; DRAZEN, JM; GOETZL, EJ; AUSTEN, KF			FUNCTIONAL SPECIFICITY OF HUMAN LUNG ACIDIC TETRAPEPTIDES CONSTITUTING EOSINOPHIL CHEMOTACTIC FACTOR OF ANAPHYLAXIS (ECF-A)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		GOETZL EJ, 1975, P NATL ACAD SCI  OCT	1	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					190	190						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000003
J	COLTEN, HR; POLAKOFF, PL; WEINSTEIN, SF; STRIEDER, D				COLTEN, HR; POLAKOFF, PL; WEINSTEIN, SF; STRIEDER, D			IMMEDIATE HYPERSENSITIVITY TO HOG TRYPSIN RESULTING FROM INDUSTRIAL EXPOSURE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					130	130						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800149
J	CROPP, GJ				CROPP, GJ			EFFECTIVENESS OF ATROPINE SULFATE AS A BRONCHODILATOR IN ASTHMATIC CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		GOLD WM, 1972, J APPL PHYSIOL, V33, P719, DOI 10.1152/jappl.1972.33.6.719	1	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					98	98						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800074
J	FRANZ, ML; GALANT, SP				FRANZ, ML; GALANT, SP			CORRELATION OF SERUM IGE CUTANEOUS DELAYED HYPERSENSITIVITY (CDH) IN ATOPIC CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					113	113						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800110
J	GLOVSKY, M; GHEKIERE, L; ROTH, R; CAMPBELL, D				GLOVSKY, M; GHEKIERE, L; ROTH, R; CAMPBELL, D			IDENTIFICATION OF ANTIGEN ACTIVITY OF DOG DANDER EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					76	77						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800020
J	MCDONALD, JL; SOLOMON, WR				MCDONALD, JL; SOLOMON, WR			EFFECTS OF OUTDOOR ACTIVITY ON AEROALLERGENS IN HUMAN MICROENVIRONMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					89	89						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800052
J	OKAZAKI, T; OKAZAKI, A; REISMAN, RE; ARBESMAN, CE				OKAZAKI, T; OKAZAKI, A; REISMAN, RE; ARBESMAN, CE			GLYCOGENOLYSIS AND CONTROL OF ANAPHYLACTIC HISTAMINE-RELEASE BY CYCLIC ADENOSINE MONOPHOSPHATE-RELATED AGENTS .2. MODIFICATION OF HISTAMINE-RELEASE BY GLYCOGENOLYTIC METABOLITES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY, DEPT MED, BUFFALO, NY USA; SUNY, DEPT MICROBIOL, BUFFALO, NY USA; BUFFALO GEN HOSP, ALLERGY RES LAB, 100 HIGH ST, BUFFALO, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; Buffalo General Medical Center								ANDERSSON R, 1972, ACTA PHYSIOL SCAND, V85, P312, DOI 10.1111/j.1748-1716.1972.tb05267.x; ANDERSSON R, 1972, ADV CYCLIC NUCLEOTID, P213; CHEUNG WY, 1967, BIOCHEMISTRY-US, V6, P1079, DOI 10.1021/bi00856a017; HARPER HA, 1971, REV PHYSIOLOGICAL CH, P227; LICHTENSTEIN LM, 1971, J IMMUNOL, V107, P1131; OKAZAKI T, 1975, J ALLERGY CLIN IMMUN, V56, P243, DOI 10.1016/0091-6749(75)90098-6; ORANGE RP, 1971, J EXP MED          S, V134, P136; ORANGE RP, 1971, BIOCHEMISTRY ACUTE A, P189; REID E, 1967, ENZYME CYTOLOGY, P321; UZUNOV P, 1972, Federation Proceedings, V31, P514; VONKORFF RW, 1964, ANAL BIOCHEM, V8, P171, DOI 10.1016/0003-2697(64)90043-0; WHELAN WJ, 1964, CONTROL GLYCOGEN MET	12	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	4					253	261		10.1016/0091-6749(75)90099-8	http://dx.doi.org/10.1016/0091-6749(75)90099-8			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AS523	51862				2022-12-18	WOS:A1975AS52300002
J	SANTILLI, J; MARSH, D; BIAS, W; SCHACTER, B; GOODFRIEND, L				SANTILLI, J; MARSH, D; BIAS, W; SCHACTER, B; GOODFRIEND, L			PUNCTURE SKIN TESTING WITH PURIFIED POLLEN ANTIGENS - USEFUL TOOL FOR GENETIC STUDIES IN ATOPIC MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					108	108						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800098
J	SCHACHTER, J				SCHACHTER, J			MEASUREMENT OF PREVALENCE OF RESPIRATORY ALLERGIES BY INTERVIEW QUESTIONNAIRE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,OFF DIRECTOR,BLDG 31,ROOM 7A30,BETHESDA,MD 20014	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								BALAMUTH E, 1965, 7 PUBL HLTH SERV WAS; CANNELL CF, 1968, 26 PUBL HLTH SERV WA; DORN HF, 1951, AJPH, V41, P271; GLEESON GA, 1972, 48 PUBL HLTH SERV WA; HOLMAN WJ, 1966, QUESTIONNAIRES RESPI; KOONS DA, 1973, 54 PUBL HLTH SERV WA; LAURENT A, 1972, 49 PUBL HLTH SERV WA; MADOW WG, 1973, 57 PUBL HLTH SERV WA; MADOW WG, 1967, 23 PUBL HLTH SERV WA; MARQUIS KH, 1972, 45 PUBL HLTH SERV WA; MARQUIS KH, 1971, 41 PUBL HLTH SERV WA; NELSON AB, 1967, VITAL HLTH STATISTIC; RHYNE MB, 1971, DETERMINATION PREVAL; WILDER CS, 1973, 84 PUBL HLTH SERV WA; WILDER CS, 1972, 75 PUBL HLTH SERV WA; WILSON RW, 1974, PERSONAL COMMUNICATI; 1970, INTERVIEWERS MANUAL; 1971, 1970 1971 HIP STAT R	18	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	4					249	255		10.1016/0091-6749(75)90144-X	http://dx.doi.org/10.1016/0091-6749(75)90144-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	W1385	1123496				2022-12-18	WOS:A1975W138500006
J	SIMS, JA; REED, CE				SIMS, JA; REED, CE			EFFECT OF MULTIPLE DOSING ON EFFICACY OF THEOPHYLLINE-EPHEDRINE COMBINATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					95	95						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800066
J	UMEMOTO, L; POOTHULLIL, J; DOLOVICH, J; HARGREAVE, FE; DAY, RP				UMEMOTO, L; POOTHULLIL, J; DOLOVICH, J; HARGREAVE, FE; DAY, RP			FACTORS WHICH INFLUENCE LATE CUTANEOUS ALLERGIC RESPONSE (LCAR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					112	113						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800109
J	BUSSE, WW; REED, CE				BUSSE, WW; REED, CE			ABNORMAL DEGRADATION OF MACROAGGREGATED ALBUMIN PARTICLES IN PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,DEPT MED,1300 UNIV AVE,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison								BEUTIVOGLIO LG, 1963, J CLIN INVEST, V42, P1193; BUSSE W, 1973, CHEST S, V63, P215; FINK JN, 1969, J ALLERGY, V43, P167; HECHSCHER T, 1968, J CLIN INVEST, V47, P1063; HENDERSON LL, 1967, SOUTH MED J, V60, P795, DOI 10.1097/00007611-196708000-00001; MUNOZ J, 1964, HYPERSENSITIVITY REA; MURPHY EDUARDO, 1967, AMER J CLIN PATHOL, V48, P18; REED CE, 1968, YALE J BIOL MED, V40, P507; SMITH JM, 1963, AM REV RESPIR DIS, V88, P858; SOLINGER A, 1973, J ALLERGY CLIN IMMUN, V51, P29; SZENTIVANYI A, 1971, IMMUNOLOGICAL DISEAS; TAPLIN GV, 1964, J NUCL MED, V5, P259; WAGNER HN, 1964, NEW ENGL J MED, V271, P377, DOI 10.1056/NEJM196408202710801; WAGNER HN, 1967, RADIOLOGY, V88, P142; WILSON AF, 1970, AM J MED, V48, P416, DOI 10.1016/0002-9343(70)90040-9; WOOLCOCK AJ, 1966, AUSTRALAS ANN MED, V15, P196	16	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	5					271	277		10.1016/0091-6749(74)90105-5	http://dx.doi.org/10.1016/0091-6749(74)90105-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S9114	4362673				2022-12-18	WOS:A1974S911400003
J	CLONINGE.P; WILSON, AF; NOVEY, HS				CLONINGE.P; WILSON, AF; NOVEY, HS			6 MONTH EVALUATION OF A NEW LONG-ACTING BRONCHODILATOR, TERBUTALINE - COMPARISON WITH EPHEDRINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					84	84						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000048
J	DWYER, JM; MANGI, RJ; KANTOR, FS				DWYER, JM; MANGI, RJ; KANTOR, FS			POOR CORRELATION BETWEEN CUTANEOUS ANERGY AND IN-VITRO LYMPHOCYTE COMPETENCE IN SARCOIDOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					69	69						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000010
J	EVANS, R; ROCKLIN, RE; PENCE, HL; KAPLAN, HM				EVANS, R; ROCKLIN, RE; PENCE, HL; KAPLAN, HM			EFFECT OF IMMUNOTHERAPY ON HUMORAL AND CELLULAR RESPONSES IN RAGWEED HAY-FEVER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					114	114						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000122
J	LEE, TP; STORMS, W; BUSSE, W; REED, CE				LEE, TP; STORMS, W; BUSSE, W; REED, CE			STUDY OF ATOPIC EPIDERMIS - ADENYL-CYCLASE SYSTEM AND MITOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					99	99						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000087
J	MANCINI, RE; FAINBOIM, L; ALONSO, A				MANCINI, RE; FAINBOIM, L; ALONSO, A			EFFECT OF INTRATESTICULAR INJECTION OF ANTISPERM SERUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FAC MED BUENOS AIRES,CENTRO INVEST REPROD,PISO 10,BUENOS AIRES,ARGENTINA	University of Buenos Aires				Fainboim, Leonardo/0000-0002-8907-0341				BISHOP DW, 1965, ANN NY ACAD SCI, V124, P247, DOI 10.1111/j.1749-6632.1965.tb18960.x; BROWN PC, 1969, J PATHOL, V98, P277, DOI 10.1002/path.1710980407; BROWN PC, 1967, IMMUNOLOGY, V13, P307; FREUND J, 1953, J EXP MED, V97, P711, DOI 10.1084/jem.97.5.711; JOHNSON MH, 1970, J REPROD FERTIL, V22, P119; JOHNSON MH, 1970, J PATHOL, V101, P129, DOI 10.1002/path.1711010208; MANCINI RE, 1969, 1 P S IMM REPR GIN; POKORNA Z, 1970, FOLIA BIOL-PRAGUE, V16, P320; SETCHELL BP, 1970, TESTIS; TOULLET F, 1972, ANN I PASTEUR PARIS, V123, P116; TUNK KSK, 1971, IMMUNOL, V106, P1463; WILLSON JT, 1972, INT ARCH ALLER A IMM, V43, P172, DOI 10.1159/000230835	12	4	4	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	2					69	76		10.1016/0091-6749(74)90034-7	http://dx.doi.org/10.1016/0091-6749(74)90034-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T7816	4604387				2022-12-18	WOS:A1974T781600001
J	PATRUCCO, R; MARSH, DG				PATRUCCO, R; MARSH, DG			IMMUNE-RESPONSE TO ASCARIS ANTIGEN IN INBRED MICE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					65	65						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000001
J	SIEGEL, S; BERNSTEI.IL; KATZ, R; YAMATE, M				SIEGEL, S; BERNSTEI.IL; KATZ, R; YAMATE, M			DOUBLE-BLIND CONTROLLED EVALUATION OF ORAL SALBUTAMOL (ALBUTEROL)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					83	83						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000046
J	BERMAN, SZ; MATHISON, DA; STEVENSON, DD; TAN, EM; VAUGHAN, JH				BERMAN, SZ; MATHISON, DA; STEVENSON, DD; TAN, EM; VAUGHAN, JH			TRANSCRICO-THYROID CULTURES IN INFECTIOUS ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					122	123		10.1016/S0091-6749(73)80095-8	http://dx.doi.org/10.1016/S0091-6749(73)80095-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913		Bronze			2022-12-18	WOS:A1973O791300095
J	BIERMAN, CW; PIERSON, WE; SHAPIRO, GG; VANARSDE.PP				BIERMAN, CW; PIERSON, WE; SHAPIRO, GG; VANARSDE.PP			PHARMACOLOGICAL ASSESSMENT OF SINGLE DRUGS AND DRUG COMBINATIONS IN EXERCISE-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					88	88		10.1016/S0091-6749(73)80023-5	http://dx.doi.org/10.1016/S0091-6749(73)80023-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300023
J	LEVINE, BB; STEMBER, RH; FOTINO, M				LEVINE, BB; STEMBER, RH; FOTINO, M			RAGWEED HAY-FEVER - GENETIC-CONTROL AND LINKAGE TO HL-A HAPLOTYPES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					81	81		10.1016/S0091-6749(73)80010-7	http://dx.doi.org/10.1016/S0091-6749(73)80010-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300010
J	LOWELL, FC				LOWELL, FC			SMALL PARTICLES AS A SOURCE OF ALLERGEN DERIVED FROM POLLEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																		BUSSE, 1972, J ALLERGY CLIN IMMUN, V50, P289; REBHUN, 1954, J ALLERGY CLIN IMMUN, V25, P407	2	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	3					187	188		10.1016/0091-6749(73)90024-9	http://dx.doi.org/10.1016/0091-6749(73)90024-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P0896					2022-12-18	WOS:A1973P089600007
J	TAUBER, AI; KALINER, M; STECHSCHULTE, DJ; AUSTEN, KF				TAUBER, AI; KALINER, M; STECHSCHULTE, DJ; AUSTEN, KF			EFFECT OF PROSTAGLANDINS ON IMMUNOLOGICAL RELEASE OF HISTAMINE FROM HUMAN LUNG TISSUE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					106	106		10.1016/S0091-6749(73)80061-2	http://dx.doi.org/10.1016/S0091-6749(73)80061-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300061
J	BARBORIAK, JJ; SOSMAN, AJ; MAKSUD, MG; FINK, JN				BARBORIAK, JJ; SOSMAN, AJ; MAKSUD, MG; FINK, JN			METABOLIC CHANGES IN PATIENTS WITH POSTEXERCISE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					116	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700066
J	GALANT, SP; BULLOCK, J; WONG, D; MAIBACH, HI				GALANT, SP; BULLOCK, J; WONG, D; MAIBACH, HI			INHIBITORY EFFECT OF ANTIALLERGIC DRUGS ON ALLERGEN-INDUCED AND HISTAMINE-INDUCED WHEAL AND FLARE RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					119	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700073
J	GARRIE, SA; WOLFJURG.P				GARRIE, SA; WOLFJURG.P			COMPARISON OF METHODS OF COUNTING SKIN WINDOW COVERSLIPS - STATISTICAL-ANALYSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note																		BOGGS D, 1969, AM J PATHOL, V44, P763; BULLOCK JD, 1967, ANN ALLERGY, V40, P73; EIDINGER D, 1962, NATURE, V196, P683, DOI 10.1038/196683a0; EIDINGER D, 1964, J ALLERGY, V35, P77, DOI 10.1016/0021-8707(64)90052-8; FEINBERG AR, 1967, J ALLERGY, V40, P73, DOI 10.1016/0021-8707(67)90100-1; HALD H, 1952, STATISTICAL THEORY W; PRIEST RJ, 1960, GASTROENTEROLOGY, V38, P715; REBUCK J W, 1968, Biochemical Pharmacology, P159; REBUCK JW, 1958, ANN NY ACAD SCI, V73, P8, DOI 10.1111/j.1749-6632.1959.tb40790.x; REBUCK JW, 1953, ANN NY ACAD SCI, V56, P715, DOI 10.1111/j.1749-6632.1953.tb27394.x; REBUCK JW, 1954, AM REV TUBERC PULM, V69, P216; REBUCK JW, 1955, ANN NY ACAD SCI, V59, P757, DOI 10.1111/j.1749-6632.1955.tb45983.x; RIIS P, 1959, THESIS COPENHAGEN; SEINFELD BM, 1966, J ALLERGY, V38, P156, DOI 10.1016/0021-8707(66)90038-4; WOLFJURGENSEN P, 1967, DAN MED BULL, V14, P249; WOLFJURGENSEN P, 1965, ACTA DERM-VENEREOL, V45, P207; WOLFJURGENSEN P, 1966, THESIS COPENHAGEN	17	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	4					238	&		10.1016/0091-6749(72)90086-3	http://dx.doi.org/10.1016/0091-6749(72)90086-3			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M1477	4551811	Bronze			2022-12-18	WOS:A1972M147700004
J	MEYERS, RL; SEDA, RP; TOKRISNA, A; THAYER, KH; BERNSMAS.AW; CALDWELL, CJ				MEYERS, RL; SEDA, RP; TOKRISNA, A; THAYER, KH; BERNSMAS.AW; CALDWELL, CJ			LOW-MOLECULAR WEIGHT MATERIAL FROM BERMUDA (CYNODON) GRASS POLLEN - STUDIES ON IMMUNOCHEMICAL AND IMMUNOLOGICAL ACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		HADDAD, 1971, IMMUNOLOGY, V20, P545; 1971, J ALLERG CL, V47, P100; 1970, J ALLERG CL, V45, P14	3	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					114	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700061
J	NELSON, HS				NELSON, HS			EFFECT OF EPHEDRINE ON METABOLIC RESPONSE TO EPINEPHRINE INFUSION IN NORMAL MEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					105	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700042
J	SOLOMON, WR				SOLOMON, WR			FUNGUS AEROSOLS ASSOCIATED WITH OPERATION OF COLD STEAM VAPORIZERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					99	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700032
J	WEISBERG, SC; PAN, PM; MATHEWS, KP				WEISBERG, SC; PAN, PM; MATHEWS, KP			EFFECTS OF POLLEN EXTRACTS ON IN-VITRO H-3-THYMIDINE UPTAKE OF LYMPHOCYTES FROM NORMAL INDIVIDUALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					125	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700086
J	MALKIEL, S; HARGIS, BJ				MALKIEL, S; HARGIS, BJ			ADJUVANT ACTIVITY OF BACILLUS-SUBTILIS AND SUBTILISIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BELIN L, 1970, LANCET, V2, P1153; BERNSTEIN I L, 1971, Journal of Allergy, V47, P97; Heidelberger M, 1935, J EXP MED, V62, P697, DOI 10.1084/jem.62.5.697; KABAT EA, 1948, EXPERIMENTAL IMMUNOC; MALKIEL S, 1965, INT ARCH ALLER A IMM, V26, P319, DOI 10.1159/000229584; MALKIEL S, 1958, J ALLERGY, V29, P524, DOI 10.1016/0021-8707(58)90024-8; MALKIEL S, 1952, P SOC EXP BIOL MED, V80, P122; MALKIEL S, 1952, J ALLERGY, V23, P352, DOI 10.1016/0021-8707(52)90055-5; OUCHTERLONY O, 1949, ACTA PATHOL SCAND, V26, P506; OVARY Z, 1958, J IMMUNOL, V81, P355; PATERSON PY, 1959, CELLULAR HUMORAL ASP	11	4	4	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	4					220	&		10.1016/0091-6749(71)90068-6	http://dx.doi.org/10.1016/0091-6749(71)90068-6			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5566	4157464	Bronze			2022-12-18	WOS:A1971K556600004
J	McCluskey, D; Benzian-Olsson, N; Mahil, SK; Hassi, NK; Wohnhaas, CT; Burden, AD; Griffiths, CEM; Ingram, JR; Levell, NJ; Parslew, R; Pink, AE; Reynolds, NJ; Warren, RB; Visvanathan, S; Baum, P; Barker, JN; Smith, CH; Capon, F				McCluskey, Daniel; Benzian-Olsson, Natashia; Mahil, Satveer K.; Hassi, Niina Karoliina; Wohnhaas, Christian T.; Burden, A. David; Griffiths, Christopher E. M.; Ingram, John R.; Levell, Nick J.; Parslew, Richard; Pink, Andrew E.; Reynolds, Nick J.; Warren, Richard B.; Visvanathan, Sudha; Baum, Patrick; Barker, Jonathan N.; Smith, Catherine H.; Capon, Francesca		Apricot & Plum Study Team	Single-cell analysis implicates T(H)17-to-T(H)2 cell plasticity in the pathogenesis of palmoplantar pustulosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Single-cell RNA sequencing; scRNA-Seq; T-cell plasticity; palmoplantar pustulosis; PPP		Background: Palmoplantar pustulosis (PPP) is a severe inflammatory skin disorder characterized by eruptions of painful, neutrophil-filled pustules on the palms and soles. Although PPP has a profound effect on quality of life, it remains poorly understood and notoriously difficult to treat. Objective: We sought to investigate the immune pathways that underlie the pathogenesis of PPP. Methods: We applied bulk and single-cell RNA sequencing (RNA-Seq) methods to the analysis of skin biopsy samples and peripheral blood mononuclear cells. We validated our results by flow cytometry and immune fluorescence microscopy Results: Bulk RNA-Seq of patient skin detected an unexpected signature of T-cell activation, with a significant overexpression of several T(H)2 genes typically upregulated in atopic dermatitis. To further explore these findings, we carried out single-cell RNA-Seq in peripheral blood mononuclear cells of healthy and affected individuals. Memory CD4(+) T cells of PPP patients were skewed toward a T(H)17 phenotype, a phenomenon that was particularly significant among cutaneous lymphocyte-associated antigen-positive skin-homing cells. We also identified a subset of memory CD4(+) T cells that expressed both T(H)17 (KLRB1/ CD161) and T(H)2 (GATA3) markers, with pseudotime analysis suggesting that the population was the result of T(H)17 to T(H)2 plasticity. Interestingly, the GATA3(+)/CD161(+) cells were overrepresented among the peripheral blood mononuclear cells of affected individuals, both in the single-cell RNA-Seq data set and in independent flow cytometry experiments. Dual-positive cells were also detected in patient skin by immune fluorescence microscopy. Conclusions: PPP is associated with complex T-cell activation patterns and may explain why biologic drugs that target individual T helper cell populations have shown limited therapeutic efficacy.	[McCluskey, Daniel; Benzian-Olsson, Natashia; Hassi, Niina Karoliina; Capon, Francesca] Kings Coll London, Dept Med & Mol Genet, London, England; [Mahil, Satveer K.; Pink, Andrew E.; Barker, Jonathan N.; Smith, Catherine H.] Kings Coll London, St Johns Inst Dermatol, Fac Life Sci & Med, London, England; [Wohnhaas, Christian T.; Baum, Patrick] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Burden, A. David] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Griffiths, Christopher E. M.; Warren, Richard B.] Univ Manchester, Natl Inst Hlth Res NIHR, Manchester Biomed Res CTr, Salford Royal Natl Hlth Serv NHS Fdn Trust,Dermat, Manchester, Lancs, England; [Ingram, John R.] Cardiff Univ, Dept Dermatol, Div Infect & Immun, Cardiff, Wales; [Levell, Nick J.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Parslew, Richard] Royal Liverpool Hosp, Dept Dermatol, Liverpool, Merseyside, England; [Reynolds, Nick J.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, England; [Levell, Nick J.] Newcastle Hosp NHS Fdn Trust, Dept Dermatol, Newcastle, NSW, Australia; [Levell, Nick J.] Newcastle Hosp NHS Fdn Trust, NIHR Newcastle Biomed Res Ctr, Newcastle, NSW, Australia; [Visvanathan, Sudha] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA	University of London; King's College London; University of London; King's College London; Boehringer Ingelheim; University of Glasgow; Salford Royal NHS Foundation Trust; University of Manchester; Cardiff University; University of East Anglia; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Newcastle University - UK; Boehringer Ingelheim	Capon, F (corresponding author), Guys Hosp, 9th Floor Tower Wing, London SE1 9RT, England.	francesca.capon@kcl.ac.uk	; Smith, Catherine/G-5268-2012	Hassi, Niina Karoliina/0000-0002-1548-1199; Reynolds, Nick/0000-0002-6484-825X; Smith, Catherine/0000-0001-9918-1144; Mahil, Satveer/0000-0003-4692-3794; Levell, Nick/0000-0003-3393-8305				Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Benzian-Olsson N, 2020, JAMA DERMATOL, V156, P1216, DOI 10.1001/jamadermatol.2020.3275; Burden AD, 2016, ROOKS TXB DERMATOLOG, DOI DOI 10.1002/9781118441213.RTD0036; Cano-Gamez E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15543-y; Cosmi L, 2014, CURR OPIN PHARMACOL, V17, P12, DOI 10.1016/j.coph.2014.06.004; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Cro S, 2022, BRIT J DERMATOL, V186, P245, DOI 10.1111/bjd.20653; Garcia G, 2005, CURR ALLERGY ASTHM R, V5, P155, DOI 10.1007/s11882-005-0090-0; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Koga T, 2016, CLIN IMMUNOL, V173, P147, DOI 10.1016/j.clim.2016.10.003; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Mossner R, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13753; Mossner R, 2015, J INVEST DERMATOL, V135, P2538, DOI 10.1038/jid.2015.186; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Mrowietz U, 2021, DERMATOLOGY THER, V11, P571, DOI 10.1007/s13555-021-00504-0; Mrowietz U, 2019, J AM ACAD DERMATOL, V80, P1344, DOI 10.1016/j.jaad.2019.01.066; Navarini AA, 2017, J EUR ACAD DERMATOL, V31, P1792, DOI 10.1111/jdv.14386; Obeid G, 2021, BRIT J DERMATOL, V184, P1023, DOI 10.1111/bjd.19560; Schafflick D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14118-w; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Terui T, 2019, JAMA DERMATOL, V155, P1153, DOI 10.1001/jamadermatol.2019.1394; Tortola L, 2020, IMMUNITY, V53, P597, DOI 10.1016/j.immuni.2020.07.001; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Twelves S, 2019, J ALLERGY CLIN IMMUN, V143, P1021, DOI 10.1016/j.jaci.2018.06.038; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wohnhaas CT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46932-z; Xu WH, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0899-2; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	34	3	3	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2022	150	4					882	893		10.1016/j.jaci.2022.04.027	http://dx.doi.org/10.1016/j.jaci.2022.04.027			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	6A3QR	35568077	hybrid, Green Accepted, Green Submitted			2022-12-18	WOS:000880573000017
J	Lee-Sarwar, K; Dedrick, S; Momeni, B; Kelly, RS; Zeiger, RS; O'Connor, GT; Sandel, MT; Bacharier, LB; Beigelman, A; Laranjo, N; Gold, DR; Lasky-Su, J; Litonjua, AA; Liu, YY; Weiss, ST				Lee-Sarwar, Kathleen; Dedrick, Sandra; Momeni, Babak; Kelly, Rachel S.; Zeiger, Robert S.; O'Connor, George T.; Sandel, Megan T.; Bacharier, Leonard B.; Beigelman, Avraham; Laranjo, Nancy; Gold, Diane R.; Lasky-Su, Jessica; Litonjua, Augusto A.; Liu, Yang-Yu; Weiss, Scott T.			Association of the gut microbiome and metabolome with wheeze frequency in childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Microbiome; metabolomics; asthma; wheeze	SOY GENISTEIN; LUNG-FUNCTION; VITAMIN-D; CHILDREN	Background: While the microbiome has an established role in asthma development, less is known about its contribution to morbidity in children with asthma.Objective: In this ancillary study of the Vitamin D Antenatal Asthma Reduction Trial (VDAART), we analyzed the gut microbiome and metabolome of wheeze frequency in children with asthma.Methods: Bacterial 16S ribosomal RNA microbiome and untargeted metabolomic profiling were performed on fecal samples collected from 3-year-old children with parent-reported physician-diagnosed asthma. We analyzed wheeze frequency by calculating the proportion of quarterly questionnaires administered between ages 3 and 5 years in which parents reported the child had wheezed (wheeze proportion). Taxa and metabolites associated with wheeze were analyzed by identifying log fold changes with respect to wheeze frequency and correlation/linear regression analyses, respectively. Microbe- metabolite and microbe-microbe correlation networks were compared between subjects with high and low wheeze proportion.Results: Specific taxa, including the genus Veillonella and histidine pathway metabolites, were enriched in subjects with high wheeze proportion. Among wheeze-associated taxa, Veillonella and Oscillospiraceae UCG-005, which was inversely associated with wheeze, were correlated with the greatest number of fecal metabolites. Microbial networks were similar between subjects with low versus high wheeze frequency.Conclusion: Gut microbiome features are associated with wheeze frequency in children with asthma, suggesting an impact of the gut microbiome on morbidity in childhood asthma. (J Allergy Clin Immunol 2022;150:325-36.)	[Lee-Sarwar, Kathleen; Dedrick, Sandra; Kelly, Rachel S.; Laranjo, Nancy; Gold, Diane R.; Lasky-Su, Jessica; Liu, Yang-Yu; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Lee-Sarwar, Kathleen; Dedrick, Sandra; Kelly, Rachel S.; Laranjo, Nancy; Gold, Diane R.; Lasky-Su, Jessica; Liu, Yang-Yu; Weiss, Scott T.] Harvard Med Sch, Boston, MA 02115 USA; [Lee-Sarwar, Kathleen] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Dedrick, Sandra; Momeni, Babak] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Zeiger, Robert S.] Kaiser Permanente Bernard J Tyson Sch Med, Dept Clin Sci, Pasadena, CA USA; [O'Connor, George T.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Sandel, Megan T.] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Bacharier, Leonard B.] Vanderbilt Univ, Med Ctr, Vanderbilt Childrens Hosp, Dept Pediat Allergy Immunol & Pulm, Nashville, TN USA; [Beigelman, Avraham] Washington Univ, Sch Med, Dept Pediat, Div Pediat Allergy Immunol & Pulm Med, St Louis, MO 63110 USA; [Beigelman, Avraham] Tel Aviv Univ, Schneider Childrens Med Ctr Israel, Kipper Inst Allergy & Immunol, Tel Aviv, Israel; [Gold, Diane R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Litonjua, Augusto A.] Univ Rochester, Med Ctr, Div Pediat Pulm Med, Golisano Childrens Hosp Strong, Rochester, MN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Boston College; Kaiser Permanente; Boston University; Boston University; Boston Medical Center; Vanderbilt University; Washington University (WUSTL); Tel Aviv University; Harvard University; Harvard T.H. Chan School of Public Health; University of Rochester	Liu, YY; Weiss, ST (corresponding author), Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	yyl@channing.harvard.edu; restw@channing.harvard.edu		Lee-Sarwar, Kathleen/0000-0003-0550-1640; Zeiger, Robert/0000-0001-5788-5063	Vitamin D Antenatal Asthma Reduction Trial (VDAART); National Heart, Lung, and Blood Institute [U01HL091528]; National Institutes of Health [R01HL108818, R01HL123915, R01HL141826, K08 HL148178]; ECHO;  [OD023268]	Vitamin D Antenatal Asthma Reduction Trial (VDAART); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECHO; 	The Vitamin D Antenatal Asthma Reduction Trial (VDAART) was funded by U01HL091528 from the National Heart, Lung, and Blood Institute. Additional funding came from National Institutes of Health grants R01HL108818, R01HL123915, R01HL141826, and K08 HL148178, and ECHO grant OD023268.	Andrianasolo RM, 2020, EUR J NUTR, V59, P1553, DOI 10.1007/s00394-019-02011-7; Arrieta MC, 2018, J ALLERGY CLIN IMMUN, V142, P424, DOI 10.1016/j.jaci.2017.08.041; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Barcik W, 2019, ALLERGY, V74, P899, DOI 10.1111/all.13709; Barcik W, 2016, J ALLERGY CLIN IMMUN, V138, P1491, DOI 10.1016/j.jaci.2016.05.049; Bime C, 2012, PRIM CARE RESP J, V21, P398, DOI 10.4104/pcrj.2012.00073; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bridgewater Br E. A. M, 2014, METABOLOMICS, P04, DOI [DOI 10.4172/2153-0769.1000132, 10.4172/2153-0769.1000132]; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Cepeda AM, 2017, LUNG, V195, P683, DOI 10.1007/s00408-017-0044-z; Chauhan BF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002314.pub3; Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036; Chiu CY, 2020, ALLERGY, V75, P2846, DOI 10.1111/all.14438; Cox C, 2015, CAN RESPIR J, V22, P221, DOI 10.1155/2015/459187; Denner DR, 2016, J ALLERGY CLIN IMMUN, V137, P1398, DOI 10.1016/j.jaci.2015.10.017; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fedarko MW, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa023; Fitzpatrick AM, 2016, J ALLERGY CLIN IMMUN, V138, P1608, DOI 10.1016/j.jaci.2016.09.028; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holecek M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030848; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huang Yvonne J, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS48, DOI 10.1513/AnnalsATS.201306-187MG; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Kim SH, 2020, ALLERGY, V75, P1991, DOI 10.1111/all.14236; Lee-Sarwar KA, 2019, J ALLERGY CLIN IMMUN, V144, P442, DOI 10.1016/j.jaci.2019.02.032; Li Z, 2017, THORAX, V72, P206, DOI 10.1136/thoraxjnl-2016-208375; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mapesa, 2013, NATURAL PRODUCTS, P2433, DOI [DOI 10.1007/978-3-642-22144-6_94, 10.1007/978-3-642-22144-6_94]; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; Morgan M, 2012, DIRICHLETMULTINOMIAL; Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5; Nishiuma T, 2008, AM J PHYSIOL-LUNG C, V294, pL1085, DOI 10.1152/ajplung.00445.2007; Ono Jennie G, 2015, Mol Cell Pediatr, V2, P13, DOI 10.1186/s40348-015-0025-3; Panda L, 2018, EUR MED J, V3, P49; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; Props R, 2017, ISME J, V11, P584, DOI 10.1038/ismej.2016.117; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramadan AA, 2019, CLIN CHEST MED, V40, P163, DOI 10.1016/j.ccm.2018.10.010; Satinsky BM, 2013, METHOD ENZYMOL, V531, P237, DOI 10.1016/B978-0-12-407863-5.00012-5; Smith LJ, 2004, J ASTHMA, V41, P833, DOI 10.1081/JAS-200038447; Stammler F, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0175-0; Struyf A, 1997, J STAT SOFTW, V1, P1, DOI DOI 10.18637/JSS.V001.I04; Trifilieff A, 2012, J PHARMACOL EXP THER, V342, P399, DOI 10.1124/jpet.112.191585; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Wang ZQ, 2021, J THORAC DIS, DOI 10.21037/jtd-20-2189; Worgall TS, 2017, CURR OPIN CLIN NUTR, V20, P99, DOI 10.1097/MCO.0000000000000349; Worgall TS, 2013, SCI TRANSL MED, V5, P1; Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7; Yamamoto EA, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03141; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1; Zhang QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152724; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhou YJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13698-x; Zierer J, 2018, NAT GENET, V50, P790, DOI 10.1038/s41588-018-0135-7	62	3	3	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2022	150	2					325	336		10.1016/j.jaci.2022.02.005	http://dx.doi.org/10.1016/j.jaci.2022.02.005			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	6I4IV	35196534				2022-12-18	WOS:000886091500016
J	Coppola, S; Insalaco, A; Zara, E; Di Rocco, M; Marafon, DP; Spadaro, F; Pannone, L; Farina, L; Pasquini, L; Martinelli, S; De Benedetti, F; Tartaglia, M				Coppola, Simona; Insalaco, Antonella; Zara, Erika; Di Rocco, Martina; Marafon, Denise Pires; Spadaro, Francesca; Pannone, Luca; Farina, Luciapia; Pasquini, Luca; Martinelli, Simone; De Benedetti, Fabrizio; Tartaglia, Marco			Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CDC42; NOCARH syndrome; autoinflammation; HLH; MAS; cytopenia; anakinra; emapalumab; palmitoylation; Golgi apparatus	ACTIVATION	Background: Pathogenic missense variants in cell division control protein 42 (CDC42) differentially affect protein function, causing a clinically wide phenotypic spectrum variably affecting neurodevelopment, hematopoiesis, and immune response. More recently, 3 variants at the C-terminus of CDC42 were proposed to similarly impact protein function and cause a novel autoinflammatory disorder. Objectives: We sought to clinically and functionally classify these variants to improve patient management. Methods: Comparative analysis of the available clinical data and medical history of patients was performed. In vitro and in vivo studies were carried out to functionally characterize individual variants. Results: Differently from what had previously been observed for the p.R186C change causing neonatal-onset cytopenia, autoinflammation, and recurrent hemophagocytic lymphohistiocytosis, p.C188Y and p.*192Cext*24 promoted accelerated protein degradation. Unprenylated CDC42(C188Y) did not behave as a membrane-bound protein, whereas the residual CDC42(*192Cext*24) mutant replicated the CDC42(R186C) behavior, being targeted to the Golgi apparatus in a palmitoylationdependent manner. Assessment of in vitro polarized migration and development in Caenorhabditis elegans documented a lossof-function behavior of the p.C188Y and p.*192Cext*24 variants. Consistently, the 3 pathogenic variants were associated with different clinical presentations, with dysmorphisms, severity, and age of onset of cytopenia and extent of autoinflammation representing major differences. Conclusions: Pathogenic variants at the CDC42 C-terminus differently impact protein stability, localization, and function, and cause different diseases, with p.R186C specifically associated with neonatal-onset pancytopenia and severe autoinflammation/hemophagocytic lymphohistiocytosis requiring emapalumab and bone marrow transplantation, and p.C188Y and p.*192Cext*24 causing anakinra-sensitive autoinflammation.	[Coppola, Simona] Ist Super Sanita, Natl Ctr Rare Dis, Rome, Italy; [Insalaco, Antonella; Marafon, Denise Pires; Farina, Luciapia; De Benedetti, Fabrizio] Osped Pediat Bambino Gesu, IRCCS, Div Rheumatol, I-00146 Rome, Italy; [Zara, Erika; Pannone, Luca; Tartaglia, Marco] Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Zara, Erika] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Di Rocco, Martina; Martinelli, Simone] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy; [Di Rocco, Martina] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy; [Spadaro, Francesca; Pasquini, Luca] Ist Super Sanita, Core Facil, Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; IRCCS Bambino Gesu; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; Istituto Superiore di Sanita (ISS)	De Benedetti, F (corresponding author), Osped Pediat Bambino Gesu, IRCCS, Div Rheumatol, I-00146 Rome, Italy.; Tartaglia, M (corresponding author), Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy.	fabrizio.debenedetti@opbg.net; marco.tartaglia@opbg.net	Insalaco, Antonella/HGC-9288-2022; Zara, Erika/ABI-7681-2020; Coppola, Simona/A-6638-2015; pasquini, luca/J-8319-2016	Insalaco, Antonella/0000-0003-1443-1840; Zara, Erika/0000-0003-0292-6862; Coppola, Simona/0000-0001-7851-9409; pasquini, luca/0000-0002-3484-6288	Italian Ministry of Health [5x1000]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 21614]; Italian Ministry of Research [FOE 2019]; Fondazione Bambino Gesu; Istituto Superiore di Sanita	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Bambino Gesu; Istituto Superiore di Sanita	This work was supported, in part, by grants from the Italian Ministry of Health (Ricerca Corrente 2019-2021 to F.D.B. and M.T. and grant no. 5x1000 to M.T.), Associazione Italiana per la Ricerca sul Cancro (AIRC; grant no. IG 21614 to M.T.), Italian Ministry of Research (grant no. FOE 2019 to M.T.), Fondazione Bambino Gesu (Vite Coraggiose to M.T.), and Istituto Superiore di Sanita (Bando Ricerca Indipendente ISS 2020-2022-ISS20-39c812dd2b3c to S.C.).	Asiri A, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020294; Bekhouche B, 2020, J ALLERGY CLIN IMMUN, V146, P1201, DOI 10.1016/j.jaci.2020.03.020; De Benedetti F, 2018, NEW ENGL J MED, V378, P1908, DOI 10.1056/NEJMoa1706314; Gernez Y, 2019, J ALLERGY CLIN IMMUN, V144, P1122, DOI 10.1016/j.jaci.2019.06.017; He TY, 2020, J CLIN IMMUNOL, V40, P571, DOI 10.1007/s10875-020-00786-7; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Lam MT, 2019, J EXP MED, V216, P2778, DOI 10.1084/jem.20190147; Martinelli S, 2018, AM J HUM GENET, V102, P309, DOI 10.1016/j.ajhg.2017.12.015; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Ravelli A, 2016, ANN RHEUM DIS, V75, P481, DOI 10.1136/annrheumdis-2015-208982; Szczawinska-Poplonyk A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00318; Takenouchi T, 2016, AM J MED GENET A, V170, P852, DOI 10.1002/ajmg.a.37526; Takenouchi T, 2015, AM J MED GENET A, V167, P2822, DOI 10.1002/ajmg.a.37275; Verboon JM, 2020, J CLIN IMMUNOL, V40, P554, DOI 10.1007/s10875-020-00778-7	17	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2022	150	1					223	228		10.1016/j.jaci.2022.01.024	http://dx.doi.org/10.1016/j.jaci.2022.01.024			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3C6YB	35157921				2022-12-18	WOS:000828766100025
J	Wang, XJ; Guo, YF; Cai, M; Qian, ZMM; Zhang, SY; Zhang, ZL; Yang, Y; Vaughn, MG; Aaron, HE; Wu, F; Zhang, YQ; Lin, HL				Wang, Xiaojie; Guo, Yanfei; Cai, Miao; Qian, Zhengmin Min; Zhang, Shiyu; Zhang, Zilong; Yang, Yin; Vaughn, Michael G.; Aaron, Hannah E.; Wu, Fan; Zhang, Yuqiang; Lin, Hualiang			Constituents of fine particulate matter and asthma in 6 low- and middle-income countries	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PM2.5; PM2.5 components; asthma; long-term; multi-country study	EMERGENCY-DEPARTMENT VISITS; LONG-TERM EXPOSURE; AIR-POLLUTION; AMBIENT AIR; HEALTH IMPACT; MORTALITY; COMPONENTS; DISEASES; PM2.5; PROFILE	Background: Evidence concerning the effects of different chemical components of particulate matter with an aerodynamic diameter of 2.5 mu m or less (PM2.5) on asthma is limited, and the methodology to compare the relative importance of different PM2.5 components is lacking. Objective: Our aim was to examine the associations between PM2.5 components and asthma and investigate which constituent of PM2.5 possessed the most harmful effect on asthma. Methods: A total of 45,690 subjects in 6 countries were surveyed from 2007 to 2010. We geocoded the residential community addresses of the participants and used satellite remote sensing and chemical transport modeling to estimate their annual average concentrations of PM2.5 constituents. Mixed-effects generalized additive models were utilized to examine the associations between PM2.5 constituents and prevalence of asthma. We further used counterfactual analyses to determine the potential number of asthma cases. Results: We identified 6178 patients with asthma among the participants, producing an asthma prevalence of 13.5%. The odds ratio for asthma associated with per-SD increment was 1.12 for PM2.5 mass, 1.12 for organic carbon, 1.18 for black carbon, 1.19 for sulfate, 1.28 for ammonium, and 1.21 for nitrate after controlling for potential confounders. Our counterfactual analyses suggested that ammonium was responsible for a substantial decline in asthma cases (by 1382 cases, corresponding to 22.37% of overall cases) if the concentration was reduced to the 5th percentile of the current level. Conclusions: Our study suggests that some chemical components of PM2.5 (including black carbon, organic carbon, sulfate, ammonium, and nitrate) might be hazardous constituents contributing to the prevalence of asthma; among them, ammonium might be responsible for a substantial proportion of asthma cases if reduced to a certain level.	[Wang, Xiaojie; Cai, Miao; Zhang, Shiyu; Zhang, Zilong; Yang, Yin; Lin, Hualiang] Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Peoples R China; [Guo, Yanfei] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Qian, Zhengmin Min; Aaron, Hannah E.] St Louis Univ, Dept Epidemiol & Biostat, St Louis, MO USA; [Vaughn, Michael G.] St Louis Univ, Sch Social Work, Coll Publ Hlth & Social Justice, St Louis, MO USA; [Wu, Fan] Fudan Univ, Shanghai Med Coll, Sch Publ Hlth, Shanghai, Peoples R China; [Zhang, Yuqiang] Duke Univ, Nicholas Sch Environm, Durham, NC USA	Sun Yat Sen University; Shanghai Center for Disease Control & Prevention; Saint Louis University; Saint Louis University; Fudan University; Duke University	Wu, F (corresponding author), 130 Dong An Rd, Shanghai 200032, Peoples R China.; Zhang, YQ (corresponding author), Box 90586, Durham, NC 27708 USA.; Lin, HL (corresponding author), 74 Zhongshan 2nd Rd, Guangzhou 510030, Peoples R China.	wufan@shmu.edu.cn; yuqiang.zhang@duke.edu; linhualiang@mail.sysu.edu.cn	Zhang, Yuqiang Alan/C-5027-2015	Zhang, Yuqiang Alan/0000-0002-9161-7086	National Natural Science Foundation of China [82041021]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation	Supported by the National Natural Science Foundation of China (grant 82041021) and the Guangdong Basic and Applied Basic Research Foundation (grant 2019A1515110003).	Abrams JY, 2019, ENVIRON INT, V126, P627, DOI 10.1016/j.envint.2019.01.052; Ai SQ, 2019, ENVIRON RES, V168, P141, DOI 10.1016/j.envres.2018.09.028; Arokiasamy P, 2017, AM J EPIDEMIOL, V185, P414, DOI 10.1093/aje/kww125; Bacchetti T, 2019, NUTRITION, V61, P164, DOI 10.1016/j.nut.2018.10.034; Barman N, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.07.383; Beasley R, 2015, LANCET, V386, P1075, DOI 10.1016/S0140-6736(15)00156-7; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Cai M, 2020, CLIN EPIDEMIOL, V12, P307, DOI 10.2147/CLEP.S241610; Chen RJ, 2015, ENVIRON SCI TECHNOL, V49, P11859, DOI 10.1021/acs.est.5b02527; Disease G.B.D., 2017, LANCET, V390, P1211, DOI [10.1016/S0140-6736(17)32154-2, DOI 10.1016/S0140-6736(17)32154-2]; Eilenberg SR, 2018, ATMOS ENVIRON, V190, P116, DOI 10.1016/j.atmosenv.2018.06.041; Fuertes E, 2020, ENVIRON INT, V136, DOI 10.1016/j.envint.2020.105474; Ghosh T, 2012, SOCIAL GEOGRAPHY, V7, P23, DOI [10.5194/sg-7-23-2012, DOI 10.5194/SG-7-23-2012]; Gogna P, 2019, PREV MED, V122, P91, DOI 10.1016/j.ypmed.2019.03.010; Holst GJ, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2791; Hosseini B, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040341; Jung CR, 2017, ENVIRON POLLUT, V231, P1085, DOI 10.1016/j.envpol.2017.08.102; Khreis H, 2017, ENVIRON INT, V100, P1, DOI 10.1016/j.envint.2016.11.012; Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005; Kobayashi T, 2017, JAMA CARDIOL, V2, P967, DOI 10.1001/jamacardio.2017.2180; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lavigne E, 2021, ENVIRON INT, V152, DOI 10.1016/j.envint.2021.106486; Li C, 2017, ENVIRON SCI TECHNOL, V51, P11185, DOI 10.1021/acs.est.7b02530; Lin HL, 2017, HYPERTENSION, V69, P806, DOI [10.1161/HYPERTENSIONAHA.116.08839, 10.1161/hypertensionaha.116.08839]; Lin HL, 2016, ENVIRON POLLUT, V208, P758, DOI 10.1016/j.envpol.2015.10.056; Lin WW, 2011, ENVIRON HEALTH PERSP, V119, P1507, DOI 10.1289/ehp.1103461; Ma YX, 2017, ENVIRON POLLUT, V230, P974, DOI 10.1016/j.envpol.2017.06.104; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Osvald EC, 2020, THORAX, V75, P1040, DOI 10.1136/thoraxjnl-2020-214655; Pateraki S, 2020, CHEMOSPHERE, V241, DOI 10.1016/j.chemosphere.2019.125026; Pignatti P, 2013, INT ARCH ALLERGY IMM, V160, P409, DOI 10.1159/000343020; Qiu H, 2015, ENVIRON POLLUT, V199, P192, DOI 10.1016/j.envpol.2015.02.002; Ruan ZL, 2019, ENVIRON RES, V177, DOI 10.1016/j.envres.2019.108581; Rylance S, 2019, THORAX, V74, P1070, DOI 10.1136/thoraxjnl-2018-212945; Saglimbene VM, 2019, CLIN J AM SOC NEPHRO, V14, P250, DOI 10.2215/CJN.08580718; Sarnat SE, 2015, ENVIRON HEALTH PERSP, V123, P437, DOI 10.1289/ehp.1307776; Schlesinger RB, 2007, INHAL TOXICOL, V19, P811, DOI 10.1080/08958370701402382; Shi QX, 2019, SCI TOTAL ENVIRON, V659, P354, DOI 10.1016/j.scitotenv.2018.12.375; Shi WM, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106176; Smits HH, 2016, CURR OPIN IMMUNOL, V42, P41, DOI 10.1016/j.coi.2016.05.009; Stern J., 2020, SEMIN IMMUNOPATHOL, V42, P5, DOI [10.1007/s00281-020-00785-1, DOI 10.1007/s00281-020-00785-1]; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; Yang Y, 2018, ENVIRON POLLUT, V243, P815, DOI 10.1016/j.envpol.2018.09.056; Zeng XW, 2020, ENVIRON INT, V143, DOI 10.1016/j.envint.2020.105967; Zhang ZL, 2021, ENVIRON SCI TECHNOL, V55, P3807, DOI 10.1021/acs.est.0c05931; Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203	47	3	3	11	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2022	150	1					214	+		10.1016/j.jaci.2021.12.779	http://dx.doi.org/10.1016/j.jaci.2021.12.779			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3C6YB	34971647				2022-12-18	WOS:000828766100024
J	Alligon, M; Mahlaoui, N; Courteille, V; Costes, L; Afonso, V; Randrianomenjanahary, P; de Vergnes, N; Ranohavimparany, A; Vo, D; Hafsa, I; Bach, P; Benoit, V; Garcelon, N; Fischer, A				Alligon, Mickael; Mahlaoui, Nizar; Courteille, Virginie; Costes, Laurence; Afonso, Veronica; Randrianomenjanahary, Philippe; de Vergnes, Nathalie; Ranohavimparany, Anja; Vo, Duy; Hafsa, Ines; Bach, Perrine; Benoit, Vincent; Garcelon, Nicolas; Fischer, Alain		CEREDIH French PID Study Grp	An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Primary immunodeficiencies; inborn errors of immunity; epidemiology; cohort study; registry; noninfectious complications; autoimmunity; inflammation; malignancies; allergy	STEM-CELL TRANSPLANTATION; COMMON VARIABLE IMMUNODEFICIENCY; QUALITY-OF-LIFE; IMMUNE-DEFICIENCY; HEALTH CONDITIONS; INBORN-ERRORS; INFECTIONS; CHILDHOOD; MORTALITY; ADULTS	Background: Noninfectious manifestations-allergy, autoimmunity/inflammation, lymphoproliferation, and malignancies-are known to exist in many primary immunodeficiency diseases (PID) and to participate in prognosis. Objective: To obtain a global view on their occurrence, we retrieved data from a retrospective cohort of 1375 patients included in the French National Reference Center for Primary Immune Deficiencies (CEREDIH) for whom we had a 10-year follow-up since inclusion in the registry. Methods: These patients were followed for 10 years (2009-2018) by specialized centers in university hospitals. This study showed that 20.1% of patients without prior curative therapy (n = 1163) developed at least 1 manifestation (event) encompassing 277 events. Results: Autoimmune/inflammatory events (n = 138) and malignancies (n = 85) affected all age classes and virtually all PID diagnostic groups. They were associated with a risk of death that occurred in 195 patients (14.2%) and were found to be causal in 43% of cases. Malignancies (odds ratio, 5.62; 95% confidence interval, 3.66-8.62) and autoimmunity (odds ratio, 1.9; 95% confidence interval, 1.27-2.84) were clearly identified as risk factors for lethality. Patients who underwent curative therapy (mostly allogeneic hematopoietic stem cell transplantation, with a few cases of gene therapy or thymus transplantation) before the 10-year study period (n = 212) had comparatively reduced but still detectable clinical manifestations (n = 16) leading to death in 9.4% of them. Conclusion: This study points to the frequency and severity of noninfectious manifestations in various PID groups across all age groups. These results warrant further prospective analysis to better assess their consequences and to adapt therapy, notably indication of curative therapy. (J Allergy Clin Immunol 2022;149:2116-25.)	[Alligon, Mickael; Mahlaoui, Nizar; Courteille, Virginie; Costes, Laurence; Afonso, Veronica; Randrianomenjanahary, Philippe; de Vergnes, Nathalie; Ranohavimparany, Anja; Vo, Duy; Hafsa, Ines; Bach, Perrine; Fischer, Alain] Necker Enfants Malades Univ Hosp, Assistance Publ Hop Paris APHP, French Natl Reference Ctr Primary Immune Deficien, CERE DIH, Paris, France; [Mahlaoui, Nizar; Fischer, Alain] Necker Enfants Malades Univ Hosp, Assistance Publ Hop Paris APHP, Pediat Immuno Hematol & Rheumatol Unit, Paris, France; [Benoit, Vincent; Garcelon, Nicolas] Univ Paris, Imagine Inst, Data Sci Platform, INSERM UMR 1163, Paris, France; [Fischer, Alain] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst INSERM UMR 1163, Paris, France; [Fischer, Alain] Coll France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Fischer, A (corresponding author), Inst Imagine, 24 Blvd Montparnasse, F-75015 Paris, France.	alain.fischer@aphp.fr	sokol, harry/E-2290-2019	sokol, harry/0000-0002-2914-1822; Garcelon, Nicolas/0000-0002-3326-2811	LFB Biomedicaments; Takeda; Grifols; CSL Behring; Binding Site; Octapharma	LFB Biomedicaments; Takeda(Takeda Pharmaceutical Company Ltd); Grifols; CSL Behring; Binding Site; Octapharma	CEREDIH uses the European Society for Immunodeficiencies (ESID) registry platform to collect patient data. CEREDIH receives unrestricted grants from the following pharmaceutical companies: LFB Biomedicaments, Takeda, Grifols, CSL Behring, Binding Site, and Octapharma; and from the following patient associations: IRIS and AT Europe	Aguilar C, 2014, CLIN INFECT DIS, V59, P1462, DOI 10.1093/cid/ciu646; Barlogis V, 2018, J PEDIATR-US, V194, P211, DOI 10.1016/j.jpeds.2017.10.029; Barlogis V, 2017, J ALLERGY CLIN IMMUN, V139, P1275, DOI 10.1016/j.jaci.2016.08.027; Beaute J, 2010, CLIN IMMUNOL, V135, P264, DOI 10.1016/j.clim.2010.02.021; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Cheminant M, 2019, J ALLERGY CLIN IMMUN, V143, P2311, DOI 10.1016/j.jaci.2019.01.046; Chiesa R, 2020, BLOOD, V136, P1201, DOI 10.1182/blood.2020005590; Coignard-Biehler H, 2019, J CLIN IMMUNOL, V39, P702, DOI 10.1007/s10875-019-00658-9; CONLEY ME, 1986, J PEDIATR-US, V108, P915, DOI 10.1016/S0022-3476(86)80927-1; Dunogue B, 2017, CLIN INFECT DIS, V64, P767, DOI 10.1093/cid/ciw837; Farmer JR, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01740; Feuille EJ, 2018, J CLIN IMMUNOL, V38, P28, DOI 10.1007/s10875-017-0456-9; Fischer A, 2017, J ALLERGY CLIN IMMUN, V140, P1388, DOI 10.1016/j.jaci.2016.12.978; Fox TA, 2018, BLOOD, V131, P917, DOI 10.1182/blood-2017-09-807487; Fusaro M, 2021, J ALLERGY CLIN IMMUN, V147, P734, DOI 10.1016/j.jaci.2020.05.046; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Goussault H, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1242-4; Heimall J, 2017, BIOL BLOOD MARROW TR, V23, P379, DOI 10.1016/j.bbmt.2016.12.619; Leung J, 2018, J CLIN IMMUNOL, V38, P717, DOI 10.1007/s10875-018-0534-7; Mayor PC, 2018, J ALLERGY CLIN IMMUN, V141, P1028, DOI 10.1016/j.jaci.2017.05.024; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Odnoletkova I, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0941-0; Pensieri MV, 2019, SCAND J GASTROENTERO, V54, P164, DOI 10.1080/00365521.2019.1568543; Pulvirenti F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02546; Quinti I, 2012, BLOOD, V120, P1953, DOI 10.1182/blood-2012-05-431064; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Salvator H, 2015, EUR RESPIR J, V45, P1613, DOI 10.1183/09031936.00118414; Scheible R, 2019, BIOINFORMATICS, V35, P5367, DOI 10.1093/bioinformatics/btz525; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Seidel MG, 2019, J ALLER CL IMM-PRACT, V7, P1763, DOI 10.1016/j.jaip.2019.02.004; Tangye SG, 2021, J CLIN IMMUNOL, V41, P666, DOI 10.1007/s10875-021-00980-1; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Thalhammer J, 2021, J ALLERGY CLIN IMMUN, V148, P1332, DOI 10.1016/j.jaci.2021.04.015; Tuano KS, 2015, J ALLERGY CLIN IMMUN, V135, P273, DOI 10.1016/j.jaci.2014.09.024; Yakaboski E, 2020, J CLIN IMMUNOL, V40, P524, DOI 10.1007/s10875-020-00769-8	35	3	3	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2116	2125		10.1016/j.jaci.2021.12.790	http://dx.doi.org/10.1016/j.jaci.2021.12.790			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2E6QP	35031273				2022-12-18	WOS:000812351900006
J	Brown, KR; Baker, J; Vereda, A; Beyer, K; Burks, AW; du Toit, G; Hourihane, JO; Jones, SM; Norval, D; Dana, A; Shreffler, W; Vickery, BP; Casale, T; Skeel, B; Adelman, D				Brown, Kari R.; Baker, James; Vereda, Andrea; Beyer, Kirsten; Burks, A. Wesley; du Toit, George; Hourihane, Jonathan O'b; Jones, Stacie M.; Norval, David; Dana, Adrian; Shreffler, Wayne; Vickery, Brian P.; Casale, Thomas; Skeel, Ben; Adelman, Daniel			Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PTAH; oral immunotherapy; peanut allergy; peanut (Arachis hypogaea) allergen powder; pooled safety	ORAL IMMUNOTHERAPY; EUROPEAN ACADEMY; POSITION PAPER; DOUBLE-BLIND	Background: Peanut (Arachis hypogaea) allergen powder-dnfp (PTAH; previously known asAR101) is a daily oral immunotherapy approved to mitigate allergic reactions after accidental peanut exposure in peanut-allergic individuals aged 4-17 years. Objective: We sought to comprehensively summarize the PTAH safety profile for up to similar to 2 years of treatment. Methods: Safety and adverse event (AE) data from participants aged 4-17 years from 3 controlled, phase 3 and 2 open-label extension trials were pooled and assessed. Results: Of the 944 individuals receiving >= 1 PTAH dose, median exposure was similar to 49 weeks; most participants experienced >= 1 treatment-related AE (TRAE; n 5 853; 90.4%). A total of 829 participants experienced TRAEs with a maximum severity of mild (497, 52.6%) or moderate (332, 35.2%); 24 participants (2.5%) experienced TRAEs graded as severe. Overall, 80 participants (9.5%) discontinued as a result of AEs; most experienced gastrointestinal symptoms and discontinued during the first 6 months. When adjusted for exposure, AEs and TRAEs occurred at a rate of 76.4 and 58.7 events per participant-year of exposure (PYE), respectively, during updosing; AEs and TRAEs decreased to 23.0 and 14.2, respectively, during 300 mg maintenance. Overall, exposure-adjusted rates of systemic allergic reactions were 0.12 events/PYE (mild), 0.11 events/PYE (moderate), and 0.01 events/PYE (severe [anaphylaxis]). Conclusion: The safety profile of PTAH was consistent across trials, manageable, and improved over time. AEs were predominantly mild to moderate, and all grades declined in frequency with continued treatment. These data can be used to facilitate shared decision-making discussions with patients and families considering treatment with PTAH.	[Brown, Kari R.; Dana, Adrian; Adelman, Daniel] Aimmune Therapeut, 8000 Marina Blvd,Suite 300, Brisbane, Qld 94005, Australia; [Baker, James] Univ Michigan, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI USA; [Vereda, Andrea; Norval, David; Skeel, Ben] Aimmune Therapeut, London, England; [Beyer, Kirsten] Charite Univ Med Berlin, Berlin, Germany; [Burks, A. Wesley] Univ N Carolina, Dept Pediat, Food Allergy Initiat, Div Allergy Immunol & Rheumatol, Chapel Hill, NC USA; [du Toit, George] Guys & St Thomas NHS Fdn Trust, London, England; [Hourihane, Jonathan O'b] Royal Coll Surgeons Ireland, Paediat & Child Hlth, Dublin, Ireland; [Jones, Stacie M.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Jones, Stacie M.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Shreffler, Wayne] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Vickery, Brian P.] Emory Univ, Sch Med, Atlanta, GA USA; [Casale, Thomas] Univ S Florida, Tampa, FL 33620 USA; [Adelman, Daniel] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of North Carolina; University of North Carolina Chapel Hill; Guy's & St Thomas' NHS Foundation Trust; Royal College of Surgeons - Ireland; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; Harvard University; Massachusetts General Hospital; Emory University; State University System of Florida; University of South Florida; University of California System; University of California San Francisco	Brown, KR (corresponding author), Aimmune Therapeut, 8000 Marina Blvd,Suite 300, Brisbane, Qld 94005, Australia.	kbrown@aimmune.com			Aimmune Therapeutics; Nestle Health Science company	Aimmune Therapeutics; Nestle Health Science company(Nestle SA)	Aimmune Therapeutics, a Nestle Health Science company, designed and sponsored the clinical trials and analyses described, and provided financial support for the development of this report. There were no agreements between the sponsor and the authors or their institutions that treated the trial data as confidential information of the sponsor.	Calderon MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001936.pub2; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Dua S, 2019, J ALLERGY CLIN IMMUN, V144, P1584, DOI 10.1016/j.jaci.2019.06.038; Dufresne E, 2020, ALLERGY, V75, P1291, DOI 10.1111/all.14072; Fleischer DM, 2019, JAMA-J AM MED ASSOC, V321, P946, DOI 10.1001/jama.2019.1113; Martin-Munoz MF, 2019, PEDIAT ALLERG IMM-UK, V30, P214, DOI 10.1111/pai.13002; Martin-Munoz MF, 2019, PEDIAT ALLERG IMM-UK, V30, P81, DOI 10.1111/pai.12974; Kulis MD, 2018, J ALLERGY CLIN IMMUN, V141, P491, DOI 10.1016/j.jaci.2017.12.979; Lucendo AJ, 2014, ANN ALLERG ASTHMA IM, V113, P624, DOI 10.1016/j.anai.2014.08.004; MALLING HJ, 1993, ALLERGY, V48, P9; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; O'BHourihane J, 2020, LANCET CHILD ADOLESC, V4, P728, DOI 10.1016/S2352-4642(20)30234-0; Pajno GB, 2013, PEDIAT ALLERG IMM-UK, V24, P376, DOI 10.1111/pai.12077; palforzia, 2020, PALFORZIA PEANUT ARA; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Vickery BP, 2021, J ALLER CL IMM-PRACT, V9, P1879, DOI 10.1016/j.jaip.2020.12.029; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Wright BL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02624	19	3	3	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2043	+		10.1016/j.jaci.2021.12.780	http://dx.doi.org/10.1016/j.jaci.2021.12.780			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	34971646	hybrid			2022-12-18	WOS:000833525500027
J	Kolkhir, P; Munoz, M; Asero, R; Ferrer, M; Kocaturk, E; Metz, M; Xiang, YK; Maurer, M				Kolkhir, Pavel; Munoz, Melba; Asero, Riccardo; Ferrer, Marta; Kocaturk, Emek; Metz, Martin; Xiang, Yi-Kui; Maurer, Marcus			Autoimmune chronic spontaneous urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Chronic spontaneous urticaria; autoallergy; autoimmunity; type I; type IIb; BHRA; BAT; IgE; IgG-anti-TPO; treatment; markers	CHRONIC IDIOPATHIC URTICARIA; SERUM SKIN-TEST; BASOPHIL ACTIVATION TEST; ANTI-IGE AUTOANTIBODIES; FC-EPSILON-RI; HISTAMINE-RELEASE; CLINICAL-RESPONSE; CYCLOSPORINE-A; MAST-CELLS; OMALIZUMAB	Chronic spontaneous urticaria (CSU) is a debilitating mast cell-driven disease characterized by recurrent wheals and/or angioedema. Substantial progress has been made in dissecting the 2 main autoimmune mechanisms that drive the pathogenesis of CSU. Type I autoimmune (autoallergic) CSU is associated with IgE antibodies against autoantigens, for example, thyroid peroxidase and IL-24. Type IIb autoimmune CSU is mediated by autoantibodies that activate mast cells, for example, via IgE-and Fc epsilon RI, and is present in less than 10% of patients with CSU when strict criteria are used, that is, triple positivity of autologous serum skin test, immunoassays for IgG autoantibodies, and basophil activation tests. A subpopulation of patients with CSU has both types. Type IIb autoimmune CSU is characterized by higher disease severity, concomitant autoimmune diseases, low levels of total IgE, elevated levels of IgG-anti-thyroid peroxidase, basopenia, eosinopenia, poor response to antihistamines and to omalizumab, and a good response to cyclosporine. Novel targeted therapies for CSU are under development such as ligelizumab, an anti-IgE, fenebrutinib and remibrutinib, Bruton's tyrosine kinase inhibitors, and dupilumab, an anti-IL-4R alpha. Further studies should investigate the overlap between autoallergic and type IIb autoimmune CSU, optimize the diagnosis of both autoimmune endotypes using easy-to-perform, noninvasive, and inexpensive markers, and assess differences in response to therapy.	[Kolkhir, Pavel; Munoz, Melba; Metz, Martin; Xiang, Yi-Kui; Maurer, Marcus] Charite Univ Med Berlin, Inst Allergol, Charitepl 1, D-10117 Berlin, Germany; [Kolkhir, Pavel; Munoz, Melba; Metz, Martin; Xiang, Yi-Kui; Maurer, Marcus] Free Univ Berlin, Berlin, Germany; [Kolkhir, Pavel; Munoz, Melba; Metz, Martin; Xiang, Yi-Kui; Maurer, Marcus] Humboldt Univ, Berlin, Germany; [Kolkhir, Pavel; Munoz, Melba; Metz, Martin; Xiang, Yi-Kui; Maurer, Marcus] Fraunhofer Inst Translat Med & Pharmacol ITMP, Allergol & Immunol, Berlin, Germany; [Kolkhir, Pavel] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Div Immune Mediated Skin Dis, Moscow, Russia; [Munoz, Melba] Charite Univ Med Berlin, Berlin Inst Hlth, Clinician Scientist Program, Berlin, Germany; [Asero, Riccardo] Clin San Carlo, Ambulatorio Allergol, Paderno Dugnano, Italy; [Ferrer, Marta] Clin Univ Navarra, Inst Invest Sanitaria Navarra Pamplona IDISNA, Dept Allergy & Clin Immunol, Madrid, Spain; [Ferrer, Marta] Madrid ARADyAL, RETIC Asma Reacc Adversas & Alerg, Madrid, Spain; [Kocaturk, Emek] Koc Univ, Sch Med, Dept Dermatol, Istanbul, Turkey	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Sechenov First Moscow State Medical University; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Navarra; Koc University	Maurer, M (corresponding author), Charite Univ Med Berlin, Inst Allergol, Charitepl 1, D-10117 Berlin, Germany.	marcus.maurer@charite.de	Metz, Martin/B-8799-2009; Xiang, Yi-Kui/AAL-5489-2021; Maurer, Marcus/ABG-2174-2020	Metz, Martin/0000-0002-4070-9976; Xiang, Yi-Kui/0000-0003-3432-6837; Maurer, Marcus/0000-0002-4121-481X; Munoz, Melba/0000-0003-3386-4502				Akdis CA, 2020, ALLERGY, V75, P1582, DOI 10.1111/all.14318; Altrichter S, 2022, J ALLERGY CLIN IMMUN, V149, P1683, DOI 10.1016/j.jaci.2021.12.772; Altrichter S, 2020, J ALLERGY CLIN IMMUN, V145, P1510, DOI 10.1016/j.jaci.2020.03.005; Altrichter S, 2020, ALLERGY, V75, P3208, DOI 10.1111/all.14412; Altrichter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014794; Arm JP, 2014, CLIN EXP ALLERGY, V44, P1371, DOI 10.1111/cea.12400; Asero R, 2001, CLIN EXP ALLERGY, V31, P1105, DOI 10.1046/j.1365-2222.2001.01131.x; Asero R, 2022, EUR ANN ALLERGY CLIN, V54, P30, DOI 10.23822/EurAnnACI.1764-1489.191; Asero R, 2021, Eur Ann Allergy Clin Immunol, DOI 10.23822/EurAnnACI.1764-1489.238; Asero R, 2020, CLIN EXP IMMUNOL, V200, P242, DOI 10.1111/cei.13428; Asero R, 2003, J ALLERGY CLIN IMMUN, V111, P425, DOI 10.1067/mai.2003.15; Asero R, 2002, ANN ALLERG ASTHMA IM, V89, P195, DOI 10.1016/S1081-1206(10)61937-0; Asero R, 2021, EXPERT REV CLIN IMMU, V17, DOI 10.1080/1744666X.2021.1882304; Asero R, 2017, INT ARCH ALLERGY IMM, V172, P40, DOI 10.1159/000453453; Asero R, 2015, J ALLERGY CLIN IMMUN, V135, P1401, DOI 10.1016/j.jaci.2014.11.016; Atwa MA, 2014, J EUR ACAD DERMATOL, V28, P469, DOI 10.1111/jdv.12124; Balp MM, 2015, PATIENT, V8, P551, DOI 10.1007/s40271-015-0145-9; Bar-Sela S, 1999, J ALLERGY CLIN IMMUN, V103, P1216, DOI 10.1016/S0091-6749(99)70204-6; Bernstein JA, 2002, ANN ALLERG ASTHMA IM, V89, P212, DOI 10.1016/S1081-1206(10)61941-2; Bernstein JA, 2020, NEW ENGL J MED, V383, P1389, DOI 10.1056/NEJMc2016395; Bracken SJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00627; Chan YC, 2014, J ALLERGY CLIN IMMUN, V134, P1394, DOI 10.1016/j.jaci.2014.06.029; Chang TW, 2015, J ALLERGY CLIN IMMUN, V135, P337, DOI 10.1016/j.jaci.2014.04.036; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; Chen YD, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2020.100501; Cildag Songul, 2021, Med Pharm Rep, V94, P53, DOI 10.15386/mpr-1598; Combalia A, 2018, SKIN PHARMACOL PHYS, V31, P184, DOI 10.1159/000487402; Concha LB, 2004, ALLERGY ASTHMA PROC, V25, P293; Cugno M, 2018, ALLERGY, V73, P2408, DOI 10.1111/all.13587; Curto-Barredo L, 2018, ACTA DERM-VENEREOL, V98, P641, DOI 10.2340/00015555-2941; Curto-Barredo L, 2016, IMMUN INFLAMM DIS, V4, P441, DOI 10.1002/iid3.125; de Montjoye L, 2021, EUR ANN ALLERGY CLIN, V53, P55, DOI 10.23822/EurAnnACI.1764-1489.132; de Montjoye L, 2019, ALLERGY, V74, P1811, DOI 10.1111/all.13832; Dellon ES, 2020, NEW ENGL J MED, V383, P1624, DOI 10.1056/NEJMoa2012047; ELIAS J, 1986, J ALLERGY CLIN IMMUN, V78, P914, DOI 10.1016/0091-6749(86)90240-X; Endo T, 2020, ASIA PAC ALLERGY, V10, DOI 10.5415/apallergy.2020.10.e12; Endo T, 2019, ALLERGOL INT, V68, P270, DOI 10.1016/j.alit.2018.09.006; Ertas R, 2018, ALLERGY, V73, P705, DOI 10.1111/all.13345; Ertas R, 2020, ALLERGY, V75, P468, DOI 10.1111/all.14033; Ferrer M, 1999, J ALLERGY CLIN IMMUN, V104, P169, DOI 10.1016/S0091-6749(99)70129-6; Ferrer M, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0074-7; Fiebiger E, 1998, J CLIN INVEST, V101, P243, DOI 10.1172/JCI511; Fok JS, 2021, ALLERGY, V76, P2965, DOI 10.1111/all.14757; Frezzolini A, 2006, ALLERGY, V61, P1071, DOI 10.1111/j.1398-9995.2006.01033.x; Fricke J, 2020, ALLERGY, V75, P423, DOI 10.1111/all.14037; Fujisawa D, 2014, J ALLERGY CLIN IMMUN, V134, P622, DOI 10.1016/j.jaci.2014.05.004; Gasser P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13815-w; Gericke J, 2017, J ALLERGY CLIN IMMUN, V139, P1059, DOI 10.1016/j.jaci.2016.07.047; Ghazanfar MN, 2016, BRIT J DERMATOL, V175, P404, DOI 10.1111/bjd.14540; GRATTAN CEH, 1986, BRIT J DERMATOL, V114, P583, DOI 10.1111/j.1365-2133.1986.tb04065.x; GRATTAN CEH, 1990, INT ARCH ALLER A IMM, V93, P198, DOI 10.1159/000235301; Grattan CEH, 2000, BRIT J DERMATOL, V143, P365, DOI 10.1046/j.1365-2133.2000.03664.x; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; GRUBER BL, 1988, J INVEST DERMATOL, V90, P213, DOI 10.1111/1523-1747.ep12462239; Guillen-Aguinaga S, 2016, BRIT J DERMATOL, V175, P1153, DOI 10.1111/bjd.14768; Guo J, 1997, CLIN IMMUNOL IMMUNOP, V82, P157, DOI 10.1006/clin.1996.4297; HANNAMHARRIS AC, 1985, J LEUKOCYTE BIOL, V38, P231, DOI 10.1002/jlb.38.2.231; Hatada Y, 2013, INT ARCH ALLERGY IMM, V161, P154, DOI 10.1159/000350388; Hawro T, 2021, 30 EUROPEAN ACAD DER; Henault J, 2016, NAT IMMUNOL, V17, P196, DOI 10.1038/ni.3326; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Holm JG, 2018, J DERMATOL TREAT, V29, P80, DOI 10.1080/09546634.2017.1329505; Hossein Zadeh Attar M, 2019, EUR J DERMATOL, V29, P614, DOI 10.1684/ejd.2019.3680; Irinyi B, 2007, INT ARCH ALLERGY IMM, V144, P217, DOI 10.1159/000103995; Iyer AS, 2011, J BIOL CHEM, V286, P9503, DOI 10.1074/jbc.M110.165613; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Kaplan A, 2016, J ALLERGY CLIN IMMUN, V137, P474, DOI 10.1016/j.jaci.2015.08.023; Kaul M, 2021, CTS-CLIN TRANSL SCI, V14, P1756, DOI 10.1111/cts.13005; Kay AB, 2015, BRIT J DERMATOL, V172, P1294, DOI 10.1111/bjd.13621; Khan DA, 2021, J ALLER CL IMM-PRACT, V9, P2170, DOI 10.1016/j.jaip.2021.03.012; Kikuchi Y, 2002, J ALLERGY CLIN IMMUN, V109, P114, DOI 10.1067/mai.2002.120954; Kolkhir P, 2021, J ALLER CL IMM-PRACT, V9, P4138, DOI 10.1016/j.jaip.2021.07.043; Kolkhir P, 2022, NAT REV IMMUNOL, V22, P294, DOI 10.1038/s41577-021-00622-y; Kolkhir P, 2021, ALLERGY ASTHMA IMMUN, V13, P545, DOI 10.4168/aair.2021.13.4.545; Kolkhir P, 2020, J ALLER CL IMM-PRACT, V8, P318, DOI 10.1016/j.jaip.2019.08.025; Kolkhir P, 2018, J ALLERGY CLIN IMMUN, V141, P1166, DOI 10.1016/j.jaci.2017.09.010; Kolkhir P, 2017, J ALLERGY CLIN IMMUN, V139, P1772, DOI 10.1016/j.jaci.2016.08.050; Kolkhir P, 2017, INT J DERMATOL, V56, pE89, DOI 10.1111/ijd.13538; Konstantinou GN, 2013, ALLERGY, V68, P27, DOI 10.1111/all.12056; Konstantinou GN, 2009, ALLERGY, V64, P1256, DOI 10.1111/j.1398-9995.2009.02132.x; Kuithanan K, 2019, ALLERGY ASTHMA IMMUN, V11, P736, DOI 10.4168/aair.2019.11.5.736; Kulthanan K, 2018, J ALLER CL IMM-PRACT, V6, P586, DOI 10.1016/j.jaip.2017.07.017; Lakin E, 2019, THERANOSTICS, V9, P829, DOI 10.7150/thno.29902; Lee JK, 2019, J ALLER CL IMM-PRACT, V7, P1659, DOI 10.1016/j.jaip.2018.11.018; LEZNOFF A, 1983, ARCH DERMATOL, V119, P636, DOI 10.1001/archderm.119.8.636; Loria MP, 2001, IMMUNOPHARM IMMUNOT, V23, P205, DOI 10.1081/IPH-100103860; MacGlashan D, 2011, INT IMMUNOPHARMACOL, V11, P475, DOI 10.1016/j.intimp.2010.12.018; Magen E, 2015, ALLERGY ASTHMA PROC, V36, P138, DOI 10.2500/aap.2015.36.3829; Marcelino J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.742470; Marsland AM, 2005, CLIN EXP ALLERGY, V35, P554, DOI 10.1111/j.1365-2222.2005.02242.x; Maurer M, 2017, ALLERGY, V72, P2005, DOI 10.1111/all.13209; Maurer M, 2016, ALLERGY, V71, P1210, DOI 10.1111/all.12901; Maurer M, 2011, ALLERGY, V66, P317, DOI 10.1111/j.1398-9995.2010.02496.x; Maurer M, 2021, 30 EUROPEAN ACAD DER; Maurer M, 2021, J ALLER CL IMM-PRACT, V9, P1067, DOI 10.1016/j.jaip.2020.11.043; Maurer M, 2020, INT ARCH ALLERGY IMM, V181, P321, DOI 10.1159/000507218; Maurer M, 2019, NEW ENGL J MED, V381, P1321, DOI 10.1056/NEJMoa1900408; Maurer M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00689; Maurer M, 2011, J ALLERGY CLIN IMMUN, V128, P202, DOI 10.1016/j.jaci.2011.04.038; Mendelson MH, 2017, J DERMATOL TREAT, V28, P229, DOI 10.1080/09546634.2016.1227421; Metz M, 2021, NAT MED, V27, P1961, DOI 10.1038/s41591-021-01537-w; Miescher Sylvia M., 2001, Human Antibodies, V10, P119; NATBONY SF, 1983, J ALLERGY CLIN IMMUN, V71, P177, DOI 10.1016/0091-6749(83)90096-9; Nettis E, 2018, ANN ALLERG ASTHMA IM, V121, P474, DOI 10.1016/j.anai.2018.06.014; Noordenbos T, 2016, J LEUKOCYTE BIOL, V100, P453, DOI 10.1189/jlb.3HI1215-542R; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; Ogasawara H, 2019, J LEUKOCYTE BIOL, V106, P1069, DOI 10.1002/JLB.2AB1018-405R; Palacios T, 2016, J ALLER CL IMM-PRACT, V4, P529, DOI 10.1016/j.jaip.2015.11.025; Puccetti A, 2005, CLIN EXP ALLERGY, V35, P1599, DOI 10.1111/j.1365-2222.2005.02380.x; Rijavec M, 2021, ALLERGY, V76, P1254, DOI 10.1111/all.14577; Sabag DA, 2020, CLIN EXP ALLERGY, V50, P799, DOI 10.1111/cea.13616; Sabate-Bresco M, 2021, J ALLER CL IMM-PRACT, V9, P2284, DOI 10.1016/j.jaip.2021.03.038; Sabroe RA, 2002, J ALLERGY CLIN IMMUN, V110, P492, DOI 10.1067/mai.2002.126782; Sanchez J, 2021, ALLERGY ASTHMA IMMUN, V13, P746, DOI 10.4168/aair.2021.13.5.746; Sanchez J, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/4202145; Sanchez J, 2019, ALLERGY ASTHMA IMMUN, V11, P29, DOI 10.4168/aair.2019.11.1.29; Santiago L, 2019, BRIT J DERMATOL, V180, P199, DOI 10.1111/bjd.17005; Sanz ML, 1996, J INVEST ALLERG CLIN, V6, P152; Sauer M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.657211; Schmetzer O, 2018, J ALLERGY CLIN IMMUN, V142, P876, DOI 10.1016/j.jaci.2017.10.035; Schoepke N, 2019, ALLERGY, V74, P2427, DOI 10.1111/all.13949; Schulman ES, 2001, AM J RESP CRIT CARE, V164, pS6, DOI 10.1164/ajrccm.164.supplement_1.2103025; Shin YS, 2015, J KOREAN MED SCI, V30, P705, DOI 10.3346/jkms.2015.30.6.705; Soundararajan S, 2005, J ALLERGY CLIN IMMUN, V115, P815, DOI 10.1016/j.jaci.2004.12.1120; STELLATO C, 1992, J INVEST DERMATOL, V98, P800, DOI 10.1111/1523-1747.ep12499960; Suzuki Y, 2020, EUR J PHARMACOL, V878, DOI 10.1016/j.ejphar.2020.173104; Taskapan O, 2008, CLIN EXP DERMATOL, V33, P754, DOI 10.1111/j.1365-2230.2008.02819.x; Toubi E, 2021, J DERMATOL, V48, P1786, DOI 10.1111/1346-8138.16119; Toyoda M, 1996, AM J DERMATOPATH, V18, P49, DOI 10.1097/00000372-199602000-00008; Trischler J, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1255; Turk M, 2022, ALLERGY, V77, P323, DOI 10.1111/all.15119; Turk M, 2020, J ALLER CL IMM-PRACT, V8, P113, DOI 10.1016/j.jaip.2019.07.021; Wedi B, 2020, ALLERGY, V75, P2229, DOI 10.1111/all.14213; Yanase Y, 2021, J ALLERGY CLIN IMMUN, V147, P1101, DOI 10.1016/j.jaci.2020.08.018; Ye YM, 2014, J KOREAN MED SCI, V29, P43, DOI 10.3346/jkms.2014.29.1.43; Zhang LM, 2022, ALLERGY ASTHMA IMMUN, V14, P131, DOI 10.4168/aair.2022.14.1.131; Zuberbier T, 2002, J ALLERGY CLIN IMMUN, V109, P343, DOI 10.1067/mai.2002.121309; Zuberbier T, 2022, ALLERGY, V77, P734, DOI 10.1111/all.15090	138	3	3	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1819	1831		10.1016/j.jaci.2022.04.010	http://dx.doi.org/10.1016/j.jaci.2022.04.010			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35667749				2022-12-18	WOS:000833525500002
J	Tsai, M; Valent, P; Galli, SJ				Tsai, Mindy; Valent, Peter; Galli, Stephen J.			KIT as a master regulator of the mast cell lineage	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergic disorders; KIT; mast cells; parasite immunity; stem cell factor (SCF)	FC-EPSILON-RI; RECEPTOR TYROSINE KINASE; DEPENDENT MEDIATOR RELEASE; CONNECTIVE-TISSUE TYPE; EMBRYONIC STEM-CELLS; PROTOONCOGENE C-KIT; CORD-BLOOD-CELLS; RECOMBINANT HUMAN; BONE-MARROW; GROWTH-FACTOR	The discovery in 1987/1988 and 1990 of the cell surface receptor KIT and its ligand, stem cell factor (SCF), was a critical achievement in efforts to understand the development and function of multiple distinct cell lineages. These include hematopoietic progenitors, melanocytes, germ cells, and mast cells, which all are significantly affected by loss-of-function mutations of KIT or SCF. Such mutations also influence the development and/or function of additional cells, including those in parts of the central nervous system and the interstitial cells of Cajal (which control gut motility). Many other cells can express KIT constitutively or during immune responses, including dendritic cells, eosinophils, type 2 innate lymphoid cells, and taste cells. Yet the biological importance of KIT in many of these cell types largely remains to be determined. We here review the history of work investigating mice with mutations affecting the white spotting locus (which encodes KIT) or the steel locus (which encodes SCF), focusing especially on the influence of such mutations on mast cells. We also briefly review efforts to target the KIT/SCF pathway with anti-SCF or anti-Kit antibodies in mouse models of allergic disorders, parasite immunity, or fibrosis in which mast cells are thought to play significant roles.	[Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Valent, Peter] Med Univ Vienna, Div Hematol, Dept Internal Med 1, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Ctr Clin Sci Res, 269 Campus Dr,Rm 3255b, Stanford, CA 94305 USA.	sgalli@stanford.edu		Tsai, Mindy/0000-0002-8421-4721; Valent, Peter/0000-0003-0456-5095	NIH [U19 AI104209, R01 AI132494, R21 AI163438, R01 AI165373]; United States-Israel Binational Science Foundation [2017182]; Austrian Science Fund (FWF) [P32470-B, F4704-B20]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	S.J.G.: NIH U19 AI104209, NIH R01 AI132494, NIH R21 AI163438, NIH R01 AI165373, and United States-Israel Binational Science Foundation (Grant 2017182). P.V.: the Austrian Science Fund (FWF), projects P32470-B and F4704-B20.	Ainsua-Enrich E, 2015, J IMMUNOL, V194, P4309, DOI 10.4049/jimmunol.1402887; Ainsua-Enrich E, 2012, J IMMUNOL, V189, P2727, DOI 10.4049/jimmunol.1200380; Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; Akin C, 2022, J ALLERGY CLIN IMMUN, V149, P1912, DOI 10.1016/j.jaci.2022.04.020; Alvarado D, 2022, ALLERGY, V77, P2393, DOI 10.1111/all.15262; ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; ANDERSON DM, 1991, CELL GROWTH DIFFER, V2, P373; ANDO A, 1993, J CLIN INVEST, V92, P1639, DOI 10.1172/JCI116749; Arock M, 2015, LEUKEMIA, V29, P1223, DOI 10.1038/leu.2015.24; Arock M, 2022, J ALLERGY CLIN IMMUN, V149, P1855, DOI 10.1016/j.jaci.2022.04.004; Bachelet I, 2008, J IMMUNOL, V180, P6064, DOI 10.4049/jimmunol.180.9.6064; BISCHOFF SC, 1992, J EXP MED, V175, P237, DOI 10.1084/jem.175.1.237; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Choo E, 2021, CHEMOSENS PERCEPT, V14, P41, DOI 10.1007/s12078-019-09277-5; COLUMBO M, 1992, J IMMUNOL, V149, P599; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Costa JJ, 1996, J EXP MED, V183, P2681, DOI 10.1084/jem.183.6.2681; Cruse G, 2014, IMMUNOL ALLERGY CLIN, V34, P219, DOI 10.1016/j.iac.2014.01.002; Da Silva CA, 2006, FUND CLIN PHARMACOL, V20, P21, DOI 10.1111/j.1472-8206.2005.00390.x; Dahlin JS, 2017, BLOOD, V130, P1785, DOI 10.1182/blood-2017-03-773374; DASTYCH J, 1994, J IMMUNOL, V152, P213; DeAngelo DJ, 2021, NAT MED, V27, P2183, DOI 10.1038/s41591-021-01538-9; Derakhshan T, 2021, J EXP MED, V218, DOI 10.1084/jem.20200321; Desai A, 2019, J ALLERGY CLIN IMMUN, V144, P613, DOI 10.1016/j.jaci.2019.05.007; Donaldson LE, 1996, INT IMMUNOL, V8, P559, DOI 10.1093/intimm/8.4.559; Draber P, 2016, EUR J PHARMACOL, V778, P11, DOI 10.1016/j.ejphar.2015.02.057; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; DURAND B, 1994, BLOOD, V84, P3667, DOI 10.1182/blood.V84.11.3667.bloodjournal84113667; Dvorak AM, 1998, J ALLERGY CLIN IMMUN, V101, P793, DOI 10.1016/S0091-6749(98)70404-X; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fonseca W, 2019, MUCOSAL IMMUNOL, V12, P445, DOI 10.1038/s41385-018-0117-1; Gagari E, 1997, BLOOD, V89, P2654, DOI 10.1182/blood.V89.8.2654; GALLI SJ, 1993, J CLIN INVEST, V91, P148, DOI 10.1172/JCI116164; GALLI SJ, 1990, LAB INVEST, V62, P5; Galli SJ, 2020, ANNU REV IMMUNOL, V38, P49, DOI 10.1146/annurev-immunol-071719-094903; Galli SJ, 2017, NEW ENGL J MED, V376, P1983, DOI 10.1056/NEJMe1702653; Galli SJ, 2015, ADV IMMUNOL, V126, P45, DOI 10.1016/bs.ai.2014.11.002; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Givi ME, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/813091; Gotlib J, 2021, NAT MED, V27, P2192, DOI 10.1038/s41591-021-01539-8; Gotlib J, 2016, NEW ENGL J MED, V374, P2530, DOI 10.1056/NEJMoa1513098; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Hill PB, 1996, IMMUNOLOGY, V87, P326, DOI 10.1046/j.1365-2567.1996.455545.x; Ho CCM, 2017, CELL, V168, P1041, DOI 10.1016/j.cell.2017.02.011; Hsu YR, 1997, J BIOL CHEM, V272, P6406, DOI 10.1074/jbc.272.10.6406; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631; IEMURA A, 1994, AM J PATHOL, V144, P321; IRANI AMA, 1992, BLOOD, V80, P3009; Ito T, 2012, J IMMUNOL, V188, P5428, DOI 10.4049/jimmunol.1103366; Iwaki S, 2005, J BIOL CHEM, V280, P40261, DOI 10.1074/jbc.M506063200; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Kalesnikoff J, 2006, P NATL ACAD SCI USA, V103, P2659, DOI 10.1073/pnas.0511191103; Kanagaratham C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.603050; Kapur R, 1998, BLOOD, V91, P879, DOI 10.1182/blood.V91.3.879.879_879_889; Karimi K, 2000, EXP HEMATOL, V28, P626, DOI 10.1016/S0301-472X(00)00161-2; Kim DK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246216; Kirshenbaum Arnold S, 2006, Methods Mol Biol, V315, P105; KIRSHENBAUM AS, 1992, J IMMUNOL, V148, P772; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, BLOOD, V53, P492; Kolkhir P, 2022, NAT REV IMMUNOL, V22, P294, DOI 10.1038/s41577-021-00622-y; Kovarova M, 2010, BLOOD, V115, P3695, DOI 10.1182/blood-2009-08-237206; L'Italien L, 2018, CLIN CANCER RES, V24, P3465, DOI 10.1158/1078-0432.CCR-17-3786; Lee YN, 2011, BLOOD, V117, P3629, DOI 10.1182/blood-2010-07-293548; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; London CA, 2017, CLIN CANCER RES, V23, P2565, DOI 10.1158/1078-0432.CCR-16-2152; MacNeil AJ, 2014, J LEUKOCYTE BIOL, V95, P903, DOI 10.1189/jlb.0713401; Maguire Aindriu R R, 2021, Immunohorizons, V5, P182, DOI 10.4049/immunohorizons.2000040; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; MANOVA K, 1992, J NEUROSCI, V12, P4663; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; Maurer M, 2004, LAB INVEST, V84, P1593, DOI 10.1038/labinvest.3700196; Maurer M, 2021, J ALLER CL IMM-PRACT, V9, P1067, DOI 10.1016/j.jaip.2020.11.043; MEININGER CJ, 1992, BLOOD, V79, P958; MEKORI YA, 1993, J IMMUNOL, V151, P3775; Mirmonsef P, 1999, J IMMUNOL, V163, P2530; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; MORII E, 1992, DEV BRAIN RES, V65, P123, DOI 10.1016/0165-3806(92)90016-P; NEWLANDS GFJ, 1995, BLOOD, V86, P1968, DOI 10.1182/blood.V86.5.1968.bloodjournal8651968; NILSSON G, 1994, BLOOD, V84, P1519; NILSSON G, 1994, J IMMUNOL, V153, P3717; Oliveira SHP, 2001, AM J PHYSIOL-LUNG C, V280, pL1242, DOI 10.1152/ajplung.2001.280.6.L1242; Oriss TB, 2014, CURR OPIN ALLERGY CL, V14, P7, DOI 10.1097/ACI.0000000000000019; Paivandy A, 2021, J INNATE IMMUN, V13, P131, DOI 10.1159/000513582; Ptaschinski C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.604192; Radinger Madeleine, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0737s90; Rasky A, 2020, AM J PHYSIOL-LUNG C, V318, pL200, DOI 10.1152/ajplung.00114.2019; Reber LL, 2012, TRENDS IMMUNOL, V33, P613, DOI 10.1016/j.it.2012.09.008; Reitz M, 2017, MUCOSAL IMMUNOL, V10, P481, DOI 10.1038/mi.2016.56; RENNICK D, 1995, BLOOD, V85, P57, DOI 10.1182/blood.V85.1.57.bloodjournal85157; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sharma N, 2014, J IMMUNOL, V192, P4859, DOI 10.4049/jimmunol.1301155; Sharma N, 2012, MOL CELL BIOL, V32, P2653, DOI 10.1128/MCB.00308-12; Shimizu Y, 2002, CLIN EXP ALLERGY, V32, P872, DOI 10.1046/j.1365-2222.2002.01373.x; SILLABER C, 1991, J IMMUNOL, V147, P4224; Sonnenblick A, 2004, MOL CELL BIOL, V24, P10584, DOI 10.1128/MCB.24.24.10584-10592.2004; Sundstrom M, 2001, EXP CELL RES, V267, P144, DOI 10.1006/excr.2001.5239; Tajima Y, 1998, P NATL ACAD SCI USA, V95, P11903, DOI 10.1073/pnas.95.20.11903; TAYLOR AM, 1995, IMMUNOLOGY, V86, P427; Terhorst-Molawi D, 2022, J ALLERGY CLIN IMMUN, V149, pAB178; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; Tsai M, 2002, INT J HEMATOL, V75, P345, DOI 10.1007/BF02982122; TSAI M, 1991, J EXP MED, V174, P125, DOI 10.1084/jem.174.1.125; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; VALENT P, 1992, ADV IMMUNOL, V52, P333, DOI 10.1016/S0065-2776(08)60879-2; VALENT P, 1992, BLOOD, V80, P2237; Valent P, 2022, J ALLERGY CLIN IMMUN, V149, P1866, DOI 10.1016/j.jaci.2022.04.003; Valent P, 2020, THERANOSTICS, V10, P10743, DOI 10.7150/thno.46719; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P1125, DOI 10.1016/j.jaip.2019.01.006; van der Kleij HPM, 2003, J IMMUNOL, V171, P2074, DOI 10.4049/jimmunol.171.4.2074; Wang D, 2014, J EXP MED, V211, P2635, DOI 10.1084/jem.20140470; Wang XS, 2006, INT IMMUNOPHARMACOL, V6, P839, DOI 10.1016/j.intimp.2005.12.004; Wang Y, 2021, ALLERGY, V76, P2288, DOI 10.1111/all.14808; Wei JJ, 2012, CANCER IMMUNOL IMMUN, V61, P303, DOI 10.1007/s00262-011-1098-z; WERSHIL BK, 1992, J EXP MED, V175, P245, DOI 10.1084/jem.175.1.245; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Yamada N, 2003, J INVEST DERMATOL, V121, P1425, DOI 10.1046/j.1523-1747.2003.12613.x; Yamazaki S, 2015, J IMMUNOL, V195, P3427, DOI 10.4049/jimmunol.1402856; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Yuan Q, 1997, J EXP MED, V186, P313, DOI 10.1084/jem.186.2.313; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	133	3	3	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1845	1854		10.1016/j.jaci.2022.04.012	http://dx.doi.org/10.1016/j.jaci.2022.04.012			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35469840				2022-12-18	WOS:000833525500004
J	Gras-Pena, R; Danzl, NM; Khosravi-Maharlooei, M; Campbell, SR; Ruiz, AE; Parks, CA; Savage, WMS; Holzl, MA; Chatterjee, D; Sykes, M				Gras-Pena, Rafael; Danzl, Nichole M.; Khosravi-Maharlooei, Mohsen; Campbell, Sean R.; Ruiz, Amanda E.; Parks, Christopher A.; Savage, William Meng Suen; Holzl, Markus A.; Chatterjee, Debanjana; Sykes, Megan			Human stem cell-derived thymic epithelial cells enhance human T-cell development in a xenogeneic thymus	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Embryonic stem cell differentiation; TEC; third pharyngeal pouch; thymus; xenotransplantation	LIMB TENDON DEVELOPMENT; SONIC HEDGEHOG; TISSUE; DIFFERENTIATION; EXPRESSION; PORCINE; GENE; ORGANOGENESIS; INHIBITION; GROWTH	Background: Generation of thymic tissue from pluripotent stem cells would provide therapies for acquired and congenital thymic insufficiency states. Objectives: This study aimed to generate human thymic epithelial progenitors from human embryonic stem cells (hES-TEPs) and to assess their thymopoietic function in vivo. Methods: This study differentiated hES-TEPs by mimicking developmental queues with FGF8, retinoic acid, SHH, Noggin, and BMP4. Their function was assessed in reaggregate cellular grafts under the kidney capsule and in hybrid thymi by incorporating them into swine thymus (SwTHY) grafts implanted under the kidney capsules of immunodeficient mice that received human hematopoietic stem and progenitor cells (hHSPCs) intravenously. Results: Cultured hES-TEPs expressed FOXN1 and formed colonies expressing EPCAM and both cortical and medullary thymic epithelial cell markers. In thymectomized immunodeficient mice receiving hHSPCs, hES-TEPs mixed with human thymic mesenchymal cells supported human T-cell development. Hypothesizing that support from non-epithelial thymic cells might allow long-term function of hES-TEPs, the investigators injected them into SwTHY tissue, which supports human thymopoiesis in NOD severe combined immunodeficiency IL2Rgnull mice receiving hHSPCs. hES-TEPs integrated into SwTHY grafts, enhanced human thymopoiesis, and increased peripheral CD4 1 naive T-cell reconstitution. Conclusions: This study has developed and demonstrated in vivo thymopoietic function of hES-TEPs generated with a novel differentiation protocol. The SwTHY hybrid thymus model demonstrates beneficial effects on human thymocyte development of hES-TEPs maturing in the context of a supportive thymic structure.	[Gras-Pena, Rafael] Columbia Univ, Columbia Ctr Human Dev, New York, NY 10032 USA; [Gras-Pena, Rafael; Danzl, Nichole M.; Khosravi-Maharlooei, Mohsen; Campbell, Sean R.; Ruiz, Amanda E.; Parks, Christopher A.; Savage, William Meng Suen; Holzl, Markus A.; Chatterjee, Debanjana; Sykes, Megan] Columbia Univ, Columbia Ctr Translat Immunol, Coll Phys & Surg, Dept Med, 650 West 168th St,Black Bldg, New York, NY 10032 USA; [Sykes, Megan] Columbia Univ, Dept Surg, New York, NY 10032 USA; [Sykes, Megan] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Gras-Pena, R (corresponding author), Columbia Univ, Columbia Ctr Translat Immunol, Coll Phys & Surg, Dept Med, 650 West 168th St,Black Bldg, New York, NY 10032 USA.; Sykes, M (corresponding author), Columbia Univ, Columbia Ctr Translat Immunol, Dept Med, Coll Phys & Surg, 650 West 168th St,Black Bldg 1512,Mailbox 127, New York, NY 10032 USA.	rg2837@cumc.columbia.edu; megan.sykes@columbia.edu		Parks, Christopher/0000-0002-2772-2965; Ruiz, Amanda/0000-0002-6404-4905	National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [UC4DK104207]; NIH National Institute of Allergy and Infectious Diseases (NIAID) [P01AI045897]; Office of the Director, NIH [S10RR027050]; NIH NIDDK [F32DK095539]; Naomi Berrie Center Fellowship; American Diabetes Association (ADA) grant [7-11-MN-62]; ADA Postdoctoral Fellowship; Columbia University Naomi Berrie Diabetes Center Russell Berrie Foundation Fellowship;  [P30CA013696]	National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Naomi Berrie Center Fellowship; American Diabetes Association (ADA) grant; ADA Postdoctoral Fellowship; Columbia University Naomi Berrie Diabetes Center Russell Berrie Foundation Fellowship; 	This research was supported by the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) award UC4DK104207 and NIH National Institute of Allergy and Infectious Diseases (NIAID) P01AI045897. Research reported in this publication was performed in the CCTI Flow Cytometry Core and Herbert Irving Comprehensive Cancer Center Flow Cytometry Shared Resources, supported in part by the Office of the Director, NIH under award S10RR027050 and in part through Center grant P30CA013696. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. N.M.D. was supported by NIH NIDDK F32DK095539, Naomi Berrie Center Fellowship, and American Diabetes Association (ADA) grant 7-11-MN-62. M.K.M. was supported by an ADA Postdoctoral Fellowship and also a Columbia University Naomi Berrie Diabetes Center Russell Berrie Foundation Fellowship.	Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Albazerchi A, 2007, DEV BIOL, V301, P489, DOI 10.1016/j.ydbio.2006.08.057; Bain VE, 2016, DEVELOPMENT, V143, P4027, DOI 10.1242/dev.141903; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Bohr S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064223; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Bonnin MA, 2005, MECH DEVELOP, V122, P573, DOI 10.1016/j.mod.2004.11.005; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chhatta AR, 2019, J ALLERGY CLIN IMMUN, V144, P1416, DOI 10.1016/j.jaci.2019.05.042; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; DeWolf S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121256; Diman NYSG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027624; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Farley AM, 2013, DEVELOPMENT, V140, P2015, DOI 10.1242/dev.087320; Fink PJ, 2011, NAT REV IMMUNOL, V11, P544, DOI 10.1038/nri3028; Furumoto T, 1999, DEV BIOL, V210, P15, DOI 10.1006/dbio.1999.9261; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; Garg V, 2001, DEV BIOL, V235, P62, DOI 10.1006/dbio.2001.0283; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2018, INT J DEV BIOL, V62, P775, DOI 10.1387/ijdb.180284jg; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Guo QX, 2007, DEVELOPMENT, V134, P2251, DOI 10.1242/dev.004929; Haddadi MH, 2020, BLOOD REV, V41, DOI 10.1016/j.blre.2019.100645; Hetzer-Egger C, 2002, EUR J IMMUNOL, V32, P1175, DOI 10.1002/1521-4141(200204)32:4<1175::AID-IMMU1175>3.0.CO;2-U; Hongo D, 2007, J INFECT DIS, V196, P900, DOI 10.1086/520516; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kalscheuer H, 2014, J IMMUNOL, V192, P3442, DOI 10.4049/jimmunol.1302886; Khosravi-Maharlooei M, 2020, EUR J IMMUNOL, V50, P138, DOI 10.1002/eji.201948205; Khosravi-Maharlooei M, 2019, J CLIN INVEST, V129, P2446, DOI 10.1172/JCI124358; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Lai LJ, 2009, STEM CELLS, V27, P3012, DOI 10.1002/stem.238; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Manley NR, 2010, PROG MOL BIOL TRANSL, V92, P103, DOI 10.1016/S1877-1173(10)92005-X; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; MILLER JF, 1961, LANCET, V2, P748; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Nauman G, 2020, XENOTRANSPLANTATION, V27, DOI 10.1111/xen.12558; Nikolic B, 1999, TRANSPLANT P, V31, P924, DOI 10.1016/S0041-1345(98)01838-7; Onoe T, 2010, J IMMUNOL, V184, P6756, DOI 10.4049/jimmunol.0901711; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Patel SR, 2006, GENE EXPR PATTERNS, V6, P794, DOI 10.1016/j.modgep.2006.01.011; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Probst S, 2011, DEVELOPMENT, V138, P1913, DOI 10.1242/dev.063966; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Sacedon R, 2003, J HISTOCHEM CYTOCHEM, V51, P1557, DOI 10.1177/002215540305101115; Saldana JI, 2016, J AUTOIMMUN, V68, P86, DOI 10.1016/j.jaut.2015.12.004; Shimizu I, 2008, TRANSPLANTATION, V86, P601, DOI 10.1097/TP.0b013e318182d47a; Siepe M, 2009, TISSUE ENG PT A, V15, P1787, DOI 10.1089/ten.tea.2008.0356; Skogberg G, 2015, IMMUNOL CELL BIOL, V93, P727, DOI 10.1038/icb.2015.33; Soh CL, 2014, STEM CELL REP, V2, P925, DOI 10.1016/j.stemcr.2014.04.009; Stuckey DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017620; Su M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09882; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Sun XN, 2013, CELL STEM CELL, V13, P230, DOI 10.1016/j.stem.2013.06.014; Sykes M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6298; Tanabe T, 2017, AM J TRANSPLANT, V17, P1778, DOI 10.1111/ajt.14210; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Villegas JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01663; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Vitelli F, 2010, J MOL CELL CARDIOL, V49, P836, DOI 10.1016/j.yjmcc.2010.08.023; Wallin J, 1996, DEVELOPMENT, V122, P23; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamazaki Y, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax1036; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60	79	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1755	1771		10.1016/j.jaci.2021.09.038	http://dx.doi.org/10.1016/j.jaci.2021.09.038			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3I4PN	34695489				2022-12-18	WOS:000832701000007
J	Redmond, C; Akinoso-Imran, AQ; Heaney, LG; Sheikh, A; Kee, F; Busby, J				Redmond, Charlene; Akinoso-Imran, Abdul Qadr; Heaney, Liam G.; Sheikh, Aziz; Kee, Frank; Busby, John			Socioeconomic disparities in asthma health care utilization, exacerbations, and mortality: A systematic review and meta-analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Asthma; socioeconomic status; disparities; inequalities	EMERGENCY-DEPARTMENT VISITS; PATIENTS REQUIRING INTUBATION; RISK-FACTORS; CHILDHOOD ASTHMA; INSURANCE STATUS; HOSPITAL READMISSIONS; CHILDREN; OUTCOMES; ADULTS; LITERACY	Background: Prior studies investigating the effect of socioeconomic status (SES) on asthma health care outcomes have been heterogeneous in the populations studied and methodologies used. Objective: We sought to systematically synthesize evidence investigating the impact of SES on asthma health care utilization, exacerbations, and mortality. Methods: We searched Embase, Medline, and Web of Science for studies reporting differences in primary care attendance, exacerbations, emergency department attendance, hospitalization, ventilation/intubation, readmission, and asthma mortality by SES. Study quality was assessed using the Newcastle Ottawa Scale, and meta-analyses were conducted using random-effects models. We conducted several prespecified subgroup analyses, including by health care system (insurance based vs universal government funded) and time period (before vs after 2010). Results: A total of 61 studies, comprising 1,145,704 patients, were included. Lower SES was consistently associated with increased secondary health care utilization including emergency department attendance (odds ratio [OR], 1.61; 95% confidence interval [CI], 1.40-1.84), hospitalization (OR, 1.63; 95% CI, 1.34-1.99), and readmission (OR, 1.31; 95% CI, 1.19-1.44). Substantial associations were also found between SES and ventilation/intubation (OR, 1.76; 95% CI, 1.13-2.73), although there was no association with primary care attendances (OR, 0.79; 95% CI, 0.51-1.24). We found evidence of borderline significance for increased exacerbations (OR, 1.18; 95% CI, 0.98-1.42) and mortality (OR, 1.12; 95% CI, 0.92-1.37) among more deprived groups. There was no convincing evidence that disparities were associated with country-level health care funding models or that disparities have narrowed over time. Conclusions: Patients with a lower SES have substantially increased secondary care health care utilization. We found evidence suggestive of increased exacerbations and mortality risk, although CIs were wide. These disparities have been consistently reported worldwide, including within countries offering universally funded health care systems. Systematic review registration: CRD42020173544.	[Redmond, Charlene; Akinoso-Imran, Abdul Qadr; Kee, Frank; Busby, John] Queens Univ, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, North Ireland; [Heaney, Liam G.] Queens Univ, Ctr Expt Med, Sch Med Dent & Biomed Sci, Belfast, North Ireland; [Sheikh, Aziz] Univ Edinburgh, Usher Inst, Asthma UK Ctr Appl Res, Ctr Med Informat, Edinburgh, Scotland	Queens University Belfast; Queens University Belfast; University of Edinburgh	Busby, J (corresponding author), Queens Univ, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, North Ireland.	john.busby@qub.ac.uk		Redmond, Charlene/0000-0002-5595-0308	Department for the Economy, Northern Ireland; Health Data Research UK [JHR1157-100/1230]	Department for the Economy, Northern Ireland; Health Data Research UK	C. Redmond is in receipt of a PhD stipend alongside the payment of university fees from the Department for the Economy, Northern Ireland. A. Q. Akinoso-Imran is supported by Health Data Research UK grant JHR1157-100/1230.	Adams RJ, 2000, THORAX, V55, P566, DOI 10.1136/thorax.55.7.566; Adams RJ, 2009, INT J PUBLIC HEALTH, V54, P183, DOI 10.1007/s00038-009-7113-x; Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; Agabiti N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-457; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Al-Dawood KM, 2002, ANN SAUDI MED, V22, P29, DOI 10.5144/0256-4947.2002.29; Al-Muhsen S, 2015, ANN THORAC MED, V10, P123, DOI 10.4103/1817-1737.150735; Alsabbagh MHDW, 2014, VALUE HEALTH, V17, P288, DOI 10.1016/j.jval.2013.11.011; Alsallakh MA, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003497; Amre DK, 2002, J ASTHMA, V39, P625, DOI 10.1081/JAS-120014927; [Anonymous], 2020, GINI INDEX WORLD BAN; Apter AJ, 2013, J ALLERGY CLIN IMMUN, V132, P321, DOI 10.1016/j.jaci.2013.02.014; Ather S, 2004, J ASTHMA, V41, P709, DOI 10.1081/JAS-200027829; Auger KA, 2013, PEDIATRICS, V131, P64, DOI 10.1542/peds.2012-1055; Backman H, 2017, EUR CLIN RESPIR J, V4, DOI 10.1080/20018525.2017.1334508; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Bair YA, 2001, J GEN INTERN MED, V16, P475, DOI 10.1046/j.1525-1497.2001.016007475.x; Barton CA, 2005, J ASTHMA, V42, P249, DOI 10.1081/JAS-200057881; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Black MH, 2013, AM J EPIDEMIOL, V178, P1120, DOI 10.1093/aje/kwt093; Bloomberg GR, 2003, AM J RESP CRIT CARE, V167, P1068, DOI 10.1164/rccm.2201015; Bosworth B, 2018, ANNU REV PUBL HEALTH, V39, P237, DOI 10.1146/annurev-publhealth-040617-014615; Boulet LP, 1996, AM J EMERG MED, V14, P623, DOI 10.1016/S0735-6757(96)90075-3; Capo-Ramos DE, 2014, J ASTHMA, V51, P618, DOI 10.3109/02770903.2014.895010; Carroll CL, 2010, J ASTHMA, V47, P460, DOI 10.3109/02770903.2010.481344; Chang J, 2014, J PEDIATR HEALTH CAR, V28, P71, DOI 10.1016/j.pedhc.2012.11.001; Chen E, 2017, J ALLERGY CLIN IMMUN, V140, P828, DOI 10.1016/j.jaci.2016.11.040; Chen Y, 2004, RESP MED, V98, P446, DOI 10.1016/j.rmed.2003.11.005; Chen YC, 2018, J NURS SCHOLARSHIP, V50, P265, DOI 10.1111/jnu.12377; Coster JE, 2017, ACAD EMERG MED, V24, P1137, DOI 10.1111/acem.13220; DAVIDSON AE, 1994, ANN ALLERGY, V72, P469; Davidson E, 2010, PRIM CARE RESP J, V19, P202, DOI 10.4104/pcrj.2010.00013; Deeks JJ, COCHRANE HDB SYSTEMA, pch 10; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Desager K, 2018, ACTA CLIN BELG, V73, P348, DOI 10.1080/17843286.2017.1409684; DeWalt DA, 2007, AMBUL PEDIATR, V7, P25, DOI 10.1016/j.ambp.2006.10.001; Dick S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006554; Dickman SL, 2017, LANCET, V389, P1431, DOI 10.1016/S0140-6736(17)30398-7; Dilokthornsakul Piyameth, 2016, Value Health Reg Issues, V9, P105, DOI 10.1016/j.vhri.2016.03.001; Dima AL, 2015, EUR RESPIR J, V45, P994, DOI 10.1183/09031936.00172114; Eisner MD, 2001, RESP RES, V2, P53, DOI 10.1186/rr37; Ferris TG, 2001, AMBUL PEDIATR, V1, P267, DOI 10.1367/1539-4409(2001)001<0267:IAQOCF>2.0.CO;2; Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P563, DOI 10.1001/archpedi.154.6.563; Forbes L, 2007, THORAX, V62, P855, DOI 10.1136/thx.2006.058362; GBD 2017 Gastrooesophageal, 2020, LANCET GASTROENTEROL, V5, P561, DOI 10.1016/S2468-1253(19)30408-X; Gershon Andrea S, 2014, Ann Am Thorac Soc, V11, P1195, DOI 10.1513/AnnalsATS.201403-094OC; Gershon AS, 2012, COPD, V9, P216, DOI 10.3109/15412555.2011.648030; Grant EN, 2005, ANN ALLERG ASTHMA IM, V95, P19, DOI 10.1016/S1081-1206(10)61183-0; Grunwell JR, 2018, PEDIATR CRIT CARE ME, V19, pE585, DOI 10.1097/PCC.0000000000001695; Gushue C, 2019, J ASTHMA, V56, P1070, DOI 10.1080/02770903.2018.1523929; Hasegawa K, 2016, WEST J EMERG MED, V17, P22, DOI 10.5811/westjem.2015.11.28715; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horner SD, 2008, CLIN NURSE SPEC, V22, P192, DOI 10.1097/01.NUR.0000311708.40190.ca; Jackson JW, 2021, EPIDEMIOLOGY, V32, P282, DOI 10.1097/EDE.0000000000001319; Jamrozik E, 2009, RESPIROLOGY, V14, P814, DOI 10.1111/j.1440-1843.2009.01562.x; Jroundi I, 2021, J ASTHMA, V58, P10, DOI 10.1080/02770903.2019.1663430; Kaur BP, 2015, INT ARCH ALLERGY IMM, V168, P71, DOI 10.1159/000441687; Kenyon CC, 2014, J PEDIATR-US, V164, P300, DOI 10.1016/j.jpeds.2013.10.003; Kim H, 2009, PREV CHRONIC DIS, V6; Kullgren JT, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0894-z; Lasmar Laura Maria de Lima Belizario Facury, 2006, J. bras. pneumol., V32, P391, DOI 10.1590/S1806-37132006000500004; LESON S, 1995, J ASTHMA, V32, P379, DOI 10.3109/02770909509082763; LeSon S, 1996, J ASTHMA, V33, P27, DOI 10.3109/02770909609077760; LESON S, 1995, J ASTHMA, V32, P97, DOI 10.3109/02770909509083230; LESON S, 1995, J ASTHMA, V32, P285, DOI 10.3109/02770909509044836; Liu SY, 2009, PUBLIC HEALTH REP, V124, P65, DOI 10.1177/003335490912400110; Lutfiyya MN, 2011, J ASTHMA, V48, P931, DOI 10.3109/02770903.2011.619023; MacDonald LA, 2009, AM J EPIDEMIOL, V169, P1411, DOI 10.1093/aje/kwp082; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; Mancuso CA, 2006, J GEN INTERN MED, V21, P813, DOI 10.1111/j.1525-1497.2006.00528.x; Masefield S, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02295-2016; Mazalovic K, 2018, J ASTHMA, V55, P1043, DOI 10.1080/02770903.2017.1391280; Meng YY, 2006, ANN ALLERG ASTHMA IM, V96, P291, DOI 10.1016/S1081-1206(10)61238-0; Milaniak I, 2019, BRAIN BEHAV IMMUN, V78, P161, DOI 10.1016/j.bbi.2019.01.018; Modesti PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147601; Mowat DHR, 1998, ASTHMA GEN PRACT, V6, P9; Murphy J, 2021, J ASTHMA, V58, P683, DOI 10.1080/02770903.2020.1711916; Nardini S, 2017, MULTIDISCIP RESP MED, V12, DOI 10.1186/s40248-017-0109-0; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; O'Connell D., 2012, NEWCASTLE OTTAWA SCA; Ortega AN, 2001, MED CARE, V39, P1065, DOI 10.1097/00005650-200110000-00004; Pesola GR, 2004, ACAD EMERG MED, V11, P944, DOI 10.1197/j.aem.2004.03.020; Peters AT, 2008, ANN ALLERG ASTHMA IM, V100, P301, DOI 10.1016/S1081-1206(10)60590-X; Piper CN, 2010, J CHILD HEALTH CARE, V14, P271, DOI 10.1177/1367493510371629; Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063; Roberts NJ, 2013, RESP MED, V107, P1172, DOI 10.1016/j.rmed.2013.04.004; Rodriguez-Martinez CE, 2014, PEDIATR PULM, V49, P1058, DOI 10.1002/ppul.22936; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schultz WM, 2018, CIRCULATION, V137, P2166, DOI 10.1161/CIRCULATIONAHA.117.029652; Schwendicke F, 2015, J DENT RES, V94, P10, DOI 10.1177/0022034514557546; Scott A, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1061-8; Seibert Ryan G, 2019, Health Lit Res Pract, V3, pe9, DOI 10.3928/24748307-20181113-01; Shechter J, 2019, J COMMUN HEALTH, V44, P948, DOI 10.1007/s10900-019-00653-6; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Singh SK, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1124-z; Soremekun S, 2020, AM J RESP CRIT CARE, V201; Spurrier NJ, 2003, J PAEDIATR CHILD H, V39, P15, DOI 10.1046/j.1440-1754.2003.00064.x; Stanford R, 2000, MedGenMed, V2, pE5; StataCorp, 2015, STAT STAT SOFTW REL; Stein JS, 2021, J BEHAV MED, V44, P222, DOI 10.1007/s10865-020-00178-7; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; STODDARD JJ, 1994, NEW ENGL J MED, V330, P1421, DOI 10.1056/NEJM199405193302006; Stormacq C, 2019, HEALTH PROMOT INT, V34, pE1, DOI 10.1093/heapro/day062; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Sullivan PW, 2020, J ASTHMA, V57, P271, DOI 10.1080/02770903.2019.1571080; Sun XY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-261; Suruki RY, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0409-3; Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184; To T, 2008, AMBUL PEDIATR, V8, P281, DOI 10.1016/j.ambp.2008.04.008; To Teresa, 2014, Ann Am Thorac Soc, V11, P1210, DOI 10.1513/AnnalsATS.201404-138OC; van der Heide I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-179; van der Merwe L, 2006, THORAX, V61, P756, DOI 10.1136/thx.2005.052308; van Loenen T, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1119-2; Vart P, 2017, AM J PREV MED, V53, P730, DOI 10.1016/j.amepre.2017.06.036; Wainwright NWJ, 2007, ALLERGY, V62, P554, DOI 10.1111/j.1398-9995.2007.01316.x; Walters R, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08991-0; Weaver RR, 2014, SOC SCI MED, V102, P58, DOI 10.1016/j.socscimed.2013.11.033; Williams MV, 1998, CHEST, V114, P1008, DOI 10.1378/chest.114.4.1008; Wright K, 2009, ETHNIC DIS, V19, P71; Xie Sherrie, 2017, AMIA Jt Summits Transl Sci Proc, V2017, P123; Yan BD, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0292-3; Zejda JE, 2012, ANN AGR ENV MED, V19, P141; Zhang Q, 2017, J ASTHMA, V54, P679, DOI 10.1080/02770903.2016.1263315	123	3	3	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1617	1627		10.1016/j.jaci.2021.10.007	http://dx.doi.org/10.1016/j.jaci.2021.10.007			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	1V6XL	34673047	Green Accepted			2022-12-18	WOS:000806230000004
J	Smith, SS; Kim, R; Douglas, R				Smith, Stephanie Shintani; Kim, Raymond; Douglas, Richard			Is there a role for antibiotics in the treatment of chronic rhinosinusitis?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Chronic rhinosinusitis; antibiotics; review article	ENDOSCOPIC SINUS SURGERY; PLACEBO-CONTROLLED TRIAL; MAXIMAL MEDICAL THERAPY; STAPHYLOCOCCUS-AUREUS; DOUBLE-BLIND; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; NASAL POLYPS; LONG-TERM; MACROLIDE ANTIBIOTICS	Rhinosinusitis is one of the most common reasons for adult outpatient antibiotic prescriptions, though there is little clinical evidence to support this practice, especially for chronic rhinosinusitis. Despite considerable research, the etiology of chronic rhinosinusitis, including the pathogenic role of microbes, remains poorly understood. Rigorous studies of the efficacy of antibiotic treatment of chronic sinusitis are surprisingly few in number and the results are somewhat conflicting. This review article will review the rationales for and against the treatment of chronic rhinosinusitis with antibiotics, based on current evidence and understanding of pathophysiology, and will also summarize the current guidelines.	[Smith, Stephanie Shintani] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, 676 N St Clair,Ste 1325, Chicago, IL 60607 USA; [Smith, Stephanie Shintani] Northwestern Univ, Feinberg Sch Med, Ctr Hlth Serv & Outcomes Res, Inst Publ Hlth & Med, Chicago, IL 60607 USA; [Kim, Raymond; Douglas, Richard] Univ Auckland, Dept Surg, Auckland, New Zealand	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Auckland	Smith, SS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, 676 N St Clair,Ste 1325, Chicago, IL 60607 USA.	s-shintani@northwestern.edu			Chronic Rhinosinusitis Integrative Studies Program grant from the National Institutes of Health, Bethesda, Md, National Institute of Allergy and Infectious Diseases [U19 AI106683]	Chronic Rhinosinusitis Integrative Studies Program grant from the National Institutes of Health, Bethesda, Md, National Institute of Allergy and Infectious Diseases	S.S.S. is supported by the Chronic Rhinosinusitis Integrative Studies Program grant from the National Institutes of Health, Bethesda, Md, National Institute of Allergy and Infectious Diseases (grant no. U19 AI106683). The funding organizations did not contribute to the design or conduct of this study, preparation, review, approval, or the decision to submit this manuscript for publication.	Aanaes K, 2021, ACTA OTO-LARYNGOL, V141, P181, DOI 10.1080/00016489.2020.1841909; Ahovuo-Saloranta A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000243.pub3; Albu S, 2010, AM J RHINOL ALLERGY, V24, P306, DOI 10.2500/ajra.2010.24.3475; Amini M., 2009, Iranian Journal of Clinical Infectious Diseases, V4, P197; Bacci G, 2020, BIORXIV; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bassiouni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123216; Berkhout MC, 2013, J CYST FIBROS, V12, P525, DOI 10.1016/j.jcf.2013.01.002; Bhattacharyya N, 2005, AM J RHINOL, V19, P544, DOI 10.1177/194589240501900602; Biswas K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00134; Bonestroo HJC, 2010, J CYST FIBROS, V9, P130, DOI 10.1016/j.jcf.2010.01.001; Briaud P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52975-z; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Sabino HAC, 2017, INT FORUM ALLERGY RH, V7, P135, DOI 10.1002/alr.21846; Carr TF, 2016, JAMA OTOLARYNGOL, V142, P138, DOI 10.1001/jamaoto.2015.3059; Cervin A, 2005, OTOLARYNG CLIN N AM, V38, P1339, DOI 10.1016/j.otc.2005.08.002; Cho DY, 2019, INT FORUM ALLERGY RH, V9, P486, DOI 10.1002/alr.22285; Cho DY, 2019, AM J RHINOL ALLERGY, V33, P129, DOI 10.1177/1945892418815615; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Comegna M, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10070828; Daood U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67616-z; Dubin MG, 2007, AM J RHINOL, V21, P483, DOI 10.2500/ajr.2007.21.3047; Dubin MG, 2007, ANN ALLERG ASTHMA IM, V98, P32, DOI 10.1016/S1081-1206(10)60856-3; Ehnhage A, 2008, INT J ANTIMICROB AG, V31, P561, DOI 10.1016/j.ijantimicag.2008.01.027; Fan Y, 2014, J LARYNGOL OTOL, V128, P236, DOI 10.1017/S0022215114000279; Fang AF, 2009, INT J ANTIMICROB AG, V34, P67, DOI 10.1016/j.ijantimicag.2009.01.014; Fang CH, 2018, INT FORUM ALLERGY RH, V8, P522, DOI 10.1002/alr.22085; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Garbutt JM, 2012, JAMA-J AM MED ASSOC, V307, P685, DOI 10.1001/jama.2012.138; Gaurav A, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106022; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Goddard JC, 2017, OTOLARYNG HEAD NECK, V139, pP75; Hadley JA, 2010, LARYNGOSCOPE, V120, P1057, DOI 10.1002/lary.20878; Hansen MP, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011825.pub2; Harvey RJ, 2008, OTOLARYNG HEAD NECK, V139, P137, DOI 10.1016/j.otohns.2008.04.020; Harvey RJ, 2009, IMMUNOL ALLERGY CLIN, V29, P689, DOI 10.1016/j.iac.2009.07.006; Hauser LJ, 2015, INT FORUM ALLERGY RH, V5, P3, DOI 10.1002/alr.21428; Head K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011994.pub2; Hill RLR, 2000, J HOSP INFECT, V45, P198, DOI 10.1053/jhin.2000.0733; Hoggard M, 2017, CLIN MICROBIOL REV, V30, P321, DOI 10.1128/CMR.00060-16; Huck W, 1993, Arch Fam Med, V2, P497, DOI 10.1001/archfami.2.5.497; Hugenholtz P, 2002, GENOME BIOL, V3; Jaffe A, 1998, LANCET, V351, P420, DOI 10.1016/S0140-6736(05)78360-4; Jareoncharsri P, 2004, RHINOLOGY, V42, P23; Jeronimo LP, 2020, INT FORUM ALLERGY RH, V10, P884, DOI 10.1002/alr.22568; Jervis-Bardy J, 2012, LARYNGOSCOPE, V122, P2148, DOI 10.1002/lary.23486; Jervis-Bardy J, 2012, INT FORUM ALLERGY RH, V2, P111, DOI 10.1002/alr.20106; Jervis-Bardy J, 2009, AM J RHINOL ALLERGY, V23, P549, DOI 10.2500/ajra.2009.23.3366; Jiang RS, 2008, AM J RHINOL, V22, P608, DOI 10.2500/ajr.2008.22.3241; Johansen HK, 2012, J CYST FIBROS, V11, P525, DOI 10.1016/j.jcf.2012.04.011; Kamel C, 2012, INFECT CONT HOSP EP, V33, P608, DOI 10.1086/665723; Karanth TK, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012979.pub2; Kaszuba SM, 2006, AM J RHINOL, V20, P186, DOI 10.1177/194589240602000214; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; Kim RJT, 2015, INT FORUM ALLERGY RH, V5, P380, DOI 10.1002/alr.21431; Kim RJT, 2013, AM J RHINOL ALLERGY, V27, pE183, DOI 10.2500/ajra.2013.27.3974; Kisiel MA, 2020, POL J OTOLARYNGOL, V74, P33, DOI 10.5604/01.3001.0013.7851; Klein EY, 2021, LANCET INFECT DIS, V21, P107, DOI 10.1016/S1473-3099(20)30332-7; Lasso A, 2017, CLIN OTOLARYNGOL, V42, P637, DOI 10.1111/coa.12787; Lechien JR, 2021, ENT-EAR NOSE THROAT, V100, p569S, DOI 10.1177/0145561319892460; Lee LN, 2011, LARYNGOSCOPE, V121, P1092, DOI 10.1002/lary.21550; LEGENT F, 1994, CHEMOTHERAPY, V40, P8, DOI 10.1159/000239310; Lemiengre MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006089.pub4; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Lindbaek M, 1996, BMJ-BRIT MED J, V313, P325, DOI 10.1136/bmj.313.7053.325; Lindbaek Morten, 1998, Rhinology (Utrecht), V36, P7; Liu Z, 2020, ALLERGY ASTHMA IMMUN, V12, P176, DOI 10.4168/aair.2020.12.2.176; Lund VJ, 2005, OTOLARYNG CLIN N AM, V38, P1301, DOI 10.1016/j.otc.2005.07.003; Mainz JG, 2009, THORAX, V64, P535, DOI 10.1136/thx.2008.104711; Mainz JG, 2014, DRUG DES DEV THER, V8, P209, DOI 10.2147/DDDT.S54064; Margaritis VK, 2007, AM J RHINOL, V21, P574, DOI 10.2500/ajr.2007.21.3071; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V116, P1289, DOI 10.1016/j.jaci.2005.08.044; Merenstein D, 2005, J FAM PRACTICE, V54, P144; Namyslowski G, 2002, J CHEMOTHERAPY, V14, P508, DOI 10.1179/joc.2002.14.5.508; Oakley GM, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0696-z; Oomen Karin P Q, 2012, Int J Otolaryngol, V2012, P789572, DOI 10.1155/2012/789572; Orecka B, 1998, MED SCI MONIT, V4, pPI551; Orlandi RR, 2021, INT FORUM ALLERGY RH, V11, P213, DOI 10.1002/alr.22741; Peters AT, 2014, ANN ALLERG ASTHMA IM, V113, P347, DOI 10.1016/j.anai.2014.07.025; Soter ACPB, 2017, RHINOLOGY, V55, P175, DOI 10.4193/Rhino15.291; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Psaltis AJ, 2007, LARYNGOSCOPE, V117, P1302, DOI 10.1097/MLG.0b013e31806009b0; Ramakrishnan VR, 2015, J ALLERGY CLIN IMMUN, V136, P334, DOI 10.1016/j.jaci.2015.02.008; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Rudmik L, 2016, INT FORUM ALLERGY RH, V6, P557, DOI 10.1002/alr.21769; Ryu Gwanghui, 2021, Journal of Rhinology, V28, P44, DOI 10.18787/jr.2020.00343; Sadarangani SP, 2015, MAYO CLIN PROC, V90, P109, DOI 10.1016/j.mayocp.2014.09.006; Shah GB, 2018, INT FORUM ALLERGY RH, V8, P729, DOI 10.1002/alr.22082; Sharp HJ, 2007, ARCH OTOLARYNGOL, V133, P260, DOI 10.1001/archotol.133.3.260; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Shimizu T, 2016, AURIS NASUS LARYNX, V43, P131, DOI 10.1016/j.anl.2015.08.014; Siu J, 2020, XENOBIOTICA, V50, P1443, DOI 10.1080/00498254.2020.1814973; Smith SS, 2013, J ALLERGY CLIN IMMUN, V132, P1230, DOI 10.1016/j.jaci.2013.07.009; Soler ZM, 2013, INT FORUM ALLERGY RH, V3, P31, DOI 10.1002/alr.21064; Spagnolo P, 2013, EUR RESPIR J, V42, P239, DOI 10.1183/09031936.00136712; Sreenath SB, 2015, INT FORUM ALLERGY RH, V5, P820, DOI 10.1002/alr.21542; Stalman W, 1997, BRIT J GEN PRACT, V47, P794; Stevens WW, 2019, J ALLER CL IMM-PRACT, V7, P2812, DOI 10.1016/j.jaip.2019.05.009; Stevens WW, 2017, J ALLER CL IMM-PRACT, V5, P1061, DOI 10.1016/j.jaip.2016.12.027; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Takizawa H, 1997, AM J RESP CRIT CARE, V156, P266, DOI 10.1164/ajrccm.156.1.9612065; TAMAOKI J, 1992, J ANTIMICROB CHEMOTH, V29, P173, DOI 10.1093/jac/29.2.173; Tan BK, 2017, J ALLERGY CLIN IMMUN, V139, P699, DOI 10.1016/j.jaci.2016.06.063; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Uren B, 2008, LARYNGOSCOPE, V118, P1677, DOI 10.1097/MLG.0b013e31817aec47; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Van Zele T, 2010, J ALLERGY CLIN IMMUN, V125, P1069, DOI 10.1016/j.jaci.2010.02.020; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; Verderosa AD, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00824; Vickery TW, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0853-7; Videler WJ, 2011, ALLERGY, V66, P1457, DOI 10.1111/j.1398-9995.2011.02693.x; Mackenzie BW, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01697-w; Wallwork B, 2006, LARYNGOSCOPE, V116, P189, DOI 10.1097/01.mlg.0000191560.53555.08; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Whelan FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172811; Wood AJ, 2012, AM J RHINOL ALLERGY, V26, P265, DOI 10.2500/ajra.2012.26.3779; Yanagihara K, 2002, J ANTIMICROB CHEMOTH, V49, P867, DOI 10.1093/jac/dkf013; Young J, 2008, LANCET, V371, P908, DOI 10.1016/S0140-6736(08)60416-X; Zhang Z, 2014, INT FORUM ALLERGY RH, V4, P403, DOI 10.1002/alr.21277; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	127	3	3	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1504	1512		10.1016/j.jaci.2022.02.004	http://dx.doi.org/10.1016/j.jaci.2022.02.004			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3W0TR	35217148	Bronze			2022-12-18	WOS:000842068800002
J	Johansen, JD; Bonefeld, CM; Schwensen, JFB; Thyssen, JP; Uter, W				Johansen, Jeanne Duus; Bonefeld, Charlotte Menne; Schwensen, Jakob Ferlov Baselius; Thyssen, Jacob Pontoppidan; Uter, Wolfgang			Novel insights into contact dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergic contact dermatitis; irritant contact dermatitis; innate immunity; TRM cells; IL-16; CXCL9; CXCL10; ZBP1; epidermal transcriptome; JAK-1 inhibitor; dupilumab; methylisothiazolinone; isobornyl acrylate	T-CELL-CLONES; INTERFERON-GAMMA; IFN-GAMMA; CYTOKINE PRODUCTION; EFFECTOR CD8(+); NICKEL; HYPERSENSITIVITY; SENSITIZATION; ELICITATION; RESPONSES	Contact dermatitis is a common disease that is caused by repeated skin contact with contact allergens or irritants, resulting in allergic contact dermatitis (ACD) and/or irritant contact dermatitis. Attempts have been made to identify biomarkers to distinguish irritant and allergic patch test reactions, which could aid diagnosis. Some promising candidates have recently been identified, but verification and validation in clinical cases still need to be done. New causes of ACD are constantly being recognized. In this review, 10 new contact allergens from recent years, several relating to anti aging products, have been identified. Frequent allergens causing considerable morbidity in the population, such as the preservative methylisothiazolinone, have been regulated in the European Union. A significant drop in the number of cases has been seen, whereas high rates are still occurring in other areas such as North America. Other frequent causes are fragrance allergens, especially the widely used terpenes and acrylates found in medical devices for control of diabetes. These represent unsolved problems. Recent advances in immunology have opened the way for a better understanding of the complexity of contact dermatitis, especially ACD-a disease that may be more heterogenous that previous understood, with several subtypes. With the rapidly evolving molecular understanding of ACD, the potential for development of new drugs for personalized treatment of contact dermatitis is considerable. (J Allergy Clin Immunol 2022;149:1162-71.)	[Johansen, Jeanne Duus; Schwensen, Jakob Ferlov Baselius; Thyssen, Jacob Pontoppidan] Univ Copenhagen, Gentofte Hosp, Natl Allergy Res Ctr, Dept Skin & Allergy, Copenhagen, Denmark; [Bonefeld, Charlotte Menne] Univ Copenhagen, LEO Fdn Skin Immunol Res Ctr, Dept Immunol & Microbiol, Copenhagen, Denmark; [Uter, Wolfgang] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, Erlangen, Germany; [Johansen, Jeanne Duus] Univ Copenhagen, Gentofte Hosp, Natl Allergy Res Ctr, Dept Skin & Allergy, DK-2900 Hellerup, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Erlangen Nuremberg; University of Copenhagen; Herlev & Gentofte Hospital	Johansen, JD (corresponding author), Univ Copenhagen, Gentofte Hosp, Natl Allergy Res Ctr, Dept Skin & Allergy, DK-2900 Hellerup, Denmark.	Jeanne.duus.johansen@regionh.dk	Johansen, Jeanne/AAM-6382-2021	Johansen, Jeanne/0000-0002-3537-8463	European Union [VS/2019/0040]; Danish Environmental Protection Agency; Leo Foundation	European Union(European Commission); Danish Environmental Protection Agency; Leo Foundation(LEO Pharma)	The authors have received support for other research activities from the European Union research fund DG Employment, Social Affairs and Inclusion (grant VS/2019/0040 [to J.D.G. and W.U.]), the Danish Environmental Protection Agency to (J.D.G.), and the Leo Foundation (to J.D.G. and C.B.).	Aerts O, 2020, CONTACT DERMATITIS, V83, P172, DOI 10.1111/cod.13626; Aerts O, 2020, DERMATITIS, V31, P4, DOI 10.1097/DER.0000000000000549; Ahlstrom MG, 2021, CONTACT DERMATITIS, V84, P419, DOI 10.1111/cod.13786; Ahrensboll-Friis U, 2021, CONTACT DERMATITIS, V84, P75, DOI 10.1111/cod.13664; Albanesi C, 1999, J IMMUNOL, V162, P494; Alinaghi F, 2019, CONTACT DERMATITIS, V80, P77, DOI 10.1111/cod.13119; Amat-Samaranch V, 2021, CONTACT DERMATITIS, V84, P352, DOI 10.1111/cod.13747; Amin R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0261253; Amsler E, 2017, CONTACT DERMATITIS, V77, P163, DOI 10.1111/cod.12795; Atwater AR, 2021, DERMATITIS, V32, P421, DOI 10.1097/DER.0000000000000701; Atwater AR, 2021, DERMATITIS, V32, P42, DOI 10.1097/DER.0000000000000661; Badaoui A, 2021, CONTACT DERMATITIS, V85, P255, DOI 10.1111/cod.13835; Barbaud A, 2020, CURR OPIN ALLERGY CL, V20, P117, DOI 10.1097/ACI.0000000000000621; Baruffi FY, 2020, DERMATOL CLIN, V38, P379, DOI 10.1016/j.det.2020.02.008; Bennike NH, 2019, CONTACT DERMATITIS, V80, P208, DOI 10.1111/cod.13168; Brans R, 2021, CONTACT DERMATITIS, V84, P299, DOI 10.1111/cod.13746; Bregnbak D, 2013, CONTACT DERMATITIS, V69, P57, DOI 10.1111/cod.12081; Bruusgaard-Mouritsen MA, CONTACT DERMATITIS, V85, P650; Brys AK, 2020, J INVEST DERMATOL, V140, P21, DOI 10.1016/j.jid.2019.03.1133; Cavani A, 1998, J INVEST DERMATOL, V111, P621, DOI 10.1046/j.1523-1747.1998.00334.x; Comstedt LR, 2020, CONTACT DERMATITIS, V82, P218, DOI 10.1111/cod.13422; Corso R, 2021, CONTACT DERMATITIS, V85, P108, DOI 10.1111/cod.13799; Cunningham LS, 2020, CONTACT DERMATITIS, V83, P432, DOI 10.1111/cod.13685; de Wijs LEM, 2021, CLIN EXP ALLERGY, V51, P959, DOI 10.1111/cea.13892; Degraeuwe A, 2020, CONTACT DERMATITIS, V82, P412, DOI 10.1111/cod.13493; DeKoven JG, 2021, DERMATITIS, V32, P111, DOI 10.1097/DER.0000000000000729; DeKoven JG, 2018, DERMATITIS, V29, P297, DOI 10.1097/DER.0000000000000417; Dhingra N, 2014, J ALLERGY CLIN IMMUN, V134, P362, DOI 10.1016/j.jaci.2014.03.009; Dietz JB, 2021, CONTACT DERMATITIS, V84, P224, DOI 10.1111/cod.13719; Dudeck J, IMMUNITY, V54, P5; Dyring-Andersen B, 2013, CONTACT DERMATITIS, V68, P339, DOI 10.1111/cod.12043; El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084; European Commission. Directorate General for Health and Consumers, 2012, OP HYDR 3 CYCL CARB, DOI [10.2772/27531, DOI 10.2772/27531]; Flury U, 2018, CONTACT DERMATITIS, V79, P189, DOI 10.1111/cod.13025; Foo HL, 2021, DERMATITIS, V32, pE35, DOI 10.1097/DER.0000000000000546; Fortino V, 2020, P NATL ACAD SCI USA, V117, P33474, DOI 10.1073/pnas.2009192117; Funch AB, 2022, ALLERGY, V77, P513, DOI 10.1111/all.14986; Gadsboll ASO, 2020, J INVEST DERMATOL, V140, P806, DOI 10.1016/j.jid.2019.07.722; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gamradt P, 2019, J ALLERGY CLIN IMMUN, V143, P2147, DOI 10.1016/j.jaci.2018.11.048; GOCINSKI BL, 1990, J IMMUNOL, V144, P4121; Hagvall L, 2020, CONTACT DERMATITIS, V83, P372, DOI 10.1111/cod.13654; Halling AS, 2020, CONTACT DERMATITIS, V83, P37, DOI 10.1111/cod.13501; Hamnerius N, 2021, ACTA DERM-VENEREOL, V101, DOI 10.2340/00015555-3904; Han HS, 2021, CONTACT DERMATITIS, V85, P225, DOI 10.1111/cod.13855; Havmose M, 2021, CONTACT DERMATITIS, V84, P254, DOI 10.1111/cod.13717; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Helou DG, 2019, J IMMUNOL, V202, P2189, DOI 10.4049/jimmunol.1801065; Herman A, 2021, J EUR ACAD DERMATOL, V35, P1444, DOI 10.1111/jdv.17238; Herman A, 2021, CONTACT DERMATITIS, V85, P643, DOI 10.1111/cod.13956; Hoppe A, 2020, J ALLERGY CLIN IMMUN, V145, P1476, DOI 10.1016/j.jaci.2020.01.036; Hunt WTN, 2020, CONTACT DERMATITIS, V82, P161, DOI 10.1111/cod.13380; Johansen JD, 2015, CONTACT DERMATITIS, V73, P195, DOI 10.1111/cod.12432; Kawakami Y, 2021, CONTACT DERMATITIS, V85, P245, DOI 10.1111/cod.13820; King N, 2021, CONTACT DERMATITIS, V85, P637, DOI 10.1111/cod.13968; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Kondo S, 1996, J INVEST DERMATOL, V106, P993, DOI 10.1111/1523-1747.ep12338505; Koppes SA, 2017, CONTACT DERMATITIS, V77, P1, DOI 10.1111/cod.12789; Kreeshan FC, 2020, CONTACT DERMATITIS, V83, P418, DOI 10.1111/cod.13628; Lapeere H, 2020, CONTACT DERMATITIS, V83, P134, DOI 10.1111/cod.13543; Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036; Lefevre MA, 2021, ALLERGY, V76, P3697, DOI 10.1111/all.14989; Lichter J, 2021, BRIT J DERMATOL, V184, P1143, DOI 10.1111/bjd.19685; Loman L, 2022, CONTACT DERMATITIS, V86, P80, DOI 10.1111/cod.14005; Loman L, 2021, CONTACT DERMATITIS, V84, P124, DOI 10.1111/cod.13693; Machado A, 2020, CONTACT DERMATITIS, V82, P133, DOI 10.1111/cod.13418; Martin SF, 2015, CONTACT DERMATITIS, V72, P2, DOI 10.1111/cod.12311; Masjedi K, 2003, BRIT J DERMATOL, V149, P1172, DOI 10.1111/j.1365-2133.2003.05750.x; Moed H, 2004, BRIT J DERMATOL, V151, P32, DOI 10.1111/j.1365-2133.2004.05975.x; Moulon C, 1995, EUR J IMMUNOL, V25, P3308, DOI 10.1002/eji.1830251216; Moussavi A, 1998, INT ARCH ALLERGY IMM, V116, P116, DOI 10.1159/000023934; Navarro-Trivino FJ, 2020, CONTACT DERMATITIS, V83, P508, DOI 10.1111/cod.13641; Noe E, 2022, CONTACT DERMATITIS, V86, P3, DOI 10.1111/cod.13975; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Oosterhaven JAF, 2019, J DERMATOL, V46, P680, DOI 10.1111/1346-8138.14982; Oosterhaven JAF, 2019, CONTACT DERMATITIS, V80, P263, DOI 10.1111/cod.13192; Pastor-Nieto MA, 2021, CONTACT DERMATITIS, V84, P201, DOI 10.1111/cod.13709; Rafei-Shamsabadi DA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02591; Rafei-Shamsabadi DA, 2018, J INVEST DERMATOL, V138, P1962, DOI 10.1016/j.jid.2018.03.001; Raffi J, 2020, J AM ACAD DERMATOL, V82, P132, DOI 10.1016/j.jaad.2019.09.028; Renaudin H, 2021, CONTACT DERMATITIS, V84, P462, DOI 10.1111/cod.13761; Ruge IF, 2020, CONTACT DERMATITIS, V83, P137, DOI 10.1111/cod.13545; Russo JP, 2020, CONTACT DERMATITIS, V83, P391, DOI 10.1111/cod.13661; Schmidt JD, 2017, CONTACT DERMATITIS, V76, P218, DOI 10.1111/cod.12715; Schnuch A, 2020, CONTACT DERMATITIS, V82, P87, DOI 10.1111/cod.13414; Schubert S, 2020, CONTACT DERMATITIS, V83, P487, DOI 10.1111/cod.13686; Schwensen JF, 2017, BRIT J DERMATOL, V176, P176, DOI 10.1111/bjd.14825; Schwensen JFB, 2021, CONTACT DERMATITIS, V85, P710, DOI 10.1111/cod.13948; Siemund I, 2021, CONTACT DERMATITIS, V85, P582, DOI 10.1111/cod.13907; Hafner MDS, 2020, AN BRAS DERMATOL, V95, P696, DOI 10.1016/j.abd.2020.04.011; Silverberg JI, 2021, J AM ACAD DERMATOL; Simonsen AB, 2021, CONTACT DERMATITIS, V84, P144, DOI 10.1111/cod.13727; SINIGAGLIA F, 1985, J IMMUNOL, V135, P3929; Solberg J, 2021, J DERMATOL SCI, V101, P14, DOI 10.1016/j.jdermsci.2020.10.011; Sukakul T, 2022, CONTACT DERMATITIS, V86, P15, DOI 10.1111/cod.13980; Sukakul T, 2021, CONTACT DERMATITIS, V84, P175, DOI 10.1111/cod.13723; Svedman C, 2021, J EUR ACAD DERMATOL, V35, P730, DOI 10.1111/jdv.16981; Svedman C, 2021, CONTACT DERMATITIS, V84, P439, DOI 10.1111/cod.13781; Svensson A, 2018, BRIT J DERMATOL, V178, P1111, DOI 10.1111/bjd.16248; Takamori A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25094-4; Tam I, 2021, CONTACT DERMATITIS, V84, P308, DOI 10.1111/cod.13749; Uter W, 2020, BRIT J DERMATOL, V183, P857, DOI 10.1111/bjd.18946; Uter W, 2020, J EUR ACAD DERMATOL, V34, P333, DOI 10.1111/jdv.15875; Uter W, 2021, CONTACT DERMATITIS, V84, P109, DOI 10.1111/cod.13704; Waldman RA, 2020, J AM ACAD DERMATOL, V82, P1251, DOI 10.1016/j.jaad.2019.12.053; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Wisgrill L, 2021, ALLERGY, V76, P804, DOI 10.1111/all.14519; Worm M, 2020, BRIT J DERMATOL, V182, P1103, DOI 10.1111/bjd.18469; Xie Z, 2020, CONTACT DERMATITIS, V83, P166, DOI 10.1111/cod.13599; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001; Yamamoto Y, 2021, J ALLERGY CLIN IMMUN, V148, P858, DOI 10.1016/j.jaci.2021.02.005; Yang TLB, 2019, J ALLERGY CLIN IMMUN, V144, P353, DOI 10.1016/j.jaci.2019.06.016; Zhang S, CELL, V184, P2151; Zhu Gefei Alex, 2020, JAAD Case Rep, V6, P296, DOI 10.1016/j.jdcr.2020.02.010	116	3	3	6	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1162	1171		10.1016/j.jaci.2022.02.002	http://dx.doi.org/10.1016/j.jaci.2022.02.002			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	0Z8PK	35183605				2022-12-18	WOS:000791333500002
J	Delmonte, OM; Castagnoli, R; Yu, J; Dvorak, CC; Cowan, MJ; Saldana, BJD; De Ravin, SS; Mamcarz, E; Chang, CK; Daley, SR; Griffith, LM; Notarangelo, LD; Puck, JM				Delmonte, Ottavia M.; Castagnoli, Riccardo; Yu, Jason; Dvorak, Christopher C.; Cowan, Morton J.; Saldana, Blachy J. Davila; De Ravin, Suk See; Mamcarz, Ewelina; Chang, Catherine K.; Daley, Stephen R.; Griffith, Linda M.; Notarangelo, Luigi D.; Puck, Jennifer M.			Poor T-cell receptor beta repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Complementarity determining region 3 (CDR3); hematopoietic cell transplantation; high-throughput sequencing; immune reconstitution; severe combined immunodeficiency (SCID); T-cell receptor (TCR); T-cell receptor beta (TRB) diversity; T-cell receptor beta (TRB) repertoire	TRANSPLANTATION	Background: Development of a diverse T-cell receptor beta (TRB) repertoire is associated with immune recovery following hematopoietic cell transplantation (HCT) for severe combined immunodeficiency (SCID). High-throughput sequencing of the TRB repertoire allows evaluation of clonotype dynamics during immune reconstitution. Objectives: We investigated whether longitudinal analysis of the TRB repertoire would accurately describe T-cell receptor diversity and illustrate the quality of T-cell reconstitution following HCT or gene therapy for SCID. Methods: We used high-throughput sequencing to study composition and diversity of the TRB repertoire in 27 infants with SCID at 3, 6, and 12 months and yearly posttreatment(s). Total RNA from peripheral blood was used as template to amplify TRB rearrangements. Results: TRB sequence analysis showed poor diversity at 3 months, followed by significant improvement by 6 months after cellular therapies. Kinetics of development of TRB diversity were similar in patients with a range of underlying gene defects. However, in patients with RAG and DCLRE1C defects, HCT with no conditioning or immune suppression only resulted in lower diversity than did HCT with conditioning. HCT from a matched donor correlated with higher diversity than did HCT from a mismatched donor. Naive CD4(+) T-cell count at 6 months post-HCT correlated with higher TRB diversity. A Shannon index of diversity of 5.2 or lower 3 months after HCT predicted a need for a second intervention. Conclusions: TRB repertoire after hematopoietic cell therapies for SCID provides a quantitative and qualitative measure of diversity of T-cell reconstitution and permits early identification of patients who may require a second intervention.	[Delmonte, Ottavia M.; Castagnoli, Riccardo; De Ravin, Suk See; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD 20892 USA; [Yu, Jason; Dvorak, Christopher C.; Cowan, Morton J.; Chang, Catherine K.; Puck, Jennifer M.] Univ Calif San Francisco, Sch Med, Dept Pediat, Div Allergy Immunol & Blood & Marrow Transplantat, San Francisco, CA USA; [Yu, Jason; Cowan, Morton J.; Puck, Jennifer M.] Smith Cardiovasc Res Inst, San Francisco, CA USA; [Yu, Jason; Dvorak, Christopher C.; Cowan, Morton J.; Chang, Catherine K.; Puck, Jennifer M.] UCSF Benioff Childrens Hosp, San Francisco, CA USA; [Saldana, Blachy J. Davila] Childrens Natl Med Ctr, Div Blood & Marrow Transplantat, Washington, DC USA; [Mamcarz, Ewelina] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, Memphis, TN USA; [Daley, Stephen R.] Queensland Univ Technol, Sch Biomed Sci, Ctr Immunol & Infect Control, Brisbane, Qld, Australia; [Griffith, Linda M.] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; Children's National Health System; St Jude Children's Research Hospital; Queensland University of Technology (QUT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Notarangelo, LD (corresponding author), NIAID, Lab Clin Immunol & Microbiol, Bldg 10,Room 5W-3950,10 Ctr Dr,MSC 1456, Bethesda, MD 20892 USA.; Puck, JM (corresponding author), UCSF Sch Med, Dept Pediat, Box 3118,555 Mission Bay Blvd,South,Rm SC-252K, San Francisco, CA 94143 USA.	luigi.notarangelo2@nih.gov; Jennifer.Puck@ucsf.edu	Castagnoli, Riccardo/AAF-8555-2019	Castagnoli, Riccardo/0000-0003-0029-9383; Dvorak, Christopher/0000-0002-6146-3952; Daley, Stephen/0000-0002-5870-644X; De Ravin, Suk See/0000-0002-9800-774X	National Institute of Allergy and Infectious Diseases (NIAID) [U54-AI082973]; Office of Rare Diseases Research, National Center for Advancing Translational Sci-ences, National Institutes of Health (NIH) , Bethesda, Md; Division of Intramural Research, NIAID, NIH [1 ZIA AI001222-02]; California Institute of Regenerative Medicine [CLIN2-10830, CLIN2-09504]; Lisa and Douglas Goldman Fund	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Rare Diseases Research, National Center for Advancing Translational Sci-ences, National Institutes of Health (NIH) , Bethesda, Md; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Lisa and Douglas Goldman Fund	The Primary Immune Deficiency Treatment Consortium is funded by the National Institute of Allergy and Infectious Diseases (NIAID; grant no. U54-AI082973) and the Office of Rare Diseases Research, National Center for Advancing Translational Sci-ences, National Institutes of Health (NIH) , Bethesda, Md. Additional funding has come from the Division of Intramural Research, NIAID, NIH (grant no. 1 ZIA AI001222-02 to L.D.N.) and the California Institute of Regenerative Medicine (grant no. CLIN2-10830 to M.J.C. and grant no. CLIN2-09504 to Dr Gottschalk, supporting gene therapy trials for DCLRE1C and IL2RG SCID) . J.M.P. received further support from the Lisa and Douglas Goldman Fund.	Admiraal R, 2015, LANCET HAEMATOL, V2, pE194, DOI 10.1016/S2352-3026(15)00045-9; Bosticardo M, 2020, BLOOD ADV, V4, P2611, DOI 10.1182/bloodadvances.2020001730; Daley SR, 2019, J ALLERGY CLIN IMMUN, V144, P333, DOI 10.1016/j.jaci.2019.03.022; Dobbs K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00798; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Gkazi AS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02547; Haddad E, 2018, BLOOD, V132, P1737, DOI 10.1182/blood-2018-03-840702; Horn B, 1999, BONE MARROW TRANSPL, V24, P1009, DOI 10.1038/sj.bmt.1702011; Lev A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030494; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Zvyagin IV, 2017, LEUKEMIA, V31, P1145, DOI 10.1038/leu.2016.321	15	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1113	1119		10.1016/j.jaci.2021.07.029	http://dx.doi.org/10.1016/j.jaci.2021.07.029			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO6CI	34384841	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000765811400009
J	Dribin, TE; Schnadower, D; Wang, JL; Camargo, CA; Michelson, KA; Shaker, M; Rudders, SA; Vyles, D; Golden, DBK; Spergel, JM; Campbell, RL; Neuman, MI; Capucilli, PS; Pistiner, M; Castells, M; Lee, J; Brousseau, DC; Schneider, LC; Assa'ad, AH; Risma, KA; Mistry, RD; Campbell, DE; Worm, M; Turner, PJ; Witry, JK; Zhang, Y; Sobolewski, B; Sampson, HA				Dribin, Timothy E.; Schnadower, David; Wang, Julie; Camargo, Carlos A., Jr.; Michelson, Kenneth A.; Shaker, Marcus; Rudders, Susan A.; Vyles, David; Golden, David B. K.; Spergel, Jonathan M.; Campbell, Ronna L.; Neuman, Mark, I; Capucilli, Peter S.; Pistiner, Michael; Castells, Mariana; Lee, Juhee; Brousseau, David C.; Schneider, Lynda C.; Assa'ad, Amal H.; Risma, Kimberly A.; Mistry, Rakesh D.; Campbell, Dianne E.; Worm, Margitta; Turner, Paul J.; Witry, John K.; Zhang, Yin; Sobolewski, Brad; Sampson, Hugh A.			Anaphylaxis knowledge gaps and future research priorities: A consensus report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; anaphylaxis; basic science; emergency department; feasibility; impact; population science; research; translational science	ACUTE ALLERGIC REACTIONS; SEVERITY GRADING SYSTEM; EUROPEAN ACADEMY; DIAGNOSIS; TRENDS; RISK; HOSPITALIZATIONS; IMMUNOTHERAPY; EPIDEMIOLOGY; VALIDATION	Background: Despite a better understanding of the epidemiology, pathogenesis, and management of patients with anaphylaxis, there remain knowledge gaps. Enumerating and prioritizing these gaps would allow limited scientific resources to be directed more effectively. Objective: We sought to systematically describe and appraise anaphylaxis knowledge gaps and future research priorities based on their potential impact and feasibility. Methods: We convened a 25-member multidisciplinary panel of anaphylaxis experts. Panelists formulated knowledge gaps/research priority statements in an anonymous electronic survey. Four anaphylaxis themed writing groups were formed to refine statements: (1) Population Science, (2) Basic and Translational Sciences, (3) Emergency Department Care/Acute Management, and (4) Long-Term Management Strategies and Prevention. Revised statements were incorporated into an anonymous electronic survey, and panelists were asked to rate the impact and feasibility of addressing statements on a continuous 0 to 100 scale. Results: The panel generated 98 statements across the 4 anaphylaxis themes: Population Science (29), Basic and Translational Sciences (27), Emergency Department Care/Acute Management (24), and Long-Term Management Strategies and Prevention (18). Median scores for impact and feasibility ranged from 50.0 to 95.0 and from 40.0 to 90.0, respectively. Key statements based on median rating for impact/feasibility included the need to refine anaphylaxis diagnostic criteria, identify reliable diagnostic, predictive, and prognostic anaphylaxis bioassays, develop clinical prediction models to standardize postanaphylaxis observation periods and hospitalization criteria, and determine immunotherapy best practices. Conclusions: We identified and systematically appraised anaphylaxis knowledge gaps and future research priorities. This study reinforces the need to harmonize scientific pursuits to optimize the outcomes of patients with and at risk of anaphylaxis. (J Allergy Clin Immunol 2022;149:999-1009.)	[Dribin, Timothy E.; Schnadower, David; Sobolewski, Brad] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Emergency Med, Cincinnati, OH USA; [Dribin, Timothy E.; Schnadower, David; Assa'ad, Amal H.; Zhang, Yin; Sobolewski, Brad] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH USA; [Wang, Julie; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Div Allergy & Immunol, New York, NY USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Emergency Med, Boston, MA USA; [Michelson, Kenneth A.; Neuman, Mark, I] Harvard Med Sch, Div Emergency Med, Dept Pediat, Boston Childrens Hosp, Boston, MA USA; [Michelson, Kenneth A.; Rudders, Susan A.; Neuman, Mark, I; Schneider, Lynda C.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Shaker, Marcus] Dartmouth Geisel Sch Med, Hanover, NH USA; [Shaker, Marcus] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Rudders, Susan A.; Schneider, Lynda C.] Harvard Med Sch, Div Immunol, Boston Childrens Hosp, Boston, MA USA; [Vyles, David; Brousseau, David C.] Med Coll Wisconsin, Dept Pediat, Sect Pediat Emergency Med, Milwaukee, WI USA; [Golden, David B. K.] Johns Hopkins Univ, Div Allergy & Clin Immunol, Sch Med, Baltimore, MD USA; [Spergel, Jonathan M.; Lee, Juhee; Risma, Kimberly A.] Univ Penn, Childrens Hosp Philadelphia, Div Allergy & Immunol, Perelman Sch Med, Philadelphia, PA USA; [Campbell, Ronna L.] Mayo Clin, Dept Emergency Med, Rochester, NY USA; [Capucilli, Peter S.] Rochester Reg Hlth, Rochester, NY USA; [Pistiner, Michael] Harvard Med Sch, Massachusetts Gen Hosp Children, Dept Pediat, Boston, MA USA; [Castells, Mariana] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Allergy & Clin Immunol, Boston, MA USA; [Assa'ad, Amal H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Allergy & Immunol, Cincinnati, OH USA; [Mistry, Rakesh D.] Childrens Hosp Colorado, Dept Pediat, Sect Emergency Med, Aurora, CO USA; [Campbell, Dianne E.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Campbell, Dianne E.] Childrens Hosp Westmead, Dept Allergy & Immunol, Sydney, NSW, Australia; [Worm, Margitta] Charite Univ Med Berlin, Dept Dermatol & Allergol, Div Allergy & Immunol, Berlin, Germany; [Turner, Paul J.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Witry, John K.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH USA; [Zhang, Yin] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Dartmouth College; Dartmouth College; Harvard University; Boston Children's Hospital; Harvard Medical School; Medical College of Wisconsin; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Children's Hospital Colorado; University of Sydney; University of Sydney; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dribin, TE (corresponding author), Cincinnati Childrens Hosp, 3244 Burnet Ave, Cincinnati, OH 45229 USA.	Timothy.Dribin@cchmc.org	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Campbell, Dianne/0000-0002-0907-6963; Dribin, Tim/0000-0002-7483-1750; Turner, Paul/0000-0001-9862-5161	Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [2UL1TR001425-05A1]; National Center for Advancing Transla-tional Sciences of the National Institutes of Health [2KL2TR001426-05A1]	Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); National Center for Advancing Transla-tional Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. The project described was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) (award no. 2UL1TR001425-05A1) . The content is solely the responsi-bility of the authors and does not necessarily represent the official views of the NIH. The project described was supported by the National Center for Advancing Transla-tional Sciences of the National Institutes of Health under (award no. 2KL2TR001426-05A1) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Arthur G, 2015, LANCET RESP MED, V3, P350, DOI 10.1016/S2213-2600(15)00087-9; Aun MV, 2014, J ALLER CL IMM-PRACT, V2, P414, DOI [10.1016/j.jaip.2014.03.014, 10.1016/j.jaip.2014.08.015]; Bilaver LA, 2019, ANN ALLERG ASTHMA IM, V122, P373, DOI 10.1016/j.anai.2019.01.014; Brauer CEL, 2016, J ALLER CL IMM-PRACT, V4, P1220, DOI 10.1016/j.jaip.2016.06.003; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Campbell RL, 2012, J ALLERGY CLIN IMMUN, V129, P748, DOI 10.1016/j.jaci.2011.09.030; Cardona V, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100472; Castells M, 2019, NEW ENGL J MED, V381, P2338, DOI 10.1056/NEJMra1807761; Castells M, 2017, J ALLERGY CLIN IMMUN, V140, P321, DOI 10.1016/j.jaci.2017.06.012; Chong KW, 2020, ANN ALLERG ASTHMA IM, V124, P473, DOI 10.1016/j.anai.2019.12.023; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Cianferoni A, 2021, J ALLERGY CLIN IMMUN, V147, P1123, DOI 10.1016/j.jaci.2021.02.012; Cianferoni A, 2012, IMMUNOL ALLERGY CLIN, V32, P165, DOI 10.1016/j.iac.2011.10.002; DeJonckheere M, 2019, J MIX METHOD RES, V13, P481, DOI 10.1177/1558689818778469; Dispenza MC, 2020, J CLIN INVEST, V130, P4759, DOI 10.1172/JCI138448; Dodd A, 2021, RESUSCITATION, V163, P86, DOI 10.1016/j.resuscitation.2021.04.010; Dribin TE, 2021, J ALLERGY CLIN IMMUN, V148, P173, DOI 10.1016/j.jaci.2021.01.003; Dribin TE, 2020, J ALLERGY CLIN IMMUN, V146, P1089, DOI 10.1016/j.jaci.2020.08.015; Dribin TE, 2020, J ALLER CL IMM-PRACT, V8, P1400, DOI 10.1016/j.jaip.2019.09.028; Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e20; Feehley T, 2019, NAT MED, V25, P448, DOI 10.1038/s41591-018-0324-z; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Francuzik W, 2021, J ALLERGY CLIN IMMUN, V147, P653, DOI 10.1016/j.jaci.2020.06.008; Goldberg MR, 2020, J ALLER CL IMM-PRACT, V8, P125, DOI 10.1016/j.jaip.2019.07.034; Golden DBK, 2004, NEW ENGL J MED, V351, P668, DOI 10.1056/NEJMoa022952; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Greenhawt M, 2020, ANN ALLERG ASTHMA IM, V125, P124, DOI 10.1016/j.anai.2020.05.029; Greenhawt M, 2019, J ALLER CL IMM-PRACT, V7, P1148, DOI 10.1016/j.jaip.2018.10.052; Griffith DM, 2020, ETHNIC DIS, V30, P129, DOI 10.18865/ed.30.S1.129; Grzeskowiak LE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56961-3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hemmings O, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0831-5; Hogan SP, 2021, J ALLERGY CLIN IMMUN, V148, P86, DOI 10.1016/j.jaci.2021.04.031; Huang YJ, 2017, J ALLERGY CLIN IMMUN, V139, P1099, DOI 10.1016/j.jaci.2017.02.007; Isabwe GAC, 2018, J ALLERGY CLIN IMMUN, V142, P159, DOI 10.1016/j.jaci.2018.02.018; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Luskin KT, 2021, J ALLER CL IMM-PRACT, V9, P2235, DOI 10.1016/j.jaip.2021.03.005; Lyons JJ, 2021, J ALLERGY CLIN IMMUN, V147, P622, DOI 10.1016/j.jaci.2020.06.035; Michelson KA, 2020, J ALLER CL IMM-PRACT, V8, P767, DOI 10.1016/j.jaip.2019.07.018; Michelson KA, 2016, ACAD EMERG MED, V23, P623, DOI 10.1111/acem.12922; Muraro A, 2017, ALLERGY, V72, P1006, DOI 10.1111/all.13132; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Pascal M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01584; Pistiner M, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.11.005; Pouessel G, 2018, CLIN EXP ALLERGY, V48, P1584, DOI 10.1111/cea.13287; Robinson LB, 2021, ANN ALLERG ASTHMA IM, V126, P168, DOI 10.1016/j.anai.2020.09.003; Ruiz-Garcia M, 2021, J ALLERGY CLIN IMMUN, V147, P633, DOI 10.1016/j.jaci.2020.06.033; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Schoonenboom J, 2017, KOLNER Z SOZIOL SOZ, V69, P107, DOI 10.1007/s11577-017-0454-1; Shaker M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13951; Shaker M, 2020, J ALLER CL IMM-PRACT, V8, P565, DOI 10.1016/j.jaip.2019.09.037; Shaker MS, 2020, J ALLER CL IMM-PRACT, V8, P2310, DOI 10.1016/j.jaip.2020.05.007; Shaker MS, 2020, J ALLERGY CLIN IMMUN, V145, P1082, DOI 10.1016/j.jaci.2020.01.017; Sloane D, 2016, J ALLER CL IMM-PRACT, V4, P497, DOI 10.1016/j.jaip.2015.12.019; Stafford A, 2021, J ALLERGY CLIN IMMUN, V148, P83, DOI 10.1016/j.jaci.2021.04.017; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; Tanno LK, 2020, ALLERGY, V75, P2206, DOI 10.1111/all.14468; Turner PJ, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.08.041; Turner PJ, 2020, J ALLER CL IMM-PRACT, V8, P1169, DOI 10.1016/j.jaip.2019.11.027; Turner PJ, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100066; Turner PJ, 2017, J ALLER CL IMM-PRACT, V5, P1169, DOI 10.1016/j.jaip.2017.06.031; Turner PJ, 2016, CURR OPIN ALLERGY CL, V16, P441, DOI 10.1097/ACI.0000000000000305; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V135, P956, DOI 10.1016/j.jaci.2014.10.021; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P1125, DOI 10.1016/j.jaip.2019.01.006; Wasserman RL, 2021, J ALLER CL IMM-PRACT, V9, P1826, DOI 10.1016/j.jaip.2021.02.046; Wood RA, 2014, J ALLERGY CLIN IMMUN, V133, P461, DOI 10.1016/j.jaci.2013.08.016	69	3	3	4	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					999	1009		10.1016/j.jaci.2021.07.035	http://dx.doi.org/10.1016/j.jaci.2021.07.035			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34390722	Green Submitted			2022-12-18	WOS:000765938100029
J	Lin, B; Goldbach-Mansky, R				Lin, Bin; Goldbach-Mansky, Raphaela			Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Interferonopathies; inflammasomopathies; Aicardi-Goutieres syndrome; STING; JAK inhibitor; interferon; inflamma-some; proteasome-associated autoinflammatory syndrome	AICARDI-GOUTIERES-SYNDROME; CYCLIC GMP-AMP; KERATOENDOTHELIITIS FUGAX HEREDITARIA; ENCODING MEVALONATE KINASE; ADENOSINE-DEAMINASE 2; INNATE IMMUNE SENSOR; I INTERFERON; INFLAMMATORY CASPASES; NALP3 INFLAMMASOME; MUTATION UNDERLIES	A number of systemic autoinflammatory diseases arise from gain-of-function mutations in genes encoding IL-1-activating inflammasomes or cytoplasmic nucleic acid sensors including the receptor and sensor STING and result in increased IL-1 and type I interferon production, respectively. Blocking these pathways in human diseases has provided proof-of-concept, confirming the prominent roles of these cytokines in disease pathogenesis. Recent insights into the multilayered regulation of these sensor pathways and insights into their role in amplifying the disease pathogenesis of monogenic and complex genetic diseases spurred new drug development targeting the sensors. This review provides insights into the pathogenesis and genetic causes of these "prototypic"diseases caused by gain-of function mutations in IL-1-activating inflammasomes (inflammasomopathies) and in interferon-activating pathways (interferonopathies) including STING-associated vasculopathy with onset in infancy, Aicardi-Goutieres syndrome, and proteasome-associated autoinflammatory syndromes that link activation of the viral sensors STING, "self"nucleic acid metabolism, and the ubiquitin-proteasome system to "type I interferon production"and human diseases. Clinical responses and biomarker changes to Janus kinase inhibitors confirm a role of interferons, and a growing number of diseases with "interferon signatures"unveil extensive cross-talk between major inflammatory pathways. Understanding these interactions promises new tools in tackling the significant clinical challenges in treating patients with these conditions. (J Allergy Clin Immunol 2022;149:819-32.)	[Lin, Bin; Goldbach-Mansky, Raphaela] NIAID, Translat Autoinflammatory Dis Sect, Lab Clin Immunol & Microbiol, NIH, 10 Ctr Dr, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lin, B (corresponding author), NIAID, Translat Autoinflammatory Dis Sect, Lab Clin Immunol & Microbiol, NIH, 10 Ctr Dr, Bethesda, MD 20814 USA.	bin.lin@nih.gov; goldbacr@mail.nih.gov	Lin, Bin/W-6461-2019	Lin, Bin/0000-0002-8032-937X	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States	This work is supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States.	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 1997, CELL, V90, P797; Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Akwa Y, 1998, J IMMUNOL, V161, P5016; Alehashemi S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01840; An J, 2017, ARTHRITIS RHEUMATOL, V69, P131, DOI 10.1002/art.39810; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Arimoto K, 2017, NAT STRUCT MOL BIOL, V24, P279, DOI 10.1038/nsmb.3378; Arora S, 2019, NAT BIOTECHNOL, V37, P139, DOI 10.1038/s41587-018-0007-9; Barry R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05321-2; Bernot A, 1997, NAT GENET, V17, P25; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Boyadzhiev M, 2019, PEDIATR RHEUMATOL, V17, DOI 10.1186/s12969-019-0322-9; Brault M, 2018, J IMMUNOL, V200, P2748, DOI 10.4049/jimmunol.1701492; Brehm A, 2015, J CLIN INVEST, V125, P4196, DOI 10.1172/JCI81260; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burian M, 2018, J INVEST DERMATOL, V138, P2507, DOI 10.1016/j.jid.2018.08.004; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Canna SW, 2015, SEMIN IMMUNOPATHOL, V37, P387, DOI 10.1007/s00281-015-0493-5; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Cetin G, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11010060; Christgen S, 2020, CELL RES, V30, P315, DOI 10.1038/s41422-020-0295-8; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; Davidson S, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0748-y; de Jesus AA, 2020, J CLIN INVEST, V130, P1669, DOI 10.1172/JCI129301; de Jesus AA, 2019, J ALLERGY CLIN IMMUN, V143, P1939, DOI 10.1016/j.jaci.2018.12.1012; Deng ZM, 2020, J EXP MED, V217, DOI 10.1084/jem.20201045; Deng ZM, 2020, J IMMUNOL, V204, P2360, DOI 10.4049/jimmunol.2000028; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Drutman SB, 2019, P NATL ACAD SCI USA, V116, P19055, DOI 10.1073/pnas.1906184116; Duncan CJA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7501; Durham GA, 2019, TRENDS PHARMACOL SCI, V40, P298, DOI 10.1016/j.tips.2019.03.001; Ebstein F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02756; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; ELLER MS, 1995, J CELL SCI, V108, P2741; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Fabre A, 2017, INTRACTABLE RARE DIS, V6, P152, DOI 10.5582/irdr.2017.01040; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Flemming A, 2019, NAT REV IMMUNOL, V19, P349, DOI 10.1038/s41577-019-0169-9; FLOYD K, 1982, J PHYSIOL-LONDON, V323, P65, DOI 10.1113/jphysiol.1982.sp014061; Fremond ML, 2016, J ALLERGY CLIN IMMUN, V138, P1752, DOI 10.1016/j.jaci.2016.07.015; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Girard-Guyonvarc'h C, 2018, BLOOD, V131, P1430, DOI 10.1182/blood-2017-06-789552; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Grandemange S, 2017, ANN RHEUM DIS, V76, P1191, DOI 10.1136/annrheumdis-2016-210021; Greiner-Tollersrud OK, 2020, ADA2 IS LYSOSOMAL DN, DOI [10.1101/2020.06.21.162990, DOI 10.1101/2020.06.21.162990, 10.1101/2020.06. 21.162990]; Gruber C, 2020, J EXP MED, V217, DOI 10.1084/jem.20192319; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Hadjadj J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18925-4; Harapas CR, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0750-4; Hartley JL, 2010, GASTROENTEROLOGY, V138, P2388, DOI 10.1053/j.gastro.2010.02.010; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; Hermann M, 2017, TRENDS IMMUNOL, V38, P79, DOI 10.1016/j.it.2016.11.001; Hiejima E, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008601; Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jang MA, 2015, AM J HUM GENET, V96, P266, DOI 10.1016/j.ajhg.2014.11.019; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato Y, 2018, ANN RHEUM DIS, V77, P1507, DOI 10.1136/annrheumdis-2018-212988; Keskitalo S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02770; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Konig N, 2017, ANN RHEUM DIS, V76, P468, DOI 10.1136/annrheumdis-2016-209841; Konno H, 2018, CELL REP, V23, P1112, DOI 10.1016/j.celrep.2018.03.115; Krei JM, 2021, CLIN EXP IMMUNOL, V203, P174, DOI 10.1111/cei.13543; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lamrini H, HETEROZYGOUS RELA MU; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Leavenworth JW, 2015, NAT IMMUNOL, V16, P96, DOI 10.1038/ni.3050; Lee AJ, 2017, J EXP MED, V214, P1153, DOI 10.1084/jem.20160880; Lee PY, 2020, J ALLERGY CLIN IMMUN, V146, P1194, DOI 10.1016/j.jaci.2020.07.033; Lee PY, 2020, J ALLERGY CLIN IMMUN, V145, P1664, DOI [10.1016/j.jaci.2019.12908, 10.1016/j.jaci.2019.12.908]; Lee-Kirsch MA, 2017, ANNU REV MED, V68, P297, DOI 10.1146/annurev-med-050715-104506; Lepelley A, 2020, J EXP MED, V217, DOI 10.1084/jem.20200600; Li Y, 2019, P NATL ACAD SCI USA, V116, P16479, DOI 10.1073/pnas.1901090116; Lin B, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.636225; Lin B, 2020, J ALLERGY CLIN IMMUN, V146, P1204, DOI 10.1016/j.jaci.2020.06.032; Lin FC, 2014, CYTOKINE GROWTH F R, V25, P369, DOI 10.1016/j.cytogfr.2014.07.015; Linossi EM, 2015, IMMUNOL REV, V266, P123, DOI 10.1111/imr.12305; Liu X, 2018, CELL, V174, P187, DOI 10.1016/j.cell.2018.04.017; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Luksch H, 2019, J ALLERGY CLIN IMMUN, V144, P254, DOI 10.1016/j.jaci.2019.01.044; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; Mamai O, 2015, J INVEST DERMATOL, V135, P304, DOI 10.1038/jid.2014.311; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; Maubach G, 2017, TRENDS MOL MED, V23, P1138, DOI 10.1016/j.molmed.2017.10.004; Melki I, 2017, J ALLERGY CLIN IMMUN, V140, P543, DOI 10.1016/j.jaci.2016.10.031; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Morgan NV, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-74; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Motwani M, 2019, P NATL ACAD SCI USA, V116, P7941, DOI 10.1073/pnas.1818281116; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakanishi H, 2017, P NATL ACAD SCI USA, V114, pE7766, DOI 10.1073/pnas.1702946114; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Park YH, 2020, NAT IMMUNOL, V21, P857, DOI 10.1038/s41590-020-0705-6; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Parry DA, 2016, J ALLERGY CLIN IMMUN, V137, P955, DOI 10.1016/j.jaci.2015.08.051; Pescatore A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.245; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Poli MC, 2018, AM J HUM GENET, V102, P1126, DOI 10.1016/j.ajhg.2018.04.010; Raffaele CGL, 2020, RHEUMATOLOGY, V59, P905, DOI 10.1093/rheumatology/kez444; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rice L, 2019, J CLIN IMMUNOL, V39, P249, DOI 10.1007/s10875-019-00618-3; Rittling SR, 2015, J DENT RES, V94, P1638, DOI 10.1177/0022034515605270; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; RUUSUVAARA P, 1987, ACTA OPHTHALMOL, V65, P159; Saldanha RG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01535; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Schnappauf O, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01745; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shen C, 2019, CURR OPIN STRUC BIOL, V58, P18, DOI 10.1016/j.sbi.2019.03.033; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Smahi A, 2000, NATURE, V405, P466; Soler VJ, 2013, J MED GENET, V50, P246, DOI 10.1136/jmedgenet-2012-101325; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Starokadomskyy P, 2016, NAT IMMUNOL, V17, P495, DOI 10.1038/ni.3409; Steiner A, 2020, ACTIVATION STING DUE, DOI [10.1101/2020.07.09.194399, DOI 10.1101/2020.07.09.194399]; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Turunen JA, 2018, AM J OPHTHALMOL, V188, P41, DOI 10.1016/j.ajo.2018.01.017; Uggenti C, 2020, NAT GENET, V52, P1364, DOI 10.1038/s41588-020-00737-3; Van Eyck L, 2014, NEW ENGL J MED, V371, P480, DOI 10.1056/NEJMc1405506; Van Eyck L, 2014, NEW ENGL J MED, V371, P478, DOI 10.1056/NEJMc1405506; van Montfrans J, 2014, NEW ENGL J MED, V371, P478, DOI 10.1056/NEJMc1405506; Van Montfrans JM, 2016, RHEUMATOLOGY, V55, P902, DOI 10.1093/rheumatology/kev439; Vanderver A, 2020, NEW ENGL J MED, V383, P986, DOI 10.1056/NEJMc2001362; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Volpi S, 2019, J CLIN IMMUNOL, V39, P476, DOI 10.1007/s10875-019-00645-0; Watkin LB, 2015, NAT GENET, V47, P654, DOI 10.1038/ng.3279; Weiss ES, 2018, BLOOD, V131, P1442, DOI 10.1182/blood-2017-12-820852; Wu JJ, 2020, IMMUNITY, V53, P115, DOI 10.1016/j.immuni.2020.06.009; Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yamashiro LH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17156-x; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhai Z, 2020, PHARM BASEL, V14, P23; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	191	3	3	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					819	832		10.1016/j.jaci.2021.10.027	http://dx.doi.org/10.1016/j.jaci.2021.10.027			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34893352				2022-12-18	WOS:000765938100004
J	Luo, YY; Vallone, VF; He, JJ; Frischbutter, S; Kolkhir, P; Monino-Romero, S; Stachelscheid, H; Streu-Haddad, V; Maurer, M; Siebenhaar, F; Scheffel, J				Luo, Yanyan; Vallone, Valeria Fernandez; He, Jiajun; Frischbutter, Stefan; Kolkhir, Pavel; Monino-Romero, Sherezade; Stachelscheid, Harald; Streu-Haddad, Viktoria; Maurer, Marcus; Siebenhaar, Frank; Scheffel, Joerg			A novel approach for studying mast cell-driven disorders: Mast cells derived from induced pluripotent stem cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cell; induced pluripotent stem cell; mast cell-driven disorder; disease-specific; patient-specific; urticaria; masto-cytosis; allergy testing; drug screening	DISEASE; TRYPTASE; CULTURE; LAD2	Background: Mast cells (MCs) are considered the main effectors in allergic reactions and well known for their contribution to the pathogenesis of various inflammatory diseases, urticaria, and mastocytosis. To study their functions in vitro, human primary MCs are isolated directly from several tissues or differentiated from hematopoietic progenitors. However, these techniques bear several disadvantages and challenges including low proliferation capacity, donor-dependent heterogeneity, and the lack of a continuous cell source. Objective: To address this, we developed a novel strategy for the rapid and efficient differentiation of MCs from human-induced pluripotent stem cells (hiPSCs). Methods: A 4-step protocol for the generation of hiPSC-derived MCs, based on the use of 3 hiPSC lines, was established and validated by comparison with human skin MCs and peripheral hematopoietic stem cell-derived MCs. Results: hiPSC-MCs share phenotypic and functional characteristics of human skin MCs and peripheral hematopoietic stem cell-derived MCs. They display stable expression of the MC-associated receptors CD117, Fc epsilon RI alpha, and Mas-related G protein-coupled receptor X2 and degranulate in response to IgE/anti-IgE and substance P. Conclusions: This novel hiPSC-based approach provides a sustainable and homogeneous source for a rapid and highly productive generation of phenotypically mature, functional MCs, and its principle allows for the investigation of disease-and patient-specific MC populations.	[Luo, Yanyan; He, Jiajun; Frischbutter, Stefan; Kolkhir, Pavel; Monino-Romero, Sherezade; Streu-Haddad, Viktoria; Maurer, Marcus; Siebenhaar, Frank; Scheffel, Joerg] Charite Univ Med Berlin, Dermatol Allergol, Allergie Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany; [Luo, Yanyan; He, Jiajun; Frischbutter, Stefan; Kolkhir, Pavel; Monino-Romero, Sherezade; Streu-Haddad, Viktoria; Maurer, Marcus; Siebenhaar, Frank; Scheffel, Joerg] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Luo, Yanyan; He, Jiajun; Frischbutter, Stefan; Kolkhir, Pavel; Monino-Romero, Sherezade; Streu-Haddad, Viktoria; Maurer, Marcus; Siebenhaar, Frank; Scheffel, Joerg] Berlin Inst Hlth, Berlin, Germany; [Vallone, Valeria Fernandez; Stachelscheid, Harald] Charite Univ Med Berlin, Charite BIH Ctr Therapy & Res, BIH Stem Cell Core Facil, Berlin, Germany; [He, Jiajun] Southwest Med Univ, Dept Dermatol, Affiliated Hosp, Luzhou, Peoples R China; [Kolkhir, Pavel] Sechenov Univ, Div Immune Med Skin Dis, IM Sechenov Moscow State Med Univ 1, Moscow, Russia; [Luo, Yanyan; He, Jiajun; Frischbutter, Stefan; Kolkhir, Pavel; Monino-Romero, Sherezade; Streu-Haddad, Viktoria; Maurer, Marcus; Siebenhaar, Frank; Scheffel, Joerg] Fraunhofer Inst Translat Med & Pharmacol ITMP, Allergol & Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Southwest Medical University; Sechenov First Moscow State Medical University	Maurer, M; Scheffel, J (corresponding author), Charite Univ Med Berlin, Dermatol Allergol, Dept Dermatol & Allergy, Charitepl 1, D-10117 Berlin, Germany.	yanyan.luo@charite.de	Frischbutter, Stefan/AAM-9487-2021; Maurer, Marcus/ABG-2174-2020; Fernandez Vallone, Valeria/A-8057-2017	Frischbutter, Stefan/0000-0003-3971-7343; Maurer, Marcus/0000-0002-4121-481X; Siebenhaar, Frank/0000-0003-4532-1644; Fernandez Vallone, Valeria/0000-0003-3875-9170; Stachelscheid, Harald/0000-0002-9283-4605	GA<SUP>2</SUP>LEN (Global Allergy and Asthma European Network)	GA<SUP>2</SUP>LEN (Global Allergy and Asthma European Network)	This work was funded by GA<SUP>2</SUP>LEN (Global Allergy and Asthma European Network).	Akin C, 2017, J ALLERGY CLIN IMMUN, V140, P349, DOI 10.1016/j.jaci.2017.06.007; Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Brockow K, 2014, IMMUNOL ALLERGY CLIN, V34, P283, DOI 10.1016/j.iac.2014.01.003; Calero-Nieto FJ, 2014, EMBO J, V33, P1212, DOI 10.1002/embj.201386825; Elitt MS, 2018, HUM MOL GENET, V27, pR89, DOI 10.1093/hmg/ddy186; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Guhl S, 2010, EXP DERMATOL, V19, P845, DOI 10.1111/j.1600-0625.2010.01103.x; Hamey FK, 2021, ALLERGY, V76, P1731, DOI 10.1111/all.14633; Holm M, 2008, J IMMUNOL METHODS, V336, P213, DOI 10.1016/j.jim.2008.04.019; Igarashi A, 2018, ALLERGOL INT, V67, P234, DOI 10.1016/j.alit.2017.08.008; Ikuno T, 2019, J TOXICOL SCI, V44, P789, DOI 10.2131/jts.44.789; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jong J, 2012, EXP MOL MED, V44, P202, DOI 10.3858/emm.2012.44.3.015; Kauts ML, 2018, STEM CELL REP, V11, P1009, DOI 10.1016/j.stemcr.2018.08.007; Kirshenbaum AS, 2014, INT ARCH ALLERGY IMM, V164, P265, DOI 10.1159/000365729; Kovarova M, 2010, BLOOD, V115, P3695, DOI 10.1182/blood-2009-08-237206; Kuhn H, 2021, J ALLERGY CLIN IMMUN, V147, P456, DOI 10.1016/j.jaci.2020.08.027; Laidlaw TM, 2011, J ALLERGY CLIN IMMUN, V127, P815, DOI 10.1016/j.jaci.2010.12.1101; Maaninka K, 2013, J ALLERGY CLIN IMMUN, V132, P463, DOI 10.1016/j.jaci.2013.02.011; MacArthur CC, 2019, CYTOTHERAPY, V21, pS13, DOI 10.1016/j.jcyt.2019.03.574; Metcalfe DD, 2017, ANNU REV PATHOL-MECH, V12, P487, DOI 10.1146/annurev-pathol-052016-100312; O'Shea O, 2020, STEM CELL RES, V45, DOI 10.1016/j.scr.2020.101773; Pardanani A, 2016, AM J HEMATOL, V91, P1147, DOI 10.1002/ajh.24553; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Ribatti D, 2018, INT ARCH ALLERGY IMM, V176, P55, DOI 10.1159/000487538; Schmetzer O, 2016, EUR J PHARMACOL, V778, P2, DOI 10.1016/j.ejphar.2015.07.016; Siebenhaar F, 2018, TRENDS IMMUNOL, V39, P151, DOI 10.1016/j.it.2017.10.005; Siiskonen H, 2020, METHODS MOL BIOL, V2154, P33, DOI 10.1007/978-1-0716-0648-3_4; Stellato C, 1996, J ALLERGY CLIN IMMUN, V97, P838, DOI 10.1016/S0091-6749(96)80162-X; Theoharides TC, 2015, NEW ENGL J MED, V373, P163, DOI 10.1056/NEJMra1409760; Vatine GD, 2019, CELL STEM CELL, V24, P995, DOI 10.1016/j.stem.2019.05.011; Vitte J, 2015, MOL IMMUNOL, V63, P18, DOI 10.1016/j.molimm.2014.04.001; Walasek MA, 2017, EXP HEMATOL, V53, pS59; Wang Z, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040341; WEIDNER N, 1991, J INVEST DERMATOL, V96, pS26, DOI 10.1111/1523-1747.ep12468966	36	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1060	+		10.1016/j.jaci.2021.07.027	http://dx.doi.org/10.1016/j.jaci.2021.07.027			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO6CI	34371081				2022-12-18	WOS:000765811400004
J	Penagos, M; Durham, SR				Penagos, Martin; Durham, Stephen R.			Allergen immunotherapy for long-term tolerance and prevention	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergen immunotherapy; long-term efficacy; tolerance; prevention; sublingual immunotherapy; subcutaneous immuno-therapy; allergic rhinitis; allergic asthma	GRASS-POLLEN IMMUNOTHERAPY; HOUSE-DUST MITE; DOUBLE-BLIND; SUBLINGUAL IMMUNOTHERAPY; EAACI GUIDELINES; CONTROLLED-TRIAL; DERMATOPHAGOIDES-PTERONYSSINUS; CLINICAL-EFFICACY; SLIT-TABLET; FOLLOW-UP	Allergen immunotherapy is effective for the treatment of allergic rhinitis, allergic asthma, and Hymenoptera venom allergy. In view of potential side effects, cost, and the necessary patient commitment, an important question is whether allergen immunotherapy provides persistent clinical benefits after treatment discontinuation. Here, we appraise the existing evidence for long-term effects of both subcutaneous and sublingual immunotherapy in terms of clinical efficacy, immune mechanisms, prevention of asthma development, and prevention of new allergen sensitizations. Evidence from large, randomized, double-blind, placebo-controlled clinical trials that include a follow-up phase after treatment cessation demonstrate long-term efficacy. The data strongly support recommendations in international guidelines that both sublingual and subcutaneous immunotherapy should be continued for a minimum of 3 years to achieve disease modification and longterm tolerance. Grass pollen immunotherapy for seasonal rhinitis may inhibit the onset of asthma symptoms and requirements for asthma medication. Whether early intervention in infancy with mite sublingual immunotherapy may prevent asthma remains to be tested.	[Penagos, Martin; Durham, Stephen R.] Imperial Coll London, Royal Brompton Hosp, Natl Heart & Lung Inst, Allergy & Clin Immunol,Div Resp Sci, London, England	Imperial College London; Royal Brompton Hospital	Durham, SR (corresponding author), Imperial Coll London, Dovehouse St, London SW3 6LY, England.	s.durham@imperial.ac.uk						Agache I, 2019, ALLERGY, V74, P855, DOI 10.1111/all.13749; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 1998, EUR J IMMUNOL, V28, P914, DOI 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C; Alviani C, 2020, J ALLERGY CLIN IMMUN, V145, P1711, DOI 10.1016/j.jaci.2020.01.048; Ariano R, 1999, ALLERGY, V54, P313, DOI 10.1034/j.1398-9995.1999.00900.x; Bergmann KC, 2014, J ALLERGY CLIN IMMUN, V133, P1608, DOI 10.1016/j.jaci.2013.11.012; Biedermann T, 2019, J ALLERGY CLIN IMMUN, V143, P1058, DOI 10.1016/j.jaci.2018.12.1001; Bilo MB, 2019, EUR ANN ALLERGY CLIN, V51, P244, DOI 10.23822/EurAnnACI.1764-1489.113; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Bonifazi F, 2005, ALLERGY, V60, P1459, DOI 10.1111/j.1398-9995.2005.00960.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Chinthrajah RS, 2019, LANCET, V394, P1437, DOI 10.1016/S0140-6736(19)31793-3; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Corren J, 2019, NAT IMMUNOL, V20, P1603, DOI 10.1038/s41590-019-0524-9; Corrigan CJ, 2005, ALLERGY, V60, P801, DOI 10.1111/j.1398-9995.2005.00790.x; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Demoly P, 2021, J ALLERGY CLIN IMMUN, V147, P1020, DOI 10.1016/j.jaci.2020.07.036; Demoly P, 2016, J ALLERGY CLIN IMMUN, V137, P444, DOI 10.1016/j.jaci.2015.06.036; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; Dhami S, 2017, ALLERGY, V72, P1825, DOI 10.1111/all.13208; Dhami S, 2017, ALLERGY, V72, P1597, DOI 10.1111/all.13201; Di Bona D, 2017, ALLERGY, V72, P691, DOI 10.1111/all.13104; Didier A, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0057-8; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; DuBuske LM, 2011, ALLERGY ASTHMA PROC, V32, P466, DOI 10.2500/108854111798840203; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Durham SR, 2016, J ALLERGY CLIN IMMUN, V137, P339, DOI 10.1016/j.jaci.2015.12.1298; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Francis JN, 2008, J ALLERGY CLIN IMMUN, V121, P1120, DOI 10.1016/j.jaci.2008.01.072; FRANKLAND AW, 1954, LANCET, V1, P1055; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Fritzsching B, 2021, LANCET REG HEALTH-EU, V13; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Global Initiative for Asthma, 2022, GLOB STRAT ASTHM MAN; Golden DBK, 2017, ANN ALLERG ASTHMA IM, V118, P28, DOI 10.1016/j.anai.2016.10.031; Golden DBK, 2005, J ALLERGY CLIN IMMUN, V115, P439, DOI 10.1016/j.jaci.2005.01.005; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Gunawardana NC, 2018, ANN ALLERG ASTHMA IM, V121, P293, DOI 10.1016/j.anai.2018.07.014; Halken S, 2017, PEDIAT ALLERG IMM-UK, V28, P728, DOI 10.1111/pai.12807; Hamid QA, 1997, J ALLERGY CLIN IMMUN, V99, P254, DOI 10.1016/S0091-6749(97)70106-4; HAUGAARD L, 1991, J ALLERGY CLIN IMMUN, V87, P699, DOI 10.1016/0091-6749(91)90391-Z; Hylander T, 2013, J ALLERGY CLIN IMMUN, V131, P412, DOI 10.1016/j.jaci.2012.10.056; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; JOHNSTONE DE, 1968, PEDIATRICS, V42, P793; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Kirtland ME, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.599083; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; LOWELL FC, 1965, NEW ENGL J MED, V273, P675, DOI 10.1056/NEJM196509232731302; Marogna M, 2008, ANN ALLERG ASTHMA IM, V101, P206, DOI 10.1016/S1081-1206(10)60211-6; Mosges R, 2018, ALLERGY, V73, P896, DOI 10.1111/all.13358; Mosges R, 2017, IMMUNOTHERAPY-UK, V9, P1225, DOI 10.2217/imt-2017-0058; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Muraro A, 2018, ALLERGY, V73, P739, DOI 10.1111/all.13420; Naclerio RM, 1997, J ALLERGY CLIN IMMUN, V100, P293, DOI 10.1016/S0091-6749(97)70240-9; Niederberger V, 2018, J ALLERGY CLIN IMMUN, V142, P497, DOI 10.1016/j.jaci.2017.09.052; Nolte H, 2020, J ALLER CL IMM-PRACT, V8, P2322, DOI 10.1016/j.jaip.2020.03.041; Noon L, 1911, LANCET, V1, P1572; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; O'Hehir RE, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0587-0; O'Hehir RE, 2009, AM J RESP CRIT CARE, V180, P936, DOI 10.1164/rccm.200905-0686OC; Orengo JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03636-8; Ott H, 2009, ALLERGY, V64, P1394, DOI [10.1111/j.1398-9995.2008.01875.x, 10.1111/j.1398-9995.2009.02194.x]; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Pajno GB, 2001, CLIN EXP ALLERGY, V31, P1392, DOI 10.1046/j.1365-2222.2001.01161.x; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Penagos M, 2019, CURR OPIN ALLERGY CL, V19, P594, DOI 10.1097/ACI.0000000000000585; Penagos Martin, 2018, Curr Treat Options Allergy, V5, P275, DOI 10.1007/s40521-018-0176-2; Pilette C, 2007, J IMMUNOL, V178, P4658, DOI 10.4049/jimmunol.178.7.4658; Renand A, 2018, J ALLERGY CLIN IMMUN, V141, P1750, DOI 10.1016/j.jaci.2017.09.041; Roberts G, 2006, J ALLERGY CLIN IMMUN, V117, P263, DOI 10.1016/j.jaci.2005.09.054; Roberts G, 2018, ALLERGY, V73, P765, DOI 10.1111/all.13317; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Senti G, 2009, J ALLERGY CLIN IMMUN, V124, P997, DOI 10.1016/j.jaci.2009.07.019; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; Shamji MH, 2017, ALLERGY, V72, P1156, DOI 10.1111/all.13138; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Shamji MH, 2021, J ALLERGY CLIN IMMUN, V148, P1061, DOI 10.1016/j.jaci.2021.03.030; Shamji MH, 2021, AM J RESP CRIT CARE, V204, P23, DOI 10.1164/rccm.202011-4107OC; Shamji MH, 2021, ALLERGY, V76, P3627, DOI 10.1111/all.14908; Shamji MH, 2021, J ALLER CL IMM-PRACT, V9, P1769, DOI 10.1016/j.jaip.2021.03.029; Shamji MH, 2018, J ALLERGY CLIN IMMUN, V141, P448, DOI 10.1016/j.jaci.2017.09.013; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Spertini F, 2016, J ALLERGY CLIN IMMUN, V138, P162, DOI 10.1016/j.jaci.2016.02.044; Sturm GJ, 2018, ALLERGY, V73, P744, DOI 10.1111/all.13262; Valovirta E, 2018, J ALLERGY CLIN IMMUN, V141, P529, DOI 10.1016/j.jaci.2017.06.014; VANDERHEIJDEN FL, 1993, J IMMUNOL, V150, P3643; Virchow JC, 2016, JAMA-J AM MED ASSOC, V315, P1715, DOI 10.1001/jama.2016.3964; Wahn U, 2012, J ALLERGY CLIN IMMUN, V130, P886, DOI 10.1016/j.jaci.2012.06.047; WARNER JO, 1978, LANCET, V2, P912; Yonekura S, 2021, J ALLER CL IMM-PRACT, V9, P4103, DOI 10.1016/j.jaip.2021.06.060; Zolkipli Z, 2015, J ALLERGY CLIN IMMUN, V136, P1541, DOI 10.1016/j.jaci.2015.04.045	96	3	3	3	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					802	811		10.1016/j.jaci.2022.01.007	http://dx.doi.org/10.1016/j.jaci.2022.01.007			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	35085663				2022-12-18	WOS:000765938100002
J	Tei, R; Iijima, K; Matsumoto, K; Kobayashi, T; Lama, J; Jacobsen, EA; Kita, H				Tei, Rinna; Iijima, Koji; Matsumoto, Koji; Kobayashi, Takao; Lama, Jyoti; Jacobsen, Elizabeth A.; Kita, Hirohito			TLR3-driven IFN-beta antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Group 2 innate lymphoid cell; lung; poly (I:C); IL-5; IL-7; IL-13; IL-33; TSLP; IFN-beta	TRANSCRIPTION FACTOR GATA3; LYMPHOID-CELLS; INTERFERON-BETA; RECEPTOR; ASTHMA; INFLAMMATION; INDUCTION; IMMUNITY; DISEASES; ALPHA	Background: Group 2 innate lymphoid cells (ILC2s) are involved in type 2 immune responses in mucosal organs and are associated with various allergic diseases in humans. Studies are needed to understand the molecules and pathways that control ILC2s. Objective: The aims of this study were to develop a mouse model that limits the innate type 2 immune response in the lung and to investigate the immunologic mechanisms involved in regulation of lung ILC2s. Methods: Naive BALB/c mice were administered various Toll like receptor agonists and exposed intranasally to the fungal allergen Alternaria alternata. The mechanisms were investigated using gene knockout mice as well as cultures of lung cells and isolated lung ILC2s. Results: Polyinosinic-polycytidylic acid, or poly (I:C), effectively inhibited innate type 2 response to A alternata. Poly (I:C) promoted production of IFN alpha, -beta, and -gamma, and its inhibitory effects were dependent on the IFN-alpha/beta receptor pathway. IFN-beta was 100 times more potent than IFN-alpha at inhibiting type 2 cytokine production by lung ILC2s. Signal transducer and activator of transcription 5 (STAT5)-activating cytokines, including IL-2, IL-7, and thymic stromal lymphopoietin, but not IL-33, promoted survival and proliferation of lung ILC2s in vitro, while IFN-beta blocked these effects. Expression of the transcription factor GATA3, which is critical for differentiation and maintenance of ILC2s, was inhibited by IFN-beta. Conclusions: IFN-beta blocks the effects of STAT5-activating cytokines on lung ILC2s and inhibits their survival and effector functions. Administration of IFN-beta may provide a new strategy to treat diseases involving ILC2s.	[Tei, Rinna; Iijima, Koji; Matsumoto, Koji; Kobayashi, Takao; Jacobsen, Elizabeth A.; Kita, Hirohito] Mayo Clin Arizona, Div Allergy Asthma & Clin Immunol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA; [Tei, Rinna; Iijima, Koji; Matsumoto, Koji; Kobayashi, Takao; Jacobsen, Elizabeth A.; Kita, Hirohito] Mayo Clin Arizona, Dept Med, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA; [Tei, Rinna] Dokkyo Med Univ, Dept Pulm Med & Clin Immunol, Mibu, Tochigi, Japan; [Lama, Jyoti] Mayo Grad Sch Biomed Sci, Immunol Program, Rochester, MN USA; [Lama, Jyoti] Mayo Grad Sch Biomed Sci, Immunol Program, Scottsdale, AZ USA; [Jacobsen, Elizabeth A.; Kita, Hirohito] Mayo Clin Rochester, Dept Immunol, Rochester, MN USA; [Jacobsen, Elizabeth A.; Kita, Hirohito] Mayo Clin Arizona, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Dokkyo Medical University; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Kita, H (corresponding author), Mayo Clin Arizona, Div Allergy Asthma & Clin Immunol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.; Kita, H (corresponding author), Mayo Clin Arizona, Dept Med, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	kita.hirohito@mayo.edu		Lama, Jyoti/0000-0001-8452-3594; Kita, Hirohito/0000-0002-6854-2936	National Institutes of Health [R37AI71106, R0HL117823]; Mayo Graduate School; Mayo Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation	This work was supported by grants from the National Institutes of Health (R37AI71106, R0HL117823), Mayo Graduate School, and Mayo Foundation.	Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Bartemes K, 2018, J IMMUNOL, V200, P229, DOI 10.4049/jimmunol.1602085; Bartemes KR, 2021, J ALLERGY CLIN IMMUN, V147, P1531, DOI 10.1016/j.jaci.2021.03.015; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Boonpiyathad T, 2019, SEMIN IMMUNOL, V46, DOI 10.1016/j.smim.2019.101333; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jakimovski D, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a032003; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kaur S, 2013, NAT IMMUNOL, V14, P884, DOI 10.1038/ni.2686; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Maazi H, 2018, J ALLERGY CLIN IMMUN, V141, P893, DOI 10.1016/j.jaci.2017.04.043; Markowitz CE, 2007, NEUROLOGY, V68, pS8, DOI 10.1212/01.wnl.0000277703.74115.d2; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7; Morita H, 2016, J ALLERGY CLIN IMMUN, V138, P1253, DOI 10.1016/j.jaci.2016.09.011; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reder AT, 2014, J INTERF CYTOK RES, V34, P589, DOI 10.1089/jir.2013.0158; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; She L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236744; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Szeles L, 2015, J IMMUNOL, V195, P1025, DOI 10.4049/jimmunol.1402033; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thio CLP, 2019, J ALLERGY CLIN IMMUN, V144, P682, DOI 10.1016/j.jaci.2019.03.008; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; van der Ploeg EK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd3489; Villarino AV, 2017, J EXP MED, V214, P2999, DOI 10.1084/jem.20150907; Wada K, 2013, INT ARCH ALLERGY IMM, V161, P75, DOI 10.1159/000350365; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208	53	3	3	3	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1044	+		10.1016/j.jaci.2021.07.041	http://dx.doi.org/10.1016/j.jaci.2021.07.041			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO6CI	34428519				2022-12-18	WOS:000765811400003
J	Berdyshev, E; Goleva, E; Bissonnette, R; Bronova, I; Bronoff, AS; Richers, B; Garcia, S; Gama, MR; Taylor, P; Bologna, G; Agueusop, I; Boguniewicz, M; Harel, S; Levit, N; Rossi, A; Zhang, A; Leung, D				Berdyshev, Evgeny; Goleva, Elena; Bissonnette, Robert; Bronova, Irina; Bronoff, Anna Sofia; Richers, Brittany; Garcia, Shannon; Gama, Marco Ramirez; Taylor, Patricia; Bologna, Gabriel; Agueusop, Inoncent; Boguniewicz, Mark; Harel, Sivan; Levit, Noah; Rossi, Ana; Zhang, Annie; Leung, Donald			Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									[Berdyshev, Evgeny; Goleva, Elena; Bronova, Irina; Bronoff, Anna Sofia; Richers, Brittany; Garcia, Shannon; Gama, Marco Ramirez; Taylor, Patricia; Boguniewicz, Mark; Leung, Donald] Natl Jewish Hlth, Denver, CO USA; [Bissonnette, Robert] Innovaderm Res Inc, Montreal, PQ, Canada; [Bologna, Gabriel; Agueusop, Inoncent; Rossi, Ana; Zhang, Annie] Sanofi Genzyme, Paris, France; [Harel, Sivan; Levit, Noah] Regeneron Pharmaceut Inc, Tarrytown, NY USA	National Jewish Health; Innovaderm Research Inc.; Regeneron									0	3	3	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2		S		029	AB10	AB10						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	0H8SE					2022-12-18	WOS:000778999300029
J	Chatchatee, P; Nowak-Wegrzyn, A; Lange, L; Benjaponpitak, S; Chong, KW; Sangsupawanich, P; van Ampting, MTJ; Nijhuis, MMO; Harthoorn, LF; Langford, JE; Knol, J; Knipping, K; Garssen, J; Trendelenburg, V; Pesek, R; Davis, CM; Muraro, A; Erlewyn-Lajeunesse, M; Fox, AT; Michaelis, LJ; Beyer, K				Chatchatee, Pantipa; Nowak-Wegrzyn, Anna; Lange, Lars; Benjaponpitak, Suwat; Chong, Kok Wee; Sangsupawanich, Pasuree; van Ampting, Marleen T. J.; Nijhuis, Manon M. Oude; Harthoorn, Lucien F.; Langford, Jane E.; Knol, Jan; Knipping, Karen; Garssen, Johan; Trendelenburg, Valerie; Pesek, Robert; Davis, Carla M.; Muraro, Antonella; Erlewyn-Lajeunesse, Mich; Fox, Adam T.; Michaelis, Louise J.; Beyer, Kirsten		PRESTO Study Team	Tolerance development in cow's milk-allergic infants receiving amino acid-based formula: A randomized controlled trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cow's milk allergy; prebiotics; probiotics; amino acid-based formula; oral tolerance; infection; synbiotics	LIFE GUT MICROBIOME; NATURAL-HISTORY; FOOD ALLERGY; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; GROWTH; IGE	Background: Tolerance development is an important clinical outcome for infants with cow's milk allergy. Objective: This multicenter, prospective, randomized, double-blind, controlled clinical study (NTR3725) evaluated tolerance development to cow's milk (CM) and safety of an amino acid- based formula (AAF) including synbiotics (AAF-S) comprising prebiotic oligosaccharides (oligofructose, inulin) and probiotic Bifidobacterium breve M-16V in infants with confirmed IgE-mediated CM allergy. Methods: Subjects aged <= 13 months with IgE-mediated CM allergy were randomized to receive AAF-S (n = 80) or AAF (n = 89) for 12 months. Stratification was based on CM skin prick test wheal size and study site. After 12 and 24 months, CM tolerance was evaluated by double-blind, placebo-controlled food challenge. A logistic regression model used the all-subjects randomized data set. Results: At baseline, mean +/- SD age was 9.36 +/- 2.53 months. At 12 and 24 months, respectively, 49% and 62% of subjects were CM tolerant (AAF-S 45% and 64%; AAF 52% and 59%), and not differ significantly between groups. During the 12-month intervention, the number of subjects reporting at least 1 adverse event did not significantly differ between groups; however, fewer subjects required hospitalization due to serious adverse events categorized as infections in the AAF-S versus AAF group (9% vs 20%; P = .036). Conclusions: After 12 and 24 months, CM tolerance was not different between groups and was in line with natural outgrowth. Results suggest that during the intervention, fewer subjects receiving AAF-S required hospitalization due to infections.	[Chatchatee, Pantipa] Chulalongkorn Univ, Pediat Allergy & Clin Immunol Res Unit, Div Allergy & Immunol, Dept Pediat,Fac Med,King Chulalongkorn Mem Hosp,T, Bangkok, Thailand; [Nowak-Wegrzyn, Anna] New York Univ Langone Hlth, Dept Pediat, Allergy & Immunol, New York, NY USA; [Nowak-Wegrzyn, Anna] Univ Warmia & Mazury, Coll Med, Dept Pediat Gastroenterol & Nutr, Olsztyn, Poland; [Lange, Lars] St Marien Hosp, Bonn, Germany; [Benjaponpitak, Suwat] Mahidol Univ, Ramathibodi Hosp, Dept Pediat, Pediat Allergy & Immunol Div,Fac Med, Bangkok, Thailand; [Chong, Kok Wee] KK Womens & Childrens Hosp, Allergy Serv, Dept Paediat Med, Singapore, Singapore; [Sangsupawanich, Pasuree] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Thailand; [van Ampting, Marleen T. J.; Nijhuis, Manon M. Oude; Harthoorn, Lucien F.; Langford, Jane E.; Knol, Jan; Knipping, Karen; Garssen, Johan] Danone Nutr Res, Uppsalalaan 12, NL-3584 CT Utrecht, Netherlands; [Knol, Jan] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands; [Garssen, Johan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Trendelenburg, Valerie; Beyer, Kirsten] Charite Univ Med Berlin, Dept Pediat Pneumol Immunol & Intens Care Med, Berlin, Germany; [Pesek, Robert] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Davis, Carla M.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Muraro, Antonella] Padua Univ Hosp, Food Allergy Referral Ctr, Padua, Italy; [Erlewyn-Lajeunesse, Mich] Univ Hosp Southampton, Southampton, Hants, England; [Fox, Adam T.] Guys & St Thomas NHS Fdn Trust, London, England; [Michaelis, Louise J.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England	Chulalongkorn University; New York University; University of Warmia & Mazury; St. Marien Hospital; Mahidol University; KK Women's & Children's Hospital; Prince of Songkla University; Danone Nutricia; Wageningen University & Research; Utrecht University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Arkansas Children's Hospital; Baylor College of Medicine; University of Padua; Azienda Ospedaliera - Universita di Padova; Guy's & St Thomas' NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust	van Ampting, MTJ (corresponding author), Danone Nutr Res, Uppsalalaan 12, NL-3584 CT Utrecht, Netherlands.	marleen.vanampting@nutricia.com	Knol, Jan/A-2178-2010	Knol, Jan/0000-0002-2103-5961; van Ampting, Marleen/0000-0001-5545-9060; Nowak-Wegrzyn, Anna/0000-0002-0960-9854	Danone Nutricia Research, Utrecht, The Netherlands	Danone Nutricia Research, Utrecht, The Netherlands(Danone Nutricia)	This study was funded by Danone Nutricia Research, Utrecht, The Netherlands.	Ahrens B, 2012, CLIN EXP ALLERGY, V42, P1630, DOI 10.1111/cea.12001; Alves-Correia M, 2019, ALLERGOL IMMUNOPATH, V47, P133, DOI 10.1016/j.aller.2018.07.007; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Babaie D, 2017, IRAN J ALLERGY ASTHM, V16, P45; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V138, P1122, DOI 10.1016/j.jaci.2016.03.041; Burks AW, 2015, PEDIAT ALLERG IMM-UK, V26, P316, DOI 10.1111/pai.12390; Canani RB, 2017, J ALLERGY CLIN IMMUN, V139, P1906, DOI 10.1016/j.jaci.2016.10.050; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Canani RB, 2013, J PEDIATR-US, V163, P771, DOI 10.1016/j.jpeds.2013.03.008; Candy DCA, 2018, PEDIATR RES, V83, P677, DOI 10.1038/pr.2017.270; Caubet JC, 2017, ALLERGY, V72, P1677, DOI 10.1111/all.13167; D'Auria E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061399; Doherty AM, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00091; Dong P, 2018, SAUDI J BIOL SCI, V25, P875, DOI 10.1016/j.sjbs.2017.11.051; Flom JD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051051; Fox A, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100034; Fox AT, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0241-3; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Harvey BM, 2014, PEDIATR RES, V75, P343, DOI 10.1038/pr.2013.211; Hill DJ, 2007, CLIN EXP ALLERGY, V37, P808, DOI 10.1111/j.1365-2222.2007.02724.x; Host A, 2014, ENDOCR METAB IMMUNE, V14, P2, DOI 10.2174/1871530314666140121142900; Koletzko S, 2012, J PEDIATR GASTR NUTR, V55, P221, DOI 10.1097/MPG.0b013e31825c9482; Mota I, 2018, ASIA PAC ALLERGY, V8, DOI 10.5415/apallergy.2018.8.e28; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Sampson HA, 2019, J ALLERGY CLIN IMMUN, V143, P486, DOI 10.1016/j.jaci.2018.12.989; Sardecka-Milewska I, 2020, J INVEST ALLERG CLIN, V30, P182, DOI 10.18176/jiaci.0422; Savage J, 2015, IMMUNOL ALLERGY CLIN, V35, P45, DOI 10.1016/j.iac.2014.09.004; Schoemaker AA, 2015, ALLERGY, V70, P963, DOI 10.1111/all.12630; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Spergel JM, 2013, J ALLERGY CLIN IMMUN, V131, P813, DOI 10.1016/j.jaci.2013.01.027; Stewart CJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0295-1; Takahashi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16730-6; van Esch BCAM, 2016, IMMUN INFLAMM DIS, V4, P155, DOI 10.1002/iid3.101; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Vissing NH, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0933; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P1103, DOI 10.1016/j.jaci.2015.10.005; Wood RA, 2013, J ALLERGY CLIN IMMUN, V131, P805, DOI 10.1016/j.jaci.2012.10.060; Wopereis H, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0267-6; Xinias I, 2019, ANN ALLERG ASTHMA IM, V123, P304, DOI 10.1016/j.anai.2019.06.024; Zhao W, 2019, ANN ALLERG ASTHMA IM, V122, P276, DOI 10.1016/j.anai.2018.12.012	41	3	3	4	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					650	+		10.1016/j.jaci.2021.06.025	http://dx.doi.org/10.1016/j.jaci.2021.06.025			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34224785	Green Published			2022-12-18	WOS:000752623200023
J	Custovic, A; Siddiqui, S; Saglani, S				Custovic, Adnan; Siddiqui, Salman; Saglani, Sejal			Considering biomarkers in asthma disease severity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe asthma; T2 asthma; eosinophils; FENO; allergic sensitization; immune responses; microbial dysbiosis	DOUBLE-BLIND; PERSISTENT ASTHMA; CHILDHOOD ASTHMA; RISK; SENSITIZATION; CHILDREN; THERAPY; MANAGEMENT; BIOLOGICS; INSIGHTS	Among patients with asthma, reliance on the type/dose of prescribed medication and symptom control does not adequately capture those at risk of adverse outcomes, and we need biomarkers for risk and treatment stratification that are consistently accurate, readily quantifiable, and reproducible. Most patients with severe asthma, regardless of age, have predominant type-2 inflammation-mediated disease, making airway/blood eosinophils, fractional exhaled nitric oxide, periostin, and/or allergic sensitization potentially important biomarkers for severe disease. In both adult and pediatric asthma, there is scope to improve prediction of severe attacks by using a composite type-2 biomarker of blood eosinophils and fractional exhaled nitric oxide. Technological advances in component-resolved diagnostics microarray technologies coupled with the development of interpretation software offer a possibility to use component-resolved diagnostics as biomarkers of asthma severity among sensitized patients with asthma. Genetic predisposition and polygenic risk scores of relevant traits (eg, lung function, host immune responses, biomarkers of exposure from the indoor and outdoor environment, infection, and microbial dysbiosis) may also contribute to prediction algorithms. We challenge the idea that asthma can be accurately defined in an individual patient by a discrete and static "endotype" (eg, type-2-high asthma). As we traverse the new era of molecular endotyping in asthma, we need to understand how relevant mechanisms impact patient outcomes, and in parallel develop new tools and approaches to stratify therapies and define individual patient trajectories.	[Custovic, Adnan; Saglani, Sejal] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Siddiqui, Salman] Univ Leicester, Dept Resp Sci, Leicester, Leics, England; [Siddiqui, Salman] Glenfield Hosp, NIHR Resp Biomed Res Unit, Leicester, Leics, England	Imperial College London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Custovic, A (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	a.custovic@imperial.ac.uk						Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; [Anonymous], 2014, WHY ASTHMA STILL KIL; Belgrave DCM, 2018, LANCET RESP MED, V6, P526, DOI 10.1016/S2213-2600(18)30099-7; Belgrave DCM, 2013, J ALLERGY CLIN IMMUN, V132, P575, DOI 10.1016/j.jaci.2013.05.041; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bossley CJ, 2016, J ALLERGY CLIN IMMUN, V138, P413, DOI 10.1016/j.jaci.2015.12.1347; Bush A, 2008, LANCET, V372, P1019, DOI 10.1016/S0140-6736(08)61422-1; Bush A, 2017, LANCET RESP MED, V5, P844, DOI 10.1016/S2213-2600(17)30379-X; Bush A, 2010, LANCET, V376, P814, DOI 10.1016/S0140-6736(10)61054-9; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Corbin LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03109-y; Couillard S, 2022, THORAX, V77, P199, DOI [10.1136/thoraxjnl-2021-217325, 10.1136/thorax-2021-BTSabstracts.8]; Custovic A, 2020, EXPERT REV CLIN IMMU, V16, P873, DOI 10.1080/1744666X.2020.1816825; Custovic A, 2018, AM J RESP CRIT CARE, V197, P1265, DOI 10.1164/rccm.201708-1762OC; Custovic A, 2015, THORAX, V70, P799, DOI 10.1136/thoraxjnl-2015-206781; Deliu M, 2018, CLIN EXP ALLERGY, V48, P39, DOI 10.1111/cea.13014; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Edwards MR, 2013, MUCOSAL IMMUNOL, V6, P797, DOI 10.1038/mi.2012.118; Fitzpatrick AM, 2016, J ALLERGY CLIN IMMUN, V138, P1608, DOI 10.1016/j.jaci.2016.09.028; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Fleming L, 2016, J ALLERGY CLIN IMMUN, V138, P292, DOI 10.1016/j.jaci.2015.12.1317; Fontanella S, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002691; Fricker M, 2022, ALLERGY, V77, P1204, DOI 10.1111/all.15087; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Heaney LG, 2021, CHEST, V160, P814, DOI 10.1016/j.chest.2021.04.013; Heaney LG, 2021, LANCET RESP MED, V9, P57, DOI 10.1016/S2213-2600(20)30397-0; Hill DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087681; Holguin F, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00588-2019; Holt PG, 2016, J ALLERGY CLIN IMMUN, V137, P379, DOI 10.1016/j.jaci.2015.08.044; Howard R, 2018, J ALLERGY CLIN IMMUN, V142, P1322, DOI 10.1016/j.jaci.2017.11.064; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Jackson DJ, 2020, DRUG SAFETY, V43, P409, DOI 10.1007/s40264-020-00926-3; Jochmann A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00910-2017; Koo S, 2016, CHEST, V149, P98, DOI 10.1378/chest.14-3241; Kraft M, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00413-2021; Krings JG, 2019, J ALLER CL IMM-PRACT, V7, P1379, DOI 10.1016/j.jaip.2019.03.008; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Ledford D, 2017, J ALLERGY CLIN IMMUN, V140, P162, DOI 10.1016/j.jaci.2016.08.054; Levy ML, 2015, THORAX, V70, P209, DOI 10.1136/thoraxjnl-2015-206800; Lipworth BJ, 2021, J ALLER CL IMM-PRACT, V9, P4235, DOI 10.1016/j.jaip.2021.07.023; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Marinho S, 2007, ALLERGY, V62, P385, DOI 10.1111/j.1398-9995.2006.01294.x; Marinho Susana, 2011, Clin Transl Allergy, V1, P16, DOI 10.1186/2045-7022-1-16; McDonald VM, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02191-2017; Moll M, 2020, LANCET RESP MED, V8, P696, DOI 10.1016/S2213-2600(20)30101-6; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Muthu V, 2018, CLIN EXP ALLERGY, V48, P1107, DOI 10.1111/cea.13216; Niespodziana K, 2020, J ALLERGY CLIN IMMUN, V145, P1529, DOI 10.1016/j.jaci.2020.02.001; O'Byrne PM, 2016, LANCET RESP MED, V4, P797, DOI 10.1016/S2213-2600(16)30227-2; O'Hehir RE, 2018, AM J RESP CRIT CARE, V198, P126, DOI 10.1164/rccm.201711-2337LE; Oksel C, 2018, CURR OPIN ALLERGY CL, V18, P109, DOI 10.1097/ACI.0000000000000430; Osman LM, 2002, THORAX, V57, P190, DOI 10.1136/thorax.57.3.190; Patel DF, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0693; Paterson CA, 2021, ENVIRON RES, V202, DOI 10.1016/j.envres.2021.111631; Porsbjerg CM, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00260-2020; Price DB, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0282-7; Roberts G, 2016, ALLERGY, V71, P1540, DOI 10.1111/all.12939; Roberts G, 2020, J ALLERGY CLIN IMMUN, V146, P821, DOI 10.1016/j.jaci.2020.02.031; Robinson PFM, 2021, AM J RESP CRIT CARE, V204, P523, DOI 10.1164/rccm.202009-3696OC; Ross KR, 2020, J ALLERGY CLIN IMMUN, V145, P140, DOI 10.1016/j.jaci.2019.09.030; Shah SP, 2019, J ALLER CL IMM-PRACT, V7, P2624, DOI 10.1016/j.jaip.2019.04.043; Sharples J, 2012, EUR RESPIR J, V40, P264, DOI 10.1183/09031936.00209511; Shrine N, 2019, LANCET RESP MED, V7, P20, DOI 10.1016/S2213-2600(18)30389-8; Simpson A, 2005, J ALLERGY CLIN IMMUN, V116, P744, DOI 10.1016/j.jaci.2005.06.032; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Thien F, 2018, RESPIROLOGY, V23, P976, DOI 10.1111/resp.13410; Thien F, 2018, LANCET PLANET HEALTH, V2, pE255, DOI 10.1016/s2542-5196(18)30120-7; Tran TN, 2021, J ASTHMA ALLERGY, V14, P727, DOI 10.2147/JAA.S306416; von Bulow A, 2018, RESP MED, V145, P41, DOI 10.1016/j.rmed.2018.10.020; Wardlaw AJ, 2021, J ASTHMA ALLERGY, V14, P557, DOI 10.2147/JAA.S251709; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Zheng XY, 2021, ENVIRON INT, V150, DOI 10.1016/j.envint.2021.106435	75	3	3	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					480	487		10.1016/j.jaci.2021.11.021	http://dx.doi.org/10.1016/j.jaci.2021.11.021			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34942235				2022-12-18	WOS:000752623200003
J	Murangi, T; Prakash, P; Moreira, BP; Basera, W; Botha, M; Cunningham, S; Facey-Thomas, H; Halajian, A; Joshi, L; Ramjith, J; Falcone, FH; Horsnell, W; Levin, ME				Murangi, Tatenda; Prakash, Prema; Moreira, Bernardo Pereira; Basera, Wisdom; Botha, Maresa; Cunningham, Stephen; Facey-Thomas, Heidi; Halajian, Ali; Joshi, Lokesh; Ramjith, Jordache; Falcone, Franco H.; Horsnell, William; Levin, Michael E.			Ascaris lumbricoides and ticks associated with sensitization to galactose alpha 1,3-galactose and elicitation of the alpha-gal syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Alpha-gal; food allergy; galactose-alpha-1,3-galactose; helminths; meat allergy; red meat allergy; ticks; Ascaris lumbricoides; anaphylaxis; Rhipicephalus evertsi; Amblyomma hebraeum	RED MEAT ALLERGY; IGE ANTIBODIES; ANAPHYLAXIS; CONVENIENT; EPITOPE; BITES	Background: IgE to galactose alpha-1,3 galactose (alpha-gal) causes alpha-gal syndrome (delayed anaphylaxis after ingestion of mammalian meat). Development of sensitization has been attributed to tick bites; however, the possible role of other parasites has not been well studied. Objective: Our aims were to assess the presence, relative abundances, and site of localization of alpha-gal-containing proteins in common ectoparasites and endoparasites endemic in an area of high prevalence of alpha-gal syndrome, as well as to investigate the ability of ascaris antigens to elicit a reaction in a humanized rat basophil in vitro sensitization model. Methods: Levels of total IgE, Ascaris-specific IgE, and alpha-gal IgE were measured in sera from patients with challenge-proven alpha-gal syndrome and from controls without allergy. The presence, concentration, and localization of alpha-gal in parasites were assessed by ELISA, Western blotting, and immunohistochemistry. The ability of Ascaris lumbricoides antigen to elicit IgE-dependent reactivity was demonstrated by using the RS-ATL8 basophil reporter system. Results: Alpha-gal IgE level correlated with A lumbricoides-specific IgE level. Alpha-gal protein at 70 to 130 kDa was detected in A lumbricoides at concentrations higher than those found in Rhipicephalus evertsi and Amblyomma hebraeum ticks. Immunohistochemistry was used to localize alpha-gal in tick salivary acini and the helminth gut. Non-alpha-gal-containing A lumbricoides antigens activated RS-ATL8 basophils primed with serum from subjects with alpha-gal syndrome. Conclusion: We demonstrated the presence, relative abundances, and site of localization of alpha-gal-containing proteins in parasites. The activation of RS-ATL8 IgE reporter cells primed with serum from subjects with alpha-gal syndrome on exposure to non-alpha-gal-containing A lumbricoides proteins indicates a possible role of exposure to A lumbricoides in alpha-gal sensitization and clinical reactivity.	[Murangi, Tatenda; Horsnell, William] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Inst Infect Dis & Mol Med, Dept Pathol,Div Immunol, Cape Town, South Africa; [Prakash, Prema; Moreira, Bernardo Pereira; Falcone, Franco H.] Justus Liebig Univ Giessen, Biomed Res Ctr Seltersberg, Inst Parasitol, Giessen, Germany; [Basera, Wisdom] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Basera, Wisdom] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa; [Botha, Maresa; Facey-Thomas, Heidi; Levin, Michael E.] Univ Cape Town, Dept Paediat, Div Paediat Allergy, Cape Town, South Africa; [Cunningham, Stephen; Joshi, Lokesh] Natl Univ Ireland Galway, Biomed Sci, Glycosci Grp, Galway, Ireland; [Halajian, Ali] Univ Limpopo, Res Adm & Dev, Sovenga, South Africa; [Ramjith, Jordache] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Hlth Evidence, Biostat Res Grp,Med Ctr, Nijmegen, Netherlands; [Horsnell, William] Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Cape Town; Justus Liebig University Giessen; University of Cape Town; South African Medical Research Council; University of Cape Town; Ollscoil na Gaillimhe-University of Galway; University of Limpopo; Radboud University Nijmegen; University of Birmingham	Levin, ME (corresponding author), Red Cross Childrens Hosp, Room 516,ICH Bldg,Klipfontein Rd, Cape Town, South Africa.	Michael.levin@uct.ac.za	Ramjith, Jordache/N-7307-2018; Ramjith, Jordache/AAB-7339-2019	Ramjith, Jordache/0000-0003-4431-7395; Ramjith, Jordache/0000-0003-4431-7395	Birmingham-Nottingham Strategic Collaboration Fund; LOEWE Centre DRUID within the Hessian Excellence Initiative; National Research Foundation Innovation MD Scholarship	Birmingham-Nottingham Strategic Collaboration Fund; LOEWE Centre DRUID within the Hessian Excellence Initiative; National Research Foundation Innovation MD Scholarship	Supported by the Birmingham-Nottingham Strategic Collaboration Fund (to W.G.C.H. and F.H.F.); the LOEWE Centre DRUID within the Hessian Excellence Initiative (P.P., B.P.M., and F.H.F.), and a National Research Foundation Innovation M&D Scholarship (to T.M.).	Acevedo N, 2011, INT ARCH ALLERGY IMM, V154, P195, DOI 10.1159/000321106; Apostolovic D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05355-4; Apostolovic D, 2020, ALLERGY, V75, P217, DOI 10.1111/all.13978; Apostolovic D, 2016, ALLERGO J, V25, P29, DOI 10.1007/s15007-016-1044-7; Arkestal K, 2011, J ALLERGY CLIN IMMUN, V127, P1024, DOI 10.1016/j.jaci.2011.01.033; Benede S, 2016, EBIOMEDICINE, V7, P27, DOI 10.1016/j.ebiom.2016.04.012; Cabezas-Cruz A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32664-z; Chinuki Y, 2016, ALLERGY, V71, P421, DOI 10.1111/all.12804; Commins SP, 2014, J ALLERGY CLIN IMMUN, V134, P108, DOI 10.1016/j.jaci.2014.01.024; Commins SP, 2013, CURR ALLERGY ASTHM R, V13, P72, DOI 10.1007/s11882-012-0315-y; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Crispell G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01056; Cross JH, 1996, ENTERIC NEMATODES HU; Cunningham S, 2013, ANAL CHEM, V85, P949, DOI 10.1021/ac302587q; Duffy MS, 2006, GLYCOBIOLOGY, V16, P854, DOI 10.1093/glycob/cwl001; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fernandez-Soto P, 2001, ANN TROP MED PARASIT, V95, P97, DOI 10.1080/00034980020035960; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Hamsten C, 2013, ALLERGY, V68, P549, DOI 10.1111/all.12128; Hamsten C, 2013, J ALLERGY CLIN IMMUN, V132, P1431, DOI 10.1016/j.jaci.2013.07.050; Horak IG, 2018, IXODID TICKS ACARI I, DOI DOI 10.1007/978-3-319-70642-9; Iweala OI, 2020, J ALLERGY CLIN IMMUN, V146, P450, DOI 10.1016/j.jaci.2020.02.006; Khoo KH, 1997, MOL BIOCHEM PARASIT, V86, P237, DOI 10.1016/S0166-6851(97)00036-4; Kirkeby S, 2001, IMMUNOL CELL BIOL, V79, P121, DOI 10.1046/j.1440-1711.2001.00992.x; Koike C, 2007, P NATL ACAD SCI USA, V104, P559, DOI 10.1073/pnas.0610012104; Levin M, 2019, ANN ALLERG ASTHMA IM, V122, P598, DOI 10.1016/j.anai.2019.03.021; Lochnit G, 1997, GLYCOCONJUGATE J, V14, P389, DOI 10.1023/A:1018530914067; Mabelane T, 2018, PEDIAT ALLERG IMM-UK, V29, P841, DOI 10.1111/pai.12969; McSharry C, 1999, INFECT IMMUN, V67, P484, DOI 10.1128/IAI.67.2.484-489.1999; Morisset M, 2012, ALLERGY, V67, P609, DOI 10.1111/j.1398-9995.2012.02799.x; Nakamura R, 2010, ALLERGY, V65, P1266, DOI 10.1111/j.1398-9995.2010.02363.x; Okano M, 1999, J IMMUNOL, V163, P6712; Roman-Carrasco P, 2019, ALLERGY, V74, P1956, DOI 10.1111/all.13873; Steinke JW, 2015, J ALLERGY CLIN IMMUN, V135, P589, DOI 10.1016/j.jaci.2014.12.1947; Van Nunen SA, 2009, MED J AUSTRALIA, V190, P510, DOI 10.5694/j.1326-5377.2009.tb02533.x; van Stijn CMW, 2010, INT J PARASITOL, V40, P215, DOI 10.1016/j.ijpara.2009.07.009; Wan D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003124	38	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					698	+		10.1016/j.jaci.2021.07.018	http://dx.doi.org/10.1016/j.jaci.2021.07.018			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA		Green Submitted			2022-12-18	WOS:000752623200027
J	Ramos, SA; Morton, JJ; Yadav, P; Reed, B; Alizadeh, SI; Shilleh, AH; Perrenoud, L; Jaggers, J; Kappler, J; Jimeno, A; Russ, HA				Ramos, Stephan A.; Morton, John J.; Yadav, Prabha; Reed, Brendan; Alizadeh, Sheila, I; Shilleh, Ali H.; Perrenoud, Loni; Jaggers, James; Kappler, John; Jimeno, Antonio; Russ, Holger A.			Generation of functional human thymic cells from induced pluripotent stem cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Human neonatal thymus; patient derived induced pluripotent stem cells; direct differentiation; thymic epithelial progenitors; thymic epithelial cells; single-cell RNA sequencing	MATURATION; MOUSE; DIFFERENTIATION; ORGANOGENESIS; THYMOCYTES; MICE	Background: The thymus is a glandular organ that is essential for the formation of the adaptive immune system by educating developing T cells. The thymus is most active during childhood and involutes around the time of adolescence, resulting in a severe reduction or absence of naive T-cell output. The ability to generate a patient-derived human thymus would provide an attractive research platform and enable the development of novel cell therapies. Objectives: This study sought to systematically evaluate signaling pathways to develop a refined direct differentiation protocol that generates patient-derived thymic epithelial progenitor cells from multiple induced pluripotent stem cells (iPSCs) that can further differentiate into functional patient-derived thymic epithelial cells on transplantation into athymic nude mice. Methods: Directed differentiation of iPSC generated TEPs that were transplanted into nude mice. Between 14 and 19 weeks posttransplantation, grafts were removed and analyzed by flow cytometry, quantitative PCR, bulk RNA sequencing, and single-cell RNA sequencing for markers of thymic-cell and T-cell development. Results: A direct differentiation protocol that allows the generation of patient-derived thymic epithelial progenitor cells from multiple iPSC lines is described. On transplantation into athymic nude mice, patient-derived thymic epithelial progenitor cells further differentiate into functional patient-derived thymic epithelial cells that can facilitate the development of T cells. Single-cell RNA sequencing analysis of iPSC-derived grafts shows characteristic thymic subpopulations and patient-derived thymic epithelial cell populations that are indistinguishable from TECs present in primary neonatal thymus tissue. Conclusions: These findings provide important insights and resources for researchers focusing on human thymus biology.	[Ramos, Stephan A.; Yadav, Prabha; Reed, Brendan; Alizadeh, Sheila, I; Shilleh, Ali H.; Kappler, John; Russ, Holger A.] Univ Colorado, Barbara Davis Ctr Diabet, Anschutz Med Campus,1775 Aurora Court,M20-4202G, Aurora, CO 80045 USA; [Morton, John J.; Perrenoud, Loni; Jimeno, Antonio] Univ Colorado, Sch Med, Div Med Oncol, Dept Med, Aurora, CO 80045 USA; [Reed, Brendan] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Jimeno, Antonio; Russ, Holger A.] Univ Colorado, Sch Med, Charles C Gates Ctr Regenerat Med, Aurora, CO 80045 USA; [Jaggers, James] Univ Colorado, Sch Med, Surg Cardiothorac Dept, Aurora, CO 80045 USA; [Kappler, John] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Russ, HA (corresponding author), Univ Colorado, Barbara Davis Ctr Diabet, Anschutz Med Campus,1775 Aurora Court,M20-4202G, Aurora, CO 80045 USA.; Jimeno, A (corresponding author), Univ Colorado, Canc Ctr, Anschutz Med Campus,12801 East 17th Ave, Aurora, CO 80045 USA.; Jimeno, A (corresponding author), Charles C Gates Ctr Stem Cell Biol, Anschutz Med Campus,12801 East 17th Ave, Aurora, CO 80045 USA.	antonio.jimeno@cuanschutz.edu; holger.russ@cuauschutz.edu			National Institutes of Health (NIH) [NIH-T32-GM008730, NIH-T32-AR0007411-35, NIH-T32-DK120520-01A1]; Children's Diabetes Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK120444]; National Institute of Allergy and Infectious Diseases [R21AI140044]; NIDDK-supported Human Islets Research Network [RRID:SCR_014393, UC24 DK1041162]; Culshaw Junior Investigator Award in Diabetes; University of Colorado Grubstake award; Juvenile Diabetes Research Foundation [2-SRA-2019-781-SB]; NIH [R01CA149456, R01CA213102]; Daniel and Janet Mordecai Foundation; Karsh Family Foundation; Peter and Rhonda Grant Foundation; NIDDK [P30-DK116073]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Diabetes Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK-supported Human Islets Research Network; Culshaw Junior Investigator Award in Diabetes; University of Colorado Grubstake award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daniel and Janet Mordecai Foundation; Karsh Family Foundation; Peter and Rhonda Grant Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Institutes of Health (NIH): ``Pre-doctoral Training in Molecular Biology'' grant NIH-T32-GM008730 (to S.A.R.), ``Pre-doctoral Training in Stem Cell Biology'' grant NIH-T32-AR0007411-35 (to A.H.S.) and ``Predoctoral training in Diabetes/Bioengineering'' grant NIH-T32-DK120520-01A1 (to A.H.S.). Work in the laboratory of H.A.R. is supported by the Children`s Diabetes Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01DK120444 and National Institute of Allergy and Infectious Diseases grant R21AI140044, a new investigator award from the NIDDK-supported Human Islets Research Network (grant RRID:SCR_014393; UC24 DK1041162), the Culshaw Junior Investigator Award in Diabetes, a University of Colorado Grubstake award, and the Juvenile Diabetes Research Foundation (grant 2-SRA-2019-781-SB). Work in the laboratory of A.J. is supported by NIH grants R01CA149456 and R01CA213102, the Daniel and Janet Mordecai Foundation, the Karsh Family Foundation, and the Peter and Rhonda Grant Foundation, as well by as anonymous donors. This work was supported by NIDDK grant P30-DK116073 to the University of Colorado Diabetes Research Center.	103 Genomics, WHAT IS CELL RANG; Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; [Anonymous], 2019, CLIN IMMUNOL; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Benjamini Y., 1995, J R STAT SOC B, V57, P289; Blackburn CC, 1996, IMMUNOLOGY; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Campinoti S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20082-7; Chen SF, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1469-3; Cheng L, 2009, J BIOL CHEM; Chhatta AR, 2019, J ALLERGY CLIN IMMUN, V144, P1416, DOI 10.1016/j.jaci.2019.05.042; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; IKEHARA S, 1984, P NATL ACAD SCI-BIOL, V81, P886, DOI 10.1073/pnas.81.3.886; KENNEDY JD, 1992, J IMMUNOL, V148, P1620; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kogut I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03190-3; KOLLMANN TR, 1993, J EXP MED, V177, P821, DOI 10.1084/jem.177.3.821; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lepletier A, 2019, CELL REP, V27, P3887, DOI 10.1016/j.celrep.2019.05.045; Li J, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.178988; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu D, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.178582; Mackall CL, 1997, IMMUNOL REV, V160, P91, DOI 10.1111/j.1600-065X.1997.tb01030.x; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; Miller CN, 2018, NATURE, V559, P627, DOI 10.1038/s41586-018-0345-2; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Pabst R, 2019, CELL TISSUE RES, V376, P19, DOI 10.1007/s00441-019-02994-z; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Perniola R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00098; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; SHORES EW, 1994, INT IMMUNOL, V6, P1393, DOI 10.1093/intimm/6.9.1393; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun XN, 2013, CELL STEM CELL, V13, P230, DOI 10.1016/j.stem.2013.06.014; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vaidya HJ, 2016, EUR J IMMUNOL, V46, P1826, DOI 10.1002/eji.201545814; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Yamazaki Y, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax1036; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702	55	3	3	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					767	+		10.1016/j.jaci.2021.07.021	http://dx.doi.org/10.1016/j.jaci.2021.07.021			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA					2022-12-18	WOS:000752623200034
J	Bakker, DS; De Graaf, M; Nierkens, S; Delemarre, EM; Knol, E; Van Wijk, F; De Bruin-Weller, MS; Drylewicz, J; Thijs, JL				Bakker, Daphne S.; de Graaf, Marlies; Nierkens, Stefan; Delemarre, Eveline M.; Knol, Edward; van Wijk, Femke; de Bruin-Weller, Marjolein S.; Drylewicz, Julia; Thijs, Judith L.			Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; pediatric; biomarkers; endotypes; personalized medicine; principal components analysis; cluster analysis	NATURAL COURSE; CHILDREN; SEVERITY; TH2; EXPRESSION; CHEMOKINES; EFFICACY; FEATURES; MODERATE; EOTAXIN	Background: Increasing evidence shows that pediatric atopic dermatitis (AD) differs from adult AD on a biologic level. Broad biomarker profiling across a wide range of ages of pediatric patients with AD is lacking. Objective: Our aim was to identify serum biomarker profiles in children with AD aged 0 to 17 years and compare these profiles with those previously found in adults with AD. Methods: Luminex multiplex immunoassays were used to measure 145 biomarkers in serum from 240 children with AD (aged 0-17 years). Principal components analysis followed by unsupervised k-means clustering were performed to identify patient clusters. Patients were stratified into age groups (0-4 years, 5-11 years, and 12-17 years) to assess association between age and cluster membership. Results: Children aged 0 to 4 years had the highest levels of T(H)1 cell-skewing markers and lowest levels of T(H)17 cell-related markers. T(H)2 cell-related markers did not differ significantly between age groups. Similar to the pattern in adults, cluster analysis identified 4 distinct pediatric patient clusters (T(H)2 cell/ retinol-dominant, skin-homing-dominant, T(H)1 cell/T(H)2 cell/ T(H)17 cell/HL-1-dominant, and T(H)1 cell/IL-1/eosinophil-inferior clusters). Only the T(H)1 cell/T(H)2 cell/T(H)17 cell/IL-1-dominant cluster resembled 1 of the previously identified adult clusters. Although no association with age or age of onset seemed to be found, disease severity was significantly associated with the skinhoming-dominant cluster. Conclusion: Four distinct patient clusters based on serum biomarker profiles could be identified in a large cohort of pediatric patients with AD, of which 1 was similar to previously identified adult clusters. The identification of endotypes driven by distinct underlying immunopathologic pathways might be useful to define pediatric patients with AD who are at risk of persistent disease and may necessitate different targeted treatment approaches.	[Bakker, Daphne S.; de Graaf, Marlies; de Bruin-Weller, Marjolein S.; Thijs, Judith L.] Univ Med Ctr Utrecht, Natl Expertise Ctr Atop Dermatitis, Dept Dermatol & Allergol, Utrecht, Netherlands; [Bakker, Daphne S.; Nierkens, Stefan; Delemarre, Eveline M.; Knol, Edward; van Wijk, Femke; Drylewicz, Julia] Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Thijs, JL (corresponding author), Univ Med Ctr Utrecht, Dept Dermatol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	j.thijs@umcutrecht.nl	Drylewicz, Julia/I-4703-2019	Drylewicz, Julia/0000-0002-9434-8459	Regeneron; Sanofi Genzyme Pharmaceuticals, Inc.	Regeneron(Regeneron); Sanofi Genzyme Pharmaceuticals, Inc.	Supported by Regeneron and Sanofi Genzyme Pharmaceuticals, Inc.	Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Bakker DS, 2021, J ALLERGY CLIN IMMUN, V147, P189, DOI 10.1016/j.jaci.2020.04.062; Bieber T, 2017, J ALLERGY CLIN IMMUN, V139, pS58, DOI 10.1016/j.jaci.2017.01.008; Brunner PM, 2019, J AM ACAD DERMATOL, V81, P510, DOI 10.1016/j.jaad.2019.04.036; Brunner PM, 2019, ANN ALLERG ASTHMA IM, V122, P318, DOI 10.1016/j.anai.2018.11.025; Brunner PM, 2019, J ALLERGY CLIN IMMUN, V143, P142, DOI 10.1016/j.jaci.2018.07.028; Brunner PM, 2018, J ALLERGY CLIN IMMUN, V141, P2094, DOI 10.1016/j.jaci.2018.02.040; Chensue SW, 1996, J IMMUNOL, V157, P4602; Czarnowicki T, 2020, J ALLERGY CLIN IMMUN, V145, P215, DOI 10.1016/j.jaci.2019.09.031; Czarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P941, DOI 10.1016/j.jaci.2015.05.049; Daniluk U, 2019, INT J DERMATOL, V58, P1056, DOI 10.1111/ijd.14438; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; Esaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1639, DOI 10.1016/j.jaci.2016.07.013; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; Folster-Holst R, 2014, J EUR ACAD DERMATOL, V28, P5, DOI 10.1111/jdv.12481; Guttman-Yassky E, 2018, EXP DERMATOL, V27, P409, DOI 10.1111/exd.13336; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hill DA, 2018, ANN ALLERG ASTHMA IM, V120, P131, DOI 10.1016/j.anai.2017.10.037; Hill DA, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0673-z; Hon KL, 2011, PEDIAT ALLERG IMM-UK, V22, P704, DOI 10.1111/j.1399-3038.2011.01174.x; Hua TC, 2014, BRIT J DERMATOL, V170, P130, DOI 10.1111/bjd.12603; Hulshof L, 2019, BRIT J DERMATOL, V180, P621, DOI 10.1111/bjd.16994; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li XM, 2017, AM J PHYSIOL-LUNG C, V313, pL592, DOI 10.1152/ajplung.00409.2016; Lyons JJ, 2015, IMMUNOL ALLERGY CLIN, V35, P161, DOI 10.1016/j.iac.2014.09.008; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271; McKenzie C, 2019, ANN ALLERG ASTHMA IM, V123, P173, DOI 10.1016/j.anai.2019.05.014; Mihaly J, 2011, EXP DERMATOL, V20, P326, DOI 10.1111/j.1600-0625.2010.01225.x; Mitra AK, 1998, LANCET, V351, P1033, DOI 10.1016/S0140-6736(05)79000-0; Morita E, 2001, ALLERGY, V56, P194, DOI 10.1034/j.1398-9995.2001.056002194.x; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Nakazato J, 2008, PEDIAT ALLERG IMM-UK, V19, P605, DOI 10.1111/j.1399-3038.2007.00692.x; Paracha PI, 2000, AM J CLIN NUTR, V72, P1164; Park CW, 2005, BRIT J DERMATOL, V152, P1173, DOI 10.1111/j.1365-2133.2005.06474.x; R Development Core Team, 2018, R LANG ENV STAT COMP; Siegfried EC, 2019, PEDIATR DERMATOL, V36, P172, DOI 10.1111/pde.13707; Sohn MH, 2004, ALLERGY ASTHMA PROC, V25, P181; Song TW, 2006, CLIN EXP ALLERGY, V36, P346, DOI 10.1111/j.1365-2222.2006.02430.x; Strickland I, 2017, J ALLERGY CLIN IMMUN, V140, P1703, DOI 10.1016/j.jaci.2017.06.046; Tamagawa-Mineoka Risa, 2008, Allergol Int, V57, P391, DOI 10.2332/allergolint.O-08-537; Thijs JL, 2017, J ALLERGY CLIN IMMUN, V140, P730, DOI 10.1016/j.jaci.2017.03.023; Thorndike RL., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Thorsteinsdottir S, 2019, JAMA DERMATOL, V155, P50, DOI 10.1001/jamadermatol.2018.4061; Wang HH, 2016, J ALLERGY CLIN IMMUN, V138, P1719, DOI 10.1016/j.jaci.2016.05.038; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Wollenberg A, 2017, J AM ACAD DERMATOL, V76, pAB20; WUTHRICH B, 1992, ARCH DERMATOL RES, V284, P339, DOI 10.1007/BF00372036	48	3	3	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					125	134		10.1016/j.jaci.2021.06.029	http://dx.doi.org/10.1016/j.jaci.2021.06.029			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	34237306	hybrid			2022-12-18	WOS:000744544500022
J	Jarrell, JA; Baker, MC; Perugino, CA; Liu, H; Bloom, MS; Maehara, T; Wong, HH; Lanz, TV; Adamska, JZ; Kongpachith, S; Sokolove, J; Stone, JH; Pillai, SS; Robinson, WH				Jarrell, Justin A.; Baker, Matthew C.; Perugino, Cory A.; Liu, Hang; Bloom, Michelle S.; Maehara, Takashi; Wong, Heidi H.; Lanz, Tobias, V; Adamska, Julia Z.; Kongpachith, Sarah; Sokolove, Jeremy; Stone, John H.; Pillai, Shiv S.; Robinson, William H.			Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL-1 receptor antagonist; cytokine; IgG4-related dis-ease; lupus; rheumatoid arthritis; autoimmune disease; autoanti-bodies; plasmablast; sequencing	FIBROSIS; IDENTIFICATION; INTERFERON; MECHANISMS; PROTEIN; IL-33	Background: IgG4-related disease (IgG4-RD) is a fibroinflammatory condition involving loss of B-cell tolerance and production of autoantibodies. However, the relevant targets and role of these aberrant humoral immune responses are not defined. Objective: Our aim was to identify novel autoantibodies and autoantigen targets that promote pathogenic responses in IgG4-RD. Methods: We sequenced plasmablast antibody repertoires in patients with IgG4-RD. Representative mAbs were expressed and their specificities characterized by using cytokine microarrays. The role of anti-IL-1 receptor antagonist (IL-1RA) autoantibodies was investigated by using in vitro assays. Results: We identified strong reactivity against human IL-1RA by using a clonally expanded plasmablast-derived mAb from a patient with IgG4-RD. Plasma from patients with IgG4-RD exhibited elevated levels of reactivity against IL-1RA compared with plasma from the controls and neutralized IL-1RA activity, resulting in inflammatory and fibrotic mediator production in vitro. IL-1RA was detected in lesional tissues from patients with IgG4-RD. Patients with anti-IL-1RA autoantibodies of the IgG4 subclass had greater numbers of organs affected than did those without anti-IL-1RA autoantibodies. Peptide analyses identified IL-1RA epitopes targeted by anti-IL-1RA antibodies at sites near the IL-1RA/IL-1R interface. Serum from patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) also had elevated levels of anti-IL-1RA autoantibodies compared with those of the controls. Conclusion: A subset of patients with IgG4-RD have anti-IL-1RA autoantibodies, which promote proinflammatory and profibrotic meditator production via IL-1RA neutralization. These findings support a novel immunologic mechanism underlying the pathogenesis of IgG4-RD. Anti-IL-1RA autoantibodies are also present in a subset of patients with SLE and RA, suggesting a potential common pathway in multiple autoimmune diseases. (J Allergy Clin Immunol 2022;149:358-68.)	[Jarrell, Justin A.; Baker, Matthew C.; Bloom, Michelle S.; Maehara, Takashi; Wong, Heidi H.; Lanz, Tobias, V; Adamska, Julia Z.; Kongpachith, Sarah; Sokolove, Jeremy; Robinson, William H.] Stanford Univ, Dept Med, Div Immunol & Rheumatol, Palo Alto, CA 94304 USA; [Jarrell, Justin A.; Bloom, Michelle S.; Maehara, Takashi; Wong, Heidi H.; Lanz, Tobias, V; Adamska, Julia Z.; Kongpachith, Sarah; Sokolove, Jeremy; Robinson, William H.] Stanford Univ, Inst Immun Transplant & Infect, Palo Alto, CA 94304 USA; [Jarrell, Justin A.; Bloom, Michelle S.; Maehara, Takashi; Wong, Heidi H.; Lanz, Tobias, V; Adamska, Julia Z.; Kongpachith, Sarah; Sokolove, Jeremy; Robinson, William H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Perugino, Cory A.; Liu, Hang; Stone, John H.; Pillai, Shiv S.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Wong, Heidi H.] Heidelberg Univ, Med Fac Mannheim, Dept Neurol, Heidelberg, Germany	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Harvard Medical School; Massachusetts General Hospital; Ruprecht Karls University Heidelberg	Robinson, WH (corresponding author), Div Immunol & Rheumatol, 269 Campus Dr, Stanford, CA 94305 USA.	w.robinson@stanford.edu		Robinson, William/0000-0003-4385-704X; Baker, Matthew/0000-0002-0002-1907; Adamska, Julia/0000-0001-8657-4141	Stanford Graduate Fellowship; Rheumatology Research Foundation; National Institutes of Health [T32AI07290, 2T32AR050942-11, T32AR007258, UM1 AI1144295, U19 AI110495, R01AR06367604, U19AI11049103]	Stanford Graduate Fellowship(Stanford University); Rheumatology Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grants from the Stanford Graduate Fellowship (to J.A.J.), the Rheumatology Research Foundation (to M.C.B. and C.A.P.), and the National Institutes of Health (grants T32AI07290 [to J.A.J.], 2T32AR050942-11 [to M.C.B.], T32AR007258 [to C.A.P.], UM1 AI1144295 [to J.H.S.], U19 AI110495 [to S.S.P.], and R01AR06367604 and U19AI11049103 [to W.H.R.]).	Ayatollahi M, 2004, J EUR ACAD DERMATOL, V18, P241, DOI 10.1111/j.1468-3083.2004.00708.x; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Cappellano G, 2012, AM J CLIN EXP IMMUNO, V1, P136; Della-Torre E, 2020, J ALLERGY CLIN IMMUN, V145, P968, DOI 10.1016/j.jaci.2019.07.004; Elliott SE, 2018, ARTHRITIS RHEUMATOL, V70, P1946, DOI 10.1002/art.40587; Endo T, 2009, DIABETES, V58, P732, DOI 10.2337/db08-0493; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Futei Y, 2001, J DERMATOL SCI, V26, P55, DOI 10.1016/S0923-1811(00)00158-4; Gupta S, 2016, ARTHRITIS RHEUMATOL, V68, P1677, DOI 10.1002/art.39607; Hubers LM, 2018, GUT, V67, P728, DOI 10.1136/gutjnl-2017-314548; Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0; Kelso A, 1998, IMMUNOL CELL BIOL, V76, P300, DOI 10.1046/j.1440-1711.1998.00757.x; Koneczny I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00097; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Lin CH, 2016, NAT MED, V22, P994, DOI 10.1038/nm.4158; Mahajan VS, 2014, ANNU REV PATHOL-MECH, V9, P315, DOI 10.1146/annurev-pathol-012513-104708; Nishimori I, 2005, GUT, V54, P274, DOI 10.1136/gut.2004.049064; Perugino CA, 2019, J ALLERGY CLIN IMMUN, V143, P736, DOI 10.1016/j.jaci.2018.05.011; Price JV, 2013, J CLIN INVEST, V123, P5135, DOI 10.1172/JCI70231; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Robinson WH, 2002, BIOTECHNIQUES, P66; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; Shiokawa M, 2016, GUT, V65, P1322, DOI 10.1136/gutjnl-2015-310336; Sjowall C, 2004, J AUTOIMMUN, V22, P315, DOI 10.1016/j.jaut.2004.02.003; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; SUZUKI H, 1991, CLIN EXP IMMUNOL, V85, P407; Tan TK, 2010, AM J PATHOL, V176, P1256, DOI 10.2353/ajpath.2010.090188; Tan YC, 2014, ARTHRITIS RHEUMATOL, V66, P2706, DOI 10.1002/art.38754; Umehara H, 2017, MOD RHEUMATOL, V27, P381, DOI 10.1080/14397595.2017.1290911; Wu LY, 2018, INFLAMMATION, V41, P878, DOI 10.1007/s10753-018-0742-6; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807	32	3	3	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					358	368		10.1016/j.jaci.2021.05.002	http://dx.doi.org/10.1016/j.jaci.2021.05.002			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	33974929				2022-12-18	WOS:000747922700005
J	Navrazhina, K; Garcet, S; Zheng, XZ; Hur, HB; Frew, JW; Krueger, JG				Navrazhina, Kristina; Garcet, Sandra; Zheng, Xiuzhong; Hur, Hong Beom; Frew, John W.; Krueger, James G.			High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hidradenitis suppurativa; perilesional; neutrophils; IL-17 signaling; lesional; nonlesional; lipocalin-2	QUALITY-OF-LIFE; INTERLEUKIN (IL)-17; TH17 CYTOKINES; ACNE; KERATINOCYTES; PREVALENCE; MORBIDITY; PATHWAY; LESIONS; SYSTEM	Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease presenting with diverse manifestations ranging from nodules and abscesses to draining tunnels. Whether the underlying inflammation from lesions extends to relatively healthy-appearing adjacent perilesional and distant nonlesional skin has not been systematically evaluated. Objective: We sought to characterize lesional, perilesional, and nonlesional skin in patients with HS. Methods: Skin biopsy samples were collected under ultrasound guidance from patients with active, untreated moderate-tosevere HS. Site-matched control biopsy samples from healthy volunteers were used for comparison. Results: RNA sequencing demonstrated that HS skin clustered separately from healthy control skin, with perilesional and lesion skin clustering together and away from nonlesional skin. Immunohistochemistry analysis identified psoriasiform hyperplasia with keratin 16 positivity in both perilesional and lesional skin, with comparable levels of CD3(+), CD11c(+), and neutrophil elastase-positive cellular infiltration. There was a marked upregulation of IL-17 signaling in perilesional and lesional skin. HS samples clustered on the basis of expression of lipocalin-2 (LCN2), with samples characterized by high LCN2 expression in the skin exhibiting a differing transcriptomic profile with significantly higher overall inflammation than that of skin characterized by low LCN2 levels. Conclusions: Perilesional HS skin has a transcriptomic and molecular profile comparable to that of lesional skin. HS can be grouped into 2 distinct subtypes based on molecular levels of LCN2 in the skin, with the LCN2-high subtype exhibiting an overall higher inflammatory burden and an upregulation of targetable cytokines. To our knowledge, this is the first study to characterize a unique HS subtype (and a potential endotype) that may guide future therapeutic targets.	[Navrazhina, Kristina; Garcet, Sandra; Zheng, Xiuzhong; Frew, John W.; Krueger, James G.] Rockefeller Univ, Lab Investigat Dermatol, 1230 York Ave, New York, NY 10065 USA; [Navrazhina, Kristina] Rockefeller Univ, Res Bioinformat, Ctr Clin & Translat Sci, New York, NY 10065 USA; [Hur, Hong Beom] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA	Rockefeller University; Rockefeller University	Krueger, JG (corresponding author), Rockefeller Univ, Lab Investigat Dermatol, 1230 York Ave, New York, NY 10065 USA.	jgk@rockefeller.edu			Medical Science Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health [T32GM007739]; National Center for Advancing Translational Sciences of the National Institutes of Health Clinical and Translational Science Award program [UL1TR001866]; Shapiro-Silverberg Fund for the Advancement of Translational Research; Hidradenitis Suppurativa Foundation	Medical Science Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health; National Center for Advancing Translational Sciences of the National Institutes of Health Clinical and Translational Science Award program; Shapiro-Silverberg Fund for the Advancement of Translational Research; Hidradenitis Suppurativa Foundation	Supported by a Medical Science Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health (award T32GM007739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program [to K.N.]), the National Center for Advancing Translational Sciences of the National Institutes of Health Clinical and Translational Science Award program (grant UL1TR001866 [to J.W.F. and J.G.K.]), the Shapiro-Silverberg Fund for the Advancement of Translational Research (to J.W.F.), and the Hidradenitis Suppurativa Foundation Danby Grant (to J.W.F.).	Albanesi C, 1999, J IMMUNOL, V162, P494; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Assan F, 2020, J ALLERGY CLIN IMMUN, V146, P452, DOI 10.1016/j.jaci.2020.01.045; Banerjee A, 2017, IMMUNOL INVEST, V46, P149, DOI 10.1080/08820139.2016.1230867; Blok JL, 2016, BRIT J DERMATOL, V174, P1392, DOI 10.1111/bjd.14371; Brodmerkel C, 2019, J ALLERGY CLIN IMMUN, V143, P1965, DOI 10.1016/j.jaci.2019.01.017; Byrd AS, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav5908; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Catapano M, 2020, J INVEST DERMATOL, V140, P816, DOI 10.1016/j.jid.2019.08.444; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Daxhelet M, 2020, DERMATOLOGY, V236, P431, DOI 10.1159/000507348; Deckers IE, 2016, DERMATOL CLIN, V34, P17, DOI 10.1016/j.det.2015.07.003; Del Duca E, 2019, J INVEST DERMATOL, V139, P2228, DOI 10.1016/j.jid.2019.04.008; Delany E, 2018, J EUR ACAD DERMATOL, V32, P467, DOI 10.1111/jdv.14686; Di Caprio R, 2017, ARCH DERMATOL RES, V309, P673, DOI 10.1007/s00403-017-1769-5; Dufour DN, 2014, POSTGRAD MED J, V90, P216, DOI 10.1136/postgradmedj-2013-131994; Fang H, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0384-y; Frew JW, 2021, CLIN EXP DERMATOL, V46, P306, DOI 10.1111/ced.14448; Frew JW, 2019, BRIT J DERMATOL, V181, P1339, DOI 10.1111/bjd.18309; Frew JW, 2020, J AM ACAD DERMATOL, V82, P1150, DOI 10.1016/j.jaad.2019.12.044; Frew JW, 2019, THER ADV CHRONIC DIS, V10, DOI 10.1177/2040622319830646; Garg A, 2017, JAMA DERMATOL, V153, P760, DOI 10.1001/jamadermatol.2017.0201; Ghias MH, 2020, J INVEST DERMATOL, V140, P531, DOI 10.1016/j.jid.2019.09.009; Glickman JW, 2021, J AM ACAD DERMATOL, V84, P370, DOI 10.1016/j.jaad.2020.04.138; Grand D, 2020, EXP DERMATOL, V29, P86, DOI 10.1111/exd.14056; Gudjonsson JE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139930; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hoffman LK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203672; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Ingram JR, 2018, BRIT J DERMATOL, V178, P917, DOI 10.1111/bjd.16101; Jemec GBE, 1996, J AM ACAD DERMATOL, V35, P191, DOI 10.1016/S0190-9622(96)90321-7; Jenei A, 2019, J INVEST DERMATOL, V139, P964, DOI 10.1016/j.jid.2018.10.020; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Kanni T, 2018, BRIT J DERMATOL, V179, P413, DOI 10.1111/bjd.16428; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; Kelly G, 2015, BRIT J DERMATOL, V173, P1431, DOI 10.1111/bjd.14075; Kim TG, 2014, J INVEST DERMATOL, V134, P1462, DOI 10.1038/jid.2013.534; Kimball AB, 2016, J EUR ACAD DERMATOL, V30, P989, DOI 10.1111/jdv.13216; Kurek A, 2013, J DTSCH DERMATOL GES, V11, P743, DOI 10.1111/ddg.12067; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lima AL, 2016, BRIT J DERMATOL, V174, P514, DOI 10.1111/bjd.14214; Lowe MM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139932; Mahil SK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2514; Marzano AV, 2017, BRIT J DERMATOL, V176, P1588, DOI 10.1111/bjd.15226; Matusiak L, 2017, J AM ACAD DERMATOL, V76, P670, DOI 10.1016/j.jaad.2016.10.042; Matusiak L, 2010, ACTA DERM-VENEREOL, V90, P264, DOI 10.2340/00015555-0866; Matusiak L, 2010, J AM ACAD DERMATOL, V62, P706, DOI 10.1016/j.jaad.2009.09.021; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Moran B, 2017, J INVEST DERMATOL, V137, P2389, DOI 10.1016/j.jid.2017.05.033; Musilova J, 2020, J INVEST DERMATOL, V140, P1091, DOI 10.1016/j.jid.2019.08.453; Navrazhina K, 2020, BRIT J DERMATOL, V182, P1045, DOI 10.1111/bjd.18556; Navrazhina K, 2021, J INVEST DERMATOL, V141, P2197, DOI 10.1016/j.jid.2021.02.742; Navrazhina K, 2021, J ALLERGY CLIN IMMUN, V147, P2213, DOI 10.1016/j.jaci.2020.12.651; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Reddy S, 2020, JAMA DERMATOL, V156, P65, DOI 10.1001/jamadermatol.2019.3412; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Sabat R, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0149-1; Sabat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031810; Sanyal RD, 2019, ANN ALLERG ASTHMA IM, V122, P99, DOI 10.1016/j.anai.2018.08.024; Saunte DML, 2017, JAMA-J AM MED ASSOC, V318, P2019, DOI 10.1001/jama.2017.16691; Schlapbach C, 2011, J AM ACAD DERMATOL, V65, P790, DOI 10.1016/j.jaad.2010.07.010; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Thomi R, 2017, J EUR ACAD DERMATOL, V31, P2091, DOI 10.1111/jdv.14389; Thorsvik S, 2017, J GASTROEN HEPATOL, V32, P128, DOI 10.1111/jgh.13598; van der Zee HH, 2012, BRIT J DERMATOL, V166, P98, DOI 10.1111/j.1365-2133.2011.10643.x; Visvanathan S, 2019, J ALLERGY CLIN IMMUN, V143, P2158, DOI 10.1016/j.jaci.2018.11.042; Von der Werth JM, 2001, BRIT J DERMATOL, V144, P809, DOI 10.1046/j.1365-2133.2001.04137.x; von Laffert M, 2011, BRIT J DERMATOL, V164, P367, DOI 10.1111/j.1365-2133.2010.10034.x; von Laffert M, 2010, EXP DERMATOL, V19, P533, DOI 10.1111/j.1600-0625.2009.00915.x; Vossen ARJV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02965; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Witte-Handel E, 2019, J INVEST DERMATOL, V139, P1294, DOI 10.1016/j.jid.2018.11.018; Wolk K, 2021, BRIT J DERMATOL, V185, P164, DOI 10.1111/bjd.19795; Wolk K, 2017, BRIT J DERMATOL, V177, P1385, DOI 10.1111/bjd.15424; Wolkenstein P, 2007, J AM ACAD DERMATOL, V56, P621, DOI 10.1016/j.jaad.2006.08.061; Zouboulis CC, 2020, J EUR ACAD DERMATOL, V34, P846, DOI 10.1111/jdv.16147; Zouboulis CC, 2019, J EUR ACAD DERMATOL, V33, P19, DOI 10.1111/jdv.15233; Zouboulis CC, 2017, BRIT J DERMATOL, V177, P1401, DOI 10.1111/bjd.15748	84	3	3	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					135	+		10.1016/j.jaci.2021.05.027	http://dx.doi.org/10.1016/j.jaci.2021.05.027			22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	34081946				2022-12-18	WOS:000744544500023
J	Nunes-Santos, CJ; Koh, C; Rai, A; Sacco, K; Marciano, BE; Kleiner, DE; Marko, J; Bergerson, JRE; Stack, M; Rivera, MM; Constantine, G; Strober, W; Uzel, G; Fuss, IJ; Notarangelo, LD; Holland, SM; Rosenzweig, SD; Heller, T				Nunes-Santos, Cristiane J.; Koh, Christopher; Rai, Anjali; Sacco, Keith; Marciano, Beatriz E.; Kleiner, David E.; Marko, Jamie; Bergerson, Jenna R. E.; Stack, Michael; Rivera, Maria M.; Constantine, Gregory; Strober, Warren; Uzel, Gulbu; Fuss, Ivan J.; Notarangelo, Luigi D.; Holland, Steven M.; Rosenzweig, Sergio D.; Heller, Theo			Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Primary immunodeficiency; inborn errors of immunity; liver disease; thrombocytopenia; splenomegaly; hepatomegaly; alkaline phosphatase; portal hypertension; CVID; HSCT	LIVER-DISEASE; PORTAL-HYPERTENSION; DISORDERS; CHILDREN; TRANSPLANTATION; MANIFESTATIONS; EXPERIENCE; MORTALITY; INFANTS	Background: Late-onset complications in X-linked agammaglobulinemia (XLA) are increasingly recognized. Nodular regenerative hyperplasia (NRH) has been reported in primary immunodeficiency but data in XLA are limited. Objectives: This study sought to describe NRH prevalence, associated features, and impact in patients with XLA. Methods: Medical records of all patients with XLA referred to the National Institutes of Health between October 1994 and June 2019 were reviewed. Liver biopsies were performed when clinically indicated. Patients were stratified into NRH+ or NRH- groups, according to their NRH biopsy status. Fisher exact test and Mann-Whitney test were used for statistical comparisons. Results: Records of 21 patients with XLA were reviewed, with a cumulative follow-up of 129 patient-years. Eight patients underwent >= 1 liver biopsy of whom 6 (29% of the National Institutes of Health XLA cohort) were NRH+. The median age at NRH diagnosis was 20 years (range, 17-31). Among patients who had liver biopsies, alkaline phosphatase levels were only increased in patients who were NRH+ (P = .04). Persistently low platelet count (<100,000 per mu L for >6 months), mildly to highly elevated hepatic venous pressure gradient and either hepatomegaly and/or splenomegaly were present in all patients who were NRH+. In opposition, persistently low platelet counts were not seen in patients who were NRH-, and hepatosplenomegaly was observed in only 1 patient who was NRH-. Hepatic venous pressure gradient was normal in the only patient tested who was NRH-. All-cause mortality was higher among patients who were NRH+ (5 of 6, 83%) than in the rest of the cohort (1 of 15, 7% among patients who were NRH- and who were classified as unknown; P = .002). Conclusions: NRH is an underreported, frequent, and severe complication in XLA, which is associated with increased morbidity and mortality.	[Nunes-Santos, Cristiane J.; Rosenzweig, Sergio D.] NIH, Immunol Serv, Dept Lab Med, Clin Ctr, Bldg 10,Room 2C306,10 Ctr Dr, Bethesda, MD 20892 USA; [Marko, Jamie] NIH, Dept Radiol & Imaging Sci, Clin Ctr, Bethesda, MD 20892 USA; [Koh, Christopher; Rai, Anjali; Rivera, Maria M.; Heller, Theo] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Sacco, Keith; Marciano, Beatriz E.; Bergerson, Jenna R. E.; Stack, Michael; Uzel, Gulbu; Notarangelo, Luigi D.; Holland, Steven M.] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Strober, Warren; Fuss, Ivan J.] NIAID, Mucosal Immun Sect, Lab Host Defenses, NIH, Bethesda, MD 20892 USA; [Constantine, Gregory] NIAID, Allergy & Immunol Fellowship Program, NIH, Bethesda, MD 20892 USA; [Kleiner, David E.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenzweig, SD (corresponding author), NIH, Immunol Serv, Dept Lab Med, Clin Ctr, Bldg 10,Room 2C306,10 Ctr Dr, Bethesda, MD 20892 USA.; Heller, T (corresponding author), NIDDK, Translat Hepatol Sect, Liver Dis Branch, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	srosenzweig@cc.nih.gov; theoh@intra.niddk.nih.gov	Rivera, Maria/GYU-2150-2022	Nunes-Santos, Cristiane/0000-0002-2727-1877; Heller, Theo/0000-0002-2643-6289; Constantine, Gregory/0000-0001-5379-9475	Intramural Research Program, National Institutes of Health Clinical Center, National Institute of Allergy and Infectious Diseases; National Institute of Diabetes, and Digestive and Kidney Diseases; NIH	Intramural Research Program, National Institutes of Health Clinical Center, National Institute of Allergy and Infectious Diseases; National Institute of Diabetes, and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TWe thank the patients and their families for their participation in the NIH research protocols. This work was supported by the Intramural Research Program, National Institutes of Health Clinical Center, National Institute of Allergy and Infectious Diseases, and the National Institute of Diabetes, and Digestive and Kidney Diseases, and NIH. The content of this article does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.	Aadam Z, 2016, J CLIN IMMUNOL, V36, P187, DOI 10.1007/s10875-016-0251-z; Abu-Arja RF, 2015, PEDIATR BLOOD CANCER, V62, P1674, DOI 10.1002/pbc.25554; Azzu V, 2019, J ALLER CL IMM-PRACT, V7, P2484, DOI 10.1016/j.jaip.2019.04.016; Azzu V, 2018, LIVER TRANSPLANT, V24, P171, DOI 10.1002/lt.24979; Barmettler S, 2017, J CLIN IMMUNOL, V37, P287, DOI 10.1007/s10875-017-0374-x; Ben-Yakov G, 2018, J ALLER CL IMM-PRACT, V6, P1763, DOI 10.1016/j.jaip.2018.01.005; BRUTON OC, 1952, PEDIATRICS, V9, P722; Bucciol G, 2018, J CLIN IMMUNOL, V38, P748, DOI 10.1007/s10875-018-0558-z; Chen XF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004544; Crotty R, 2020, AM J SURG PATHOL, V44, P617, DOI 10.1097/PAS.0000000000001452; Daou H, 2021, J CUTAN PATHOL, V48, P567, DOI 10.1111/cup.13860; El-Sayed ZA, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100018; Esenboga S, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12647; Feld JJ, 2015, ALIMENT PHARM THER, V42, P912, DOI 10.1111/apt.13347; Feld JJ, 2008, GASTROENTEROLOGY, V134, P1917, DOI 10.1053/j.gastro.2008.02.081; Fuss IJ, 2013, J CLIN IMMUNOL, V33, P748, DOI 10.1007/s10875-013-9873-6; Giorgetti OB, 2016, MEDICINA-BUENOS AIRE, V76, P65; Hadzic N, 2019, HEPATOLOGY, V69, P2717, DOI 10.1002/hep.30596; Hartleb M, 2011, WORLD J GASTROENTERO, V17, P1400, DOI 10.3748/wjg.v17.i11.1400; Hernandez-Trujillo VP, 2014, J CLIN IMMUNOL, V34, P627, DOI 10.1007/s10875-014-0056-x; Ho HE, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00149; Hussain N, 2007, HEPATOLOGY, V45, P675, DOI 10.1002/hep.21524; Jharap B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120299; Koh C, 2017, HEPATOLOGY, V66, P591, DOI 10.1002/hep.29217; Konus OL, 1998, AM J ROENTGENOL, V171, P1693, DOI 10.2214/ajr.171.6.9843315; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Lougaris V, 2020, J ALLERGY CLIN IMMUN, V146, P429, DOI 10.1016/j.jaci.2020.03.001; Malamut G, 2008, J HEPATOL, V48, P74, DOI 10.1016/j.jhep.2007.08.011; Milligan KL, 2016, J CLIN IMMUNOL, V36, P739, DOI 10.1007/s10875-016-0334-x; Mohammadinejad P, 2015, J INVEST ALLERG CLIN, V25, P416; O'Brien K, 2006, CLIN GASTROENTEROL H, V4, P387, DOI 10.1016/j.cgh.2005.12.013; Pac M, 2017, ARCH MED SCI, V13, P412, DOI 10.5114/aoms.2016.60338; Pecoraro A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00338; Pulvirenti F, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/672458; Reshamwala PA, 2006, HEPATOLOGY, V44, P7, DOI 10.1002/hep.21258; ROSENBERG HK, 1991, AM J ROENTGENOL, V157, P119, DOI 10.2214/ajr.157.1.2048509; Shillitoe B, 2017, CLIN IMMUNOL, V183, P54, DOI 10.1016/j.clim.2017.07.008; Shillitoe BMJ, 2019, CURR OPIN ALLERGY CL, V19, P571, DOI 10.1097/ACI.0000000000000584; Singh S, 2016, ANN ALLERG ASTHMA IM, V117, P405, DOI 10.1016/j.anai.2016.07.044; Slade CA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00694; STROMEYER FW, 1981, HUM PATHOL, V12, P60, DOI 10.1016/S0046-8177(81)80242-0; Swaminathan VV, 2020, PEDIATR TRANSPLANT, V24, DOI 10.1111/petr.13625; Tisza MJ, 2020, ELIFE, V9, DOI 10.7554/eLife.51971; Trenschel GM, 2000, PEDIATR RADIOL, V30, P64, DOI 10.1007/s002470050016; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; WANLESS IR, 1980, MEDICINE, V59, P367, DOI 10.1097/00005792-198009000-00004; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; Ward C, 2008, CLIN EXP IMMUNOL, V153, P331, DOI 10.1111/j.1365-2249.2008.03711.x; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad	51	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					400	+		10.1016/j.jaci.2021.05.028	http://dx.doi.org/10.1016/j.jaci.2021.05.028			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	34087243				2022-12-18	WOS:000747922700009
J	Tsumura, M; Miki, M; Mizoguchi, Y; Hirata, O; Nishimura, S; Tamaura, M; Kagawa, R; Hayakawa, S; Kobayashi, M; Okada, S				Tsumura, Miyuki; Miki, Mizuka; Mizoguchi, Yoko; Hirata, Osamu; Nishimura, Shiho; Tamaura, Moe; Kagawa, Reiko; Hayakawa, Seiichi; Kobayashi, Masao; Okada, Satoshi			Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-gamma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mendelian susceptibility to mycobacterial diseases; MSMD; STAT1; IFN-gR1; mycobacteria; osteomyelitis; osteoclastogenesis	RECEPTOR 1 DEFICIENCY; BACILLE CALMETTE-GUERIN; MYCOBACTERIUM-AVIUM INFECTION; INTERFERON-GAMMA; MENDELIAN SUSCEPTIBILITY; IL-12R-BETA-1 DEFICIENCY; IFN-GAMMA-R1 DEFICIENCY; CLINICAL-FEATURES; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; STAT1 DEFICIENCY	Background: Patients with Mendelian susceptibility to mycobacterial disease (MSMD) experience recurrent and/or persistent infectious diseases associated with poorly virulent mycobacteria. Multifocal osteomyelitis is among the representative manifestations of MSMD. The frequency of multifocal osteomyelitis is especially high in patients with MSMD etiologies that impair cellular response to IFN-y, such as IFN-yR1, IFN-yR2, or STAT1 deficiency. Objectives: This study sought to characterize the mechanism underlying multifocal osteomyelitis in MSMD. Methods: GM colonies prepared from bone marrow mononuclear cells from patients with autosomal dominant (AD) IFN-yR1 deficiency, AD STAT1 deficiency, or STAT1 gain of function (GOF) and from healthy controls were differentiated into osteoclasts in the presence or absence of IFN-y. The inhibitory effect of IFN-y on osteoclastogenesis was investigated by quantitative PCR, immunoblotting, tartrate-resistant acid phosphatase staining, and pit formation assays. Results: Increased osteoclast numbers were identified by examining the histopathology of osteomyelitis in patients with AD IFN-yR1 deficiency or AD STAT1 deficiency. In the presence of receptor activator of nuclear factor kappa-B ligand and M-CSF, GM colonies from patients with AD IFN-yR1 deficiency, AD STAT1 deficiency, or STAT1 GOF differentiated into osteoclasts, similar to GM colonies from healthy volunteers. IFN-y concentration-dependent inhibition of osteoclast formation was impaired in GM colonies from patients with AD IFN-yR1 deficiency or AD STAT1 deficiency, whereas it was enhanced in GM colonies from patients with STAT1 GOF. Conclusions: Osteoclast differentiation is increased in AD IFNyR1 deficiency and AD STAT1 deficiency due to an impaired response to IFN-y, leading to excessive osteoclast proliferation and, by inference, increased bone resorption in infected foci, which may underlie multifocal osteomyelitis. (J Allergy Clin Immunol 2022; 149:252-61.)	[Tsumura, Miyuki; Miki, Mizuka; Mizoguchi, Yoko; Hirata, Osamu; Nishimura, Shiho; Tamaura, Moe; Kagawa, Reiko; Hayakawa, Seiichi; Kobayashi, Masao; Okada, Satoshi] Hiroshima Univ, Dept Pediat, Grad Sch Biomed Sci, Hiroshima, Japan; [Miki, Mizuka] Hiroshima Red Cross Hosp, Dept Pediat, Hiroshima, Japan; [Miki, Mizuka] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Hirata, Osamu] Hiroshima City Hiroshima Citizens Hosp, Hidamari Children Clin, Hiroshima, Japan; [Nishimura, Shiho] Hiroshima City Hiroshima Citizens Hosp, Dept Pediat, Hiroshima, Japan; [Tamaura, Moe] Hiroshima Nishi Med Ctr, Dept Pediat, Hiroshima, Japan; [Kobayashi, Masao] Chugoku Shikoku Block Blood Ctr, Japanese Red Cross, Hiroshima, Japan	Hiroshima University; Hiroshima City Hospital; Hiroshima City Hospital; Japanese Red Cross Medical Center	Okada, S (corresponding author), Hiroshima Univ, Dept Pediat, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	sokada@hiroshima-u.ac.jp	Okada, Satoshi/B-8901-2011	Okada, Satoshi/0000-0002-4622-5657	Japan Society for the Promotion of Science [15K21189, 17K10112, 20K08158, 22591161, 16H05355, 19H03620]; Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development [JP16ek0109179, JP19ek0109209, JP20ek0109480]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	These authors contributed equally to this work. This study was supported in part by Grants in Aid for Scientific Research from the Japan Society for the Promotion of Science (grants 15K21189, 17K10112, and 20K08158 to M.T.; 22591161 to M.K.; 16H05355 and 19H03620 to S.O.) and was supported in part by the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (grants JP16ek0109179, JP19ek0109209, and JP20ek0109480 to S.O.) .	Abe K, 2012, INT J MOL MED, V29, P1007, DOI 10.3892/ijmm.2012.952; Al-Kzayer LFY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00058; Allende LM, 2001, CLIN DIAGN LAB IMMUN, V8, P133, DOI 10.1128/CDLI.8.1.133-137.2001; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Arend SM, 2001, NETH J MED, V59, P140, DOI 10.1016/S0300-2977(01)00152-8; Arias AA, 2017, J CLIN IMMUNOL, V37, P732, DOI 10.1007/s10875-017-0435-1; Azarsiz E, 2021, ASIAN PAC J ALLERGY; Bax HI, 2013, J CLIN IMMUNOL, V33, P991, DOI 10.1007/s10875-013-9882-5; Boehmer DFR, 2020, J ALLER CL IMM-PRACT, V8, P3102, DOI 10.1016/j.jaip.2020.06.034; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Boisson-Dupuis S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau8714; Bossi G, 2020, J PEDIATR GENET, V09, P186, DOI 10.1055/s-0039-1700803; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burns C, 2016, J ALLER CL IMM-PRACT, V4, P777, DOI 10.1016/j.jaip.2016.02.015; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Cheng J, 2012, J INTERF CYTOK RES, V32, P34, DOI 10.1089/jir.2011.0019; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; de Jong R, 1998, SCIENCE, V280, P1435; de Souza TL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00616; Dizaj MA, 2018, IMMUNOGENETICS, V70, P373, DOI 10.1007/s00251-017-1041-3; Dogruel D, 2019, TURKISH J PEDIATR, V61, P174, DOI 10.24953/turkjped.2019.02.004; Dorman SE, 1999, J PEDIATR-US, V135, P640, DOI 10.1016/S0022-3476(99)70064-8; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Dotta L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01161; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Edgar JDM, 2001, J PEDIATR-US, V139, P600, DOI 10.1067/mpd.2001.117068; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; Esteve-Sole A, 2018, J CLIN IMMUNOL, V38, P712, DOI 10.1007/s10875-018-0535-6; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Furukawa M, 2009, J IMMUNOL, V183, P2397, DOI 10.4049/jimmunol.0802091; Glanzmann B, 2018, J CLIN IMMUNOL, V38, P460, DOI 10.1007/s10875-018-0509-8; Glosli H, 2008, CLIN INFECT DIS, V46, pE23, DOI 10.1086/525855; Goktrurk B, 2016, TURKISH J PEDIATR, V58, P331; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Han JY, 2004, CLIN INFECT DIS, V39, P868, DOI 10.1086/423804; Hirata O, 2013, HAEMATOLOGICA, V98, P1641, DOI 10.3324/haematol.2013.083741; Hofmann SR, 2017, CURR OSTEOPOROS REP, V15, P542, DOI 10.1007/s11914-017-0405-9; Hofmann SR, 2016, J RHEUMATOL, V43, P1956, DOI 10.3899/jrheum.160256; Hoshina T, 2011, J CLIN IMMUNOL, V31, P309, DOI 10.1007/s10875-010-9498-y; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Ivashkiv LB, 2011, ANN NY ACAD SCI, V1237, P88, DOI 10.1111/j.1749-6632.2011.06217.x; Janssen R, 2002, J IMMUNOL, V169, P3900, DOI 10.4049/jimmunol.169.7.3900; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Kagawa R, 2017, J ALLERGY CLIN IMMUN, V140, P232, DOI 10.1016/j.jaci.2016.09.035; KepenekliKadayifci E, 2017, ASIAN PAC J ALLERGY, V35, P161, DOI 10.12932/AP0790; Khoshnevisan R, 2019, J CLIN TUBER OTH MYC, V17, DOI 10.1016/j.jctube.2019.100123; Kim Jung Ha, 2014, J Bone Metab, V21, P233, DOI 10.11005/jbm.2014.21.4.233; Kong XF, 2018, NAT IMMUNOL, V19, P973, DOI 10.1038/s41590-018-0178-z; Kong XF, 2010, BLOOD, V116, P5895, DOI 10.1182/blood-2010-04-280586; Kong XF, 2010, HUM MOL GENET, V19, P434, DOI 10.1093/hmg/ddp507; Koscielniak E, 2003, PEDIATR INFECT DIS J, V22, P378; Kristensen IA, 2011, J CLIN IMMUNOL, V31, P265, DOI 10.1007/s10875-010-9480-8; Lee WI, 2009, J CLIN IMMUNOL, V29, P238, DOI 10.1007/s10875-008-9253-9; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Mahdaviani SA, 2020, J CLIN IMMUNOL, V40, P872, DOI 10.1007/s10875-020-00813-7; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Menaa C, 2000, BIOCHEM BIOPH RES CO, V267, P943, DOI 10.1006/bbrc.1999.2042; Michniacki TF, 2019, J CLIN IMMUNOL, V39, P257, DOI 10.1007/s10875-019-00621-8; Mizoguchi Y, 2014, J LEUKOCYTE BIOL, V95, P667, DOI 10.1189/jlb.0513250; Muriel-Vizcaino R, 2016, J CLIN IMMUNOL, V36, P420, DOI 10.1007/s10875-016-0292-3; Muszlak M, 2007, ARCH PEDIATRIE, V14, P270, DOI 10.1016/j.arcped.2006.11.023; Nagy E, 2017, AM J PATHOL, V187, P1413, DOI 10.1016/j.ajpath.2017.02.012; Naviglio S, 2017, J CLIN IMMUNOL, V37, P701, DOI 10.1007/s10875-017-0430-6; Nekooie-Marnany N, 2018, J CLIN IMMUNOL, V38, P787, DOI 10.1007/s10875-018-0548-1; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Noordzij JG, 2007, J CLIN IMMUNOL, V27, P490, DOI 10.1007/s10875-007-9097-8; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Obinata K, 2013, J INFECT CHEMOTHER, V19, P757, DOI 10.1007/s10156-012-0493-5; Okada S, 2007, J MED GENET, V44, P485, DOI 10.1136/jmg.2007.049635; Parackova Z, 2020, J CLIN IMMUNOL, V40, P165, DOI 10.1007/s10875-019-00720-6; Park JH, 2017, MOL CELLS, V40, P706, DOI 10.14348/molcells.2017.0225; Prando C, 2013, MEDICINE, V92, P109, DOI 10.1097/MD.0b013e31828a01f9; Prucha M, 2020, CASE REP IMMUNOL, V2020, DOI 10.1155/2020/8836685; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Ramirez-Alejo N, 2014, CLIN GENET, V86, P161, DOI 10.1111/cge.12253; RASZKA WV, 1994, CLIN PEDIATR, V33, P611, DOI 10.1177/000992289403301007; Remiszewski P, 2006, RESPIRATION, V73, P375, DOI 10.1159/000088682; Reuter U, 2002, BLOOD, V100, P4234, DOI 10.1182/blood-2002-02-0433; Roesler J, 1999, EXP HEMATOL, V27, P1368, DOI 10.1016/S0301-472X(99)00077-6; Roesler J, 2011, PEDIATR INFECT DIS J, V30, P265, DOI 10.1097/INF.0b013e3181f6f78a; Rosain J, 2019, IMMUNOL CELL BIOL, V97, P360, DOI 10.1111/imcb.12210; Rosain J, 2018, J CLIN IMMUNOL, V38, P617, DOI 10.1007/s10875-018-0527-6; Rose DM, 2014, J ALLERGY CLIN IMMUN, V133, P591, DOI 10.1016/j.jaci.2013.07.054; Sakata S, 2020, INT IMMUNOL, V32, P663, DOI 10.1093/intimm/dxaa043; Sampaio EP, 2012, J CLIN IMMUNOL, V32, P681, DOI 10.1007/s10875-012-9659-2; Sarrafzadeh SA, 2019, J CLIN IMMUNOL, V39, P287, DOI 10.1007/s10875-019-0593-4; Sarrafzadeh SA, 2016, IRAN J PUBLIC HEALTH, V45, P370; Sasaki Y, 2002, J INFECT DIS, V185, P706, DOI 10.1086/339011; Sharma VK, 2015, J CLIN IMMUNOL, V35, P459, DOI 10.1007/s10875-015-0173-1; Shoji K, 2018, PEDIATR INT, V60, P1043, DOI 10.1111/ped.13691; Sologuren I, 2011, HUM MOL GENET, V20, P1509, DOI 10.1093/hmg/ddr029; Storgaard M, 2006, SCAND J IMMUNOL, V64, P137, DOI 10.1111/j.1365-3083.2006.01775.x; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2002, ARTHRITIS RES THER, V4, pS227, DOI 10.1186/ar581; Takeda K, 2014, CLIN IMMUNOL, V151, P25, DOI 10.1016/j.clim.2014.01.004; Staines-Boone AT, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00075; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tan C, 2016, TURKISH J PEDIATR, V58, P356, DOI 10.24953/turkjped.2016.04.002; Taur PD, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.631298; Thumbigere-Math V, 2019, J BONE MINER RES, V34, P1155, DOI 10.1002/jbmr.3690; Tsumura M, 2012, HUM MUTAT, V33, P1377, DOI 10.1002/humu.22113; Ueki M, 2017, CLIN IMMUNOL, V174, P24, DOI 10.1016/j.clim.2016.11.004; ul Akbar N, 2019, IMMUNOL RES, V67, P408, DOI 10.1007/s12026-019-09094-8; Vairo D, 2011, BLOOD, V118, P1806, DOI 10.1182/blood-2011-01-330571; Villella A, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e47; Vinh DC, 2009, CLIN INFECT DIS, V49, pE62, DOI 10.1086/605532; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Wang Quan, 2014, Zhonghua Er Ke Za Zhi, V52, P387; Wu UI, 2016, SEMIN IMMUNOPATHOL, V38, P199, DOI 10.1007/s00281-015-0552-y; Xia XL, 2020, CYTOKINE GROWTH F R, V55, P48, DOI 10.1016/j.cytogfr.2020.03.003; Xiong Q, 2016, JOINT BONE SPINE, V83, P276, DOI 10.1016/j.jbspin.2015.07.010; Ying WJ, 2019, J CLIN IMMUNOL, V39, P600, DOI 10.1007/s10875-019-00672-x; Zerbe CS, 2005, CLIN INFECT DIS, V41, pE38, DOI 10.1086/432120; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018; Zhou XP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215648	131	3	3	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					252	+		10.1016/j.jaci.2021.05.018	http://dx.doi.org/10.1016/j.jaci.2021.05.018			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	34176646	Green Submitted			2022-12-18	WOS:000741453800007
J	Altman, MC; Flynn, K; Rosasco, MG; Dapas, M; Kattan, M; Lovinsky-Desir, S; O'Connor, GT; Gill, MA; Gruchalla, RS; Liu, AH; Pongracic, JA; Hershey, GKK; Zoratti, EM; Teach, SJ; Rastrogi, D; Wood, RA; Bacharier, LB; LeBeau, P; Gergen, PJ; Togias, A; Busse, WW; Presnell, S; Gern, JE; Ober, C; Jackson, DJ				Altman, Matthew C.; Flynn, Kaitlin; Rosasco, Mario G.; Dapas, Matthew; Kattan, Meyer; Lovinsky-Desir, Stephanie; O'Connor, George T.; Gill, Michelle A.; Gruchalla, Rebecca S.; Liu, Andrew H.; Pongracic, Jacqueline A.; Hershey, Gurjit K. Khurana; Zoratti, Edward M.; Teach, Stephen J.; Rastrogi, Deepa; Wood, Robert A.; Bacharier, Leonard B.; LeBeau, Petra; Gergen, Peter J.; Togias, Alkis; Busse, William W.; Presnell, Scott; Gern, James E.; Ober, Carole; Jackson, Daniel J.		NIAID Inner City Asthma Consortium	Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; expression quantitative trait; MUC5AC	GENOME-WIDE; HAY-FEVER; ASSOCIATION; RISK; LATINO; ECZEMA	Background: Mucus plugging can worsen asthma control, lead to reduced lung function and fatal exacerbations. MUC5AC is the secretory mucin implicated in mucus plugging, and MUC5AC gene expression has been associated with development of airway obstruction and asthma exacerbations in urban children with asthma. However, the genetic determinants of MUC5AC expression are not established. Objectives: This study sought to assess single-nucleotide polymorphisms (SNPs) that influence MUC5AC expression and relate to pulmonary functions in childhood asthma. Methods: This study used RNA-sequencing data from upper airway samples and performed cis-expression quantitative trait loci (eQTL) and allele-specific expression analyses in 2 cohorts of predominantly Black and Hispanic urban children, a high asthma-risk birth cohort, and an exacerbation-prone asthma cohort. Inducible MUC5AC eQTLs were further investigated during incipient asthma exacerbations. Significant eQTLs SNPs were tested for associations with lung function measurements and their functional consequences were investigated in DNA regulatory databases. Results: Two independent groups of SNPs in the MUC5AC gene that were significantly associated with MUC5AC expression were identified. Moreover, these SNPs showed stronger eQTL associations with MUC5AC expression during asthma exacerbations, which is consistent with inducible expression. SNPs in 1 group also showed significant association with decreased pulmonary functions. These SNPs included multiple EGR1 transcription factor binding sites, suggesting a mechanism of effect. Conclusions: These findings demonstrate the applicability of organ-specific RNA-sequencing data to determine genetic factors contributing to a key disease pathway. Specifically, they suggest important genetic variations that may underlie propensity to mucus plugging in asthma and could be important in targeted asthma phenotyping and disease management strategies. (J Allergy Clin Immunol 2021;148:1505-14.)	[Altman, Matthew C.] Univ Washington, Dept Med, Seattle, WA USA; [Altman, Matthew C.; Flynn, Kaitlin; Rosasco, Mario G.; Presnell, Scott] Benaroya Res Inst, Seattle, WA 98101 USA; [Dapas, Matthew; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kattan, Meyer; Lovinsky-Desir, Stephanie] Columbia Univ, New York, NY USA; [O'Connor, George T.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Gill, Michelle A.; Gruchalla, Rebecca S.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Liu, Andrew H.] Univ Colorado, Sch Med, Childrens Hosp, Aurora, CO USA; [Pongracic, Jacqueline A.] Ann Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Zoratti, Edward M.] Henry Ford Hlth Syst, Detroit, MI USA; [Teach, Stephen J.; Rastrogi, Deepa] Childrens Natl Hosp, Washington, DC USA; [Wood, Robert A.] Johns Hopkins Univ, Dept Pediat, Med Ctr, Baltimore, MD 21218 USA; [Bacharier, Leonard B.] Washington Univ, St Louis, MO 63110 USA; [LeBeau, Petra] Rho Inc, Chapel Hill, NC USA; [Gergen, Peter J.; Togias, Alkis] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Busse, William W.; Gern, James E.; Jackson, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Chicago; Columbia University; Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Ann & Robert H. Lurie Children's Hospital of Chicago; Cincinnati Children's Hospital Medical Center; Henry Ford Health System; Henry Ford Hospital; Children's National Health System; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); Rho; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison	Altman, MC (corresponding author), Benaroya Res Inst, Syst Immunol Div, 1201 Ninth Ave, Seattle, WA 98101 USA.	maltman@benaroyaresearch.org			National Institute of Allergy and Infectious Diseases through the Inner City Asthma Consortium [UM1 AI11427]	National Institute of Allergy and Infectious Diseases through the Inner City Asthma Consortium	This work in this study was funded by the National Institute of Allergy and Infectious Diseases through the Inner City Asthma Consortium (UM1 AI11427).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Altman MC, 2021, J ALLERGY CLIN IMMUN, V148, P1198, DOI 10.1016/j.jaci.2021.02.040; Altman MC, 2019, NAT IMMUNOL, V20, P637, DOI 10.1038/s41590-019-0347-8; Bonser LR, 2016, J CLIN INVEST, V126, P2367, DOI 10.1172/JCI84910; Boucher RC, 2019, NEW ENGL J MED, V380, P1941, DOI 10.1056/NEJMra1813799; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Evans CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7281; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Gern James E, 2009, BMC Pulm Med, V9, P17, DOI 10.1186/1471-2466-9-17; Graffelman J, 2015, J STAT SOFTW, V64, P1; Guo XL, 2014, AM J RESP CELL MOL, V50, P223, DOI 10.1165/rcmb.2013-0235OC; Guo XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025452; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Johnson L, 2013, RESPIROLOGY, V18, P1003, DOI 10.1111/resp.12092; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuyper LM, 2003, AM J MED, V115, P6, DOI 10.1016/S0002-9343(03)00241-9; Lesurf R, 2016, NUCLEIC ACIDS RES, V44, pD126, DOI 10.1093/nar/gkv1203; Lira-Navarrete E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7937; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; MESSER JW, 1960, DIS CHEST, V38, P616, DOI 10.1378/chest.38.6.616; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mohammadi P, 2017, GENOME RES, V27, P1872, DOI 10.1101/gr.216747.116; Naqvi M, 2008, ANN ALLERG ASTHMA IM, V100, P551, DOI 10.1016/S1081-1206(10)60055-5; Neophytou AM, 2016, AM J RESP CRIT CARE, V193, P1271, DOI 10.1164/rccm.201508-1706OC; Ober C, 2016, ANN AM THORAC SOC, V13, pS85, DOI 10.1513/AnnalsATS.201507-459MG; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; Ramana CV, 2009, MOL IMMUNOL, V47, P623, DOI 10.1016/j.molimm.2009.09.001; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shin J-H, 2006, J STAT SOFTW, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Shrine N, 2019, LANCET RESP MED, V7, P20, DOI 10.1016/S2213-2600(18)30389-8; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Urquhart A, 2020, J ASTHMA, V57, P510, DOI 10.1080/02770903.2019.1590588; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Wang SB, 2017, BIOCHEM BIOPH RES CO, V490, P147, DOI 10.1016/j.bbrc.2017.06.014; Xu F, 2018, TOXICOL LETT, V294, P145, DOI 10.1016/j.toxlet.2018.05.003; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1	47	3	3	3	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1505	1514		10.1016/j.jaci.2021.04.035	http://dx.doi.org/10.1016/j.jaci.2021.04.035		DEC 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM1ZO		Green Accepted			2022-12-18	WOS:000728634000017
J	Mullol, J; Boyce, J; Dahl, SE; Dahlen, B; Picado, C; Bobolea, I				Mullol, Joaquim; Boyce, Joshua; Dahl, Sven-Erik; Dahlen, Barbro; Picado, Cesar; Bobolea, Irina			Eicosanoid dysregulation and type 2 inflammation in AERD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Prostaglandin; leukotrienes; type 2 inflammation; NSAIDs; AERD	EXACERBATED RESPIRATORY-DISEASE; CHRONIC RHINOSINUSITIS; ASPIRIN; ASTHMA		[Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Rhinol Unit & Smell Clin, Barcelona, Spain; [Mullol, Joaquim; Picado, Cesar; Bobolea, Irina] IDIBAPS, Clin & Expt Resp Immunoallergy, Barcelona, Spain; [Mullol, Joaquim; Picado, Cesar; Bobolea, Irina] CIBER Resp Dis CIBERES, Barcelona, Spain; [Boyce, Joshua] Brigham & Womens Hosp, Allergy & Immunol Div, 75 Francis St, Boston, MA 02115 USA; [Dahl, Sven-Erik; Dahlen, Barbro] Karolinska Inst, Expt Asthma & Allergy Res, Inst Environm Med IMM, Stockholm, Sweden; [Dahl, Sven-Erik; Dahlen, Barbro] Karolinska Univ Hosp, Dept Resp Med, Stockholm, Sweden; [Picado, Cesar] Univ Barcelona, Barcelona, Spain; [Bobolea, Irina] Hosp Clin Barcelona, Allergy Sect, Pulmonol & Allergy Dept, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Harvard University; Brigham & Women's Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Mullol, J (corresponding author), Hosp Clin Barcelona, IDIBAPS, C Villarroel 170, Barcelona 08036, Spain.	jmullol@clinic.cat	BOBOLEA, IRINA/AFR-1732-2022	BOBOLEA, IRINA/0000-0002-7425-2417				Buchheit KM, 2016, J ALLERGY CLIN IMMUN, V137, P1566, DOI 10.1016/j.jaci.2015.10.020; Hayashi H, 2020, AM J RESP CRIT CARE, V201, P1488, DOI 10.1164/rccm.201906-1215OC; Kowalski ML, 2019, ALLERGY, V74, P28, DOI 10.1111/all.13599; Laidlaw TM, 2021, J ALLER CL IMM-PRACT, V9, P1133, DOI 10.1016/j.jaip.2020.09.063; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Mustafa SS, 2021, AM J RHINOL ALLERGY, V35, P399, DOI 10.1177/1945892420961969; Safholm J, 2015, J ALLERGY CLIN IMMUN, V136, P1232, DOI 10.1016/j.jaci.2015.04.002; Stevens WW, 2021, J ALLERGY CLIN IMMUN, V147, P827, DOI 10.1016/j.jaci.2020.10.043; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; Takahashi T, 2017, J ALLERGY CLIN IMMUN, V140, P720, DOI 10.1016/j.jaci.2017.01.022	10	3	3	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1157	1160		10.1016/j.jaci.2021.08.015	http://dx.doi.org/10.1016/j.jaci.2021.08.015		NOV 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	34464635	Bronze			2022-12-18	WOS:000717415000011
J	Zimmermann, N; Abonia, JP; Dreskin, SC; Akin, C; Bolton, S; Happel, CS; Geller, M; Larenas-Linnemann, D; Nanda, A; Peterson, K; Wasan, A; Wechsler, J; Zhang, SM; Bernstein, JA				Zimmermann, Nives; Abonia, J. Pablo; Dreskin, Stephen C.; Akin, Cem; Bolton, Scott; Happel, Corinne S.; Geller, Mario; Larenas-Linnemann, Desiree; Nanda, Anil; Peterson, Kathryn; Wasan, Anita; Wechsler, Joshua; Zhang, Simin; Bernstein, Jonathan A.			Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Systemic mastocytosis; cutaneous mastocytosis; biopsy; mast cells; eosinophils; bone marrow; skin; gastrointestinal tract; work group; consensus; allergy; dermatology; pathology; gastroenterology	IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; MAJOR BASIC-PROTEIN; SYSTEMIC MASTOCYTOSIS; GASTROINTESTINAL-TRACT; KIT D816V; MYELOPROLIFERATIVE DISORDER; MYELOID/LYMPHOID NEOPLASM; RISK-STRATIFICATION; THERAPEUTIC TARGET; MYELOID-LEUKEMIA	Mast cells and eosinophils are commonly found, expectedly or unexpectedly, in human tissue biopsies. Although the clinical significance of their presence, absence, quantity, and quality continues to be investigated in homeostasis and disease, there are currently gaps in knowledge related to what constitutes quantitatively relevant increases in mast cell and eosinophil number in tissue specimens for several clinical conditions. Diagnostically relevant thresholds of mast cell and eosinophil numbers have been proposed and generally accepted by the medical community for a few conditions, such as systemic mastocytosis and eosinophilic esophagitis. However, for other mast cell- and eosinophil-associated disorders, broad discrepancies remain regarding diagnostic thresholds and how samples are processed, routinely and/or specially stained, and interpreted and/or reported by pathologists. These discrepancies can obfuscate or delay a patient's correct diagnosis. Therefore, a work group was assembled to review the literature and develop a standardized consensus for assessing the presence of mast cells and eosinophils for a spectrum of clinical conditions, including systemic mastocytosis and cutaneous mastocytosis, mast cell activation syndrome, eosinophilic esophagitis, eosinophilic gastritis/enteritis, and hypereosinophilia/hypereosinophilic syndrome. The intent of this work group is to build a consensus among pathology, allergy, dermatology, hematology/oncology, and gastroenterology stakeholders for qualitatively and quantitatively assessing mast cells and eosinophils in skin, gastrointestinal, and bone marrow pathologic specimens for the benefit of clinical practice and patients. (J Allergy Clin Immunol 2021;148:964-83.)	[Zimmermann, Nives; Abonia, J. Pablo] Univ Cincinnati, Dept Pathol, Coll Med, Cincinnati, OH 45367 USA; [Zimmermann, Nives; Abonia, J. Pablo] Univ Cincinnati, Dept Lab Med, Coll Med, Cincinnati, OH 45367 USA; [Abonia, J. Pablo; Bolton, Scott] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45367 USA; [Zhang, Simin; Bernstein, Jonathan A.] Univ Cincinnati, Coll Med, Allergy Sect, Div Immunol,Dept Internal Med, Cincinnati, OH 45367 USA; [Zimmermann, Nives] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Happel, Corinne S.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; [Happel, Corinne S.] Cincinnati Childrens Hosp Med Ctr, Div Hepatol, Cincinnati, OH 45229 USA; [Happel, Corinne S.] Cincinnati Childrens Hosp Med Ctr, Div Nutr, Cincinnati, OH 45229 USA; [Dreskin, Stephen C.] Univ Colorado, Dept Internal Med, Div Allergy & Immunol, Aurora, CO USA; [Akin, Cem] Univ Michigan, Dept Internal Med, Div Allergy & Immunol, Ann Arbor, MI 48109 USA; [Happel, Corinne S.] Johns Hopkins Sch Med, Dept Internal Med, Div Allergy & Immunol, Baltimore, MD USA; [Geller, Mario] Acad Med Rio de Janeiro, Dept Med, Rio De Janeiro, Brazil; [Nanda, Anil] Hosp Med Sur, Ctr Excelencia Asma & Alergia, Ciudad De Mexico, Mexico; [Nanda, Anil] Asthma & Allergy Ctr, Lewisville, TX USA; [Nanda, Anil] Asthma & Allergy Ctr, Flower Mound, TX USA; [Nanda, Anil] Univ Texas Southwestern Med Ctr Dallas, Div Allergy & Immunol, Dallas, TX 75390 USA; [Peterson, Kathryn] Univ Utah, Hlth Sci Ctr, Dept Med, Div Gastroenterol, Salt Lake City, UT USA; [Wasan, Anita] Allergy & Asthma Ctr, Div Gastroenterol Hepatol & Nutr, Mclean, VA USA; [Wechsler, Joshua] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Allergy & Immunol, Chicago, IL USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Utah System of Higher Education; University of Utah; Ann & Robert H. Lurie Children's Hospital of Chicago	Bernstein, JA (corresponding author), Univ Cincinnati, Div Immunol, Allergy Sect, Coll Med, 231 Albert Cabin Way,ML 563, Cincinnati, OH 45367 USA.	bernstja@ucmail.uc.edu			National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [U54 AI117804, R01 AI124355-01]; Patient-Centered Outcomes Research Institute [SC14-1403-11593]	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI)	PA has received grants from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (U54 AI117804 and R01 AI124355-01), the Patient-Centered Outcomes Research Institute (SC14-1403-11593), and Shire/Takeda. SCD has received grant support from the NIH and Genentech, Inc; is a member of theMedical Expert Panel, Department of Health and Human Services, and Division of Vaccine Injury Compensation; and serves on an advisory board and/or is a consultant for Allakos, CSL Behring, BioCryst, Grifols, and Ukko. CA has received research grant support from Blueprint Medicines and is a consultant for Blueprint Medicine and Novartis. DL-L has received personal fees from Allakos, Amstrong, AstraZeneca, DBV Technologies, Grunenthal, GlaxoSmithKline, MEDA, Mylan, Menarini, Merck Sharp and Dohme, Novartis, Pfizer, Sanofi, Siegfried, UCB, and Gossamer; and grants from Sanofi, AstraZeneca, Novartis, UCB, GlaxoSmithKline, Teva, and the Purina Institute. KP has received equity in Nexeos; research support from AstraZeneca, Ellodi, Sanofi-Regeneron, and Adare; independent grants from the NIH, Chobani, and Allakos; and consulting/advisory board fees fromAlladapt, Eli Lily, Medscape, Ellodi, and Takeda. JBW has received consulting fees for medical advisory boards for Allakos andRegeneron. JABis a consultant principal investigator for Blueprint Medicine, Celldex, Allakos, AstraZeneca, Sanofi-Regeneron, Novartis, Genentech, Shire/Takeda, CSL Behring, Pharming, Biomarin, Kalvista, Ionis, and Merck; and speaker for GlaxoSmithKline, Sanofi-Regeneron, AstraZeneca, Novartis, Genentech, Pharming, Optinose, CSL Behring, and Shire/Takeda. The rest of the authors declare that they have no relevant conflicts of interest.	Abonia JP, 2010, J ALLERGY CLIN IMMUN, V126, P140, DOI 10.1016/j.jaci.2010.04.009; Accioly JW, 2000, J EUR ACAD DERMATOL, V14, P75, DOI 10.1046/j.1468-3083.2000.00021.x; Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Alsaad KO, 2005, J CLIN PATHOL, V58, P1233, DOI 10.1136/jcp.2005.027151; Alvarez-Twose I, 2016, J ALLERGY CLIN IMMUN, V137, P168, DOI 10.1016/j.jaci.2015.05.008; Alvarez-Twose I, 2012, J CLIN ONCOL, V30, pE126, DOI 10.1200/JCO.2011.38.9973; Arock M, 2015, LEUKEMIA, V29, P1223, DOI 10.1038/leu.2015.24; Bain BJ, 1996, BRIT J HAEMATOL, V95, P2; Baird JH, 2018, CURR HEMATOL MALIG R, V13, P407, DOI 10.1007/s11899-018-0469-3; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Bashashati M, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13192; Behdad A, 2013, ARCH PATHOL LAB MED, V137, P1220, DOI 10.5858/arpa.2013-0271-CR; Blatt K, 2015, BLOOD, V126, P2832, DOI 10.1182/blood-2015-03-637728; Bolton SM, 2020, AM J GASTROENTEROL, V115, P224, DOI 10.14309/ajg.0000000000000474; Caldwell JM, 2014, J ALLERGY CLIN IMMUN, V134, P1114, DOI 10.1016/j.jaci.2014.07.026; Cancian M, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-018-0316-z; Carlson JA, 2010, HISTOPATHOLOGY, V56, P3, DOI 10.1111/j.1365-2559.2009.03443.x; Carter MC, 2015, J ALLERGY CLIN IMMUN, V136, P1673, DOI 10.1016/j.jaci.2015.04.024; Chernetsova E, 2016, HUM PATHOL, V54, P55, DOI 10.1016/j.humpath.2016.03.004; Cho YT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061243; Chonabayashi K, 2014, ANN HEMATOL, V93, P535, DOI 10.1007/s00277-013-1843-9; Choudhary Sonal, 2013, J Clin Aesthet Dermatol, V6, P31; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Collins MH, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12470; Collins MH, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00261; Comfere NI, 2014, INT J DERMATOL, V53, P549, DOI 10.1111/ijd.12330; de Graauw E, 2015, IMMUNOL ALLERGY CLIN, V35, P545, DOI 10.1016/j.iac.2015.05.005; DeBrosse CW, 2006, PEDIATR DEVEL PATHOL, V9, P210, DOI 10.2350/11-05-0130.1; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dominguez-Cherit J, 2015, DERMATOL CLIN, V33, P273, DOI 10.1016/j.det.2014.12.008; Doyle LA, 2014, IMMUNOL ALLERGY CLIN, V34, P323, DOI 10.1016/j.iac.2014.01.010; Doyle LA, 2014, AM J SURG PATHOL, V38, P832, DOI 10.1097/PAS.0000000000000190; Durham SR, 1999, CLIN EXP ALLERGY, V29, P1490; Egawa G, 2018, ALLERGOL INT, V67, P3, DOI 10.1016/j.alit.2017.10.002; Elvevi A, 2011, WORLD J GASTROENTERO, V17, P3948, DOI 10.3748/wjg.v17.i34.3948; Escribano L, 2009, J ALLERGY CLIN IMMUN, V124, P514, DOI 10.1016/j.jaci.2009.05.003; Falchi L, 2014, LEUKEMIA, V28, P2090, DOI 10.1038/leu.2014.168; Fang H, 2018, AM J CLIN PATHOL, V150, P421, DOI [10.1093/AJCP/AQY064, 10.1093/ajcp/aqy064]; FILLEY WV, 1982, LANCET, V2, P11; FLAUM MA, 1981, BLOOD, V58, P1012; Frings VG, 2018, AM J DERMATOPATH, V40, P7, DOI 10.1097/DAD.0000000000000842; Giannetti MP, 2021, J ALLERGY CLIN IMMUN, V147, P1497, DOI 10.1016/j.jaci.2020.11.017; Gotlib J, 2017, AM J HEMATOL, V92, P1243, DOI 10.1002/ajh.24880; Gotlib J, 2016, NEW ENGL J MED, V374, P2530, DOI 10.1056/NEJMoa1513098; Grand FH, 2007, EXP HEMATOL, V35, P1723, DOI 10.1016/j.exphem.2007.07.002; Guilarte M, 2007, GUT, V56, P203, DOI 10.1136/gut.2006.100594; Hahn HP, 2007, AM J SURG PATHOL, V31, P1669, DOI 10.1097/PAS.0b013e318078ce7a; Hamilton MJ, 2021, AM J SURG PATHOL, V45, P997, DOI 10.1097/PAS.0000000000001676; Hartmann K, 2016, J ALLERGY CLIN IMMUN, V137, P35, DOI 10.1016/j.jaci.2015.08.034; Heuser M, 2016, DTSCH ARZTEBL INT, V113, P317, DOI 10.3238/arztebl.2016.0317; Hoermann G, 2014, FASEB J, V28, P3540, DOI 10.1096/fj.14-250894; Hoffmann KM, 2008, BLOOD, V112, P1655, DOI 10.1182/blood-2008-03-147785; Hollmann TJ, 2008, AM J SURG PATHOL, V32, P139, DOI 10.1097/PAS.0b013e3180ca9a02; Horny HP, 2010, PATHOBIOLOGY, V77, P169, DOI 10.1159/000305552; Horny HP, 1998, AM J SURG PATHOL, V22, P1132, DOI 10.1097/00000478-199809000-00013; Horny HP, 2004, J CLIN PATHOL, V57, P604, DOI 10.1136/jcp.2003.014860; Huang LS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004934; Hull C., 2019, APPROACH PATIENT CUT; Itoh E, 2017, J ALLERGY CLIN IMMUN, V139, P363, DOI 10.1016/j.jaci.2016.06.049; Jaffe ES, 2001, WHO CLASSIFICATION T; Jakate S, 2006, ARCH PATHOL LAB MED, V130, P362; Janssens AS, 2005, J CLIN PATHOL, V58, P285, DOI 10.1136/jcp.2004.017210; Jawhar M, 2017, LEUKEMIA, V31, P2271, DOI 10.1038/leu.2017.240; Jawhar M, 2016, LEUKEMIA, V30, P2342, DOI 10.1038/leu.2016.190; Jawhar M, 2016, LEUKEMIA, V30, P136, DOI 10.1038/leu.2015.284; Karray M, 2020, KAPOSI VARICELLIFORM; KAWABORI S, 1992, AM J RESP CELL MOL, V6, P37, DOI 10.1165/ajrcmb/6.1.37; Khoury P, 2018, J ALLER CL IMM-PRACT, V6, P1446, DOI 10.1016/j.jaip.2018.04.030; Krauth MT, 2007, EXP HEMATOL, V35, P108, DOI 10.1016/j.exphem.2006.09.008; Kristensen T, 2013, DERMATOLOGY, V226, P233, DOI 10.1159/000349986; Kristensen T, 2013, EUR J HAEMATOL, V91, P106, DOI 10.1111/ejh.12128; KUECK BD, 1991, HEMATOL PATHOL, V5, P195; Lee JK, 2008, WORLD J GASTROENTERO, V14, P7005, DOI 10.3748/wjg.14.7005; Lee JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185602; Lee SH, 2008, INT J LAB HEMATOL, V30, P349, DOI 10.1111/j.1751-553X.2008.01100.x; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; Leiferman KM, 2018, J ALLER CL IMM-PRACT, V6, P1462, DOI 10.1016/j.jaip.2018.06.002; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Llamas-Velasco M, 2012, ACTAS DERMO-SIFILOGR, V103, P12, DOI [10.1016/j.ad.2011.05.007, 10.1016/j.adengl.2011.05.005]; LLOYD G, 1975, GUT, V16, P861, DOI 10.1136/gut.16.11.861; LOMAZI Elizete Aparecida, 2017, Arq. Gastroenterol., V54, P192, DOI [10.1590/s0004-2803.201700000-23, 10.1590/S0004-2803.201700000-23]; Long H, 2016, CLIN REV ALLERG IMMU, V50, P189, DOI 10.1007/s12016-015-8485-8; Lykkegaard C, 2015, ONCOTARGET, V6, P40588, DOI 10.18632/oncotarget.5845; Lyons JJ, 2016, NAT GENET, V48, P1564, DOI 10.1038/ng.3696; Lyons JJ, 2014, J ALLERGY CLIN IMMUN, V133, P1471, DOI 10.1016/j.jaci.2013.11.039; Maccaferri M, 2017, LEUKEMIA LYMPHOMA, V58, P489, DOI 10.1080/10428194.2016.1197396; Maric I, 2007, J ALLERGY CLIN IMMUN, V120, P680, DOI 10.1016/j.jaci.2007.05.024; Martin LJ, 2015, J ALLERGY CLIN IMMUN, V135, P1519, DOI 10.1016/j.jaci.2015.03.004; MEHREGAN DR, 1992, J AM ACAD DERMATOL, V26, P441, DOI 10.1016/0190-9622(92)70069-R; Mital A, 2011, EUR J HAEMATOL, V86, P531, DOI 10.1111/j.1600-0609.2011.01598.x; Morgado JM, 2013, HISTOPATHOLOGY, V63, P780, DOI 10.1111/his.12221; Morgado Jose Mario, 2014, Methods Mol Biol, V1192, P205, DOI 10.1007/978-1-4939-1173-8_16; Mueller S, 2006, J CLIN PATHOL, V59, P1175, DOI 10.1136/jcp.2005.031922; National Academies of Sciences Engineering and Medicine., 2015, IMPR DIAGN HLTH CAR; Naumann N, 2018, GENE CHROMOSOME CANC, V57, P252, DOI 10.1002/gcc.22526; Nelson M, 2021, NEUROGASTROENT MOTIL, V33, DOI 10.1111/nmo.14055; O'Neill M, 2010, J CUTAN PATHOL, V37, P919, DOI 10.1111/j.1600-0560.2009.01414.x; O'Sullivan M, 2000, NEUROGASTROENT MOTIL, V12, P449; Ortonne N, 2015, BRIT J DERMATOL, V173, P50, DOI 10.1111/bjd.13683; Pardanani A, 2016, AM J HEMATOL, V91, P1147, DOI 10.1002/ajh.24553; Pardanani A, 2010, BLOOD, V115, P150, DOI 10.1182/blood-2009-10-249979; Pardanani A, 2009, BLOOD, V114, P3769, DOI 10.1182/blood-2009-05-220145; Pardanani AD, 2016, BRIT J HAEMATOL, V175, P534, DOI 10.1111/bjh.13865; Protheroe C, 2009, CLIN GASTROENTEROL H, V7, P749, DOI 10.1016/j.cgh.2009.03.022; Ramsey ML, 2020, SKIN BIOPSY; Ravindran A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02193; Reichard KK, 2015, AM J CLIN PATHOL, V144, P493, DOI 10.1309/AJCPSGQ71GJQQACL; Ribatti D, 2009, CANCER LETT, V279, P209, DOI 10.1016/j.canlet.2009.01.039; Ribatti D, 2018, INT ARCH ALLERGY IMM, V176, P55, DOI 10.1159/000487538; Saad AG, 2011, PEDIATR DEVEL PATHOL, V14, P294, DOI 10.2350/10-07-0878-OA.1; Santos DD, 2006, CLIN LYMPHOMA MYELOM, V6, P478, DOI 10.3816/CLM.2006.n.029; SARIN SK, 1987, DIGEST DIS SCI, V32, P363, DOI 10.1007/BF01296289; Sato Tomotaka, 2017, Med Mycol J, V58, pE71, DOI 10.3314/mmj.17.006; Scolapio JS, 1996, GASTROINTEST ENDOSC, V44, P608, DOI 10.1016/S0016-5107(96)70019-6; Shah S, 2018, AM J HEMATOL, V93, P1461, DOI 10.1002/ajh.25265; Shih AR, 2016, HISTOPATHOLOGY, V69, P1021, DOI 10.1111/his.13033; Shwin KW, 2017, DERMATOL CLIN, V35, P21, DOI 10.1016/j.det.2016.07.005; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Sotlar K, 2011, MODERN PATHOL, V24, P585, DOI 10.1038/modpathol.2010.224; Sperr WR, 2001, LEUKEMIA RES, V25, P529, DOI 10.1016/S0145-2126(01)00041-8; Strasser DS, 2018, HISTOPATHOLOGY, V73, P454, DOI 10.1111/his.13653; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; STROBEL S, 1981, J CLIN PATHOL, V34, P851, DOI 10.1136/jcp.34.8.851; Sundram UN, 2007, J CUTAN PATHOL, V34, P289, DOI 10.1111/j.1600-0560.2006.00602.x; Swerdlow SH., 2008, WHO CLASSIFICATION T, V2; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Takahashi M, 2016, FORENSIC SCI INT, V266, P14, DOI 10.1016/j.forsciint.2016.04.025; Tan A, 2006, CLIN CHEM, V52, P2250, DOI 10.1373/clinchem.2006.068205; Tappata M, 2018, ALLERGY, V73, P2088, DOI 10.1111/all.13530; Tison BE, 2010, J ALLERGY CLIN IMMUN, V125, pAB182, DOI 10.1016/j.jaci.2009.12.713; Vajpeyi R., 2016, DIAGNOSTIC HISTOPATH, V22, P167, DOI DOI 10.1016/J.MPDHP.2016.04.005; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893; Valent P, 2017, CANCER RES, V77, P1261, DOI 10.1158/0008-5472.CAN-16-2234; Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019; Vu H, 2006, LEUKEMIA, V20, P1414, DOI 10.1038/sj.leu.2404266; Walz C, 2011, BLOOD, V118, P2239, DOI 10.1182/blood-2011-03-343426; Wang SA, 2017, HAEMATOLOGICA, V102, P1352, DOI 10.3324/haematol.2017.165340; Wang SA, 2016, MODERN PATHOL, V29, P854, DOI 10.1038/modpathol.2016.75; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Watkins CE, 2011, DERMATOL REP, V3, P23, DOI 10.4081/dr.2011.e12; Weaver J, 2009, ARCH PATHOL LAB MED, V133, P1490, DOI 10.1043/1543-2165-133.9.1490; Weber A, 2003, BRIT J DERMATOL, V148, P224, DOI 10.1046/j.1365-2133.2003.05090.x; Weiler CR, 2019, J ALLERGY CLIN IMMUN, V144, P883, DOI 10.1016/j.jaci.2019.08.023; WELLER PF, 1994, BLOOD, V83, P2759, DOI 10.1182/blood.V83.10.2759.2759; Wilcox RA, 2017, AM J HEMATOL, V92, P1085, DOI 10.1002/ajh.24876; Willetts L, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-116; Wright BL, 2011, NEW ENGL J MED, V365, P187, DOI 10.1056/NEJMc1103005; Zaliova M, 2016, HAEMATOLOGICA, V101, P1082, DOI 10.3324/haematol.2016.144345; Zare-Mirzaie A, 2012, SAUDI J GASTROENTERO, V18, P322, DOI 10.4103/1319-3767.101128; Zhang LY, 2006, LEUKEMIA RES, V30, P373, DOI 10.1016/j.leukres.2005.08.015; Zimmermann N, 2020, CANCER GENET-NY, V244, P55, DOI 10.1016/j.cancergen.2020.03.002	154	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					964	983		10.1016/j.jaci.2021.06.030	http://dx.doi.org/10.1016/j.jaci.2021.06.030		OCT 2021	20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	34384610	Bronze			2022-12-18	WOS:000705023300005
J	Gulen, T; Teufelberger, A; Ekoff, M; Westerberg, CM; Lyberg, K; Dahlen, SE; Dahlen, B; Nilsson, G				Gulen, Theo; Teufelberger, Andrea; Ekoff, Maria; Westerberg, Christine Moller; Lyberg, Katarina; Dahlen, Sven-Erik; Dahlen, Barbro; Nilsson, Gunnar			Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mastocytosis; anaphylaxis; tryptase; mast cell; plasma proteomic; PAPP-A; galectin-3; allergin-1; TPSAB1	PROTEIN-A; ALLERGIN-1; ASTHMA	Background: Mastocytosis encompasses a heterogeneous group of disorders characterized by accumulation of clonal mast cells (MCs) in the skin and/or internal organs. Patients typically present with a broad variety of recurrent mediator-related clinical symptoms, including severe anaphylaxis. However, not all patients with mastocytosis experience anaphylactic reactions. Objective: We sought to identify disease-specific biomarkers in plasma that could be used to predict patients with mastocytosis with increased risk of anaphylaxis. Methods: Nineteen patients (>_18 years) and 2 control groups (11 subjects with allergic asthma and 13 healthy volunteers without history of atopy) were recruited. In total, 248 plasma proteins were analyzed by Proximity Extension Assay using Olink Proseek Multiplex panels. Results: We identified 4 novel proteins, in addition to tryptase, E-selectin, adrenomedullin, T-cell immunoglobulin, and mucin domain 1, and CUB domain-containing protein 1/CD138 to be significantly increased in patients with mastocytosis compared with both patients with asthma and healthy controls. Furthermore, we investigated whether we could discriminate between patients with mastocytosis with or without anaphylaxis. In addition to tryptase, we identified 3 novel proteins, that is, allergin-1, pregnancy-associated plasma protein-A, and galectin-3, with significantly different levels in patients with mastocytosis with anaphylaxis compared with those without anaphylaxis. Conclusions: Newly identified proteomic biomarkers may be used to predict patients with mastocytosis with increased risk of anaphylaxis. (J Allergy Clin Immunol 2021;148:889-94.)	[Gulen, Theo; Dahlen, Barbro] Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden; [Gulen, Theo; Dahlen, Barbro] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden; [Gulen, Theo; Teufelberger, Andrea; Ekoff, Maria; Westerberg, Christine Moller; Lyberg, Katarina; Nilsson, Gunnar] Karolinska Inst, Div Immunol & Allergy, Dept Med Solna, Stockholm, Sweden; [Gulen, Theo; Teufelberger, Andrea; Ekoff, Maria; Westerberg, Christine Moller; Lyberg, Katarina; Nilsson, Gunnar] Karolinska Univ Hosp, Clin Immunol & Transfus Med, Stockholm, Sweden; [Gulen, Theo; Teufelberger, Andrea; Ekoff, Maria; Westerberg, Christine Moller; Lyberg, Katarina; Dahlen, Sven-Erik; Dahlen, Barbro; Nilsson, Gunnar] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Gulen, Theo; Teufelberger, Andrea; Ekoff, Maria; Westerberg, Christine Moller; Lyberg, Katarina; Dahlen, Barbro; Nilsson, Gunnar] Karolinska Univ Hosp, Mastocytosis Ctr Karolinska, Stockholm, Sweden; [Gulen, Theo; Teufelberger, Andrea; Ekoff, Maria; Westerberg, Christine Moller; Lyberg, Katarina; Dahlen, Barbro; Nilsson, Gunnar] Karolinska Inst, Stockholm, Sweden; [Dahlen, Barbro] Inst Environm Med, Karolinska Inst, Expt Allergy & Asthma Res, Stockholm, Sweden; [Nilsson, Gunnar] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Uppsala University	Gulen, T (corresponding author), Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden.	theo.gulen@sll.se	Gulen, Theo/D-8682-2018	Gulen, Theo/0000-0002-1683-8882; Teufelberger, Andrea/0000-0002-1142-949X	Swedish Research Council - Medicine and Health; Swedish Cancer Society; Swedish Heart-Lung Foundation; Ellen, Walter and Lennart Hesselman's Foundation; Konsul ThC Berghs Foundation; Stockholm County Council Research Funds (ALF); ChAMP (Centre for Allergy Research Highlights Asthma Markers of Phenotype) consortium - Swedish Foundation for Strategic Research; AstraZeneca; Karolinska Institutet; Science for Life Laboratory Joint Research Collaboration	Swedish Research Council - Medicine and Health(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Ellen, Walter and Lennart Hesselman's Foundation; Konsul ThC Berghs Foundation; Stockholm County Council Research Funds (ALF); ChAMP (Centre for Allergy Research Highlights Asthma Markers of Phenotype) consortium - Swedish Foundation for Strategic Research; AstraZeneca(AstraZeneca); Karolinska Institutet(Karolinska Institutet); Science for Life Laboratory Joint Research Collaboration	This work was supported by the Swedish Research Council -Medicine and Health, the Swedish Cancer Society, the Swedish Heart-Lung Foundation, the Ellen, Walter and Lennart Hesselman's Foundation, Konsul ThC Berghs Foundation, the Stockholm County Council Research Funds (ALF); the ChAMP (Centre for Allergy Research Highlights Asthma Markers of Phenotype) consortium, which is funded by the Swedish Foundation for Strategic Research, the Karolinska Institutet; AstraZeneca; and Science for Life Laboratory Joint Research Collaboration.	Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brockow K, 2008, ALLERGY, V63, P226, DOI 10.1111/j.1398-9995.2007.01569.x; Bulut I, 2018, J ASTHMA, V55, P1116, DOI 10.1080/02770903.2017.1396471; Butterfield JH, 2018, IMMUNOL ALLERGY CLIN, V38, P397, DOI 10.1016/j.iac.2018.04.011; Coskun A, 2007, ADV THER, V24, P362, DOI 10.1007/BF02849905; Gulen T, 2017, CLIN EXP ALLERGY, V47, P909, DOI 10.1111/cea.12914; Gulen T, 2016, J INTERN MED, V279, P211, DOI 10.1111/joim.12410; Gulen T, 2014, CLIN EXP ALLERGY, V44, P121, DOI 10.1111/cea.12225; Gulen T, 2017, J ALLER CL IMM-PRACT, V5, P1248, DOI 10.1016/j.jaip.2017.02.008; Gulen T, 2014, LANCET, V383, P1608, DOI 10.1016/S0140-6736(14)60585-7; He YW, 2018, BIOL CHEM, V399, P1091, DOI 10.1515/hsz-2017-0308; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Lin YH, 2020, INT IMMUNOL, V32, P213, DOI 10.1093/intimm/dxz075; Mauri P, 2014, IMMUNOL LETT, V162, P2, DOI 10.1016/j.imlet.2014.08.010; Metcalfe DD, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0094-3; Nagai K, 2013, PLOS ONE, V8, P1; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Sciacchitano S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020379; Terklsen CJ, 2009, AM J CARDIOL, V103, P29, DOI 10.1016/j.amjcard.2008.08.027; Tertti R, 2009, CLIN CHEM, V55, P1214, DOI 10.1373/clinchem.2008.108738; Zudaire E, 2006, AM J PATHOL, V168, P280, DOI 10.2353/ajpath.2006.050291	24	3	3	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					889	894		10.1016/j.jaci.2021.02.023	http://dx.doi.org/10.1016/j.jaci.2021.02.023		SEP 2021	6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UM1AT	33667475				2022-12-18	WOS:000693072000002
J	Chen, YH; Zastrow, DB; Metcalfe, RD; Gartner, L; Krause, F; Morton, CJ; Marwaha, S; Fresard, L; Huang, Y; Zhao, CL; McCormack, C; Bick, D; Worthey, EA; Eng, CM; Gold, J; Montgomery, SB; Fisher, PG; Ashley, EA; Wheeler, MT; Parker, MW; Shanmugasundaram, V; Putoczki, TL; Schmidt-Arras, D; Laurence, A; Bernstein, JA; Griffin, MDW; Uhlig, HH				Chen, Yin-Huai; Zastrow, Diane B.; Metcalfe, Riley D.; Gartner, Lisa; Krause, Freia; Morton, Craig J.; Marwaha, Shruti; Fresard, Laure; Huang, Yong; Zhao, Chunli; McCormack, Colleen; Bick, David; Worthey, Elizabeth A.; Eng, Christine M.; Gold, Jessica; Montgomery, Stephen B.; Fisher, Paul G.; Ashley, Euan A.; Wheeler, Matthew T.; Parker, Michael W.; Shanmugasundaram, Veerabahu; Putoczki, Tracy L.; Schmidt-Arras, Dirk; Laurence, Arian; Bernstein, Jonathan A.; Griffin, Michael D. W.; Uhlig, Holm H.		Undiagnosed Dis Network	Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL-6; IL-11; LIF; IL6ST; GP130; STAT3; hyper-IgE syndrome	EVOLUTIONARY CONSERVATION; SIGNAL TRANSDUCER; CRYSTAL-STRUCTURE; RECEPTOR; MUTATIONS; GP130; RESIDUES; INSIGHTS; FAMILY; DOMAIN	Background: Biallelic variants in IL6ST, encoding GP130, cause a recessive form of hyper-IgE syndrome (HIES) characterized by high IgE level, eosinophilia, defective acute phase response, susceptibility to bacterial infections, and skeletal abnormalities due to cytokine-selective loss of function in GP130, with defective IL-6 and IL-11 and variable oncostatin M (OSM) and IL-27 levels but sparing leukemia inhibitory factor (LIF) signaling. Objective: Our aim was to understand the functional and structural impact of recessive HIES-associated IL6ST variants. Methods: We investigated a patient with HIES by using exome, genome, and RNA sequencing. Functional assays assessed IL-6, IL-11, IL-27, OSM, LIF, CT-1, CLC, and CNTF signaling. Molecular dynamics simulations and structural modeling of GP130 cytokine receptor complexes were performed. Results: We identified a patient with compound heterozygous novel missense variants in IL6ST (p.Ala517Pro and the exon-skipping null variant p.Gly484_Pro518delinsArg). The p.Ala517Pro variant resulted in a more profound IL-6- and IL-11-dominated signaling defect than did the previously identified recessive HIES IL6ST variants p.Asn404Tyr and p.Pro498Leu. Molecular dynamics simulations suggested that the p.Ala517Pro and p.Asn404Tyr variants result in increased flexibility of the extracellular membrane-proximal domains of GP130. We propose a structural model that explains the cytokine selectivity of pathogenic IL6ST variants that result in recessive HIES. The variants destabilized the conformation of the hexameric cytokine receptor complexes, whereas the trimeric LIF-GP130-LIFR complex remained stable through an additional membrane-proximal interaction. Deletion of this membrane-proximal interaction site in GP130 consequently caused additional defective LIF signaling and Stuve-Wiedemann syndrome. Conclusion: Our data provide a structural basis to understand clinical phenotypes in patients with IL6ST variants.	[Chen, Yin-Huai; Gartner, Lisa; Laurence, Arian; Uhlig, Holm H.] Univ Oxford, Translat Gastroenterol Unit, Oxford, England; [Uhlig, Holm H.] Univ Oxford, Dept Paediat, Oxford, England; [Zastrow, Diane B.; Marwaha, Shruti; Fresard, Laure; Huang, Yong; Zhao, Chunli; McCormack, Colleen; Eng, Christine M.; Montgomery, Stephen B.; Fisher, Paul G.; Ashley, Euan A.; Wheeler, Matthew T.; Bernstein, Jonathan A.] Stanford Univ, Ctr Undiagnosed Dis, Sch Med, Stanford, CA 94305 USA; [Gold, Jessica; Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Montgomery, Stephen B.; Ashley, Euan A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Fisher, Paul G.] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Metcalfe, Riley D.; Morton, Craig J.; Parker, Michael W.; Griffin, Michael D. W.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Putoczki, Tracy L.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Krause, Freia; Schmidt-Arras, Dirk] Christian Albrechts Univ Kiel, Inst Biochem, Kiel, Germany; [Fresard, Laure; Montgomery, Stephen B.] Stanford Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Wheeler, Matthew T.] Stanford Sch Med, Dept Med, Stanford, CA 94305 USA; [Bick, David; Worthey, Elizabeth A.] Hudson Alpha Inst Biotechnol, Huntsville, AL USA; [Eng, Christine M.] Baylor Coll Med, Houston, TX 77030 USA; NIH, Undiagnosed Dis Network, Common Fund, Off Director, Bldg 10, Bethesda, MD 20892 USA; [Undiagnosed Dis Network] NHGRI, NIH, Bethesda, MD 20892 USA; [Parker, Michael W.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Shanmugasundaram, Veerabahu] Bristol Myers Squibb, Cambridge, England; [Putoczki, Tracy L.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Uhlig, Holm H.] Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; Stanford University; Stanford University; Stanford University; Stanford University; University of Melbourne; University of Melbourne; University of Kiel; Stanford University; Stanford University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); St. Vincent's Institute of Medical Research; Bristol-Myers Squibb; Walter & Eliza Hall Institute; University of Oxford	Laurence, A (corresponding author), Univ Oxford, Translat Gastroenterol Unit, Oxford, England.	arian.laurence@ndm.ox.ac.uk	Morton, Craig/GON-8638-2022; Parker, Michael W/F-9069-2013; Chen, Hebe/ABH-4764-2020; Schmidt-Arras, Dirk/ABB-6644-2020	Morton, Craig/0000-0001-5452-5193; Parker, Michael W/0000-0002-3101-1138; Chen, Hebe/0000-0002-8890-691X; Schmidt-Arras, Dirk/0000-0002-1072-7495; Uhlig, Holm/0000-0002-6111-7355; SHANMUGASUNDARAM, VEERABAHU/0000-0003-0566-6779; Griffin, Michael/0000-0001-9845-7735; Gartner, Lisa/0000-0002-3273-651X; Metcalfe, Riley/0000-0002-7154-780X	Biomedical Research Centre for the Oxford GI Biobank [11/YH/0020, 16/YH/0247]; National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford; Health Research Oxford Biomedical Research Centre; Leona M. and Harry B. Helmsley Charitable Trust; Celgene/BMS via a Celgene Oxford fellowship program; National Institutes of Health Common Fund through the Office of Strategic Coordination/Office of the National Institutes of Health Director [U01 HG007708, U01 HG007530, U01 HG007942, U01 HG007943, U01 HG010218]; Stanford Clinical and Translational Science Award [UL1 TR001085]; Australian National Health and Medical Research Council Independent Research Institutes [9000587]; Victorian State Government Operational Infrastructure Support Program; National Health and Medical Research Council [APP1147621, APP1080498, APP1117183]; Australian Research Council [LE170100200, FT140100544]; Victorian Cancer Agency Fellowship [MCRF16009]; Deutsche Forschungsgemeinschaft [SFB841 C1]	Biomedical Research Centre for the Oxford GI Biobank; National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford; Health Research Oxford Biomedical Research Centre; Leona M. and Harry B. Helmsley Charitable Trust; Celgene/BMS via a Celgene Oxford fellowship program; National Institutes of Health Common Fund through the Office of Strategic Coordination/Office of the National Institutes of Health Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Clinical and Translational Science Award; Australian National Health and Medical Research Council Independent Research Institutes; Victorian State Government Operational Infrastructure Support Program; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Cancer Agency Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Biomedical Research Centre for the Oxford GI Biobank (grants 11/YH/0020 and 16/YH/0247) and by the National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford. H.H.U. is supported by the Health Research Oxford Biomedical Research Centre and the Leona M. and Harry B. Helmsley Charitable Trust. Part of the work is funded by Celgene/BMS via a Celgene Oxford fellowship program that supports H.H.U., A.L., and Y.-H.C. Research reported in this article was supported in part by the National Institutes of Health Common Fund through the Office of Strategic Coordination/Office of the National Institutes of Health Director (under awards U01 HG007708, U01 HG007530, U01 HG007942, U01 HG007943, and U01 HG010218). This work was also supported by the Stanford Clinical and Translational Science Award to Spectrum (UL1 TR001085). We gratefully acknowledge infrastructure support from the Australian National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme (grant 9000587) and the Victorian State Government Operational Infrastructure Support Program, with additional support from the National Health and Medical Research Council (project grants APP1147621 and APP1080498). This research was undertaken using the Linkage Infrastructure, Equipment and Facilities High-Performance Computing General-Purpose Computing on Graphics Processing Units Facility, which is hosted at the University of Melbourne and was established with the assistance of an Australian Research Council Linkage Infrastructure, Equipment and Facilities grant (LE170100200). M.D.W.G. is the recipient of an Australian Research Council Future Fellowship (FT140100544), M.W.P. is a National Health and Medical Research Council Senior Principal Fellow (APP1117183), and T.L.P. is supported by a Victorian Cancer Agency Fellowship (MCRF16009). D.S.-A. was supported by the Deutsche Forschungsgemeinschaft (project grant SFB841 C1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Beziat V, 2020, J EXP MED, V217; Beziat V, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4956; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen YH, 2020, J EXP MED, V217, DOI 10.1084/jem.20191306; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Dagoneau N, 2004, AM J HUM GENET, V74, P298, DOI 10.1086/381715; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8; Frey-Jakobs S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4941; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Janssens K, 2015, ANN NY ACAD SCI, V1351, P52, DOI 10.1111/nyas.12821; Keupp K, 2013, MOL GENET GENOM MED, V1, P223, DOI 10.1002/mgg3.28; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035; Metcalfe RD, 2020, J BIOL CHEM, V295, P8285, DOI 10.1074/jbc.RA119.012351; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Ogata A, 2019, MOD RHEUMATOL, V29, P258, DOI [10.1080/14397595.2018.1546357, 10.1080/14397595.2018.1533514]; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Rose-John S, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028415; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schwerd T, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0098-z; Schwerd T, 2017, J EXP MED, V214, P2547, DOI 10.1084/jem.20161810; Shahin T, 2019, HAEMATOLOGICA, V104, P609, DOI 10.3324/haematol.2018.194233; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Timmermann A, 2002, EUR J BIOCHEM, V269, P2716, DOI 10.1046/j.1432-1033.2002.02941.x; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Xu YB, 2010, J BIOL CHEM, V285, P21214, DOI 10.1074/jbc.C110.129502; Zou X, 2009, VET PATHOL, V46, P514, DOI 10.1354/vp.08-VP-0239-B-BC	50	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					585	598		10.1016/j.jaci.2021.02.044	http://dx.doi.org/10.1016/j.jaci.2021.02.044		AUG 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33771552				2022-12-18	WOS:000687104900010
J	Kamikaseda, Y; Uruno, T; Kunimura, K; Harada, A; Saiki, K; Oisaki, K; Sakata, D; Nakahara, T; Kido-Nakahara, M; Kanai, M; Nakamura, S; Ohkawa, Y; Furue, M; Fukui, Y				Kamikaseda, Yasuhisa; Uruno, Takehito; Kunimura, Kazufumi; Harada, Akihito; Saiki, Kuniko; Oisaki, Kounosuke; Sakata, Daiji; Nakahara, Takeshi; Kido-Nakahara, Makiko; Kanai, Motomu; Nakamura, Seiji; Ohkawa, Yasuyuki; Furue, Masutaka; Fukui, Yoshinori			Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; IL-31; TH cells; EPAS1; SP1; small-molecule compounds	T-CELLS; RECEPTOR	Background: IL-31 is a major pruritogen associated with atopic dermatitis (AD). Although a specific antibody for IL-31 receptor has been shown to alleviate pruritus in patients with AD, therapeutic approaches to inhibition of IL-31 production remain unexploited. IL-31 production by TH cells critically depends on the transcription factor EPAS1, which mediates IL31 promoter activation in collaboration with SP1. Objective: We aimed at developing small-molecule inhibitors that selectively block IL-31 production by TH cells. Methods: We generated the reporter cell line that inducibly expressed EPAS1 in the presence of doxycycline to mediate Il31 promoter activation, and we screened 9600 chemical compounds. The selected compounds were further examined by using TH cells from a spontaneous mouse model of AD and TH cells from patients with AD. Results: We have identified 4-(2-(4-isopropylbenzylidene) hydrazineyl)benzoic acid (IPHBA) as an inhibitor of IL31 induction. Although IPHBA did not affect nonspecific T-cell proliferation, IPHBA inhibited antigen-induced IL-31 production by TH cells from both an AD mouse model and patients with AD without affecting other cytokine production and hypoxic responses. In line with this, itch responses induced by adoptive transfer of IL-31-producing TH cells were attenuated when mice were orally treated with IPHBA. Mechanistically, IPHBA inhibited the association between EPAS1 and SP1, resulting in defective recruitment of both transcription factors to the specific sites of the IL31 promoter. We also determined the structure-activity relationship of IPHBA by synthesizing and analyzing 201 analogous compounds. Conclusion: IPHBA could be a potential drug leading to inhibition of EPAS1-driven IL-31 production.	[Kamikaseda, Yasuhisa; Uruno, Takehito; Kunimura, Kazufumi; Sakata, Daiji; Fukui, Yoshinori] Kyushu Univ, Dept Immunobiol & Neurosci, Div Immunogenet, Grad Sch Med Sci,Med Inst Bioregulat, Fukuoka, Japan; [Harada, Akihito; Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Res Ctr Trans Med, Div Transcript,Grad Sch Med Sci, Fukuoka, Japan; [Kamikaseda, Yasuhisa; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Grad Sch Med Sci, Fukuoka, Japan; [Nakahara, Takeshi; Kido-Nakahara, Makiko; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan; [Saiki, Kuniko; Oisaki, Kounosuke; Kanai, Motomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; University of Tokyo	Fukui, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Oisaki, Kounosuke/A-6117-2009; Ohkawa, Yasuyuki/ABG-1839-2021	Oisaki, Kounosuke/0000-0002-0499-8168; Ohkawa, Yasuyuki/0000-0001-6440-9954; Fukui, Yoshinori/0000-0003-2335-8745; Kunimura, Kazufumi/0000-0002-3445-804X; Uruno, Takehito/0000-0002-2812-9645	Leading Advanced Projects for Medical Innovation [JP19gm0010001]; Advanced Research and Development Programs for Medical Innovation [JP20gm1310005]; Japan Agency for Medical Research and Development	Leading Advanced Projects for Medical Innovation; Advanced Research and Development Programs for Medical Innovation; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	Supported by Leading Advanced Projects for Medical Innovation (grant JP19gm0010001) and Advanced Research and Development Programs for Medical Innovation (grant JP20gm1310005) from Japan Agency for Medical Research and Development (to Y.F.) .	Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Furue M, 2018, ALLERGY, V73, P29, DOI 10.1111/all.13239; Kabashima K, 2018, J ALLERGY CLIN IMMUN, V142, P1121, DOI 10.1016/j.jaci.2018.03.018; Mikulska JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135141; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Pawlus MR, 2013, CELL SIGNAL, V25, P1895, DOI 10.1016/j.cellsig.2013.05.018; Peng T, 2020, J MED CHEM, V63, P10594, DOI 10.1021/acs.jmedchem.9b02170; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Topal FA, 2020, CURR OPIN ALLERGY CL, V20, P367, DOI 10.1097/ACI.0000000000000658; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Xu JJ, 2020, IMMUNITY, V53, P371, DOI 10.1016/j.immuni.2020.06.023; Yamamura K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13946; Zhang QA, 2010, DIS MARKERS, V29, P131, DOI 10.3233/DMA-2010-0737; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	22	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					633	638		10.1016/j.jaci.2021.03.029	http://dx.doi.org/10.1016/j.jaci.2021.03.029		AUG 2021	6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33819507	Green Published			2022-12-18	WOS:000687104900015
J	Smith, AM; Harper, N; Meunier, JA; Branum, AP; Jimenez, F; Pandranki, L; Carrillo, A; Dela Cruz, CS; Restrepo, MI; Maselli, DJ; Rather, CG; Heisser, AH; Ramirez, DA; He, WJ; Clark, RA; Andrews, CP; Evans, SE; Pugh, JA; Zhang, N; Lee, GC; Moreira, AG; Segal, LN; Ramirez, RM; Jacobs, RL; Manoharan, MS; Okulicz, JF; Ahuja, SK				Smith, Alisha M.; Harper, Nathan; Meunier, Justin A.; Branum, Anne P.; Jimenez, Fabio; Pandranki, Lavanya; Carrillo, Andrew; Dela Cruz, Charles S.; Restrepo, Marcos, I; Maselli, Diego J.; Rather, Cynthia G.; Heisser, Anna H.; Ramirez, Daniel A.; He, Weijing; Clark, Robert A.; Andrews, Charles P.; Evans, Scott E.; Pugh, Jacqueline A.; Zhang, Nu; Lee, Grace C.; Moreira, Alvaro G.; Segal, Leopoldo N.; Ramirez, Robert M.; Jacobs, Robert L.; Manoharan, Muthu Saravanan; Okulicz, Jason F.; Ahuja, Sunil K.			Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aeroallergen challenge chamber; house dust mites; allergic rhinoconjunctivitis; evoked phenotypes; maladaptation	CD8(+) T-CELLS; BARRIER FUNCTION; LEUKOTRIENE B-4; ROCK INHIBITOR; ASTHMA; RECEPTOR; SKIN; EXPRESSION; YKL-40; RISK	Background: Signifying the 2-compartments/1-disease paradigm, allergic rhinoconjunctivitis (ARC) and asthma (AA) are prevalent, comorbid conditions triggered by environmental factors (eg, house dust mites [HDMs]). However, despite the ubiquity of triggers, progression to severe ARC/AA is infrequent, suggesting either resilience or adaptation. Objective: We sought to determine whether ARC/AA severity relates to maladaptive responses to disease triggers. Methods: Adults with HDM-associated ARC were challenged repetitively with HDMs in an aeroallergen challenge chamber. Mechanistic traits associated with disease severity were identified. Results: HDM challenges evoked maladaptive (persistently higher ARC symptoms), adaptive (progressive symptom reduction), and resilient (resistance to symptom induction) phenotypes. Symptom severity in the natural environment was an imprecise correlate of the phenotypes. Nasal airway traits, defined by low inflammation-effectual epithelial integrity, moderate inflammation-effectual epithelial integrity, and higher inflammation-ineffectual epithelial integrity, were hallmarks of the resilient, adaptive, and maladaptive evoked phenotypes, respectively. Highlighting a crosstalk mechanism, peripheral blood inflammatory tone calibrated these traits: ineffectual epithelial integrity associated with CD8(+) T cells, whereas airway inflammation associated with both CD8(+) T cells and eosinophils. Hallmark peripheral blood maladaptive traits were increased natural killer and CD8(+) T cells, lower CD4(+) mucosal-associated invariant T cells, and deficiencies along the TLR-IRF-IFN antiviral pathway. Maladaptive traits tracking HDM-associated ARC also contributed to AA risk and severity models. Conclusions: Repetitive challenges with HDMs revealed that maladaptation to disease triggers may underpin ARC/AA disease severity. A combinatorial therapeutic approach may involve reversal of loss-of-beneficial-function traits (ineffectual epithelial integrity, TLR-IRF-IFN deficiencies), mitigation of gain-of-adverse-function traits (inflammation), and blocking of a detrimental crosstalk between the peripheral blood and airway compartments.	[Smith, Alisha M.; Harper, Nathan; Meunier, Justin A.; Branum, Anne P.; Jimenez, Fabio; Pandranki, Lavanya; Carrillo, Andrew; Restrepo, Marcos, I; Maselli, Diego J.; Heisser, Anna H.; He, Weijing; Clark, Robert A.; Pugh, Jacqueline A.; Lee, Grace C.; Moreira, Alvaro G.; Manoharan, Muthu Saravanan; Ahuja, Sunil K.] South Texas Vet Hlth Care Syst, Vet Adm Ctr Personalized Med, San Antonio, TX USA; [Smith, Alisha M.; Harper, Nathan; Meunier, Justin A.; Branum, Anne P.; Jimenez, Fabio; Carrillo, Andrew; He, Weijing; Ahuja, Sunil K.] South Texas Vet Hlth Care Syst, Fdn Adv Vet Hlth Res, San Antonio, TX USA; [Smith, Alisha M.; Clark, Robert A.; Zhang, Nu; Ahuja, Sunil K.] UT Hlth San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX USA; [Smith, Alisha M.; Pandranki, Lavanya; Carrillo, Andrew; Restrepo, Marcos, I; Maselli, Diego J.; Clark, Robert A.; Manoharan, Muthu Saravanan; Ahuja, Sunil K.] UT Hlth San Antonio, Dept Med, San Antonio, TX USA; [Dela Cruz, Charles S.] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA; [Rather, Cynthia G.; Ramirez, Daniel A.; Andrews, Charles P.; Ramirez, Robert M.; Jacobs, Robert L.] Biogen Res Chamber, San Antonio, TX USA; [Evans, Scott E.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Lee, Grace C.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Lee, Grace C.] UT Hlth San Antonio, Sch Med, Pharmacotherapy Educ & Res Ctr, San Antonio, TX USA; [Moreira, Alvaro G.] UT Hlth San Antonio, Dept Pediat, Div Neonatol, San Antonio, TX USA; [Segal, Leopoldo N.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY USA; [Okulicz, Jason F.] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Ahuja, Sunil K.] UT Hlth San Antonio, Dept Biochem & Struct Biol, San Antonio, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Yale University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; New York University; San Antonio Military Medical Center; University of Texas System; University of Texas Health San Antonio	Ahuja, SK (corresponding author), UTHSA, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	ahujas@uthscsa.edu	Pandranki, Lavanya/GZL-7371-2022	Evans, Scott/0000-0003-4503-0644; Branum, Anne/0000-0001-9725-8419; Segal, Leopoldo/0000-0003-3559-9431	Veterans Affairs (VA) Research Center for AIDS and HIV Infection; VA Center for Personalized Medicine [IP1 CX000875]; National Institutes of Health (NIH) [R37AI046326]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; 59th Medical Wing Intramural Award [FA8650-17-2-6816]; NIH [UL1-TR002645, K23 AI102970, R01 HL125816, T32DE014318]	Veterans Affairs (VA) Research Center for AIDS and HIV Infection(US Department of Veterans Affairs); VA Center for Personalized Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); 59th Medical Wing Intramural Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Veterans Affairs (VA) Research Center for AIDS and HIV Infection and VA Center for Personalized Medicine (grant no. IP1 CX000875), National Institutes of Health (NIH) (MERIT grant no. R37AI046326), Doris Duke Distinguished Clinical Scientist Award, and Burroughs Wellcome Clinical Scientist Award in Translational Research to S.K.A.; the 59th Medical Wing Intramural Award (grant no. FA8650-17-2-6816 to J.F.O.); the NIH Clinical and Translational Science Award (grant no. UL1-TR002645 to R.A.C.); the NIH (grant nos. K23 AI102970 and R01 HL125816 to L.N.S.); and the NIH COSTAR institutional research training grant (grant no. T32DE014318 to A.M.S.). The views expressed are those of the authors and do not reflect the official views or policy of the Department of Defense or its components.	Ahuja SK, 2017, J ALLERGY CLIN IMMUN, V139, P844, DOI 10.1016/j.jaci.2016.08.019; Altman MC, 2018, J ALLERGY CLIN IMMUN, V142, P1856, DOI 10.1016/j.jaci.2018.02.019; Alvarez F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00522; Bara I, 2012, AM J RESP CRIT CARE, V185, P715, DOI 10.1164/rccm.201105-0915OC; Baraldo S, 2018, AM J RESP CRIT CARE, V197, P673, DOI 10.1164/rccm.201706-1249LE; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Casciano J, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0271-8; Chandra S, 2018, J IMMUNOL, V200, P1995, DOI 10.4049/jimmunol.1701525; Chen RC, 2017, AM J RESP CRIT CARE, V196, P700, DOI 10.1164/rccm.201612-2427OC; Chung EH, 2014, ANN ALLERG ASTHMA IM, V112, P211, DOI 10.1016/j.anai.2013.12.006; CONNELL JT, 1968, J ALLERGY, V41, P123, DOI 10.1016/0021-8707(68)90053-1; Dakhama A, 2013, ALLERGY, V68, P666, DOI 10.1111/all.12135; den Otter I, 2016, EUR RESPIR J, V48, P393, DOI 10.1183/13993003.01525-2015; Ellis AK, 2019, ANN ALLERG ASTHMA IM, V122, P639, DOI 10.1016/j.anai.2019.03.007; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Firszt R, 2014, EUR RESPIR J, V43, P464, DOI 10.1183/09031936.00068712; Ganjian H, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00277; Gelfand EW, 2006, J ALLERGY CLIN IMMUN, V117, P577, DOI 10.1016/j.jaci.2005.12.1340; Gomez JL, 2015, J ALLERGY CLIN IMMUN, V136, P51, DOI 10.1016/j.jaci.2014.11.027; Gordon ED, 2016, P NATL ACAD SCI USA, V113, P8765, DOI 10.1073/pnas.1601914113; Gorska MM, 2017, CURR OPIN ALLERGY CL, V17, P50, DOI 10.1097/ACI.0000000000000327; Hamada A, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03225; Hamelmann E, 1996, J EXP MED, V183, P1719, DOI 10.1084/jem.183.4.1719; Hinks TSC, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0092-2019; Hinks TSC, 2016, IMMUNOLOGY, V148, P1, DOI 10.1111/imm.12582; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jacobs RL, 2015, J ALLERGY CLIN IMMUN, V135, P1071, DOI 10.1016/j.jaci.2014.09.047; Johnston SL, 2016, AM J RESP CRIT CARE, V194, P1, DOI 10.1164/rccm.201602-0223ED; Karimi K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00159; Katz Lynn E, 2014, Ann Am Thorac Soc, V11, P531, DOI 10.1513/AnnalsATS.201310-354OC; Koeken V, 2019, CLIN MICROBIOL INFEC; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; Konradsen JR, 2013, J ALLERGY CLIN IMMUN, V132, P328, DOI 10.1016/j.jaci.2013.03.003; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Lee N, 2014, AM J RESP CRIT CARE, V190, P1383, DOI 10.1164/rccm.201403-0601OC; Lewis Christina C, 2009, J Allergy Clin Immunol, V123, P795, DOI 10.1016/j.jaci.2009.01.003; Li H, 2021, J ALLERGY CLIN IMMUN, V147, P941, DOI 10.1016/j.jaci.2020.09.032; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Marshall A, 2009, CELL TISSUE RES, V335, P383, DOI 10.1007/s00441-008-0719-0; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Miller M, 2015, J IMMUNOL, V195, P3546, DOI 10.4049/jimmunol.1501105; Miyahara N, 2005, J IMMUNOL, V174, P4979, DOI 10.4049/jimmunol.174.8.4979; Miyahara N, 2004, NAT MED, V10, P865, DOI 10.1038/nm1081; Miyahara N, 2004, J IMMUNOL, V172, P2549, DOI 10.4049/jimmunol.172.4.2549; Modena BD, 2017, AM J RESP CRIT CARE, V195, P1449, DOI 10.1164/rccm.201607-1407OC; Mulder WJM, 2019, NAT REV DRUG DISCOV, V18, P553, DOI 10.1038/s41573-019-0025-4; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Novakovic B, 2017, IMMUNITY, V47, P1019, DOI 10.1016/j.immuni.2017.12.005; O'Sullivan S, 2001, AM J RESP CRIT CARE, V164, P560, DOI 10.1164/ajrccm.164.4.2102018; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Omraninava M, 2020, EUR ANN ALLERGY CLIN; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Pascoe CD, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0545-9; Pfaar O, 2017, ALLERGY, V72, P1035, DOI 10.1111/all.13133; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Raemdonck K, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0359-y; Rupani H, 2016, AM J RESP CRIT CARE, V194, P26, DOI 10.1164/rccm.201502-0280OC; Sahin-Yilmaz AA, 2006, J ALLERGY CLIN IMMUN, V118, P1190, DOI 10.1016/j.jaci.2006.04.006; Savenije OE, 2014, J ALLERGY CLIN IMMUN, V134, P170, DOI 10.1016/j.jaci.2013.12.1080; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Singhania A, 2018, AM J RESP CELL MOL, V58, P261, DOI 10.1165/rcmb.2017-0162OC; Sinha A, 2019, ELIFE, P8; Sridhar S, 2019, RESP RES, V20, DOI 10.1186/s12931-018-0968-8; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tan HT, 2018, ALLERGY; Togias A, 2019, J ALLERGY CLIN IMMUN, V143, P1003, DOI 10.1016/j.jaci.2018.07.041; Tsai YH, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01962-2017; Waage J, 2018, NAT GENET, V50, P1072, DOI 10.1038/s41588-018-0157-1; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yan XT, 2015, AM J RESP CRIT CARE, V191, P1116, DOI 10.1164/rccm.201408-1440OC; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhu J, 2019, J ALLERGY CLIN IMMUN, V143, P114, DOI 10.1016/j.jaci.2018.04.003; Zingkou E, 2019, J DERMATOL SCI, V95, P28, DOI 10.1016/j.jdermsci.2019.06.004	82	3	3	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					533	549		10.1016/j.jaci.2021.01.008	http://dx.doi.org/10.1016/j.jaci.2021.01.008		AUG 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33493557	Green Accepted, hybrid			2022-12-18	WOS:000687104900006
J	Hogan, SP				Hogan, Simon P.			Severity grading system for acute allergic reactions-time for validation and assessment of best practices	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Anaphylaxis; severity; grading system	ANAPHYLAXIS		[Hogan, Simon P.] Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hogan, SP (corresponding author), Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, Ann Arbor, MI 48109 USA.	sihogan@med.umich.edu		Hogan, Simon/0000-0001-5793-4304	National Institutes of Health [AI138177, AI140133, AI112626]; Mary H. Weiser Food Allergy Center (MHWFAC); Askwith Endowment of the MHWFAC	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary H. Weiser Food Allergy Center (MHWFAC); Askwith Endowment of the MHWFAC	Funding was provided by the National Institutes of Health (grant nos. AI138177, AI140133, and AI112626), the Mary H. Weiser Food Allergy Center (MHWFAC), and the Askwith Endowment of the MHWFAC.	Beck SC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00494; Cox LS, 2017, J ALLER CL IMM-PRACT, V5, P58, DOI 10.1016/j.jaip.2016.11.009; Dribin TE, 2021, J ALLERGY CLIN IMMUN, V148, P173, DOI 10.1016/j.jaci.2021.01.003; Shaker MS, 2020, J ALLERGY CLIN IMMUN, V145, P1082, DOI 10.1016/j.jaci.2020.01.017; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; van der Velde JL, 2013, CURR ALLERGY ASTHM R, V13, P651, DOI 10.1007/s11882-013-0391-7; Vantur R, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-020-00367-2; Veugelers R, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01029-4; Vidal C, 2019, J ALLER CL IMM-PRACT, V7, P1298, DOI 10.1016/j.jaip.2018.12.006; Wood RA, 2014, J ALLERGY CLIN IMMUN, V133, P461, DOI 10.1016/j.jaci.2013.08.016	10	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					86	88		10.1016/j.jaci.2021.04.031	http://dx.doi.org/10.1016/j.jaci.2021.04.031		JUL 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	33965430				2022-12-18	WOS:000669906700014
J	Papi, A; Virchow, JC; Singh, D; Kots, M; Vele, A; Georges, G; Canonica, GW				Papi, Alberto; Virchow, Johann Christian; Singh, Dave; Kots, Maxim; Vele, Andrea; Georges, George; Canonica, Giorgio Walter			Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analyses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; exacerbations; pharmacotherapy; inhaled corticosteroid; long-acting beta(2)-agonist; long-acting muscarinic antagonist	RHINOVIRUS INFECTION; TIOTROPIUM; EPIDEMIOLOGY	Background: Previous studies have shown seasonal variation in asthma exacerbations, peaking over the winter months. A single-inhaler triple therapy containing extrafine formulations of the inhaled corticosteroid (ICS) beclomethasone dipropionate (BDP), long-acting beta(2)-agonist formoterol fumarate (FF), and long-acting muscarinic antagonist glycopyrronium (G) is in development for asthma. Objective: We sought to evaluate whether calendar season impacted the relative effect of BDP/FF/G versus BDP/FF on moderate and severe asthma exacerbations. Methods: TRIMARAN and TRIGGER were double-blind 52-week studies comparing BDP/FF/G with BDP/FF (TRIMARAN medium-dose ICS; TRIGGER high-dose) in adults with uncontrolled asthma (Asthma Control Questionnaire-7 score >= 1.5), prebronchodilator FEV1 less than 80% predicted, history of 1 or more asthma exacerbation, who had been receiving ICS/long-acting beta(2)-agonist for at least 4 weeks before entry. Moderate and severe asthma exacerbations were captured throughout each study. In these post hoc analyses, the annual moderate and severe exacerbation rate was calculated for each month, with rate ratios determined from events grouped by season. Results: In patients who received BDP/FF alone, there was a marked seasonal effect on the occurrence of asthma exacerbations, with the rate highest in the winter months. However, the addition of the long-acting muscarinic antagonist component to BDP/FF reduced this seasonal variation, especially during the winter, such that the relative effect of BDP/FF/G versus BDP/FF was greatest in the winter (significant 20.3% reduction [P = .0008]). Reductions in the other seasons ranged between 8.6% and 12.0%. Conclusions: These post hoc analyses indicate that inhaled triple therapy with extrafine BDP/FF/G reduces seasonal peaks in moderate and severe exacerbations, and confirm the overall utility of adding long-acting muscarinic antagonist to ICS/long-acting beta(2)-agonist in the management of asthma.	[Papi, Alberto] Univ Ferrara, Univ Hosp S Anna, Resp Med Unit, Ferrara, Italy; [Virchow, Johann Christian] Univ Med Rostock, Abt Pneumol, Zentrum Innere Med, Rostock, Germany; [Singh, Dave] Univ Manchester, Manchester Univ NHS Fdn Trust, Med Evaluat Unit, Manchester, Lancs, England; [Kots, Maxim; Vele, Andrea; Georges, George] Chiesi Farmaceut SpA, Global Clin Dev, Parma, Italy; [Canonica, Giorgio Walter] Humanitas Univ & Res Hosp IRCCS, Ctr Personalized Med Asthma & Allergy, Milan, Italy	University of Ferrara; Arcispedale Sant'Anna; University of Rostock; University of Manchester; Chiesi Pharmaceuticals Inc	Papi, A (corresponding author), Univ Ferraro Univ Hosp S Anna, Resp Med Unit, Ferrara, Italy.	ppa@unife.it		Kots, Maxim/0000-0003-3466-4641	National Institute for Health Research Manchester Biomedical Research Centre; Chiesi Farmaceutici SpA	National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Chiesi Farmaceutici SpA(Chiesi Pharmaceuticals Inc)	The funder of the study, Chiesi Farmaceutici SpA, was responsible for the design of TRIMARAN and TRIGGER, and for conducting the post hoc analyses that are reported in this article. Employees of the sponsor (as authors) were involved in the writing of this article, and in the decision to submit for publication. D.S. is supported by the National Institute for Health Research Manchester Biomedical Research Centre.	Altzibar JM, 2015, CLIN EXP ALLERGY, V45, P1099, DOI 10.1111/cea.12419; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; DuBuske L, 2018, ALLERGY ASTHMA PROC, V39, P345, DOI 10.2500/aap.2018.39.4162; FitzGerald JM, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00964-2019; Iesato K, 2008, RESPIRATION, V76, P434, DOI 10.1159/000151729; Johnston NW, 2006, THORAX, V61, P722, DOI 10.1136/thx.2005.045161; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Papi A, 2013, J ALLERGY CLIN IMMUN, V132, P1075, DOI 10.1016/j.jaci.2013.05.028; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sears MR, 2008, J ALLERGY CLIN IMMUN, V122, P662, DOI 10.1016/j.jaci.2008.08.003; Staton TL, 2017, J ALLERGY CLIN IMMUN, V139, P1682, DOI 10.1016/j.jaci.2017.01.028; Virchow JC, 2015, RESP MED, V109, P547, DOI 10.1016/j.rmed.2015.01.012; Virchow JC, 2019, LANCET, V394, P1737, DOI 10.1016/S0140-6736(19)32215-9; Wang Y, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00278; Witonsky J, 2019, J ASTHMA, V56, P927, DOI 10.1080/02770903.2018.1514627; Yamaya M, 2012, EUR RESPIR J, V40, P122, DOI 10.1183/09031936.00065111	17	3	3	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					262	+		10.1016/j.jaci.2021.01.007	http://dx.doi.org/10.1016/j.jaci.2021.01.007		JUL 2021	6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IW	33485959	hybrid			2022-12-18	WOS:000669908500009
J	Shafer, S; Yao, YK; Comrie, W; Cook, S; Zhang, Y; Yesil, G; Karakoc-Aydiner, E; Baris, S; Cokugras, H; Aydemir, S; Kiykim, A; Ozen, A; Lenardo, M				Shafer, Samantha; Yao, Yikun; Comrie, William; Cook, Sarah; Zhang, Yu; Yesil, Gozde; Karakoc-Aydiner, Elif; Baris, Safa; Cokugras, Haluk; Aydemir, Sezin; Kiykim, Ayca; Ozen, Ahmet; Lenardo, Michael			Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						TRAF3IP2; Act1; IL-17; signaling; chronic mucocuta-neous candidiasis; antifungal immunity; recurrent fungal infections	MUTATION; DISEASE; ACT1	Background: TRAF3 interacting protein 2 (TRAF3IP2) (Act1) is an adapter protein that interacts with IL-17R via its similar expression to fibroblast growth factor genes and IL-17R domain and coordinates 2 separate proinflammatory pathways following IL-17 cytokine stimulation. Objective: We sought to elucidate the immunologic consequences of TRAF3IP2 homozygous mutations to improve treatments for immunodeficiency patients with chronic mucocutaneous candidiasis. Methods: We describe 2 patients presenting with chronic mucocutaneous candidiasis who harbor biallelic nonsense mutations in TRAF3IP2. The cellular and molecular features of this genetic defect were assessed using in vitro cytokine assays and protein analysis. Results: We show that the homozygous mutation causes complete loss of protein expression. We also show that the absence of TRAF3IP2 was associated with a defective response to combined IL-2/IL-25 (IL-17E) stimulation. Conclusions: Failure to initiate normal signaling downstream of IL-17R engagement likely contributes to the patients' recurrent fungal infections. These findings add to our molecular understanding of genetic defects affecting this critical pathway of antifungal immunity. (J Allergy Clin Immunol 2021;148:256-61.)	[Shafer, Samantha; Yao, Yikun; Comrie, William; Cook, Sarah; Zhang, Yu; Lenardo, Michael] NIAID, Mol Dev Immune Syst Sect, Lab Mune Syst Biol, NIH, Bethesda, MD USA; [Yesil, Gozde] NIAID, Clin Genom Program, NIH, Bethesda, MD USA; [Karakoc-Aydiner, Elif; Baris, Safa; Ozen, Ahmet] Marmara Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Istanbul, Turkey; [Karakoc-Aydiner, Elif; Baris, Safa; Ozen, Ahmet] Istanbul Univ Cerrahpasa Pediat Allergy & Immunol, Istanbul Jeffrey Modell Diagnost Ctr Primary Immu, Istanbul, Turkey; [Karakoc-Aydiner, Elif; Baris, Safa; Ozen, Ahmet] Istanbul Univ Cerrahpasa Pediat Allergy & Immunol, Isil Berat Barlan Ctr Translat Med, Istanbul, Turkey; [Cokugras, Haluk; Aydemir, Sezin; Kiykim, Ayca] Istanbul Univ Cerrahpasa Pediat Allergy & Immunol, Cerrahpasa Med Fac, Istanbul, Turkey	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Marmara University; Istanbul University - Cerrahpasa	Lenardo, M (corresponding author), NIH, Bldg 10 Rm 11N311,10 Ctr Dr,MSC 1892, Bethesda, MD 20892 USA.	LENARDO@NIH.GOV	KIYKIM, Ayca/J-6400-2017; YESIL, GOZDE/ABE-1615-2020; Yao, Yikun/AAH-9197-2021; /R-6749-2017	KIYKIM, Ayca/0000-0001-5821-3963; YESIL, GOZDE/0000-0003-1964-6306; /0000-0002-9065-1901; Yao, Yikun/0000-0002-8890-2409; Shafer, Sam/0000-0001-9429-414X	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); American Diabetes Association [1-16-PDF-025]; National Institute of General Medical Sciences, NIH [1FI2GM11997901]	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Diabetes Association(American Diabetes Association); National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH). This work was also funded by a fellowship grant (grant no. 1-16-PDF-025 toW.C.) from the American Diabetes Association and an F12 postdoctoral fellowship (grant no. 1FI2GM11997901 toW.C.) from the National Institute of General Medical Sciences, NIH. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.	Bhattad S, 2019, J CLIN IMMUNOL, V39, P596, DOI 10.1007/s10875-019-00664-x; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Choi S, 2017, TRENDS IMMUNOL, V38, P622, DOI 10.1016/j.it.2017.06.006; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Comrie WA, 2018, J ALLERGY CLIN IMMUN, V141, P1507, DOI 10.1016/j.jaci.2017.11.036; Doyle MS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4071; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Matsushima Y, 2010, J IMMUNOL, V185, P2340, DOI 10.4049/jimmunol.0900694; Nemer G, 2020, CLIN GENET, V98, P116, DOI 10.1111/cge.13767; Okada S, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.71; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592; Snow AL, 2009, J CLIN INVEST, V119, P2976, DOI 10.1172/JCI39518	16	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					256	+		10.1016/j.jaci.2020.12.629	http://dx.doi.org/10.1016/j.jaci.2020.12.629		JUL 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IW	33359359	Green Accepted			2022-12-18	WOS:000669908500008
J	Theoharides, TC; Conti, P				Theoharides, Theoharis C.; Conti, Pio			Mast cells to dendritic cells: Let IL-13 shut your IL-12 down	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Atopic dermatitis; dendritic cells; IL-12; IL-13; IL-33; mast cells; T(H)1 cell; T(H)2 cell			[Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Immunol, Lab Mol Immunopharmacol & Drug Discovery, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Grad Sch Biomed Sci, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Med Ctr, Boston, MA 02111 USA; [Conti, Pio] Univ G dAnnunzio, Postgrad Med Sch, Chieti, Italy	Tufts University; Tufts University; Tufts University; Tufts Medical Center; G d'Annunzio University of Chieti-Pescara	Theoharides, TC (corresponding author), Tufts Univ, Sch Med, Dept Immunol, 136 Harrison Ave,Suite 304, Boston, MA 02111 USA.	theoharis.theoharides@tufts.edu						Bitton A, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw2938; Hamid Q, 1996, J ALLERGY CLIN IMMUN, V98, P225, DOI 10.1016/S0091-6749(96)70246-4; Honda T, 2020, J ALLERGY CLIN IMMUN, V145, P1136, DOI 10.1016/j.jaci.2020.02.008; Junttila IS, 2013, J ALLERGY CLIN IMMUN, V132, P704, DOI 10.1016/j.jaci.2013.03.033; Kaur D, 2006, ALLERGY, V61, P1047, DOI 10.1111/j.1398-9995.2006.01139.x; Khattri S, 2017, EXP DERMATOL, V26, P28, DOI 10.1111/exd.13112; Leyva-Castillo JM, 2021, J ALLERGY CLIN IMMUN, V147, P2305, DOI 10.1016/j.jaci.2020.11.036; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Obara W, 2002, DERMATOLOGY, V205, P11, DOI 10.1159/000063145; Wollenberg A, 2019, J ALLERGY CLIN IMMUN, V143, P135, DOI 10.1016/j.jaci.2018.05.029	10	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2073	2074		10.1016/j.jaci.2021.03.032	http://dx.doi.org/10.1016/j.jaci.2021.03.032		JUN 2021	2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33831419	Bronze			2022-12-18	WOS:000657814800012
J	van der Loeff, IS; Sprenkeler, EGG; Tool, ATJ; Abinun, M; Grainger, A; Engelhardt, KR; van Houdt, M; Janssen, H; Kuijpers, TW; Hambleton, S				van der Loeff, Ina Schim; Sprenkeler, Evelien G. G.; Tool, Anton T. J.; Abinun, Mario; Grainger, Angela; Engelhardt, Karin R.; van Houdt, Michel; Janssen, Hans; Kuijpers, Taco W.; Hambleton, Sophie			Defective neutrophil development and specific granule deficiency caused by a homozygous splice-site mutation in SMARCD2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Splice-site mutation; CEBP epsilon; lactoferrin; chemotaxis; neutrophil-specific granule deficiency; phagocyte disorder; inborn error of immunity	DIFFERENTIATION	Background: SMARCD2 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 2) has recently been shown to have a critical role in granulopoiesis in humans, mice, and zebrafish. Our patient presented with delayed cord separation, failure to thrive, and sepsis. Retrospective whole-exome sequencing confirmed a homozygous splice-site mutation in SMARCD2. Objective: We sought to provide the second description of human SMARCD2 deficiency and the first functional analysis of human primary SMARCD2-deficient cells. Methods: Heparinized venous blood and bone marrow were collected from the patient after obtaining informed consent. Patient leukocytes and CD34(+) cells were then isolated, phenotyped, and assessed functionally. Results: Circulating neutrophils appeared phenotypically immature, lacking multilobed nuclei, and neutrophil granules lacked lactoferrin but showed normal levels of myeloperoxidase. Neutrophil oxidative burst was preserved in response to phorbol 12-myristate 13-acetate. Patient bone marrow-derived neutrophils and white blood cells showed a severely impaired chemotactic response. Furthermore, white blood cells showed defective in vitro killing of Staphylococcus aureus, consistent with a specific granule deficiency. Finally, patient bone marrow-derived CD34(+) cells showed markedly impaired in vitro expansion and differentiation toward the neutrophil lineage. Before her molecular diagnosis, our patient underwent hematopoietic stem cell transplantation and is well 8 years later. Conclusions: This report highlights an important role for SMARCD2 in human myelopoiesis and the curative effect of hematopoietic stem cell transplantation for the hematopoietic features of SMARCD2 deficiency.	[van der Loeff, Ina Schim; Grainger, Angela; Engelhardt, Karin R.; Hambleton, Sophie] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Immun & Inflammat Theme, Newcastle Upon Tyne, Tyne & Wear, England; [van der Loeff, Ina Schim; Abinun, Mario; Hambleton, Sophie] Newcastle Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp GNCH, Newcastle Upon Tyne, Tyne & Wear, England; [Sprenkeler, Evelien G. G.; Tool, Anton T. J.; van Houdt, Michel; Kuijpers, Taco W.] Sanquin Res, Dept Blood Cell Res, Amsterdam, Netherlands; [Sprenkeler, Evelien G. G.; Kuijpers, Taco W.] Univ Amsterdam, Amsterdam Univ, Emma Childrens Hosp, Dept Pediat Immunol Rheumatol & Infect Dis,Med C, Amsterdam, Netherlands; [Janssen, Hans] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Emma Children's Hospital; University of Amsterdam; Netherlands Cancer Institute	Hambleton, S (corresponding author), Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Med Sch,Primary Immunodeficiency Grp,Immun & Infl, 3rd Floor,William Leech Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	sophie.hambleton@newcastle.ac.uk		Schim van der Loeff, Ina/0000-0003-1196-6196	Medical Research Council; Sir Jules Thorn Trust [12/JTA]; Wellcome [207556_Z_17_Z]; European Union [668303]; Center of Immunodeficiencies Amsterdam [CIDA-2015]; National Institute for Health Research	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Trust; Wellcome; European Union(European Commission); Center of Immunodeficiencies Amsterdam; National Institute for Health Research(National Institute for Health Research (NIHR))	Work in the Primary Immunodeficiency Group was supported by the Medical Research Council, the Sir Jules Thorn Trust (grant no. 12/JTA) and Wellcome (grant no. 207556_Z_17_Z). E.G.G.S. and T.W.K. were funded in part by the European Union's Horizon 2020 research and innovation program (grant agreement no. 668303), and T.W.K. was funded in part by the Center of Immunodeficiencies Amsterdam (grant no. CIDA-2015). I.S.v.d.L. is supported by an academic clinical fellowship from the National Institute for Health Research.	Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Grassi L, 2018, CELL REP, V24, P2784, DOI 10.1016/j.celrep.2018.08.018; Kuijpers TW, 2007, BLOOD, V109, P3529, DOI 10.1182/blood-2006-05-021402; Kuijpers TW, 2017, J ALLERGY CLIN IMMUN, V140, P273, DOI 10.1016/j.jaci.2016.09.061; Lekstrom-Himes JA, 1999, J EXP MED, V189, P1847, DOI 10.1084/jem.189.11.1847; MEERHOF LJ, 1986, J LEUKOCYTE BIOL, V39, P699, DOI 10.1002/jlb.39.6.699; Priam P, 2017, NAT GENET, V49, P753, DOI 10.1038/ng.3812; Sprenkeler EGG, 2020, BLOOD, V135, P2171, DOI 10.1182/blood.2019002633; STRAUSS RG, 1974, NEW ENGL J MED, V290, P478, DOI 10.1056/NEJM197402282900903; Witzel M, 2017, NAT GENET, V49, P742, DOI 10.1038/ng.3833; Zhao XW, 2013, BLOOD, V122, P109, DOI 10.1182/blood-2013-03-494039	11	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2381	+		10.1016/j.jaci.2020.11.025	http://dx.doi.org/10.1016/j.jaci.2020.11.025		JUN 2021	7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7ID	33279574	hybrid, Green Published			2022-12-18	WOS:000657773400004
J	Camacho-Ordonez, N; Ballestar, E; Timmers, HTM; Grimbacher, B				Camacho-Ordonez, Nadezhda; Ballestar, Esteban; Timmers, H. Th Marc; Grimbacher, Bodo			What can clinical immunology learn from inborn errors of epigenetic regulators?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Epigenetic regulation; inborn errors of epigenetic regulators; immune system; immune response; lymphocyte differentiation	WOLF-HIRSCHHORN-SYNDROME; DNA METHYLTRANSFERASE 1; OF-FUNCTION MUTATIONS; B-CELL DEVELOPMENT; GENE-EXPRESSION; CHARGE SYNDROME; T-CELLS; ANTIBODY DEFICIENCY; 22Q11.2 DELETION; WHOLE-GENOME	The epigenome is at the interface between environmental factors and the genome, regulating gene transcription, DNA repair, and replication. Epigenetic modifications play a crucial role in establishing and maintaining cell identity and are especially crucial for neurology, musculoskeletal integrity, and the function of the immune system. Mutations in genes encoding for the components of the epigenetic machinery lead to the development of distinct disorders, especially involving the central nervous system and host defense. In this review, we focus on the role of epigenetic modifications for the function of the immune system. By studying the immune phenotype of patients with monogenic mutations in components of the epigenetic machinery (inborn errors of epigenetic regulators), we demonstrate the importance of DNA methylation, histone modifications, chromatin remodeling, noncoding RNAs, and mRNA processing for immunity. Moreover, we give a short overview on therapeutic strategies targeting the epigenome.	[Camacho-Ordonez, Nadezhda; Grimbacher, Bodo] Albert Ludwigs Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency,Inst Immunodeficiency, Freiburg, Germany; [Camacho-Ordonez, Nadezhda] Albert Ludwigs Univ Freiburg, Fac Biol, Freiburg, Germany; [Ballestar, Esteban] Josep Carreras Res Inst IJC, Epigenet & Immune Dis Grp, Barcelona, Spain; [Timmers, H. Th Marc] German Canc Res Ctr, Partner Site Freiburg, German Canc Consortium DKTK, Heidelberg, Spain; [Timmers, H. Th Marc] Albert Ludwigs Univ Freiburg, Fac Med, Med Ctr, Dept Urol, Freiburg, Spain; [Grimbacher, Bodo] Satellite Ctr Freiburg, DZIF German Ctr Infect Res, Freiburg, Spain; [Grimbacher, Bodo] Albert Ludwigs Univ, CIBSS Ctr Integrat Biol Signalling Studies, Freiburg, Spain; [Grimbacher, Bodo] Satellite Ctr Freiburg, RESIST Cluster Excellence 2155, Hanover Med Sch, Freiburg, Spain	University of Freiburg; University of Freiburg; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Grimbacher, B (corresponding author), Univ Hosp Freiburg, Breisacher Str 115, D-79106 Freiburg, Germany.	bodo.grimbacher@uniklinik-freiburg.de	Ballestar, Esteban/ABG-8561-2020	Grimbacher, Bodo/0000-0002-6897-6806	Center for Chronic Immunodeficiency, Freiburg Center for Rare Diseases (FZSE); Instituto de Salud Carlos III (ISCIII) [AC18/00057]; i-PAD project (E-RARE); Deutsche Forschungsgemeinschaft [SFB850, SFB992, TI688/1-1, GR1617/14-1/iPAD, SFB1160/2_B5/IMPATH, RESIST-EXC 2155, 390874280, CIBSS-EXC-2189, 390939984]; BMBF [GAIN 01GM1910A]	Center for Chronic Immunodeficiency, Freiburg Center for Rare Diseases (FZSE); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); i-PAD project (E-RARE); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was partially supported by the Center for Chronic Immunodeficiency, Freiburg Center for Rare Diseases (FZSE). E.B. is funded by Instituto de Salud Carlos III (ISCIII), Ref. AC18/00057, associated with i-PAD project (E-RARE). The work of H.Th.M.T. is financially supported by grants from the Deutsche Forschungsgemeinschaft (grant nos. SFB850, SFB992, and TI688/1-1). B.G. is funded by the Deutsche Forschungsgemeinschaft (grant nos. GR1617/14-1/iPAD; SFB1160/2_B5/IMPATH; RESIST-EXC 2155-Project ID 390874280; and CIBSS-EXC-2189-Project ID 390939984) and the BMBF (grant no. GAIN 01GM1910A).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; aan de Kerk DJ, 2016, J CLIN IMMUNOL, V36, P656, DOI 10.1007/s10875-016-0321-2; Aapola U, 2002, NUCLEIC ACIDS RES, V30, P3602, DOI 10.1093/nar/gkf474; Accomando WP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r50; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Almecija AC, 2019, J PEDIAT HEMATOL ONC, V41, pE114, DOI 10.1097/MPH.0000000000001182; Aref-Eshghi E, 2017, EPIGENETICS-US, V12, P923, DOI 10.1080/15592294.2017.1381807; Audia JE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019521; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Ayala R, 2018, NATURE, V556, P391, DOI 10.1038/s41586-018-0021-6; Baets J, 2015, BRAIN, V138, P845, DOI 10.1093/brain/awv010; Ballestar E, 2017, NAT REV RHEUMATOL, V13, P593, DOI 10.1038/nrrheum.2017.147; Ballestar E, 2010, CLIN REV ALLERG IMMU, V39, P30, DOI 10.1007/s12016-009-8168-4; Banka S, 2012, EUR J HUM GENET, V20, P381, DOI 10.1038/ejhg.2011.220; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Bansbach CE, 2010, NUCLEUS-AUSTIN, V1, P245, DOI 10.4161/nucl.1.3.11739; Baradaran-Heravi A, 2012, HUM MOL GENET, V21, P2572, DOI 10.1093/hmg/dds083; Baron U, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3508; Bates SE, 2020, NEW ENGL J MED, V383, P650, DOI 10.1056/NEJMra1805035; Battaglia A, 2015, AM J MED GENET C, V169, P216, DOI 10.1002/ajmg.c.31449; Bauer M, 2015, J CLIN IMMUNOL, V35, P168, DOI 10.1007/s10875-015-0129-5; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Belkaya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027580; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bewersdorf JP, 2019, THER ADV HEMATOL, V10, DOI 10.1177/2040620718816698; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blagitko-Dorfs N, 2019, LEUKEMIA, V33, P945, DOI 10.1038/s41375-018-0293-8; Blossey R, 2018, BIOPHYS J, V114, P2255, DOI 10.1016/j.bpj.2017.12.008; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Boerkoel CF, 2000, EUR J PEDIATR, V159, P1, DOI 10.1007/s004310050001; Bogaert DJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02434-4; BOLDEN AH, 1986, MOL CELL BIOL, V6, P1135, DOI 10.1128/MCB.6.4.1135; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Bonilla FA, 2016, J ALLER CL IMM-PRACT, V4, P38, DOI 10.1016/j.jaip.2015.07.025; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Bousfiha A, 2020, J CLIN IMMUNOL, V40, P66, DOI 10.1007/s10875-020-00758-x; Buchbinder D, 2011, J CLIN IMMUNOL, V31, P773, DOI 10.1007/s10875-011-9561-3; Bunney PE, 2017, PHYSIOL BEHAV, V176, P139, DOI 10.1016/j.physbeh.2017.03.040; Butcher DT, 2017, AM J HUM GENET, V100, P773, DOI 10.1016/j.ajhg.2017.04.004; Campos-Sanchez E, 2017, CELL REP, V19, P1586, DOI 10.1016/j.celrep.2017.04.069; Candotti F, 2018, J CLIN IMMUNOL, V38, P13, DOI 10.1007/s10875-017-0453-z; Cantoni S, 2019, EUR J INTERN MED, V69, pE3, DOI 10.1016/j.ejim.2019.08.003; Centore RC, 2020, TRENDS GENET, V36, P936, DOI 10.1016/j.tig.2020.07.011; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chen CL, 2006, J PHARMACOL EXP THER, V319, P533, DOI 10.1124/jpet.106.106658; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng Y, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0095-0; Chouery E, 2012, CLIN GENET, V82, P489, DOI 10.1111/j.1399-0004.2011.01783.x; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Clewing JM, 2007, J MED GENET, V44, P122, DOI 10.1136/jmg.2006.044313; Cliffe ST, 2012, J ALLERGY CLIN IMMUN, V130, P735, DOI 10.1016/j.jaci.2012.02.054; Conteduca G, 2018, AUTOIMMUN REV, V17, P325, DOI 10.1016/j.autrev.2017.10.017; Cronk JC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88257; Cronk JC, 2015, IMMUNITY, V42, P679, DOI 10.1016/j.immuni.2015.03.013; Daniel JA, 2012, BBA-GENE REGUL MECH, V1819, P733, DOI 10.1016/j.bbagrm.2012.01.019; de Greef JC, 2011, AM J HUM GENET, V88, P796, DOI 10.1016/j.ajhg.2011.04.018; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; de Vries PJ, 2006, J INTELL DISABIL RES, V50, P690, DOI 10.1111/j.1365-2788.2006.00817.x; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Derar N, 2019, GENET MED, V21, P185, DOI 10.1038/s41436-018-0014-8; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Diets IJ, 2019, GENET MED, V21, P572, DOI 10.1038/s41436-018-0079-4; DiNardo CD, 2019, BLOOD, V133, P7, DOI 10.1182/blood-2018-08-868752; Du QM, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01365; Duan R, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00937-8; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Ea CK, 2012, J BIOL CHEM, V287, P31207, DOI 10.1074/jbc.M112.365601; El Chaer F, 2020, CURR HEMATOL MALIG R, V15, P83, DOI 10.1007/s11899-020-00582-5; Elizondo LI, 2009, J MED GENET, V46, P49, DOI 10.1136/jmg.2008.060095; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fasan O, 2016, TRANSL ONCOL, P72; Fedele P, 2017, EXPERT OPIN INV DRUG, V26, P1199, DOI 10.1080/13543784.2017.1386172; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Flach H, 2010, IMMUNITY, V33, P723, DOI 10.1016/j.immuni.2010.11.013; Fliegauf M, 2015, AM J HUM GENET, V97, P389, DOI 10.1016/j.ajhg.2015.07.008; Florath I, 2014, HUM MOL GENET, V23, P1186, DOI 10.1093/hmg/ddt531; Fox R, 2016, J PERIPHER NERV SYST, V21, P150, DOI 10.1111/jns.12178; Frans G, 2016, AM J MED GENET A, V170, P801, DOI 10.1002/ajmg.a.37499; Fraschilla I, 2020, TRENDS IMMUNOL, V41, P572, DOI 10.1016/j.it.2020.04.007; Fung WLA, 2015, GENET MED, V17, P599, DOI 10.1038/gim.2014.175; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Ghasemi S, 2020, PHARMACOGENOMICS J, V20, P367, DOI 10.1038/s41397-019-0138-5; GINDER GD, 1984, P NATL ACAD SCI-BIOL, V81, P3954, DOI 10.1073/pnas.81.13.3954; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gray PEA, 2011, INT J IMMUNOGENET, V38, P501, DOI 10.1111/j.1744-313X.2011.01041.x; Guo CJ, 2018, AUTOIMMUN REV, V17, P78, DOI 10.1016/j.autrev.2017.11.012; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hanley-Lopez J, 1998, J PEDIATR-US, V133, P141, DOI 10.1016/S0022-3476(98)70194-5; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Harada T, 2016, INT J HEMATOL, V104, P300, DOI 10.1007/s12185-016-2008-0; HASHIMOTO K, 1994, AM J MED GENET, V49, P266, DOI 10.1002/ajmg.1320490304; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; He YF, 2020, P NATL ACAD SCI USA, V117, P20100, DOI 10.1073/pnas.2004112117; Helfricht A, 2020, J EXP MED, V217, DOI 10.1084/jem.20191688; Heremans J, 2018, J ALLERGY CLIN IMMUN, V142, P630, DOI 10.1016/j.jaci.2017.11.061; Hernando H, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r3; Heyn H, 2012, EPIGENETICS-US, V7, P542, DOI 10.4161/epi.20523; Hollmann TJ, 2011, AM J SURG PATHOL, V35, pE47, DOI 10.1097/PAS.0b013e31822b325b; Hsu P, 2016, J ALLER CL IMM-PRACT, V4, P96, DOI 10.1016/j.jaip.2015.09.004; Hsu P, 2014, J PAEDIATR CHILD H, V50, P504, DOI 10.1111/jpc.12497; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Issa JPJ, 2015, LANCET ONCOL, V16, P1099, DOI 10.1016/S1470-2045(15)00038-8; Italiano A, 2018, LANCET ONCOL, V19, P649, DOI 10.1016/S1470-2045(18)30145-1; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; James LI, 2013, CLIN PHARMACOL THER, V93, P312, DOI 10.1038/clpt.2013.6; Jenness C, 2018, P NATL ACAD SCI USA, V115, pE876, DOI 10.1073/pnas.1717509115; Jhamnani RD, 2017, CURR OPIN ALLERGY CL, V17, P391, DOI 10.1097/ACI.0000000000000401; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jiang S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004824; Jiang S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01391-5; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Jones KM, 2015, STEM CELLS, V33, P196, DOI 10.1002/stem.1822; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kaiwar C, 2019, CLIN IMMUNOL, V207, P55, DOI 10.1016/j.clim.2018.09.013; Kalac M, 2011, BLOOD, V118, P5506, DOI 10.1182/blood-2011-02-336891; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Klemann C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00297; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Kracker S, 2015, J ALLERGY CLIN IMMUN, V135, P998, DOI 10.1016/j.jaci.2014.08.030; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Kroesen M, 2014, ONCOTARGET, V5, P6558, DOI 10.18632/oncotarget.2289; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; KUROKI Y, 1981, J PEDIATR-US, V99, P570, DOI 10.1016/S0022-3476(81)80256-9; Kurumizaka H, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.10.012; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Lai NS, 2017, CLIN EXP IMMUNOL, V187, P327, DOI 10.1111/cei.12903; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lana E, 2012, EUR J HUM GENET, V20, P1044, DOI 10.1038/ejhg.2012.41; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Legendre M, 2017, AM J MED GENET C, V175, P417, DOI 10.1002/ajmg.c.31591; Licciardi F, 2019, J CLIN IMMUNOL, V39, P234, DOI 10.1007/s10875-019-00596-6; Lindsley AW, 2016, J ALLERGY CLIN IMMUN, V137, P179, DOI 10.1016/j.jaci.2015.06.002; Lio CWJ, 2020, IMMUNOLOGY, V161, P165, DOI 10.1111/imm.13207; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Lopez-Moyado IF, 2020, NAT GENET, V52, P554, DOI 10.1038/s41588-020-0641-2; Lorenzini T, 2020, J ALLERGY CLIN IMMUN, V146, P901, DOI 10.1016/j.jaci.2019.11.051; Marchal C, 2019, NAT REV MOL CELL BIO, V20, P721, DOI 10.1038/s41580-019-0162-y; Margot H, 2020, GENET MED, V22, P181, DOI 10.1038/s41436-019-0623-x; Meda F, 2011, CELL MOL IMMUNOL, V8, P226, DOI 10.1038/cmi.2010.78; Merico D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9718; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mishra A, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0477-2; Miyake N, 2016, CLIN GENET, V89, P115, DOI 10.1111/cge.12586; Muegge K, 2005, BIOCHEM CELL BIOL, V83, P548, DOI 10.1139/O05-119; Nevado J, 2020, AM J MED GENET A, V182, P257, DOI 10.1002/ajmg.a.61406; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; NIIKAWA N, 1981, J PEDIATR-US, V99, P565, DOI 10.1016/S0022-3476(81)80255-7; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nitta H, 2013, J HUM GENET, V58, P455, DOI 10.1038/jhg.2013.56; O'Driscoll CM, 2013, J NEUROIMMUNOL, V265, P61, DOI 10.1016/j.jneuroim.2013.09.002; Okur V, 2018, AM J MED GENET A, V176, P1773, DOI 10.1002/ajmg.a.38852; Olins DE, 2003, NAT REV MOL CELL BIO, V4, P809, DOI 10.1038/nrm1225; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Paradowska-Stolarz AM, 2014, ADV CLIN EXP MED, V23, P485, DOI 10.17219/acem/24111; Pilarowski GO, 2020, J ALLERGY CLIN IMMUN, V145, P982, DOI 10.1016/j.jaci.2019.11.034; Poli J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0290; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Proekt I, 2017, CURR OPIN IMMUNOL, V49, P71, DOI 10.1016/j.coi.2017.10.003; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Rae W, 2017, ARCH IMMUNOL THER EX, V65, P101, DOI 10.1007/s00005-016-0414-x; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rivers E, 2017, EUR J IMMUNOL, V47, P1857, DOI 10.1002/eji.201646715; Rodriguez-Cortez VC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8335; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roifman CM, 1999, CLIN GENET, V55, P103, DOI 10.1034/j.1399-0004.1999.550206.x; Roscioli T, 2006, NAT GENET, V38, P620, DOI 10.1038/ng1780; Runge JS, 2018, G3-GENES GENOM GENET, V8, P1095, DOI 10.1534/g3.117.300504; Sandweiss AJ, 2020, LANCET NEUROL, V19, P689, DOI 10.1016/S1474-4422(20)30217-9; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Saraiva JM, 1999, J MED GENET, V36, P786, DOI 10.1136/jmg.36.10.786; Satterlee JS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6507; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; SMITH SS, 1991, J MOL BIOL, V217, P39, DOI 10.1016/0022-2836(91)90609-A; Spegarova JS, 2020, BLOOD, V136, P1055, DOI 10.1182/blood.2020005844; Stagi S, 2016, IMMUNOL RES, V64, P345, DOI 10.1007/s12026-015-8707-4; Stellacci E, 2016, AM J MED GENET A, V170, P2389, DOI 10.1002/ajmg.a.37681; Sterlin D, 2016, J CLIN IMMUNOL, V36, P149, DOI 10.1007/s10875-016-0240-2; Sullivan KE, 2004, CURR OPIN ALLERGY CL, V4, P505, DOI 10.1097/00130832-200412000-00006; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Talbert PB, 2017, NAT REV MOL CELL BIO, V18, P115, DOI 10.1038/nrm.2016.148; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Teng L, 2015, BIOINFORMATICS, V31, P2560, DOI 10.1093/bioinformatics/btv158; Thijssen PE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8870; Turunen JJ, 2013, WIRES RNA, V4, P61, DOI 10.1002/wrna.1141; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Ufartes R, 2018, HUM MOL GENET, V27, P1343, DOI 10.1093/hmg/ddy045; Unoki M, 2019, J CLIN INVEST, V129, P78, DOI 10.1172/JCI99751; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Van Esch H, 2011, MOL SYNDROMOL, V2, P128, DOI 10.1159/000329580; Van Laarhoven PM, 2015, HUM MOL GENET, V24, P4443, DOI 10.1093/hmg/ddv180; van Schouwenburg PA, 2015, CLIN IMMUNOL, V160, P301, DOI 10.1016/j.clim.2015.05.020; Velasco G, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-56; Verma B, 2018, SEMIN CELL DEV BIOL, V79, P103, DOI 10.1016/j.semcdb.2017.09.036; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vogelmann A, 2020, CURR OPIN CHEM BIOL, V57, P8, DOI 10.1016/j.cbpa.2020.01.010; Von Hoff D D, 1976, Ann Intern Med, V85, P237; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang LQ, 2013, BLOOD, V121, P3631, DOI 10.1182/blood-2012-08-451765; Wang T, 2012, CLIN IMMUNOL, V145, P102, DOI 10.1016/j.clim.2012.07.016; Willemsen MH, 2011, MOL SYNDROMOL, V2, P202, DOI 10.1159/000335648; Willhoft O, 2020, CURR OPIN STRUC BIOL, V61, P50, DOI 10.1016/j.sbi.2019.09.002; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Wong MTY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142350; Wong MTY, 2015, EUR J HUM GENET, V23, P1451, DOI 10.1038/ejhg.2015.7; Woo V, 2017, CURR OPIN IMMUNOL, V44, P52, DOI 10.1016/j.coi.2016.12.001; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yamagishi M, 2017, CURR OPIN ONCOL, V29, P375, DOI 10.1097/CCO.0000000000000390; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang TS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004430; Zachariah RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049763; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang Y, 2017, J MED VIROL, V89, P1069, DOI 10.1002/jmv.24728; Zhang YX, 2013, BLOOD, V122, P2823, DOI 10.1182/blood-2013-02-481788; Zheng H, 2019, NAT REV MOL CELL BIO, V20, P535, DOI 10.1038/s41580-019-0132-4; Zollino M, 2003, AM J HUM GENET, V72, P590, DOI 10.1086/367925	240	3	3	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1602	1618		10.1016/j.jaci.2021.01.035	http://dx.doi.org/10.1016/j.jaci.2021.01.035		MAY 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33609625				2022-12-18	WOS:000647680800006
J	Du, ZC; Chen, AW; Huang, L; Dai, X; Chen, QY; Yang, D; Li, LL; Miller, H; Westerberg, L; Ding, Y; Tang, XM; Kubo, M; Jiang, LP; Zhao, XD; Wang, H; Liu, CH				Du, Zuochen; Chen, Anwei; Huang, Lu; Dai, Xin; Chen, Qiuyue; Yang, Di; Li, Liling; Miller, Heather; Westerberg, Lisa; Ding, Yuan; Tang, Xuemei; Kubo, Masato; Jiang, Liping; Zhao, Xiaodong; Wang, Hua; Liu, Chaohong			STAT3 couples with 14-3-3 sigma to regulate BCR signaling, B-cell differentiation, and IgE production	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						STAT3; HIES; B cells; BCR; 14-3-3 sigma protein	CLASS-SWITCH; ACTIN CYTOSKELETON; ACTIVATION; MUTATIONS; TRANSCRIPTION; TRANSDUCER; DEFICIENCY; GENE; PHOSPHORYLATION; MAINTENANCE	Background: STAT3 or dedicator of cytokinesis protein 8 (Dock8) loss-of-function (LOF) mutations cause hyper-IgE syndrome. The role of abnormal T-cell function has been extensively investigated; however, the contribution of B-cellintrinsic dysfunction to elevated IgE levels is unclear. Objective: We sought to determine the underlying molecular mechanism of how STAT3 regulates B-cell receptor (BCR) signaling, B-cell differentiation, and IgE production. Methods: We used samples from patients with STAT3 LOF mutation and samples from the STAT3 B-cell-specific knockout (KO) mice Mb1(Cre) Stat3(flox/flox) mice (B-STAT3 KO) to investigate the mechanism of hyper-IgE syndrome. Results: We found that the peripheral B-cell homeostasis in B-STAT3 KO mice mimicked the phenotype of patients with STAT3 LOF mutation, having decreased levels of follicular and germinal center B cells but increased levels of marginal zone and IgE(+) B cells. Furthermore, B-STAT3 KO B cells had reduced BCR signaling following antigenic stimulation owing to reduced BCR clustering and decreased accumulation of Wiskott-Aldrich syndrome protein and F-actin. Excitingly, a central hub protein, 14-3-3 sigma, which is essential for the increase in IgE production, was enhanced in the B cells of B-STAT3 KO mice and patients with STAT3 LOF mutation. The increase of 14-3-3 sigma was associated with increased expression of the upstream mediator, microRNA146A. Inhibition of 14-3-3 sigma with R18 peptide in B-STAT3 KO mice rescued the BCR signaling, follicular, germinal center, and IgE(+) B-cell differentiation to the degree seen in wild-type mice. Conclusions: Altogether, our study has established a novel regulatory pathway of STAT3-miRNA146A-14-3-3 sigma to regulate BCR signaling, peripheral B-cell differentiation, and IgE production.	[Du, Zuochen; Chen, Anwei; Huang, Lu; Yang, Di; Li, Liling; Jiang, Liping; Zhao, Xiaodong] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Child Infect & Immun, 136,Zhongshan 2nd Rd, Chongqing 400014, Peoples R China; [Du, Zuochen; Chen, Anwei; Huang, Lu; Yang, Di; Li, Liling; Jiang, Liping; Zhao, Xiaodong] Chongqing Med Univ, Childrens Hosp, Dept Pediat, Res Inst, Chongqing, Peoples R China; [Du, Zuochen; Chen, Anwei; Huang, Lu; Yang, Di; Li, Liling; Jiang, Liping; Zhao, Xiaodong] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorder, Chongqing, Peoples R China; [Du, Zuochen; Chen, Anwei; Huang, Lu; Yang, Di; Li, Liling; Jiang, Liping; Zhao, Xiaodong] Chongqing Med Univ, Childrens Hosp, Int Sci & Technol Cooperat Base Child Dev & Crit, Chongqing, Peoples R China; [Chen, Anwei; Wang, Hua] Chongqing Med Univ, Childrens Hosp, Dept Dermatol, 136,Zhongshan 2nd Rd, Chongqing 400014, Peoples R China; [Ding, Yuan] Chongqing Med Univ, Childrens Hosp, Div Immunol, Chongqing, Peoples R China; [Tang, Xuemei] Chongqing Med Univ, Childrens Hosp, Dept Rheumatol & Immunol, Chongqing, Peoples R China; [Du, Zuochen] Zunyi Med Univ, Affiliated Hosp, Dept Pediat 2, Zunyi, Guizhou, Peoples R China; [Dai, Xin; Chen, Qiuyue; Liu, Chaohong] Huazhong Uni Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan, Peoples R China; [Miller, Heather] Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Rocky Mt Labs, Lab Intracellular Parasites, Hamilton, MT USA; [Westerberg, Lisa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kubo, Masato] RIKEN Yokohama Inst, Ctr Integrat Med Sci, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Zunyi Medical University; Huazhong University of Science & Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet; RIKEN	Zhao, XD (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Child Infect & Immun, 136,Zhongshan 2nd Rd, Chongqing 400014, Peoples R China.; Wang, H (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Dermatol, 136,Zhongshan 2nd Rd, Chongqing 400014, Peoples R China.; Liu, CH (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pathogen Biol, Lead Contact, Wuhan 430030, Peoples R China.	zhaoxd530@aliyun.com; huawang@hospital.cqmu.edu.cn; chaohongliu80@126.com		Westerberg, Lisa/0000-0003-2943-2192	National Natural Science Foundation of China [81861138002, 81722002, 31970839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the National Natural Science Foundation of China (grants 81861138002, 81722002, and 31970839).	Al Khatib S, 2009, J ALLERGY CLIN IMMUN, V124, P342, DOI 10.1016/j.jaci.2009.05.004; Al-Shaikhly T, 2019, IMMUNOL CELL BIOL, V97, P368, DOI 10.1111/imcb.12209; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Carruthers NJ, 2017, EUR J PHARMACOL, V811, P66, DOI 10.1016/j.ejphar.2017.05.049; Chou WC, 2006, BLOOD, V108, P3005, DOI 10.1182/blood-2006-05-024430; de Lendonck LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071029; Deenick EK, 2013, J EXP MED, V210, P2739, DOI 10.1084/jem.20130323; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Ding CL, 2016, J IMMUNOL, V196, P4477, DOI 10.4049/jimmunol.1502043; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Grimbacher B, 2005, IMMUNOL REV, V203, P244, DOI 10.1111/j.0105-2896.2005.00228.x; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Huang L, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001750; Jabara HH, 2008, J ALLERGY CLIN IMMUN, V121, P191, DOI 10.1016/j.jaci.2007.08.008; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kikuchi H, 2011, BIOCHEM BIOPH RES CO, V405, P657, DOI 10.1016/j.bbrc.2011.01.088; Lam T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080414; Levy DE, 2007, NEW ENGL J MED, V357, P1655, DOI 10.1056/NEJMe078197; Li F, 2017, MOL IMMUNOL, V92, P180, DOI 10.1016/j.molimm.2017.10.023; Liu CH, 2011, J IMMUNOL, V187, P230, DOI 10.4049/jimmunol.1100157; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; McIlwain DR, 2015, EUR J IMMUNOL, V45, P418, DOI 10.1002/eji.201445060; Meyer-Bahlburg A, 2008, BLOOD, V112, P4158, DOI 10.1182/blood-2008-02-140814; Meyer-Bahlburg A, 2012, J ALLERGY CLIN IMMUN, V129, P559, DOI 10.1016/j.jaci.2011.09.017; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Raybuck AL, 2018, J IMMUNOL, V200, P2627, DOI 10.4049/jimmunol.1701321; Ren JP, 2016, J VIRAL HEPATITIS, V23, P755, DOI 10.1111/jvh.12537; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Saki N, 2014, HEMATOLOGY, V19, P141, DOI 10.1179/1607845413Y.0000000105; Seeley-Fallen MK, 2014, P NATL ACAD SCI USA, V111, P9881, DOI 10.1073/pnas.1321971111; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Song WX, 2014, BBA-BIOMEMBRANES, V1838, P569, DOI 10.1016/j.bbamem.2013.07.016; Speckmann C, 2008, CLIN IMMUNOL, V129, P448, DOI 10.1016/j.clim.2008.08.002; Su YW, 2011, P NATL ACAD SCI USA, V108, P1555, DOI 10.1073/pnas.1017729108; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Sun XY, 2018, BLOOD ADV, V2, P401, DOI 10.1182/bloodadvances.2017007880; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thomas MD, 2006, CELL IMMUNOL, V239, P92, DOI 10.1016/j.cellimm.2006.04.007; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; WINGELHOFER B, 2018, LEUKEMIA, V32, P1; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yang L, 2019, J ALLERGY CLIN IMMUN; Yang LL, 2014, CURR OPIN PEDIATR, V26, P697, DOI 10.1097/MOP.0000000000000158; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Yuan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17663; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	59	3	3	2	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1907	+		10.1016/j.jaci.2020.09.033	http://dx.doi.org/10.1016/j.jaci.2020.09.033		MAY 2021	23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33045280				2022-12-18	WOS:000651594300010
J	Soriano, VX; Koplin, JJ; Forrester, M; Peters, RL; O'Hely, M; Dharmage, SC; Wright, R; Ranganathan, S; Burgner, D; Thompson, K; Dwyer, T; Vuillerman, P; Ponsonby, AL				Soriano, Victoria X.; Koplin, Jennifer J.; Forrester, Mike; Peters, Rachel L.; O'Hely, Martin; Dharmage, Shyamali C.; Wright, Rosemary; Ranganathan, Sarath; Burgner, David; Thompson, Kristie; Dwyer, Terence; Vuillerman, Peter; Ponsonby, Anne-Louise		BIS Investigator Grp	Infant pacifier sanitization and risk of challenge- proven food allergy: A cohort study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Pacifier; dummy; food allergy; birth cohort; microbial exposure; sanitization; antiseptic	POPULATION; DISEASE; ASSOCIATION; IMMUNOLOGY; ECZEMA	Background: Environmental microbial exposure plays a role in immune system development and susceptibility to food allergy. Objective: We sought to investigate whether infant pacifier use during the first postnatal year, with further consideration of sanitization, alters the risk of food allergy by age 1 year. Methods: The birth cohort recruited pregnant mothers at under 28 weeks' gestation in southeast Australia, with 894 families followed up when infants turned 1 year. Infants were excluded if born under 32 weeks, with a serious illness, major congenital malformation, or genetic disease. Questionnaire data, collected at recruitment and infant ages 1, 6, and 12 months, included pacifier use and pacifier sanitization (defined as the joint exposure of a pacifier and cleaning methods). Challenge-proven food allergy was assessed at 12 months. Results: Any pacifier use at 6 months was associated with food allergy (adjusted odds ratio, 1.94; 95% CI, 1.04-3.61), but not pacifier use at other ages. This overall association was driven by the joint exposure of pacifier-antiseptic use (adjusted odds ratio, 4.83; 95% CI, 1.10-21.18) compared with no pacifier use. Using pacifiers without antiseptic at 6 months was not associated with food allergy. Among pacifier users, antiseptic cleaning was still associated with food allergy (adjusted odds ratio, 3.56; 95% CI, 1.18-10.77) compared with no antiseptic use. Furthermore, persistent and repeated antiseptic use over the first 6 months was associated with higher food allergy risk (P =.029). Conclusions: This is the first report of a pacifier-antiseptic combination being associated with a higher risk of subsequent food allergy. Future work should investigate underlying biological pathways.	[Soriano, Victoria X.; Koplin, Jennifer J.; Peters, Rachel L.] Univ Melbourne, Populat Hlth, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Soriano, Victoria X.; Koplin, Jennifer J.; Peters, Rachel L.; Ranganathan, Sarath; Burgner, David] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Forrester, Mike; O'Hely, Martin; Vuillerman, Peter] Deakin Univ, Sch Med, Geelong, Vic, Australia; [Forrester, Mike; Vuillerman, Peter] Barwon Hlth, Childrens Serv, Geelong, Vic, Australia; [Forrester, Mike] St John God Hosp, Geelong, Vic, Australia; [O'Hely, Martin; Ranganathan, Sarath; Burgner, David; Vuillerman, Peter; Ponsonby, Anne-Louise] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Dharmage, Shyamali C.; Ponsonby, Anne-Louise] Univ Melbourne, Allergy & Lung Hlth Unit, Sch Populat & Global Hlth, Parkville, Vic, Australia; [Wright, Rosemary] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia; [Thompson, Kristie] Univ Queensland, Queensland Alliance Environm Hlth Sci, Brisbane, Qld, Australia; [Dwyer, Terence] Murdoch Childrens Res Inst, Heart Res Grp, Parkville, Vic, Australia; [Dwyer, Terence] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England; [Ponsonby, Anne-Louise] Florey Inst Neurosci & Mental Hlth, Neuroepidemiol Res Grp, Parkville, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Deakin University; St John of God Health Care; Murdoch Children's Research Institute; University of Melbourne; Australian National University; University of Queensland; Murdoch Children's Research Institute; University of Oxford; Florey Institute of Neuroscience & Mental Health	Ponsonby, AL (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	annelouise.ponsonby@florey.edu.au		Koplin, Jennifer/0000-0002-7576-5142; Soriano, Victoria Ximena/0000-0002-8412-5657; Peters, Rachel/0000-0002-2411-6628	National Health and Medical Research Council of Australia (NHMRC); Jack Brockhoff Foundation; Scobie Trust; Shane O'Brien Memorial Asthma Foundation; OurWomen's Our Children's Fund Raising Committee Barwon Health; Shepherd Foundation; Rotary Club of Geelong; Ilhan Food Allergy Foundation; GMHBA Limited; Vanguard Investments Australia Ltd; Percy Baxter Charitable Trust; Perpetual Trustees; Victorian Government's Operational Infrastructure Program; NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Jack Brockhoff Foundation; Scobie Trust; Shane O'Brien Memorial Asthma Foundation; OurWomen's Our Children's Fund Raising Committee Barwon Health; Shepherd Foundation; Rotary Club of Geelong; Ilhan Food Allergy Foundation; GMHBA Limited; Vanguard Investments Australia Ltd; Percy Baxter Charitable Trust; Perpetual Trustees; Victorian Government's Operational Infrastructure Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The establishment work and infrastructure for the Barwon Infant Study was provided by the Murdoch Children's Research Institute, Deakin University, and Barwon Health. Subsequent funding was secured from the National Health and Medical Research Council of Australia (NHMRC), The Jack Brockhoff Foundation, the Scobie Trust, the Shane O'Brien Memorial Asthma Foundation, the OurWomen's Our Children's Fund Raising Committee Barwon Health, The Shepherd Foundation, the Rotary Club of Geelong, the Ilhan Food Allergy Foundation, GMHBA Limited, Vanguard Investments Australia Ltd, and the Percy Baxter Charitable Trust, Perpetual Trustees. In kind support was provided by the Cotton On Foundation and CreativeForce. The study sponsors were not involved in the collection, analysis, and interpretation of data; writing of the report; nor the decision to submit the report for publication. Research at the Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Program. V.X.S. is supported by a PhD scholarship from the NHMRC-funded Centre for Food and Allergy Research. R.L.P. and J.J.K. are supported by NHMRC-funded fellowships.	Abou-Jaoude E, 2018, ANN ALLERG ASTHMA IM, V121, pS47, DOI 10.1016/j.anai.2018.09.148; Aichbhaumik N, 2008, CLIN EXP ALLERGY, V38, P1787, DOI 10.1111/j.1365-2222.2008.03079.x; Berin MC, 2013, CURR BIOL, V23, pR389, DOI 10.1016/j.cub.2013.02.043; Bunyavanich S, 2019, J ALLERGY CLIN IMMUN, V144, P1468, DOI 10.1016/j.jaci.2019.10.019; Comina Elodie, 2006, Nurs Health Sci, V8, P216, DOI 10.1111/j.1442-2018.2006.00282.x; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Gupta RS, 2016, ALLERGY ASTHMA PROC, V37, pE140, DOI 10.2500/aap.2016.37.3988; Hesselmar B, 2013, PEDIATRICS, V131, pE1829, DOI 10.1542/peds.2012-3345; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Jaafar SH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007202.pub4; Jahreis S, 2018, J ALLERGY CLIN IMMUN, V141, P741, DOI 10.1016/j.jaci.2017.03.017; Johnston LK, 2014, J IMMUNOL, V192, P2529, DOI 10.4049/jimmunol.1303026; Koplin JJ, 2012, J ALLERGY CLIN IMMUN, V129, P1145, DOI 10.1016/j.jaci.2011.09.044; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Larson K, 2017, MCN-AM J MATERN-CHIL, V42, P72, DOI 10.1097/NMC.0000000000000313; Marrs T, 2013, PEDIAT ALLERG IMM-UK, V24, DOI 10.1111/pai.12064; Martin PE, 2015, CLIN EXP ALLERGY, V45, P255, DOI 10.1111/cea.12406; Mitchell EA, 2012, J PAEDIATR CHILD H, V48, P626, DOI 10.1111/j.1440-1754.2011.02215.x; Molloy J, 2017, ALLERGY, V72, P1222, DOI 10.1111/all.13122; Moon RY, 2011, PEDIATRICS, V128, P1030, DOI 10.1542/peds.2011-2284; Moreno-Betancur M, 2018, INT J EPIDEMIOL, V47, P217, DOI 10.1093/ije/dyx194; Osborne NJ, 2010, CLIN EXP ALLERGY, V40, P1516, DOI 10.1111/j.1365-2222.2010.03562.x; Raising Children's Network, 2017, DUMM ADV DIS; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sexton S, 2009, AM FAM PHYSICIAN, V79, P681; Sherriff A, 2002, ARCH DIS CHILD, V87, P26, DOI 10.1136/adc.87.1.26; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; Vuillermin P, 2015, INT J EPIDEMIOL, V44, P1148, DOI 10.1093/ije/dyv026; Vuillermin PJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14552-1; Welten Marieke, 2018, Diagn Progn Res, V2, P5, DOI 10.1186/s41512-018-0024-7	34	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1823	+		10.1016/j.jaci.2021.01.032	http://dx.doi.org/10.1016/j.jaci.2021.01.032		MAY 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33810856				2022-12-18	WOS:000651594300003
J	Wright, RJ				Wright, Rosalind J.			Hormones and women's respiratory health across the lifespan: Windows of opportunity for advancing research	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Reproductive hormones; asthma; women's health; life course; vulnerable windows	ASTHMA		[Wright, Rosalind J.] Dept Environm Med & Publ Hlth, New York, NY USA; [Wright, Rosalind J.] Inst Expos Res, New York, NY USA		Wright, RJ (corresponding author), Icahn Sch Med Mt Sinai, 1236 Pk Ave, New York, NY 10056 USA.	rosalind.wright@mssm.edu			National Institutes of Health [UH3 OD023337, U2CES026561, P30 ES023515, UL1 TR001433]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	During preparation of this article, R. J. Wright was supported by the National Institutes of Health (grants UH3 OD023337, U2CES026561, P30 ES023515, and UL1 TR001433) to advance life course research.	Ben-Shlomo Y, 2016, INT J EPIDEMIOL, V45, P973, DOI 10.1093/ije/dyw096; Dennis KK, 2017, ENVIRON HEALTH PERSP, V125, P502, DOI 10.1289/EHP474; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Kroon J, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa113; Levy BD, 2015, AM J RESP CRIT CARE, V192, P1366, DOI 10.1164/rccm.201505-0963WS; Niedzwiecki MM, 2019, ANNU REV PHARMACOL, V59, P107, DOI 10.1146/annurev-pharmtox-010818-021315; Novak J, 2020, ENVIRON POLLUT, V264, DOI 10.1016/j.envpol.2020.114654; Shah SA, 2021, J ALLERGY CLIN IMMUN, V147, P1662, DOI 10.1016/j.jaci.2020.11.024; Varshavsky J, 2020, REPROD TOXICOL, V92, P14, DOI 10.1016/j.reprotox.2019.04.004; Yung JA, 2018, ANN ALLERG ASTHMA IM, V120, P488, DOI 10.1016/j.anai.2018.01.016	10	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1643	1645		10.1016/j.jaci.2021.02.033	http://dx.doi.org/10.1016/j.jaci.2021.02.033		MAY 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33713762	Bronze			2022-12-18	WOS:000647680800012
J	Chinthrajah, RS; Galli, SJ				Chinthrajah, R. Sharon; Galli, Stephen J.			Omalizumab in "non-IgE-mediated" diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Omalizumab; IgE; mechanism; Fc epsilon RI; Fc epsilon RII			[Chinthrajah, R. Sharon; Galli, Stephen J.] Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA USA; [Chinthrajah, R. Sharon] Stanford Univ, Div Pulm Allergy & Crit Care Med, Stanford, CA USA; [Galli, Stephen J.] Stanford Univ, Dept Pathol, Stanford, CA USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Galli, SJ (corresponding author), Ctr Clin Sci Res, 269 Campus Dr,Rm 3255b, Stanford, CA 94305 USA.	sgalli@stanford.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19AI104209, R01AI125567, UM1AI130839]; Sean N. Parker Center for Allergy and Asthma Research at Stanford University	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sean N. Parker Center for Allergy and Asthma Research at Stanford University	This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (grant nos. U19AI104209, R01AI125567, and UM1AI130839) and the Sean N. Parker Center for Allergy and Asthma Research at Stanford University.	Cardet JC, 2019, J ALLERGY CLIN IMMUN, V143, P923, DOI 10.1016/j.jaci.2019.01.016; Cox L, 2007, J ALLERGY CLIN IMMUN, V120, P1373, DOI 10.1016/j.jaci.2007.09.032; Gasser P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13815-w; Guntern P, 2020, ALLERGY, V75, P2491, DOI 10.1111/all.14308; Jafari SMS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01919; Kaplan AP, 2017, ALLERGY, V72, P519, DOI 10.1111/all.13083; Lopez-Abente J, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.00751-2020; Noga O, 2006, J ALLERGY CLIN IMMUN, V117, P1493, DOI 10.1016/j.jaci.2006.02.028; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; van Beek N, 2017, JAMA DERMATOL, V153, P30, DOI 10.1001/jamadermatol.2016.3357	10	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1207	1208		10.1016/j.jaci.2020.10.033	http://dx.doi.org/10.1016/j.jaci.2020.10.033		APR 2021	2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	33160970	Bronze			2022-12-18	WOS:000637368900008
J	Darby, M; Roberts, LB; Mackowiak, C; Chetty, A; Tinelli, S; Schnoeller, C; Quesniaux, V; Berrard, S; Togbe, D; Selkirk, ME; Ryffel, B; Horsnell, WGC				Darby, Matthew; Roberts, Luke B.; Mackowiak, Claire; Chetty, Alisha; Tinelli, Sasha; Schnoeller, Corinna; Quesniaux, Valerie; Berrard, Sylvie; Togbe, Dieudonnee; Selkirk, Murray E.; Ryffel, Bernard; Horsnell, William G. C.			ILC3-derived acetylcholine promotes protease-driven allergic lung pathology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ROR-GAMMA; T-CELLS		[Darby, Matthew; Chetty, Alisha; Tinelli, Sasha; Horsnell, William G. C.] Univ Cape Town, Dept Pathol, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Afr,Div Immunol, Cape Town, South Africa; [Roberts, Luke B.; Schnoeller, Corinna; Selkirk, Murray E.] Imperial Coll London, Dept Life Sci, London, England; [Roberts, Luke B.] Kings Coll London, Sch Immunol & Microbial Sci, London, England; [Mackowiak, Claire; Quesniaux, Valerie; Togbe, Dieudonnee; Ryffel, Bernard; Horsnell, William G. C.] CNRS, INEM UMR7355 Expt & Mol Immunol & Neurogenet, Orleans, France; [Mackowiak, Claire; Quesniaux, Valerie; Togbe, Dieudonnee; Ryffel, Bernard; Horsnell, William G. C.] Univ Orleans, Orleans, France; [Berrard, Sylvie] Univ Paris, INSERM, Paris, France; [Horsnell, William G. C.] Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Cape Town; Imperial College London; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Birmingham	Horsnell, WGC (corresponding author), Univ Cape Town, Dept Pathol, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Afr,Div Immunol, Cape Town, South Africa.; Horsnell, WGC (corresponding author), CNRS, INEM UMR7355 Expt & Mol Immunol & Neurogenet, Orleans, France.; Horsnell, WGC (corresponding author), Univ Orleans, Orleans, France.; Horsnell, WGC (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	wghorsnell@gmail.com		Horsnell, William Gordon Charles/0000-0001-7172-408X; Chetty, Alisha/0000-0002-6834-5764; Mackowiak, Claire/0000-0003-1267-5905; Roberts, Luke/0000-0003-1143-304X; Darby, Matthew/0000-0002-3701-0056; Selkirk, Murray/0000-0002-6274-6014	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R015856/1]; Royal Society International Exchange [IES\R1\180108]; Le Studium-Marie Curie Fellowship; European Regional Development fund (FEDER) [2016-00110366, EX005756]; NRF (SA) Competitive Support for Rated Researchers [111815]; Carnegie Corporation of New York DEAL Fellowship; National Research Foundation (SA) [99610]; Wellcome Trust [203135/Z/16/Z]; BBSRC [BB/R015856/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society International Exchange(Royal Society of London); Le Studium-Marie Curie Fellowship; European Regional Development fund (FEDER)(European Commission); NRF (SA) Competitive Support for Rated Researchers; Carnegie Corporation of New York DEAL Fellowship; National Research Foundation (SA); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by research funding from the Biotechnology and Biological Sciences Research Council (BBSRC, grant BB/R015856/1), Royal Society International Exchange (grant IES\R1\180108), Le Studium-Marie Curie Fellowship, European Regional Development fund (FEDER No 2016-00110366 and EX005756); the NRF (SA) Competitive Support for Rated Researchers (grant 111815), Carnegie Corporation of New York DEAL Fellowship, and the National Research Foundation (SA) (grant 99610). The Wellcome Centre for Infectious Disease Research in Africa is supported by core funding from the Wellcome Trust (grant 203135/Z/16/Z).	Ardain A, 2019, NATURE, V570, P528, DOI 10.1038/s41586-019-1276-2; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cox MA, 2019, SCIENCE, V363, P639, DOI 10.1126/science.aau9072; Darby M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004636; De Grove KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145961; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Jonckheere AC, 2019, CURR OPIN ALLERGY CL, V19, P53, DOI 10.1097/ACI.0000000000000497; Kim J, 2019, J ALLERGY CLIN IMMUN, V143, P1769, DOI 10.1016/j.jaci.2018.10.040; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Madouri F, 2017, J ALLERGY CLIN IMMUN, V139, P1650, DOI 10.1016/j.jaci.2016.08.044; Michaudel C, 2018, J ALLERGY CLIN IMMUN, V142, P942, DOI 10.1016/j.jaci.2017.11.044; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Roberts LB., 2017, INFLUENCE NONNEURONA; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006	16	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1513	+		10.1016/j.jaci.2020.10.038	http://dx.doi.org/10.1016/j.jaci.2020.10.038		APR 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UU3GE	33461747	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000698687100002
J	Engeroff, P; Plattner, K; Storni, F; Thoms, F; Boligan, KF; Muerner, L; Eggel, A; von Gunten, S; Bachmann, MF; Vogel, M				Engeroff, Paul; Plattner, Kevin; Storni, Federico; Thoms, Franziska; Boligan, Kayluz Frias; Muerner, Lukas; Eggel, Alexander; von Gunten, Stephan; Bachmann, Martin F.; Vogel, Monique			Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Anti-IgE autoantibodies; glycans; IgE regulation; allergy; hypersensitivity	FC-EPSILON-RI; B-CELLS; GLYCOSYLATION; OMALIZUMAB; SERUM; CLEARANCE	Background: IgE causes anaphylaxis in type I hypersensitivity diseases by activating degranulation of effector cells such as mast cells and basophils. The mechanisms that control IgE activity and prevent anaphylaxis under normal conditions are still enigmatic. Objective: We aimed to unravel how anti-IgE autoantibodies are induced and we aimed to understand their role in regulating serum IgE level and allergic anaphylaxis. Methods: We immunized mice with different forms of IgE and tested anti-IgE autoantibody responses and their specificities. We then analyzed the effect of those antibodies on serum kinetics and their in vitro and in vivo impact on anaphylaxis. Finally, we investigated anti-IgE autoantibodies in human sera. Results: Immunization of mice with IgE-immune complexes induced glycan-specific anti-IgE autoantibodies. The anti-IgE autoantibodies prevented effector cell sensitization, reduced total IgE serum levels, protected mice from passive and active IgE sensitization, and resulted in cross-protection against different allergens. Furthermore, glycan-specific anti-IgE autoantibodies were present in sera from subjects with allergy and subjects without allergy. Conclusion: In conclusion, this study provided the first evidence that in the murine model, the serum level and anaphylactic activity of IgE may be downregulated by glycan-specific IgG anti-IgE autoantibodies.	[Engeroff, Paul; Plattner, Kevin; Storni, Federico; Eggel, Alexander; Bachmann, Martin F.; Vogel, Monique] Univ Bern, Univ Hosp Rheumatol Immunol & Allergol, Bern, Switzerland; [Engeroff, Paul; Plattner, Kevin; Storni, Federico; Eggel, Alexander; Bachmann, Martin F.; Vogel, Monique] Univ Bern, Dept BioMed Res, Bern, Switzerland; [Engeroff, Paul; Plattner, Kevin; Storni, Federico] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Boligan, Kayluz Frias; Muerner, Lukas; von Gunten, Stephan] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Thoms, Franziska] Zurich Univ Hosp, Dept Dermatol, Zurich, Switzerland; [Bachmann, Martin F.] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Bern; University of Bern; University of Bern; University of Bern; University of Zurich; University Zurich Hospital; University of Oxford	Vogel, M (corresponding author), Inselspital Bern, Dept Rheumatol Immunol & Allergol, Sahlihaus 2, CH-3010 Bern, Switzerland.	monique.vogel@dbmr.unibe.ch	Engeroff, Paul/AGS-3183-2022; Storni, Federico/CAH-3483-2022	Engeroff, Paul/0000-0002-3409-512X; Frias Boligan, Kayluz/0000-0001-8160-0670; von Gunten, Stephan/0000-0002-2753-8738; Murner, Lukas/0000-0001-5972-6410; Plattner, Kevin/0000-0002-2414-9593; Eggel, Alexander/0000-0001-8746-3339	Swiss National Science Foudation (SNF) [310030_179165/1]; SNF [310039_185114, 310030_184757]; National Institutes of Health, National Heart Lung and Blood Institute [RO1 HL141493]	Swiss National Science Foudation (SNF)(Swiss National Science Foundation (SNSF)); SNF; National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by funding from the following grants: Swiss National Science Foudation (SNF) grant 310030_179165/1 to Monique Vogel; SNF grant 310039_185114 to Martin F. Bachmann; SNF grant 310030_184757 to Stephan von Gunten; National Institutes of Health, National Heart Lung and Blood Institute grant RO1 HL141493 to Alexander Eggel.	Abraham I, 2016, ALLERGY, V71, P593, DOI 10.1111/all.12815; Arnold JN, 2004, J IMMUNOL, V173, P6831, DOI 10.4049/jimmunol.173.11.6831; Chan YC, 2014, J ALLERGY CLIN IMMUN, V134, P1394, DOI 10.1016/j.jaci.2014.06.029; Cheng LE, 2010, J IMMUNOL, V185, P5040, DOI 10.4049/jimmunol.1001900; Ding ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28290; Dombrowicz D, 1996, J IMMUNOL, V157, P1645; Eggel A, 2014, J ALLERGY CLIN IMMUN, V133, P1709, DOI 10.1016/j.jaci.2014.02.005; Engeroff P, 2018, ALLERGY, V73, P341, DOI 10.1111/all.13268; Engeroff P, 2020, J ALLERGY CLIN IMMUN, V145, P301, DOI 10.1016/j.jaci.2019.07.045; Engeroff P, 2018, J ALLERGY CLIN IMMUN, V142, P557, DOI 10.1016/j.jaci.2017.09.024; Fehr T, 1997, J EXP MED, V185, P1785, DOI 10.1084/jem.185.10.1785; Fellmann M, 2015, IMMUN INFLAMM DIS, V3, P339, DOI 10.1002/iid3.72; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gasser P, 2018, CURR OPIN IMMUNOL, V54, P86, DOI 10.1016/j.coi.2018.05.015; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Greer AM, 2014, J CLIN INVEST, V124, P1187, DOI 10.1172/JCI68964; HABA S, 1985, J IMMUNOL, V134, P3291; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; JENSENJAROLIM E, 1992, J ALLERGY CLIN IMMUN, V89, P31, DOI 10.1016/S0091-6749(05)80038-7; Kim B, 2012, NATURE, V491, P613, DOI 10.1038/nature11546; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Lawrence MG, 2017, J ALLERGY CLIN IMMUN, V139, P422, DOI 10.1016/j.jaci.2016.04.056; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Marone G, 1999, CLIN EXP ALLERGY, V29, P17; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; NETTLETON MY, 1995, INT ARCH ALLERGY IMM, V107, P328, DOI 10.1159/000237017; Pennington LF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11610; Plomp R, 2014, J PROTEOME RES, V13, P536, DOI 10.1021/pr400714w; Sanjuan MA, 2016, J ALLERGY CLIN IMMUN, V137, P1651, DOI 10.1016/j.jaci.2016.04.007; Schneider C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010524; Selb R, 2017, J ALLERGY CLIN IMMUN, V139, P290, DOI 10.1016/j.jaci.2016.03.042; Shade KTC, 2020, NATURE, V582, P265, DOI 10.1038/s41586-020-2311-z; Shade KTC, 2015, J EXP MED, V212, P457, DOI 10.1084/jem.20142182; SHAKIB F, 1991, INT ARCH ALLER A IMM, V95, P102, DOI 10.1159/000235413; Storni F, 2020, J ALLERGY CLIN IMMUN, V145, P1240, DOI 10.1016/j.jaci.2019.12.007; Takeda K, 2009, CURR OPIN IMMUNOL, V21, P660, DOI 10.1016/j.coi.2009.09.005; Thoms F, 2019, J ALLERGY CLIN IMMUN, V144, P193, DOI 10.1016/j.jaci.2019.01.050; Uermosi C, 2010, J ALLERGY CLIN IMMUN, V126, P375, DOI 10.1016/j.jaci.2010.05.040; Wu LC, 2014, NAT REV IMMUNOL, V14, P247, DOI 10.1038/nri3632; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0; YU Y, 1995, ALLERGY, V50, P119, DOI 10.1111/j.1398-9995.1995.tb05067.x; Zha LS, 2018, J ALLERGY CLIN IMMUN, V142, P1529, DOI 10.1016/j.jaci.2017.09.054; ZURCHER AW, 1995, IMMUNOL LETT, V46, P49, DOI 10.1016/0165-2478(95)00014-V	45	3	3	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1430	1441		10.1016/j.jaci.2020.11.031	http://dx.doi.org/10.1016/j.jaci.2020.11.031		APR 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	33309740	Green Published			2022-12-18	WOS:000647154500008
J	Kim, KW; Park, SC; Cho, HJ; Jang, H; Park, J; Shim, HS; Kim, EG; Kim, MN; Hong, JY; Kim, YH; Lee, S; Weiss, ST; Kim, CH; Won, S; Sohn, MH				Kim, Kyung Won; Park, Sang-Cheol; Cho, Hyung-Ju; Jang, Haerin; Park, Jaehyun; Shim, Hyo Sup; Kim, Eun Gyul; Kim, Mi Na; Hong, Jung Yeon; Kim, Yoon Hee; Lee, Sanghun; Weiss, Scott T.; Kim, Chang-Hoon; Won, Sungho; Sohn, Myung Hyun			Integrated genetic and epigenetic analyses uncover MSI2 association with allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopy; eosinophilia; GWAS; genetic; epigenetic; methylation	EPIGENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; DNA METHYLATION; RISK LOCI; DISEASE; RHINITIS; GWAS; IGE	Background: The relationship between allergic and eosinophilic inflammation, either systemic or local, in allergic diseases remains unclear. Objective: We performed combined genome-wide association study (GWAS) and epigenome-wide (EWAS) for atopy and tissue eosinophilia to identify both genetic and epigenetic signatures between systemic and local allergic inflammation, and to capture global patterns of gene regulation. Methods: We included 126 subjects for atopy analysis and 147 for tissue eosinophilia analysis, as well as 18 normal nasal tissue samples. We identified differentially methylated positions (DMPs) and genes associated with atopy and tissue eosinophilia. Furthermore, we performed mendelian randomization analysis and penalized regression along with replication in an independent cohort. Results: EWAS identified genes, including Musashi RNA binding protein 2 (MSI2), associated with atopy, which contained enriched DMPs that genetically affect atopy. A direct association was observed between MSI2 single-nucleotide polymorphisms and atopy, as was a causal effect of changes in MSI2 expression and methylation on atopy, which was replicated in a Costa Rican population. Regarding tissue eosinophilia, EWAS identified genes with enriched DMPs directly contributing to tissue eosinophilia at the gene level, including CAMK1D. The gene ontology terms of the identified genes for both phenotypes encompassed immune-related terms. Conclusion: EWAS combined with GWAS identified novel candidate genes, especially the methylation of MSI2, contributing to systemic allergic inflammation. Certain genes displayed a greater association with either systemic or local allergic inflammation; however, it is expected that a harmonized effect of these genes influences immune responses.	[Kim, Kyung Won; Jang, Haerin; Kim, Eun Gyul; Kim, Mi Na; Hong, Jung Yeon; Sohn, Myung Hyun] Severance Hosp, Brain Korea 21 PLUS Project Med Sci, Inst Immunol & Immunol Dis, Dept Pediat,Inst Allergy,Severance Biomed Sci Ins, Seoul, South Korea; [Cho, Hyung-Ju; Kim, Chang-Hoon] Taste Res Ctr, Korea Mouse Phenotyping Ctr KMPC, Airway Mucus Inst, Dept Otorhinolaryngol, Seoul, South Korea; [Shim, Hyo Sup] Yonsei Univ, Dept Pathol, Severance Hosp, Coll Med, Seoul, South Korea; [Kim, Yoon Hee] Yonsei Univ, Coll Med, Dept Pediat, Gangnam Severance Hosp,Inst Allergy, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Dept Publ Hlth Sci, 1 Kwanak Ro, Seoul 151742, South Korea; [Park, Sang-Cheol; Won, Sungho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Park, Jaehyun; Won, Sungho] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Coll Nat Sci, Seoul, South Korea; [Lee, Sanghun] Dankook Univ, Grad Sch, Dept Med Consilience, Yongin, South Korea; [Weiss, Scott T.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Dankook University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Won, S (corresponding author), Seoul Natl Univ, Dept Publ Hlth Sci, 1 Kwanak Ro, Seoul 151742, South Korea.; Sohn, MH (corresponding author), Yonsei Univ, Coll Med, Dept Pediat, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Kim, CH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, 50-1 Yonsei Ro, Seoul 03722, South Korea.	ENTMAN@yuhs.ac; won1@snu.ac.kr; mhsohn@yuhs.ac	Lee, SangHun/GPW-6306-2022; Kim, Chang-Hoon/D-7205-2016	Kim, Mi Na/0000-0002-1675-0688; Sohn, Myung Hyun/0000-0002-2478-487X; Shim, Hyo Sup/0000-0002-5718-3624; Kim, Yoon Hee/0000-0002-2149-8501; Kim, Kyung Won/0000-0003-4529-6135; Cho, Hyung-Ju/0000-0002-2851-3225; Lee, Sanghun/0000-0002-0573-9555; Kim, Chang-Hoon/0000-0003-1238-6396	National Research Foundation of Korea (NRF) - Korean government [NRF-2015R1D1A1A01061217, NRF-2018R1A5A2025079, NRF-2020R1A2B5B02001713]; Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the NRF [NRF-2017M3A9C4065964]; Bio & Medical Technology Development Program of the NRF - Ministry of Science, ICT & Future Planning [NRF-2016M3A9D5A01952414]; NRF grant - Korea government through the Ministry of Science, ICT & Future Planning [2019R1A2C1089841]; National Heart, Lung and Blood Institute, National Institutes of Health [P01 HL132825]	National Research Foundation of Korea (NRF) - Korean government(National Research Foundation of Korea); Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the NRF; Bio & Medical Technology Development Program of the NRF - Ministry of Science, ICT & Future Planning; NRF grant - Korea government through the Ministry of Science, ICT & Future Planning; National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Research Foundation of Korea (NRF) grants funded by theKorean government (grants NRF-2015R1D1A1A01061217, NRF-2018R1A5A2025079, and NRF-2020R1A2B5B02001713); the Bio-Synergy Research Project (grant NRF-2017M3A9C4065964) of the Ministry of Science, ICT and Future Planning through the NRF, the Bio & Medical Technology Development Program of the NRF funded by the Ministry of Science, ICT & Future Planning (grant NRF-2016M3A9D5A01952414); an NRF grant funded by the Korea government through the Ministry of Science, ICT & Future Planning (grant 2019R1A2C1089841); and grant P01 HL132825 from the National Heart, Lung and Blood Institute, National Institutes of Health (to S.T. Weiss).	Arasi S, 2016, PEDIAT ALLERG IMM-UK, V27, P569, DOI 10.1111/pai.12577; Bonini S, 2001, ANN ALLERG ASTHMA IM, V87, P48, DOI 10.1016/S1081-1206(10)62341-1; Cardenas A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11058-3; Chawes BLK, 2009, ALLERGY, V64, P1547, DOI 10.1111/j.1398-9995.2009.02085.x; Chen W, 2017, J ALLERGY CLIN IMMUN, V140, P571, DOI 10.1016/j.jaci.2016.11.030; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Dhana K, 2018, AM J EPIDEMIOL, V187, P1662, DOI 10.1093/aje/kwy025; Duggimpudi S, 2018, J BIOL CHEM, V293, P15359, DOI 10.1074/jbc.RA118.002243; Ek WE, 2017, EPIGENOMICS-UK, V9, P407, DOI 10.2217/epi-2016-0158; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gandhi NA, 2017, EXPERT REV CLIN IMMU, V13, P425, DOI 10.1080/1744666X.2017.1298443; Gim J, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00329; Gim J, 2017, GENETICS, V207, P1147, DOI 10.1534/genetics.117.300283; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V119, P654, DOI 10.1016/j.jaci.2006.12.609; Janson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049615; Jeon JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177406; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kim KW, 2019, ALLERGY ASTHMA IMMUN, V11, P170, DOI 10.4168/aair.2019.11.2.170; Lin J, 2016, ONCOTARGET, V7, P48978, DOI 10.18632/oncotarget.9832; Lutz SM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0299-4; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Ober C, 2016, ANN AM THORAC SOC, V13, pS85, DOI 10.1513/AnnalsATS.201507-459MG; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Peng C, 2019, EPIGENETICS-US, V14, P445, DOI 10.1080/15592294.2019.1590085; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Perez MK, 2014, IMMUNOL ALLERGY CLIN, V34, P777, DOI 10.1016/j.iac.2014.07.002; Potaczek DP, 2017, EPIGENOMICS-UK, V9, P539, DOI 10.2217/epi-2016-0162; Reese SE, 2019, J ALLERGY CLIN IMMUN, V143, P2062, DOI 10.1016/j.jaci.2018.11.043; Song YE, 2018, BIOINFORMATICS, V34, P2851, DOI 10.1093/bioinformatics/bty180; van Leeuwen EM, 2015, NAT PROTOC, V10, P1285, DOI 10.1038/nprot.2015.077; Xu CJ, 2018, LANCET RESP MED, V6, P379, DOI 10.1016/S2213-2600(18)30052-3; Yii ACA, 2018, ALLERGY, V73, P1964, DOI 10.1111/all.13496; Zaghdoudi T., 2018, J OPEN SOURCE SOFTW, V3, P523	35	3	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1453	1463		10.1016/j.jaci.2020.06.040	http://dx.doi.org/10.1016/j.jaci.2020.06.040		APR 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	32795589				2022-12-18	WOS:000647154500010
J	Muthu, V; Agarwal, R				Muthu, Valliappan; Agarwal, Ritesh			Is the "probable'' category required in the diagnosis of ABPA?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Muthu, Valliappan; Agarwal, Ritesh] Postgrad Inst Med Educ & Res PGIMER, Dept Pulm Med, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Dept Pulm Med, Chandigarh, India.	agarwal.ritesh@outlook.in	Agarwal, Ritesh/A-3063-2009; Muthu, Valliappan/AAA-1265-2021	Agarwal, Ritesh/0000-0003-2547-7668; Muthu, Valliappan/0000-0003-0410-8468				Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Asano K, 2021, J ALLERGY CLIN IMMUN, V147, P1261, DOI 10.1016/j.jaci.2020.08.029; Saxena P, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.08.043; Uffredi ML, 2003, EUR J CLIN MICROBIOL, V22, P457, DOI 10.1007/s10096-003-0970-y; Vergidis P, 2020, CLIN MICROBIOL INFEC, V26, P935, DOI 10.1016/j.cmi.2019.11.019	5	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1119	1121		10.1016/j.jaci.2020.11.029	http://dx.doi.org/10.1016/j.jaci.2020.11.029		MAR 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	33419605				2022-12-18	WOS:000635524300026
J	Abbott, J; Ehler, AC; Jayaraman, D; Reynolds, PR; Otsu, K; Manka, L; Gelfand, EW				Abbott, Jordan; Ehler, Angelica C.; Jayaraman, Divya; Reynolds, Paul R.; Otsu, Kanao; Manka, Laurie; Gelfand, Erwin W.			Heterozygous IKK beta activation loop mutation results in a complex immunodeficiency syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NF-KAPPA-B; MULTIPLE		[Abbott, Jordan; Jayaraman, Divya; Reynolds, Paul R.; Gelfand, Erwin W.] Natl Jewish Hlth, Immunodeficiency Diag & Treatment Program, Dept Pediat, Denver, CO 80206 USA; [Abbott, Jordan; Ehler, Angelica C.] Univ Colorado, Sch Med, Dept Pediat, Sect Allergy & Immunol, Aurora, CO 80045 USA; [Abbott, Jordan; Ehler, Angelica C.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Otsu, Kanao; Manka, Laurie] Natl Jewish Hlth, Dept Med, Denver, CO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; National Jewish Health	Abbott, J (corresponding author), Natl Jewish Hlth, Immunodeficiency Diag & Treatment Program, Dept Pediat, Denver, CO 80206 USA.; Abbott, J (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Sect Allergy & Immunol, Aurora, CO 80045 USA.; Abbott, J (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.	Jordan.abbott@cuanschutz.edu	Abbott, Jordan K/P-2509-2016	Abbott, Jordan K/0000-0001-6334-5266	NIAID/NIH [K08AI141734]	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIAID/NIH K08AI141734 (to J.A.).	Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Cardinez C, 2018, J EXP MED, V215, P2715, DOI 10.1084/jem.20180639; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Gallo LH, 2014, CELL CYCLE, V13, P3964, DOI 10.4161/15384101.2014.988026; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Jimi E, 2008, IMMUNITY, V29, P523, DOI 10.1016/j.immuni.2008.08.010; Kai X, 2014, J BIOL CHEM, V289, P26960, DOI 10.1074/jbc.M114.598763; Rossi D, 2011, BLOOD, V118, P4930, DOI 10.1182/blood-2011-06-359166; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005	9	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					737	+		10.1016/j.jaci.2020.06.007	http://dx.doi.org/10.1016/j.jaci.2020.06.007		FEB 2021	5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32554083	hybrid, Green Accepted			2022-12-18	WOS:000616665800037
J	Eichenfield, L; Flohr, C; Sidbury, R; Szalai, Z; Galus, R; Yao, ZR; Takahashi, H; Barbarot, SE; Feeney, C; Zhang, F; DiBonaventura, M; Rojo, R; Valdez, H; Chan, G				Eichenfield, Lawrence; Flohr, Carsten; Sidbury, Robert; Szalai, Zsuzsanna; Galus, Ryszard; Yao, Zhirong; Takahashi, Hidetoshi; Barbarot, S. Ebastien; Feeney, Claire; Zhang, Fan; DiBonaventura, Marco; Rojo, Ricardo; Valdez, Hernan; Chan, Gary			Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									[Eichenfield, Lawrence] Univ Calif San Diego, San Diego, CA USA; [Flohr, Carsten] Kings Coll London, Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London, England; [Sidbury, Robert] Seattle Childrens Hosp, Seattle, WA USA; [Szalai, Zsuzsanna] Heim Pal Childrens Hosp, Budapest, Hungary; [Galus, Ryszard] Med Univ Warsaw, Warsaw, Poland; [Yao, Zhirong] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Takahashi, Hidetoshi] Takagi Dermatol Clin, Sapporo, Hokkaido, Japan; [Barbarot, S. Ebastien] CHU Hotel Dieu, Nantes, France; [Feeney, Claire] Pfizer Ltd, New York, NY USA; [Zhang, Fan; DiBonaventura, Marco; Rojo, Ricardo; Valdez, Hernan; Chan, Gary] Pfizer Inc, New York, NY USA	University of California System; University of California San Diego; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Seattle Children's Hospital; Medical University of Warsaw; Shanghai Jiao Tong University; Nantes Universite; CHU de Nantes; Pfizer; Pfizer									0	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2		S		467	AB146	AB146						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QX2DK					2022-12-18	WOS:000629158000470
J	Kaiser, FMP; Reisli, I; Pico-Knijnenburg, I; Langerak, AW; Kavelaars, FG; Artac, H; IJspeert, H; van der Burg, M				Kaiser, Fabian M. P.; Reisli, Ismail; Pico-Knijnenburg, Ingrid; Langerak, Anton W.; Kavelaars, Francois G.; Artac, Hasibe; IJspeert, Hanna; van der Burg, Mirjam			Protein functionality as a potential bottleneck for somatic revertant variants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; IMMUNODEFICIENCY; PATIENT		[Kaiser, Fabian M. P.; Langerak, Anton W.; IJspeert, Hanna; van der Burg, Mirjam] Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [Kaiser, Fabian M. P.] Univ Med Ctr Rotterdam, Dept Pediat, Rotterdam, Netherlands; [Kavelaars, Francois G.] Univ Med Ctr Rotterdam, Dept Hematol, Rotterdam, Netherlands; [Reisli, Ismail] Necmettin Erbakan Univ, Dept Pediat Immunol & Allergy, Meram Med Fac, Konya, Turkey; [Pico-Knijnenburg, Ingrid; van der Burg, Mirjam] Leiden Univ, Lab Pediat Immunol, Dept Pediat, Med Ctr, Leiden, Netherlands; [Artac, Hasibe] Selcuk Univ, Dept Pediat Immunol & Allergy, Fac Med, Konya, Turkey	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Necmettin Erbakan University; Selcuk University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Selcuk University	van der Burg, M (corresponding author), Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands.; van der Burg, M (corresponding author), Leiden Univ, Lab Pediat Immunol, Dept Pediat, Med Ctr, Leiden, Netherlands.	m.van_der_burg@lumc.nl		van der Burg, Mirjam/0000-0002-1510-3104	Stichting Sophia Kinderziekenhuis Fonds [S15-07]	Stichting Sophia Kinderziekenhuis Fonds	This work has been funded by the Stichting Sophia Kinderziekenhuis Fonds (grant no. S15-07 Genes and Immunity in SCID) (M.v.d.B.).	Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Blazquez-Moreno A, 2017, BLOOD, V130, P1205, DOI 10.1182/blood-2017-01-762864; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Harter C, 1996, BBA-REV BIOMEMBRANES, V1286, P75, DOI 10.1016/0304-4157(96)00003-2; Marin AV, 2017, J ALLERGY CLIN IMMUN, V139, P347, DOI 10.1016/j.jaci.2016.06.020; Mensa-Vilaro A, 2019, J ALLERGY CLIN IMMUN, V143, P359, DOI 10.1016/j.jaci.2018.09.009; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Roberts JL, 2007, BLOOD, V109, P3198, DOI 10.1182/blood-2006-08-043166; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	11	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					391	+		10.1016/j.jaci.2020.04.045	http://dx.doi.org/10.1016/j.jaci.2020.04.045		JAN 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32422145	Green Published, hybrid			2022-12-18	WOS:000607781700014
J	Newberry, RD; Hogan, SP				Newberry, Rodney D.; Hogan, Simon P.			Intestinal epithelial cells in tolerance and allergy to dietary antigens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Dietary antigens; intestinal epithelium; oral tolerance; food allergy; goblet cell-associated antigen passages			[Newberry, Rodney D.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Hogan, Simon P.] Univ Michigan, Sch Med, Dept Pathol, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Hogan, SP (corresponding author), Univ Michigan, Sch Med, Pathol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	rnewerry@wustl.edu; sihogan@med.umich.edu			National Institutes of Health [DK097317, AI131342, AI112626, AI138177, AI140133]; Food Allergy Research AMP; Education, Michigan Food Allergy Research Accelerator (M-FARA); Mary H. Weiser Food Allergy Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Research AMP; Education, Michigan Food Allergy Research Accelerator (M-FARA); Mary H. Weiser Food Allergy Center	This work was supported by the National Institutes of Health (grant nos. DK097317 and AI131342 to R.D. N., grant no. AI112626 to S.P.H. and R.D.N., and grant nos. AI138177 and AI140133 to S.P.H.), Food Allergy Research & Education, Michigan Food Allergy Research Accelerator (M-FARA), and the Mary H. Weiser Food Allergy Center (to S.P.H.).	Allaire JM, 2018, TRENDS IMMUNOL, V39, P677, DOI 10.1016/j.it.2018.04.002; Knoop KA, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137943; Knoop KA, 2018, MUCOSAL IMMUNOL, V11, P1551, DOI 10.1038/s41385-018-0039-y; Kulkarni DH, 2019, CELL MOL GASTROENTER, V7, P729, DOI 10.1016/j.jcmgh.2019.01.003; Noah TK, 2019, J ALLERGY CLIN IMMUN, V144, P1058, DOI 10.1016/j.jaci.2019.04.030; Ohsaki A, 2018, J EXP MED, V215, P91, DOI 10.1084/jem.20171163; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Said H. M., 2012, PHYSL GASTROINTESTIN; Yu W, 2016, NAT REV IMMUNOL, V16, P751, DOI 10.1038/nri.2016.111	10	3	3	2	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					45	48		10.1016/j.jaci.2020.10.030	http://dx.doi.org/10.1016/j.jaci.2020.10.030		JAN 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	33144143	Bronze			2022-12-18	WOS:000613645900004
J	Van Gerven, L; Steelant, B; Cools, L; Callebaut, I; Backaert, W; de Hoon, J; Ampe, E; Talavera, K; Hellings, PW				Van Gerven, Laura; Steelant, Brecht; Cools, Leen; Callebaut, Ina; Backaert, Wout; de Hoon, Jan; Ampe, Els; Talavera, Karel; Hellings, Peter W.			Low-dose capsaicin (0.01 mM) nasal spray is equally effective as the current standard treatment for idiopathic rhinitis: A randomized, double-blind, placebo-controlled trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NONALLERGIC RHINITIS; HYPERREACTIVITY		[Van Gerven, Laura; Cools, Leen; Callebaut, Ina; Hellings, Peter W.] Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium; [de Hoon, Jan; Ampe, Els] Univ Hosp Leuven, Ctr Clin Pharmacol, Leuven, Belgium; [Van Gerven, Laura; Steelant, Brecht; Backaert, Wout; Hellings, Peter W.] Katholieke Univ Leuven, Allergy & Clin Immunol Res Unit, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Talavera, Karel] Katholieke Univ Leuven, Lab Ion Channel Res & TRP Res Platform Leuven TRP, Dept Cellular & Mol Med, Leuven, Belgium; [Hellings, Peter W.] Acad Med Ctr Amsterdam, Dept Otorhinolaryngol, Amsterdam, Netherlands; [Hellings, Peter W.] Univ Ghent, Lab Upper Airways Res, Dept Otorhinolaryngol, Ghent, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University of Amsterdam; Academic Medical Center Amsterdam; Ghent University	Van Gerven, L (corresponding author), Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium.; Van Gerven, L (corresponding author), Katholieke Univ Leuven, Allergy & Clin Immunol Res Unit, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.	laura.vangerven@uzleuven.be	Van Gerven, Laura/ABG-5800-2021	Van Gerven, Laura/0000-0002-5325-7956; Callebaut, Ina/0000-0002-6666-6783; Backaert, Wout/0000-0001-7942-3345	TBM grant of the Fund for Scientific Research (FWO) Flanders, Belgium [130240]; FWO [G076513N]	TBM grant of the Fund for Scientific Research (FWO) Flanders, Belgium(FWO); FWO(FWO)	L.V.G. is supported by a TBM grant (project number 130240) of the Fund for Scientific Research (FWO) Flanders, Belgium. P.W.H. is the recipient of a senior researcher with a fellowship from the FWO (G076513N). B.S. is a postdoctoral fellow of the FWO.	BARANIUK JN, 1991, AM J RESP CELL MOL, V4, P228, DOI 10.1165/ajrcmb/4.3.228; Blom HM, 1997, J ALLERGY CLIN IMMUN, V100, P739, DOI 10.1016/S0091-6749(97)70267-7; Gevorgyan A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010591.pub2; Hellings PW, 2017, ALLERGY, V72, P1657, DOI 10.1111/all.13200; LACROIX JS, 1991, CLIN EXP ALLERGY, V21, P595, DOI 10.1111/j.1365-2222.1991.tb00852.x; Lundblad L, 2001, ACTA OTO-LARYNGOL, V121, P505, DOI 10.1080/000164801300366679; Van Gerven L, 2017, J ALLERGY CLIN IMMUN, V140, P437, DOI 10.1016/j.jaci.2017.03.014; Van Gerven L, 2014, J ALLERGY CLIN IMMUN, V133, P1332, DOI 10.1016/j.jaci.2013.08.026; Van Rijswijk JB, 2003, ALLERGY, V58, P754, DOI 10.1034/j.1398-9995.2003.00203.x	9	3	3	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					397	+		10.1016/j.jaci.2020.04.054	http://dx.doi.org/10.1016/j.jaci.2020.04.054		JAN 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32439432	Bronze, Green Published			2022-12-18	WOS:000607781700016
J	Yu, W; Zhou, XY; Lyu, SC; Davis, MM; Nadeau, KC				Yu, Wong; Zhou, Xiaoying; Lyu, Shu Chen; Davis, Mark M.; Nadeau, Kari C.			Regulation of peanut-specific CD8(+) T cells from nonallergic individuals	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Yu, Wong; Zhou, Xiaoying; Lyu, Shu Chen; Nadeau, Kari C.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Yu, Wong; Zhou, Xiaoying; Lyu, Shu Chen; Nadeau, Kari C.] Stanford Univ, Dept Med, Div Pulm & Crit Care Med, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Nadeau, KC (corresponding author), Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA.; Nadeau, KC (corresponding author), Stanford Univ, Dept Med, Div Pulm & Crit Care Med, Sch Med, Stanford, CA 94305 USA.	knadeau@stanford.edu		Davis, Mark/0000-0001-6868-657X	National Institutes of Health [R01AI140134, U19AI104209]; Sean N. Parker Center for Allergy and Asthma at Stanford University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sean N. Parker Center for Allergy and Asthma at Stanford University	This work was funded by the National Institutes of Health (grant nos. R01AI140134 and U19AI104209) and the Sean N. Parker Center for Allergy and Asthma at Stanford University.	Dresch C, 2012, TRENDS IMMUNOL, V33, P381, DOI 10.1016/j.it.2012.04.009; Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Mazzarella G, 2008, GASTROENTEROLOGY, V134, P1017, DOI 10.1053/j.gastro.2008.01.008; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; van Wijk F, 2005, J IMMUNOL, V174, P174, DOI 10.4049/jimmunol.174.1.174; Wen T, 2019, J CLIN INVEST, V129, P2014, DOI 10.1172/JCI125917; Yu W, 2019, J ALLERGY CLIN IMMUN, V143, P1948, DOI 10.1016/j.jaci.2019.01.011; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001	9	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					385	+		10.1016/j.jaci.2020.07.032	http://dx.doi.org/10.1016/j.jaci.2020.07.032		JAN 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32835695	Bronze, Green Accepted			2022-12-18	WOS:000607781700012
J	Hofman, ZLM; Clark, CC; Hack, CE; de Maat, S; Maas, C				Hofman, Zonne L. M.; Clark, Chantal C.; Hack, C. Erik.; de Maat, Steven; Maas, Coen			Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INHIBITOR		[Hofman, Zonne L. M.; Clark, Chantal C.; de Maat, Steven; Maas, Coen] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Hofman, Zonne L. M.; Hack, C. Erik.] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Maas, C (corresponding author), Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands.	cmaas4@umcutrecht.nl		Maas, Coen/0000-0003-4593-0976; Clark, Chantal/0000-0001-9614-7135				Aygoren-Pursun E, 2018, NEW ENGL J MED, V379, P352, DOI 10.1056/NEJMoa1716995; Bird JE, 2012, THROMB HAEMOSTASIS, V107, P1141, DOI [10.1160/TH11-10-0682, 10.1160/TH-11-10-0682]; Cornpropst M, 2016, ALLERGY, V71, P1676, DOI 10.1111/all.12930; Hofman ZLM, 2017, J ALLERGY CLIN IMMUN, V140, P1700, DOI 10.1016/j.jaci.2017.07.012; Kalfus I., W SOC ALL ASTHM IMM; Kalfus I, 2017, J ALLERGY CLIN IMMUN, V139, pAB378, DOI 10.1016/j.jaci.2016.12.905; Kaplan AP, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00206; Lara-Marquez ML, 2018, CLIN EXP ALLERGY, V48, P1429, DOI 10.1111/cea.13219; Zhang JW, 2013, J ALLERGY CLIN IMMUN, V131, pAB210, DOI 10.1016/j.jaci.2012.12.1419	9	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6								10.1016/j.jaci.2020.03.038	http://dx.doi.org/10.1016/j.jaci.2020.03.038			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32360287	Bronze			2022-12-18	WOS:000596937900028
J	Nelson, HS				Nelson, Harold S.			2020 Updated Asthma Guidelines: Allergen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergen immunotherapy; AIT; subcutaneous immunotherapy; SCIT; sublingual immunotherapy; SLIT; Expert Panel; asthma	SUBLINGUAL IMMUNOTHERAPY; TABLET		[Nelson, Harold S.] Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA	National Jewish Health	Nelson, HS (corresponding author), Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA.	nelsonh@njhealth.org						Amar SM, 2009, J ALLERGY CLIN IMMUN, V124, P150, DOI 10.1016/j.jaci.2009.04.037; [Anonymous], 2007, NIH PUBLICATION; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; de Blay F, 2014, RESP MED, V108, P1430, DOI 10.1016/j.rmed.2014.07.017; Epstein TG, 2019, J ALLER CL IMM-PRACT, V7, P1996, DOI 10.1016/j.jaip.2019.01.058; JOHNSTONE DE, 1968, PEDIATRICS, V42, P793; Lin SY, 2018, AHRQ PUBLICATION; Virchow JC, 2016, JAMA-J AM MED ASSOC, V315, P1715, DOI 10.1001/jama.2016.3964; Wang L, 2014, ALLERGY, V69, P1181, DOI 10.1111/all.12188; Xu K, 2018, ANN ALLERG ASTHMA IM, V121, P186, DOI 10.1016/j.anai.2018.05.019	10	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1286	1287		10.1016/j.jaci.2020.10.011	http://dx.doi.org/10.1016/j.jaci.2020.10.011			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	33280713	Bronze			2022-12-18	WOS:000596937900007
J	Cirillo, E; Giardino, G; Ricci, S; Moschese, V; Lougaris, V; Conti, F; Azzari, C; Barzaghi, F; Canessa, C; Martire, B; Badolato, R; Dotta, L; Soresina, A; Cancrini, C; Finocchi, A; Montin, D; Romano, R; Amodio, D; Ferrua, F; Tommasini, A; Baselli, LA; Dellepiane, RM; Polizzi, A; Chessa, L; Marzollo, A; Cicalese, MP; Putti, MC; Pession, A; Aiuti, A; Locatelli, F; Plebani, A; Pignata, C				Cirillo, Emilia; Giardino, Giuliana; Ricci, Silvia; Moschese, Viviana; Lougaris, Vassilios; Conti, Francesca; Azzari, Chiara; Barzaghi, Federica; Canessa, Clementina; Martire, Baldassarre; Badolato, Raffaele; Dotta, Laura; Soresina, Annarosa; Cancrini, Caterina; Finocchi, Andrea; Montin, Davide; Romano, Roberta; Amodio, Donato; Ferrua, Francesca; Tommasini, Alberto; Baselli, Lucia Augusta; Dellepiane, Rosa Maria; Polizzi, Agata; Chessa, Luciana; Marzollo, Antonio; Cicalese, Maria Pia; Putti, Maria Caterina; Pession, Andrea; Aiuti, Alessandro; Locatelli, Franco; Plebani, Alessandro; Pignata, Claudio			Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Transitional care; inborn errors of immunity; primary immunodeficiency; humoral immune defects; DiGeorge syndrome; combined immunodeficiency; innate immune defects; DNA repair syndromes; Italian Network of Primary Immunodeficiencies	COMMON VARIABLE IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; 22Q11.2 DELETION SYNDROME; TERM-FOLLOW-UP; ATAXIA-TELANGIECTASIA; CELL TRANSPLANTATION; MOVEMENT-DISORDERS; LARGE COHORT; VACCINATION; DEFICIENCY	Medical advances have dramatically improved the long-term prognosis of children and adolescents with inborn errors of immunity (IEIs). Transfer of the medical care of individuals with pediatric IEIs to adult facilities is also a complex task because of the large number of distinct disorders, which requires involvement of patients and both pediatric and adult care providers. To date, there is no consensus on the optimal pathway of the transitional care process and no specific data are available in the literature regarding patients with IEIs. We aimed to develop a consensus statement on the transition process to adult health care services for patients with IEIs. Physicians from major Italian Primary Immunodeficiency Network centers formulated and answered questions after examining the currently published literature on the transition from childhood to adulthood. The authors voted on each recommendation. The most frequent IEIs sharing common main clinical problems requiring full attention during the transitional phase were categorized into different groups of clinically related disorders. For each group of clinically related disorders, physicians from major Italian Primary Immunodeficiency Network institutions focused on selected clinical issues representing the clinical hallmark during early adulthood.	[Cirillo, Emilia; Giardino, Giuliana; Romano, Roberta; Pignata, Claudio] Univ Naples Federico II, Dept Translat Med Sci, Pediat Sect, Via S Pansini 5, I-80131 Naples, Italy; [Ricci, Silvia; Azzari, Chiara; Canessa, Clementina] Univ Florence, Dept Hlth Sci, Div Pediat Immunol, Florence, Italy; [Ricci, Silvia; Azzari, Chiara; Canessa, Clementina] Meyer Childrens Hosp, Florence, Italy; [Moschese, Viviana] Univ Roma Tor Vergata, Pediat Immunopathol & Allergol Unit, Rome, Italy; [Lougaris, Vassilios; Badolato, Raffaele; Dotta, Laura; Soresina, Annarosa; Plebani, Alessandro] Univ Brescia & Dept Pediat, Dept Clin & Expt Sci, ASST Spedali Civili Brescia, Brescia, Italy; [Conti, Francesca; Pession, Andrea] Univ Bologna, Unit Pediat, St Orsola Univ Hosp, Bologna, Italy; [Barzaghi, Federica; Ferrua, Francesca; Cicalese, Maria Pia; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy & Pediat, Milan, Italy; [Martire, Baldassarre] Mons AR Dimiccoli Hosp, Maternal Infant Dept, Unit Pediat & Neonatol, Barletta, Italy; [Cancrini, Caterina; Finocchi, Andrea; Amodio, Donato] Bambino Gesu Pediat Hosp, Acad Dept Pediat, Unit Immunol & Infect Dis, Rome, Italy; [Cancrini, Caterina; Finocchi, Andrea; Amodio, Donato] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Montin, Davide] Univ Turin, Regina Margherita Children Hosp, Dept Publ Hlth & Pediat, Div Pediat Immunol & Rheumatol, Turin, Italy; [Tommasini, Alberto] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Pediat, Trieste, Italy; [Tommasini, Alberto] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Baselli, Lucia Augusta; Dellepiane, Rosa Maria] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pediat, Milan, Italy; [Polizzi, Agata] Univ Catania, Dept Educ Sci, Catania, Italy; [Chessa, Luciana] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy; [Marzollo, Antonio; Putti, Maria Caterina] Univ Padua, Dept Womens & Childrens Hlth, Pediat Hematol Oncol Unit, Padua, Italy; [Locatelli, Franco] Univ Rome, IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol & Oncol, Rome, Italy	University of Naples Federico II; University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Rome Tor Vergata; Hospital Spedali Civili Brescia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Bambino Gesu; University of Rome Tor Vergata; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; IRCCS Burlo Garofolo; University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Catania; Sapienza University Rome; University of Padua; IRCCS Bambino Gesu; Sapienza University Rome	Pignata, C (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Pediat Sect, Via S Pansini 5, I-80131 Naples, Italy.	pignata@unina.it	Ricci, silvia/AAY-6957-2021; Marzollo, Antonio/J-3579-2018; Ferrua, Francesca/K-4340-2016; Romano, Roberta/AIA-0238-2022; Finocchi, Andrea/K-5926-2016; Giardino, Giuliana/AAF-9841-2021; Amodio, Donato/AAA-9016-2019; Badolato, Raffaele/A-8081-2010; Conti, Francesca/Q-1845-2019; Baselli, Lucia Augusta/HCH-8750-2022; MOSCHESE, VIVIANA/AHE-8931-2022; /K-2737-2018	Marzollo, Antonio/0000-0003-2177-8500; Ferrua, Francesca/0000-0002-5695-4490; Finocchi, Andrea/0000-0003-0958-8536; Amodio, Donato/0000-0003-4550-3018; Badolato, Raffaele/0000-0001-7375-5410; Conti, Francesca/0000-0002-3665-8926; Baselli, Lucia Augusta/0000-0003-1171-1185; MOSCHESE, VIVIANA/0000-0001-7650-0632; /0000-0001-7140-1694				Agarwal S, 2019, ANN ALLERG ASTHMA IM, V123, P454, DOI 10.1016/j.anai.2019.07.014; Agarwal S, 2011, INFLAMM BOWEL DIS, V17, P251, DOI 10.1002/ibd.21376; Aguilar C, 2014, CLIN INFECT DIS, V59, P1462, DOI 10.1093/cid/ciu646; Amer Acad Pediat, 2011, PEDIATRICS, V128, P182, DOI 10.1542/peds.2011-0969; Amirifar P, 2019, PEDIAT ALLERG IMM-UK, V30, P277, DOI 10.1111/pai.13020; [Anonymous], 2018, AM J MED GENET A, V176, P2121, DOI 10.1002/ajmg.a.38474; Azizi G, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12663; Bachmeyer C, 2000, EUR J GASTROEN HEPAT, V12, P1033, DOI 10.1097/00042737-200012090-00013; Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041; Bergerson JRE, 2019, IMMUNOL ALLERGY CLIN, V39, P49, DOI 10.1016/j.iac.2018.08.007; Bhatt JM, 2015, EUR RESPIR REV, V24, P565, DOI 10.1183/16000617.0066-2015; Bin Riaz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00777; BLUM RW, 1993, J ADOLESCENT HEALTH, V14, P570, DOI 10.1016/1054-139X(93)90143-D; Bonilla FA, 2015, J ALLERGY CLIN IMMUN, V136, P1186, DOI 10.1016/j.jaci.2015.04.049; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; Broccoletti T, 2011, EUR J NEUROL, V18, P564, DOI 10.1111/j.1468-1331.2010.03203.x; Brosens LAA, 2008, CLIN GASTROENTEROL H, V6, P115, DOI 10.1016/j.cgh.2007.08.019; Buchbinder D, 2015, J CLIN IMMUNOL, V35, P119, DOI 10.1007/s10875-014-0121-5; Castagnoli R, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00295; Chawner SJRA, 2017, BRIT J PSYCHIAT, V211, P223, DOI 10.1192/bjp.bp.116.195651; Chessa L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-5; Cicalese MP, 2020, PEDIAT ALLERG IMM-UK, V31, P5, DOI 10.1111/pai.13149; Cifaldi C, 2017, PEDIAT ALLERG IMM-UK, V28, P203, DOI 10.1111/pai.12684; Cinetto F, 2019, EXPERT REV RESP MED, V13, P823, DOI 10.1080/17476348.2019.1641085; Cirillo E, 2015, ANN NY ACAD SCI, V1356, P90, DOI 10.1111/nyas.12849; Cirillo E, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-1; Connelly JA, 2018, J PEDIAT INF DIS SOC, V7, pS31, DOI 10.1093/jpids/piy015; Costain G, 2011, J MED GENET, V48, P819, DOI 10.1136/jmedgenet-2011-100440; Debatin KM, 2017, BLOOD, V130, P2582, DOI 10.1182/blood-2017-10-811125; Dorna MB, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00122; Dunogue B, 2017, CLIN INFECT DIS, V64, P767, DOI 10.1093/cid/ciw837; Eibl MM, 2015, IMMUNOTHERAPY-UK, V7, P1273, DOI 10.2217/IMT.15.74; Farmer JR, 2019, J ALLER CL IMM-PRACT, V7, P1970, DOI 10.1016/j.jaip.2019.02.038; Ferrua F, 2019, LANCET HAEMATOL, V6, pE239, DOI 10.1016/S2352-3026(19)30021-3; Fiksinski AM, 2018, AM J MED GENET A, V176, P2182, DOI 10.1002/ajmg.a.40387; Fioredda F, 2018, BRIT J HAEMATOL, V183, P110, DOI 10.1111/bjh.15495; Fischer A, 2017, J ALLERGY CLIN IMMUN, V140, P1388, DOI 10.1016/j.jaci.2016.12.978; Freeman AF, 2007, J ALLERGY CLIN IMMUN, V119, P1234, DOI 10.1016/j.jaci.2006.12.666; Fuss IJ, 2013, J CLIN IMMUNOL, V33, P748, DOI 10.1007/s10875-013-9873-6; Gallo V, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00466; Gernez Y, 2018, J ALLER CL IMM-PRACT, V6, P996, DOI 10.1016/j.jaip.2017.06.041; Teive HAG, 2018, PARKINSONISM RELAT D, V46, P3, DOI 10.1016/j.parkreldis.2017.12.009; Giardino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4590127; Giardino G, 2016, PEDIAT ALLERG IMM-UK, V27, P220, DOI 10.1111/pai.12496; Gothelf D, 2013, J AM ACAD CHILD PSY, V52, P1192, DOI 10.1016/j.jaac.2013.08.008; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Gutierrez MJ, 2018, SEMIN ARTHRITIS RHEU, V48, P318, DOI 10.1016/j.semarthrit.2018.02.013; Hamid IJA, 2017, BLOOD, V129, P2198, DOI 10.1182/blood-2016-11-748616; Hampson FA, 2012, CLIN RADIOL, V67, P587, DOI 10.1016/j.crad.2011.10.028; Hashmi S, 2015, BIOL BLOOD MARROW TR, V21, P225, DOI 10.1016/j.bbmt.2014.06.035; Inamoto Y, 2015, BONE MARROW TRANSPL, V50, P1013, DOI 10.1038/bmt.2015.63; Kang EM, 2011, J ALLERGY CLIN IMMUN, V127, P1319, DOI 10.1016/j.jaci.2011.03.028; Kiaee F, 2019, EXPERT REV CLIN IMMU, V15, P1105, DOI 10.1080/1744666X.2019.1658523; Kindler O, 2018, CURR OPIN PEDIATR, V30, P855, DOI 10.1097/MOP.0000000000000680; Kojima S, 2018, BRIT J HAEMATOL, V183, P11, DOI 10.1111/bjh.15493; Kralickova P, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03135; Kraus C, 2018, WIEN KLIN WOCHENSCHR, V130, P283, DOI 10.1007/s00508-018-1335-y; Krauthammer A, 2018, NUTRITION, V46, P48, DOI 10.1016/j.nut.2017.08.008; Kuo CY, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0823-5; Leone P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020451; Levy A, 2018, MOVEMENT DISORD, V33, P1372, DOI 10.1002/mds.27449; Lougaris V, 2020, J ALLERGY CLIN IMMUN, V146, P429, DOI 10.1016/j.jaci.2020.03.001; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Maarschalk-Ellerbroek LJ, 2014, J CLIN IMMUNOL, V34, P642, DOI 10.1007/s10875-014-0068-6; Maffeis M, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00232; Maglione PJ, 2015, J ALLER CL IMM-PRACT, V3, P941, DOI 10.1016/j.jaip.2015.07.004; Manesh AT, 2017, ALLERGOL IMMUNOPATH, V45, P602, DOI 10.1016/j.aller.2017.01.006; Martire B, 2008, CLIN IMMUNOL, V126, P155, DOI 10.1016/j.clim.2007.09.008; Martire B, 2018, VACCINE, V36, P3541, DOI 10.1016/j.vaccine.2018.01.061; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; McGrath-Morrow S, 2008, PEDIATR PULM, V43, P59, DOI 10.1002/ppul.20738; McGrath-Morrow SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209496; Meneret A, 2014, NEUROLOGY, V83, P1087, DOI 10.1212/WNL.0000000000000794; Montella S, 2012, RESPIROLOGY, V17, P87, DOI 10.1111/j.1440-1843.2011.02067.x; Montin D, 2019, J ALLER CL IMM-PRACT, V7, P2369, DOI 10.1016/j.jaip.2019.03.014; Morsheimer M, 2017, AM J MED GENET A, V173, P2366, DOI 10.1002/ajmg.a.38319; Nissenkorn A, 2016, PEDIATR RES, V79, P889, DOI 10.1038/pr.2016.19; Okuno Y, 2015, J CLIN IMMUNOL, V35, P610, DOI 10.1007/s10875-015-0202-0; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Paulino TL, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0689-y; Peshko D, 2019, J ALLER CL IMM-PRACT, V7, P1929, DOI 10.1016/j.jaip.2019.02.013; Piliero LM, 2004, BLOOD, V103, P1020, DOI 10.1182/blood-2003-08-2824; Pommerening H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0373-z; Pulvirenti F, 2020, J CLIN IMMUNOL, V40, P289, DOI 10.1007/s10875-019-00725-1; Pulvirenti F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02546; Quinti I, 2007, J CLIN IMMUNOL, V27, P308, DOI 10.1007/s10875-007-9075-1; Quinti I, 2016, J ALLER CL IMM-PRACT, V4, P1169, DOI 10.1016/j.jaip.2016.07.012; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Resnick ES, 2012, CURR OPIN ALLERGY CL, V12, P595, DOI 10.1097/ACI.0b013e32835914b9; Rosenberg PS, 2010, BRIT J HAEMATOL, V150, P196, DOI 10.1111/j.1365-2141.2010.08216.x; Ross LJ, 2015, J PAEDIATR CHILD H, V51, P802, DOI 10.1111/jpc.12828; Rothblum-Oviatt C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0543-7; Rubin LG, 2014, CLIN INFECT DIS, V58, P309, DOI [10.1093/cid/cit684, 10.1093/cid/cit816]; Shashi V, 2010, J GENET COUNS, V19, P535, DOI 10.1007/s10897-010-9309-x; Shaw P, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00434; Shillitoe B, 2017, CLIN IMMUNOL, V183, P54, DOI 10.1016/j.clim.2017.07.008; Shulzhenko N, 2018, CLIN IMMUNOL, V197, P139, DOI 10.1016/j.clim.2018.09.008; Slack J, 2018, J ALLERGY CLIN IMMUN, V141, P322, DOI 10.1016/j.jaci.2017.02.036; Smyth AE, 2018, J CLIN IMMUNOL, V38, P468, DOI 10.1007/s10875-018-0513-z; Sobh A, 2016, J ALLER CL IMM-PRACT, V4, P1066, DOI 10.1016/j.jaip.2016.09.012; Sorensen RU, 2018, J ALLERGY CLIN IMMUN, V142, P1759, DOI 10.1016/j.jaci.2018.10.013; Speckmann C, 2017, J ALLERGY CLIN IMMUN, V139, P1302, DOI 10.1016/j.jaci.2016.07.040; Sullivan KE, 2008, IMMUNOL ALLERGY CLIN, V28, P353, DOI 10.1016/j.iac.2008.01.003; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Tanimura M, 2015, INT J CARDIOL, V196, P88, DOI 10.1016/j.ijcard.2015.05.183; Tesch VK, 2020, J ALLERGY CLIN IMMUN, V145, P1452, DOI 10.1016/j.jaci.2019.12.896; Toubiana J, 2016, BLOOD, V127, P3154, DOI 10.1182/blood-2015-11-679902; Unolt M, 2018, AM J MED GENET A, V176, P2087, DOI 10.1002/ajmg.a.38662; Uzzan Mathieu, 2016, Curr Gastroenterol Rep, V18, P17, DOI 10.1007/s11894-016-0491-3; van der Poorten DK, 2018, J CLIN IMMUNOL, V38, P768, DOI 10.1007/s10875-018-0546-3; van Os NJH, 2020, J NEUROL, V267, P830, DOI 10.1007/s00415-019-09641-1; van Os NJH, 2017, CLIN IMMUNOL, V178, P45, DOI 10.1016/j.clim.2017.01.009; Verhagen MMM, 2009, NEUROLOGY, V73, P430, DOI 10.1212/WNL.0b013e3181af33bd; Voll SL, 2017, GENET MED, V19, P204, DOI 10.1038/gim.2016.98; Vorstman JAS, 2015, JAMA PSYCHIAT, V72, P377, DOI 10.1001/jamapsychiatry.2014.2671; White PH, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3610; White PH, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2587; Woelke S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02000; Yamashita M, 2019, INT J HEMATOL, V109, P603, DOI 10.1007/s12185-019-02619-9; Yeo AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38901-3; Yonkof JR, 2019, J CLIN IMMUNOL, V39, P448, DOI 10.1007/s10875-019-00635-2; Zhang Q, 2018, MAMM GENOME, V29, P603, DOI 10.1007/s00335-018-9767-2	122	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					967	983		10.1016/j.jaci.2020.08.010	http://dx.doi.org/10.1016/j.jaci.2020.08.010			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	OP5VH	32827505	Bronze			2022-12-18	WOS:000588153700033
J	Goncalves, P; Charbit, B; Lenoir, C; Duffy, D; Fischer, A; Di Santo, JP				Goncalves, Pedro; Charbit, Bruno; Lenoir, Christelle; Duffy, Darragh; Fischer, Alain; Di Santo, James P.		Milieu Interieur Consortium	Antibody-coated microbiota in nasopharynx of healthy individuals and IVIg-treated patients with hypogammaglobulinemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CELLS		[Goncalves, Pedro; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, Paris, France; [Goncalves, Pedro; Duffy, Darragh; Di Santo, James P.] INSERM, U1223, Paris, France; [Charbit, Bruno; Duffy, Darragh] Inst Pasteur, Ctr Translat Res, Paris, France; [Lenoir, Christelle; Fischer, Alain] INSERM, UMR 1163, Paris, France; [Duffy, Darragh] Inst Pasteur, Dept Immunol, Lab Dendrit Cell Immunobiol, Paris, France; [Fischer, Alain] Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, Paris, France; [Fischer, Alain] Necker Enfants Malades Hosp, AP HP, Dept Pediat Immunol Hematol & Rheumatol, Paris, France; [Fischer, Alain] Coll France, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Di Santo, JP (corresponding author), Inst Pasteur, Innate Immun Unit, Paris, France.; Di Santo, JP (corresponding author), INSERM, U1223, Paris, France.	james.di-santo@pasteur.fr	Di Santo, James P/M-4298-2014; Charbit, Bruno/AAI-9714-2021; Gomperts Boneca, Ivo/H-1677-2014	Di Santo, James P/0000-0002-7146-1862; Charbit, Bruno/0000-0002-5478-482X; Gomperts Boneca, Ivo/0000-0001-8122-509X; Goncalves, Pedro/0000-0002-4127-1152	Labex Milieu Interieur [ANR 10-LBX-69-01 MI]; Institut Pasteur; INSERM; European Research Council under the European Union [695467]	Labex Milieu Interieur; Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council under the European Union(European Research Council (ERC))	Labex Milieu Interieur ANR 10-LBX-69-01 MI (http://www.milieuinterieur.fr/en) funded this study and the researcher P. Goncalves. This study was also partially supported by grants from the Institut Pasteur, INSERM, and the European Research Council under the European Union's Horizon 2020 research and innovation program (695467, ILC_REACTIVITY).	Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Fadlallah J, 2019, J ALLERGY CLIN IMMUN, V143, P1575, DOI 10.1016/j.jaci.2018.09.036; Fadlallah J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1217; Jorgensen SF, 2019, J ALLERGY CLIN IMMUN, V143, P1969, DOI 10.1016/j.jaci.2019.01.019; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; Micol R, 2012, J ALLERGY CLIN IMMUN, V129, P770, DOI 10.1016/j.jaci.2011.09.047; Moor K, 2016, NAT PROTOC, V11, P1531, DOI 10.1038/nprot.2016.091; Nielsen SCA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2004; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Quereda JJ, 2016, P NATL ACAD SCI USA, V113, P5706, DOI 10.1073/pnas.1523899113; Schickel JN, 2017, J EXP MED, V214, P1991, DOI 10.1084/jem.20160201; Thomas S, 2015, CLIN IMMUNOL, V157, P277, DOI 10.1016/j.clim.2014.12.004	13	3	3	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2020	145	6					1686	+		10.1016/j.jaci.2020.01.002	http://dx.doi.org/10.1016/j.jaci.2020.01.002			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LW4ZZ	31954779	Green Published			2022-12-18	WOS:000539157800024
J	Kroner, JW; Kyzy, AB; Burkle, JW; Martin, LJ; LeMasters, GK; Bernstein, DI; Lockey, JE; Ryan, P; Hershey, GKK; Myers, JMB				Kroner, John W.; Kyzy, Asel Baatyrbek; Burkle, Jeffrey W.; Martin, Lisa J.; LeMasters, Grace K.; Bernstein, David I.; Lockey, James E.; Ryan, Patrick; Hershey, Gurjit K. Khurana; Myers, Jocelyn M. Biagini			Atopic dermatitis independently increases sensitization above parental atopy: The MPAACH study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHILDREN		[Kroner, John W.; Kyzy, Asel Baatyrbek; Burkle, Jeffrey W.; Hershey, Gurjit K. Khurana; Myers, Jocelyn M. Biagini] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Ryan, Patrick] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.; Ryan, Patrick; Hershey, Gurjit K. Khurana; Myers, Jocelyn M. Biagini] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [LeMasters, Grace K.; Lockey, James E.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Bernstein, David I.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Myers, JMB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA.; Myers, JMB (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	Jocelyn.biagini.myers@cchmc.org	Martin, Lisa/E-2425-2016; Ryan, Patrick/HDO-1133-2022	Martin, Lisa/0000-0001-8702-9946; 	National Institutes of Health [U19AI070235, R01ES011170]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the National Institutes of Health (grants U19AI070235 and R01ES011170).	Amat F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131369; Chan SMH, 2012, ALLERGY, V67, P336, DOI 10.1111/j.1398-9995.2011.02765.x; Dharma C, 2018, CLIN EXP ALLERGY, V48, P48, DOI 10.1111/cea.13063; Epstein TG, 2012, ANN ALLERG ASTHMA IM, V108, P145, DOI 10.1016/j.anai.2012.01.004; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; LeMasters GK, 2006, J PEDIATR-US, V149, P505, DOI 10.1016/j.jpeds.2006.06.035; Nissen SP, 2013, PEDIAT ALLERG IMM-UK, V24, P549, DOI 10.1111/pai.12108; von Kobyletzki LB, 2013, DERMATOLOGY, V226, P222, DOI 10.1159/000349983	9	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1464	1466		10.1016/j.jaci.2020.01.041	http://dx.doi.org/10.1016/j.jaci.2020.01.041			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	32035158	Bronze, Green Accepted			2022-12-18	WOS:000531063400018
J	McSweeney, SM; White, IR; Kimber, I; McFadden, JP; Tziotzios, C				McSweeney, Sheila M.; White, Ian R.; Kimber, Ian; McFadden, John P.; Tziotzios, Christos			Contact allergy across the human lifespan	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Contact allergy; allergic contact dermatitis; aging			[McSweeney, Sheila M.; White, Ian R.; McFadden, John P.; Tziotzios, Christos] St Johns Inst Dermatol, Dept Cutaneous Allergy, London, England; [Kimber, Ian] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England	University of London; King's College London; University of Manchester	McSweeney, SM (corresponding author), Guys Hosp, St Johns Inst Dermatol, London SE1 9RT, England.	sheila.mcsweeney@kcl.ac.uk		McSweeney, Sheila/0000-0001-7977-6028; Tziotzios, Christos/0000-0003-1662-4494				Alinaghi F, 2019, CONTACT DERMATITIS, V80, P77, DOI 10.1111/cod.13119; Chambers ES, 2020, IMMUNOLOGY, V160, P116, DOI 10.1111/imm.13152; Garg S, 2013, BRIT J DERMATOL, V169, P854, DOI 10.1111/bjd.12556; Gimenez-Arnau AM, 2017, J EUR ACAD DERMATOL, V31, P664, DOI 10.1111/jdv.14063; GIRARD JP, 1977, CLIN EXP IMMUNOL, V27, P85; Kimber I, 2012, CONTACT DERMATITIS, V67, P179, DOI 10.1111/j.1600-0536.2012.02148.x; Lynch MD, 2017, J ALLERGY CLIN IMMUN, V140, P1451, DOI 10.1016/j.jaci.2017.03.054; McFadden JP, 2013, CONTACT DERMATITIS, V69, P53, DOI 10.1111/cod.12093; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; ROUPE G, 1978, ACTA DERM-VENEREOL, V58, P65	10	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1352	1354		10.1016/j.jaci.2020.03.014	http://dx.doi.org/10.1016/j.jaci.2020.03.014			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	32247849	Bronze			2022-12-18	WOS:000531063400004
J	Yaghoubi, M; Adibi, A; Zafari, Z; FitzGerald, JM; Aaron, SD; Johnson, KM; Sadatsafavi, M				Yaghoubi, Mohsen; Adibi, Amin; Zafari, Zafar; Mark FitzGerald, J.; Aaron, Shawn D.; Johnson, Kate M.; Sadatsafavi, Mohsen			Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; cost-effectiveness analysis; diagnosis; medical test	UNCONTROLLED ASTHMA; NATURAL-HISTORY; HEALTH; ADHERENCE; BURDEN; ADULTS; PHYSICIANS; PNEUMONIA; PANEL	Background: Asthma diagnosis in the community is often made without objective testing. Objective: The aim of this study was to evaluate the cost-effectiveness of implementing a stepwise objective diagnostic verification algorithm among patients with community-diagnosed asthma in the United States. Methods: We developed a probabilistic time-in-state cohort model that compared a stepwise asthma verification algorithm on the basis of spirometry testing and a methacholine challenge test against the current standard of care over 20 years. Model input parameters were informed from the literature and with original data analyses when required. The target population was US adults (>15 years old) with physician-diagnosed asthma. The final outcomes were costs (in 2018 dollars) and quality-adjusted life years (QALYs), discounted at 3% annually. Deterministic and probabilistic analyses were undertaken to examine the effect of alternative assumptions and uncertainty in model parameters on the results. Results: In a simulated cohort of 10,000 adults with diagnosed asthma, the stepwise algorithm resulted in removal of the diagnosis of 3,366. This was projected to be associated with savings of $36.26 million in direct costs and a gain of 4,049.28 QALYs over 20 years. Extrapolating these results to the US population indicated an undiscounted potential savings of $56.48 billion over 20 years. The results were robust against alternative assumptions and plausible changes in values of input parameters. Conclusion: Implementation of a simple diagnostic testing algorithm to verify asthma diagnosis might result in substantial savings and improvement in patients' quality of life.	[Yaghoubi, Mohsen; Adibi, Amin; Johnson, Kate M.; Sadatsafavi, Mohsen] Univ British Columbia, Resp Evaluat Sci Program, Collaborat Outcomes Res & Evaluat, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Zafari, Zafar] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Mark FitzGerald, J.; Sadatsafavi, Mohsen] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Aaron, Shawn D.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of British Columbia; University System of Maryland; University of Maryland Baltimore; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute	Sadatsafavi, M (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	msafavi@mail.ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Yaghoubi, Mohsen/T-6630-2017; Yaghoubi, Mohsen/AAU-4689-2021	Sadatsafayi, Mohsen/0000-0002-0419-7862; Yaghoubi, Mohsen/0000-0002-6912-7267; Yaghoubi, Mohsen/0000-0002-6912-7267; Adibi, Amin/0000-0003-2748-4781	MethaPharm Inc (Brantford, Ontario, Canada)	MethaPharm Inc (Brantford, Ontario, Canada)	This study was funded by MethaPharm Inc (Brantford, Ontario, Canada) through an independent research contract.	Aaron SD, 2018, AM J RESP CRIT CARE, V198, P1012, DOI 10.1164/rccm.201804-0682CI; Aaron SD, 2017, JAMA-J AM MED ASSOC, V317, P269, DOI 10.1001/jama.2016.19627; American Thoracic Society, ATS COD BILL Q; Andrade LF, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0854-6; Bansal Vikas, 2015, Acta Med Acad, V44, P135, DOI 10.5644/ama2006-124.141; Campbell JD, 2010, ALLERGY, V65, P1141, DOI 10.1111/j.1398-9995.2010.02336.x; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Centers for Disease Control and Prevention. National Center for Health Statistics, 2018, PROD; Chauhan BF, 2012, COCHRANE DB SYST REV, V5; Chen WJ, 2016, THORAX, V71, P267, DOI 10.1136/thoraxjnl-2015-207530; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; de Marco R, 2002, J ALLERGY CLIN IMMUN, V110, P228, DOI 10.1067/mai.2002.125600; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Global Initiative for Asthma (GINA), 2019, GLOB STRAT ASTHM MAN; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Kleinman NL, 2013, J OCCUP ENVIRON MED, V55, P1149, DOI 10.1097/JOM.0b013e3182a7e6af; Lee LK, 2018, J ASTHMA, V55, P208, DOI 10.1080/02770903.2017.1316394; Lloyd Andrew, 2007, Prim Care Respir J, V16, P22, DOI 10.3132/pcrj.2007.00002; Luks VP, 2010, EUR RESPIR J, V36, P255, DOI 10.1183/09031936.00165109; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Ng B, 2018, BIORXIV; Ng B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031306; Nunes Carlos, 2017, Asthma Res Pract, V3, P1, DOI 10.1186/s40733-016-0029-3; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; O'Dowd LC, 2003, AM J MED, V114, P391, DOI 10.1016/S0002-9343(03)00007-X; Pakhale S, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-27; Park H, 2015, CLIN THER, V37, P1466, DOI 10.1016/j.clinthera.2015.04.013; Sokol KC, 2015, AM J MED, V128, P502, DOI 10.1016/j.amjmed.2014.12.006; Sumino K, 2012, J ALLERGY CLIN IMMUN, V130, P69, DOI 10.1016/j.jaci.2012.02.025; Suruki RY, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0409-3; Torrego A, 2014, COCHRANE DB SYST REV, V3; United States Census Bureau, POPULATION PROJECTIO; University of British Columbia, EC BURD ASTHM EBA; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Weiler JM, 2016, J ALLERGY CLIN IMMUN, V138, P1292, DOI 10.1016/j.jaci.2016.05.029; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028; Wu AC, 2015, ANN AM THORAC SOC, V12, P161, DOI 10.1513/AnnalsATS.201410-459OC; Yaghoubi M, 2019, AM J RESP CRIT CARE, V200, P1102, DOI 10.1164/rccm.201901-0016OC; Zafari Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146003; Zafari Z, 2014, J ALLERGY CLIN IMMUN, V134, P908, DOI 10.1016/j.jaci.2014.04.009	43	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1367	+		10.1016/j.jaci.2019.11.038	http://dx.doi.org/10.1016/j.jaci.2019.11.038			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	31837372	Green Submitted, hybrid			2022-12-18	WOS:000531063400010
J	Ballas, ZK				Ballas, Zuhair K.			AAAAI Foundation Faculty Development awardees: 2020	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergy/immunology			[Ballas, Zuhair K.] Univ Iowa, Div Immunol, Iowa City, IA USA	University of Iowa	Ballas, ZK (corresponding author), Univ Iowa, Dept Internal Med, C42-E13,GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	ballasz@uiowa.edu						Andersen YMF, 2016, J ALLERGY CLIN IMMUN, V138, P310, DOI 10.1016/j.jaci.2016.01.015; Levin M, 2019, ANN ALLERG ASTHMA IM, V122, P598, DOI 10.1016/j.anai.2019.03.021; Mattiotti A, 2018, CELL MOL LIFE SCI, V75, P2339, DOI 10.1007/s00018-018-2805-0; Miller M, 2016, J ALLERGY CLIN IMMUN, V138, P596, DOI 10.1016/j.jaci.2016.01.019; Raschke S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320724; Steinke JW, 2016, J ALLERGY CLIN IMMUN, V138, P1465, DOI 10.1016/j.jaci.2016.05.021; Undas A, 2011, J THROMB HAEMOST, V9, P870, DOI 10.1111/j.1538-7836.2011.04198.x; Wilson JM, 2018, ARTERIOSCL THROM VAS, V38, P1665, DOI 10.1161/ATVBAHA.118.311222; Wilson JM, 2018, EMJ ALLERGY IMMUNOL, V3, P89	9	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1148	1152		10.1016/j.jaci.2020.02.012	http://dx.doi.org/10.1016/j.jaci.2020.02.012			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	32112791	Bronze			2022-12-18	WOS:000523633400010
J	Iglesia, EGA; Kim, EH				Iglesia, Edward G. A.; Kim, Edwin H.			Low-risk infants may still benefit from allergenic food consumption	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Iglesia, Edward G. A.; Kim, Edwin H.] Univ N Carolina, Sch Med, UNC Food Allergy Initiat, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Iglesia, EGA (corresponding author), Univ N Carolina, Sch Med, UNC Food Allergy Initiat, Chapel Hill, NC 27515 USA.	edward_iglesia@med.unc.edu		Iglesia, Edward/0000-0002-6838-5387	National Institutes of Health (NIH) [5T32AI007062]; NIH/National Institute of Allergy and Infectious Diseases; NIH/National Center for Complementary and Integrative Health, Food Allergy Research Education; Wallace Research Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Center for Complementary and Integrative Health, Food Allergy Research Education; Wallace Research Foundation	E.G.A.I. is supported by the National Institutes of Health (NIH) (Award no. 5T32AI007062). E.H.K. receives funding from the NIH/National Institute of Allergy and Infectious Diseases, the NIH/National Center for Complementary and Integrative Health, Food Allergy Research & Education, and the Wallace Research Foundation.	Abrams E, 2019, PAED CHILD HEALT-CAN, V24, P56, DOI 10.1093/pch/pxy195; British Society for Allergy & Clinical Immunology, 2018, PREV FOOD ALL HIGH R; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Netting MJ, 2017, J ALLER CL IMM-PRACT, V5, P1617, DOI 10.1016/j.jaip.2017.03.013; Perkin MR, 2019, J ALLERGY CLIN IMMUN, V144, P1606, DOI 10.1016/j.jaci.2019.06.045; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Scientific Advisory Committee on Nutrition Public Health England UK, 2018, FEED 1 YEAR LIF; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010	9	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1305	1305		10.1016/j.jaci.2020.01.016	http://dx.doi.org/10.1016/j.jaci.2020.01.016			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	32111421				2022-12-18	WOS:000523633400030
J	Kahlenberg, JM; Billi, AC; Eyerich, K; Gudjonsson, JE				Kahlenberg, J. Michelle; Billi, Allison C.; Eyerich, Kilian; Gudjonsson, Johann E.			Biologics in the treatment of skin and rheumatologic diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Inflammation; biologics; autoimmune disease; autoinflammatory	PSORIASIS; THERAPY		[Kahlenberg, J. Michelle] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Billi, Allison C.; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Eyerich, Kilian] Karolinska Inst, Dept Med Solna, Div Dermatol & Venereol, Stockholm, Sweden; [Eyerich, Kilian] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Eyerich, Kilian] Karolinska Univ Hosp, Dept Dermatol & Venereol, Unit Dermatol, Stockholm, Sweden; [Eyerich, Kilian] Tech Univ Munich, Munich, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Technical University of Munich	Gudjonsson, JE (corresponding author), Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA.	johanng@med.umich.edu	Billi, Allison/AAP-1684-2021		NIAMS NIH HHS [T32 AR007197] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Casteele NV, 2017, GASTROENTEROLOGY, V153, P835, DOI 10.1053/j.gastro.2017.07.031; Egeberg A, 2019, J AM ACAD DERMATOL, V81, P173, DOI 10.1016/j.jaad.2019.03.048; Jacobsen FW, 2017, J BIOL CHEM, V292, P1865, DOI 10.1074/jbc.M116.748525; Ko JM, 2009, J DERMATOL TREAT, V20, P100, DOI 10.1080/09546630802441234; Morand EF, 2020, NEW ENGL J MED, V382, P211, DOI 10.1056/NEJMoa1912196; Papp K, 2011, BRIT J DERMATOL, V164, P434, DOI 10.1111/j.1365-2133.2010.10139.x; Runcie K, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0051-4; Strand V, 2017, BIODRUGS, V31, P299, DOI 10.1007/s40259-017-0231-8; Thiebault H, 2016, EUR J GASTROEN HEPAT, V28, P876, DOI 10.1097/MEG.0000000000000643; Toussirot E, 2012, JOINT BONE SPINE, V79, P457, DOI 10.1016/j.jbspin.2011.10.001	10	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1138	1141		10.1016/j.jaci.2020.02.017	http://dx.doi.org/10.1016/j.jaci.2020.02.017			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	32112793	Green Accepted, Bronze			2022-12-18	WOS:000523633400007
J	Mazzucchelli, J; Aranda, CS; Gouveia-Pereira, M; Barreiros, LA; Carvalho, BTC; Condino-Neto, A; De Moraes-Pinto, MI				Mazzucchelli, Juliana; Aranda, Carolina Sanchez; Gouveia-Pereira, Mariana; Barreiros, Lucila Akune; Costa Carvalho, Beatriz Tavares; Condino-Neto, Antonio; de Moraes-Pinto, Maria Isabel			The panorama in diagnoses of severe combined immunodeficiency begins to change in Brazil	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Mazzucchelli, Juliana; Aranda, Carolina Sanchez; Gouveia-Pereira, Mariana; Costa Carvalho, Beatriz Tavares; de Moraes-Pinto, Maria Isabel] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Barreiros, Lucila Akune; Condino-Neto, Antonio] Univ Sao Paulo, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Aranda, CS (corresponding author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	carolaaranda@yahoo.com.br	Carvalho, Beatriz/GXA-0720-2022; Condino-Neto, Antonio/D-4762-2012	Condino-Neto, Antonio/0000-0002-1069-3117	Jeffrey Modell Foundation	Jeffrey Modell Foundation	The Jeffrey Modell Foundation funded the SCID BRAZIL project through grants CHILDREN (2016). This study had been carried out in accordance with the Code of Ethics of theWorld	Ogando JCB, 2019, J ALLERGY CLIN IMMUN, V144, P897, DOI 10.1016/j.jaci.2019.08.002; de Moraes-Pinto MI, 2014, MEM I OSWALDO CRUZ, V109, P989, DOI 10.1590/0074-0276140182; Mazzucchelli JTL, 2014, J INVEST ALLERG CLIN, V24, P184; Kanegae MPP, 2016, J PEDIAT-BRAZIL, V92, P374, DOI 10.1016/j.jped.2015.10.006	4	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					1029	1029		10.1016/j.jaci.2019.12.895	http://dx.doi.org/10.1016/j.jaci.2019.12.895			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31955817	Bronze			2022-12-18	WOS:000518756700039
J	Mitts, KB; Chang, EH				Mitts, Kyle B.; Chang, Eugene H.			Genetics of chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Genetics; chronic rhinosinusitis; phenotype; endotype; transcriptome			[Mitts, Kyle B.; Chang, Eugene H.] Univ Arizona, Coll Med, Dept Otolaryngol Head & Neck Surg, Tucson, AZ USA	University of Arizona	Chang, EH (corresponding author), 1501 N Campbell Ave, Tucson, AZ 85713 USA.	echang@oto.arizona.edu			NIAID NIH HHS [R01 AI146131] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chang EH, 2016, J ALLERGY CLIN IMMUN, V139; Chang EH, 2018, J ALLERGY CLIN IMMUN, V141, P1291, DOI 10.1016/j.jaci.2017.11.052; Chang EH, 2014, INT FORUM ALLERGY RH, V4, P132, DOI 10.1002/alr.21252; Cormier C, 2014, INT FORUM ALLERGY RH, V4, P207, DOI 10.1002/alr.21276; Farquhar DR, 2015, INT FORUM ALLERGY RH, V5, P111, DOI 10.1002/alr.21437; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Li CW, 2013, CURR ALLERGY ASTHM R, V13, P209, DOI 10.1007/s11882-012-0328-6; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Pinto JM, 2008, LARYNGOSCOPE, V118, P2067, DOI 10.1097/MLG.0b013e3181805147; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324	10	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					777	779		10.1016/j.jaci.2020.01.029	http://dx.doi.org/10.1016/j.jaci.2020.01.029			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	32007429	Bronze			2022-12-18	WOS:000518756700012
J	Bieber, T				Bieber, Thomas			Leveraging the nice face of Janus kinase inhibition-ruxolitinib cream in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Atopic dermatitis; microbiome; biologics			[Bieber, Thomas] Rheinische Friedrich Wilhelm Univ, Univ Med Ctr, Dept Dermatol & Allergy, Bonn, Germany; [Bieber, Thomas] Rheinische Friedrich Wilhelm Univ, Univ Med Ctr, Christine Kuhne Ctr Allergy Res & Educ, Bonn, Germany	University of Bonn; University of Bonn	Bieber, T (corresponding author), Univ Hosp, Dept Dermatol & Allergy, CK CARE, Venusbrg Campus 1, D-53127 Bonn, Germany.	Thomas.Bieber@ukbonn.de			Christine Kuhne-Center for Allergy Research and Education	Christine Kuhne-Center for Allergy Research and Education	This study was supported by the Christine Kuhne-Center for Allergy Research and Education.	Bieber T, 2019, J DTSCH DERMATOL GES, V17, P1150, DOI 10.1111/ddg.13965_g; Cotter DG, 2018, J AM ACAD DERMATOL, V78, pS53, DOI 10.1016/j.jaad.2017.12.019; Gadina M, 2019, RHEUMATOLOGY, V58, P4, DOI 10.1093/rheumatology/key432; Kim BS, 2020, J ALLERGY CLIN IMMUN, V145, P572, DOI 10.1016/j.jaci.2019.08.042; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Paller AS, 2017, J ALLERGY CLIN IMMUN, V140, P633, DOI 10.1016/j.jaci.2017.07.006; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020	9	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					489	490		10.1016/j.jaci.2019.12.012	http://dx.doi.org/10.1016/j.jaci.2019.12.012			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31870763				2022-12-18	WOS:000512887400009
J	Busse, W; Pavord, I; Wenzel, S; Bateman, E; Casale, T; FitzGerald, J; Rice, M; Deniz, Y; Patel, N; Harel, S; Rowe, P; Graham, N; O'Riordan, T				Busse, William; Pavord, Ian; Wenzel, Sally; Bateman, Eric; Casale, Thomas; FitzGerald, J.; Rice, Megan; Deniz, Yamo; Patel, Naimish; Harel, Sivan; Rowe, Paul; Graham, Neil; O'Riordan, Thomas			Baseline FeNO as a Prognostic Biomarker for Subsequent Severe Asthma Exacerbations in Patients With Uncontrolled, Moderate-to-Severe Asthma Receiving Placebo in the LIBERTY ASTHMA QUEST Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 13-16, 2020	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Busse, William] Univ Wisconsin, Sch Med, Madison, WI 53706 USA; [Pavord, Ian] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England; [Wenzel, Sally] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Bateman, Eric] Univ Cape Town, Lung Inst, Rondebosch, South Africa; [Bateman, Eric] Univ Cape Town, Rondebosch, South Africa; [Casale, Thomas] Univ S Florida, Tampa, FL 33620 USA; [FitzGerald, J.] Univ British Columbia, Vancouver, BC, Canada; [Rice, Megan; Patel, Naimish; Rowe, Paul; O'Riordan, Thomas] Sanofi, Paris, France; [Deniz, Yamo; Harel, Sivan; Graham, Neil] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	University of Wisconsin System; University of Wisconsin Madison; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cape Town; University of Cape Town; State University System of Florida; University of South Florida; University of British Columbia; Sanofi-Aventis; Sanofi France; Regeneron									0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2		S		063	AB21	AB21						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	KQ7IJ					2022-12-18	WOS:000517092700064
J	Dalan, D; Bunderson, L; Anderson, J; Lucas, R				Dalan, Dan; Bunderson, Landon; Anderson, James; Lucas, Richard			Results of a Beta Test Evaluating Automated Pollen Identification During Ragweed Pollen Season	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 13-16, 2020	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Bunderson, Landon; Lucas, Richard] PollenSense, Provo, UT USA; [Anderson, James] Environm Allergy Assays, Provo, UT USA										0	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2		S		109	AB36	AB36						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	KQ7IJ					2022-12-18	WOS:000517092700110
J	Hong, Y; Capitani, M; Murphy, C; Pandey, S; Cavounidis, A; Takeshita, H; Nanthapisal, S; Yasuda, T; Bader-Meunier, B; McCreary, D; Omoyinmi, E; Rao, A; Booth, C; Gilmour, K; Sebire, N; Shah, N; Klein, N; Bullock, AN; Eleftheriou, D; Uhlig, HH; Brogan, P				Hong, Ying; Capitani, Melania; Murphy, Claire; Pandey, Sumeet; Cavounidis, Athena; Takeshita, Haruo; Nanthapisal, Sira; Yasuda, Toshihiro; Bader-Meunier, Brigitte; McCreary, Dara; Omoyinmi, Ebun; Rao, Anupama; Booth, Claire; Gilmour, Kimberly; Sebire, Neil; Shah, Neil; Klein, Nigel; Bullock, Alex N.; Eleftheriou, Despina; Uhlig, Holm H.; Brogan, Paul			Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Hong, Ying; Murphy, Claire; Nanthapisal, Sira; McCreary, Dara; Omoyinmi, Ebun; Booth, Claire; Klein, Nigel; Eleftheriou, Despina; Brogan, Paul] UCL, Great Ormond St Inst Child Hlth, London, England; [Capitani, Melania; Pandey, Sumeet; Cavounidis, Athena; Uhlig, Holm H.] Univ Oxford, Translat Gastroenterol Unit, Dept Pediat, Oxford, England; [Capitani, Melania; Pandey, Sumeet; Cavounidis, Athena; Uhlig, Holm H.] Univ Oxford, Oxford Biomed Res Ctr BRC, Oxford, England; [Murphy, Claire; Rao, Anupama; Booth, Claire; Gilmour, Kimberly; Sebire, Neil; Shah, Neil; Klein, Nigel; Eleftheriou, Despina; Brogan, Paul] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Takeshita, Haruo] Shimane Univ, Dept Legal Med, Matsue, Shimane, Japan; [Nanthapisal, Sira] Thammasat Univ, Bangkok, Thailand; [Yasuda, Toshihiro] Univ Fukui, Dept Med Genet & Biochem, Fukui, Japan; [Bader-Meunier, Brigitte] Hop Necker Enfants Malad, AP HP, Dept Pediat Immunol & Rheumatol, Paris, France; [Bullock, Alex N.] Univ Oxford, Nuffield Dept Med, Struct Genom Consortium, Oxford, England; [Eleftheriou, Despina] UCL, Arthrit Res UK Ctr Adolescent Rheumatol, London, England	University of London; University College London; University of Oxford; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Shimane University; Thammasat University; University of Fukui; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of London; University College London	Hong, Y (corresponding author), UCL, Great Ormond St Inst Child Hlth, London, England.	y.hong@ucl.ac.uk	Nanthapisal, Sira/ABD-7818-2021; Booth, Claire/I-3667-2016	Brogan, Paul/0000-0001-6178-6893; Uhlig, Holm/0000-0002-6111-7355; Sebire, Neil/0000-0001-5348-9063; Booth, Claire/0000-0002-2626-5037; Klein, Nigel/0000-0003-3925-9258	Great Ormond Street Hospital Children's Charity; Versus Arthritis [21791, 21593, 21064]; BRC [11/YH/0020, 16/YH/0247]; NIHR Oxford Biomedical Research Centre (BRC); University of Oxford; Wellcome Trust [106169/ZZ14/Z]; Structural Genomics Consortium SGC; NIHR Oxford BRC; Leona M. and Harry B. Helmsley Charitable Trust; Rosetrees; MRC [1946380] Funding Source: UKRI	Great Ormond Street Hospital Children's Charity; Versus Arthritis(Versus Arthritis); BRC; NIHR Oxford Biomedical Research Centre (BRC); University of Oxford; Wellcome Trust(Wellcome Trust); Structural Genomics Consortium SGC; NIHR Oxford BRC; Leona M. and Harry B. Helmsley Charitable Trust; Rosetrees(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by Rosetrees, Great Ormond Street Hospital Children's Charity, and Versus Arthritis (grants 21791, 21593 and 21064). All research at the Great Ormond Street Hospital National Health Service (NHS) Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the National Institute of Health Research (NIHR)'s Great Ormond Street Hospital Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. We acknowledge support for set-up of pilot experiments by the VBRC to the Oxford GI biobank (11/YH/0020 and 16/YH/0247). The research was also supported by the NIHR Oxford Biomedical Research Centre (BRC), University of Oxford, Wellcome Trust (grant 106169/ZZ14/Z), and the Structural Genomics Consortium SGC. H.H.U. is supported by NIHR Oxford BRC and the Leona M. and Harry B. Helmsley Charitable Trust.	Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Pawaria S, 2015, J IMMUNOL, V194, P1403, DOI 10.4049/jimmunol.1402893; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Takeshita H, 1998, FEBS LETT, V440, P239, DOI 10.1016/S0014-5793(98)01456-2; Ueki M, 2010, CLIN CHIM ACTA, V411, P92, DOI 10.1016/j.cca.2009.10.013; Varela-Ramirez A, 2017, NUCLEIC ACIDS RES, V45, P6217, DOI 10.1093/nar/gkx222	12	3	3	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					701	+		10.1016/j.jaci.2019.11.020	http://dx.doi.org/10.1016/j.jaci.2019.11.020			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31775019	hybrid			2022-12-18	WOS:000512887400031
J	Levi-Schaffer, F; Mankuta, D				Levi-Schaffer, Francesca; Mankuta, David			Omalizumab safety in pregnancy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Omalizumab; thrombocytopenia; placental transfer; pregnancy; preterm delivery; fetal malformations; drug safety	ASTHMA; RISK; IGE		[Levi-Schaffer, Francesca] Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, Jerusalem, Israel; [Mankuta, David] Hadassah Hebrew Univ Hosp, Dept Obstet & Gynecol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Levi-Schaffer, F (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Pharmacol & Expt Therapeut Unit,Fac Med, POB 12065, IL-91120 Jerusalem, Israel.	francescal@ekmd.huji.ac.il		Levi-Schaffer, Francesca/0000-0003-0620-2810	Israel Science Foundation; Rosetrees Trust (United Kingdom); United StatesIsrael Binational Science Foundation (BSF); Israel Ministry of Science and Technology; Aimwell Charitable Trust (United Kingdom)	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust (United Kingdom); United StatesIsrael Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Aimwell Charitable Trust (United Kingdom)	F.L.-S.'s research is funded partly by the Israel Science Foundation, Rosetrees Trust (United Kingdom), Aimwell Charitable Trust (United Kingdom), the United StatesIsrael Binational Science Foundation (BSF), and the Israel Ministry of Science and Technology.	Bousquet J, 2011, ALLERGY, V66, P671, DOI 10.1111/j.1398-9995.2010.02522.x; Bundhoo A, 2015, CLIN EXP ALLERGY, V45, P1085, DOI 10.1111/cea.12508; Cohen JM, 2019, J ALLER CL IMM-PRACT, V7, P2672, DOI 10.1016/j.jaip.2019.05.043; Cuervo-Pardo L, 2016, EUR ANN ALLERGY CLIN, V48, P145; Garne E, 2015, J ALLERGY CLIN IMMUN, V136, P1496, DOI 10.1016/j.jaci.2015.05.043; Murphy VE, 2013, BJOG-INT J OBSTET GY, V120, P812, DOI 10.1111/1471-0528.12224; Namazy J, 2015, J ALLERGY CLIN IMMUN, V135, P407, DOI 10.1016/j.jaci.2014.08.025; Namazy JA, 2020, J ALLERGY CLIN IMMUN, V145, P528, DOI 10.1016/j.jaci.2019.05.019; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Rejno G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104755	10	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					481	483		10.1016/j.jaci.2019.11.018	http://dx.doi.org/10.1016/j.jaci.2019.11.018			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31778706	Bronze			2022-12-18	WOS:000512887400006
J	Strauss, R; Jawhari, N				Strauss, Ronald; Jawhari, Nesreen			The Treatment of Asthma Exacerbations with Subcutaneous Terbutaline	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 13-16, 2020	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Strauss, Ronald; Jawhari, Nesreen] Cleveland Allergy & Astma Ctr, Cleveland, OH USA										0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2		S		054	AB18	AB18						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	KQ7IJ					2022-12-18	WOS:000517092700055
J	Kumar, R; Seibold, MA; Burchard, EG				Kumar, Rajesh; Seibold, Max A.; Burchard, Esteban G.			Atopic dermatitis, race, and genetics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Atopic dermatitis; genetics; race/ethnicity			[Kumar, Rajesh] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Seibold, Max A.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; National Jewish Health; University of California System; University of California San Francisco	Kumar, R (corresponding author), Northwestern Feinberg Sch Med, Dept Pediat, Div Allergy & Clin Immunol, 225 E Chicago Ave,Box 60, Chicago, IL 60611 USA.; Kumar, R (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave,Box 60, Chicago, IL 60611 USA.	rkumar@luriechildrens.org		Kumar, Rajesh/0000-0002-1962-7108				Abuabara K, 2020, J ALLERGY CLIN IMMUN, V145; Almoguera B, 2019, J ALLERGY CLIN IMMUN, V143, P1229, DOI 10.1016/j.jaci.2018.10.038; Demoly P, 2014, ALLERGY, V69, P559, DOI 10.1111/all.12386; Margolis DJ, 2014, JAMA DERMATOL, V150, P254, DOI 10.1001/jamadermatol.2013.7954; Margolis DJ, 2014, J ALLERGY CLIN IMMUN, V133, P784, DOI 10.1016/j.jaci.2013.09.015; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Sanyal RD, 2019, ANN ALLERG ASTHMA IM, V122, P99, DOI 10.1016/j.anai.2018.08.024; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; SILVERBERG JI, 2019, JAMA DERMATOL, DOI DOI 10.1111/BJD.18002	10	3	3	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					108	110		10.1016/j.jaci.2019.11.008	http://dx.doi.org/10.1016/j.jaci.2019.11.008			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31738993	Bronze			2022-12-18	WOS:000505590800015
J	Cyphert-Daly, JM; Yang, ZH; Ingram, JL; Tighe, RM; Que, LG				Cyphert-Daly, Jaime M.; Yang, Zhonghui; Ingram, Jennifer L.; Tighe, Robert M.; Que, Loretta G.			Physiologic response to chronic house dust mite exposure in mice is dependent on lot characteristics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							AIRWAY INFLAMMATION; ALLERGY		[Cyphert-Daly, Jaime M.; Yang, Zhonghui; Ingram, Jennifer L.; Tighe, Robert M.; Que, Loretta G.] Duke Univ, Sch Med, Dept Pulm & Crit Care Med, Durham, NC 27710 USA	Duke University	Que, LG (corresponding author), Duke Univ, Sch Med, Dept Pulm & Crit Care Med, Durham, NC 27710 USA.	Loretta.Que@duke.edu		Tighe, Robert/0000-0002-3465-9861	National Heart, Lung, and Blood Institute (NHLBI) [R01-HL107590]; NHLBI [R01HL130234-01A1]; National Institute of Environmental Health Sciences (NIEHS) [R01 ES027574-01A1, NIEHS R01 ES028829-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130234, R01HL107590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027574, R01ES028829] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Heart, Lung, and Blood Institute (NHLBI) grant number R01-HL107590 (L.G.Q.), NHLBI grant number R01HL130234-01A1 (J.L.I.), and National Institute of Environmental Health Sciences (NIEHS) grant numbers R01 ES027574-01A1 and NIEHS R01 ES028829-01A1 (R.M.T.). This project utitilized the Duke Rodent Inhalation and Physiology Core Resource Facility.	ASHERSON GL, 1968, IMMUNOLOGY, V15, P405; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Cheng RYS, 2014, ENVIRON MOL MUTAGEN, V55, P244, DOI 10.1002/em.21851; EICHLER I, 1988, ALLERGY, V43, P458, DOI 10.1111/j.1398-9995.1988.tb00919.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Nakagami Y, 2008, J IMMUNOL, V181, P2203, DOI 10.4049/jimmunol.181.3.2203; Piyadasa H, 2016, BIOL OPEN, V5, P112, DOI 10.1242/bio.014464; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Woo LN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24574-x; Yoon JH, 1999, ACTA OTO-LARYNGOL, V119, P905	11	3	3	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1428	+		10.1016/j.jaci.2019.07.019	http://dx.doi.org/10.1016/j.jaci.2019.07.019			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31369802	Green Accepted, Bronze			2022-12-18	WOS:000495004700037
J	Georas, SN				Georas, Steve N.			Targeting histone deacetylases to restore epithelial barrier integrity: A new option for personalized medicine in patients with allergic airway disorders?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; allergic rhinitis; epithelial cell; tight junction; barrier dysfunction; histone deacetylase; epigenetics; personalized medicine			[Georas, Steve N.] Univ Rochester, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA	University of Rochester	Georas, SN (corresponding author), Univ Rochester, 601 Elmwood Ave,Box 692, Rochester, NY 14642 USA.	Steve_Georas@urmc.rochester.edu						Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fukuda K, 2019, CANCER RES, V79, P1658, DOI 10.1158/0008-5472.CAN-18-2052; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Steelant B, 2019, J ALLERGY CLIN IMMUN, V144, P1242, DOI 10.1016/j.jaci.2019.04.027; Steelant B, 2016, J ALLERGY CLIN IMMUN, V137, P1043, DOI 10.1016/j.jaci.2015.10.050; Toki S, 2016, THORAX, V71, P633, DOI 10.1136/thoraxjnl-2015-207728; Valapour M, 2002, J ALLERGY CLIN IMMUN, V109, P238, DOI 10.1067/mai.2002.121145; Wawrzyniak P, 2017, J ALLERGY CLIN IMMUN, V139, P93, DOI 10.1016/j.jaci.2016.03.050; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038	10	3	3	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1172	1174		10.1016/j.jaci.2019.09.007	http://dx.doi.org/10.1016/j.jaci.2019.09.007			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31557501	Bronze			2022-12-18	WOS:000495004700008
J	Jonckheere, AC; Seys, S; Dilissen, E; Schelpe, AS; Van der Eycken, S; Corthout, S; Verhalle, T; Goossens, J; Vanbelle, V; Aertgeerts, S; Troosters, T; Peers, K; Dupont, L; Bullens, D				Jonckheere, Anne-Charlotte; Seys, Sven; Dilissen, Ellen; Schelpe, An-Sofie; Van der Eycken, Sarah; Corthout, Steffie; Verhalle, Tulasi; Goossens, Janne; Vanbelle, Vincent; Aertgeerts, Sven; Troosters, Thierry; Peers, Koen; Dupont, Lieven; Bullens, Dominique			Early-onset airway damage in early-career elite athletes: A risk factor for exercise-induced bronchoconstriction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PREVALENCE; PATTERN		[Jonckheere, Anne-Charlotte; Seys, Sven; Dilissen, Ellen; Schelpe, An-Sofie; Van der Eycken, Sarah; Corthout, Steffie; Verhalle, Tulasi; Goossens, Janne; Bullens, Dominique] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Allergy & Clin Immunol Res Grp, Leuven, Belgium; [Vanbelle, Vincent] Flemish Swimming Federat, Merelbeke, Belgium; [Aertgeerts, Sven] Katholieke Univ Leuven, Acad Ctr Gen Practitioners, Leuven, Belgium; [Troosters, Thierry] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Peers, Koen] UZ Leuven, Sport Med Advice Ctr, Leuven, Belgium; [Dupont, Lieven] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Lab Pneumol, Leuven, Belgium; [Dupont, Lieven] UZ Leuven, Clin Div Resp Med, Leuven, Belgium; [Bullens, Dominique] UZ Leuven, Clin Div Paediat, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Bullens, D (corresponding author), Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Allergy & Clin Immunol Res Grp, Leuven, Belgium.; Bullens, D (corresponding author), UZ Leuven, Clin Div Paediat, Leuven, Belgium.	dominique.bullens@kuleuven.be	Jonckheere, Anne-Charlotte/P-4556-2019; Bullens, Dominique M A/T-6211-2017	Jonckheere, Anne-Charlotte/0000-0003-4943-892X; Schelpe, An-Sofie/0000-0002-3059-364X; Seys, Sven/0000-0002-4399-9892; Goossens, Janne/0000-0002-9383-8886; Bullens, Dominique M A/0000-0002-4595-9579	Study Center for Allergy Projects (Haarlem, The Netherlands); Fund for Scientific Research Flanders (FWO) [G0560.13]; FWO-SB fellowship [1S20418N]; Climbing for Life Research Fund	Study Center for Allergy Projects (Haarlem, The Netherlands)(Netherlands Government); Fund for Scientific Research Flanders (FWO)(FWO); FWO-SB fellowship; Climbing for Life Research Fund	A.-C.J. was supported by a grant from the Study Center for Allergy Projects (Haarlem, The Netherlands) and a grant from the Fund for Scientific Research Flanders (FWO) (grant no. G0560.13). Currently, she is supported by an FWO-SB fellowship (grant no. 1S20418N). D.B. received a research grant from the Climbing for Life Research Fund. D.B. and L.D. are recipients of a senior researcher fellowship from the Fund for Scientific Research Flanders (FWO).	Bonini M, 2018, IMMUNOL ALLERGY CLIN, V38, P205, DOI 10.1016/j.iac.2018.01.007; Boulet LP, 2015, NEW ENGL J MED, V372, P641, DOI 10.1056/NEJMra1407552; de Aguiar KB, 2018, PEDIATR PULM, V53, P412, DOI 10.1002/ppul.23951; Jonckheere AC, 2018, PEDIAT ALLERG IMM-UK, V29, P648, DOI 10.1111/pai.12949; Levai IK, 2016, RESPIROLOGY, V21, P1391, DOI 10.1111/resp.12859; Pedersen L, 2008, J ALLERGY CLIN IMMUN, V122, P322, DOI 10.1016/j.jaci.2008.04.041; Rundell KW, 2018, IMMUNOL ALLERGY CLIN, V38, P183, DOI 10.1016/j.iac.2018.01.009; Seys SF, 2015, ALLERGY, V70, P187, DOI 10.1111/all.12540; Van der Eycken S, 2016, RESP MED, V111, P91, DOI 10.1016/j.rmed.2015.12.012	9	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1423	+		10.1016/j.jaci.2019.07.014	http://dx.doi.org/10.1016/j.jaci.2019.07.014			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31356920				2022-12-18	WOS:000495004700035
J	Jones, AC; Anderson, D; Galbraith, S; Fantino, E; Cardenas, DG; Read, JF; Serralha, M; Holt, BJ; Strickland, DH; Sly, PD; Bosco, A; Holt, PG				Jones, Anya C.; Anderson, Denise; Galbraith, Sally; Fantino, Emmanuelle; Cardenas, Diana Gutierrez; Read, James F.; Serralha, Michael; Holt, Barbara J.; Strickland, Deborah H.; Sly, Peter D.; Bosco, Anthony; Holt, Patrick G.			Immunoinflammatory responses to febrile lower respiratory infections in infants display uniquely complex/intense transcriptomic profiles	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							VIRAL-INFECTIONS; RISK; ASTHMA; ATOPY		[Jones, Anya C.; Anderson, Denise; Read, James F.; Serralha, Michael; Holt, Barbara J.; Strickland, Deborah H.; Bosco, Anthony; Holt, Patrick G.] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia; [Jones, Anya C.; Read, James F.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Galbraith, Sally; Fantino, Emmanuelle; Cardenas, Diana Gutierrez; Sly, Peter D.; Holt, Patrick G.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Queensland	Holt, PG (corresponding author), Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia.; Holt, PG (corresponding author), Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia.	Patrick.Holt@telethonkids.org.au	Jones, Anya/AAE-8029-2021; Strickland, Deborah/AGV-6937-2022; Bosco, Anthony/AAC-6900-2022; Sly, Peter D/F-1486-2010; Serralha, Michael/CAA-0940-2022; Fantino, Emmanuelle/F-1654-2010; Holt, Patrick/H-1548-2011	Jones, Anya/0000-0002-6649-4977; Strickland, Deborah/0000-0003-0114-4201; Sly, Peter D/0000-0001-6305-2201; Bosco, Anthony/0000-0002-4335-615X; Anderson, Denise/0000-0003-0643-4136; Fantino, Emmanuelle/0000-0001-9046-3655; Holt, Patrick/0000-0003-1193-0935; Serralha, Michael/0000-0002-0121-2879	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia.	Holt PG, 2019, J ALLERGY CLIN IMMUN, V143, P1176, DOI 10.1016/j.jaci.2018.08.035; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P653, DOI 10.1016/j.jaci.2009.12.018; HOLT PG, 1992, CLIN EXP ALLERGY, V22, P1093, DOI 10.1111/j.1365-2222.1992.tb00135.x; Kusel MMH, 2012, EUR RESPIR J, V39, P876, DOI 10.1183/09031936.00193310; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008	8	3	3	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1411	1413		10.1016/j.jaci.2019.07.043	http://dx.doi.org/10.1016/j.jaci.2019.07.043			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31437489	Bronze			2022-12-18	WOS:000495004700031
J	MacGlashan, D				MacGlashan, Donald			Blocking antibodies in immunotherapy: Quality versus quantity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Basophils; oral immunotherapy; peanut allergy	OMALIZUMAB		[MacGlashan, Donald] Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	MacGlashan, D (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	dmacglas@jhmi.edu			NIAID NIH HHS [U01 AI100952] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		LICHTENS.LM, 1968, AM J MED, V44, P514, DOI 10.1016/0002-9343(68)90052-1; MacGlashan D, 2016, J ALLERGY CLIN IMMUN, V137, P1256, DOI 10.1016/j.jaci.2015.10.043; MacGlashan DW, 2013, J ALLERGY CLIN IMMUN, V132, P906, DOI 10.1016/j.jaci.2013.04.056; MacGlashan DW, 2012, J ALLERGY CLIN IMMUN, V130, P1130, DOI 10.1016/j.jaci.2012.05.038; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P210, DOI 10.1016/0091-6749(73)90059-6; Patil SU, 2019, J ALLERGY CLIN IMMUN, V144, P1310, DOI 10.1016/j.jaci.2019.07.028; PLATTSMILLS TAE, 1976, J CLIN INVEST, V57, P1041, DOI 10.1172/JCI108346	7	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1177	1179		10.1016/j.jaci.2019.09.024	http://dx.doi.org/10.1016/j.jaci.2019.09.024			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31589878	Bronze			2022-12-18	WOS:000495004700010
J	Lutter, R; Ravanetti, L				Lutter, Rene; Ravanetti, Lara			Cadherin-related family member 3 (CDHR3) drives differentiation of ciliated bronchial epithelial cells and facilitates rhinovirus C infection, although with a little help	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; exacerbation; transepithelial resistance	BINDING		[Lutter, Rene] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Resp Med, Amsterdam, Netherlands; [Lutter, Rene; Ravanetti, Lara] Univ Amsterdam, Amsterdam Infect & Immun Inst, Amsterdam Univ Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Lutter, R (corresponding author), Univ Amsterdam, Amsterdam Infect & Immun Inst, Dept Resp Med, Amsterdam UMC, Room K0-150, NL-1105 AZ Amsterdam, Netherlands.; Lutter, R (corresponding author), Univ Amsterdam, Amsterdam Infect & Immun Inst, Dept Expt Immunol, Amsterdam UMC, Room K0-150, NL-1105 AZ Amsterdam, Netherlands.	r.lutter@amsterdamumc.nl	Ravanetti, Lara/AAW-9314-2021					Basnet S, 2019, AM J RESP CELL MOL B; Blaas Dieter, 2016, Mol Cell Pediatr, V3, P21, DOI 10.1186/s40348-016-0049-3; Bochkov YA, 2016, VIROLOGY, V499, P350, DOI 10.1016/j.virol.2016.09.025; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2018, AM J RESP CRIT CARE, V197, P589, DOI 10.1164/rccm.201705-1021OC; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Everman JL, 2019, J ALLERGY CLIN IMMUN, V144, P962, DOI 10.1016/j.jaci.2019.01.052; Griggs TF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0567-0; Watters K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007477	9	3	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					926	927		10.1016/j.jaci.2019.07.021	http://dx.doi.org/10.1016/j.jaci.2019.07.021			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31376404	Bronze			2022-12-18	WOS:000488803900006
J	Cardet, JC; Jiang, XF; Lu, Q; Gerard, N; McIntire, K; Boushey, HA; Castro, M; Chinchilli, VM; Codispoti, CD; Dyer, AM; Holguin, F; Kraft, M; Lazarus, S; Lemanske, RF; Lugogo, N; Mauger, D; Moore, WC; Moy, J; Ortega, VE; Peters, SP; Smith, LJ; Solway, J; Sorkness, CA; Sumino, K; Wechsler, ME; Wenzel, S; Israel, E				Cardet, Juan Carlos; Jiang, Xiaofeng; Lu, Quan; Gerard, Norma; McIntire, Kristen; Boushey, Homer A.; Castro, Mario; Chinchilli, Vernon M.; Codispoti, Christopher D.; Dyer, Anne-Marie; Holguin, Fernando; Kraft, Monica; Lazarus, Stephen; Lemanske, Robert F.; Lugogo, Njira; Mauger, Dave; Moore, Wendy C.; Moy, James; Ortega, Victor E.; Peters, Stephen P.; Smith, Lewis J.; Solway, Julian; Sorkness, Christine A.; Sumino, Kaharu; Wechsler, Michael E.; Wenzel, Sally; Israel, Elliot		AsthmaNet Investigators	Loss of bronchoprotection with ICS plus LABA treatment, beta-receptor dynamics, and the effect of alendronate	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						beta(2)-Adrenergic receptor; bronchoprotection; downregulation; bisphosphonate; loss of bronchoprotection; controller therapy; salmeterol; beta(2)-agonists	BETA(2)-ADRENERGIC RECEPTORS; BRONCHIAL RESPONSIVENESS; AIRWAY RESPONSIVENESS; RAPID ONSET; TOLERANCE; SALMETEROL; ASTHMA; SALBUTAMOL; FORMOTEROL; FARNESYL	Background: Loss of bronchoprotection (LOBP) with a regularly used long-acting beta(2)-adrenergic receptor agonist (LABA) is well documented. LOBP has been attributed to beta(2)-adrenergic receptor (B2AR) downregulation, a process requiring farnesylation, which is inhibited by alendronate. Objective: We sought to determine whether alendronate can reduce LABA-associated LOBP in inhaled corticosteroid (ICS)-treated patients. Methods: We conducted a randomized, double-blind, placebo-controlled, parallel-design, proof-of-concept trial. Seventy-eight participants with persistent asthma receiving 250 mg of fluticasone twice daily for 2 weeks were randomized to receive alendronate or placebo while initiating salmeterol for 8 weeks. Salmeterol-protected methacholine challenges (SPMChs) and PBMC B2AR numbers (radioligand binding assay) and signaling (cyclic AMP ELISA) were assessed before randomization and after 8 weeks of ICS plus LABA treatment. LOBP was defined as a more than 1 doubling dose reduction in SPMCh PC20 value. Results: The mean doubling dose reduction in SPMCh PC20 value was 0.50 and 0.27 with alendronate and placebo, respectively (P = .62). Thirty-eight percent of participants receiving alendronate and 33% receiving placebo had LOBP (P = .81). The after/before ICS plus LABA treatment ratio of B2AR number was 1.0 for alendronate (P = .86) and 0.8 for placebo (P = .15; P = .31 for difference between treatments). The B2AR signaling ratio was 0.89 for alendronate (P = .43) and 1.02 for placebo (P = .84; P = .44 for difference). Changes in lung function and B2AR number and signaling were similar between those who did and did not experience LOBP. Conclusion: This study did not find evidence that alendronate reduces LABA-associated LOBP, which relates to the occurrence of LOBP in only one third of participants. LOBP appears to be less common than presumed in concomitant ICS plus LABA-treated asthmatic patients. B2AR downregulation measured in PBMCs does not appear to reflect LOBP.	[Cardet, Juan Carlos; McIntire, Kristen; Israel, Elliot] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Jiang, Xiaofeng; Lu, Quan] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Jiang, Xiaofeng; Lu, Quan] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Gerard, Norma] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Boushey, Homer A.; Lazarus, Stephen] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Castro, Mario; Sumino, Kaharu] Washington Univ, Dept Med, St Louis, MO USA; [Chinchilli, Vernon M.; Dyer, Anne-Marie; Mauger, Dave] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Codispoti, Christopher D.; Moy, James] Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA; [Codispoti, Christopher D.; Moy, James] John H Stroger Jr Hosp Cook Cty, Dept Pediat, Chicago, IL USA; [Holguin, Fernando; Wenzel, Sally] Pittsburgh Univ, Dept Med, Pittsburgh, PA USA; [Kraft, Monica] Univ Arizona, Dept Med, Tucson, AZ USA; [Lemanske, Robert F.; Sorkness, Christine A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Lemanske, Robert F.; Sorkness, Christine A.] Univ Wisconsin, Dept Pharm Practice, Madison, WI USA; [Lugogo, Njira] Duke Univ, Dept Med, Durham, NC 27706 USA; [Moore, Wendy C.; Ortega, Victor E.; Peters, Stephen P.] Wake Forest Univ, Dept Med, Winston Salem, NC USA; [Smith, Lewis J.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Solway, Julian] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Wechsler, Michael E.] Natl Jewish Univ, Dept Med, Denver, CO USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Rush University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University; Wake Forest University; Northwestern University; Feinberg School of Medicine; University of Chicago	Israel, E (corresponding author), Brigham & Womens Hosp, Asthma Res Ctr, 75 Francis St,Surg Bldg 1,Suite 155, Boston, MA 02115 USA.	eisrael@bwh.harvard.edu	Wechsler, Michael/AAC-5506-2019; Sumino, Kaharu/AAA-2028-2021	Sumino, Kaharu/0000-0002-6214-2966; Wenzel, Sally/0000-0002-4242-0164	National Heart, Lung, and Blood Institute [HL098102, U10HL098096, UL1TR000150, UL1TR000430, UL1TR000050, HL098075, UL1TR001082, HL098090, HL098177, UL1TR000439, HL098098, UL1TR000448, HL098107, HL098112, HL098103, UL1TR000454, HL098115]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR001082, UL1TR002003, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI125785] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants HL098102, U10HL098096, UL1TR000150, UL1TR000430, UL1TR000050, HL098075, UL1TR001082, HL098090, HL098177, UL1TR000439, HL098098, UL1TR000448, HL098107, HL098112, HL098103, UL1TR000454, and HL098115 awarded by the National Heart, Lung, and Blood Institute.	Aziz I, 1998, EUR RESPIR J, V12, P580, DOI 10.1183/09031936.98.12030580; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Bonini M, 2013, AM J RESP CRIT CARE, V188, P1407, DOI 10.1164/rccm.201307-1323OC; Boulet LP, 1998, EUR RESPIR J, V11, P1091, DOI 10.1183/09031936.98.11051091; BUSSE WW, 1985, AM REV RESPIR DIS, V132, P1194; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; COCKCROFT DW, 1995, AM J RESP CRIT CARE, V152, P1485, DOI 10.1164/ajrccm.152.5.7582281; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; Diel IJ, 1998, NEW ENGL J MED, V339, P357, DOI 10.1056/NEJM199808063390601; Drotar DE, 1998, ANN ALLERG ASTHMA IM, V80, P31, DOI 10.1016/S1081-1206(10)62935-3; Duque G, 2011, BRIT J PHARMACOL, V162, P1109, DOI 10.1111/j.1476-5381.2010.01111.x; Erin EM, 2008, CHEST, V134, P740, DOI 10.1378/chest.07-2575; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; FitzGerald JM, 1999, J ALLERGY CLIN IMMUN, V103, P427, DOI 10.1016/S0091-6749(99)70467-7; Giannini D, 1996, CHEST, V110, P1452, DOI 10.1378/chest.110.6.1452; Global Initiative for Asthma, 2018, GLOB STRAT ASTHM MAN; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Haney S, 2005, RESP MED, V99, P566, DOI 10.1016/j.rmed.2004.10.014; Jiang XF, 2012, FASEB J, V26, P1995, DOI 10.1096/fj.11-193870; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; Kalra S, 1996, CHEST, V109, P953, DOI 10.1378/chest.109.4.953; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; MAK JCW, 1995, J CLIN INVEST, V96, P99, DOI 10.1172/JCI118084; Mauger EA, 2001, CONTROL CLIN TRIALS, V22, p244S, DOI 10.1016/S0197-2456(01)00159-3; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Peters SP, 2016, NEW ENGL J MED, V375, P850, DOI 10.1056/NEJMoa1511190; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Profita M, 2005, ALLERGY, V60, P323, DOI 10.1111/j.1398-9995.2005.00702.x; Rhim SY, 2009, CLIN THER, V31, P1037, DOI 10.1016/j.clinthera.2009.05.001; RYBERG M, 1991, SCAND J DENT RES, V99, P212; RYBERG M, 1995, ARCH ORAL BIOL, V40, P187, DOI 10.1016/0003-9969(95)98807-B; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; SEARS MR, 1994, DRUG SAFETY, V11, P259, DOI 10.2165/00002018-199411040-00005; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Stempel DA, 2016, NEW ENGL J MED, V374, P1; VANESSENZANDVLIET EE, 1992, AM REV RESPIR DIS, V146, P547, DOI 10.1164/ajrccm/146.3.547; VATHENEN AS, 1988, LANCET, V1, P554; Yang J, 2013, INT J BIOCHEM CELL B, V45, P657, DOI 10.1016/j.biocel.2012.12.016; Yates DH, 1996, AM J RESP CRIT CARE, V154, P1603, DOI 10.1164/ajrccm.154.6.8970342; YATES DH, 1995, AM J RESP CRIT CARE, V152, P1170, DOI 10.1164/ajrccm.152.4.7551366	48	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					416	+		10.1016/j.jaci.2019.01.049	http://dx.doi.org/10.1016/j.jaci.2019.01.049			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	30872116	Green Accepted, Bronze			2022-12-18	WOS:000478789300011
J	Honda, Y; Ono, S; Honda, T; Kataoka, TR; Egawa, G; Kitoh, A; Otsuka, A; Nakajima, S; Nomura, T; Dainichi, T; Kabashima, K				Honda, Yuki; Ono, Sachiko; Honda, Tetsuya; Kataoka, Tatsuki R.; Egawa, Gyohei; Kitoh, Akihiko; Otsuka, Atsushi; Nakajima, Saeko; Nomura, Takashi; Dainichi, Teruki; Kabashima, Kenji			Murine neonatal skin mast cells are phenotypically immature and minimally sensitized with transplacentally transferred IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FCRN		[Honda, Yuki; Ono, Sachiko; Honda, Tetsuya; Egawa, Gyohei; Kitoh, Akihiko; Otsuka, Atsushi; Nakajima, Saeko; Nomura, Takashi; Dainichi, Teruki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Kataoka, Tatsuki R.] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto, Japan; [Kabashima, Kenji] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, Singapore, Singapore; [Kabashima, Kenji] Agcy Sci Technol & Res, Skin Res Inst Singapore, Biopolis, Singapore, Singapore	Kyoto University; Kyoto University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS)	Honda, T; Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.; Kabashima, K (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, Singapore, Singapore.; Kabashima, K (corresponding author), Agcy Sci Technol & Res, Skin Res Inst Singapore, Biopolis, Singapore, Singapore.	hontetsu@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp	Dainichi, Teruki/AAL-5400-2020; Nakajima, Saeko/AAB-1577-2021	Dainichi, Teruki/0000-0002-9497-0029; Egawa, Gyohei/0000-0002-6101-4719; Otsuka, Atsushi/0000-0001-7365-947X; Nakajima, Saeko/0000-0003-0831-1447	Japan Society for the Promotion of Science KAKENHI [JP15K09766, JP15H05096, 263395, 17J10049]; Japan Agency for Medical Research and Development (AMED) [16ek0410011h0003, 16he0902003h0002]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	Supported by grants from the Japan Society for the Promotion of Science KAKENHI (JP15K09766, JP15H05096 [to T.H.], 263395 [to K.K.], and 17J10049) and the Japan Agency for Medical Research and Development (AMED; 16ek0410011h0003 and 16he0902003h0002 [to K.K.]).	AVRECH OM, 1994, INT ARCH ALLERGY IMM, V103, P160, DOI 10.1159/000236622; Bundhoo A, 2015, CLIN EXP ALLERGY, V45, P1085, DOI 10.1111/cea.12508; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Li ZQ, 2018, IMMUNITY, V49, P640, DOI 10.1016/j.immuni.2018.09.023; MICHEL FB, 1980, J ALLERGY CLIN IMMUN, V65, P422, DOI 10.1016/0091-6749(80)90234-1; Paveglio S, 2012, CLIN EXP ALLERGY, V42, P1791, DOI 10.1111/j.1365-2222.2012.04043.x; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Wang ZP, 2017, J ALLERGY CLIN IMMUN, V139, P1205, DOI 10.1016/j.jaci.2016.09.019	9	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					617	+		10.1016/j.jaci.2019.05.011	http://dx.doi.org/10.1016/j.jaci.2019.05.011			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31125593	Green Submitted			2022-12-18	WOS:000478789300034
J	Moiseev, S; Zagvozdkina, E; Kazarina, V; Bulanov, N; Novikov, P				Moiseev, Sergey; Zagvozdkina, Eugenia; Kazarina, Viktoria; Bulanov, Nikolai; Novikov, Pavel			Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PLACEBO		[Moiseev, Sergey; Zagvozdkina, Eugenia; Kazarina, Viktoria; Bulanov, Nikolai; Novikov, Pavel] Sechenov First Moscow State Med Univ, Tareev Clin Internal Dis, Moscow, Russia	Sechenov First Moscow State Medical University	Moiseev, S (corresponding author), Sechenov First Moscow State Med Univ, Tareev Clin Internal Dis, Moscow, Russia.	clinpharm@mtu-net.ru	Moiseev, Sergey/P-3310-2019; Bulanov, Nikolay/AAZ-5043-2020	Moiseev, Sergey/0000-0002-7232-4640; 	Russian Academic Excellence Project 5-100	Russian Academic Excellence Project 5-100(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	Supported by the Russian Academic Excellence Project 5-100.	Cottin V, 2017, AUTOIMMUN REV, V16, P1, DOI 10.1016/j.autrev.2016.09.018; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Steinfeld J, 2019, J ALLERGY CLIN IMMUN, V143, P2170, DOI 10.1016/j.jaci.2018.11.041; Wechsler ME, 2017, NEW ENGL J MED, V376, P1921, DOI 10.1056/NEJMoa1702079	4	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					621	621		10.1016/j.jaci.2019.03.030	http://dx.doi.org/10.1016/j.jaci.2019.03.030			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31056188	Bronze			2022-12-18	WOS:000478789300035
J	Netting, MJ; Allen, KJ				Netting, Merryn J.; Allen, Katrina J.			Reconciling breast-feeding and early food introduction guidelines in the prevention and management of food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Breast-feeding; food allergy; infant feeding guidelines	DIAGNOSIS; DIET; MILK		[Netting, Merryn J.] South Australian Hlth & Med Res Inst, Women & Kids Theme, Adelaide, SA, Australia; [Netting, Merryn J.] Univ Adelaide, Sch Med, Discipline Paediat, Adelaide, SA, Australia; [Netting, Merryn J.] Womens & Childrens Hosp, Nutr Dept, Adelaide, SA, Australia; [Allen, Katrina J.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Allen, Katrina J.] Univ Melbourne, Parkville, Vic, Australia; [Allen, Katrina J.] Royal Childrens Hosp, Parkville, Vic, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne	Netting, MJ (corresponding author), South Australian Hlth & Med Res Inst, Womens & Kids Theme, 72 King William Rd, North Adelaide, SA 5006, Australia.	merryn.netting@sahmri.com						Allen JW, 2020, ALLERGY, V75, P673, DOI 10.1111/all.13979; Allen KJ, 2009, J PAEDIATR CHILD H, V45, P481, DOI 10.1111/j.1440-1754.2009.01546.x; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Bode L, 2014, ADV NUTR, V5, P571, DOI 10.3945/an.114.006643; Bravi F, 2016, AM J CLIN NUTR, V104, P646, DOI 10.3945/ajcn.115.120881; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132; Luyt D, 2014, CLIN EXP ALLERGY, V44, P642, DOI 10.1111/cea.12302; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; National Academies of Sciences Engineering and Medicine, 2017, FINDING PATH SAFETY; Netting MJ, 2017, J PAEDIATR CHILD H, V53, P870, DOI 10.1111/jpc.13594; Netting MJ, 2014, NUTRITION, V30, P1225, DOI 10.1016/j.nut.2014.02.015; Nowak-Wegrzyn A, 2017, J ALLERGY CLIN IMMUN, V139, P1111, DOI 10.1016/j.jaci.2016.12.966; Palmer DJ, 2006, CURR OPIN CLIN NUTR, V9, P284, DOI 10.1097/01.mco.0000222113.46042.50; Perkin MR, 2016, J ALLERGY CLIN IMMUN, V137, P1477, DOI 10.1016/j.jaci.2015.12.1322; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010; UK Scientific Advisory Committee on Nutrition and the Committee on Toxicity of Chemicals, 2018, JOINT SACN COT WORK; UNICEF WHO, 2003, GLOB STRAT INF YOUNG; Venter C, 2018, CLIN EXP ALLERGY, V48, P121, DOI 10.1111/cea.13087; Venter C, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0162-y; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7	23	3	3	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					397	+		10.1016/j.jaci.2019.06.004	http://dx.doi.org/10.1016/j.jaci.2019.06.004			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31395151	Bronze			2022-12-18	WOS:000478789300005
J	Wu, CC; Kim, JN; Wang, ZP; Chang, YL; Zengler, K; Di Nardo, A				Wu, Chia-Chi; Kim, Ji-Nu; Wang, Zhenping; Chang, Yu-Ling; Zengler, Karsten; Di Nardo, Anna			Mast cell recruitment is modulated by the hairless skin microbiome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MATURATION		[Wu, Chia-Chi; Wang, Zhenping; Chang, Yu-Ling; Di Nardo, Anna] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA; [Kim, Ji-Nu; Zengler, Karsten] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Di Nardo, A (corresponding author), Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA.	adinardo@ucsd.edu		Chang, Yu-Ling/0000-0003-4650-7117	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases through NIH [5R01AI106874]	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases through NIH	Supported by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases through NIH grant 5R01AI106874 (to A.D.N.).	BERGSTRESSER PR, 1984, J INVEST DERMATOL, V83, P214, DOI 10.1111/1523-1747.ep12263584; Bertolini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094260; Botchkarev VA, 1997, ARCH DERMATOL RES, V289, P292, DOI 10.1007/s004030050195; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fujii M, 2015, EXP DERMATOL, V24, P108, DOI 10.1111/exd.12592; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Igawa S, 2017, TRANSL RES, V184, P68, DOI 10.1016/j.trsl.2017.03.003; KOIZUMI T, 1987, IMMUNOGENETICS, V26, P36, DOI 10.1007/BF00345452; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009; Wang ZP, 2017, J ALLERGY CLIN IMMUN, V139, P1205, DOI 10.1016/j.jaci.2016.09.019	13	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					330	+		10.1016/j.jaci.2019.02.033	http://dx.doi.org/10.1016/j.jaci.2019.02.033			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30928651	Green Accepted, Bronze			2022-12-18	WOS:000473432800040
J	London, SJ; Melen, E				London, Stephanie J.; Melen, Erik			Genomic interactions with exposure to inhaled pollutants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Gene-environment interaction; epigenetics; methylation; genetic susceptibility; air pollution; smoking	AIR-POLLUTION; DNA METHYLATION; CHILDHOOD ASTHMA; SMOKING; GSTP1; TNF		[London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [London, Stephanie J.] NIEHS, Immun Inflammat & Dis Lab, Div Intramural Res, NIH,Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA; [Melen, Erik] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Melen, Erik] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Melen, Erik] South Gen Hosp, Sachs Childrens Hosp, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Karolinska Institutet; Karolinska Institutet	London, SJ (corresponding author), NIEHS, Res Triangle Pk, NC 27709 USA.	London2@niehs.nih.gov	London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290	European Research Council [757919]; Swedish Research Council; Strategic Research Area Epidemiology at Karolinska Institutet; Swedish Heart and Lung Foundation; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [ZO1 ES49019]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019, ZIAES043012] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Area Epidemiology at Karolinska Institutet; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	E.M. is supported by grants from the European Research Council (no. 757919), the Swedish Research Council, the Strategic Research Area Epidemiology at Karolinska Institutet, and the Swedish Heart and Lung Foundation. S.J.L. is supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (ZO1 ES49019).	Dai X, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0771-0; Fuertes E, 2013, J ALLERGY CLIN IMMUN, V132, P342, DOI 10.1016/j.jaci.2013.03.007; Gref A, 2017, AM J RESP CRIT CARE, V195, P1373, DOI 10.1164/rccm.201605-1026OC; Gruzieva O, 2017, ENVIRON HEALTH PERSP, V125, P104, DOI 10.1289/EHP36; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Joubert BR, 2016, AM J HUM GENET, V98, P680, DOI 10.1016/j.ajhg.2016.02.019; Kim J, 2019, GENETICS, V211, P483, DOI 10.1534/genetics.118.301394; MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P418, DOI 10.1289/ehp.1307459; Panni T, 2016, ENVIRON HEALTH PERSP, V124, P983, DOI 10.1289/ehp.1509966; Reese SE, 2019, J ALLERGY CLIN IMMUN, V143, P2062, DOI 10.1016/j.jaci.2018.11.043; Valeri L, 2017, EPIGENOMICS-UK, V9, P253, DOI 10.2217/epi-2016-0145; Zeng X, 2019, ENVIRON INT, V122, P263, DOI 10.1016/j.envint.2018.11.017	13	3	3	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2011	+		10.1016/j.jaci.2019.04.008	http://dx.doi.org/10.1016/j.jaci.2019.04.008			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	31029775	Bronze, Green Accepted			2022-12-18	WOS:000470113200004
J	Carpaij, OA; Vonk, JM; Nawijn, MC; Kerstjens, HAM; Koppelman, GH; van den Berge, M				Carpaij, Orestes A.; Vonk, Judith M.; Nawijn, Martijn C.; Kerstjens, Huib A. M.; Koppelman, Gerard H.; van den Berge, Maarten			Applying the CAMP trial asthma remission prediction model to the Dutch asthma remission studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EARLY ADULTHOOD; RISK-FACTORS; PERSISTENCE		[Carpaij, Orestes A.; Vonk, Judith M.; Nawijn, Martijn C.; Kerstjens, Huib A. M.; Koppelman, Gerard H.; van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Carpaij, Orestes A.; Kerstjens, Huib A. M.; van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Carpaij, OA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands.; Carpaij, OA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands.	o.a.carpaij@umcg.nl	Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252; Kerstjens, Huib/0000-0001-7705-7927; Nawijn, Martijn/0000-0003-3372-6521; van den Berge, Maarten/0000-0002-9336-7340				Aydogan M, 2013, J ASTHMA, V50, P938, DOI 10.3109/02770903.2013.831872; Carpaij OA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01974-2016; Chhabra SK, 1998, J ASTHMA, V35, P361, DOI 10.3109/02770909809075669; Sekerel BE, 2006, ALLERGY, V61, P869, DOI 10.1111/j.1398-9995.2006.01082.x; Taylor DR, 2005, CHEST, V127, P845, DOI 10.1378/chest.127.3.845; Vonk JM, 2004, THORAX, V59, P925, DOI 10.1136/thx.2003.016246; Wang AL, 2019, J ALLERGY CLIN IMMUN, V143	7	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1973	1975		10.1016/j.jaci.2019.01.040	http://dx.doi.org/10.1016/j.jaci.2019.01.040			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30876728	Bronze, Green Published			2022-12-18	WOS:000466784600045
J	Cayrol, C; Girard, JP				Cayrol, Corinne; Girard, Jean-Philippe			Innate lymphoid cells in asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; innate lymphoid cells; group 2 innate lymphoid cells; type 2 inflammation; macrophage			[Cayrol, Corinne; Girard, Jean-Philippe] Univ Toulouse, IPBS, Toulouse, France	Universite de Toulouse	Girard, JP (corresponding author), Univ Toulouse, IPBS, CNRS, 205 Route Narbonne, F-31077 Toulouse, France.	Jean-Philippe.Girard@ipbs.fr	GIRARD, Jean-Philippe/F-5229-2010; CAYROL, Corinne/C-2106-2011	GIRARD, Jean-Philippe/0000-0002-9154-1691; CAYROL, Corinne/0000-0002-7813-4397	Agence Nationale de la Recherche [ANR-16-CE15-0009-01]; LABEX TOUCAN	Agence Nationale de la Recherche(French National Research Agency (ANR)); LABEX TOUCAN	Work in the Girard laboratory is supported by the Agence Nationale de la Recherche (ANR-16-CE15-0009-01) and LABEX TOUCAN.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chen RC, 2017, AM J RESP CRIT CARE, V196, P700, DOI 10.1164/rccm.201612-2427OC; Christianson CA, 2015, J ALLERGY CLIN IMMUN, V136, P59, DOI 10.1016/j.jaci.2014.11.037; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim J, 2019, J ALLERGY CLIN IMMUN, V143; Nagakumar P, 2016, J ALLERGY CLIN IMMUN, V137, P624, DOI 10.1016/j.jaci.2015.06.038; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037	10	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1739	1741		10.1016/j.jaci.2019.03.011	http://dx.doi.org/10.1016/j.jaci.2019.03.011			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30926530	Bronze			2022-12-18	WOS:000466784600009
J	Trivellin, G; Stratakis, CA				Trivellin, Giampaolo; Stratakis, Constantine A.			CD40LG duplications in patients with X-LAG syndrome commonly undergo random X-chromosome inactivation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GIGANTISM		[Trivellin, Giampaolo; Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Trivellin, G (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD USA.	giampaolo.trivellin@nih.gov	Trivellin, Giampaolo/J-6583-2016; Stratakis, Constantine/AAP-4745-2020	Trivellin, Giampaolo/0000-0003-2384-4153; 	Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER	Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by the Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	Bertelsen B, 2011, J MOL DIAGN, V13, P537, DOI 10.1016/j.jmoldx.2011.05.003; Daly AF, 2016, ENDOCR-RELAT CANCER, V23, P221, DOI 10.1530/ERC-16-0082; Gordon RJ, 2016, PITUITARY, V19, P560, DOI 10.1007/s11102-016-0743-0; Le Coz C, 2018, J ALLERGY CLIN IMMUN, V141, P2308, DOI 10.1016/j.jaci.2018.02.010; Trivellin G, 2014, NEW ENGL J MED, V371, P2363, DOI 10.1056/NEJMoa1408028; Trivellin G, 2018, BEST PRACT RES CL EN, V32, P125, DOI 10.1016/j.beem.2018.02.004; Yarman S, 2015, GENET TEST MOL BIOMA, V19, P394, DOI 10.1089/gtmb.2014.0333	7	3	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1659	1659		10.1016/j.jaci.2018.12.1017	http://dx.doi.org/10.1016/j.jaci.2018.12.1017			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30773288	Bronze			2022-12-18	WOS:000463348900052
J	Lafon, DC; Nahm, MH				LaFon, David C.; Nahm, Moon H.			Interlaboratory variability in multiplexed pneumococcal antibody testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[LaFon, David C.; Nahm, Moon H.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Nahm, MH (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.; Nahm, MH (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	mnahm@uabmc.edu			University of Alabama at Birmingham institutional funding; National Institutes of Health institutional training grant [5T32HL105346-8]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105346] Funding Source: NIH RePORTER	University of Alabama at Birmingham institutional funding; National Institutes of Health institutional training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The University of Alabama at Birmingham institutional funding was used to conduct this study; however, the funding source had no direct role in study design, execution, or publication. D.C.L. is supported by the National Institutes of Health institutional training grant (grant no. 5T32HL105346-8).	Addae-Mensah I, 2005, WHO TECH REP SER, V929, P1; Beck SC, 2013, ANN CLIN BIOCHEM, V50, P517, DOI 10.1177/0004563213500241; Daly TM, 2014, CLIN VACCINE IMMUNOL, V21, P982, DOI 10.1128/CVI.00235-14; Hajjar J, 2018, J ALLERGY CLIN IMMUN, V142, P1358, DOI 10.1016/j.jaci.2018.06.013; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Schaballie H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00546; Sorensen RU, 1998, J ALLERGY CLIN IMMUN, V102, P215, DOI 10.1016/S0091-6749(98)70089-2; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Zhang XC, 2013, CLIN VACCINE IMMUNOL, V20, P957, DOI 10.1128/CVI.00223-13	9	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1255	1258		10.1016/j.jaci.2018.10.057	http://dx.doi.org/10.1016/j.jaci.2018.10.057			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30468776	Green Accepted, Bronze			2022-12-18	WOS:000460272900055
J	Soklic, TK; Silar, M; Rijavec, M; Koren, A; Kern, I; Hocevar-Boltezar, I; Korosec, P				Soklic, Tanja Kosak; Silar, Mira; Rijavec, Matija; Koren, Ana; Kern, Izidor; Hocevar-Boltezar, Irena; Korosec, Peter			CD3(+)CD4(-)CD8(-) mucosal T cells are associated with uncontrolled chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HUMAN MAST-CELLS; PERIPHERAL-BLOOD; BINDING		[Soklic, Tanja Kosak; Hocevar-Boltezar, Irena] Univ Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Ljubljana, Slovenia; [Silar, Mira; Rijavec, Matija; Koren, Ana; Kern, Izidor; Korosec, Peter] Univ Clin Resp & Allerg Dis, Golnik, Slovenia	University Medical Centre Ljubljana	Soklic, TK (corresponding author), Univ Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Ljubljana, Slovenia.	tanja.soklic@kclj.si	Soklic, Tanja K/AAA-3235-2021; Soklic, Tanja Kosak/ABI-4907-2020	Soklic, Tanja Kosak/0000-0002-9326-7606; Rijavec, Matija/0000-0002-2596-4952				Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Alunno A, 2013, ANN RHEUM DIS, V72, P286, DOI 10.1136/annrheumdis-2012-201511; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Callebaut I, 2014, AM J RHINOL ALLERGY, V28, P290, DOI 10.2500/ajra.2014.28.4052; Crispin JC, 2009, J IMMUNOL, V183, P4675, DOI 10.4049/jimmunol.0901533; Derycke L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097581; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Hedrich CM, 2014, J BIOL CHEM, V289, P2361, DOI 10.1074/jbc.M113.523605; Hellings PW, 2013, ALLERGY, V68, P1, DOI 10.1111/all.12040; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; Maehara A, 2018, J INVEST DERMATOL, V138, P1221, DOI 10.1016/j.jid.2017.11.025; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Shiba E, 2017, J BIOL CHEM, V292, P2924, DOI 10.1074/jbc.M116.768366; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023	16	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1235	+		10.1016/j.jaci.2018.10.045	http://dx.doi.org/10.1016/j.jaci.2018.10.045			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30439404	Green Published, Bronze			2022-12-18	WOS:000460272900048
J	Beck, LA; Silverberg, JI; Grebe, K; Hong, F; Parmentier, J; Teixeira, H; Guttman-Yassky, E				Beck, Lisa A.; Silverberg, Jonathan I.; Grebe, Kristie; Hong, Feng; Parmentier, Julie; Teixeira, Henrique; Guttman-Yassky, Emma			Eosinophil Count and Serum Immunoglobulin E Levels in Atopic Dermatitis: Analysis of Upadacitinib Phase 2 Study Findings	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Beck, Lisa A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Silverberg, Jonathan I.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Grebe, Kristie; Hong, Feng; Parmentier, Julie; Teixeira, Henrique] AbbVie Inc, N Chicago, IL USA; [Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	University of Rochester; Northwestern University; Feinberg School of Medicine; AbbVie; Icahn School of Medicine at Mount Sinai			silverberg, jonathan/ABH-2765-2021	silverberg, jonathan/0000-0003-3686-7805					0	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		376	AB125	AB125		10.1016/j.jaci.2018.12.379	http://dx.doi.org/10.1016/j.jaci.2018.12.379			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200372
J	Choi, BS; Nikoyan, E; Wi, CI; King, KS; Ryu, E; Sheen, YH; Seol, HY; Boyce, TG; Johnson, JN; Juhn, YJ				Choi, Bong Seok; Nikoyan, Editt; Wi, Chung-Il; King, Katherine S.; Ryu, Euijung; Sheen, Youn Ho; Seol, Hee Yun; Boyce, Thomas G.; Johnson, Jonathan N.; Juhn, Young J.			Atopic Asthma as an Unrecognized Risk Factor for Kawasaki Disease: A Population-Based Case-Control Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Choi, Bong Seok] Kyungpook Natl Univ, Sch Med, Daegu, South Korea; [Nikoyan, Editt] Mayo Clin & Mayo Grad Sch Med, Rochester, MN USA; [Wi, Chung-Il; King, Katherine S.; Ryu, Euijung; Seol, Hee Yun; Boyce, Thomas G.; Johnson, Jonathan N.; Juhn, Young J.] Mayo Clin, Rochester, MN USA; [Sheen, Youn Ho] CHA Univ, Sch Med, CHA Gangnam Med Ctr, Dept Pediat, Seoul, South Korea	Kyungpook National University; Mayo Clinic; Mayo Clinic; Pochon Cha University									0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		320	AB106	AB106		10.1016/j.jaci.2018.12.323	http://dx.doi.org/10.1016/j.jaci.2018.12.323			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200316
J	Dhar, S; Larche, M				Dhar, Sudeshna; Larche, Mark			PVX108 Peptide Immunotherapy Significantly Reduces Markers of Peanut-Induced Anaphylaxis in a Dose-Dependent Manner	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Dhar, Sudeshna] McMaster Univ, Hamilton, ON, Canada; [Dhar, Sudeshna] St Josephs Healthcare, Hamilton, ON, Canada; [Larche, Mark] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada	McMaster University; McMaster University			Larché, Margaret J/B-2327-2008						0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		L15	AB426	AB426		10.1016/j.jaci.2018.12.959	http://dx.doi.org/10.1016/j.jaci.2018.12.959			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200944
J	Greiwe, JC; Oppenheimer, J; Fleischer, DM; Bird, JA; Pongracic, JA; Greenhawt, M				Greiwe, Justin C.; Oppenheimer, John; Fleischer, David M.; Bird, J. Andrew; Pongracic, Jacqueline A.; Greenhawt, Matthew			Trends in Oral Food Challenge Practices Among Allergists In The United StatesA Workgroup Report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Greiwe, Justin C.] Bernstein Allergy Grp Inc, Cincinnati, OH USA; [Oppenheimer, John] Pulm & Allergy Associates, Morristown, NJ USA; [Fleischer, David M.; Greenhawt, Matthew] Childrens Hosp Colorado, Aurora, CO USA; [Bird, J. Andrew] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Pongracic, Jacqueline A.] Childrens Hosp Chicago, Chicago, IL USA	Children's Hospital Colorado; University of Texas System; University of Texas Southwestern Medical Center Dallas									0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		494	AB163	AB163		10.1016/j.jaci.2018.12.497	http://dx.doi.org/10.1016/j.jaci.2018.12.497			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200490
J	Gross, GN; Amar, NJ; Fernando, N; Caracta, CF; Tantry, SK				Gross, Gary N.; Amar, Niran J.; Fernando, Nelumka; Caracta, Cynthia F.; Tantry, Sudeesh K.			Olopatadine/Mometasone Combination Nasal Spray for the Treatment of Seasonal Allergic Rhinitis: A Pooled Analysis of Efficacy and Safety	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Gross, Gary N.] Pharmaceut Res & Consulting Inc, Dallas, TX USA; [Amar, Niran J.] Allergy & Asthma Res Inst, Waco, TX USA; [Fernando, Nelumka; Caracta, Cynthia F.; Tantry, Sudeesh K.] Glenmark Pharmaceut Inc, Paramus, NJ USA										0	3	3	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		189	AB64	AB64						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200189
J	Hampton, SL; De Donatis, GM; Murugesan, NI; Rushbrooke, LJ; Li, L; Duckworth, E; Smith, MD; Morten, RM; Maetzel, A; Yea, CM; Feener, EP				Hampton, Sally L.; De Donatis, Gian Marco; Murugesan, Nivetha I.; Rushbrooke, Louise J.; Li, Lily; Duckworth, Edward; Smith, Michael D.; Morten, Rachel M.; Maetzel, Andreas; Yea, Christopher M.; Feener, Edward P.			KVD900 as a Single Dose, Rapid, Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema Attacks: Pharmacokinetic and Pharmacodynamic results from a Phase 1 Single Ascending Dose Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Hampton, Sally L.; De Donatis, Gian Marco; Rushbrooke, Louise J.; Duckworth, Edward; Morten, Rachel M.; Yea, Christopher M.] KalVista Pharmaceut, Salisbury, Wilts, England; [Murugesan, Nivetha I.; Li, Lily; Smith, Michael D.; Maetzel, Andreas; Feener, Edward P.] KalVista Pharmaceut, Cambridge, MA USA										0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		116	AB40	AB40						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200116
J	Heine, RG; Peters, R; Cameron, DJ; Alex, G; Oliver, MR; Hardikar, W; Chow, CW; McWilliam, VL; Moore, DJ; Kakakios, AM; Cheah, E; O'Loughlin, EV; Axelrad, C; Allen, K				Heine, Ralf G.; Peters, Rachel; Cameron, Don J.; Alex, George; Oliver, Mark R.; Hardikar, Winita; Chow, Chung W.; McWilliam, Vicki L.; Moore, David J.; Kakakios, Alyson M.; Cheah, Eric; O'Loughlin, Edward V.; Axelrad, Christine; Allen, Katrina			Effect of a 4-Food Elimination Diet and Omeprazole in Children with Eosinophilic Esophagitis - A Randomized, Controlled Trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Heine, Ralf G.; Peters, Rachel; McWilliam, Vicki L.; Allen, Katrina] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cameron, Don J.; Alex, George; Oliver, Mark R.; Hardikar, Winita; Chow, Chung W.; McWilliam, Vicki L.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Alex, George; Oliver, Mark R.; Hardikar, Winita; Chow, Chung W.] Univ Melbourne, Melbourne, Vic, Australia; [Moore, David J.] Womens & Childrens Hosp, Adelaide, SA, Australia; [Kakakios, Alyson M.; Cheah, Eric; O'Loughlin, Edward V.] Childrens Hosp Westmead, Sydney, NSW, Australia; [Axelrad, Christine] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Allen, Katrina] Royal Childrens Hosp, Parkville, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Womens & Childrens Hospital Australia; University of Sydney; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne			Cameron, Don/ABI-5165-2020; McWilliam, Vicki/S-9462-2019						0	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		936	AB309	AB309		10.1016/j.jaci.2018.12.941	http://dx.doi.org/10.1016/j.jaci.2018.12.941			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200927
J	Hourihane, JO; Lieberman, JA; Bird, JA; Carr, TF; Griffin, NM; Brown, KR; Zawadzki, R; Abbas, A; Matthews, J; Jones, SM				Hourihane, Jonathan O'B.; Lieberman, Jay A.; Bird, J. Andrew; Carr, Tara F.; Griffin, Noelle M.; Brown, Kari R.; Zawadzki, Rezi; Abbas, Allyah; Matthews, John; Jones, Stacie M.			Accidental Exposures to Peanut and Other Food Allergens: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Hourihane, Jonathan O'B.] Univ Coll Cork, Cork, Ireland; [Lieberman, Jay A.] Univ Tennessee, Ctr Hlth Sci, Le Bonheur Childrens Hosp, Memphis, TN 38163 USA; [Bird, J. Andrew] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Carr, Tara F.] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA; [Griffin, Noelle M.; Brown, Kari R.; Zawadzki, Rezi; Matthews, John] Aimmune Therapeut, Brisbane, CA USA; [Abbas, Allyah] Aimmune Therapeut, London, England; [Jones, Stacie M.] UAMS Arkansas Childrens Hosp, Little Rock, AR USA	University College Cork; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Arizona; Arkansas Children's Hospital									0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		804	AB265	AB265						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200796
J	Huang, YP; Xie, Y; Jiang, HH; Abel, PW; Panettieri, RA; Casale, TB; Tu, YP				Huang, Yapei; Xie, Yan; Jiang, Haihong; Abel, Peter W.; Panettieri, Reynold A., Jr.; Casale, Thomas B.; Tu, Yaping			Upregulated P-Rex1 exacerbates human airway smooth muscle hyperplasia in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Huang, Yapei; Xie, Yan; Jiang, Haihong; Abel, Peter W.; Tu, Yaping] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA; [Panettieri, Reynold A., Jr.] Rutgers State Univ, Rutgers Biomed & Hlth Sci, Rutgers Inst Translat Med & Sci, New Brunswick, NJ USA; [Casale, Thomas B.] Univ S Florida, Sch Med, Dept Internal Med, Tampa, FL 33620 USA	Creighton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University System of Florida; University of South Florida	Casale, TB (corresponding author), Univ S Florida, Sch Med, Dept Internal Med, Tampa, FL 33620 USA.	tbcasale@health.usf.edu; Yapingtu@creighton.edu	panettieri, reynold/AAG-9485-2019	, Yapei/0000-0002-9883-813X	National Institutes of Health (NIH) [R01HL116849, R01HL097796, P01 HL114471, P30 ES013508]; Nebraska State LB595 grant; NIH National Center for Research Resources [G20-RR024001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116849, P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska State LB595 grant; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (NIH; grant no. R01HL116849 to Y.T. and T.B.C.; grant nos. R01HL097796, P01 HL114471, and P30 ES013508 to R.A.P.); Nebraska State LB595 grant to Y.T. and P.W.A.; and the NIH National Center for Research Resources (grant no. G20-RR024001).	Andre-Gregoire G, 2018, J ALLERGY CLIN IMMUN, V142, P824, DOI 10.1016/j.jaci.2017.09.049; Banerjee Audreesh, 2012, Am J Respir Cell Mol Biol, V46, P132, DOI 10.1165/rcmb.2010-0276OC; Berair R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-145; Campbell AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059361; Dutting S, 2015, J THROMB HAEMOST, V13, P827, DOI 10.1111/jth.12861; King GG, 2018, RESPIROLOGY, V23, P262, DOI 10.1111/resp.13251; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Simeone-Penney MC, 2008, AM J PHYSIOL-LUNG C, V294, pL698, DOI 10.1152/ajplung.00529.2007; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wong CYA, 2016, PROTEIN CELL, V7, P445, DOI 10.1007/s13238-016-0261-x; Xie Y, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0418-4; Xie Y, 2012, J ALLERGY CLIN IMMUN, V130, P968, DOI 10.1016/j.jaci.2012.05.004	12	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					778	+		10.1016/j.jaci.2018.09.020	http://dx.doi.org/10.1016/j.jaci.2018.09.020			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30312708				2022-12-18	WOS:000457718700039
J	Inhaber, N; Zuraw, BL; Marier, JF; Lu, P; Wang, Y				Inhaber, Neil; Zuraw, Bruce L.; Marier, Jean-Francois; Lu, Peng; Wang, Yi			Relationship Between Body Weight, PK/PD, and Attack Responses Following Subcutaneous Administration of Lanadelumab in Patients with Hereditary Angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Inhaber, Neil; Lu, Peng; Wang, Yi] Shire, Lexington, MA USA; [Zuraw, Bruce L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Marier, Jean-Francois] Certara Strateg Consulting, Montreal, PQ, Canada	Shire Pharmaceuticals Limited; University of California System; University of California San Diego									0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		115	AB39	AB39						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200115
J	Mahdavinia, M; Batra, PS				Mahdavinia, Mahboobeh; Batra, Pete S.			Staphylococcus aureus, epithelial disruption, and nasal polyps: Are we one step ahead in combatting this foe?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Chronic rhinosinusitis; Staphylococcus aureus; Rho-associated protein kinase inhibitor; nasal polyp; epithelium	CELLS		[Mahdavinia, Mahboobeh] Rush Univ, Med Ctr, Div Allergy Immunol, Dept Internal Med, Chicago, IL 60612 USA; [Batra, Pete S.] Rush Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Chicago, IL 60612 USA; [Mahdavinia, Mahboobeh; Batra, Pete S.] Rush Univ, Med Ctr, Rush Ctr Airway Dis, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Batra, PS (corresponding author), Rush Univ, Med Ctr, Otorhinolaryngol Head & Neck Surg, 1611 W Harrison St,Suite 550, Chicago, IL 60612 USA.	Pete_Batra@rush.edu		Mahdavinia, mahboobeh/0000-0003-4004-203X				Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Boyer L, 2006, J CELL BIOL, V173, P809, DOI 10.1083/jcb.200509009; Hermann I, 2015, AM J RESP CELL MOL, V52, P14, DOI 10.1165/rcmb.2014-0082OC; Mahdavinia M, 2016, CLIN EXP ALLERGY, V46, P21, DOI 10.1111/cea.12666; Menko AS, 2014, EXP CELL RES, V322, P133, DOI 10.1016/j.yexcr.2013.12.021; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Sachse F, 2010, ALLERGY, V65, P1430, DOI 10.1111/j.1398-9995.2010.02381.x; SZCZEKLIK A, 1988, CLIN ALLERGY, V18, P15, DOI 10.1111/j.1365-2222.1988.tb02838.x; Valera FCP, 2019, J ALLERGY CLIN IMMUN, V143, P591, DOI 10.1016/j.jaci.2018.05.035; Van Zele T, 2010, J ALLERGY CLIN IMMUN, V125, P1069, DOI 10.1016/j.jaci.2010.02.020; Zhang N, 2016, ALLERGY, V71, P295, DOI 10.1111/all.12809	11	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					563	564		10.1016/j.jaci.2018.11.021	http://dx.doi.org/10.1016/j.jaci.2018.11.021			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30528615	Bronze			2022-12-18	WOS:000457718700016
J	Martin, V; Virkud, YV; Seay, HL; Keet, C; Shreffler, WG; Yuan, Q				Martin, Victoria; Virkud, Yamini V.; Seay, Hannah L.; Keet, Corinne; Shreffler, Wayne G.; Yuan, Qian			A Prospective Assessment of Food Protein-Induced Allergic Proctocolitis from the GMAP Healthy Infant Cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Martin, Victoria; Virkud, Yamini V.; Shreffler, Wayne G.; Yuan, Qian] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Martin, Victoria; Virkud, Yamini V.; Seay, Hannah L.; Shreffler, Wayne G.; Yuan, Qian] Massachusetts Gen Hosp, Food Allergy Ctr, Boston, MA 02114 USA; [Keet, Corinne] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Johns Hopkins University									0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		409	AB136	AB136		10.1016/j.jaci.2018.12.412	http://dx.doi.org/10.1016/j.jaci.2018.12.412			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200405
J	Maspero, JF; Corren, J; Ford, LB; Sher, L; Chipps, BE; Peters, AT; Rice, M; Rowe, P; Lu, YF; Harel, S; Staudinger, H; Amin, N; Ruddy, M; Graham, NMH; Teper, A				Maspero, Jorge F.; Corren, Jonathan; Ford, Linda B.; Sher, Lawrence; Chipps, Bradley E.; Peters, Anju T.; Rice, Megan; Rowe, Paul; Lu, Yufang; Harel, Sivan; Staudinger, Heribert; Amin, Nikhil; Ruddy, Marcella; Graham, Neil M. H.; Teper, Ariel			Dupilumab Suppresses Type 2 Biomarkers in Asthma Patients With and Without Comorbid Chronic Rhinosinusitis With or Without Nasal Polyposis (CRS/NP): Post Hoc Analysis of LIBERTY ASTHMA QUEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Maspero, Jorge F.] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina; [Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ford, Linda B.] Asthma & Allergy Ctr, Bellevue, NE USA; [Sher, Lawrence] Peninsula Res Associates, Rolling Hills Estate, CA USA; [Chipps, Bradley E.] Capital Allergy & Resp Dis Ctr, Sacramento, CA USA; [Peters, Anju T.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Peters, Anju T.] Northwestern Univ, Feinberg Sch Med, Sinus & Allergy Ctr, Chicago, IL 60611 USA; [Rice, Megan; Rowe, Paul; Staudinger, Heribert; Teper, Ariel] Sanofi, Bridgewater, NJ USA; [Lu, Yufang; Harel, Sivan; Amin, Nikhil; Ruddy, Marcella; Graham, Neil M. H.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Sanofi-Aventis; Regeneron									0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		296	AB98	AB98		10.1016/j.jaci.2018.12.299	http://dx.doi.org/10.1016/j.jaci.2018.12.299			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200293
J	Metcalfe, DD				Metcalfe, Dean D.			A personal perspective on mentoring	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Mentorship; mentoring; education; allergy; immunology; mast cells			[Metcalfe, Dean D.] NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, Bldg 10,Rm 11N244B,10 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Metcalfe, DD (corresponding author), NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, Bldg 10,Rm 11N244B,10 Ctr Dr, Bethesda, MD 20892 USA.	dmetcalfe@niaid.nih.gov			Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Akdis CA, 2017, J ALLERGY CLIN IMMUN, V140, P384, DOI 10.1016/j.jaci.2017.06.001; Austen KF, 2018, J ALLERGY CLIN IMMUN, V141, P880, DOI 10.1016/j.jaci.2018.01.004	2	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					548	549		10.1016/j.jaci.2018.10.002	http://dx.doi.org/10.1016/j.jaci.2018.10.002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30312707	Bronze			2022-12-18	WOS:000457718700010
J	Movsisyan, MR; Hakobyan, AV; Gambarov, SS				Movsisyan, Mariam R.; Hakobyan, Armine V.; Gambarov, Spartak S.			Pollen Food Allergy Syndrome (PFAS) Among Young Armenian Adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Movsisyan, Mariam R.; Hakobyan, Armine V.; Gambarov, Spartak S.] Yerevan State Med Univ, Yerevan, Armenia	Yerevan State Medical University									0	3	4	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		L37	AB433	AB433		10.1016/j.jaci.2018.12.981	http://dx.doi.org/10.1016/j.jaci.2018.12.981			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200965
J	Prunicki, M; Zhou, XY; Nadeau, K				Prunicki, Mary; Zhou, Xiaoying; Nadeau, Kari			The Impact of a Prescribed Burn versus a Wildfire on the Immune and Cardiovascular Systems of Children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Prunicki, Mary; Zhou, Xiaoying; Nadeau, Kari] Stanford Univ, Stanford, CA 94305 USA	Stanford University									0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		248	AB81	AB81						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200248
J	Riedl, MA; Anderson, JT; Cicardi, M; Li, HH; Lockey, RF; Longhurst, H; Maurer, M; Lu, P; Hao, J; Banerji, A				Riedl, Marc A.; Anderson, John T.; Cicardi, Marco; Li, H. Henry; Lockey, Richard F.; Longhurst, Hilary; Maurer, Marcus; Lu, Peng; Hao, James; Banerji, Aleena			Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Riedl, Marc A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Anderson, John T.] Clin Res Ctr Alabama, Birmingham, AL USA; [Cicardi, Marco] Univ Milan, Dept Biomed & Clin Sci, Luigi Sacco Hosp, ASST Fatebenefratelli Sacco, Milan, Italy; [Li, H. Henry] Inst Asthma & Allergy, Chevy Chase, MD USA; [Lockey, Richard F.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA; [Longhurst, Hilary] Cambridge Univ Hosp NHS Fdn Trust, Dept Immunol, Addenbrookes Hosp, Cambridge, England; [Longhurst, Hilary] Barts Hlth NHS Trust, Dept Immunol, London, England; [Maurer, Marcus] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany; [Lu, Peng; Hao, James] Shire, Lexington, MA USA; [Banerji, Aleena] Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, Boston, MA USA	University of California System; University of California San Diego; University of Milan; Luigi Sacco Hospital; State University System of Florida; University of South Florida; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Barts Health NHS Trust; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Shire Pharmaceuticals Limited; Harvard University; Harvard Medical School; Massachusetts General Hospital			Banerji, Aleena/ABG-1245-2021; Maurer, Marcus/ABG-2174-2020	Maurer, Marcus/0000-0002-4121-481X					0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		112	AB38	AB38						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200112
J	Wang, Y; Marier, JF; Kassir, N; Gosselin, NH; Martin, P				Wang, Yi; Marier, Jean-Francois; Kassir, Nastya; Gosselin, Nathalie H.; Martin, Patrick			Exposure-Response Analyses of Lanadelumab in Patients with Hereditary Angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Wang, Yi; Martin, Patrick] Shire, Lexington, MA USA; [Marier, Jean-Francois; Kassir, Nastya; Gosselin, Nathalie H.] Certara Strateg Consulting, Montreal, PQ, Canada	Shire Pharmaceuticals Limited			Kassir, Nastya/AAK-2491-2021	Kassir, Nastya/0000-0001-6193-2993					0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		120	AB41	AB41						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200120
J	Anagusko, CLY; Mendonca, J; Lopes, MM; Torres, P; Martins, CSF; Castro, FM; Wilson, JM; Yang, AC; Platts-Mills, TAE				Yonekura Anagusko, Claudia Leiko; Mendonca, Juliana; Lopes, Mariele Morandin; Torres, Pablo; Ferreira Martins, Catherine Sonaly; Castro, Fabio M.; Wilson, Jeffrey M.; Yang, Ariana C.; Platts-Mills, Thomas A. E.			Specific IgG4 to milk proteins during oral immunotherapy for milk allergy: relationship to eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Yonekura Anagusko, Claudia Leiko; Mendonca, Juliana; Lopes, Mariele Morandin; Ferreira Martins, Catherine Sonaly; Castro, Fabio M.; Yang, Ariana C.] Univ Sao Paulo, Hosp Clin, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Torres, Pablo] Univ Sao Paulo, Sao Paulo, Brazil; [Wilson, Jeffrey M.] Univ Virginia Hlth Syst, Div Asthma Allergy & Immunol, Charlottesville, VA USA; [Platts-Mills, Thomas A. E.] Univ Virginia, Charlottesville, VA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Virginia; University of Virginia			Castro, Fabio/AAP-5433-2020; Wilson, JM/AAD-6421-2020	Wilson, JM/0000-0002-5975-1760					0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		416	AB138	AB138						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200412
J	Zahirovi, A; Koren, A; Kopac, P; Strukelj, B; Korosec, P; Lunder, M				Zahirovi, Abida; Koren, Ana; Kopac, Peter; Strukelj, Borut; Korosec, Peter; Lunder, Mojca			Identification of bee venom Api m 1 IgE epitopes and characterization of corresponding mimotopes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HYMENOPTERA VENOM; IMMUNOGLOBULIN-E; ALLERGEN; IMMUNOTHERAPY; ANTIBODIES		[Zahirovi, Abida; Strukelj, Borut; Lunder, Mojca] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Koren, Ana; Kopac, Peter; Korosec, Peter] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia	University of Ljubljana; University Clinic Golnik	Lunder, M (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	mojca.lunder@ffa.uni-lj.si	Zahirovic, Abida/AAN-9626-2020	Zahirovic, Abida/0000-0001-9262-7553; Kopac, Peter/0000-0001-7261-6689	Slovenian Research Agency [P4-0127]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was financially supported by the Slovenian Research Agency through Research programme P4-0127.	dos Santos-Pinto JRA, 2015, J ALLERGY CLIN IMMUN, V135, P264, DOI 10.1016/j.jaci.2014.07.006; Dhami S, 2017, ALLERGY, V72, P342, DOI 10.1111/all.13077; Henry KA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00755; JUTEL M, 1995, J IMMUNOL, V154, P4187; Korosec P, 2009, CLIN EXP ALLERGY, V39, P1730, DOI 10.1111/j.1365-2222.2009.03347.x; Lunder M, 2005, APPL BIOCHEM BIOTECH, V127, P125, DOI 10.1385/ABAB:127:2:125; Luzar J, 2016, MOL IMMUNOL, V71, P176, DOI 10.1016/j.molimm.2016.02.004; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Molek P, 2016, ACTA CHIM SLOV, V63, P914, DOI 10.17344/acsi.2016.2458; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Niederberger V, 2018, J ALLERGY CLIN IMMUN, V142, P497, DOI 10.1016/j.jaci.2017.09.052; Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036; Rueff F, 2014, CLIN EXP ALLERGY, V44, P736, DOI 10.1111/cea.12275; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sturm GJ, 2009, INT ARCH ALLERGY IMM, V148, P261, DOI 10.1159/000161586	15	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					791	+		10.1016/j.jaci.2018.10.003	http://dx.doi.org/10.1016/j.jaci.2018.10.003			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30315830				2022-12-18	WOS:000457718700043
J	Chung, KF				Chung, Kian Fan			Shedding light on corticosteroid-resistant type 2-high severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; type 2 inflammation; corticosteroid resistance; eosinophils	INSENSITIVITY; INFLAMMATION		[Chung, Kian Fan] Imperial Coll London, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England; [Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, London, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital	Chung, KF (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426				Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Chang PJ, 2012, J ALLERGY CLIN IMMUN, V130, P877, DOI 10.1016/j.jaci.2012.07.017; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Peters MC, 2019, J ALLERGY CLIN IMMUN, V143, P104, DOI 10.1016/j.jaci.2017.12.1009; Phipatanakul W, 2017, AM J RESP CRIT CARE, V195, P1439, DOI 10.1164/rccm.201607-1453OC; Rossios C, 2018, J ALLERGY CLIN IMMUN, V141, P560, DOI 10.1016/j.jaci.2017.02.045; Seys SF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0524-y; ten Brinke A, 2004, AM J RESP CRIT CARE, V170, P601, DOI 10.1164/rccm.200404-440OC; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	10	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					89	90		10.1016/j.jaci.2018.11.002	http://dx.doi.org/10.1016/j.jaci.2018.11.002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30445061	Bronze			2022-12-18	WOS:000454918300012
J	Ha, SG; Dileepan, M; Ge, XN; Kang, BN; Greenberg, YG; Rao, A; Muralidhar, G; Medina-Kauwe, L; Thompson, MA; Pabelick, CM; O'Grady, SM; Rao, SP; Sriramarao, P				Ha, Sung Gil; Dileepan, Mythili; Ge, Xiao Na; Kang, Bit Na; Greenberg, Yana G.; Rao, Amrita; Muralidhar, Girija; Medina-Kauwe, Lali; Thompson, Michael A.; Pabelick, Christina M.; O'Grady, Scott M.; Rao, Savita P.; Sriramarao, P.			Knob protein enhances epithelial barrier integrity and attenuates airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Knob protein; adenoviral capsid; allergic airway inflammation; asthma; E-cadherin; occludin; airway epithelium; barrier integrity	RESPIRATORY SYNCYTIAL VIRUS; TIGHT JUNCTION INTEGRITY; HOUSE-DUST MITE; RHINOVIRUS INFECTION; MOUSE MODEL; ADENOVIRUS; RESPONSES; ALLERGEN; IL-33; DYSFUNCTION	Background: Altered epithelial physical and functional barrier properties along with T(H)1/T(H)2 immune dysregulation are features of allergic asthma. Regulation of junction proteins to improve barrier function of airway epithelial cells has the potential for alleviation of allergic airway inflammation. Objective: We sought to determine the immunomodulatory effect of knob protein of the adenoviral capsid on allergic asthma and to investigate its mechanism of action on airway epithelial junction proteins and barrier function. Methods: Airway inflammation, including junction protein expression, was evaluated in allergen-challenged mice with and without treatment with knob. Human bronchial epithelial cells were exposed to knob, and its effects on expression of junction proteins and barrier integrity were determined. Results: Administration of knob to allergen-challenged mice suppressed airway inflammation (eosinophilia, airway hyperresponsiveness, and IL-5 levels) and prevented allergen-induced loss of airway epithelial occludin and E-cadherin expression. Additionally, knob decreased expression of T(H)2-promoting inflammatory mediators, specifically IL-33, by murine lung epithelial cells. At a cellular level, treatment of human bronchial epithelial cells with knob activated c-Jun N-terminal kinase, increased expression of occludin and E-cadherin, and enhanced epithelial barrier integrity. Conclusion: Increased expression of junction proteins mediated by knob leading to enhanced epithelial barrier function might mitigate the allergen-induced airway inflammatory response, including asthma.	[Ha, Sung Gil; Dileepan, Mythili; Ge, Xiao Na; Kang, Bit Na; Greenberg, Yana G.; Rao, Amrita; Rao, Savita P.; Sriramarao, P.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [O'Grady, Scott M.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [O'Grady, Scott M.] Univ Minnesota, Dept Integrat Biol & Physiol, St Paul, MN 55108 USA; [Muralidhar, Girija] La Jolla Inst Mol Med, La Jolla, CA USA; [Medina-Kauwe, Lali] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Medina-Kauwe, Lali] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA; [Pabelick, Christina M.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA; [Pabelick, Christina M.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Sriramarao, P.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Kang, Bit Na] Abbvie Biores Ctr, Worcester, MA USA; [Rao, Amrita] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Muralidhar, Girija] A&M Consultancies, Poway, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; AbbVie; Medical College of Wisconsin	Sriramarao, P (corresponding author), 1971 Commonwealth Ave, St Paul, MN 55108 USA.	psrao@umn.edu		Rao, Srirama/0000-0001-9082-1029; Medina-Kauwe, Lali/0000-0002-9807-5523	University of Minnesota College of Veterinary Medicine; NATIONAL CANCER INSTITUTE [R01CA140995, R01CA129822] Funding Source: NIH RePORTER	University of Minnesota College of Veterinary Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the University of Minnesota College of Veterinary Medicine.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36; Adams WC, 2012, J GEN VIROL, V93, P1339, DOI 10.1099/vir.0.039222-0; Bahaie NS, 2012, J IMMUNOL, V188, P1479, DOI 10.4049/jimmunol.1102253; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Clarke DL, 2014, CLIN SCI, V126, P567, DOI 10.1042/CS20130149; Divekar R, 2015, CURR OPIN ALLERGY CL, V15, P98, DOI 10.1097/ACI.0000000000000133; Eneling K, 2012, FASEB J, V26, P3230, DOI 10.1096/fj.12-205609; Gangl K, 2015, INT ARCH ALLERGY IMM, V166, P291, DOI 10.1159/000430441; Ge XN, 2014, GLYCOBIOLOGY, V24, P715, DOI 10.1093/glycob/cwu035; Ge XN, 2013, EXP LUNG RES, V39, P365, DOI 10.3109/01902148.2013.829537; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Gern JE, 2015, ANN AM THORAC SOC, V12, pS137, DOI 10.1513/AnnalsATS.201503-153AW; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hay J, 2015, IMMUNOLOGY, V144, P453, DOI 10.1111/imm.12391; Heijink IH, 2014, CLIN EXP ALLERGY, V44, P620, DOI 10.1111/cea.12296; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Kato Y, 2009, BRIT J CANCER, V102, P898; Khaitov MR, 2014, HUM GENE THER, V25, P642, DOI 10.1089/hum.2013.142; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kubo T, 2015, J ALLERGY CLIN IMMUN, V136, P1413, DOI 10.1016/j.jaci.2015.05.006; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Leino MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071278; Loxham M, 2014, CLIN EXP ALLERGY, V44, P1299, DOI 10.1111/cea.12309; Marten E, 2015, J CELL COMMUN SIGNAL, V9, P207, DOI 10.1007/s12079-015-0299-1; Medina-Kauwe LK, 2000, BIOTECHNIQUES, V29, P602, DOI 10.2144/00293rr03; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Otterdal K, 2006, BLOOD, V108, P928, DOI 10.1182/blood-2005-09-010629; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Rezaee F, 2014, AM J RESP CELL MOL, V50, P857, DOI 10.1165/rcmb.2013-0541RT; Salmond RJ, 2012, J ALLERGY CLIN IMMUN, V130, P1159, DOI 10.1016/j.jaci.2012.05.018; Sasaki O, 2013, J IMMUNOL, V191, P2879, DOI 10.4049/jimmunol.1300460; Severson EA, 2010, BIOCHEM BIOPH RES CO, V397, P592, DOI 10.1016/j.bbrc.2010.05.164; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Stampfli MR, 1998, CLIN EXP ALLERGY, V28, P1581; Steelant B, 2016, J ALLERGY CLIN IMMUN, V137, P1043, DOI 10.1016/j.jaci.2015.10.050; Stewart Ceri E, 2012, J Allergy (Cairo), V2012, P943982, DOI 10.1155/2012/943982; Sugita K, 2018, J ALLERGY CLIN IMMUN, V141, P300, DOI 10.1016/j.jaci.2017.02.038; Suzuki M, 2000, HUM GENE THER, V11, P827, DOI 10.1089/10430340050015446; Tamanini A, 2006, J VIROL, V80, P11241, DOI 10.1128/JVI.00721-06; Tillie-Leblond I, 2007, EUR RESPIR J, V30, P31, DOI 10.1183/09031936.00011606; Tollefson A.E., 2007, METHODS MOL MED, V130, P223; Townsend EA, 2011, J PHARMACOL EXP THER, V339, P815, DOI 10.1124/jpet.111.184416; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yamaguchi H, 2010, AM J PATHOL, V177, P698, DOI 10.2353/ajpath.2010.091226; Yeo NK, 2010, LARYNGOSCOPE, V120, P346, DOI 10.1002/lary.20764; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450	57	3	3	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1808	+		10.1016/j.jaci.2018.01.049	http://dx.doi.org/10.1016/j.jaci.2018.01.049			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	29522849	Green Accepted			2022-12-18	WOS:000452315800016
J	Mason, P; Frigo, AC; Scarpa, MC; Maestrelli, P; Guarnieri, G				Mason, Paola; Frigo, Anna Chiara; Scarpa, Maria Cristina; Maestrelli, Piero; Guarnieri, Gabriella			Cluster analysis of occupational asthma caused by isocyanates	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PHENOTYPES; IDENTIFICATION		[Mason, Paola; Frigo, Anna Chiara; Scarpa, Maria Cristina; Maestrelli, Piero; Guarnieri, Gabriella] Univ Padua, Dept Cardiol Thorac & Vasc Sci, Padua, Italy	University of Padua	Maestrelli, P (corresponding author), Univ Padua, Dept Cardiol Thorac & Vasc Sci, Padua, Italy.	piero.maestrelli@unipd.it	MASON, PAOLA/AAE-9023-2019; Guarnieri, Gabriella/O-2537-2016	MASON, PAOLA/0000-0003-3941-6698; Guarnieri, Gabriella/0000-0003-3664-2024	Italian Ministry of Education, University and Research; University of Padova; Associazione Ricerca Cura Asma (ARCA), Padova, Italy	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova; Associazione Ricerca Cura Asma (ARCA), Padova, Italy	Supported by grants from the Italian Ministry of Education, University and Research; the University of Padova; and Associazione Ricerca Cura Asma (ARCA), Padova, Italy.	*CECA, 1971, TABL REF EX SPIR; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811; Lemiere C, 2014, J ALLERGY CLIN IMMUN, V134, P1063, DOI 10.1016/j.jaci.2014.08.017; MAESTRELLI P, 1994, CLIN EXP ALLERGY, V24, P29, DOI 10.1111/j.1365-2222.1994.tb00913.x; Mason P, 2017, J OCCUP ENVIRON MED, V59, P539, DOI 10.1097/JOM.0000000000001017; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Pollaris L, 2016, ARCH TOXICOL, V90, P1709, DOI 10.1007/s00204-015-1606-6; Poulsen R, 2013, 4472013 SAS GLOB FOR; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Wisnewski A., 2013, ASTHMA WORKPLACE, P262	11	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					2011	+		10.1016/j.jaci.2018.08.018	http://dx.doi.org/10.1016/j.jaci.2018.08.018			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30176276	Bronze			2022-12-18	WOS:000452315800045
J	Chinen, J; Cowan, MJ				Chinen, Javier; Cowan, Morton J.			Advances and highlights in primary immunodeficiencies in 2017	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunology; primary immunodeficiency; nuclear factor kappa B; autoimmunity; intravenous immunoglobulin; common variable immunodeficiency; severe combined immunodeficiency; newborn screening; gene therapy	CHRONIC GRANULOMATOUS-DISEASE; CARTILAGE-HAIR HYPOPLASIA; COMMON VARIABLE IMMUNODEFICIENCY; HEMATOPOIETIC-CELL TRANSPLANTATION; PROTEIN-LOSING ENTEROPATHY; INHERITED CD70 DEFICIENCY; 3-KINASE DELTA SYNDROME; X-LINKED CARRIERS; QUALITY-OF-LIFE; B-CELLS	This manuscript reviews selected topics in primary immunodeficiency diseases (PIDDs) published in 2017. These include (1) the role of follicular T cells in the differentiation of B cells and development of optimal antibody responses; (2) impaired nuclear factor kappa B subunit 1 signaling in the pathogenesis of common variable immunodeficiency, revealing an association between impaired B-cell maturation and development of inflammatory conditions; (3) autoimmune and inflammatory manifestations in patients with PIDDs in T- and B-cell deficiencies, as well as in neutrophil disorders; (4) newly described gene defects causing PIDDs, including exostosin-like 3 (EXTL3), TNF-alpha-induced protein 3 (TNFAIP3 [A20]), actin-related protein 2/3 complex-subunit 1B (ARPC1B), v-Rel avian reticuloendotheliosis viral oncogene homolog A (RELA), hypoxia upregulated 1 (HYOU1), BTB domain and CNC homolog 2 (BACH2), CD70, and CD55; (5) use of rapamycin and the phosphoinositide 3-kinase inhibitor leniolisib to reduce autoimmunity and regulate B-cell function in the activated phosphoinositide 3-kinase delta syndrome; (6) improved outcomes in hematopoietic stem cell transplantation for severe combined immunodeficiency (SCID) in the last decade, with an overall 2-year survival of 90% in part caused by early diagnosis through implementation of universal newborn screening; (7) demonstration of the efficacy of lentiviral vector-mediated gene therapy for patients with adenosine deaminase-deficient SCID; (8) the promise of gene editing for PIDDs using CRISPR/Cas9 and zinc finger nuclease technology for SCID and chronic granulomatous disease; and (9) the efficacy of thymus transplantation in Europe, although associated with an unexpected high incidence of autoimmunity. The remarkable progress in the understanding and management of PIDDs reflects the current interest in this area and continues to improve the care of immunodeficient patients.	[Chinen, Javier] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Allergy & Rheumatol Sect, Houston, TX 77030 USA; [Cowan, Morton J.] Univ Calif San Francisco, Benioff Childrens Hosp, Allergy Immunol & Blood & Marrow Transplant Div, San Francisco, CA 94143 USA	Baylor College of Medicine; University of California System; University of California San Francisco	Chinen, J (corresponding author), Baylor Coll Med, Pediat Allergy & Immunol, 17580 I-45 South,MOB 5th Floor, The Woodlands, TX 77384 USA.	jchinen@bcm.edu			NIH [U54 AI082973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI082973, R13AI094943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.J.C. receives partial funding from NIH grant U54 AI082973.	Abolhassani H, 2017, J EXP MED, V214, P91, DOI 10.1084/jem.20160849; Achour A, 2017, J ALLERGY CLIN IMMUN, V140, P215, DOI 10.1016/j.jaci.2016.09.042; Admiraal R, 2017, J ALLERGY CLIN IMMUN, V140, P1643, DOI 10.1016/j.jaci.2016.12.992; Aeschlimann FA, 2018, ANN RHEUM DIS, V77, P728, DOI 10.1136/annrheumdis-2017-212403; Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Aubert G, 2017, J ALLERGY CLIN IMMUN, V140, P1120, DOI 10.1016/j.jaci.2016.11.051; Badran YR, 2017, J EXP MED, V214, P1937, DOI 10.1084/jem.20160724; Bahrami E, 2017, J ALLERGY CLIN IMMUN, V140, P1112, DOI 10.1016/j.jaci.2016.10.053; Battersby AC, 2017, J ALLERGY CLIN IMMUN, V140, P628, DOI 10.1016/j.jaci.2017.02.029; Bogaert DJ, 2018, J ALLERGY CLIN IMMUN, V141, P432, DOI 10.1016/j.jaci.2017.08.019; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; Cooper AR, 2017, BLOOD, V129, P2624, DOI 10.1182/blood-2016-12-756734; Coulter TI, 2017, J ALLERGY CLIN IMMUN, V139, P597, DOI 10.1016/j.jaci.2016.06.021; Davies EG, 2017, J ALLERGY CLIN IMMUN, V140, P1660, DOI 10.1016/j.jaci.2017.03.020; de la Morena MT, 2017, J ALLERGY CLIN IMMUN, V139, P1282, DOI 10.1016/j.jaci.2016.07.039; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Rose DU, 2018, CLIN IMMUNOL, V191, P75, DOI 10.1016/j.clim.2018.03.005; Dunogue B, 2017, CLIN INFECT DIS, V64, P767, DOI 10.1093/cid/ciw837; Dvorak CC, 2017, BLOOD ADV, V1, P1694, DOI 10.1182/bloodadvances.2017010835; Fischer A, 2017, J ALLERGY CLIN IMMUN, V140, P1388, DOI 10.1016/j.jaci.2016.12.978; Florea AED, 2017, J ALLERGY CLIN IMMUN, V139, P1032, DOI 10.1016/j.jaci.2016.08.028; Gudmundsdottir J, 2017, J ALLERGY CLIN IMMUN, V140, P1743, DOI 10.1016/j.jaci.2017.08.002; Guo L, 2017, J HUM GENET, V62, P797, DOI 10.1038/jhg.2017.38; Haapaniemi EM, 2017, J ALLERGY CLIN IMMUN, V139, P1391, DOI 10.1016/j.jaci.2016.09.050; Heimall J, 2017, BLOOD, V130, P2718, DOI 10.1182/blood-2017-05-781849; Hoshino A, 2017, J ALLERGY CLIN IMMUN, V140, P223, DOI 10.1016/j.jaci.2016.09.029; Hosokawa J, 2017, J ALLERGY CLIN IMMUN, V140, P288, DOI 10.1016/j.jaci.2016.10.047; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Izawa K, 2017, J EXP MED, V214, P73, DOI 10.1084/jem.20160784; Jogdand GM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00520; Kadowaki T, 2018, J ALLERGY CLIN IMMUN, V141, P1485, DOI 10.1016/j.jaci.2017.10.039; Kahr WHA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14816; Karasartova D, 2017, J CLIN IMMUNOL, V37, P388, DOI 10.1007/s10875-017-0397-3; Kaustio M, 2017, J ALLERGY CLIN IMMUN, V140, P782, DOI 10.1016/j.jaci.2016.10.054; Keller B, 2017, J ALLERGY CLIN IMMUN, V139, P220, DOI 10.1016/j.jaci.2016.04.043; Kostjukovits S, 2017, J ALLERGY CLIN IMMUN, V140, P612, DOI 10.1016/j.jaci.2017.02.016; Kostjukovits S, 2017, J MED GENET, V54, P365, DOI 10.1136/jmedgenet-2016-104279; Kostjukovits S, 2017, J ALLERGY CLIN IMMUN, V139, P375, DOI 10.1016/j.jaci.2016.07.023; Kuehn HS, 2016, NEW ENGL J MED, V374, P1032, DOI 10.1056/NEJMoa1512234; Kuijpers TW, 2017, J ALLERGY CLIN IMMUN, V140, P273, DOI 10.1016/j.jaci.2016.09.061; Kurolap A, 2017, NEW ENGL J MED, V377, P87, DOI 10.1056/NEJMc1707173; Lougaris V, 2017, J ALLERGY CLIN IMMUN, V139, P349, DOI 10.1016/j.jaci.2016.05.045; Lownik JC, 2017, J IMMUNOL, V199, P2305, DOI 10.4049/jimmunol.1700833; Ma CS, 2016, J CLIN IMMUNOL, V36, pS40, DOI 10.1007/s10875-016-0257-6; Maccari ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00543; Marciano BE, 2018, J ALLERGY CLIN IMMUN, V141, P365, DOI 10.1016/j.jaci.2017.04.035; Marciano BE, 2017, J ALLERGY CLIN IMMUN, V140, P622, DOI 10.1016/j.jaci.2017.02.026; Miot C, 2017, BLOOD, V130, P1456, DOI 10.1182/blood-2017-03-771600; Mortari EP, 2017, J ALLERGY CLIN IMMUN, V139, P1981, DOI 10.1016/j.jaci.2016.10.014; Moutsopoulos NM, 2017, NEW ENGL J MED, V376, P1141, DOI 10.1056/NEJMoa1612197; Nademi Z, 2017, J ALLERGY CLIN IMMUN, V139, P1046, DOI 10.1016/j.jaci.2016.09.040; Oud MM, 2017, AM J HUM GENET, V100, P281, DOI 10.1016/j.ajhg.2017.01.013; Ovadia A, 2017, J ALLERGY CLIN IMMUN, V140, P1199, DOI 10.1016/j.jaci.2017.05.007; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Pattarini L, 2017, J EXP MED, V214, P1529, DOI 10.1084/jem.20150402; Picard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9; Punwani D, 2017, HUM GENE THER, V28, P112, DOI 10.1089/hum.2016.064; Rao VK, 2017, BLOOD, V130, P2307, DOI 10.1182/blood-2017-08-801191; Rider NL, 2017, J CLIN IMMUNOL, V37, P461, DOI 10.1007/s10875-017-0404-8; Rowe JH, 2017, J ALLERGY CLIN IMMUN, V140, P1739, DOI 10.1016/j.jaci.2017.08.001; Schiroli G, 2017, SCI TRANSL MED, P9; Shaw KL, 2017, J CLIN INVEST, V127, P1689, DOI 10.1172/JCI90367; Silva SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180385; Silva SL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00020; Skendros P, 2017, J ALLERGY CLIN IMMUN, V140, P1378, DOI 10.1016/j.jaci.2017.02.021; Somech R, 2017, J IMMUNOL, V199, P4036, DOI 10.4049/jimmunol.1700460; Stray-Pedersen A, 2017, J ALLERGY CLIN IMMUN, V139, P232, DOI 10.1016/j.jaci.2016.05.042; Sultan S, 2017, J CLIN IMMUNOL, V37, P496, DOI 10.1007/s10875-017-0409-3; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; Sweeney CL, 2017, HUM GENE THER, V28, P565, DOI 10.1089/hum.2017.005; Sweeney CL, 2017, MOL THER, V25, P321, DOI 10.1016/j.ymthe.2016.11.012; Tabellini G, 2017, J ALLERGY CLIN IMMUN, V140, P553, DOI 10.1016/j.jaci.2016.10.051; Takagi M, 2017, J ALLERGY CLIN IMMUN, V139, P1914, DOI 10.1016/j.jaci.2016.09.038; Tuijnenburg P, 2018, J ALLERGY CLIN IMMUN, V142, P1285, DOI 10.1016/j.jaci.2018.01.039; Vargas-Hernandez A, 2018, J ALLERGY CLIN IMMUN, V141, P2142, DOI 10.1016/j.jaci.2017.08.040; Vento-Tormo R, 2017, J ALLERGY CLIN IMMUN, V139, P202, DOI 10.1016/j.jaci.2016.05.016; Volpi S, 2017, J EXP MED, V214, P623, DOI 10.1084/jem.20161525; Weinacht KG, 2017, J ALLERGY CLIN IMMUN, V139, P1629, DOI 10.1016/j.jaci.2016.11.022; Widdrington JD, 2017, J ALLERGY CLIN IMMUN, V140, P1461, DOI 10.1016/j.jaci.2017.04.048; Wolach B, 2017, AM J HEMATOL, V92, P28, DOI 10.1002/ajh.24573; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	82	3	3	2	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1041	1051		10.1016/j.jaci.2018.08.016	http://dx.doi.org/10.1016/j.jaci.2018.08.016			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	30170128	Bronze, Green Accepted			2022-12-18	WOS:000446327300003
J	Dose, J; Schloesser, A; Torres, GG; Venkatesh, G; Hasler, R; Flachsbart, F; Lieb, W; Nebel, A; Rimbach, G; Huebbe, P				Dose, Janina; Schloesser, Anke; Torres, Guillermo G.; Venkatesh, Geetha; Haesler, Robert; Flachsbart, Friederike; Lieb, Wolfgang; Nebel, Almut; Rimbach, Gerald; Huebbe, Patricia			On a Western diet, APOE epsilon 4 is associated with low innate immune sensing, but not APOE epsilon 3	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MODULATION; GENOTYPE; OBESITY; WEIGHT		[Dose, Janina; Schloesser, Anke; Rimbach, Gerald; Huebbe, Patricia] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [Dose, Janina; Torres, Guillermo G.; Venkatesh, Geetha; Haesler, Robert; Flachsbart, Friederike; Nebel, Almut] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Campus Kiel, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Epidemiol, Campus Kiel, Kiel, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Huebbe, P (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany.	huebbe@foodsci.uni-kiel.de	Torres, Guillermo G/AAR-1965-2021; Rimbach, Gerald/A-7178-2011; Lieb, Wolfgang/AAC-7650-2022; Häsler, Robert/A-4908-2009; Nebel, Almut/E-4196-2010	Torres, Guillermo G/0000-0002-4548-7815; Rimbach, Gerald/0000-0001-7888-4684; Häsler, Robert/0000-0003-4174-8229; 	Deutsche Forschungsgemeinschaft (German Research Foundation) research training program "Genes, Environment and Inflammation'' [GRK 1743/1]; EpiHealth project [FP7-HEALTH-2011-278418]; German Federal Ministry of Education and Research [01EY1103]	Deutsche Forschungsgemeinschaft (German Research Foundation) research training program "Genes, Environment and Inflammation''; EpiHealth project; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	J.D. was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) research training program "Genes, Environment and Inflammation'' (grant no. GRK 1743/1). The recruitment of study population 2 was conducted within the framework of the EpiHealth project (FP7-HEALTH-2011-278418) with the help of the PopGen Biobank (Kiel, Germany); the PopGen 2.0 network is supported by the German Federal Ministry of Education and Research (grant no. 01EY1103).	Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Azevedo OGR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089562; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Gale SC, 2014, J ALLERGY CLIN IMMUN, V134, P127, DOI 10.1016/j.jaci.2014.01.032; Hubacek JA, 2010, HUM IMMUNOL, V71, P304, DOI 10.1016/j.humimm.2010.01.008; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Slim KE, 2017, FASEB J, V31, P989, DOI 10.1096/fj.201600921RR	9	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1346	+		10.1016/j.jaci.2018.05.033	http://dx.doi.org/10.1016/j.jaci.2018.05.033			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29928926	hybrid			2022-12-18	WOS:000446327300035
J	Emi-Sugie, M; Toyama, S; Matsuda, A; Saito, H; Matsumoto, K				Emi-Sugie, Maiko; Toyama, Sumika; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji			IL-33 induces functional CCR7 expression in human mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALLERGEN-SPECIFIC IMMUNOTHERAPY; EXTRACT; GRASS		[Emi-Sugie, Maiko; Toyama, Sumika; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan; [Toyama, Sumika] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Tokyo, Japan	National Center for Child Health & Development - Japan; Juntendo University	Matsumoto, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan.	matsumoto-k@ncchd.go.jp		Saito, Hirohisa/0000-0002-6630-8337	National Institute of Biomedical Innovation [ID10-43]; National Center for Child Health and Development [26-46, 26-9]	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grants from the National Institute of Biomedical Innovation (grant no. ID10-43 to K.M.) and from the National Center for Child Health and Development (grant no. 26-46 to M.E.-S. and grant no. 26-9 to K.M.).	Amar SM, 2009, J ALLERGY CLIN IMMUN, V124, P150, DOI 10.1016/j.jaci.2009.04.037; Bachert Claus, 1996, Rhinology (Utrecht), V34, P140; Cox LS, 2017, J ALLER CL IMM-PRACT, V5, P58, DOI 10.1016/j.jaip.2016.11.009; Guest IC, 2015, LAB INVEST, V95, P886, DOI 10.1038/labinvest.2015.72; Hylander T, 2013, J ALLERGY CLIN IMMUN, V131, P412, DOI 10.1016/j.jaci.2012.10.056; Joulia R, 2017, J ALLERGY CLIN IMMUN, V140, P497, DOI 10.1016/j.jaci.2016.09.049; Juniper EF, 1999, J ALLERGY CLIN IMMUN, V104, P364, DOI 10.1016/S0091-6749(99)70380-5; Klimek L, 2005, OTOLARYNG HEAD NECK, V133, P538, DOI 10.1016/j.otohns.2005.07.020; Larenas-Linnemann D, 2008, ANN ALLERG ASTHMA IM, V100, P137, DOI 10.1016/S1081-1206(10)60422-X; LAROCCA LM, 1989, ANN ALLERGY, V63, P508; Mburu YK, 2012, J BIOL CHEM, V287, P3581, DOI 10.1074/jbc.M111.294876; Morita H, 2015, IMMUNITY, V43, P175, DOI 10.1016/j.immuni.2015.06.021; Nakajima T, 2004, J ALLERGY CLIN IMMUN, V113, P528, DOI 10.1016/j.jaci.2003.12.036; Pfaar O, 2011, INT ARCH ALLERGY IMM, V154, P336, DOI 10.1159/000321826; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105	18	3	3	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1341	+		10.1016/j.jaci.2018.06.007	http://dx.doi.org/10.1016/j.jaci.2018.06.007			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29928923	Bronze			2022-12-18	WOS:000446327300033
J	Marenholz, I; Grosche, S; Ruschendorf, F; Kalb, B; Blumchen, K; Schlags, R; Harandi, N; Price, M; Hansen, G; Seidenberg, J; Yurek, S; Homuth, G; Schmidt, CO; Nothen, MM; Hubner, N; Niggemann, B; Beyer, K; Lee, YA				Marenholz, Ingo; Grosche, Sarah; Rueschendorf, Franz; Kalb, Birgit; Blumchen, Katharina; Schlags, Rupert; Harandi, Neda; Price, Mareike; Hansen, Gesine; Seidenberg, Juergen; Yuerek, Songuel; Homuth, Georg; Schmidt, Carsten O.; Noethen, Markus M.; Hubner, Norbert; Niggemann, Bodo; Beyer, Kirsten; Lee, Young-Ae			Evaluation of food allergy candidate loci in the Genetics of Food Allergy study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA; ASSOCIATION; COCKROACH; WHEEZE; MOUSE; OXIDE		[Marenholz, Ingo; Grosche, Sarah; Rueschendorf, Franz; Kalb, Birgit; Lee, Young-Ae] Max Delbruck Ctr MDC Mol Med, Berlin, Germany; [Marenholz, Ingo; Grosche, Sarah; Kalb, Birgit; Lee, Young-Ae] MDC, Expt & Clin Res Ctr, Clin Pediat Allergy, Berlin, Germany; [Marenholz, Ingo; Rueschendorf, Franz; Kalb, Birgit; Lee, Young-Ae] Charite Univ Med Berlin, Berlin, Germany; [Kalb, Birgit; Niggemann, Bodo] Charite Univ Med Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany; [Blumchen, Katharina] Univ Hosp Frankfurt, Dept Paediat & Adolescent Med, Paediat Pneumol Allergol & Cyst Fibrosis, Frankfurt, Germany; [Schlags, Rupert; Harandi, Neda; Beyer, Kirsten] Wangen Hosp, Dept Pediat Pneumol & Allergol, Wangen Im Allgau, Germany; [Price, Mareike; Hansen, Gesine] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany; [Hansen, Gesine] German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Seidenberg, Juergen] Carl von Ossietzky Univ Oldenburg, Dept Pediat Pneumol & Allergol Neonatol & Intens, Med Campus, Oldenburg, Germany; [Homuth, Georg] Univ Med, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Greifswald, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Schmidt, Carsten O.] Univ Med Greifswald, Inst Community Med, Study Hlth Pomerania KEF, Greifswald, Germany; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hannover Medical School; Carl von Ossietzky Universitat Oldenburg; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Bonn; University of Bonn	Lee, YA (corresponding author), Max Delbruck Ctr MDC Mol Med, Berlin, Germany.; Lee, YA (corresponding author), MDC, Expt & Clin Res Ctr, Clin Pediat Allergy, Berlin, Germany.; Lee, YA (corresponding author), Charite Univ Med Berlin, Berlin, Germany.	yolee@mdc-berlin.de	Schmidt, Carsten Oliver/AAH-2778-2019; Grosche, Sarah/ABA-8480-2021	Schmidt, Carsten Oliver/0000-0001-5266-9396; Kalb, Birgit/0000-0002-3104-6736; Yurek, Songul/0000-0002-5725-0612	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03IS2061A, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	The Study of Health in Pomerania is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants nos. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania, and the network Greifswald Approach to Individualized Medicine (GANI_MED) funded by the Federal Ministry of Education and Research (grant no. 03IS2061A). Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012).	Asai Y, 2018, J ALLERGY CLIN IMMUN, V141, P991, DOI 10.1016/j.jaci.2017.09.015; Chang Carolyn, 2010, Clin Mol Allergy, V8, P11, DOI 10.1186/1476-7961-8-11; Cornell AG, 2012, J EXPO SCI ENV EPID, V22, P258, DOI 10.1038/jes.2012.3; Donohue KM, 2008, J ALLERGY CLIN IMMUN, V122, P914, DOI 10.1016/j.jaci.2008.08.034; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; Johnson EO, 2013, HUM GENET, V132, P509, DOI 10.1007/s00439-013-1266-7; Mainardi TR, 2013, PEDIATRICS, V131, pE127, DOI 10.1542/peds.2012-1072; Marenholz I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01220-0; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Olmedo O, 2011, J ALLERGY CLIN IMMUN, V128, P284, DOI 10.1016/j.jaci.2011.02.044; Perzanowski MS, 2008, J ALLERGY CLIN IMMUN, V122, P213, DOI 10.1016/j.jaci.2008.03.030; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rittenour WR, 2012, J ENVIRON MONITOR, V14, P766, DOI 10.1039/c2em10779a; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Sicherer SH, 2000, J ALLERGY CLIN IMMUN, V106, P53, DOI [10.1067/mai.2000.108105, 10.1067/mai.2000.110158]; Tamerius JD, 2013, WEATHER CLIM SOC, V5, P168, DOI 10.1175/WCAS-D-12-00030.1; The New York City Community Air Survey, 2011, RES YEAR ON MON 2008; Ullemar V, 2016, ALLERGY, V71, P230, DOI 10.1111/all.12783; Vesper S, 2007, J OCCUP ENVIRON MED, V49, P829, DOI 10.1097/JOM.0b013e3181255e98	20	3	3	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1368	+		10.1016/j.jaci.2018.06.019	http://dx.doi.org/10.1016/j.jaci.2018.06.019			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29969633	Bronze			2022-12-18	WOS:000446327300043
J	Ballas, ZK				Ballas, Zuhair K.			Asthma clinical practice guidelines: Time for an update	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergy/immunology			[Ballas, Zuhair K.] Univ Iowa, Div Immunol, Iowa City, IA USA; [Ballas, Zuhair K.] Iowa City VA, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Ballas, ZK (corresponding author), Univ Iowa, Div Immunol, GH, C42-E13,200 Hawkins Dr, Iowa City, IA 52242 USA.	ballasz@uiowa.edu		Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230	Veterans Administration; National Institutes of Health	Veterans Administration(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Z. K. Ballas serves as a consultant for Checkmate Pharmaceutical and the Immune Deficiency Foundation, receives grant support from the Veterans Administration and the National Institutes of Health, and has received royalties from UpToDate.	Asthma G.I.F, 2017, GLOB STRAT ASTHM MAN; Mensah GA, 2018, J ALLERGY CLIN IMMUN, V142, P744, DOI 10.1016/j.jaci.2018.07.004; National Heart Lung and Blood Advisory Council Asthma Expert Working Group, 2014, 3 NAT HEART LUNG BLO; National Institute for Health and Care Excellence, ASTHM DIAGN MON CHRO; Szefler SJ, 2018, J ALLERGY CLIN IMMUN, V142, P773, DOI 10.1016/j.jaci.2018.03.010	5	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					787	787		10.1016/j.jaci.2018.07.008	http://dx.doi.org/10.1016/j.jaci.2018.07.008			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	30053530	Bronze			2022-12-18	WOS:000443726500009
J	Bloodworth, MH; Rusznak, M; Bastarache, L; Wang, J; Denny, JC; Peebles, RS				Bloodworth, Melissa H.; Rusznak, Mark; Bastarache, Lisa; Wang, Janey; Denny, Joshua C.; Peebles, R. Stokes, Jr.			Association of ST2 polymorphisms with atopy, asthma, and leukemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							STRATUM-CORNEUM; CYTOKINES		[Bloodworth, Melissa H.; Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Rusznak, Mark; Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Bastarache, Lisa; Wang, Janey; Denny, Joshua C.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Peebles, RS (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.; Peebles, RS (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA.	stokes.peebles@vanderbilt.edu	Denny, Josh/AAL-3359-2021	Denny, Josh/0000-0002-3049-7332; Wang, Janey/0000-0002-3052-4812	Vanderbilt Medical Scientist Training Program [T32 GM07347]; Vanderbilt Clinical and Translational Science Award [ULTR000445];  [R01 AI 124456];  [U19 AI 095227];  [R01 AI 111820];  [2I01BX000624];  [F30 AI118376];  [R01 LM 010685]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124456, F30AI118376, U19AI095227, R01AI111820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000624, I01BX004299] Funding Source: NIH RePORTER	Vanderbilt Medical Scientist Training Program; Vanderbilt Clinical and Translational Science Award; ; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grant numbers R01 AI 124456, U19 AI 095227, R01 AI 111820, and 2I01BX000624 to R.S.P.; grant number T32 GM07347 from Vanderbilt Medical Scientist Training Program; grant number F30 AI118376 to M.H.B.; grant number ULTR000445 from Vanderbilt Clinical and Translational Science Award; and grant number R01 LM 010685 to J.C.D.	de Jongh CM, 2007, SKIN RES TECHNOL, V13, P390, DOI 10.1111/j.1600-0846.2007.00242.x; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Griesenauer B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00475; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Kezic S, 2012, J ALLERGY CLIN IMMUN, V129, P1031, DOI 10.1016/j.jaci.2011.12.989; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Levescot A, 2014, CANCER RES, V74, P2669, DOI 10.1158/0008-5472.CAN-13-2797; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Peine M, 2016, TRENDS IMMUNOL, V37, P321, DOI 10.1016/j.it.2016.03.007; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888	11	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					991	+		10.1016/j.jaci.2018.03.020	http://dx.doi.org/10.1016/j.jaci.2018.03.020			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29787780	Bronze, Green Accepted			2022-12-18	WOS:000443726500035
J	Gandhi, VD; Palikhe, NS; Hamza, SM; Dyck, JRB; Buteau, J; Vliagoftis, H				Gandhi, Vivek D.; Palikhe, Nami Shrestha; Hamza, Shereen M.; Dyck, Jason R. B.; Buteau, Jean; Vliagoftis, Harissios			Insulin decreases expression of the proinflammatory receptor proteinase-activated receptor-2 on human airway epithelial cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							OBESITY; ASTHMA		[Gandhi, Vivek D.; Palikhe, Nami Shrestha; Vliagoftis, Harissios] Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada; [Gandhi, Vivek D.; Palikhe, Nami Shrestha; Vliagoftis, Harissios] Univ Alberta, Alberta Resp Ctr, Edmonton, AB, Canada; [Hamza, Shereen M.; Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Ctr, Dept Pediat, Edmonton, AB, Canada; [Buteau, Jean] Univ Alberta, Li Ka Shing Ctr, Alberta Diabet Inst, Edmonton, AB, Canada; [Buteau, Jean] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Vliagoftis, H (corresponding author), Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada.; Vliagoftis, H (corresponding author), Univ Alberta, Alberta Resp Ctr, Edmonton, AB, Canada.	harissios.vliagoftis@ualberta.ca	Gandhi, Vivek Dipak/N-1030-2017	Gandhi, Vivek/0000-0003-4561-7277; Dyck, Jason/0000-0002-7045-2884; Shrestha, Nami/0000-0002-9456-1145	Canadian Institutes of Health Research (CIHR); Lung Association of Alberta and Northwest Territories; CIHR; Diabetes Canada; Respiratory Health Strategic Clinical Network	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta and Northwest Territories; CIHR(Canadian Institutes of Health Research (CIHR)); Diabetes Canada; Respiratory Health Strategic Clinical Network	Supported by grants from the Canadian Institutes of Health Research (CIHR) and the Lung Association of Alberta and Northwest Territories (to H.V.) and from CIHR and Diabetes Canada (to J.R.B.D.). V.D.G. received studentships from the Lung Association of Alberta and Northwest Territories and the Respiratory Health Strategic Clinical Network.	Asaduzzaman M, 2015, CLIN EXP ALLERGY, V45, P1844, DOI 10.1111/cea.12628; Baffi CW, 2016, CHEST, V149, P1525, DOI 10.1016/j.chest.2015.12.034; Husemoen LLN, 2008, ALLERGY, V63, P575, DOI 10.1111/j.1398-9995.2007.01613.x; Hyun E, 2011, CRIT REV IMMUNOL, V31, P307, DOI 10.1615/CritRevImmunol.v31.i4.30; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Loffredo LF, 2017, ALLERGY, V72, P1988, DOI 10.1111/all.13222; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Shore SA, 2007, J APPL PHYSIOL, V102, P516, DOI 10.1152/japplphysiol.00847.2006; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022	9	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					1003	+		10.1016/j.jaci.2018.04.040	http://dx.doi.org/10.1016/j.jaci.2018.04.040			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29890235	Bronze			2022-12-18	WOS:000443726500039
J	Ku, M; Ke, E; Sabouri-Ghomi, M; Abadejos, JR; Freeman, B; Nham, A; Phillips, N; Yang, KY; Lui, KO; Kirak, O				Ku, Manching; Ke, Eugene; Sabouri-Ghomi, Mohsen; Abadejos, Justin R.; Freeman, Brent; Nham, Amy; Phillips, Nathaniel; Yang, Kevin Y.; Lui, Kathy O.; Kirak, Oktay			Deconstructive somatic cell nuclear transfer reveals novel regulatory T-cell subsets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FRAMEWORK		[Ku, Manching; Kirak, Oktay] Univ Freiburg, Fac Med, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Freiburg, Germany; [Ke, Eugene] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Sabouri-Ghomi, Mohsen; Abadejos, Justin R.; Freeman, Brent; Nham, Amy; Phillips, Nathaniel; Kirak, Oktay] Scripps Res Inst, La Jolla, CA 92037 USA; [Yang, Kevin Y.; Lui, Kathy O.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Yang, Kevin Y.; Lui, Kathy O.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	University of Freiburg; Salk Institute; Scripps Research Institute; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ku, M; Kirak, O (corresponding author), Univ Freiburg, Fac Med, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Freiburg, Germany.; Kirak, O (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	manching.ku@uniklinik-freiburg.de; oktay.kirak@uniklinik-freiburg.de	Kirak, Oktay/H-6347-2013; Yang, Kevin/AAA-2623-2021; Lui, Kathy/AAC-8303-2020; Lui, Kathy O./E-4883-2015	Kirak, Oktay/0000-0002-6524-4685; Yang, Kevin/0000-0002-4200-745X; Lui, Kathy/0000-0002-1616-3643; Lui, Kathy O./0000-0002-1616-3643; Abadejos, Justin/0000-0001-8271-627X	The Scripps Research Institute start up fund; National Cancer Institute of the National Institutes of Health [T32CA009370]; NATIONAL CANCER INSTITUTE [T32CA009370] Funding Source: NIH RePORTER	The Scripps Research Institute start up fund; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by The Scripps Research Institute start up fund (O.K.) and the National Cancer Institute of the National Institutes of Health under award number T32CA009370 (E.K.).	Cardiero G, 2017, INT J BIOCHEM CELL B, V91, P212, DOI 10.1016/j.biocel.2017.07.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2012, J CLIN IMMUNOL, V32, P238, DOI 10.1007/s10875-011-9621-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drummond RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005293; Du XX, 2018, CELL RES, V28, P416, DOI 10.1038/s41422-018-0011-0; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kirak Oktay, 2010, J Vis Exp, DOI 10.3791/2168; Kirak O, 2010, SCIENCE, V328, P243, DOI 10.1126/science.1178590; Ku MC, 2016, P NATL ACAD SCI USA, V113, pE2316, DOI 10.1073/pnas.1523664113; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	23	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					997	+		10.1016/j.jaci.2018.04.038	http://dx.doi.org/10.1016/j.jaci.2018.04.038			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29857010	Green Accepted, Bronze			2022-12-18	WOS:000443726500037
J	Platts-Mills, TAE				Platts-Mills, Thomas A. E.			The continuing effect of the discovery of IgE by Kimishige Ishizaka	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							INDUCED ANAPHYLAXIS; ANTIBODY		[Platts-Mills, Thomas A. E.] Univ Virginia, Div Allergy & Immunol, Charlottesville, VA USA	University of Virginia	Platts-Mills, TAE (corresponding author), Univ Virginia, Div Allergy & Immunol, UVA Asthma Allergy & Immunol, POB 801355, Charlottesville, VA 22908 USA.	tap2z@virginia.edu		Platts-Mills, Thomas/0000-0002-1263-329X	National Institutes of Health [R37-AI-20565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grant R37-AI-20565.	Brockow K, 2015, J ALLERGY CLIN IMMUN, V135, P977, DOI 10.1016/j.jaci.2014.08.024; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Hilger C, 1997, ALLERGY, V52, P179, DOI 10.1111/j.1398-9995.1997.tb00972.x; ISHIZAKA K, 1966, J IMMUNOL, V97, P840; Ishizaka K, 2016, J ALLERGY CLIN IMMUN, V137, P1646, DOI 10.1016/j.jaci.2015.12.1343; Johansson SGO, 2016, J ALLERGY CLIN IMMUN, V137, P1671, DOI 10.1016/j.jaci.2016.04.004; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; PORTER RR, 1973, SCIENCE, V180, P713, DOI 10.1126/science.180.4087.713; PRAUSNITZ C, 1921, ZBL BAKT           1, V86, P160; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040	10	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					788	789		10.1016/j.jaci.2018.07.017	http://dx.doi.org/10.1016/j.jaci.2018.07.017			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	30075153	Bronze			2022-12-18	WOS:000443726500010
J	Kuo, HC; Lo, CC; Lin, PX; Kao, CC; Huang, YH; Lin, BS				Kuo, Ho-Chang; Lo, Chi-Chun; Lin, Pin-Xing; Kao, Chien-Chun; Huang, Ying-Hsien; Lin, Bor-Shyh			Wireless optical monitoring system identifies limb induration characteristics in patients with Kawasaki disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Kuo, Ho-Chang; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Huang, Ying-Hsien] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lo, Chi-Chun] Natl Chiao Tung Univ, Inst Elect & Control Engn, Hsinchu, Taiwan; [Lin, Pin-Xing; Kao, Chien-Chun; Lin, Bor-Shyh] Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Hsinchu, Taiwan; [Lo, Chi-Chun] Chang Gung Mem Hosp, Dept Engn & Maintenance, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Lin, BS (corresponding author), Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Hsinchu, Taiwan.	borshyhlin@gmail.com	Lin, Bor-Shyh/GYJ-0198-2022; Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Lin, Bor-Shyh/0000-0002-8653-2571				Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dietz SM, 2017, EUR J PEDIATR, V176, P995, DOI 10.1007/s00431-017-2937-5; Huang YH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040820; Huang YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050715; Kawasaki T., 2002, PEDIAT INFECT DIS, V21, P38; Kuo HC, 2017, BIOMED J, V40, P141, DOI 10.1016/j.bj.2017.04.002; Menke J, 2014, PEDIATR CARDIOL, V35, P155, DOI 10.1007/s00246-013-0754-9; Oshima S, 2011, IEEE T INF TECHNOL B, V15, P356, DOI 10.1109/TITB.2011.2116797	9	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					710	711		10.1016/j.jaci.2018.04.018	http://dx.doi.org/10.1016/j.jaci.2018.04.018			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29729939	Bronze			2022-12-18	WOS:000440664400046
J	Maroof, A; Patel, DD				Maroof, Asher; Patel, Dhavalkumar D.			TNF-alpha-induced protein 3 (A20): The immunological rheostat	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						TNF-alpha; A20; TNFAIP3; anti-TNF; IL-17; T cells	POTENT; IL-17		UCB Biopharma, New Med, Braine Lalleud, Belgium; UCB Biopharma, New Med, Slough, Berks, England		Patel, DD (corresponding author), UCB Biopharma, Chemin Foriest, B-1420 Braine Lalleud, Belgium.	dhaval.patel@ucb.com						[Anonymous], 1999, Neurology, V53, P457; Conrad C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02466-4; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Hull DN, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1197-5; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Mihara K, 2008, BRIT J PHARMACOL, V154, P153, DOI 10.1038/bjp.2008.53; Miller PG, 2015, J IMMUNOL, V195, P2633, DOI 10.4049/jimmunol.1500286; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Stoffel E, 2018, BRIT J DERMATOL, V178, P1151, DOI 10.1111/bjd.16126; Urbano PCM, 2018, J ALLERGY CLIN IMMUN, V142, P517, DOI 10.1016/j.jaci.2017.11.024; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	12	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					401	402		10.1016/j.jaci.2018.05.020	http://dx.doi.org/10.1016/j.jaci.2018.05.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29859964	Bronze			2022-12-18	WOS:000440664400007
J	Ferguson, AE; Fulkerson, PC				Ferguson, Anna E.; Fulkerson, Patricia C.			Eosinophilic esophagitis: Time to classify into endotypes?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Eosinophilic esophagitis; children; IgG(4) antibodies; assays; cow's milk; molecular allergens			[Ferguson, Anna E.] Univ Cincinnati, Coll Med, Dept Pediat,Div Gastroenterol Hepatol & Nutr, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Fulkerson, Patricia C.] Univ Cincinnati, Coll Med, Dept Pediat,Div Allergy & Immunol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Fulkerson, PC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,ML7028, Cincinnati, OH 45229 USA.	patricia.fulkerson@cchmc.org			National Institutes of Health; Knopp Biosciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knopp Biosciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	P. C. Fulkerson has received grants from the National Institutes of Health, has served as a consultant for Genentech, and has received research funding from Knopp Biosciences. A. E. Ferguson declares that she has no relevant conflicts of interest.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Arias A, 2014, GASTROENTEROLOGY, V146, P1639, DOI 10.1053/j.gastro.2014.02.006; Cheng Katherine, 2017, Transl Sci Rare Dis, V2, P141, DOI 10.3233/TRD-170016; Clayton F, 2014, GASTROENTEROLOGY, V147, P602, DOI 10.1053/j.gastro.2014.05.036; Ferguson AE, 2017, CLIN REV ALLERGY IMM; Lucendo AJ, 2017, UNITED EUR GASTROENT, V5, P335, DOI 10.1177/2050640616689525; Lynch KL, 2016, DIS ESOPHAGUS, V29, P174, DOI 10.1111/dote.12307; Petroni D, 2018, ANN ALLERG ASTHMA IM, V120, P237, DOI 10.1016/j.anai.2017.11.016; Schuyler AJ, 2018, J ALLERGY CLIN IMMUN, V142, P139, DOI 10.1016/j.jaci.2018.02.049; Unutmaz D, 2015, PLOS ONE, V10	10	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					71	72		10.1016/j.jaci.2018.04.025	http://dx.doi.org/10.1016/j.jaci.2018.04.025			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29751005	Bronze, Green Accepted			2022-12-18	WOS:000437837500010
J	Su, WR; Han, LH; Chen, XQ; Yu, JF; Cheng, XK; Huang, JW; Xiao, YC; Tian, YZ; Olsen, N; Zheng, SG; Liang, D				Su, Wenru; Han, Longhui; Chen, Xiaoqing; Yu, Jianfeng; Cheng, Xiaokang; Huang, Jingwen; Xiao, Yichen; Tian, Yunzhe; Olsen, Nancy; Zheng, Song Guo; Liang, Dan			Pharmacological inhibition of caspase-8 suppresses inflammation-induced lymphangiogenesis and allograft rejection in the cornea	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INFLAMMASOMES		[Su, Wenru; Han, Longhui; Chen, Xiaoqing; Yu, Jianfeng; Cheng, Xiaokang; Huang, Jingwen; Xiao, Yichen; Tian, Yunzhe; Liang, Dan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Han, Longhui] Hebei Prov Eye Hosp, Hebei Prov Eye Inst, Hebei Prov Key Lab Ophthalmol, Xingtai, Hebei, Peoples R China; [Olsen, Nancy; Zheng, Song Guo] Penn State Univ, Hershey Coll Med, Dept Med, Div Rheumatol, Hershey, PA 17033 USA; [Zheng, Song Guo] Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Clin Immunol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Sun Yat Sen University	Zheng, SG (corresponding author), Penn State Univ, Hershey Coll Med, Dept Med, Div Rheumatol, Hershey, PA 17033 USA.; Zheng, SG (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Clin Immunol, Guangzhou, Guangdong, Peoples R China.	songguozheng2013@yahoo.com; liangdan@gzzoc.com	chen, xia/GYR-3948-2022; Xiao, Yichen/GZS-8066-2022; chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022	Su, Wenru/0000-0002-0506-6362	National Key R&D Program of China [2017YFA0105800]; Natural Science Foundation of China [81470670, 81670897, U1601226]; Guangdong Natural Science Funds for Distinguished Young Scholar [2016A030306006]; Science and technology cooperation project of Hong Kong, Macao and Taiwan [2015DFH30190]; Zhu Jiang Star of Science and Technology Foundation in Guangzhou [201610010129]; Program from Guangdong Introducing Innovative Teams [2016ZT06S252]	National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholar; Science and technology cooperation project of Hong Kong, Macao and Taiwan; Zhu Jiang Star of Science and Technology Foundation in Guangzhou; Program from Guangdong Introducing Innovative Teams	This study was supported by the National Key R&D Program of China (grant no. 2017YFA0105800), the Natural Science Foundation of China (grant nos. 81470670, 81670897, and U1601226), Guangdong Natural Science Funds for Distinguished Young Scholar (grant no. 2016A030306006); Science and technology cooperation project of Hong Kong, Macao and Taiwan (grant no. 2015DFH30190); the Zhu Jiang Star of Science and Technology Foundation in Guangzhou (grant no. 201610010129); and Program from Guangdong Introducing Innovative Teams (grant no. 2016ZT06S252).	Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; de Torre-Minguela C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00043; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liu ZM, 2013, IMMUNOL REV, V252, P183, DOI 10.1111/imr.12038; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC	17	3	3	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					290	294		10.1016/j.jaci.2018.02.005	http://dx.doi.org/10.1016/j.jaci.2018.02.005			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29477723				2022-12-18	WOS:000437837500034
J	Suzuki, K; Nakai, A				Suzuki, Kazuhiro; Nakai, Akiko			Immune modulation by neuronal electric shock waves	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Neural regulation of immunity; cholinergic anti-inflammatory pathway; vagus nerve stimulation; electroceuticals	VAGUS NERVE-STIMULATION; DISEASE; PATHWAY		[Suzuki, Kazuhiro; Nakai, Akiko] Osaka Univ, Lab Immune Response Dynam, WPI Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan; [Suzuki, Kazuhiro] Osaka Univ, Dept Mol Immunol, Microbial Dis Res Inst, Suita, Osaka, Japan	Osaka University; Osaka University	Suzuki, K (corresponding author), Osaka Univ, Lab Immune Response Dynam, WPI Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ksuzuki@ifrec.osaka-u.ac.jp		Suzuki, Kazuhiro/0000-0002-9081-538X	Japan Society for the Promotion of Science [JP15H05656, JP 16K19154]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15H05656] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	K.S. is supported by grants from the Japan Society for the Promotion of Science (JP15H05656) and the Takeda Science Foundation. A.N. is supported by a grant from the Japan Society for the Promotion of Science (JP 16K19154).	Bonaz B, 2017, J INTERN MED, V282, P46, DOI 10.1111/joim.12611; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Martelli D, 2014, J PHYSIOL-LONDON, V592, P1677, DOI 10.1113/jphysiol.2013.268573; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Yuan HK, 2016, HEADACHE, V56, P71, DOI 10.1111/head.12647	10	3	4	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2022	2023		10.1016/j.jaci.2018.02.027	http://dx.doi.org/10.1016/j.jaci.2018.02.027			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29522847	Bronze			2022-12-18	WOS:000434701600008
J	Becker, SC; Szyska, M; Mensen, A; Hellwig, K; Otto, R; Olfe, L; Volk, HD; Dorner, T; Dorken, B; Scheibenbogen, C; Schroder, J; Hocke, AC; Na, IK				Becker, Sonya C.; Szyska, Martin; Mensen, Angela; Hellwig, Katharina; Otto, Raik; Olfe, Lisa; Volk, Hans-Dieter; Doerner, Thomas; Doerken, Bernd; Scheibenbogen, Carmen; Schroeder, Jorg; Hocke, Andreas C.; Na, Il-Kang			A comparative analysis of human bone marrow-resident and peripheral memory B cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							T-CELLS; DEFENSIN		[Becker, Sonya C.; Mensen, Angela; Olfe, Lisa; Volk, Hans-Dieter; Scheibenbogen, Carmen] Charit Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Becker, Sonya C.; Mensen, Angela; Hellwig, Katharina; Olfe, Lisa; Volk, Hans-Dieter; Doerken, Bernd; Scheibenbogen, Carmen; Hocke, Andreas C.; Na, Il-Kang] Free Univ Berlin, Berlin, Germany; [Becker, Sonya C.; Mensen, Angela; Hellwig, Katharina; Olfe, Lisa; Volk, Hans-Dieter; Doerken, Bernd; Scheibenbogen, Carmen; Hocke, Andreas C.; Na, Il-Kang] Humboldt Univ, Berlin, Germany; [Becker, Sonya C.; Mensen, Angela; Hellwig, Katharina; Olfe, Lisa; Volk, Hans-Dieter; Doerken, Bernd; Scheibenbogen, Carmen; Hocke, Andreas C.; Na, Il-Kang] Berlin Inst Hlth, Berlin, Germany; [Szyska, Martin; Na, Il-Kang] Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany; [Hellwig, Katharina; Hocke, Andreas C.] Charite Univ Med Berlin, Dept Internal Med Infect Dis & Resp Med, Berlin, Germany; [Otto, Raik] Humboldt Univ, Inst Comp Sci, Berlin, Germany; [Olfe, Lisa; Doerken, Bernd; Na, Il-Kang] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany; [Volk, Hans-Dieter; Na, Il-Kang] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Doerner, Thomas] German Arthrit Res Ctr, Berlin, Germany; [Schroeder, Jorg] Charite CVK, Dept Accid & Reconstruct Surg, Berlin, Germany; [Na, Il-Kang] Berlin Inst Hlth, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Na, IK (corresponding author), Free Univ Berlin, Berlin, Germany.; Na, IK (corresponding author), Humboldt Univ, Berlin, Germany.; Na, IK (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Na, IK (corresponding author), Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany.; Na, IK (corresponding author), Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany.; Na, IK (corresponding author), Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.; Na, IK (corresponding author), Berlin Inst Hlth, Berlin, Germany.	il-kang.na@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Scheibenbogen, Carmen/0000-0002-8554-9638; Na, Il-Kang/0000-0001-9902-5424; Otto, Raik/0000-0003-3644-743X	Else Kroner-Fresenius Foundation [EKFS 2013_A187]; Berliner Krebsgesellschaft [LOPS201604]; German Research Foundation [DFG SFB-TR84]; Bundesministerium fur Bildung und Forschung (BMBF) [031A426C]; Deutsche Forschungsgemeinschaft (DFG) [Do491/7-3, Do491/7-4, Do491/8-1, Do491/8-2]; Stiftung Charite; Berlin Institute of Health (BIH)	Else Kroner-Fresenius Foundation; Berliner Krebsgesellschaft; German Research Foundation(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stiftung Charite; Berlin Institute of Health (BIH)	This work was supported by the Else Kroner-Fresenius Foundation (grant no. EKFS 2013_A187), by the Berliner Krebsgesellschaft (grant no. LOPS201604 to L.O.), partly by the German Research Foundation (grant nos. DFG SFB-TR84, B6, and Z1a to A.C.H.), by the Bundesministerium fur Bildung und Forschung (BMBF) (with the MAPTor-NET-demonstrator research grant 031A426C), by the Deutsche Forschungsgemeinschaft (DFG) (projects Do491/7-3,4 and Do491/8-1,2), by the Stiftung Charite, and by the Berlin Institute of Health (BIH).	Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Giesecke C, 2014, J IMMUNOL, V192, P3091, DOI 10.4049/jimmunol.1302783; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Morel E, 2011, ALLERGY, V66, P360, DOI 10.1111/j.1398-9995.2010.02484.x; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; PANYUTICH AV, 1995, AM J RESP CELL MOL, V12, P351, DOI 10.1165/ajrcmb.12.3.7873202; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	12	3	3	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1911	+		10.1016/j.jaci.2017.12.983	http://dx.doi.org/10.1016/j.jaci.2017.12.983			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29355676	Bronze			2022-12-18	WOS:000432148200042
J	Lind, C; Skaarup, SH; Lorentz, A; Hoffmann, HJ				Lind, Cecilie; Skaarup, Soren Helbo; Lorentz, Axel; Hoffmann, Hans Jurgen			Basophil testing with CD63 in pollen-sensitized patients is independent of the circadian clock	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							REACTIVITY; EXPRESSION		[Lind, Cecilie; Skaarup, Soren Helbo; Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark; [Lorentz, Axel] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany; [Hoffmann, Hans Jurgen] Aarhus Univ, Dept Clin Med, Aarhus Univ Hosp, Aarhus, Denmark	Aarhus University; University Hohenheim; Aarhus University	Hoffmann, HJ (corresponding author), Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark.; Hoffmann, HJ (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus Univ Hosp, Aarhus, Denmark.	hjh@clin.au.dk	Hoffman, Hans Jurgen/I-6969-2018	Hoffman, Hans Jurgen/0000-0002-6743-7931; Skaarup, Soren/0000-0001-7975-7441	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	C. Lind has received a grant and travel support from the Lundbeck Foundation. The rest of the authors declare that they have no relevant conflicts of interest.	Ando N, 2015, ALLERGY, V70, P319, DOI 10.1111/all.12552; Baumann A, 2016, ANN ALLERG ASTHMA IM, V116, P77, DOI 10.1016/j.anai.2015.10.004; Baumann A, 2013, IMMUNOLOGY, V140, P465, DOI 10.1111/imm.12157; DEVRIES K, 1962, INT ARCH ALLER A IMM, V20, P93, DOI 10.1159/000229248; Glaumann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053465; Hoffmann HJ, 2015, ALLERGY, V70, P1393, DOI 10.1111/all.12698; Litinski M, 2009, SLEEP MED CLIN, V4, P143, DOI 10.1016/j.jsmc.2009.02.005; MacGlashan D, 2010, CLIN EXP ALLERGY, V40, P1365, DOI 10.1111/j.1365-2222.2010.03572.x; VICHYANOND P, 1989, J ALLERGY CLIN IMMUN, V83, P1101, DOI 10.1016/0091-6749(89)90452-1	9	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1906	1908		10.1016/j.jaci.2017.10.048	http://dx.doi.org/10.1016/j.jaci.2017.10.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29330012				2022-12-18	WOS:000432148200040
J	St John, AL; Ang, WXG; Rathore, APS; Abraham, SN				St John, Ashley L.; Ang, W. X. Gladys; Rathore, Abhay P. S.; Abraham, Soman N.			Reprograming immunity to food allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MAJOR PEANUT ALLERGEN; ORAL IMMUNOTHERAPY		[St John, Ashley L.; Abraham, Soman N.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore, Singapore; [St John, Ashley L.] Natl Univ Singapore, Dept Microbiol & Immunol, Singapore, Singapore; [St John, Ashley L.; Rathore, Abhay P. S.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Ang, W. X. Gladys; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA	National University of Singapore; National University of Singapore; Duke University; Duke University; Duke University	Abraham, SN (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore, Singapore.; Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA.	soman.abraham@duke.edu	Rathore, Abhay PS/ABF-7352-2020; StJohn, Ashley/AAE-4378-2021	Rathore, Abhay PS/0000-0003-2039-2964; StJohn, Ashley/0000-0001-5098-1044; Ang, Wei Xin Gladys/0000-0002-9105-0550	US National Institutes of Health [R01 AI96305, R01 AI35678, 18 R01 DK077159, R01 AI50021, R37 DK50814, R21 AI056101]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI056101, R01AI096305, R01AI050021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050814, R01DK077159] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by US National Institutes of Health grants R01 AI96305, R01 AI35678, 18 R01 DK077159, R01 AI50021, R37 DK50814, and R21 AI056101.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Berglund JP, 2017, J ALLER CL IMM-PRACT, V5, P1098, DOI 10.1016/j.jaip.2016.11.034; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; Helm RM, 2000, CURR OPIN IMMUNOL, V12, P647, DOI 10.1016/S0952-7915(00)00157-6; John ALS, 2012, NAT MATER, V11, P250, DOI [10.1038/NMAT3222, 10.1038/nmat3222]; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; KIND LS, 1955, J IMMUNOL, V74, P387; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Tabar AI, 2011, J ALLERGY CLIN IMMUN, V127, P57, DOI 10.1016/j.jaci.2010.10.025; Thyagarajan A, 2010, J ALLERGY CLIN IMMUN, V126, P31, DOI 10.1016/j.jaci.2010.05.012	12	3	3	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1936	+		10.1016/j.jaci.2018.01.020	http://dx.doi.org/10.1016/j.jaci.2018.01.020			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29421275	Bronze, Green Accepted			2022-12-18	WOS:000432148200052
J	Gevaert, E; Yousefi, S; Bachert, C; Simon, HU				Gevaert, Elien; Yousefi, Shida; Bachert, Claus; Simon, Hans-Uwe			Lytic eosinophils produce extracellular DNA traps as well as free eosinophil granules Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							APOPTOSIS; RELEASE		[Gevaert, Elien; Bachert, Claus] Univ Ghent, Upper Airways Res Lab, Fac Med, Ghent, Belgium; [Yousefi, Shida; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland	Ghent University; University of Bern	Simon, HU (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.	hans-uwe.simon@pki.unibe.ch	Yousefi, Shida/AAU-7986-2020; Bachert, Claus/J-8825-2012; Yousefi, Shida/L-9689-2016; Simon, Hans-Uwe/AAU-7410-2020; Simon, Hans-Uwe/AAU-5079-2020	Yousefi, Shida/0000-0002-9855-4305; Yousefi, Shida/0000-0002-9855-4305; Simon, Hans-Uwe/0000-0002-9404-7736; 				Amini P, 2016, EUR J IMMUNOL, V46, P178, DOI 10.1002/eji.201545615; Gevaert E, 2017, J ALLERGY CLIN IMMUN, V139, P1849, DOI 10.1016/j.jaci.2017.01.019; Persson C, 2018, J ALLERGY CLIN IMMUN, V141, P1164, DOI 10.1016/j.jaci.2017.05.047; Radonjic-Hoesli S, 2017, J ALLERGY CLIN IMMUN, V140, P1632, DOI 10.1016/j.jaci.2017.01.044; Simon HU, 1997, J IMMUNOL, V158, P3902; Ueki S, 2013, BLOOD, V121, P2074, DOI 10.1182/blood-2012-05-432088; Uller L, 2004, AM J RESP CRIT CARE, V170, P742, DOI 10.1164/rccm.200402-240OC; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Yousefi S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00328	9	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1164	1165		10.1016/j.jaci.2017.05.048	http://dx.doi.org/10.1016/j.jaci.2017.05.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	28780969	Bronze			2022-12-18	WOS:000426974800049
J	Kim, HK; Kim, JH; Kim, HJ; Kim, TH; Lee, SH				Kim, Ha Kyun; Kim, Jae Hyeong; Kim, Hyun Jung; Kim, Tae Hoon; Lee, Sang Hag			Role of TWIK-related potassium channel-1 in chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SMOOTH-MUSCLE-CELLS; REVERSES CORTICOSTEROID INSENSITIVITY; INHIBITION; PATHWAY		[Kim, Ha Kyun; Kim, Jae Hyeong; Kim, Hyun Jung; Kim, Tae Hoon; Lee, Sang Hag] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lee, SH (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	sanghag@kumc.or.kr						Armstrong J, 2011, J PHARMACOL EXP THER, V338, P732, DOI 10.1124/jpet.111.180737; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602; Hamilos DL, 2015, J ALLERGY CLIN IMMUN, V136, P1454, DOI 10.1016/j.jaci.2015.10.011; Hammaker D, 2010, ANN RHEUM DIS, V69, P77, DOI 10.1136/ard.2009.119479; Huang H, 2016, CELL MOL IMMUNOL, V13, P110, DOI 10.1038/cmi.2014.137; Jiang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09191; Knobloch J, 2013, J PHARMACOL EXP THER, V346, P290, DOI 10.1124/jpet.112.202358; Knobloch J, 2013, AM J RESP CELL MOL, V49, P114, DOI 10.1165/rcmb.2012-0287OC; Knobloch J, 2010, J PHARMACOL EXP THER, V335, P788, DOI 10.1124/jpet.110.166843; Kobayashi Y, 2013, BRIT J PHARMACOL, V169, P1024, DOI 10.1111/bph.12187; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Mercado N, 2011, MOL PHARMACOL, V80, P1128, DOI 10.1124/mol.111.071993; Mercado N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041582; Norman P, 2014, EXPERT OPIN THER PAT, V24, P1397, DOI 10.1517/13543776.2014.967213; O'Connell AD, 2002, BBA-BIOMEMBRANES, V1566, P152, DOI 10.1016/S0005-2736(02)00597-7; Rossios C, 2012, BRIT J PHARMACOL, V167, P775, DOI 10.1111/j.1476-5381.2012.01864.x; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shimomura A, 1997, LARYNGOSCOPE, V107, P1519, DOI 10.1097/00005537-199711000-00018; Singh D, 2013, THORAX, V68, P705, DOI 10.1136/thoraxjnl-2013-203498; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624	25	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1124	+		10.1016/j.jaci.2017.10.012	http://dx.doi.org/10.1016/j.jaci.2017.10.012			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	29103993	Bronze			2022-12-18	WOS:000426974800034
J	Antonevich, N; Hancharou, A; Buschik, O; Rydna, A; Chekan, V; Strinkevich, E; Dubuske, L				Antonevich, N.; Hancharou, Andrei; Buschik, O.; Rydna, A.; Chekan, V.; Strinkevich, E.; Dubuske, Lawrence			Human Olfactory Mucosa-Derived Mesenchymal Stem Cells Suppress Cytotoxic Functions of CD8+T-Lymphocytes and Natural Killer Cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Joint Congress of the American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization (AAAAI/WAO)	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Antonevich, N.; Hancharou, Andrei; Buschik, O.; Rydna, A.] Republican Res & Pract Ctr Epidemiol & Microbiol, Minsk, BELARUS; [Chekan, V.; Strinkevich, E.] State Educ Inst Belarusian Med Acad Postgrad Educ, Minsk, BELARUS; [Dubuske, Lawrence] Immunol Res Inst New England, Gardner, MA USA; [Dubuske, Lawrence] George Washington Univ, Sch Med, Washington, DC USA	George Washington University			DuBuske, Lawrence/AAV-3402-2020; Hancharou, Andrei/AAJ-2385-2021						0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		384	AB122	AB122		10.1016/j.jaci.2017.12.387	http://dx.doi.org/10.1016/j.jaci.2017.12.387			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700383
J	Chau, AS; Jongco, AM				Chau, Alice S.; Jongco, Artemio M.			Allergic and Immunologic Dysregulation in Ehlers-Danlos Syndrome: A Case Series	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Chau, Alice S.] Hofstra Northwell Sch Med, Manhasset, NY USA; [Jongco, Artemio M.] Hofstra Northwell Sch Med, Great Neck, NY USA	Northwell Health; Northwell Health			Jongco, Artemio/AAB-2168-2021						0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		395	AB125	AB125		10.1016/j.jaci.2017.12.398	http://dx.doi.org/10.1016/j.jaci.2017.12.398			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700394
J	Choudhary, S; Jerath, MR; Commins, SP				Choudhary, Shivangi; Jerath, Maya R.; Commins, Scott P.			Venom allergy is increased in alpha-gal allergy: shared environmental or immunologic factors?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Joint Congress of the American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization (AAAAI/WAO)	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Choudhary, Shivangi] Univ N Carolina, Chapel Hill, NC USA; [Jerath, Maya R.; Commins, Scott P.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine									0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		627	AB199	AB199		10.1016/j.jaci.2017.12.631	http://dx.doi.org/10.1016/j.jaci.2017.12.631			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700626
J	Flayer, CH; Ge, MQ; Tompkins, DG; Juarez, M; Miller, L; Royer, CM; Morrissey, BM; Kenyon, NJ; Haczku, A				Flayer, Cameron H.; Ge, Moyar Qing; Tompkins, Daniel G.; Juarez, Maya; Miller, Lisa; Royer, Christopher M.; Morrissey, Brian M.; Kenyon, Nicholas J.; Haczku, Angela			Group 2 innate lymphoid cells display ILC3-like functional plasticity in asthmatics and non-human primates	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Flayer, Cameron H.; Ge, Moyar Qing; Tompkins, Daniel G.; Juarez, Maya; Miller, Lisa; Royer, Christopher M.; Morrissey, Brian M.; Kenyon, Nicholas J.; Haczku, Angela] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis									0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		3	AB1	AB1		10.1016/j.jaci.2017.12.004	http://dx.doi.org/10.1016/j.jaci.2017.12.004			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700004
J	Harris, KM; Kneale, D; Lasserson, T; McDonald, V; Thomas, J; Grigg, J				Harris, Kate M.; Kneale, Dylan; Lasserson, Toby; McDonald, Vanessa; Thomas, James; Grigg, Jonathan			School-based self-management educational interventions for asthma in children and adolescents: A systematic review	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Harris, Kate M.; Grigg, Jonathan] Queen Mary Univ London, London, England; [Kneale, Dylan] UCL Inst Educ, London, England; [Lasserson, Toby] Cochrane Editorial Unit, London, England; [McDonald, Vanessa] Sch Nursing & Midwifery, Newcastle, NSW, Australia; [Thomas, James] EPPI Ctr, London, England	University of London; Queen Mary University London; University of London; University College London; UCL Institute of Education; University of London; University College London; UCL Institute of Education			MCDONALD, VANESSA/AAQ-1845-2020	MCDONALD, VANESSA/0000-0001-9890-3408					0	3	3	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		649	AB207	AB207		10.1016/j.jaci.2017.12.654	http://dx.doi.org/10.1016/j.jaci.2017.12.654			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX					2022-12-18	WOS:000429306700648
J	Iweala, OI; Savage, PB; Commins, SP				Iweala, Onyinye I.; Savage, Paul B.; Commins, Scott P.			A Role for CD1d-restricted Invariant Natural Killer T Cells and Glycolipids in Alpha-Gal Allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Iweala, Onyinye I.; Commins, Scott P.] Univ N Carolina, Chapel Hill, NC USA; [Savage, Paul B.] Brigham Young Univ, Provo, UT 84602 USA	University of North Carolina; University of North Carolina Chapel Hill; Brigham Young University			Savage, Paul B/HGB-3414-2022; Savage, Paul B/E-1448-2011; Iweala, Onyinye/AAZ-2427-2020; Iweala, Onyinye/I-4016-2019	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; Iweala, Onyinye/0000-0001-7470-7904; 					0	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		913	AB288	AB288		10.1016/j.jaci.2017.12.918	http://dx.doi.org/10.1016/j.jaci.2017.12.918			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700909
J	Kaye, L; Hoch, H; Szefler, SJ; Anderson, W; Barrett, M; Van Sickle, D; Stempel, DA				Kaye, Leanne; Hoch, Heather; Szefler, Stanley J.; Anderson, William; Barrett, Meredith; Van Sickle, David; Stempel, David A.			Real-Life Patterns of Asthma Controller Use Vary by Age, Time of Day and Season	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Kaye, Leanne; Barrett, Meredith; Stempel, David A.] Propeller Hlth, San Francisco, CA USA; [Hoch, Heather; Szefler, Stanley J.] Univ Colorado, Sch Med, Aurora, CO USA; [Hoch, Heather; Szefler, Stanley J.] Univ Colorado, Childrens Hosp Colorado, Aurora, CO USA; [Anderson, William] Univ Colorado, Sch Med, Allergy Sect, Aurora, CO USA; [Anderson, William] Childrens Hosp Colorado, Aurora, CO USA; [Van Sickle, David] Propeller Hlth, Madison, WI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado									0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		193	AB61	AB61		10.1016/j.jaci.2017.12.195	http://dx.doi.org/10.1016/j.jaci.2017.12.195			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700193
J	Lajunen, TK; Jaakkola, JJK; Jaakkola, MS				Lajunen, Taina K.; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.			IL6 polymorphisms modify the effects of smoking on the risk of adult asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SKIN PRICK TESTS; INTERLEUKIN-6; ALLERGY; INFLAMMATION		[Lajunen, Taina K.; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.] Univ Oulu, Ctr Environm & Resp Hlth Res CERH, Oulu, Finland; [Lajunen, Taina K.; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Lajunen, Taina K.; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.] Univ Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Jaakkola, JJK (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res CERH, Oulu, Finland.; Jaakkola, JJK (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.; Jaakkola, JJK (corresponding author), Univ Oulu, Oulu, Finland.	Jouni.Jaakkola@oulu.fi	Jaakkola, Jouni J.K./G-4314-2012; Lajunen, Taina K/J-7337-2013	Lajunen, Taina K/0000-0001-8012-457X; Jaakkola, Maritta S./0000-0003-1373-7784; Jaakkola, Jouni/0000-0003-4168-4683	Academy of Finland [138691, 266314, 129419]; SALVE Program; Ministry of Social Affairs and Health [STM/1523/2012]; University of Oulu; Scientific Advisory Board for Defense (MATINE) of the Ministry of Defense of Finland	Academy of Finland(Academy of Finland); SALVE Program; Ministry of Social Affairs and Health; University of Oulu; Scientific Advisory Board for Defense (MATINE) of the Ministry of Defense of Finland	Supported by the Academy of Finland (grant nos. 138691, 266314, and 129419), the SALVE Program (http://www.aka.fi/en GB/A/), the Ministry of Social Affairs and Health (grant no. STM/1523/2012; http://www.stm.fi/en/frontpage), and the University of Oulu Strategic Funding for CERH. The CIAS study was partly supported by the Scientific Advisory Board for Defense (MATINE) of the Ministry of Defense of Finland.	Antunes J, 2009, ALLERGOL IMMUNOPATH, V37, P155, DOI 10.1016/S0301-0546(09)71728-8; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bousquet J, 2012, ALLERGY, V67, P18, DOI 10.1111/j.1398-9995.2011.02728.x; Hatzis G, 2014, INT J CARDIOL, V176, P254, DOI 10.1016/j.ijcard.2014.06.058; Howard R, 1996, PEDIATR DERMATOL, V13, P246, DOI 10.1111/j.1525-1470.1996.tb01212.x; Johansen JD, 2015, CONTACT DERMATITIS, V73, P195, DOI 10.1111/cod.12432; Lajunen TK, 2016, GENES IMMUN, V17, P193, DOI 10.1038/gene.2016.8; Li FW, 2015, INT J CLIN EXP MED, V8, P12601; Piipari R, 2004, EUR RESPIR J, V24, P734, DOI 10.1183/09031936.04.00116903; Potaczek DP, 2014, INT J CARDIOL, V170, P278, DOI 10.1016/j.ijcard.2013.11.029; Ramasamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044008; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Vonk JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172716	13	3	3	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					799	+		10.1016/j.jaci.2017.09.011	http://dx.doi.org/10.1016/j.jaci.2017.09.011			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28987812	Green Accepted, Bronze			2022-12-18	WOS:000424410800044
J	Mabelane, T; Botha, M; Thomas, HF; Levin, M				Mabelane, Tshegofatso; Botha, Maresa; Thomas, Heidi Facey; Levin, Michael			Alpha Gal Allergy in rural black African subjects associated with a high prevalence of abdominal manifestations and a more rapid onset of symptoms	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Mabelane, Tshegofatso] Univ Cape Town, Polokwane, South Africa; [Botha, Maresa; Thomas, Heidi Facey] Univ Cape Town, Cape Town, South Africa; [Levin, Michael] Univ Cape Town, Dept Paediat & Child Hlth, Div Allergy, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town			Levin, Michael/AAT-2370-2020	Levin, Michael/0000-0003-2439-7981					0	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		629	AB200	AB200		10.1016/j.jaci.2017.12.633	http://dx.doi.org/10.1016/j.jaci.2017.12.633			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700628
J	Maridet, C; Perromat, M; Miquel, J; Chiaverini, C; Bessis, D; Lasek, A; Piram, M; Bursztejn, AC; Abasq, C; Phan, A; Martin, L; Brechat, B; Chong, JH; Seneschal, J; Taieb, A; Boralevi, F				Maridet, Claire; Perromat, Martin; Miquel, Juliette; Chiaverini, Christine; Bessis, Didier; Lasek, Audrey; Piram, Maryam; Bursztejn, Anne-Claire; Abasq, Claire; Phan, Alice; Martin, Ludovic; Brechat, Berenice; Chong, Jin Ho; Seneschal, Julien; Taieb, Alain; Boralevi, Franck			Childhood chronic prurigo: Interest in patch tests and delayed-reading skin prick tests to environmental allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LIFE		[Maridet, Claire; Perromat, Martin; Chong, Jin Ho; Seneschal, Julien; Taieb, Alain; Boralevi, Franck] Hop Pellegrin Enfants, Pediat Dermatol Unit, Bordeaux, France; [Brechat, Berenice] Bordeaux Univ Hosp, Dept Publ Hlth & Stat, Bordeaux, France; [Miquel, Juliette] St Pierre Univ Hosp, Dept Dermatol, St Pierre, La Reunion, France; [Chiaverini, Christine] Nice Univ Hosp, Dept Dermatol, Nice, France; [Bessis, Didier] Montpellier Univ Hosp, Dept Dermatol, Montpellier, France; [Lasek, Audrey] Lille Univ Hosp, Dept Dermatol, Lille, France; [Piram, Maryam] Hop Bicetre, Dept Dermatol, Le Kremlin Bicetre, France; [Bursztejn, Anne-Claire] Nancy Univ Hosp, Dept Dermatol, Nancy, France; [Abasq, Claire] Brest Univ Hosp, Dept Dermatol, Brest, France; [Phan, Alice] Claude Bernard Lyon 1 Univ, Pediat Dermatol Unit, Lyon, France; [Phan, Alice] Hop Femme Mere Enfant, Hosp Civils Lyon, Lyon, France; [Martin, Ludovic] Angers Univ Hosp, Dept Dermatol, Angers, France	CHU Bordeaux; CHU Bordeaux; CHU Nice; Universite de Montpellier; CHU de Montpellier; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU de Nancy; CHU Brest; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Maridet, C (corresponding author), Hop Pellegrin Enfants, Pediat Dermatol Unit, Bordeaux, France.	clairemaridet@gmail.com	TAIEB, ALAIN/AAB-1085-2021; Piram, Maryam/GOH-1774-2022	Didier, Bessis/0000-0002-3815-5417				Boralevi F, 2014, J EUR ACAD DERMATOL, V28, P1456, DOI 10.1111/jdv.12314; Fostini AC, 2013, J DERMATOL TREAT, V24, P458, DOI 10.3109/09546634.2013.814759; Hernandez RG, 2006, PEDIATRICS, V118, pE189, DOI 10.1542/peds.2005-2550; Howard R, 1996, PEDIATR DERMATOL, V13, P246, DOI 10.1111/j.1525-1470.1996.tb01212.x; JORIZZO JL, 1981, J AM ACAD DERMATOL, V4, P723, DOI 10.1016/S0190-9622(81)80205-8; Kim DH, 2012, J KOREAN MED SCI, V27, P1327, DOI 10.3346/jkms.2012.27.11.1327; PucheuHaston CM, 1996, AM J VET RES, V57, P1000; Salek MS, 2013, BRIT J DERMATOL, V169, P734, DOI 10.1111/bjd.12437; Wahlgren C F, 1991, Acta Derm Venereol Suppl (Stockh), V165, P1	9	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					797	799		10.1016/j.jaci.2017.07.049	http://dx.doi.org/10.1016/j.jaci.2017.07.049			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28943471				2022-12-18	WOS:000424410800043
J	Matsui, S; Okazawa, S; Tokui, K; Kambara, K; Imanishi, S; Taka, C; Yamada, T; Inomata, M; Miwa, T; Hayashi, R				Matsui, Shoko; Okazawa, Seisuke; Tokui, Kohtaro; Kambara, Kenta; Imanishi, Shingo; Taka, Chihiro; Yamada, Tohru; Inomata, Minehiko; Miwa, Toshiro; Hayashi, Ryuji			Allergy in IgG4-related disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Matsui, Shoko; Okazawa, Seisuke; Tokui, Kohtaro; Kambara, Kenta; Imanishi, Shingo; Taka, Chihiro; Yamada, Tohru; Inomata, Minehiko; Miwa, Toshiro; Hayashi, Ryuji] Univ Toyama, Toyama, Japan	University of Toyama			Inomata, Minehiko/ABD-9397-2020						0	3	3	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		859	AB271	AB271		10.1016/j.jaci.2017.12.864	http://dx.doi.org/10.1016/j.jaci.2017.12.864			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700856
J	Miyashita, L; Grigg, J				Miyashita, Lisa; Grigg, Jonathan			Effect of the iQOS electronic cigarette device on susceptibility to S. pneumoniae infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Miyashita, Lisa; Grigg, Jonathan] Queen Mary Univ London, London, England	University of London; Queen Mary University London									0	3	3	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		88	AB28	AB28		10.1016/j.jaci.2017.12.090	http://dx.doi.org/10.1016/j.jaci.2017.12.090			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700088
J	Pandey, R; Kapur, R				Pandey, Ruchi; Kapur, Reuben			Kinase inhibitors in clinical practice: An expanding world	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Kinase inhibitors; immune disorders; phosphoinositide 3-kinase; IPI-549	B-CELLS; PI3K-GAMMA; THERAPY		[Pandey, Ruchi; Kapur, Reuben] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Pandey, Ruchi; Kapur, Reuben] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Kapur, Reuben] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Kapur, Reuben] Indiana Univ Sch Med, Dept Mol Biol & Biochem, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Kapur, R (corresponding author), Indiana Univ Sch Med, 1044 W Walnut St,R4-168, Indianapolis, IN 46202 USA.	rkapur@iupui.edu			National Institutes of Health [T32DK-07519]; Riley Children's Foundation;  [R01HL077177];  [R01HL081111];  [R01CA173852];  [R01CA134777]; NATIONAL CANCER INSTITUTE [R01CA134777, R01CA173852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177, R01HL081111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R.P. is funded by National Institutes of Health grant T32DK-07519, and research in R.K.'s laboratory is supported by grants R01HL077177, R01HL081111, R01CA173852, and R01CA134777 and Riley Children's Foundation.	Arend KC, 2017, MOL CELL PROTEOMICS, V16, pS263, DOI 10.1074/mcp.M116.065375; Bower H, 2016, J CLIN ONCOL, V34, P2851, DOI 10.1200/JCO.2015.66.2866; Compagno M, 2017, NATURE, V542, P489, DOI 10.1038/nature21406; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Hekim C, 2017, CANCER IMMUNOL RES, V5, P157, DOI 10.1158/2326-6066.CIR-16-0061-T; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Maffei R, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0157-x; Sogi MK, 2017, ACS INFECT DIS	9	3	3	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					522	524		10.1016/j.jaci.2017.07.016	http://dx.doi.org/10.1016/j.jaci.2017.07.016			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28801197	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000424410800007
J	Patel, J; Ayars, AG; Rampur, L; Bronson, S; Altman, MC				Patel, Jay; Ayars, Andrew G.; Rampur, Lahari; Bronson, Stephen; Altman, Matthew C.			Combination anti-IgE and anti-IL5 therapies in patients with severe persistent asthma and allergic bronchopulmonary aspergillosis (ABPA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Patel, Jay; Ayars, Andrew G.; Rampur, Lahari; Bronson, Stephen; Altman, Matthew C.] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle									0	3	3	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		736	AB234	AB234		10.1016/j.jaci.2017.12.741	http://dx.doi.org/10.1016/j.jaci.2017.12.741			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700735
J	Pereira-Santos, M; Pereira, LLB; de Oliveira, DS				Pereira-Santos, Marcos; Bispo Pereira, Lucas Lue; de Oliveira, Denise Santana			Obesity, asthma, and vitamin D deficiency in pregnancy: Cause or consequence?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Pereira-Santos, Marcos; Bispo Pereira, Lucas Lue; de Oliveira, Denise Santana] Univ Fed Oeste Bahia, Ctr Biol Sci & Hlth, Barreiras, BA, Brazil; [Bispo Pereira, Lucas Lue; de Oliveira, Denise Santana] Univ Fed Oeste Bahia, Ctr Biol Sci & Hlth, Med Course, Barreiras, BA, Brazil	Universidade Federal do Oeste da Bahia; Universidade Federal do Oeste da Bahia	Pereira-Santos, M (corresponding author), Univ Fed Oeste Bahia, Ctr Biol Sci & Hlth, Barreiras, BA, Brazil.	pereira-santosm@bol.com.br	Pereira, Marcos/AAH-6051-2019	Pereira, Marcos/0000-0003-3766-2502; Lue, Lucas/0000-0002-8110-0518				Mallard SR, 2016, AM J CLIN NUTR, V104, P1151, DOI 10.3945/ajcn.116.136879; Mirzakhani H, 2017, J ALLERGY CLIN IMMUN, V140, P1453, DOI 10.1016/j.jaci.2017.03.053; Pannu PK, 2016, NUTR RES, V36, P201, DOI 10.1016/j.nutres.2015.11.013; Pereira-Santos M, 2016, OBES REV, V17, P484, DOI 10.1111/obr.12393; Vo P, 2015, EXPERT REV RESP MED, V9, P309, DOI 10.1586/17476348.2015.1042457	5	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					828	829		10.1016/j.jaci.2017.08.036	http://dx.doi.org/10.1016/j.jaci.2017.08.036			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	29169706	Bronze			2022-12-18	WOS:000424410800054
J	Sirohi, K; Verma, M; Michalec, L; Sripada, A; Rollins, D; Good, J; Martin, RJ; Gorska, MM; Alam, R				Sirohi, Kapil; Verma, Mukesh; Michalec, Lidia; Sripada, Anand; Rollins, Donald; Good, James; Martin, Richard J.; Gorska, Magdalena M.; Alam, Rafeul			Identification of MEK2 and CBX7 as Top Steroid Resistant Genes in Airway ILC2s and Lymphocytes from Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Sirohi, Kapil; Verma, Mukesh; Michalec, Lidia; Sripada, Anand; Rollins, Donald; Good, James; Martin, Richard J.; Gorska, Magdalena M.; Alam, Rafeul] Natl Jewish Hlth, 1400 Jackson St, Denver, CO USA; [Michalec, Lidia] Univ Colorado Denver, Denver, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver			Sirohi, Kapil/N-6676-2019; verma, mukesh/AAB-9330-2020; Sirohi, Kapil/GVT-2867-2022	Sirohi, Kapil/0000-0001-5039-2848; Sirohi, Kapil/0000-0001-5039-2848					0	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		2	AB1	AB1		10.1016/j.jaci.2017.12.003	http://dx.doi.org/10.1016/j.jaci.2017.12.003			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX					2022-12-18	WOS:000429306700003
J	Ta, LDH; Chan, JCY; Huang, CH; Yap, GC; Shek, LPC; Goh, A; Van Bever, HPS; Teoh, OH; Soh, JY; Thomas, B; Ramamurthy, MB; Goh, D; Lay, C; Soh, SE; Yap, F; Tan, KH; Chong, YS; Godfrey, KBM; Gluckman, PD; Chan, ECY; Lee, BW				Ta, Le Duc Huy; Chan, James Chun Yip; Huang, Chiung-Hui; Yap, Gaik Chin; Shek, Lynette Pei-Chi; Goh, Anne; Van Bever, Hugo P. S.; Teoh, Oon Hoe; Soh, Jian Yi; Thomas, Biju; Ramamurthy, Mahesh Babu; Goh, Daniel; Lay, Christophe; Soh, Shu E.; Yap, Fabian; Tan, Kok Hian; Chong, Yap-Seng; Godfrey, Keith B. M.; Gluckman, Peter D.; Chan, Eric Chun Yong; Lee, Bee Wah			Comparative Analysis of Fecal Short Chain Fatty Acids Profiles in Atopic Dermatitis And Healthy Infants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Ta, Le Duc Huy; Huang, Chiung-Hui; Yap, Gaik Chin; Shek, Lynette Pei-Chi; Van Bever, Hugo P. S.; Soh, Jian Yi; Ramamurthy, Mahesh Babu; Goh, Daniel; Lay, Christophe; Soh, Shu E.; Lee, Bee Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Chan, James Chun Yip; Chan, Eric Chun Yong] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore, Singapore; [Goh, Anne; Teoh, Oon Hoe; Thomas, Biju; Yap, Fabian; Tan, Kok Hian] KK Childrens & Womens Hosp, Dept Paediat Allergy & Resp, Singapore, Singapore; [Lay, Christophe] Danone Res Ctr Specialised Nutr, Singapore, Singapore; [Soh, Shu E.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Chong, Yap-Seng] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore, Singapore; [Chong, Yap-Seng; Gluckman, Peter D.] Agcy Sci Technol & Res Singapore, Singapore Inst Clin Sci, Singapore, Singapore; [Godfrey, Keith B. M.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith B. M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith B. M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; Danone Nutricia; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust			Chan, James Chun Yip/GXZ-8733-2022; Chan, Eric Chun Yong/E-7101-2013; Tan, Kok Hian/AFS-6514-2022						0	3	3	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		414	AB131	AB131						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX					2022-12-18	WOS:000429306700413
J	Tsoi, LC; Yang, JJ; Liang, Y; Sarkar, MK; Xing, XY; Beamer, MA; Aphale, A; Raja, K; Kozlow, JH; Getsios, S; Voorhees, JJ; Kahlenberg, JM; Elder, JT; Gudjonsson, JE				Tsoi, Lam C.; Yang, Jingjing; Liang, Yun; Sarkar, Mrinal K.; Xing, Xianying; Beamer, Maria A.; Aphale, Abhishek; Raja, Kalpana; Kozlow, Jeffrey H.; Getsios, Spiro; Voorhees, John J.; Kahlenberg, J. Michelle; Elder, James T.; Gudjonsson, Johann E.			Transcriptional determinants of individualized inflammatory responses at anatomically separate sites	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GENE-EXPRESSION; CELLS		[Tsoi, Lam C.; Liang, Yun; Sarkar, Mrinal K.; Xing, Xianying; Beamer, Maria A.; Aphale, Abhishek; Raja, Kalpana; Voorhees, John J.; Elder, James T.; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.; Yang, Jingjing] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Kozlow, Jeffrey H.] Univ Michigan, Dept Plast Surg, Ann Arbor, MI 48109 USA; [Getsios, Spiro] GlaxoSmithKline, Discovery & Preclin Dev, Dermatol Therapy Area Unit, Collegeville, PA USA; [Kahlenberg, J. Michelle] Univ Michigan, Sch Med, Dept Internal Med, Div Rheumatol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; GlaxoSmithKline; University of Michigan System; University of Michigan	Gudjonsson, JE (corresponding author), Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA.	johanng@med.umich.edu	Yang, Jingjing/X-5013-2019; Voorhees, John/AAM-9966-2020	Yang, Jingjing/0000-0002-4191-4138; Voorhees, John/0000-0003-1856-785X; Tsoi, Lam Cheung/0000-0003-1627-5722; Sarkar, Mrinal/0000-0001-8505-4259	University of Michigan Babcock Endowment Fund; National Institutes of Health (NIH) [K08-AR060802, R01-AR069071, R01-AR042742, R01-AR054966, R01-AR050511, R01-AR062382, R01-AR065183, K08AR063668, R01-AR062110]; A. Alfred Taubman Medical Research Institute Kenneth and Frances Eisenberg Emerging Scholar Award; Doris Duke Charitable Foundation [2013106]; Skin and Tissue Engineering Core of the Northwestern University Skin Disease Research Center (SDR) - NIH [P30-AR057216-01]; Dermatology Foundation; Arthritis National Research Foundation; National Psoriasis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042742, R01AR063611, R01AR062110, T32AR007197, R01AR054966, R01AR069071, K08AR060802, K08AR063668, P30AR057216, R01AR050511, R01AR065183] Funding Source: NIH RePORTER	University of Michigan Babcock Endowment Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. Alfred Taubman Medical Research Institute Kenneth and Frances Eisenberg Emerging Scholar Award; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Skin and Tissue Engineering Core of the Northwestern University Skin Disease Research Center (SDR) - NIH; Dermatology Foundation; Arthritis National Research Foundation(National Research Foundation of Korea); National Psoriasis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was in part supported by the University of Michigan Babcock Endowment Fund (L.C.T., J.J.V., and J.E.G.), the National Institutes of Health (NIH) (award nos. K08-AR060802 and R01-AR069071 to J.E.G.; R01-AR042742, R01-AR054966, R01-AR050511, R01-AR062382, and R01-AR065183 to J.T.E.; K08AR063668 to J.M.K.; and R01-AR062110 to S.G.), the A. Alfred Taubman Medical Research Institute Kenneth and Frances Eisenberg Emerging Scholar Award (J.E.G.), the Doris Duke Charitable Foundation (grant no. 2013106 to J.E.G), the Skin and Tissue Engineering Core of the Northwestern University Skin Disease Research Center (SDRC), funded by the NIH (grant no. P30-AR057216-01. to S.G.), the Dermatology Foundation (L.C.T.), the Arthritis National Research Foundation (L.C.T.), and the National Psoriasis Foundation (L.C.T.).	Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Kornienko AE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0873-8; Lamagna C, 2013, P NATL ACAD SCI USA, V110, pE3311, DOI 10.1073/pnas.1300617110; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Nishikawa R, 2016, J DERMATOL, V43, P1273, DOI 10.1111/1346-8138.13412; SKOV PS, 1984, AGENTS ACTIONS, V14, P414, DOI 10.1007/BF01973840; Tsoi LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15382; Tsoi LC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0570-4; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	11	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					805	+		10.1016/j.jaci.2017.07.054	http://dx.doi.org/10.1016/j.jaci.2017.07.054			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	29031600	Green Accepted, Bronze			2022-12-18	WOS:000424410800046
